Citrus Sinensis ID: 018786
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 350 | 2.2.26 [Sep-21-2011] | |||||||
| Q42479 | 529 | Calcium-dependent protein | yes | no | 0.768 | 0.508 | 0.821 | 1e-135 | |
| Q9FMP5 | 528 | Calcium-dependent protein | no | no | 0.805 | 0.534 | 0.715 | 1e-126 | |
| Q3E9C0 | 523 | Calcium-dependent protein | no | no | 0.808 | 0.541 | 0.708 | 1e-124 | |
| Q38868 | 541 | Calcium-dependent protein | no | no | 0.911 | 0.589 | 0.579 | 1e-115 | |
| Q9C6P3 | 521 | Calcium-dependent protein | no | no | 0.814 | 0.547 | 0.677 | 1e-115 | |
| P53683 | 533 | Calcium-dependent protein | no | no | 0.76 | 0.499 | 0.691 | 1e-114 | |
| P49101 | 513 | Calcium-dependent protein | N/A | no | 0.822 | 0.561 | 0.63 | 1e-112 | |
| P28582 | 532 | Calcium-dependent protein | N/A | no | 0.76 | 0.5 | 0.676 | 1e-112 | |
| Q9ZSA2 | 531 | Calcium-dependent protein | no | no | 0.797 | 0.525 | 0.654 | 1e-110 | |
| Q8RWL2 | 534 | Calcium-dependent protein | no | no | 0.791 | 0.518 | 0.642 | 1e-109 |
| >sp|Q42479|CDPK3_ARATH Calcium-dependent protein kinase 3 OS=Arabidopsis thaliana GN=CPK3 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 480 bits (1235), Expect = e-135, Method: Compositional matrix adjust.
Identities = 221/269 (82%), Positives = 247/269 (91%)
Query: 55 GRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDV 114
GR+LG+PME+VR TY FGRELGRGQFGVTYLVTHK+TKQQ ACKSI +R+L+++DD+EDV
Sbjct: 64 GRILGRPMEEVRRTYEFGRELGRGQFGVTYLVTHKETKQQVACKSIPTRRLVHKDDIEDV 123
Query: 115 RREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLC 174
RREVQIMHHL+GHRNIV+LKGAYEDRHSVNLIM+LC GGELFDRII+KG YSERAAA+LC
Sbjct: 124 RREVQIMHHLSGHRNIVDLKGAYEDRHSVNLIMELCEGGELFDRIISKGLYSERAAADLC 183
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA 234
RQMV VVH CHSMGVMHRDLKPENFLF S E+SPLKATDFGLSVFFKPGD FKDLVGSA
Sbjct: 184 RQMVMVVHSCHSMGVMHRDLKPENFLFLSKDENSPLKATDFGLSVFFKPGDKFKDLVGSA 243
Query: 235 YYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294
YYVAPEVL+RNYG EADIWSAGVILYILLSGVPPFWGE E IFDAIL+G +DFS+DPWP
Sbjct: 244 YYVAPEVLKRNYGPEADIWSAGVILYILLSGVPPFWGENETGIFDAILQGQLDFSADPWP 303
Query: 295 NISSSAKDIVKKMLHADPKERLSAAEVLS 323
+S AKD+V+KML DPK+RL+AAEVL+
Sbjct: 304 ALSDGAKDLVRKMLKYDPKDRLTAAEVLN 332
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Functions in abscisic acid (ABA) regulation of guard cell S-type anion-and Ca(2+)-permeable channels and stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 450 bits (1158), Expect = e-126, Method: Compositional matrix adjust.
Identities = 206/288 (71%), Positives = 246/288 (85%), Gaps = 6/288 (2%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
PP PP + +G VLG+PMEDV+ +Y G+ELGRGQFGVT+L T K T QF
Sbjct: 46 PPSPP------PATKQGPIGPVLGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQF 99
Query: 96 ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL 155
ACK+I+ RKL+N++D+EDVRREVQIMHHLTG NIVELKGAYED+HSV+L+M+LCAGGEL
Sbjct: 100 ACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGEL 159
Query: 156 FDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215
FDRIIAKGHYSERAAA+L R +V +VH CHSMGV+HRDLKPENFL + E+SPLKATDF
Sbjct: 160 FDRIIAKGHYSERAAASLLRTIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDF 219
Query: 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQ 275
GLSVF+KPG+VFKD+VGSAYY+APEVL+R YG EADIWS GV+LYILL GVPPFW E+E
Sbjct: 220 GLSVFYKPGEVFKDIVGSAYYIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESEN 279
Query: 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
IF+AILRGH+DFSSDPWP+IS AKD+VKKML++DPK+RL+AA+VL+
Sbjct: 280 GIFNAILRGHVDFSSDPWPSISPQAKDLVKKMLNSDPKQRLTAAQVLN 327
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E9C0|CDPKY_ARATH Calcium-dependent protein kinase 34 OS=Arabidopsis thaliana GN=CPK34 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 445 bits (1145), Expect = e-124, Method: Compositional matrix adjust.
Identities = 204/288 (70%), Positives = 245/288 (85%), Gaps = 5/288 (1%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
PP P P++ +G VLG+PMEDV+++Y G+ELGRGQFGVT+L T K T QF
Sbjct: 40 PPASPPPATK-----QGPIGPVLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQF 94
Query: 96 ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL 155
ACK+I+ RKL+N++D+EDVRREVQIMHHLTG NIVELKGAYED+HSV+L+M+LCAGGEL
Sbjct: 95 ACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGEL 154
Query: 156 FDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215
FDRIIAKGHYSERAAA+L R +V ++H CHSMGV+HRDLKPENFL S E+SPLKATDF
Sbjct: 155 FDRIIAKGHYSERAAASLLRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDF 214
Query: 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQ 275
GLSVF+KPG+VFKD+VGSAYY+APEVLRR YG EADIWS GV+LYILL GVPPFW E+E
Sbjct: 215 GLSVFYKPGEVFKDIVGSAYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESEN 274
Query: 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
IF+AIL G +DFSSDPWP IS AKD+V+KML++DPK+RL+AA+VL+
Sbjct: 275 GIFNAILSGQVDFSSDPWPVISPQAKDLVRKMLNSDPKQRLTAAQVLN 322
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q38868|CDPK9_ARATH Calcium-dependent protein kinase 9 OS=Arabidopsis thaliana GN=CPK9 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 416 bits (1070), Expect = e-115, Method: Compositional matrix adjust.
Identities = 201/347 (57%), Positives = 244/347 (70%), Gaps = 28/347 (8%)
Query: 1 MGNC------------NGLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSA-- 46
MGNC NG + ++ T DP P + P P P +S
Sbjct: 1 MGNCFAKNHGLMKPQQNGNTTRSVEVGVTNQDP---PSYTPQARTTQQPEKPGSVNSQPP 57
Query: 47 -----------TSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
+ T++ +L EDV+ Y G+ELGRGQFGVTYL T T +++
Sbjct: 58 PWRAAAAAPGLSPKTTTKSNSILENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKY 117
Query: 96 ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL 155
ACKSIS +KL+ + D +D+RRE+QIM HL+G NIVE KGAYED +VNL+M+LCAGGEL
Sbjct: 118 ACKSISKKKLVTKADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGEL 177
Query: 156 FDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215
FDRIIAKGHY+ERAAA++CRQ+V VV CH MGV+HRDLKPENFL SS E + +KATDF
Sbjct: 178 FDRIIAKGHYTERAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDF 237
Query: 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQ 275
GLSVF + G V++D+VGSAYYVAPEVLRR YG E DIWSAG+ILYILLSGVPPFW ETE+
Sbjct: 238 GLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEK 297
Query: 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
IFDAIL GHIDF S PWP+ISSSAKD+V++ML ADPK R+SAA+VL
Sbjct: 298 GIFDAILEGHIDFESQPWPSISSSAKDLVRRMLTADPKRRISAADVL 344
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C6P3|CDPKX_ARATH Calcium-dependent protein kinase 33 OS=Arabidopsis thaliana GN=CPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 415 bits (1066), Expect = e-115, Method: Compositional matrix adjust.
Identities = 193/285 (67%), Positives = 227/285 (79%)
Query: 38 GPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFAC 97
G +P A S +L KP EDV+ Y +ELGRGQFGVTYL T K T ++FAC
Sbjct: 42 GTNQPPPWRNPAKHSGAAAILEKPYEDVKLFYTLSKELGRGQFGVTYLCTEKSTGKRFAC 101
Query: 98 KSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD 157
KSIS +KL+ + D ED+RRE+QIM HL+G NIVE KGAYED +VNL+M+LCAGGELFD
Sbjct: 102 KSISKKKLVTKGDKEDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFD 161
Query: 158 RIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217
RI+AKGHYSERAAA++CRQ+V VV+ CH MGVMHRDLKPENFL SS E + +KATDFGL
Sbjct: 162 RILAKGHYSERAAASVCRQIVNVVNICHFMGVMHRDLKPENFLLSSKDEKALIKATDFGL 221
Query: 218 SVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
SVF + G V+KD+VGSAYYVAPEVL+R YG E DIWSAG+ILYILLSGVPPFW ETE+ I
Sbjct: 222 SVFIEEGRVYKDIVGSAYYVAPEVLKRRYGKEIDIWSAGIILYILLSGVPPFWAETEKGI 281
Query: 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
FDAIL G IDF S PWP+IS+SAKD+V++ML DPK R+SAAEVL
Sbjct: 282 FDAILEGEIDFESQPWPSISNSAKDLVRRMLTQDPKRRISAAEVL 326
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53683|CDPK2_ORYSJ Calcium-dependent protein kinase isoform 2 OS=Oryza sativa subsp. japonica GN=CPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 413 bits (1061), Expect = e-114, Method: Compositional matrix adjust.
Identities = 184/266 (69%), Positives = 228/266 (85%)
Query: 57 VLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRR 116
+LGKP +DVR+ Y G+ELGRGQFGVTYL T + +Q+ACKSIS RKL+++ D ED+RR
Sbjct: 73 ILGKPYDDVRSVYSLGKELGRGQFGVTYLCTEIASGKQYACKSISKRKLVSKADKEDIRR 132
Query: 117 EVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQ 176
E+QIM HL+G +NIVE +GAYED+ +V+++M+LCAGGELFDRIIAKGHYSERAAA +CR
Sbjct: 133 EIQIMQHLSGQQNIVEFRGAYEDKSNVHVVMELCAGGELFDRIIAKGHYSERAAATICRA 192
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYY 236
+V VV+ CH MGVMHRDLKPENFL ++ E++ LKATDFGLSVF + G +++D+VGSAYY
Sbjct: 193 VVNVVNICHFMGVMHRDLKPENFLLATKEENAMLKATDFGLSVFIEEGKMYRDIVGSAYY 252
Query: 237 VAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296
VAPEVLRRNYG E D+WSAGVILYILLSGVPPFW ETE+ IFDAIL+G IDF S PWP+I
Sbjct: 253 VAPEVLRRNYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILQGEIDFESQPWPSI 312
Query: 297 SSSAKDIVKKMLHADPKERLSAAEVL 322
S SAKD+V+KML DPK+R+++A+VL
Sbjct: 313 SESAKDLVRKMLTQDPKKRITSAQVL 338
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P49101|CDPK2_MAIZE Calcium-dependent protein kinase 2 OS=Zea mays GN=CPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 405 bits (1041), Expect = e-112, Method: Compositional matrix adjust.
Identities = 189/300 (63%), Positives = 233/300 (77%), Gaps = 12/300 (4%)
Query: 35 DPPGPPRPSSSATSATSSS------------VGRVLGKPMEDVRNTYIFGRELGRGQFGV 82
+PP SAT+SS +LGK EDVR+ Y FG+ELGRGQFGV
Sbjct: 19 NPPQQAAEVRYTPSATNSSAVPPVAVPPKPTADTILGKQYEDVRSVYSFGKELGRGQFGV 78
Query: 83 TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142
TYL T + +Q+ACKSIS RKL+++ D ED+RRE+QIM HL+G NIVE +GAYED+ +
Sbjct: 79 TYLCTEIASGRQYACKSISKRKLVSKADREDIRREIQIMQHLSGQPNIVEFRGAYEDKSN 138
Query: 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFS 202
V+++M+LCAGGELFDRIIAKGHY+ERAAA +CR +V VV+ CH MGVMHRDLKPENFL +
Sbjct: 139 VHVVMELCAGGELFDRIIAKGHYTERAAATICRAVVNVVNICHFMGVMHRDLKPENFLLA 198
Query: 203 SSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYIL 262
+ E++ LKATDFGLSVF + G +++D+VGSAYYVAPEVLRR+YG E D+WSAGVILYIL
Sbjct: 199 TMEENAMLKATDFGLSVFIEEGKMYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYIL 258
Query: 263 LSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
LSGVPPFW E E+ IFDAIL IDF S PWP+IS SAKD+V+KML DPK+RL++A+VL
Sbjct: 259 LSGVPPFWAEIEKGIFDAILHEEIDFESQPWPSISESAKDLVRKMLTRDPKKRLTSAQVL 318
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P28582|CDPK_DAUCA Calcium-dependent protein kinase OS=Daucus carota PE=2 SV=2 | Back alignment and function description |
|---|
Score = 405 bits (1040), Expect = e-112, Method: Compositional matrix adjust.
Identities = 180/266 (67%), Positives = 221/266 (83%)
Query: 57 VLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRR 116
+LGKP ED+R Y G+ELGRGQFG Y T + Q +ACKSI RKL++++D ED++R
Sbjct: 69 ILGKPFEDIRGKYTLGKELGRGQFGCVYQCTENSSGQLYACKSILKRKLVSKNDKEDIKR 128
Query: 117 EVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQ 176
E+QI+ HL+G NIVE KG +EDR SV+L+M+LCAGGELFDRIIA+GHYSERAAA +CRQ
Sbjct: 129 EIQILQHLSGQPNIVEFKGVFEDRQSVHLVMELCAGGELFDRIIAQGHYSERAAATICRQ 188
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYY 236
+V VVH CH MGVMHRDLKPENFL SS +D+ LKATDFGLSVF + G V++++VGSAYY
Sbjct: 189 IVNVVHVCHFMGVMHRDLKPENFLLSSKDKDAMLKATDFGLSVFIEEGKVYRNIVGSAYY 248
Query: 237 VAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296
VAPEVLRR+YG E DIWSAGVILYILLSGVPPFW E E+ IFDAIL G IDF S+PWP++
Sbjct: 249 VAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDAILEGVIDFESEPWPSV 308
Query: 297 SSSAKDIVKKMLHADPKERLSAAEVL 322
S+SAKD+V+KML DP+ R+++A+VL
Sbjct: 309 SNSAKDLVRKMLTQDPRRRITSAQVL 334
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZSA2|CDPKL_ARATH Calcium-dependent protein kinase 21 OS=Arabidopsis thaliana GN=CPK21 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 399 bits (1025), Expect = e-110, Method: Compositional matrix adjust.
Identities = 184/281 (65%), Positives = 224/281 (79%), Gaps = 2/281 (0%)
Query: 42 PSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSIS 101
PSS+ S +LGKP ED+R Y G+ELGRGQFG+TY+ T +ACKSI
Sbjct: 55 PSSNPVSVRDPDT--ILGKPFEDIRKFYSLGKELGRGQFGITYMCKEIGTGNTYACKSIL 112
Query: 102 SRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA 161
RKLI++ D EDV+RE+QIM +L+G NIVE+KGAYEDR S++L+M+LCAGGELFDRIIA
Sbjct: 113 KRKLISKQDKEDVKREIQIMQYLSGQPNIVEIKGAYEDRQSIHLVMELCAGGELFDRIIA 172
Query: 162 KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221
+GHYSERAAA + R +V VV CH MGV+HRDLKPENFL SS E++ LKATDFGLSVF
Sbjct: 173 QGHYSERAAAGIIRSIVNVVQICHFMGVVHRDLKPENFLLSSKEENAMLKATDFGLSVFI 232
Query: 222 KPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI 281
+ G V++D+VGSAYYVAPEVLRR+YG E DIWSAGVILYILLSGVPPFW E E+ IFD +
Sbjct: 233 EEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDEV 292
Query: 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
++G IDF S+PWP+IS SAKD+V+KML DPK R++AA+VL
Sbjct: 293 IKGEIDFVSEPWPSISESAKDLVRKMLTKDPKRRITAAQVL 333
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWL2|CDPKT_ARATH Calcium-dependent protein kinase 29 OS=Arabidopsis thaliana GN=CPK29 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 396 bits (1018), Expect = e-109, Method: Compositional matrix adjust.
Identities = 178/277 (64%), Positives = 224/277 (80%)
Query: 47 TSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI 106
++++ S +G +L +PM D+ Y +ELGRGQFG+TY T K +++ACKSIS RKLI
Sbjct: 63 STSSGSQIGPILNRPMIDLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRKLI 122
Query: 107 NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYS 166
R D+EDVRREV I+ HLTG NIVE +GAYED+ +++L+M+LC+GGELFDRII KG YS
Sbjct: 123 RRKDIEDVRREVMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGSYS 182
Query: 167 ERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226
E+ AAN+ RQ+V VVH CH MGV+HRDLKPENFL S+ EDSP+KATDFGLSVF + G V
Sbjct: 183 EKEAANIFRQIVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEGKV 242
Query: 227 FKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI 286
++D+VGSAYYVAPEVL RNYG E D+WSAGV+LYILLSGVPPFWGETE++IF+AIL G +
Sbjct: 243 YRDIVGSAYYVAPEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEGKL 302
Query: 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
D + PWP IS SAKD+++KML DPK+R++AAE L
Sbjct: 303 DLETSPWPTISESAKDLIRKMLIRDPKKRITAAEALE 339
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 350 | ||||||
| 225426094 | 528 | PREDICTED: calcium-dependent protein kin | 0.92 | 0.609 | 0.795 | 1e-151 | |
| 224053829 | 515 | calcium dependent protein kinase 3 [Popu | 0.908 | 0.617 | 0.793 | 1e-150 | |
| 224075036 | 520 | calcium dependent protein kinase 22 [Pop | 0.908 | 0.611 | 0.808 | 1e-149 | |
| 356497285 | 505 | PREDICTED: calcium-dependent protein kin | 0.88 | 0.609 | 0.791 | 1e-147 | |
| 147814808 | 482 | hypothetical protein VITISV_032639 [Viti | 0.768 | 0.558 | 0.895 | 1e-146 | |
| 255537639 | 528 | calcium-dependent protein kinase, putati | 0.814 | 0.539 | 0.841 | 1e-145 | |
| 356539541 | 505 | PREDICTED: calcium-dependent protein kin | 0.882 | 0.611 | 0.783 | 1e-144 | |
| 356513317 | 518 | PREDICTED: calcium-dependent protein kin | 0.891 | 0.602 | 0.763 | 1e-144 | |
| 114804153 | 514 | CDPK1 [Ipomoea nil] gi|397746248|gb|AFO6 | 0.882 | 0.601 | 0.746 | 1e-142 | |
| 356513319 | 532 | PREDICTED: calcium-dependent protein kin | 0.891 | 0.586 | 0.736 | 1e-141 |
| >gi|225426094|ref|XP_002272270.1| PREDICTED: calcium-dependent protein kinase 3 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1392), Expect = e-151, Method: Compositional matrix adjust.
Identities = 265/333 (79%), Positives = 288/333 (86%), Gaps = 11/333 (3%)
Query: 1 MGNCNGLPSSQTQLHSTTADPDTGP-----GHHPNGLKIDPPGPPRPSSSATSATS---- 51
MGNCNGLPS TQ A D G H NGL + PP P P T+A
Sbjct: 1 MGNCNGLPSGDTQFQ-INAGRDGGVRPSSHAHSSNGLNVRPPSPSPPPPPRTAAPVVHRP 59
Query: 52 -SSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD 110
+ GRVLG+PMEDVR TYIFGRELGRGQFGVTYLVTHK+TK+QFACKSI++RKL+NRDD
Sbjct: 60 LAGNGRVLGRPMEDVRQTYIFGRELGRGQFGVTYLVTHKETKEQFACKSIATRKLVNRDD 119
Query: 111 VEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAA 170
+EDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL+M+LCAGGELFDRIIAKGHYSERAA
Sbjct: 120 IEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLVMELCAGGELFDRIIAKGHYSERAA 179
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230
A LCRQ+VTVVH CH+MGVMHRDLKPENFLF S+AEDSPLKATDFGLSVFFKPGDVFKDL
Sbjct: 180 AALCRQIVTVVHNCHTMGVMHRDLKPENFLFLSTAEDSPLKATDFGLSVFFKPGDVFKDL 239
Query: 231 VGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS 290
VGSAYYVAPEVLRR+YGAEADIWSAGVIL+ILLSGVPPFWGE EQSIFD ILRGHIDFSS
Sbjct: 240 VGSAYYVAPEVLRRSYGAEADIWSAGVILFILLSGVPPFWGENEQSIFDTILRGHIDFSS 299
Query: 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
DPWP+IS+SAKD+VKKML ADPKERL+A +VL+
Sbjct: 300 DPWPSISNSAKDLVKKMLRADPKERLTAIDVLN 332
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053829|ref|XP_002298000.1| calcium dependent protein kinase 3 [Populus trichocarpa] gi|222845258|gb|EEE82805.1| calcium dependent protein kinase 3 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 536 bits (1381), Expect = e-150, Method: Compositional matrix adjust.
Identities = 257/324 (79%), Positives = 283/324 (87%), Gaps = 6/324 (1%)
Query: 1 MGNCNGLPSSQTQLHSTTADPDTGPGHHPNGLKIDPP-GPPRPSSSATSATSSSVGRVLG 59
MGNCN L SS + + P + G+K+ PP P P S +S++VGRVLG
Sbjct: 1 MGNCNSLASSSSTTTNHRNPPPSN-----GGIKVLPPNASPPPRSQFLHHSSAAVGRVLG 55
Query: 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ 119
+PMEDVRNTY FGRE+GRGQFGVTYLVTHK+TKQ FACKSI+ RKLINRDD+EDV REVQ
Sbjct: 56 RPMEDVRNTYTFGREVGRGQFGVTYLVTHKETKQHFACKSIAKRKLINRDDIEDVLREVQ 115
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
IMHHLTGHRN+VELKGAYEDRHSVNLIM+LC GGELFDRII KGHYSERAAANLCRQ+VT
Sbjct: 116 IMHHLTGHRNVVELKGAYEDRHSVNLIMELCEGGELFDRIITKGHYSERAAANLCRQIVT 175
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
VVH CH+MGV+HRDLKPENFLF S+ EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP
Sbjct: 176 VVHNCHTMGVIHRDLKPENFLFLSTHEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 235
Query: 240 EVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
EVLRRNYGAE DIWSAGVILYILLSGVPPFWGETEQ+IFD+ILRGHIDFSSDPWP+ISSS
Sbjct: 236 EVLRRNYGAEVDIWSAGVILYILLSGVPPFWGETEQAIFDSILRGHIDFSSDPWPSISSS 295
Query: 300 AKDIVKKMLHADPKERLSAAEVLS 323
AKD+VK+ML ADPKER+SA EVL+
Sbjct: 296 AKDLVKQMLRADPKERISAVEVLN 319
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075036|ref|XP_002304529.1| calcium dependent protein kinase 22 [Populus trichocarpa] gi|222841961|gb|EEE79508.1| calcium dependent protein kinase 22 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1377), Expect = e-149, Method: Compositional matrix adjust.
Identities = 266/329 (80%), Positives = 291/329 (88%), Gaps = 11/329 (3%)
Query: 1 MGNCNGLPSSQTQLHSTTADPDTGPGHHPNG-LKIDPPG---PPRPSSSATSATS--SSV 54
MGNCN LPSS + +TT D P PNG +K+ PP PPR S+ S ++V
Sbjct: 1 MGNCNSLPSSSST--TTTTDHHNTP---PNGVIKVLPPTATPPPRSQHHHHSSASGSTAV 55
Query: 55 GRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDV 114
GRVLG+P EDVRNTYIFGRELGRGQFGVTYLVTHK+TKQ FACKSI+SRKLINRDD+EDV
Sbjct: 56 GRVLGRPREDVRNTYIFGRELGRGQFGVTYLVTHKETKQHFACKSIASRKLINRDDIEDV 115
Query: 115 RREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLC 174
RREVQIMHHLTGHRNIVELKGAYED+HSVNLIM+LC GGELFDRIIAKGHYSERAAANLC
Sbjct: 116 RREVQIMHHLTGHRNIVELKGAYEDQHSVNLIMELCEGGELFDRIIAKGHYSERAAANLC 175
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA 234
RQ+VTVVH CH+MGV+HRDLKPENFLF S+ EDSPLKATDFGLSVFFKPGDVFKDLVGSA
Sbjct: 176 RQIVTVVHNCHTMGVIHRDLKPENFLFLSTHEDSPLKATDFGLSVFFKPGDVFKDLVGSA 235
Query: 235 YYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294
YYVAPEVLRRNYGAE DIWSAGVILYILLSGVPPFWG+TEQ IFD+ILRGHIDFSSDPWP
Sbjct: 236 YYVAPEVLRRNYGAEVDIWSAGVILYILLSGVPPFWGDTEQVIFDSILRGHIDFSSDPWP 295
Query: 295 NISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ISSSAKD+VK+M+ ADPKER+SA EVL+
Sbjct: 296 SISSSAKDLVKQMVRADPKERISAVEVLN 324
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356497285|ref|XP_003517491.1| PREDICTED: calcium-dependent protein kinase 3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 527 bits (1357), Expect = e-147, Method: Compositional matrix adjust.
Identities = 255/322 (79%), Positives = 278/322 (86%), Gaps = 14/322 (4%)
Query: 1 MGNCNGLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGK 60
MGNCN SSQTQ HS D P + NG+ + PP + SVGRVLG+
Sbjct: 1 MGNCNSEASSQTQPHS---DHHPQPRSNSNGITVLPPN-----------SKPSVGRVLGR 46
Query: 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
PMEDVR+TY FGRELGRGQFGVTYLVTHK TKQQFACKSI++ KL++RDD+EDVRREVQI
Sbjct: 47 PMEDVRSTYTFGRELGRGQFGVTYLVTHKHTKQQFACKSIATPKLVHRDDLEDVRREVQI 106
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
MHHLTGHRNIVELKGAYEDRHSVNLIM+LC GGELFDRIIAKGHYSERAAA+LCRQ+VTV
Sbjct: 107 MHHLTGHRNIVELKGAYEDRHSVNLIMELCGGGELFDRIIAKGHYSERAAADLCRQIVTV 166
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 240
VH CH+MGVMHRDLKPENFLF S E+SPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE
Sbjct: 167 VHDCHTMGVMHRDLKPENFLFLSKDENSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 226
Query: 241 VLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
VLRR+YG EADIWSAGVIL+ILLSGVPPFW + EQ IFDAILRGHIDF+SDPWP+ISSSA
Sbjct: 227 VLRRSYGPEADIWSAGVILFILLSGVPPFWSKKEQGIFDAILRGHIDFTSDPWPSISSSA 286
Query: 301 KDIVKKMLHADPKERLSAAEVL 322
KD+VKKML ADPK+RLSA EVL
Sbjct: 287 KDLVKKMLRADPKQRLSAVEVL 308
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147814808|emb|CAN61364.1| hypothetical protein VITISV_032639 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 523 bits (1347), Expect = e-146, Method: Compositional matrix adjust.
Identities = 241/269 (89%), Positives = 261/269 (97%)
Query: 55 GRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDV 114
GRVLG+PMEDVR TYIFGRELGRGQFGVTYLVTHK+TK+QFACKSI++RKL+NRDD+EDV
Sbjct: 18 GRVLGRPMEDVRQTYIFGRELGRGQFGVTYLVTHKETKEQFACKSIATRKLVNRDDIEDV 77
Query: 115 RREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLC 174
RREVQIMHHLTGHRNIVELKGAYEDRHSVNL+M+LCAGGELFDRIIAKGHYSERAAA LC
Sbjct: 78 RREVQIMHHLTGHRNIVELKGAYEDRHSVNLVMELCAGGELFDRIIAKGHYSERAAAALC 137
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA 234
RQ+VTVVH CH+MGVMHRDLKPENFLF S+AEDSPLKATDFGLSVFFKPGDVFKDLVGSA
Sbjct: 138 RQIVTVVHNCHTMGVMHRDLKPENFLFLSTAEDSPLKATDFGLSVFFKPGDVFKDLVGSA 197
Query: 235 YYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294
YYVAPEVLRR+YGAEADIWSAGVIL+ILLSGVPPFWGE EQSIFD ILRGHIDFSSDPWP
Sbjct: 198 YYVAPEVLRRSYGAEADIWSAGVILFILLSGVPPFWGENEQSIFDTILRGHIDFSSDPWP 257
Query: 295 NISSSAKDIVKKMLHADPKERLSAAEVLS 323
+IS+SAKD+VKKML ADPKERL+A +VL+
Sbjct: 258 SISNSAKDLVKKMLRADPKERLTAIDVLN 286
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255537639|ref|XP_002509886.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223549785|gb|EEF51273.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1338), Expect = e-145, Method: Compositional matrix adjust.
Identities = 244/290 (84%), Positives = 266/290 (91%), Gaps = 5/290 (1%)
Query: 34 IDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQ 93
+ P RPS A ++VGRVLG+PMEDVR+ Y FGRELGRGQFGVTYLVTHK+TKQ
Sbjct: 47 LQPTSNNRPS-----AAPAAVGRVLGRPMEDVRSIYAFGRELGRGQFGVTYLVTHKETKQ 101
Query: 94 QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGG 153
QFACKSI++RKLINRDD+EDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL+M+LCAGG
Sbjct: 102 QFACKSIATRKLINRDDIEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLVMELCAGG 161
Query: 154 ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213
ELFDRIIAKGHYSERAAANLCRQ+VTVVH CHSMGV+HRDLKPENFLF S+ E+SPLKAT
Sbjct: 162 ELFDRIIAKGHYSERAAANLCRQIVTVVHDCHSMGVIHRDLKPENFLFLSTDENSPLKAT 221
Query: 214 DFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGET 273
DFGLSVFFKPGD FKDLVGSAYYVAPEVLRRNYG DIWSAGVILYILLSGVPPFWGET
Sbjct: 222 DFGLSVFFKPGDTFKDLVGSAYYVAPEVLRRNYGPAIDIWSAGVILYILLSGVPPFWGET 281
Query: 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
EQ+IFD +LRGHIDFSSDPWP+ISSSAKD+VKKML AD K+R+SAAEVL+
Sbjct: 282 EQAIFDTVLRGHIDFSSDPWPSISSSAKDLVKKMLTADAKDRISAAEVLN 331
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356539541|ref|XP_003538256.1| PREDICTED: calcium-dependent protein kinase 3-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 517 bits (1332), Expect = e-144, Method: Compositional matrix adjust.
Identities = 253/323 (78%), Positives = 275/323 (85%), Gaps = 14/323 (4%)
Query: 1 MGNCNGLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGK 60
MGNCN PSSQTQ HS NG+ + PP + SVGRVLG+
Sbjct: 1 MGNCNSEPSSQTQPHSDHH---HHHPQPSNGITVLPPN-----------SKPSVGRVLGR 46
Query: 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
PMED R+TY FGRELGRGQFGVTY VTHK TKQQFACKSI++RKL++RDD+EDVRREVQI
Sbjct: 47 PMEDARSTYTFGRELGRGQFGVTYQVTHKHTKQQFACKSIATRKLVHRDDLEDVRREVQI 106
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
MHHLTGHRNIVELKGAYEDRHSVNLIM+LC GGELFDRIIAKGHYSERAAA+LCRQ+VTV
Sbjct: 107 MHHLTGHRNIVELKGAYEDRHSVNLIMELCGGGELFDRIIAKGHYSERAAADLCRQIVTV 166
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 240
VH CH+MGVMHRDLKPENFLF S E+SPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE
Sbjct: 167 VHDCHTMGVMHRDLKPENFLFLSKDENSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 226
Query: 241 VLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
VLRR+YG ADIWSAGVIL+ILLSGVPPFW E EQ IFDAILRGHIDF+SDPWP+ISSSA
Sbjct: 227 VLRRSYGPGADIWSAGVILFILLSGVPPFWSEKEQGIFDAILRGHIDFASDPWPSISSSA 286
Query: 301 KDIVKKMLHADPKERLSAAEVLS 323
KD+VKKML ADPK+RLSA EVL+
Sbjct: 287 KDLVKKMLRADPKQRLSAVEVLN 309
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513317|ref|XP_003525360.1| PREDICTED: calcium-dependent protein kinase 3-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1328), Expect = e-144, Method: Compositional matrix adjust.
Identities = 252/330 (76%), Positives = 281/330 (85%), Gaps = 18/330 (5%)
Query: 1 MGNCN---GLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGP----PRPSSSATSATSSS 53
MGNC+ G P++ + H H NG+ + PP P TS++SSS
Sbjct: 1 MGNCSSGAGAPTTYSDDHP-----------HHNGITVLPPNSNPSPQLPKPPPTSSSSSS 49
Query: 54 VGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED 113
+GRVLG+PMEDVR+ YIFGRELGRGQFGVTYLVTHK TK+QFACKSI++RKL+NRDD++D
Sbjct: 50 LGRVLGRPMEDVRSIYIFGRELGRGQFGVTYLVTHKATKEQFACKSIATRKLVNRDDIDD 109
Query: 114 VRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL 173
+RREVQIMHHLTGHRNIVELKGAYEDRHSVNL+M+LCAGGELFDRII KGHYSERAAAN
Sbjct: 110 IRREVQIMHHLTGHRNIVELKGAYEDRHSVNLVMELCAGGELFDRIITKGHYSERAAANS 169
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
CRQ+VTVVH CHSMGVMHRDLKPENFL + +DSPLKATDFGLSVFFKPGDVF+DLVGS
Sbjct: 170 CRQIVTVVHNCHSMGVMHRDLKPENFLLLNKNDDSPLKATDFGLSVFFKPGDVFRDLVGS 229
Query: 234 AYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293
AYYVAPEVLRR+YG EADIWSAGVILYILLSGVPPFW E EQ IFDAILRGHIDF+SDPW
Sbjct: 230 AYYVAPEVLRRSYGPEADIWSAGVILYILLSGVPPFWAENEQGIFDAILRGHIDFASDPW 289
Query: 294 PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
P+ISSSAKD+VKKML ADPKERLSA EVL+
Sbjct: 290 PSISSSAKDLVKKMLRADPKERLSAVEVLN 319
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|114804153|gb|ABC47163.2| CDPK1 [Ipomoea nil] gi|397746248|gb|AFO63177.1| calcium dependent protein kinase 1 [Ipomoea nil] | Back alignment and taxonomy information |
|---|
Score = 509 bits (1310), Expect = e-142, Method: Compositional matrix adjust.
Identities = 247/331 (74%), Positives = 280/331 (84%), Gaps = 22/331 (6%)
Query: 1 MGNCNGLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATS--------S 52
MG+CN +PSS +T+A G + DPP PP+ + + S
Sbjct: 1 MGSCNSIPSSP--FAATSA-----------GGESDPP-PPKNDITVLPPSQPPPPRPFLS 46
Query: 53 SVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE 112
VGRVLG+PMEDV +TYIFG ELGRGQFGVTYLVTH+ T+++ ACKSI++RKL+++DDV+
Sbjct: 47 GVGRVLGRPMEDVHSTYIFGGELGRGQFGVTYLVTHRKTRERLACKSIATRKLLSKDDVD 106
Query: 113 DVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAAN 172
DVRREVQIMHHLTGHRNIVELKG YEDR+ V+L+M+LCAGGELFDRIIAKGHYSERAAA
Sbjct: 107 DVRREVQIMHHLTGHRNIVELKGTYEDRNHVHLVMELCAGGELFDRIIAKGHYSERAAAG 166
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232
LCRQMVTV+HYCHSMGVMHRDLKPENFLF SS E+SPLKATDFGLSVFFKPGD FKDLVG
Sbjct: 167 LCRQMVTVLHYCHSMGVMHRDLKPENFLFLSSDENSPLKATDFGLSVFFKPGDTFKDLVG 226
Query: 233 SAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292
SAYYVAPEVLRRNYG EADIWSAGVILYILLSGVPPFWGE EQSIFDA+LRGH+DFSSDP
Sbjct: 227 SAYYVAPEVLRRNYGPEADIWSAGVILYILLSGVPPFWGENEQSIFDAVLRGHLDFSSDP 286
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
WP+ISSSAKD+VKKML +DPKERLSA +VL+
Sbjct: 287 WPSISSSAKDLVKKMLRSDPKERLSATDVLN 317
|
Source: Ipomoea nil Species: Ipomoea nil Genus: Ipomoea Family: Convolvulaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513319|ref|XP_003525361.1| PREDICTED: calcium-dependent protein kinase 3-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 506 bits (1304), Expect = e-141, Method: Compositional matrix adjust.
Identities = 252/342 (73%), Positives = 281/342 (82%), Gaps = 30/342 (8%)
Query: 1 MGNCN---GLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGP----PRPSSSATSATSSS 53
MGNC+ G P++ + H H NG+ + PP P TS++SSS
Sbjct: 1 MGNCSSGAGAPTTYSDDHP-----------HHNGITVLPPNSNPSPQLPKPPPTSSSSSS 49
Query: 54 VGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED 113
+GRVLG+PMEDVR+ YIFGRELGRGQFGVTYLVTHK TK+QFACKSI++RKL+NRDD++D
Sbjct: 50 LGRVLGRPMEDVRSIYIFGRELGRGQFGVTYLVTHKATKEQFACKSIATRKLVNRDDIDD 109
Query: 114 VRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL 173
+RREVQIMHHLTGHRNIVELKGAYEDRHSVNL+M+LCAGGELFDRII KGHYSERAAAN
Sbjct: 110 IRREVQIMHHLTGHRNIVELKGAYEDRHSVNLVMELCAGGELFDRIITKGHYSERAAANS 169
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
CRQ+VTVVH CHSMGVMHRDLKPENFL + +DSPLKATDFGLSVFFKPGDVF+DLVGS
Sbjct: 170 CRQIVTVVHNCHSMGVMHRDLKPENFLLLNKNDDSPLKATDFGLSVFFKPGDVFRDLVGS 229
Query: 234 AYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWG------------ETEQSIFDAI 281
AYYVAPEVLRR+YG EADIWSAGVILYILLSGVPPFW E EQ IFDAI
Sbjct: 230 AYYVAPEVLRRSYGPEADIWSAGVILYILLSGVPPFWAGIFTLFVNLLCEENEQGIFDAI 289
Query: 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
LRGHIDF+SDPWP+ISSSAKD+VKKML ADPKERLSA EVL+
Sbjct: 290 LRGHIDFASDPWPSISSSAKDLVKKMLRADPKERLSAVEVLN 331
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 350 | ||||||
| TAIR|locus:2128409 | 529 | CDPK6 "calcium-dependent prote | 0.76 | 0.502 | 0.823 | 1.4e-119 | |
| TAIR|locus:2177023 | 528 | CPK17 "calcium-dependent prote | 0.76 | 0.503 | 0.751 | 2e-111 | |
| TAIR|locus:2150225 | 523 | CPK34 "AT5G19360" [Arabidopsis | 0.76 | 0.508 | 0.744 | 6.1e-110 | |
| TAIR|locus:2015846 | 521 | CPK33 "calcium-dependent prote | 0.757 | 0.508 | 0.713 | 5.4e-102 | |
| TAIR|locus:2092399 | 541 | CPK9 "calmodulin-domain protei | 0.757 | 0.489 | 0.701 | 4.9e-101 | |
| TAIR|locus:2204340 | 561 | CPK29 "calcium-dependent prote | 0.757 | 0.472 | 0.664 | 6e-99 | |
| TAIR|locus:2138897 | 531 | CPK21 "calcium-dependent prote | 0.757 | 0.499 | 0.679 | 2.2e-98 | |
| TAIR|locus:2175503 | 610 | CPK1 "calcium dependent protei | 0.757 | 0.434 | 0.667 | 2.9e-96 | |
| TAIR|locus:2827528 | 544 | CPK6 "calcium dependent protei | 0.757 | 0.487 | 0.667 | 5.9e-96 | |
| TAIR|locus:2075885 | 646 | CPK2 "calmodulin-domain protei | 0.757 | 0.410 | 0.656 | 3.3e-95 |
| TAIR|locus:2128409 CDPK6 "calcium-dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1177 (419.4 bits), Expect = 1.4e-119, P = 1.4e-119
Identities = 219/266 (82%), Positives = 244/266 (91%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
LG+PME+VR TY FGRELGRGQFGVTYLVTHK+TKQQ ACKSI +R+L+++DD+EDVRRE
Sbjct: 67 LGRPMEEVRRTYEFGRELGRGQFGVTYLVTHKETKQQVACKSIPTRRLVHKDDIEDVRRE 126
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
VQIMHHL+GHRNIV+LKGAYEDRHSVNLIM+LC GGELFDRII+KG YSERAAA+LCRQM
Sbjct: 127 VQIMHHLSGHRNIVDLKGAYEDRHSVNLIMELCEGGELFDRIISKGLYSERAAADLCRQM 186
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V VVH CHSMGVMHRDLKPENFLF S E+SPLKATDFGLSVFFKPGD FKDLVGSAYYV
Sbjct: 187 VMVVHSCHSMGVMHRDLKPENFLFLSKDENSPLKATDFGLSVFFKPGDKFKDLVGSAYYV 246
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVL+RNYG EADIWSAGVILYILLSGVPPFWGE E IFDAIL+G +DFS+DPWP +S
Sbjct: 247 APEVLKRNYGPEADIWSAGVILYILLSGVPPFWGENETGIFDAILQGQLDFSADPWPALS 306
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLS 323
AKD+V+KML DPK+RL+AAEVL+
Sbjct: 307 DGAKDLVRKMLKYDPKDRLTAAEVLN 332
|
|
| TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1100 (392.3 bits), Expect = 2.0e-111, P = 2.0e-111
Identities = 200/266 (75%), Positives = 238/266 (89%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
LG+PMEDV+ +Y G+ELGRGQFGVT+L T K T QFACK+I+ RKL+N++D+EDVRRE
Sbjct: 62 LGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRRE 121
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
VQIMHHLTG NIVELKGAYED+HSV+L+M+LCAGGELFDRIIAKGHYSERAAA+L R +
Sbjct: 122 VQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRTI 181
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V +VH CHSMGV+HRDLKPENFL + E+SPLKATDFGLSVF+KPG+VFKD+VGSAYY+
Sbjct: 182 VQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYI 241
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVL+R YG EADIWS GV+LYILL GVPPFW E+E IF+AILRGH+DFSSDPWP+IS
Sbjct: 242 APEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSIS 301
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLS 323
AKD+VKKML++DPK+RL+AA+VL+
Sbjct: 302 PQAKDLVKKMLNSDPKQRLTAAQVLN 327
|
|
| TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1086 (387.4 bits), Expect = 6.1e-110, P = 6.1e-110
Identities = 198/266 (74%), Positives = 236/266 (88%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
LG+PMEDV+++Y G+ELGRGQFGVT+L T K T QFACK+I+ RKL+N++D+EDVRRE
Sbjct: 57 LGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIEDVRRE 116
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
VQIMHHLTG NIVELKGAYED+HSV+L+M+LCAGGELFDRIIAKGHYSERAAA+L R +
Sbjct: 117 VQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRTI 176
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V ++H CHSMGV+HRDLKPENFL S E+SPLKATDFGLSVF+KPG+VFKD+VGSAYY+
Sbjct: 177 VQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYI 236
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVLRR YG EADIWS GV+LYILL GVPPFW E+E IF+AIL G +DFSSDPWP IS
Sbjct: 237 APEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPWPVIS 296
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLS 323
AKD+V+KML++DPK+RL+AA+VL+
Sbjct: 297 PQAKDLVRKMLNSDPKQRLTAAQVLN 322
|
|
| TAIR|locus:2015846 CPK33 "calcium-dependent protein kinase 33" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1011 (360.9 bits), Expect = 5.4e-102, P = 5.4e-102
Identities = 189/265 (71%), Positives = 221/265 (83%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L KP EDV+ Y +ELGRGQFGVTYL T K T ++FACKSIS +KL+ + D ED+RRE
Sbjct: 62 LEKPYEDVKLFYTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLVTKGDKEDMRRE 121
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+QIM HL+G NIVE KGAYED +VNL+M+LCAGGELFDRI+AKGHYSERAAA++CRQ+
Sbjct: 122 IQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRILAKGHYSERAAASVCRQI 181
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V VV+ CH MGVMHRDLKPENFL SS E + +KATDFGLSVF + G V+KD+VGSAYYV
Sbjct: 182 VNVVNICHFMGVMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRVYKDIVGSAYYV 241
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVL+R YG E DIWSAG+ILYILLSGVPPFW ETE+ IFDAIL G IDF S PWP+IS
Sbjct: 242 APEVLKRRYGKEIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEIDFESQPWPSIS 301
Query: 298 SSAKDIVKKMLHADPKERLSAAEVL 322
+SAKD+V++ML DPK R+SAAEVL
Sbjct: 302 NSAKDLVRRMLTQDPKRRISAAEVL 326
|
|
| TAIR|locus:2092399 CPK9 "calmodulin-domain protein kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1002 (357.8 bits), Expect = 4.9e-101, P = 4.9e-101
Identities = 186/265 (70%), Positives = 220/265 (83%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L EDV+ Y G+ELGRGQFGVTYL T T +++ACKSIS +KL+ + D +D+RRE
Sbjct: 80 LENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKYACKSISKKKLVTKADKDDMRRE 139
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+QIM HL+G NIVE KGAYED +VNL+M+LCAGGELFDRIIAKGHY+ERAAA++CRQ+
Sbjct: 140 IQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRIIAKGHYTERAAASVCRQI 199
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V VV CH MGV+HRDLKPENFL SS E + +KATDFGLSVF + G V++D+VGSAYYV
Sbjct: 200 VNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGKVYRDIVGSAYYV 259
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVLRR YG E DIWSAG+ILYILLSGVPPFW ETE+ IFDAIL GHIDF S PWP+IS
Sbjct: 260 APEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGHIDFESQPWPSIS 319
Query: 298 SSAKDIVKKMLHADPKERLSAAEVL 322
SSAKD+V++ML ADPK R+SAA+VL
Sbjct: 320 SSAKDLVRRMLTADPKRRISAADVL 344
|
|
| TAIR|locus:2204340 CPK29 "calcium-dependent protein kinase 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 962 (343.7 bits), Expect = 6.0e-99, Sum P(2) = 6.0e-99
Identities = 176/265 (66%), Positives = 216/265 (81%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L +PM D+ Y +ELGRGQFG+TY T K +++ACKSIS RKLI R D+EDVRRE
Sbjct: 101 LNRPMIDLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRKLIRRKDIEDVRRE 160
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
V I+ HLTG NIVE +GAYED+ +++L+M+LC+GGELFDRII KG YSE+ AAN+ RQ+
Sbjct: 161 VMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGSYSEKEAANIFRQI 220
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V VVH CH MGV+HRDLKPENFL S+ EDSP+KATDFGLSVF + G V++D+VGSAYYV
Sbjct: 221 VNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEGKVYRDIVGSAYYV 280
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVL RNYG E D+WSAGV+LYILLSGVPPFWGETE++IF+AIL G +D + PWP IS
Sbjct: 281 APEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEGKLDLETSPWPTIS 340
Query: 298 SSAKDIVKKMLHADPKERLSAAEVL 322
SAKD+++KML DPK+R++AAE L
Sbjct: 341 ESAKDLIRKMLIRDPKKRITAAEAL 365
|
|
| TAIR|locus:2138897 CPK21 "calcium-dependent protein kinase 21" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 977 (349.0 bits), Expect = 2.2e-98, P = 2.2e-98
Identities = 180/265 (67%), Positives = 218/265 (82%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
LGKP ED+R Y G+ELGRGQFG+TY+ T +ACKSI RKLI++ D EDV+RE
Sbjct: 69 LGKPFEDIRKFYSLGKELGRGQFGITYMCKEIGTGNTYACKSILKRKLISKQDKEDVKRE 128
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+QIM +L+G NIVE+KGAYEDR S++L+M+LCAGGELFDRIIA+GHYSERAAA + R +
Sbjct: 129 IQIMQYLSGQPNIVEIKGAYEDRQSIHLVMELCAGGELFDRIIAQGHYSERAAAGIIRSI 188
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V VV CH MGV+HRDLKPENFL SS E++ LKATDFGLSVF + G V++D+VGSAYYV
Sbjct: 189 VNVVQICHFMGVVHRDLKPENFLLSSKEENAMLKATDFGLSVFIEEGKVYRDIVGSAYYV 248
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVLRR+YG E DIWSAGVILYILLSGVPPFW E E+ IFD +++G IDF S+PWP+IS
Sbjct: 249 APEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDEVIKGEIDFVSEPWPSIS 308
Query: 298 SSAKDIVKKMLHADPKERLSAAEVL 322
SAKD+V+KML DPK R++AA+VL
Sbjct: 309 ESAKDLVRKMLTKDPKRRITAAQVL 333
|
|
| TAIR|locus:2175503 CPK1 "calcium dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 957 (341.9 bits), Expect = 2.9e-96, P = 2.9e-96
Identities = 177/265 (66%), Positives = 214/265 (80%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L + E+ + Y GR+LG+GQFG T+L K T ++FACKSI+ RKL+ +DVEDVRRE
Sbjct: 139 LQRKTENFKEFYSLGRKLGQGQFGTTFLCVEKTTGKEFACKSIAKRKLLTDEDVEDVRRE 198
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+QIMHHL GH N++ +KGAYED +V+L+M+ CAGGELFDRII +GHY+ER AA L R +
Sbjct: 199 IQIMHHLAGHPNVISIKGAYEDVVAVHLVMECCAGGELFDRIIQRGHYTERKAAELTRTI 258
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V VV CHS+GVMHRDLKPENFLF S EDS LK DFGLS+FFKP DVF D+VGS YYV
Sbjct: 259 VGVVEACHSLGVMHRDLKPENFLFVSKHEDSLLKTIDFGLSMFFKPDDVFTDVVGSPYYV 318
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVLR+ YG EAD+WSAGVI+YILLSGVPPFW ETEQ IF+ +L G +DFSSDPWP+IS
Sbjct: 319 APEVLRKRYGPEADVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSIS 378
Query: 298 SSAKDIVKKMLHADPKERLSAAEVL 322
SAKD+V+KML DPK+RL+A +VL
Sbjct: 379 ESAKDLVRKMLVRDPKKRLTAHQVL 403
|
|
| TAIR|locus:2827528 CPK6 "calcium dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 954 (340.9 bits), Expect = 5.9e-96, P = 5.9e-96
Identities = 177/265 (66%), Positives = 215/265 (81%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
LG ++R+ Y R+LG+GQFG TYL T T +ACKSIS RKLI+++DVEDVRRE
Sbjct: 74 LGHKTPNIRDLYTLSRKLGQGQFGTTYLCTDIATGVDYACKSISKRKLISKEDVEDVRRE 133
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+QIMHHL GH+NIV +KGAYED V+++M+LCAGGELFDRII +GHYSER AA L + +
Sbjct: 134 IQIMHHLAGHKNIVTIKGAYEDPLYVHIVMELCAGGELFDRIIHRGHYSERKAAELTKII 193
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V VV CHS+GVMHRDLKPENFL + +D LKA DFGLSVFFKPG +FKD+VGS YYV
Sbjct: 194 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFKDVVGSPYYV 253
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVL ++YG EAD+W+AGVILYILLSGVPPFW ET+Q IFDA+L+G+IDF +DPWP IS
Sbjct: 254 APEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGYIDFDTDPWPVIS 313
Query: 298 SSAKDIVKKMLHADPKERLSAAEVL 322
SAKD+++KML + P ERL+A EVL
Sbjct: 314 DSAKDLIRKMLCSSPSERLTAHEVL 338
|
|
| TAIR|locus:2075885 CPK2 "calmodulin-domain protein kinase cdpk isoform 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 947 (338.4 bits), Expect = 3.3e-95, P = 3.3e-95
Identities = 174/265 (65%), Positives = 213/265 (80%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L + E+ + Y GR+LG+GQFG T+L K T ++ACKSIS RKL+ +DVEDVRRE
Sbjct: 175 LQRKTENFKEFYSLGRKLGQGQFGTTFLCLEKGTGNEYACKSISKRKLLTDEDVEDVRRE 234
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+QIMHHL GH N++ +KGAYED +V+L+M+LC+GGELFDRII +GHY+ER AA L R +
Sbjct: 235 IQIMHHLAGHPNVISIKGAYEDVVAVHLVMELCSGGELFDRIIQRGHYTERKAAELARTI 294
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V V+ CHS+GVMHRDLKPENFLF S EDS LK DFGLS+FFKP +VF D+VGS YYV
Sbjct: 295 VGVLEACHSLGVMHRDLKPENFLFVSREEDSLLKTIDFGLSMFFKPDEVFTDVVGSPYYV 354
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVLR+ YG E+D+WSAGVI+YILLSGVPPFW ETEQ IF+ +L G +DFSSDPWP+IS
Sbjct: 355 APEVLRKRYGPESDVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSIS 414
Query: 298 SSAKDIVKKMLHADPKERLSAAEVL 322
SAKD+V+KML DPK RL+A +VL
Sbjct: 415 ESAKDLVRKMLVRDPKRRLTAHQVL 439
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q42479 | CDPK3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8215 | 0.7685 | 0.5085 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 350 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-102 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-92 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-71 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-66 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-64 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-63 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-59 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-54 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-53 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-52 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-51 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-48 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-45 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-45 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-42 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-42 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-42 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-42 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-41 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-41 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-41 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-39 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-39 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-38 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-37 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-36 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-36 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-36 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-35 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-35 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-35 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-35 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-35 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-34 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-34 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-34 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-33 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-33 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-33 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-33 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-32 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-32 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-32 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-32 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-31 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-31 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-31 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-31 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-31 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-31 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-31 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-31 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-30 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-30 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-30 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-30 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-30 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-30 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-29 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-29 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-29 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-29 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-29 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-29 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-29 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-29 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-29 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-29 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-29 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-29 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-28 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-28 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-28 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-28 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-28 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-27 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-27 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-27 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-27 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-27 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-27 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-27 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-26 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-26 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-26 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-26 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-26 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-26 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-26 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-26 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-26 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-26 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-26 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-26 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-26 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-26 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-25 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-25 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-25 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-25 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-25 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-24 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-24 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-24 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-24 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-24 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-23 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-23 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-23 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-23 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-22 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-22 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-22 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-22 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-21 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-21 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-21 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-21 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-18 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-17 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-17 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 8e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 7e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.003 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.003 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.004 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 300 bits (771), Expect = e-102
Identities = 107/256 (41%), Positives = 147/256 (57%), Gaps = 9/256 (3%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y +LG G FG YL K T + A K I +K+ + D E + RE++I+ L H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKL-KHP 57
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
NIV L +ED + L+M+ C GG+LFD + +G SE A RQ+++ + Y HS G
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN-YG 247
++HRDLKPEN L ED +K DFGL+ PG+ VG+ Y+APEVL YG
Sbjct: 118 IVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSSAKDIVKK 306
DIWS GVILY LL+G PPF G+ + +F I + F W +IS AKD+++K
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEW-DISPEAKDLIRK 233
Query: 307 MLHADPKERLSAAEVL 322
+L DP++RL+A E L
Sbjct: 234 LLVKDPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 275 bits (706), Expect = 4e-92
Identities = 103/260 (39%), Positives = 143/260 (55%), Gaps = 11/260 (4%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y R+LG G FG Y HK T + A K + R + RRE++I+ L H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRL-SHP 58
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
NIV L A+ED+ + L+M+ C GG+LFD + G SE A + Q++ + Y HS G
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPEVLR--RN 245
++HRDLKPEN L E+ +K DFGL+ K VG+ +Y+APEVL
Sbjct: 119 IIHRDLKPENILLD---ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGE---TEQSIFDAILRGHIDFSSDPWPNISSSAKD 302
YG + D+WS GVILY LL+G PPF GE + + IL ++F W + S AKD
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 303 IVKKMLHADPKERLSAAEVL 322
++KK L+ DP +R +A E+L
Sbjct: 236 LIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 220 bits (564), Expect = 6e-71
Identities = 89/249 (35%), Positives = 135/249 (54%), Gaps = 10/249 (4%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG LV KDT + +A K + +K+I R +VE E I+ + H IV+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
A++ + L+++ GGELF + +G +SE A ++V + Y HS+G+++RDL
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 195 KPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
KPEN L D +K TDFGL+ G G+ Y+APEVL YG D
Sbjct: 120 KPENILLD---ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
WS GV+LY +L+G PPF+ E + I++ IL+ + F +S A+D++ +L DP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLLQKDP 232
Query: 313 KERLSAAEV 321
+RL +
Sbjct: 233 TKRLGSGGA 241
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 3e-66
Identities = 82/259 (31%), Positives = 137/259 (52%), Gaps = 18/259 (6%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+++G+G FG YLV K + + K I + + + ED EV+I+ L H NI++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIK 63
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRI----IAKGHYSERAAANLCRQMVTVVHYCHSMG 188
++E++ + ++M+ GG+L +I + E + Q+ + Y HS
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 189 VMHRDLKPEN-FLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN- 245
++HRD+KP+N FL S + +K DFG+S V D+ K +VG+ YY++PE+ +
Sbjct: 124 ILHRDIKPQNIFLTS----NGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI-SSSAKDIV 304
Y ++DIWS G +LY L + PF GE + IL+G P P+ SS +++V
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----PPIPSQYSSELRNLV 235
Query: 305 KKMLHADPKERLSAAEVLS 323
+L DP+ER S A++L
Sbjct: 236 SSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 203 bits (520), Expect = 8e-64
Identities = 86/276 (31%), Positives = 136/276 (49%), Gaps = 29/276 (10%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ + FG+ +G G F L K+T +++A K + R+LI V+ V+ E +++ L G
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
H I++L ++D ++ +++ GEL I G E+ +++ + Y HS
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-------------------- 226
G++HRDLKPEN L +D +K TDFG + P
Sbjct: 121 KGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 227 -FKDLVGSAYYVAPEVLRRNY-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG 284
F VG+A YV+PE+L G +D+W+ G I+Y +L+G PPF G E F IL+
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237
Query: 285 HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAE 320
F PN AKD+++K+L DP++RL E
Sbjct: 238 EYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNE 269
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 1e-63
Identities = 88/255 (34%), Positives = 125/255 (49%), Gaps = 44/255 (17%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG G FG YL K T ++ A K I + +E++ RE++I+ L H NIV+L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLN-HPNIVKLY 57
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
G +ED + + L+M+ C GG L D + G SE + Q++ + Y HS G++HRD
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAPEVLRRN--YGAEA 250
LKPEN L S ++ +K DFGLS + K +VG+ Y+APEVL Y ++
Sbjct: 118 LKPENILLDS--DNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 251 DIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310
DIWS GVILY L KD+++KML
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200
Query: 311 DPKERLSAAEVLSKF 325
DP++R SA E+L
Sbjct: 201 DPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 6e-59
Identities = 87/254 (34%), Positives = 132/254 (51%), Gaps = 16/254 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+ +G +G +L K T +A K I +I ++ V+ V E I+ +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLY 59
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + ++ L+M+ GG+L + G E A ++V + Y HS G++HRDL
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVF-------FKPGDVFKD--LVGSAYYVAPEV-LRR 244
KP+N L S+ LK TDFGLS D +D +VG+ Y+APEV L +
Sbjct: 120 KPDNILIDSNGH---LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
+ D WS G ILY L G+PPF GET + IF IL G I++ D +S A D++
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234
Query: 305 KKMLHADPKERLSA 318
K+L DP++RL A
Sbjct: 235 SKLLVPDPEKRLGA 248
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 3e-54
Identities = 89/261 (34%), Positives = 132/261 (50%), Gaps = 20/261 (7%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
G LGRG FG YL KDT + A KS+ + +++E + RE++I+ L H NIV
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSG-DSEEELEALEREIRILSSLQ-HPNIV 62
Query: 132 ELKGAYEDR--HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGV 189
G+ D +++N+ ++ +GG L + G E RQ++ + Y HS G+
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGI 122
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK---PGDVFKDLVGSAYYVAPEVLRRN- 245
+HRD+K N L S +K DFG + G+ + G+ Y++APEV+R
Sbjct: 123 VHRDIKGANILVDSDGV---VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI----SSSAK 301
YG ADIWS G + + +G PP W E A+ I S +P P I S AK
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPP-WSELGNP-MAALY--KIGSSGEP-PEIPEHLSEEAK 234
Query: 302 DIVKKMLHADPKERLSAAEVL 322
D ++K L DPK+R +A E+L
Sbjct: 235 DFLRKCLRRDPKKRPTADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-53
Identities = 84/247 (34%), Positives = 131/247 (53%), Gaps = 13/247 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG G FG LV K + FA K + R ++ E + E +I+ H IV+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILE-ECNHPFIVKLY 59
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++D+ + ++M+ C GGEL+ + +G + E A +V Y H+ G+++RDL
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV-LRRNYGAEADIW 253
KPEN L S+ +K DFG + K G G+ YVAPE+ L + Y D W
Sbjct: 120 KPENLLLDSNGY---VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176
Query: 254 SAGVILYILLSGVPPFWGETE--QSIFDAILRG--HIDFSSDPWPNISSSAKDIVKKMLH 309
S G++LY LL+G PPF + E I++ IL+G ++F + I +AKD++K++L
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN----YIDKAAKDLIKQLLR 232
Query: 310 ADPKERL 316
+P+ERL
Sbjct: 233 RNPEERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 8e-52
Identities = 87/251 (34%), Positives = 137/251 (54%), Gaps = 11/251 (4%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ + F + LG G FG LV HK + + +A K +S K++ VE V E +I+ +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR- 59
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
H +V L G+++D ++ L+M+ GGELF + G + E A Q+V + Y HS
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV-LRRN 245
+ +++RDLKPEN L S D +K TDFG + K L G+ Y+APE+ L +
Sbjct: 120 LDIVYRDLKPENLLLDS---DGYIKITDFGFAKRVKGRT--YTLCGTPEYLAPEIILSKG 174
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305
YG D W+ G+++Y +L+G PPF+ + I++ IL G + F S S AKD+++
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIR 230
Query: 306 KMLHADPKERL 316
+L D +RL
Sbjct: 231 NLLQVDLTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 9e-51
Identities = 79/255 (30%), Positives = 128/255 (50%), Gaps = 14/255 (5%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
++G+G FG Y HK T ++ A K I + E + E+QI+ H NIV+
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVK 61
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMH 191
G+Y + + ++M+ C+GG L D + + +E A +C++++ + Y HS G++H
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEA 250
RD+K N L +S E +K DFGLS +VG+ Y++APEV+ Y +A
Sbjct: 122 RDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 251 DIWSAGVILYILLSGVPPFWGETEQSIFDAILR-GHIDFSSDPWP-NISSSAKDIVKKML 308
DIWS G+ L G PP+ +E A+ + P S KD +KK L
Sbjct: 179 DIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL 235
Query: 309 HADPKERLSAAEVLS 323
+P++R +A ++L
Sbjct: 236 QKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 7e-50
Identities = 78/250 (31%), Positives = 124/250 (49%), Gaps = 6/250 (2%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ R +G+G FG +V +DTK+ FA K ++ +K + + V +V E +I+ L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HP 60
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+V L +++D ++ L++DL GG+L + K +SE ++V + Y HS G
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL-RRNYG 247
++HRD+KP+N L E + TDF ++ P + G+ Y+APEVL R+ Y
Sbjct: 121 IIHRDIKPDNILLD---EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
D WS GV Y L G P+ G + D I S+ A D + K+
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIRAKQETADVLYPATWSTEAIDAINKL 236
Query: 308 LHADPKERLS 317
L DP++RL
Sbjct: 237 LERDPQKRLG 246
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 166 bits (419), Expect = 5e-48
Identities = 96/283 (33%), Positives = 138/283 (48%), Gaps = 30/283 (10%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y R+LG G FG YL + + A K ++ + +VE RE+QI+ L
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRI---IAKGHYSERAAANLCRQMVTVVHYCH 185
NIV+L ++D S+ L+M+ GG L D + KG SE A + Q+++ + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-------FKDLVGSAYYVA 238
S G++HRD+KPEN L + +K DFGL+ VG+ Y+A
Sbjct: 119 SKGIIHRDIKPENILLDR--DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 239 PEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-------- 286
PEVL + +DIWS G+ LY LL+G+PPF GE S L+ I
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK-IILELPTPSL 235
Query: 287 --DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327
S IS +A D++KK+L DPK RLS++ LS L+
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278
|
Length = 384 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 1e-45
Identities = 87/277 (31%), Positives = 132/277 (47%), Gaps = 36/277 (12%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG +LV KDT Q +A K + +I R+ + VR E I+ IV+L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS-PWIVKLY 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++D + L+M+ GG+L + +I K + E A ++V + H +G +HRD+
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDI 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLS--------------------------VFFKPGDV-- 226
KP+N L + +K DFGL V +
Sbjct: 128 KPDNILIDADGH---IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184
Query: 227 --FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR 283
VG+ Y+APEVLR YG E D WS GVILY +L G PPF+ +T Q ++ I+
Sbjct: 185 VRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIIN 244
Query: 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAE 320
P P +S A D++ ++L DP++RL + E
Sbjct: 245 WKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFE 280
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 4e-45
Identities = 77/247 (31%), Positives = 121/247 (48%), Gaps = 7/247 (2%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ + +G FG YL + T FA K + +I ++ V +V+ E IM + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L +++ + + L+M+ GG+ I G E A ++V V H G++HR
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEA-D 251
D+KPEN L + LK TDFGLS + G K VG+ Y+APE + + D
Sbjct: 122 DIKPENLLIDQTGH---LKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 252 IWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311
WS G +++ L G PPF ET ++FD IL I++ + S A D++ ++L D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
Query: 312 PKERLSA 318
P +RL A
Sbjct: 236 PAKRLGA 242
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 1e-42
Identities = 79/268 (29%), Positives = 123/268 (45%), Gaps = 33/268 (12%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
+G+G FG V K + K I + ++ + V EV I+ L H NIV
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-EVNILRELK-HPNIVR- 63
Query: 134 KGAYEDR------HSVNLIMDLCAGGELFDRIIAK-----GHYSERAAANLCRQMVTVVH 182
Y DR ++ ++M+ C GG+L ++I K + E + Q++ ++
Sbjct: 64 ---YYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 183 YCH-----SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-KDLVGSAYY 236
CH V+HRDLKP N +F + + +K DFGL+ F K VG+ YY
Sbjct: 120 ECHNRSDPGNTVLHRDLKPAN-IFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYY 176
Query: 237 VAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295
++PE L Y ++DIWS G ++Y L + PPF + + I G P
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF----RRIPY 232
Query: 296 ISSSA-KDIVKKMLHADPKERLSAAEVL 322
SS +++K ML+ DP +R S E+L
Sbjct: 233 RYSSELNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 72/243 (29%), Positives = 126/243 (51%), Gaps = 11/243 (4%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G G FG +LV + ++ +A K ++ ++I + V E +++ ++ H I+ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLF 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
D+ + ++M+ GGELF + G +S ++V + Y HS +++RDL
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL-RRNYGAEADIW 253
KPEN L + +K TDFG + K D L G+ Y+APEV+ + + D W
Sbjct: 128 KPENILLDK---EGHIKLTDFGFAK--KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWW 182
Query: 254 SAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPK 313
+ G+++Y +L G PPF+ + I++ IL G ++F ++ AKD++KK+L D
Sbjct: 183 ALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKKLLVVDRT 238
Query: 314 ERL 316
RL
Sbjct: 239 RRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 5e-42
Identities = 77/262 (29%), Positives = 122/262 (46%), Gaps = 18/262 (6%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH 127
Y G +GRG FGV Y + +T A K IS K I + ++ + +E+ ++ +L H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLK-H 58
Query: 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM 187
NIV+ G+ E S+ +I++ G L I G + E A Q++ + Y H
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPEVLR-RN 245
GV+HRD+K N L + +D +K DFG++ +VG+ Y++APEV+
Sbjct: 119 GVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP----NISSSAK 301
+DIWS G + LL+G PP++ + I D P IS K
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI-------VQDDHPPLPEGISPELK 228
Query: 302 DIVKKMLHADPKERLSAAEVLS 323
D + + DP R +A ++L
Sbjct: 229 DFLMQCFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 8e-42
Identities = 86/255 (33%), Positives = 122/255 (47%), Gaps = 18/255 (7%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
++G+G +G +L KDT + A K + L ++V V E I+ T +V+L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSEWLVKL 66
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
A++D + L M+ GG+ + G SE A +M V H +G +HRD
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADI 252
LKPENFL +S +K TDFGLS +VGS Y+APEVLR + Y D
Sbjct: 127 LKPENFLIDASGH---IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDY 181
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAIL-------RGHIDFSSDPWPNISSSAKDIVK 305
WS G +LY L G PPF G T ++ + R D DP N+S A D++
Sbjct: 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD---DPRFNLSDEAWDLIT 238
Query: 306 KMLHADPKERLSAAE 320
K++ DP R + E
Sbjct: 239 KLI-NDPSRRFGSLE 252
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 9e-42
Identities = 88/270 (32%), Positives = 138/270 (51%), Gaps = 37/270 (13%)
Query: 78 GQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN--IVELKG 135
G +G YLV HK+T+Q+FA K I+ + LI R+ ++ V E I LT N +V +
Sbjct: 12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI---LTFAENPFVVSMFC 68
Query: 136 AYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLK 195
++E + + ++M+ GG+ + G A + V + Y H+ G++HRDLK
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLK 128
Query: 196 PENFLFSSSAEDSPLKATDFGLS--------VFFKPGDVFKD--------LVGSAYYVAP 239
P+N L +S +K TDFGLS G + KD + G+ Y+AP
Sbjct: 129 PDNLLITSMGH---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185
Query: 240 EV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN--- 295
EV LR+ YG D W+ G+ILY L G PF+G+T + +F ++ I+ WP
Sbjct: 186 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-----WPEGDE 240
Query: 296 -ISSSAKDIVKKMLHADPKERL---SAAEV 321
+ + A+D++ ++L +P ERL A EV
Sbjct: 241 ALPADAQDLISRLLRQNPLERLGTGGAFEV 270
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 1e-41
Identities = 79/259 (30%), Positives = 123/259 (47%), Gaps = 20/259 (7%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRN 129
LG+G GV Y V HK T + +A K I + D E+ R RE++ +
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKI------HVDGDEEFRKQLLRELKTLRS-CESPY 60
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM-G 188
+V+ GA+ ++++++ GG L D + G E A + RQ++ + Y H+
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DVFKDLVGSAYYVAPEVLR-RNY 246
++HRD+KP N L +S E +K DFG+S + D VG+ Y++PE ++ +Y
Sbjct: 121 IIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY 177
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP--NISSSAKDIV 304
ADIWS G+ L G PF Q F +++ D P S +D +
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLP-PGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236
Query: 305 KKMLHADPKERLSAAEVLS 323
L DPK+R SAAE+L
Sbjct: 237 SACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-41
Identities = 81/289 (28%), Positives = 128/289 (44%), Gaps = 47/289 (16%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD---VEDVRREVQIMHHLT 125
Y +LG G +GV Y K T + A K I +L N ++ +R E+ ++ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI---RLDNEEEGIPSTALR-EISLLKELK 56
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAK--GHYSERAAANLCRQMVTVV 181
H NIV+L + L+ + C D + + K G S ++ Q++ +
Sbjct: 57 -HPNIVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAPE 240
YCHS ++HRDLKP+N L + LK DFGL+ F P + V + +Y APE
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDGV---LKLADFGLARAFGIPLRTYTHEVVTLWYRAPE 168
Query: 241 VL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAI----------LRG 284
+L ++Y DIWS G I +++G P F G++E IF + +
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228
Query: 285 HIDFSSDP--W---------PNISSSAKDIVKKMLHADPKERLSAAEVL 322
D+ + P + D++ KML +P +R+SA E L
Sbjct: 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 9e-41
Identities = 81/288 (28%), Positives = 126/288 (43%), Gaps = 39/288 (13%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-VRREVQIMHHLTG 126
Y +G G G+ + ++T + A K ++ R+L + + RE++ +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQAC-Q 57
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCH 185
H +V+L + L+M+ L + + + E + R ++ V Y H
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD--VFKDLVGSAYYVAPEVL- 242
+ G+MHRDLKP N L S+ D LK DFGL+ F + ++ V + +Y APE+L
Sbjct: 117 ANGIMHRDLKPANLLISA---DGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 243 -RRNYGAEADIWSAGVILYILLSGVPPFWGET--EQ--SIFDAI---------------L 282
R Y D+W+ G I LL+G P F GE EQ +F +
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233
Query: 283 RGHIDFSSD---PW----PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
I F P P+ S A D++K +L DP +RLSAAE L
Sbjct: 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 80/283 (28%), Positives = 124/283 (43%), Gaps = 42/283 (14%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHLTGHRNI 130
++G G +GV Y K T + A K I R + RE++++ L H NI
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELN-HPNI 60
Query: 131 VELKGAYEDRHSVNLIMDLCAGG--ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
++L + + + L+ + +L + E + Q++ + +CHS G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVL--RRN 245
++HRDLKPEN L + + LK DFGL+ F P + V + +Y APE+L +
Sbjct: 119 ILHRDLKPENLLIN---TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 246 YGAEADIWSAGVILYILLSGVPPFWG--ETEQ--SIFDAI-------LRGHIDFSSD--- 291
Y DIWS G I LLS P F G E +Q IF + + +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235
Query: 292 --------PW----PNISSSAKDIVKKMLHADPKERLSAAEVL 322
P PN S A D++ +MLH DP +R++A + L
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 9e-39
Identities = 81/246 (32%), Positives = 130/246 (52%), Gaps = 11/246 (4%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
G LG G FG + HK T + +A K + R+++ V+ V +E I+ L+ H IV
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIV 81
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+ +++D + V +++ GGELF + G + A ++V Y HS +++
Sbjct: 82 NMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIY 141
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEA 250
RDLKPEN L + +K TDFG + K D L G+ Y+APEV++ + +G
Sbjct: 142 RDLKPENLLLDN---KGHVKVTDFGFAK--KVPDRTFTLCGTPEYLAPEVIQSKGHGKAV 196
Query: 251 DIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310
D W+ GV+LY ++G PPF+ +T I++ IL G + F + W A+D+VK +L
Sbjct: 197 DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKGLLQT 252
Query: 311 DPKERL 316
D +RL
Sbjct: 253 DHTKRL 258
|
Length = 329 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 1e-38
Identities = 82/292 (28%), Positives = 133/292 (45%), Gaps = 49/292 (16%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-----VRREVQIMHH 123
Y G++LG G + V Y K+T + A K I KL R + +D RE++++
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKI---KLGERKEAKDGINFTALREIKLLQE 58
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAG---GELFDRII--AKGHYSERAAANLCRQMV 178
L H NI+ L + + ++NL+ + + D+ I + +
Sbjct: 59 LK-HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIK-----SYMLMTL 112
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYV 237
+ Y HS ++HRDLKP N L +S D LK DFGL+ F P V + +Y
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIAS---DGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169
Query: 238 APEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAI---------- 281
APE+L R+YG D+WS G I LL VP G+++ IF+A+
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 282 ---LRGHIDFSSDP-------WPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
L +++F P +P S A D+++++L +P +R++A + L
Sbjct: 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 4e-37
Identities = 84/283 (29%), Positives = 134/283 (47%), Gaps = 17/283 (6%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
D R Y ++G G G Y T + T ++ A K + + + + E + E+ IM
Sbjct: 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMK 70
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY-SERAAANLCRQMVTVV 181
H NIV+ +Y + ++M+ GG L D I +E A +CR+++ +
Sbjct: 71 DCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDLVGSAYYVAPE 240
Y HS V+HRD+K +N L S +K DFG + K +VG+ Y++APE
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186
Query: 241 VLRRN-YGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDFS-SDPWPNIS 297
V++R YG + DIWS G++ + G PP+ E +++F +G + W S
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW---S 243
Query: 298 SSAKDIVKKMLHADPKERLSAAEVL-SKFLIPKKTLQTLADLL 339
KD + K L DP++R SA E+L FL + A L+
Sbjct: 244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEFAPLI 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 80/259 (30%), Positives = 131/259 (50%), Gaps = 14/259 (5%)
Query: 73 RELGRGQFGVTYLV---THKDTKQQFACKSISSRKLINR-DDVEDVRREVQIMHHLTGHR 128
R LG G +G +LV D + +A K + ++ + E R E Q++ +
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+V L A++ ++LI+D GGELF + + H++E ++V + + H +G
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG 125
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK--DLVGSAYYVAPEVLRR-- 244
+++RD+K EN L S + + TDFGLS F + + G+ Y+APEV+R
Sbjct: 126 IIYRDIKLENILLDS---EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182
Query: 245 -NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN-ISSSAKD 302
+ D WS GV+ + LL+G PF + EQ+ I R I S P+P +S+ A+D
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR-RILKSKPPFPKTMSAEARD 241
Query: 303 IVKKMLHADPKERLSAAEV 321
++K+L DPK+RL A
Sbjct: 242 FIQKLLEKDPKKRLGANGA 260
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 6e-36
Identities = 86/286 (30%), Positives = 136/286 (47%), Gaps = 43/286 (15%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ LG+G G +LV K T + FA K + +++I R+ V+ V E +I+ H +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL-ATLDHPFLPT 65
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
L +++ + L+MD C GGELF + SE A +++ + Y H +G++
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSV----------------------------FFK 222
+RDLKPEN L E + +DF LS F
Sbjct: 126 YRDLKPENILLH---ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 223 PGDVFK--DLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFD 279
F+ VG+ Y+APEV+ + +G+ D W+ G++LY +L G PF G F
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL----SAAEV 321
IL+ + F P +SSSA+D+++K+L DP +RL AAE+
Sbjct: 243 NILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 8e-36
Identities = 85/283 (30%), Positives = 141/283 (49%), Gaps = 36/283 (12%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN----RDDVEDVRREVQIMHHL--TGHR 128
+GRG +G Y H T + A K +IN DDV D++REV ++ L +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALK------IINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSM 187
NI + G+Y + +IM+ GG + R + K G +E+ + + R+++ + Y H +
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLR--R 244
GV+HRD+K N L +++ +K DFG++ + VG+ Y++APEV+ +
Sbjct: 121 GVIHRDIKAANILVTNTGN---VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI-----SSS 299
Y +ADIWS G+ +Y + +G PP+ I + S P P + S
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK------SKP-PRLEDNGYSKL 230
Query: 300 AKDIVKKMLHADPKERLSAAEVL-SKFL--IPKKTLQTLADLL 339
++ V L +PKERLSA E+L SK++ K + L +L+
Sbjct: 231 LREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKELI 273
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 80/244 (32%), Positives = 126/244 (51%), Gaps = 10/244 (4%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG LV K T + +A K + +I +D+V E +++ + T H + LK
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTALK 61
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + +M+ GGELF + + +SE A ++V+ + Y HS V++RDL
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
K EN + +D +K TDFGL G K G+ Y+APEVL N YG D
Sbjct: 122 KLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W GV++Y ++ G PF+ + + +F+ IL I F +S AK ++ +L DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 234
Query: 313 KERL 316
K+RL
Sbjct: 235 KQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 81/298 (27%), Positives = 124/298 (41%), Gaps = 68/298 (22%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--------REVQIMHHL 124
++G G +G Y +K T + A K I +E+ + RE++++ L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI---------RMENEKEGFPITAIREIKLLQKL 55
Query: 125 TGHRNIVELKGAYEDRHSVNLIM-------DLCAGGELFDRIIAKGHYSERAAANLCRQM 177
H NIV LK + ++ M DL G L D + ++E +Q+
Sbjct: 56 R-HPNIVRLKEIVTSKGKGSIYMVFEYMDHDL-TG--LLDS--PEVKFTESQIKCYMKQL 109
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP--GDVFKDLVGSAY 235
+ + Y HS G++HRD+K N L ++ LK DFGL+ + + + V + +
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVITLW 166
Query: 236 YVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR--GHIDFSSD 291
Y PE+L YG E D+WS G IL L G P F G TE + I G +
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN- 225
Query: 292 PWPN---------------------------ISSSAKDIVKKMLHADPKERLSAAEVL 322
WP I SA D++ K+L DPK+R+SA + L
Sbjct: 226 -WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 86/251 (34%), Positives = 127/251 (50%), Gaps = 17/251 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG LV HK +KQ +A K +S ++I R D E IM H IV+L
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW-IVQLH 109
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
A++D + ++M+ GG+L + +++ E+ A ++V + HSMG +HRD+
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDV 168
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDL-VGSAYYVAPEVLRRN-----YG 247
KP+N L S LK DFG + G V D VG+ Y++PEVL+ YG
Sbjct: 169 KPDNMLLDKSGH---LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL--RGHIDFSSDPWPNISSSAKDIVK 305
E D WS GV LY +L G PF+ ++ + I+ + + F D IS AKD++
Sbjct: 226 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD--IEISKQAKDLIC 283
Query: 306 KMLHADPKERL 316
L D + RL
Sbjct: 284 AFL-TDREVRL 293
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-35
Identities = 90/294 (30%), Positives = 130/294 (44%), Gaps = 47/294 (15%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMH 122
N Y +G G +GV +K T + A K K +D EDV+ REV+++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLR 55
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR-QMVTVV 181
L H NIV LK A+ + + L+ + L + + A A Q++ +
Sbjct: 56 QLR-HENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAI 113
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF--KPGDVFKDLVGSAYYVAP 239
YCHS ++HRD+KPEN L S E LK DFG + +P D V + +Y AP
Sbjct: 114 AYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE--------QSIFDAILRGHIDFS 289
E+L NYG D+W+ G I+ LL G P F G+++ + + FS
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230
Query: 290 SDP-------------------WPNISSS-AKDIVKKMLHADPKERLSAAEVLS 323
S+P +P SS A D +K L DPKERL+ E+L
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 8e-35
Identities = 79/258 (30%), Positives = 124/258 (48%), Gaps = 16/258 (6%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACK--SISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
G LG G FG Y + D FA K S++ ++ V+ + +E+ ++ L H N
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPN 63
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGV 189
IV+ G + ++ + ++L GG L + G + E RQ++ + Y H
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYG 247
+HRD+K N L ++ +K DFG++ K GS Y++APEV+ + YG
Sbjct: 124 VHRDIKGANILVDTNGV---VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD--PWPN-ISSSAKDIV 304
ADIWS G + + +G PP W + E A+ I S + P P+ +S AKD +
Sbjct: 181 LAADIWSLGCTVLEMATGKPP-WSQLEG--VAAVF--KIGRSKELPPIPDHLSDEAKDFI 235
Query: 305 KKMLHADPKERLSAAEVL 322
K L DP R +AAE+L
Sbjct: 236 LKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 83/288 (28%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y ++LG G FG YL +K+T + A K + +K + ++ ++R EV+ + L H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLR-EVKSLRKLNEHP 58
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHS 186
NIV+LK + + + + + G L+ + +SE ++ Q++ + + H
Sbjct: 59 NIVKLKEVFRENDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-- 244
G HRDLKPEN L S +K DFGL+ + + D V + +Y APE+L R
Sbjct: 118 HGFFHRDLKPENLLVSGP---EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRST 174
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWG--ETEQ--SIFDAILRGHIDFSSDPW------- 293
+Y + DIW+ G I+ L + P F G E +Q I ++L G + W
Sbjct: 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKIC-SVL-GT--PTKQDWPEGYKLA 230
Query: 294 -------------------PNISSSAKDIVKKMLHADPKERLSAAEVL 322
PN S A D++K ML DPK+R +A++ L
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 82/254 (32%), Positives = 134/254 (52%), Gaps = 18/254 (7%)
Query: 73 RELGRGQFGVTYLV---THKDTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHR 128
+ LG+G +G + V T DT + FA K + ++ N+ D + E I+ + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HP 60
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
IV+L A++ + LI++ +GGELF + +G + E A ++ + + H G
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGL---SVFFKPGDVFKDLVGSAYYVAPEVLRRN 245
+++RDLKPEN L + +K TDFGL S+ G V G+ Y+APE+L R+
Sbjct: 121 IIYRDLKPENILLDAQGH---VKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEILMRS 175
Query: 246 -YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
+G D WS G ++Y +L+G PPF E + D IL+G ++ P ++ A+D++
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231
Query: 305 KKMLHADPKERLSA 318
KK+L +P RL A
Sbjct: 232 KKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 73/253 (28%), Positives = 122/253 (48%), Gaps = 15/253 (5%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ LG+G FG L K T + +A K + ++ DDVE E +++ H + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L ++ + + +M+ GG+L I G + E A ++V + + H G+++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFK----PGDVFKDLVGSAYYVAPEVLR-RNYG 247
DLK +N L S + +K DFG+ K G G+ Y+APE+L + YG
Sbjct: 121 DLKLDNVLLDS---EGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
D W+ GV+LY +L+G PF G+ E +F +IL + + +S AK I+K
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSF 230
Query: 308 LHADPKERLSAAE 320
L +P++RL
Sbjct: 231 LTKNPEKRLGCLP 243
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 5e-34
Identities = 82/256 (32%), Positives = 130/256 (50%), Gaps = 15/256 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG LV K T + +A K + +I +D+V E +++ + T H + LK
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 61
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
A++ + +M+ GGELF + + ++E A ++V+ + Y HS V++RD+
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
K EN + +D +K TDFGL G K G+ Y+APEVL N YG D
Sbjct: 122 KLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W GV++Y ++ G PF+ + + +F+ IL I F +S AK ++ +L DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 234
Query: 313 KERL-----SAAEVLS 323
K+RL A EV+
Sbjct: 235 KQRLGGGPSDAKEVME 250
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 6e-34
Identities = 78/262 (29%), Positives = 125/262 (47%), Gaps = 37/262 (14%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI---- 130
+G+G FG Y V KDT++ +A K +S ++++ + +V H G RNI
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVA----------HTIGERNILVRT 50
Query: 131 --------VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
V LK +++ + L+ D +GGELF + +G +SE A ++V +
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALE 110
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP----GDVFKDLVGSAYYVA 238
+ H +++RDLKPEN L + + DFGLS K G+ Y+A
Sbjct: 111 HLHKYDIVYRDLKPENILLDA---TGHIALCDFGLS---KANLTDNKTTNTFCGTTEYLA 164
Query: 239 PEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296
PEVL + Y D WS GV+++ + G PF+ E Q ++ I G + F P +
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVL 221
Query: 297 SSSAKDIVKKMLHADPKERLSA 318
S + VK +L+ +P+ RL A
Sbjct: 222 SDEGRQFVKGLLNRNPQHRLGA 243
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 76/264 (28%), Positives = 127/264 (48%), Gaps = 22/264 (8%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
G ++G G FG Y + DT + A K I + + ++++ E++++ L H N+V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLK-HPNLV 62
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+ G R V + M+ C+GG L + + E Q++ + Y HS G++H
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-----GDVFKDLVGSAYYVAPEVLRRN- 245
RD+KP N + +K DFG +V K G+ + L G+ Y+APEV+
Sbjct: 123 RDIKPANIFLDHN---GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 246 ---YGAEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHIDFSSDPWP---NISS 298
+G ADIWS G ++ + +G P+ + E I + GH P P +S
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH----KPPIPDSLQLSP 235
Query: 299 SAKDIVKKMLHADPKERLSAAEVL 322
KD + + L +DPK+R +A+E+L
Sbjct: 236 EGKDFLDRCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 83/271 (30%), Positives = 134/271 (49%), Gaps = 25/271 (9%)
Query: 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREV 118
G P + N ++ ++G G G+ + T K T +Q A K + RK R E + EV
Sbjct: 15 GDPRSYLDN-FV---KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR---ELLFNEV 67
Query: 119 QIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMV 178
IM H NIVE+ +Y + ++M+ GG L D I+ +E A +C ++
Sbjct: 68 VIMRDYQ-HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVL 125
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD------LVG 232
+ + H+ GV+HRD+K ++ L +S D +K +DFG V K+ LVG
Sbjct: 126 KALSFLHAQGVIHRDIKSDSILLTS---DGRVKLSDFGFC-----AQVSKEVPRRKSLVG 177
Query: 233 SAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291
+ Y++APEV+ R YG E DIWS G+++ ++ G PP++ E I +
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKN 237
Query: 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
+S + + +ML DP +R +AAE+L
Sbjct: 238 L-HKVSPRLRSFLDRMLVRDPAQRATAAELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 7e-33
Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 20/269 (7%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ Y +G G V Y ++ A K I K + V+++R+EVQ M
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMS-QCN 57
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFD---RIIAKGHYSERAAANLCRQMVTVVHY 183
H N+V+ ++ + L+M +GG L D +G E A + ++++ + Y
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF-FKPGD----VFKDLVGSAYYVA 238
HS G +HRD+K N L ED +K DFG+S GD V K VG+ ++A
Sbjct: 118 LHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 239 PEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH---IDFSSDPW 293
PEV+ Y +ADIWS G+ L +G P+ + L+ ++ +D
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234
Query: 294 PNISSSAKDIVKKMLHADPKERLSAAEVL 322
S S + ++ L DP +R +A E+L
Sbjct: 235 K-YSKSFRKMISLCLQKDPSKRPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-33
Identities = 71/248 (28%), Positives = 122/248 (49%), Gaps = 9/248 (3%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG L HK + +A K + + ++ + + + + E ++ H +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + ++D GGELF + + + E A ++ + + Y HS+ +++RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
KPEN L S + TDFGL + G+ Y+APEVLR+ Y D
Sbjct: 123 KPENILLDS---QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W G +LY +L G+PPF+ ++D IL + PNIS SA+ +++ +L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDR 235
Query: 313 KERLSAAE 320
+RL A +
Sbjct: 236 TKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 71/264 (26%), Positives = 143/264 (54%), Gaps = 14/264 (5%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y+ +++G G FG LV K+ +Q+ K I+ K+ ++ E+ R+EV ++ ++ H
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMK-HP 59
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KG-HYSERAAANLCRQMVTVVHYCHS 186
NIV+ + ++E+ ++ ++MD C GG+L+ +I A +G + E + Q+ + + H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLR-R 244
++HRD+K +N + +D +K DFG++ V ++ + +G+ YY++PE+ R
Sbjct: 120 RKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR 176
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKDI 303
Y ++DIW+ G +LY + + F +++ I+RG S P + S +++
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG----SYPPVSSHYSYDLRNL 232
Query: 304 VKKMLHADPKERLSAAEVLSKFLI 327
V ++ +P++R S +L K I
Sbjct: 233 VSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-32
Identities = 79/254 (31%), Positives = 127/254 (50%), Gaps = 20/254 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH--HLTGHRNIVE 132
LGRG FG L +K T + +A K++ +I RD+VE + E +I + H +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L ++ V +M+ AGG+L I +SE A +V + Y H +++R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD----LVGSAYYVAPEVL-RRNYG 247
DLK +N L + + +K DFGL K G F D G+ ++APEVL +Y
Sbjct: 126 DLKLDNLLLDT---EGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKDIVKK 306
D W GV++Y +L G PF G+ E+ +FD+I+ + +P +S A I+++
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-----RYPRFLSREAISIMRR 234
Query: 307 MLHADPKERLSAAE 320
+L +P+ RL + E
Sbjct: 235 LLRRNPERRLGSGE 248
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 9e-32
Identities = 79/252 (31%), Positives = 134/252 (53%), Gaps = 14/252 (5%)
Query: 75 LGRGQFGVTYLV---THKDTKQQFACKSISSRKLINR-DDVEDVRREVQIMHHLTGHRNI 130
LG G +G +LV + D+ + +A K + ++ + E R E Q++ H+ +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
V L A++ ++LI+D GGELF + + + E+ ++V + + H +G++
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGII 127
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK--DLVGSAYYVAPEVLRRNYGA 248
+RD+K EN L S + + TDFGLS F +V + G+ Y+AP+++R G
Sbjct: 128 YRDIKLENILLDS---NGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184
Query: 249 E---ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKDIV 304
D WS GV++Y LL+G PF + E++ I R I S P+P +S+ AKDI+
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR-RILKSEPPYPQEMSALAKDII 243
Query: 305 KKMLHADPKERL 316
+++L DPK+RL
Sbjct: 244 QRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 9e-32
Identities = 85/263 (32%), Positives = 130/263 (49%), Gaps = 28/263 (10%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
ELG G FG Y HK+T A K I ++ + +++ED E+ I+ H NIV L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECK-HPNIVGL 67
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMHR 192
AY + + ++++ C GG L ++ +E +CRQM+ +++ HS V+HR
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVL------RRN 245
DLK N L + + +K DFG+S K +D +G+ Y++APEV+
Sbjct: 128 DLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI------SSS 299
Y +ADIWS G+ L L PP E + +L+ S+P P + SSS
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP---HHELNPMRVLLK---ILKSEP-PTLDQPSKWSSS 237
Query: 300 AKDIVKKMLHADPKERLSAAEVL 322
D +K L DP +R +AAE+L
Sbjct: 238 FNDFLKSCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 84/272 (30%), Positives = 131/272 (48%), Gaps = 31/272 (11%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
ELG G GV V H+ T + A K+I R IN + + RE+ I+H IV
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCN-SPYIVG 63
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRII--AKGHYSERAAANLCRQMVTVVHYCHS-MGV 189
GA+ + +++ M+ GG L D+I+ +G ER + ++ + Y H +
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG----DVFKDLVGSAYYVAPEVLRRN 245
+HRD+KP N L +S + +K DFG+S G + K VG++ Y+APE ++ N
Sbjct: 123 IHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERIQGN 174
Query: 246 -YGAEADIWSAGVILYILLSG-VP-PFWGETEQSIFDAILRGHID-----FSSDPWPNIS 297
Y ++DIWS G+ L L +G P P + IF+ +L+ ++ S + S
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE-LLQYIVNEPPPRLPSGKF---S 230
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329
+D V L DP+ER S E+L I K
Sbjct: 231 PDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-31
Identities = 81/261 (31%), Positives = 132/261 (50%), Gaps = 15/261 (5%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y R +G G FG LV H ++ Q++A K I R + VED R+E ++ + H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI--RLPKSSSAVEDSRKEAVLLAKMK-HP 58
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGH-YSERAAANLCRQMVTVVHYCHS 186
NIV K ++E + ++M+ C GG+L +I + +G + E QM V + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRR- 244
V+HRD+K +N + ++ +K DFG + + PG VG+ YYV PE+
Sbjct: 119 KRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKDI 303
Y ++DIWS G ILY L + PF + +++ + +G S P P + S + +
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG----SYKPLPSHYSYELRSL 231
Query: 304 VKKMLHADPKERLSAAEVLSK 324
+K+M +P+ R SA +LS+
Sbjct: 232 IKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 75/284 (26%), Positives = 127/284 (44%), Gaps = 49/284 (17%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG LV KDT +A K + +++ ++ V VR E I+ + +V+L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVKLY 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++D + + LIM+ GG++ ++ K ++E + + + H +G +HRD+
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDI 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFK--------------PGDVFKDL---------- 230
KP+N L + +K +DFGL K F D
Sbjct: 128 KPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 231 ---------------VGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETE 274
VG+ Y+APEV + Y E D WS GVI+Y +L G PPF +
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244
Query: 275 QSIFDAIL--RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL 316
Q + I+ + + F + +S AKD++K++ + + RL
Sbjct: 245 QETYRKIINWKETLQFPDE--VPLSPEAKDLIKRLC-CEAERRL 285
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-31
Identities = 78/254 (30%), Positives = 134/254 (52%), Gaps = 13/254 (5%)
Query: 75 LGRGQFGVTYLV---THKDTKQQFACKSISSRKLINRDD-VEDVRREVQIMHHLTGHRNI 130
LG G +G +LV T DT + +A K + L+ + VE R E ++ H+ +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
V L A++ ++LI+D +GGE+F + + ++SE +++ + + H +G++
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIV 127
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFF--KPGDVFKDLVGSAYYVAPEVLR--RNY 246
+RD+K EN L S + + TDFGLS F + + G+ Y+APE++R +
Sbjct: 128 YRDIKLENILLDS---EGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN-ISSSAKDIVK 305
G D WS G++++ LL+G PF E E++ + R I P+P+ I A+D++
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR-RILKCDPPFPSFIGPEAQDLLH 243
Query: 306 KMLHADPKERLSAA 319
K+L DPK+RL A
Sbjct: 244 KLLRKDPKKRLGAG 257
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 67/277 (24%), Positives = 117/277 (42%), Gaps = 44/277 (15%)
Query: 71 FGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
G++LG G FG K + A K++ + +E+ RE +IM L
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKL-D 59
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY-SERAAANLCRQ----MVTVV 181
H N+V+L G + + ++M+ GG+L + S + Q M
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME--- 116
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---- 237
Y S +HRDL N L E+ +K +DFGLS +DL YY
Sbjct: 117 -YLESKNFIHRDLAARNCLVG---ENLVVKISDFGLS---------RDLYDDDYYRKRGG 163
Query: 238 -------APEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDF 288
APE L+ + +++D+WS GV+L+ + + G P+ G + + + + + G+
Sbjct: 164 KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR-- 221
Query: 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325
PN D++ + DP++R + +E++
Sbjct: 222 -LPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 79/287 (27%), Positives = 121/287 (42%), Gaps = 46/287 (16%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDV-EDVRREVQIMHHLT--GHRNI 130
E+G G +G Y +T + A K + R ++ + + RE+ ++ L H NI
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 131 VEL----KGAYEDRH-SVNLIM-----DLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
V L G DR + L+ DL + G +L RQ++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQDLAT---YLSKCPKPG-LPPETIKDLMRQLLRG 119
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 240
V + HS ++HRDLKP+N L +S + +K DFGL+ + +V + +Y APE
Sbjct: 120 VDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMALTSVVVTLWYRAPE 176
Query: 241 VL-RRNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFD--------------AI 281
VL + +Y D+WS G I L P F G +E IFD ++
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236
Query: 282 LRGHIDFSS-----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
R + P I D++KKML +P +R+SA E L
Sbjct: 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 79/245 (32%), Positives = 127/245 (51%), Gaps = 11/245 (4%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG LV K T + +A K + ++ +D+V E +++ + + H + LK
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 61
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRD 193
+++ + +M+ GGELF + + +SE A ++V+ + Y HS V++RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 194 LKPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEAD 251
LK EN + +D +K TDFGL K G K G+ Y+APEVL N YG D
Sbjct: 122 LKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178
Query: 252 IWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311
W GV++Y ++ G PF+ + + +F+ IL I F +S AK ++ +L D
Sbjct: 179 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLKKD 234
Query: 312 PKERL 316
PK+RL
Sbjct: 235 PKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 78/263 (29%), Positives = 123/263 (46%), Gaps = 26/263 (9%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
+G G +G Y T + A K I KL DD E +++E+ ++ H NIV
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECR-HPNIVAY 65
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
G+Y R + ++M+ C GG L D + +G SE A +CR+ + + Y H G +HR
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVL----RRNYG 247
D+K N L + + +K DFG+S K +G+ Y++APEV + Y
Sbjct: 126 DIKGANILLTEDGD---VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYD 182
Query: 248 AEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHIDFSSDPWPNISSSAK----- 301
+ DIW+ G+ L PP + +++F I S+ P P + K
Sbjct: 183 GKCDIWALGITAIELAELQPPMFDLHPMRALF------LISKSNFPPPKLKDKEKWSPVF 236
Query: 302 -DIVKKMLHADPKERLSAAEVLS 323
D +KK L DPK+R +A ++L
Sbjct: 237 HDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 79/260 (30%), Positives = 124/260 (47%), Gaps = 18/260 (6%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+G+G FG Y K T Q A K I + D++ED+++E+Q + I +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRS-PYITK 63
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
G++ + +IM+ C GG D ++ G E A + R+++ + Y H G +HR
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEEGKIHR 122
Query: 193 DLKPENFLFSSSAEDSPLKATDFG----LSVFFKPGDVFKDLVGSAYYVAPEVLRRN-YG 247
D+K N L S + +K DFG L+ + F VG+ +++APEV++++ Y
Sbjct: 123 DIKAANILLSEEGD---VKLADFGVSGQLTSTMSKRNTF---VGTPFWMAPEVIKQSGYD 176
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
+ADIWS G+ L G PP + I + + S S KD V
Sbjct: 177 EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP--SLEGNKFSKPFKDFVSLC 234
Query: 308 LHADPKERLSAAEVLS-KFL 326
L+ DPKER SA E+L KF+
Sbjct: 235 LNKDPKERPSAKELLKHKFI 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 6e-31
Identities = 77/250 (30%), Positives = 127/250 (50%), Gaps = 16/250 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG LV K + + +A K + +I +D+V E +++ + T H + LK
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLK 61
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + + +M+ GGELF + + +SE ++V+ + Y HS +++RDL
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPG----DVFKDLVGSAYYVAPEVLRRN-YGAE 249
K EN + +D +K TDFGL K G K G+ Y+APEVL N YG
Sbjct: 122 KLENLMLD---KDGHIKITDFGLC---KEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
D W GV++Y ++ G PF+ + + +F+ IL I F +S+ AK ++ +L
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLI 231
Query: 310 ADPKERLSAA 319
DP +RL
Sbjct: 232 KDPNKRLGGG 241
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 8e-31
Identities = 78/258 (30%), Positives = 124/258 (48%), Gaps = 25/258 (9%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG G +G Y HK+T Q A K + +D++++ +E+ I+ IV+
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP-----VEEDLQEIIKEISILKQ-CDSPYIVKYY 64
Query: 135 GAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
G+Y + ++M+ C G + D +I K +E A + Q + + Y HS +HR
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKKIHR 123
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD---LVGSAYYVAPEVLRR-NYGA 248
D+K N L + E+ K DFG+S + D ++G+ +++APEV++ Y
Sbjct: 124 DIKAGNILLN---EEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178
Query: 249 EADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHIDFSSDP--WPNISSSAKDIVK 305
+ADIWS G+ + G PP+ ++IF I SDP W S D VK
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIPNKPPPTLSDPEKW---SPEFNDFVK 234
Query: 306 KMLHADPKERLSAAEVLS 323
K L DP+ER SA ++L
Sbjct: 235 KCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 80/257 (31%), Positives = 135/257 (52%), Gaps = 23/257 (8%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
++G G G+ + K + +Q A K + RK R E + EV IM H+N+VE+
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQ-HQNVVEM 83
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
+Y + ++M+ GG L D I+++ +E A +C ++ + Y HS GV+HRD
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEAD 251
+K ++ L + D +K +DFG K K LVG+ Y++APEV+ R YG E D
Sbjct: 143 IKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 252 IWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK------DIVK 305
IWS G+++ ++ G PP++ ++ A+ R P P + ++ K D ++
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQ---AMKR----LRDSPPPKLKNAHKISPVLRDFLE 252
Query: 306 KMLHADPKERLSAAEVL 322
+ML +P+ER +A E+L
Sbjct: 253 RMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 70/282 (24%), Positives = 120/282 (42%), Gaps = 51/282 (18%)
Query: 70 IFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
G++LG G FG T + + A K++ + +E+ RE +IM L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA--SEQQIEEFLREARIMRKL- 58
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY--SERAAANLCRQ----MVT 179
H NIV+L G + + ++M+ GG+L D + S + Q M
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME- 117
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV-- 237
Y S +HRDL N L E+ +K +DFGLS +DL YY
Sbjct: 118 ---YLESKNFIHRDLAARNCLVG---ENLVVKISDFGLS---------RDLYDDDYYKVK 162
Query: 238 ---------APEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286
APE L+ + +++D+WS GV+L+ + + G P+ G + + + + +G+
Sbjct: 163 GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR 222
Query: 287 DFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLSKF 325
P + ++ K ML DP++R + +E++
Sbjct: 223 L------PKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-30
Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 29/271 (10%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD------VEDVRREVQIMHHLT 125
G+ LG+G FG YL DT ++ A K + + D V + E+Q++ +L
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVP----FDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH 185
H IV+ G D ++++ M+ GG + D++ A G +E RQ++ V Y H
Sbjct: 63 -HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFG----LSVFFKPGDVFKDLVGSAYYVAPEV 241
S ++HRD+K N L S+ +K DFG L G K + G+ Y+++PEV
Sbjct: 122 SNMIVHRDIKGANILRDSAGN---VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETE--QSIFDAILRGHIDFSSDPW--PNI 296
+ YG +AD+WS G + +L+ PP W E E +IF + ++P ++
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQ-----PTNPQLPSHV 232
Query: 297 SSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327
S A++ +++ + K+R SA E+L F +
Sbjct: 233 SPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 69/248 (27%), Positives = 123/248 (49%), Gaps = 9/248 (3%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG L HK ++ +A K + + ++ + + + + E ++ H +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + ++D GGELF + + + E A ++ + + Y HS+ +++RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
KPEN L S + TDFGL + G+ Y+APEVL + Y D
Sbjct: 123 KPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W G +LY +L G+PPF+ ++D IL + PNI++SA+ +++ +L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 235
Query: 313 KERLSAAE 320
+RL A +
Sbjct: 236 TKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 71/255 (27%), Positives = 126/255 (49%), Gaps = 18/255 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G +G Y V Q +A K + + ++ + ED E++I+ + H NI+ K
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIISYK 65
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGH-----YSERAAANLCRQMVTVVHYCHSMGV 189
A+ D + + ++M+ G+L + I+K E+ + Q++ + H +
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLS-KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKI 124
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGA 248
+HRDLK N L ++ +K D G+S K ++ K +G+ +Y+APEV + R Y
Sbjct: 125 LHRDLKSANILLVANDL---VKIGDLGISKVLK-KNMAKTQIGTPHYMAPEVWKGRPYSY 180
Query: 249 EADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI-SSSAKDIVKKM 307
++DIWS G +LY + + PPF + Q + + RG P P I S ++ ++ M
Sbjct: 181 KSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY----PPIPPIYSQDLQNFIRSM 236
Query: 308 LHADPKERLSAAEVL 322
L PK R + ++L
Sbjct: 237 LQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-30
Identities = 76/247 (30%), Positives = 121/247 (48%), Gaps = 12/247 (4%)
Query: 71 FGRELGRGQFGVTYLVTHKDTK-QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
F R LG G FG L T+K+ A K K+I + V+ V E +I++++ H
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPF 92
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGV 189
V L G+++D + L+++ GGE F + + Q+V + Y S+ +
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNI 152
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGA 248
++RDLKPEN L +D +K TDFG + L G+ Y+APE+L +G
Sbjct: 153 VYRDLKPENLLLD---KDGFIKMTDFGFAKVVDTRTY--TLCGTPEYIAPEILLNVGHGK 207
Query: 249 EADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML 308
AD W+ G+ +Y +L G PPF+ I+ IL G I F + ++ K ++KK+L
Sbjct: 208 AADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLMKKLL 263
Query: 309 HADPKER 315
D +R
Sbjct: 264 SHDLTKR 270
|
Length = 340 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 83/299 (27%), Positives = 130/299 (43%), Gaps = 64/299 (21%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-RDDVEDVR---REVQIMHHLTGHR 128
+ +G G +GV K T ++ A K K+ N DD+ D + RE++++ HL H
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIK-----KISNVFDDLIDAKRILREIKLLRHL-RHE 59
Query: 129 NIVELK-----GAYEDRHSVNLIMDLCAGGELFD----RII-AKGHYSERAAANLCRQMV 178
NI+ L + ED + V ++ EL + ++I + ++ Q++
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVT------ELMETDLHKVIKSPQPLTDDHIQYFLYQIL 113
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK----DLVGSA 234
+ Y HS V+HRDLKP N L +S + LK DFGL+ P + K + V +
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNS---NCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 235 YYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAI------- 281
+Y APE+L Y DIWS G I LL+ P F G I + +
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230
Query: 282 -----------------LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ S +P S A D+++KML DPK+R++A E L+
Sbjct: 231 LKFITSEKARNYLKSLPKKPKKPL-SKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 9e-30
Identities = 70/246 (28%), Positives = 120/246 (48%), Gaps = 13/246 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG L K T + +A K + +I DDVE E +++ + +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + +M+ GG+L I G + E A ++ + + HS G+++RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 195 KPENFLFSSSAEDSPLKATDFGL---SVFFKPGDVFKDLVGSAYYVAPE-VLRRNYGAEA 250
K +N + + +K DFG+ ++F G + G+ Y+APE + + YG
Sbjct: 128 KLDNVMLDAEGH---IKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 251 DIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310
D W+ GV+LY +L+G PPF GE E +F +I+ ++ + ++S A I K +L
Sbjct: 183 DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLLTK 238
Query: 311 DPKERL 316
P +RL
Sbjct: 239 HPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 81/301 (26%), Positives = 129/301 (42%), Gaps = 61/301 (20%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ +G G FG LV DT +A K++ ++ R+ V+ E I+ + +V+
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNEWVVK 65
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L +++D+ ++ +MD GG++ +I G + E A ++ + H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR 125
Query: 193 DLKPENFLFSSSAEDSPLKATDFGL---------SVFFKPGDVFK--------------- 228
D+KP+N L D +K TDFGL S +++ GD +
Sbjct: 126 DIKPDNILID---RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 229 --------------------DLVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVP 267
LVG+ Y+APEVL R Y D WS GVILY +L G P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 268 PFW----GETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL---SAAE 320
PF ET+ + + HI +S A D++ + L ++RL A E
Sbjct: 243 PFLADTPAETQLKVINWETTLHI----PSQAKLSREASDLILR-LCCGAEDRLGKNGADE 297
Query: 321 V 321
+
Sbjct: 298 I 298
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-29
Identities = 76/272 (27%), Positives = 118/272 (43%), Gaps = 23/272 (8%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQF-ACKSISSRKLINRDD-------VEDVRREVQ 119
Y LG G FG Y V K+ Q A K I+ D + D+ EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCR 175
I+ H NIV + + + ++MDL G L + + K ++E N+
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 176 QMVTVVHYCH-SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA 234
QMV + Y H ++HRDL P N + ED + TDFGL+ +P +VG+
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQKQPESKLTSVVGTI 177
Query: 235 YYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293
Y PE+++ YG +AD+W+ G ILY + + PPF+ S+ I ++ +P
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI----VEAVYEPL 233
Query: 294 PN--ISSSAKDIVKKMLHADPKERLSAAEVLS 323
P S D++ L D + R +V +
Sbjct: 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 73/251 (29%), Positives = 122/251 (48%), Gaps = 15/251 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG L K + +A K + + ++NR + + + E ++ H +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + ++D GGELF + + + E A ++ + + Y HS+ +++RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPG----DVFKDLVGSAYYVAPEVLRRN-YGAE 249
KPEN L S + TDFGL K G D G+ Y+APEV+R+ Y
Sbjct: 123 KPENILLDSQGH---VVLTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
D W G +LY +L G+PPF+ ++D IL + P S +A I++++L
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232
Query: 310 ADPKERLSAAE 320
D + RL A E
Sbjct: 233 KDRQRRLGAKE 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 75/286 (26%), Positives = 122/286 (42%), Gaps = 53/286 (18%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-DDVEDVR--REVQIMHHLTGHRNIV 131
+G G F + T + +A K + +E V RE+Q + L+ H NI+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK-----CMKKHFKSLEQVNNLREIQALRRLSPHPNIL 61
Query: 132 ELKGAYEDRH--SVNLIMDLCAGGELFDRIIAKGHY-SERAAANLCRQMVTVVHYCHSMG 188
L DR + L+ +L L++ I + E+ + Q++ + + H G
Sbjct: 62 RLIEVLFDRKTGRLALVFEL-MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFG--LSVFFKPGDVFKDLVGSAYYVAPEVLRRN- 245
+ HRD+KPEN L +D LK DFG ++ KP + + + + +Y APE L +
Sbjct: 121 IFHRDIKPENILI----KDDILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDG 174
Query: 246 -YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH---------IDFSSDPW-- 293
YG + DIW+ G + + +LS P F G E D I + H +
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFRKSRH 231
Query: 294 -----------------PNISSSAKDIVKKMLHADPKERLSAAEVL 322
PN S+ D++KK+L DP ER++A + L
Sbjct: 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 61/258 (23%), Positives = 118/258 (45%), Gaps = 12/258 (4%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ ++G+G FGV + V K K+ +A K I K+ NR + E+ E +++ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SS 59
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHS 186
I+ ++ D+ +N++M+ G+L + E Q++ + + HS
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-KDLVGSAYYVAPEVLR-R 244
++HRD+K N +K D G++ F +VG+ YY++PE+ +
Sbjct: 120 KKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
Y ++D+W+ GV+LY +G PF + ++ I+RG S + S ++
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMY---SQQLAQLI 233
Query: 305 KKMLHADPKERLSAAEVL 322
+ L D ++R ++L
Sbjct: 234 DQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 72/251 (28%), Positives = 120/251 (47%), Gaps = 7/251 (2%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R LG+G FG + T + +ACK + +++ R E QI+ + + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS-QFVVN 64
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVM 190
L AYE + ++ L++ + GG+L I G+ + E A +++ + H +
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAE 249
+RDLKPEN L + ++ +D GL+V G+ + VG+ Y+APEVL + Y
Sbjct: 125 YRDLKPENILLD---DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
D W G ++Y ++ G PF G E+ + + R ++ S AK I K +L
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241
Query: 310 ADPKERLSAAE 320
DPK+RL E
Sbjct: 242 KDPKQRLGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 71/246 (28%), Positives = 117/246 (47%), Gaps = 9/246 (3%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R LG+G FG L K++ + +A K + ++ DDVE E +I+ H + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L ++ + +M+ GG+L I + E A ++ + + + H G+++R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 193 DLKPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEA 250
DLK +N L + K DFG+ G G+ Y+APE+L+ YG
Sbjct: 121 DLKLDNVLLD---HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 251 DIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310
D W+ GV+LY +L G PF E E +F+AIL + + + W +S A DI+K +
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LSQDAVDILKAFMTK 233
Query: 311 DPKERL 316
+P RL
Sbjct: 234 NPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 71/244 (29%), Positives = 118/244 (48%), Gaps = 10/244 (4%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG V +DT++ +A K+I +++R +V E ++ + IV LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLK 59
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + L++ GGELF + +G + A +++ + H V++RDL
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADI 252
KPEN L + DFGL + K D G+ Y+APE+L Y D
Sbjct: 120 KPENILLDYQGH---IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W+ GV+LY +L+G+PPF+ E ++ IL+ + F AKD++ +L DP
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLLSRDP 232
Query: 313 KERL 316
RL
Sbjct: 233 TRRL 236
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 79/251 (31%), Positives = 128/251 (50%), Gaps = 11/251 (4%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
++G G G+ + T K T +Q A K + RK R E + EV IM H N+V++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYH-HENVVDM 84
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
+Y + ++M+ GG L D I+ +E A +C ++ + Y H+ GV+HRD
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEAD 251
+K ++ L +S D +K +DFG K K LVG+ Y++APEV+ R YG E D
Sbjct: 144 IKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 252 IWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311
IWS G+++ ++ G PP++ E I R ++ +SS + + ML +
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-RDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
Query: 312 PKERLSAAEVL 322
P +R +A E+L
Sbjct: 260 PSQRATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 80/266 (30%), Positives = 128/266 (48%), Gaps = 25/266 (9%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
DV++ +GRG FG +V K T +A K + L+ ++ V E I+
Sbjct: 4 DVKSL------VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS- 56
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVH 182
++ I +L+ A++D+ ++ L+M+ GG+L + + + E A ++V +H
Sbjct: 57 ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDL-VGSAYYVAPE 240
H MG +HRD+KPEN L + +K DFG + V L VG+ Y+APE
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGH---IKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 241 VL-------RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL--RGHIDFSSD 291
VL + YG E D WS GVI Y ++ G PF T ++ I+ + + F D
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED 233
Query: 292 PWPNISSSAKDIVKKMLHADPKERLS 317
P +SS D+++ +L KERL
Sbjct: 234 --PKVSSDFLDLIQSLL-CGQKERLG 256
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 80/253 (31%), Positives = 128/253 (50%), Gaps = 18/253 (7%)
Query: 75 LGRGQFGVTYLV---THKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
LG+G FG +LV T D Q +A K + L RD V + E I+ + H IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEV-NHPFIV 61
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+L A++ + LI+D GG+LF R+ + ++E ++ + + HS+G+++
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK---DLVGSAYYVAPEVL-RRNYG 247
RDLKPEN L E+ +K TDFGLS + D K G+ Y+APEV+ RR +
Sbjct: 122 RDLKPENILLD---EEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
AD WS GV+++ +L+G PF G+ + IL+ + +S A+ +++ +
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRAL 232
Query: 308 LHADPKERLSAAE 320
+P RL A
Sbjct: 233 FKRNPANRLGAGP 245
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 75/266 (28%), Positives = 129/266 (48%), Gaps = 18/266 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
YI R LG+G FG L + K ++ +L ++ D E+ I+ L H
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE-RRDALNEIVILSLLQ-HP 59
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRII--AKGHYSERAAANLCRQMVTVVHYCHS 186
NI+ + D +++ + M+ GG L+D+I+ + E Q+V+ V Y H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 187 MGVMHRDLKPEN-FLFSSSAEDSPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVL 242
G++HRD+K N FL + +K DFG+S G + + +VG+ YY++PE+
Sbjct: 120 AGILHRDIKTLNIFL----TKAGLIKLGDFGISK--ILGSEYSMAETVVGTPYYMSPELC 173
Query: 243 R-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
+ Y ++DIW+ G +LY LL+ F ++ I++G+ + SS
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELI 230
Query: 302 DIVKKMLHADPKERLSAAEVLSKFLI 327
+V +L DP++R +A EVL + L+
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 77/249 (30%), Positives = 122/249 (48%), Gaps = 13/249 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG L K T + FA K++ ++ DDVE E +++ H + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + + +M+ GG+L I + G + E A +++ + + H G+++RDL
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLR-RNYGAEADI 252
K +N L +D +K DFG+ G+ G+ Y+APE+L+ + Y D
Sbjct: 123 KLDNVLLD---KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW-PN-ISSSAKDIVKKMLHA 310
WS GV+LY +L G PF GE E +FD+IL + P P IS AKD + K+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSIL------NDRPHFPRWISKEAKDCLSKLFER 233
Query: 311 DPKERLSAA 319
DP +RL
Sbjct: 234 DPTKRLGVD 242
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 69/267 (25%), Positives = 131/267 (49%), Gaps = 16/267 (5%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ +++G+GQF V Y + A K + ++++ +D +E+ ++ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD- 60
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-----KGHYSERAAANLCRQMVTVV 181
H N+++ ++ + + +N++++L G+L R+I K ER Q+ + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK-DLVGSAYYVAPE 240
+ HS +MHRD+KP N ++ +K D GL FF LVG+ YY++PE
Sbjct: 120 EHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 241 VLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQ--SIFDAILRGHIDFSSDPWPNIS 297
+ N Y ++DIWS G +LY + + PF+G+ S+ I + D+ P + S
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADHYS 234
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLSK 324
+D+V + ++ DP++R + VL
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 68/246 (27%), Positives = 117/246 (47%), Gaps = 9/246 (3%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG L K +A K + + ++ + + + E ++ H +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + ++D GGELF + + + E A ++ + + Y HS+ +++RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
KPEN L S + TDFGL +P + G+ Y+APEVLR+ Y D
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W G +LY +L G+PPF+ ++D IL + + +A D++ +LH D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQ 235
Query: 313 KERLSA 318
+ RL A
Sbjct: 236 RRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 77/275 (28%), Positives = 127/275 (46%), Gaps = 20/275 (7%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
RE+G G FG Y T + A K +S + + +D+ +EV+ + L H N +E
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIE 79
Query: 133 LKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
KG Y H+ L+M+ C G ++ + + K E A +C + + Y HS +
Sbjct: 80 YKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL----RRNY 246
HRD+K N L + E +K DFG + P + F VG+ Y++APEV+ Y
Sbjct: 138 HRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVILAMDEGQY 191
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-DFSSDPWPNISSSAKDIVK 305
+ D+WS G+ L PP + S I + SS+ W S ++ V
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW---SDYFRNFVD 248
Query: 306 KMLHADPKERLSAAEVLS-KFLIPKKTLQTLADLL 339
L P++R S+ E+L +F++ ++ + DL+
Sbjct: 249 SCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLI 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 4e-28
Identities = 75/263 (28%), Positives = 125/263 (47%), Gaps = 18/263 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL--INRDDVEDVRREVQIMHHLTG 126
YI + LG+G FG YLV K + K + + +N ++ +E Q++ L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD- 60
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAAN-----LCRQMVTVV 181
H IV+ ++ +R + +I + C G +L ++ H + + N Q++ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI-QLLLGV 119
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DVFKDLVGSAYYVAPE 240
HY H ++HRDLK +N ++ LK DFG+S D+ G+ YY++PE
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNL----LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175
Query: 241 VLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
L+ + Y +++DIWS G ILY + F G+ S+ I+ G + +
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYS---RQ 232
Query: 300 AKDIVKKMLHADPKERLSAAEVL 322
I++ ML+ DP R SAAE+L
Sbjct: 233 LNSIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 25/273 (9%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-------RDDVEDVRREVQIM 121
++ G +G+G +G YL + T + A K + I +D V+ +R E++ +
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
L H NIV+ G +++ ++ GG + + G + E+ Q++ +
Sbjct: 63 KDLD-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGL 121
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-----LVGSAYY 236
Y HS G++HRDLK +N L + D K +DFG+S K D++ + + GS ++
Sbjct: 122 AYLHSKGILHRDLKADNLLVDA---DGICKISDFGISK--KSDDIYDNDQNMSMQGSVFW 176
Query: 237 VAPEVL---RRNYGAEADIWSAGVILYILLSGVPPFWGETE--QSIFD-AILRGHIDFSS 290
+APEV+ + Y A+ DIWS G ++ + +G P W + E ++F R
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPPIPP 235
Query: 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
D N+S A D + +P R +A E+L
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 68/244 (27%), Positives = 117/244 (47%), Gaps = 9/244 (3%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG L K T + +A K + ++ DDV+ E +I+ H + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + + +M+ GG+L +I + E + ++ + + H GV++RDL
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADI 252
K +N L + + K DFG+ G G+ Y+APE+L+ YG D
Sbjct: 123 KLDNILLDA---EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W+ GV++Y +++G PPF + E +F++IL H D W +S A I+K + +P
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESIL--HDDVLYPVW--LSKEAVSILKAFMTKNP 235
Query: 313 KERL 316
+RL
Sbjct: 236 NKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 79/284 (27%), Positives = 129/284 (45%), Gaps = 42/284 (14%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG LV KDT +A K + ++ ++ V +R E I+ G +V++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW-VVKMF 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++D+ ++ LIM+ GG++ ++ K SE A + V + H +G +HRD+
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDI 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFK---------------PGDV-FKDL-------- 230
KP+N L + +K +DFGL K P D F+++
Sbjct: 128 KPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184
Query: 231 ------------VGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
VG+ Y+APEV ++ Y D WS GVI+Y +L G PPF ET Q
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244
Query: 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
+ ++ P IS AKD++ + D + R+ + V
Sbjct: 245 YRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGV 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 73/256 (28%), Positives = 126/256 (49%), Gaps = 20/256 (7%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-DVEDVRREVQIMHHLTGHRNIV 131
R +GRG + LV K T++ +A K + ++L+N D D++ V+ E + + H +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
L ++ + +++ GG+L + + E A ++ ++Y H G+++
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 119
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAE 249
RDLK +N L S +K TD+G+ +PGD G+ Y+APE+LR +YG
Sbjct: 120 RDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 250 ADIWSAGVILYILLSGVPPF---------WGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
D W+ GV+++ +++G PF TE +F IL I ++S A
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKA 232
Query: 301 KDIVKKMLHADPKERL 316
++K L+ DPKERL
Sbjct: 233 ASVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 78/258 (30%), Positives = 129/258 (50%), Gaps = 11/258 (4%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
++G G G+ + T K + + A K + RK R E + EV IM H N+VE+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQ-HENVVEM 82
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
+Y + ++M+ GG L D I+ +E A +C ++ + H+ GV+HRD
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEAD 251
+K ++ L + D +K +DFG K K LVG+ Y++APE++ R YG E D
Sbjct: 142 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 252 IWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311
IWS G+++ ++ G PP++ E I R ++ +S S K + ++L D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 312 PKERLSAAEVLSKFLIPK 329
P +R +AAE+L + K
Sbjct: 258 PAQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 70/263 (26%), Positives = 124/263 (47%), Gaps = 17/263 (6%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSIS---SRKLINRDDVEDVRREVQIMHHLTGHR 128
G++LG G F Y T A K ++ + + VE +R+E+++M L H
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HP 63
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+I+ + GA + NL ++ AGG + + G + E N Q++ + Y H
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFG----LSVFFKPGDVFK-DLVGSAYYVAPEVLR 243
++HRD+K N L S+ + L+ DFG L+ F+ L+G+ ++APEVLR
Sbjct: 124 IIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 244 -RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP---NISSS 299
YG D+WS G ++ + + PP W + S A++ I ++ ++S
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP-WNAEKHSNHLALIF-KIASATTAPSIPEHLSPG 239
Query: 300 AKDIVKKMLHADPKERLSAAEVL 322
+D+ + L P++R + E+L
Sbjct: 240 LRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-27
Identities = 74/267 (27%), Positives = 119/267 (44%), Gaps = 41/267 (15%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG LV KDT +A K + ++ ++ V +R E I+ +V++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADSLWVVKMF 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++D+ ++ LIM+ GG++ ++ K +E + V + H +G +HRD+
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDI 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFK---------------PGD-VFKDL-------- 230
KP+N L S +K +DFGL K P D F+++
Sbjct: 128 KPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 231 ------------VGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
VG+ Y+APEV + Y D WS GVI+Y +L G PPF ET Q
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244
Query: 278 FDAILRGHIDFSSDPWPNISSSAKDIV 304
+ ++ P IS AKD++
Sbjct: 245 YKKVMNWKETLIFPPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 83/251 (33%), Positives = 128/251 (50%), Gaps = 17/251 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG LV HK T++ +A K +S ++I R D E IM +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVVQLF 109
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
A++D + ++M+ GG+L + +++ E+ A ++V + HSMG +HRD+
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 168
Query: 195 KPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDL-VGSAYYVAPEVLRRN-----YG 247
KP+N L S LK DFG + K G V D VG+ Y++PEVL+ YG
Sbjct: 169 KPDNMLLDKSGH---LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL--RGHIDFSSDPWPNISSSAKDIVK 305
E D WS GV LY +L G PF+ ++ + I+ + + F D +IS AK+++
Sbjct: 226 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKEAKNLIC 283
Query: 306 KMLHADPKERL 316
L D + RL
Sbjct: 284 AFL-TDREVRL 293
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 64/258 (24%), Positives = 124/258 (48%), Gaps = 10/258 (3%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R +GRG FG+ +L K ++ K I ++ +D+ + E Q++ L+ H NI+E
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIE 63
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVM 190
+ + ++ ++M+ GG L + I + + E + Q++ +H+ H+ ++
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAE 249
HRDLK +N L +K DFG+S +VG+ Y++PE+ + Y +
Sbjct: 124 HRDLKTQNILLDK--HKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK 181
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
+DIW+ G +LY L S F ++ I+ G SD S + ++ ML+
Sbjct: 182 SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---RYSPDLRQLILSMLN 238
Query: 310 ADPKERLSAAEVLSKFLI 327
DP +R ++++++ +
Sbjct: 239 LDPSKRPQLSQIMAQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-27
Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 15/249 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG K T + +ACK + ++L R + E +I+ R IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL-EKVSSRFIVSLA 59
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHR 192
A+E + + L+M L GG+L I G + E A Q++ + + H +++R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEAD 251
DLKPEN L + ++ +D GL+V K G K G+ Y+APEVL+ Y D
Sbjct: 120 DLKPENVLLD---DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 252 IWSAGVILYILLSGVPPFWGETE----QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
++ G LY +++G PF E + + L +++ S AKD+ + +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK----FSPEAKDLCEAL 232
Query: 308 LHADPKERL 316
L DP++RL
Sbjct: 233 LQKDPEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 6e-27
Identities = 76/284 (26%), Positives = 121/284 (42%), Gaps = 53/284 (18%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ LG G FG L DT +A K++ + ++NR+ V V+ E I+ + +V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNEWVVK 65
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L +++D+ ++ +MD GG++ +I + E A ++ + H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFK--------------------PGDVFKD--- 229
D+KP+N L D +K TDFGL F+ P D++ D
Sbjct: 126 DIKPDNILIDL---DGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 230 -------------------------LVGSAYYVAPEV-LRRNYGAEADIWSAGVILYILL 263
LVG+ Y+APEV LR+ Y D WS GVIL+ +L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 264 SGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
G PPF T ++ P +S A D++ K+
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-27
Identities = 80/269 (29%), Positives = 135/269 (50%), Gaps = 21/269 (7%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSI------SSRKLINRDDVEDVRREVQIMH 122
+I G +G G FG YL + + + A K + +S K R ++ + RE+ ++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
L H NIV+ G+ D +N+ ++ GG + + G + E N RQ++ ++
Sbjct: 62 ELQ-HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-------VFFKPGDVFKDLVGSAY 235
Y H+ G++HRD+K N L + +K +DFG+S + K L GS +
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGG---IKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 236 YVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294
++APEV+++ Y +ADIWS G ++ +L+G PF T+ AI + + S +
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGENASPEIPS 234
Query: 295 NISSSAKDIVKKMLHADPKERLSAAEVLS 323
NISS A D ++K D +R +AAE+L
Sbjct: 235 NISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-27
Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 44/280 (15%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
ELG G FG Y +K+T A K I ++ + +++ED E++I+ H IV+L
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILAT-CNHPYIVKL 74
Query: 134 KGAYEDRHSVNLIMDLCAGGEL------FDRIIAKGHYSERAAANLCRQMVTVVHYCHSM 187
GA+ + ++++ C GG + DR + +E +CRQM+ + Y HSM
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGL-----TEPQIQVICRQMLEALQYLHSM 129
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSV----FFKPGDVFKDLVGSAYYVAPEVLR 243
++HRDLK N L + D +K DFG+S + D F +G+ Y++APEV+
Sbjct: 130 KIIHRDLKAGNVLLT---LDGDIKLADFGVSAKNVKTLQRRDSF---IGTPYWMAPEVVM 183
Query: 244 ------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
Y +ADIWS G+ L + PP + I + S+P P +S
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK------SEP-PTLS 236
Query: 298 SSAK------DIVKKMLHADPKERLSAAEVLSKFLIPKKT 331
+K D +K L P+ R SAA++L + T
Sbjct: 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 79/265 (29%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSI--SSRKLINRDDVEDVRREVQIMHHLTGHR 128
G+ LG+G FG YL DT ++ A K + +V + E+Q++ +L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HE 64
Query: 129 NIVELKGAYED--RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
IV+ G D ++++ M+ GG + D++ + G +E RQ++ V Y HS
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK----PGDVFKDLVGSAYYVAPEVL 242
++HRD+K N L S +K DFG S + G K + G+ Y+++PEV+
Sbjct: 125 NMIVHRDIKGANILRDSVGN---VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 243 R-RNYGAEADIWSAGVILYILLSGVPPFWGETE--QSIFDAILRGHIDFSSDPW--PNIS 297
YG +ADIWS G + +L+ PP W E E +IF + ++P P++S
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQ-----PTNPVLPPHVS 235
Query: 298 SSAKDIVKKMLHADPKERLSAAEVL 322
+D +K++ + K R SA E+L
Sbjct: 236 DHCRDFLKRIF-VEAKLRPSADELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-27
Identities = 69/244 (28%), Positives = 118/244 (48%), Gaps = 9/244 (3%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG L K T + +A K + +I DDVE E +++ + +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + +M+ GG+L +I G + E A ++ + + HS G+++RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADI 252
K +N + S +K DFG+ G K G+ Y+APE++ + YG D
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W+ GV+LY +L+G PF GE E +F +I+ ++ + ++S A I K ++ P
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHP 240
Query: 313 KERL 316
+RL
Sbjct: 241 GKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 81/293 (27%), Positives = 126/293 (43%), Gaps = 54/293 (18%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ LG G FG L DTK +A K++ + ++ R+ V V+ E I+ + +V
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNEWVVR 65
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L +++D+ ++ +MD GG++ +I G + E A ++ V H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 193 DLKPENFLFSSSAEDSPLKATDFGL---------SVFFKPGDVFK--------------- 228
D+KP+N L D +K TDFGL S +++ GD +
Sbjct: 126 DIKPDNILID---RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 229 ------------------------DLVGSAYYVAPEV-LRRNYGAEADIWSAGVILYILL 263
LVG+ Y+APEV LR Y D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 264 SGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL 316
G PPF +T ++ P +S A D++ K+ P++RL
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRG-PEDRL 294
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ +G G +G Y HK T Q A K + + D+ E+++ E I+ +
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSN 61
Query: 127 HRNIVELKGAYEDRHSVN------LIMDLCAGG---ELFDRIIAKGH-YSERAAANLCRQ 176
H NI GA+ ++ L+M+LC GG +L + KG E A + R+
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAY 235
+ + Y H V+HRD+K +N L + +AE +K DFG+S ++ +G+ Y
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAE---VKLVDFGVSAQLDSTLGRRNTFIGTPY 178
Query: 236 YVAPEV------LRRNYGAEADIWSAGVILYILLSGVPPF 269
++APEV +Y A +D+WS G+ L G PP
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 94/296 (31%), Positives = 143/296 (48%), Gaps = 45/296 (15%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
N Y +++G G+FG +LV HK T++ F K+IS R L R+ + V EV +M L
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELK- 70
Query: 127 HRNIVELKGAYEDR------HSVNLIMDLCAGGELFDRIIAK-----GHYSERAAANLCR 175
H+NIV Y DR + ++M+ C G+L R I K G E A ++ R
Sbjct: 71 HKNIVR----YIDRFLNKANQKLYILMEFCDAGDL-SRNIQKCYKMFGKIEEHAIVDITR 125
Query: 176 QMVTVVHYCHSMG-------VMHRDLKPENFLFSS--------SAEDSPL------KATD 214
Q++ + YCH++ V+HRDLKP+N S+ +A+ + L K D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 215 FGLSVFFKPGDVFKDLVGSAYYVAPEVL---RRNYGAEADIWSAGVILYILLSGVPPFWG 271
FGLS + VG+ YY +PE+L ++Y ++D+W+ G I+Y L SG PF
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 272 ETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327
S + L+ D P S ++K +L+ KER SA + L +I
Sbjct: 246 ANNFSQLISELKRGPDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298
|
Length = 1021 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 80/280 (28%), Positives = 137/280 (48%), Gaps = 14/280 (5%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
D + Y ++G+G G Y T Q+ A K ++ L + E + E+ +M
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMRE 72
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
H NIV +Y + ++M+ AGG L D ++ + E A +CR+ + + +
Sbjct: 73 NK-HPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVL 242
HS V+HRD+K +N L D +K TDFG P + +VG+ Y++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 243 -RRNYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDPWPNISSSA 300
R+ YG + DIWS G++ ++ G PP+ E ++++ G + + +S+
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIF 245
Query: 301 KDIVKKMLHADPKERLSAAEVLS-KFLIPKKTLQTLADLL 339
+D + + L D ++R SA E+L FL K L +L L+
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLI 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 12/272 (4%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R LG+G FG + T + +ACK + +++ R E QI+ + R +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS-RFVVS 64
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVM 190
L AYE + ++ L++ L GG+L I G + E A ++ + H ++
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAE 249
+RDLKPEN L + ++ +D GL+V G K VG+ Y+APEV++ Y
Sbjct: 125 YRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
D W+ G +LY +++G PF ++ + + R + + S A+ + K +L
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 310 ADPKERL-----SAAEVLSKFLIPKKTLQTLA 336
DPKERL A EV L + + L
Sbjct: 242 KDPKERLGCQGGGAREVKEHPLFKQINFKRLE 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 65/279 (23%), Positives = 121/279 (43%), Gaps = 45/279 (16%)
Query: 70 IFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
G++LG G FG T + T+ + A K++ ++ + ++ E+ E IM L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKL- 58
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQ----MVTV 180
H NIV L G + ++ + GG+L D + G + + + Q M
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM--- 115
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
Y S +HRDL N L + E+ +K +DFGLS +D+ YY
Sbjct: 116 -EYLESKNFVHRDLAARNCLVT---ENLVVKISDFGLS---------RDIYEDDYYRKRG 162
Query: 238 ---------APEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286
APE L+ + +++D+WS GV+L+ + + G P+ G + + + + + G+
Sbjct: 163 GGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR 222
Query: 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325
N +++ + DP++R + +E++
Sbjct: 223 ---LPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 79/279 (28%), Positives = 134/279 (48%), Gaps = 12/279 (4%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
D + Y ++G+G G Y T Q+ A + ++ L + E + E+ +M
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRE 73
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
+ NIV +Y + ++M+ AGG L D ++ + E A +CR+ + + +
Sbjct: 74 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK-DLVGSAYYVAPEVL 242
HS V+HRD+K +N L D +K TDFG P + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 243 -RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
R+ YG + DIWS G++ ++ G PP+ E I +P +S+ +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFR 247
Query: 302 DIVKKMLHADPKERLSAAEVLS-KFLIPKKTLQTLADLL 339
D + + L D ++R SA E+L +FL K L +L L+
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 79/251 (31%), Positives = 128/251 (50%), Gaps = 17/251 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG LV HK +++ +A K +S ++I R D E IM +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVVQLF 109
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
A++D + ++M+ GG+L + +++ E+ A ++V + HSMG++HRD+
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDV 168
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDL-VGSAYYVAPEVLRRN-----YG 247
KP+N L LK DFG + + G V D VG+ Y++PEVL+ YG
Sbjct: 169 KPDNMLLDKHGH---LKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL--RGHIDFSSDPWPNISSSAKDIVK 305
E D WS GV L+ +L G PF+ ++ + I+ + ++F D IS AK+++
Sbjct: 226 RECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED--VEISKHAKNLIC 283
Query: 306 KMLHADPKERL 316
L D + RL
Sbjct: 284 AFL-TDREVRL 293
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-26
Identities = 68/244 (27%), Positives = 117/244 (47%), Gaps = 9/244 (3%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG L K T + +A K + +I DDVE E +++ + +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + +M+ GG+L I G + E A ++ + + H G+++RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADI 252
K +N + S +K DFG+ G + G+ Y+APE++ + YG D
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W+ GV+LY +L+G PPF GE E +F +I+ ++ + ++S A I K ++ P
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLMTKHP 240
Query: 313 KERL 316
+RL
Sbjct: 241 SKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 73/246 (29%), Positives = 122/246 (49%), Gaps = 13/246 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG +L K T Q FA K++ ++ DDVE E +++ H + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + ++ +M+ GG+L I + + A +++ + + HS G+++RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLR-RNYGAEADI 252
K +N L + D +K DFG+ GD G+ Y+APE+L + Y D
Sbjct: 123 KLDNILLDT---DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP-WPN-ISSSAKDIVKKMLHA 310
WS GV+LY +L G PF G E+ +F +I +P +P ++ AKDI+ K+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSIR------MDNPCYPRWLTREAKDILVKLFVR 233
Query: 311 DPKERL 316
+P+ RL
Sbjct: 234 EPERRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 16/283 (5%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+D ++ E+G G FG Y T+ T + A K +S + +D+ +EV+ +
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
L H N +E KG Y H+ L+M+ C G + K E A + + +
Sbjct: 77 QLK-HPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 135
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
Y HS ++HRD+K N L + E +K DFG + P + F VG+ Y++APEV+
Sbjct: 136 YLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVI 189
Query: 243 ----RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-DFSSDPWPNIS 297
Y + D+WS G+ L PP + S I + S+ W +
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---T 246
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLS-KFLIPKKTLQTLADLL 339
S + V L P+ER ++AE+L F+ + + L DL+
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLI 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 79/281 (28%), Positives = 135/281 (48%), Gaps = 12/281 (4%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
D + Y ++G+G G + T Q+ A K I+ +K + E + E+ +M
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---ELIINEILVMKE 72
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
L + NIV ++ + ++M+ AGG L D ++ + E A +CR+ + + +
Sbjct: 73 LK-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEF 130
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVL 242
H+ V+HRD+K +N L D +K TDFG P + +VG+ Y++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 243 -RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
R+ YG + DIWS G++ ++ G PP+ E I +P +S +
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSPIFR 246
Query: 302 DIVKKMLHADPKERLSAAEVLSK-FLIPKKTLQTLADLLYS 341
D + + L D ++R SA E+L FL K L +L L+ +
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLILA 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 69/253 (27%), Positives = 119/253 (47%), Gaps = 16/253 (6%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R +GRG + LV K Q +A K + + + +D++ V+ E + + + +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L ++ + L+++ GG+L + + E A ++ +++ H G+++R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 193 DLKPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEA 250
DLK +N L D +K TD+G+ PGD G+ Y+APE+LR YG
Sbjct: 121 DLKLDNVLLD---ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 251 DIWSAGVILYILLSGVPPF-------WGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303
D W+ GV+++ +++G PF TE +F IL I +S A +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHV 233
Query: 304 VKKMLHADPKERL 316
+K L+ DPKERL
Sbjct: 234 LKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 76/257 (29%), Positives = 136/257 (52%), Gaps = 25/257 (9%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN-IVEL 133
+GRG FG +V K+T Q +A K ++ +++ R + R E ++ + G R I L
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN--GDRRWITNL 66
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR----QMVTVVHYCHSMGV 189
A++D +++ L+MD GG+L +++K + +R ++ R +MV + H +G
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLT-LLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLGY 123
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDL-VGSAYYVAPEVLRR--- 244
+HRD+KP+N L + ++ DFG + G V ++ VG+ Y++PE+L+
Sbjct: 124 VHRDIKPDNVLLDKNGH---IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 245 ---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL--RGHIDFSSDPWPNISSS 299
YG E D WS GV +Y +L G PF+ E+ + I+ + H F D ++S
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-TDVSEE 239
Query: 300 AKDIVKKMLHADPKERL 316
AKD++++++ P+ RL
Sbjct: 240 AKDLIRRLI-CSPETRL 255
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 69/255 (27%), Positives = 125/255 (49%), Gaps = 18/255 (7%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R +GRG + LV K T++ +A K I + + +D++ V+ E + + H +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L ++ + +++ +GG+L + + E A ++ +++ H G+++R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 193 DLKPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEA 250
DLK +N L + + +K TD+G+ +PGD G+ Y+APE+LR +YG
Sbjct: 121 DLKLDNVLLDA---EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 251 DIWSAGVILYILLSGVPPF---------WGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
D W+ GV+++ +++G PF TE +F IL I ++S A
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAS 233
Query: 302 DIVKKMLHADPKERL 316
++K L+ DPKERL
Sbjct: 234 SVLKGFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 79/288 (27%), Positives = 132/288 (45%), Gaps = 55/288 (19%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRNI 130
+G G +G+ HK+T Q A K K + +D + V+ RE++++ L H N+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQLR-HENL 62
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCR----QMVTVVHYC 184
V L + + + L+ E D + Y + R Q++ + +C
Sbjct: 63 VNLIEVFRRKKRLYLVF------EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAPEVLR 243
HS ++HRD+KPEN L S S +K DFG + PG+V+ D V + +Y APE+L
Sbjct: 117 HSHNIIHRDIKPENILVSQSG---VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV 173
Query: 244 RN--YGAEADIWSAGVILYILLSGVPPFWGETE------------------QSIFD---- 279
+ YG DIW+ G ++ +L+G P F G+++ Q IF
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233
Query: 280 -AILR----GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
A +R I+ +P +S D+ K+ L DP +R S++++L
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 67/250 (26%), Positives = 126/250 (50%), Gaps = 12/250 (4%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+++GRGQF Y T ++ A K + ++++ +D +E+ ++ L H N+++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIK 66
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRII----AKGHYSERAAANLCRQMVTVVHYCHSMG 188
++ + + +N++++L G+L I K ER Q+ + V + HS
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-FKDLVGSAYYVAPEVLRRN-Y 246
VMHRD+KP N +++ +K D GL FF LVG+ YY++PE + N Y
Sbjct: 127 VMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR-GHIDFSSDPWPNISSSAKDIVK 305
++DIWS G +LY + + PF+G+ + ++F + D+ P + S +++V
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGD-KMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVS 242
Query: 306 KMLHADPKER 315
++ DP +R
Sbjct: 243 MCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 77/262 (29%), Positives = 127/262 (48%), Gaps = 18/262 (6%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSIS--SRKLINRDDVEDVRREVQIMHHLTGHRN 129
G+ LG+G FG YL DT ++ A K + +V + E+Q++ +L H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HER 65
Query: 130 IVELKGAYEDR--HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM 187
IV+ G DR ++ + M+ GG + D++ A G +E RQ++ + Y HS
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFG----LSVFFKPGDVFKDLVGSAYYVAPEVLR 243
++HRD+K N L S+ +K DFG L G + + G+ Y+++PEV+
Sbjct: 126 MIVHRDIKGANILRDSAGN---VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 244 -RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN-ISSSAK 301
YG +AD+WS G + +L+ PP W E E AI + ++ P+ IS A+
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP-WAEYEA--MAAIFKIATQPTNPQLPSHISEHAR 239
Query: 302 DIVKKMLHADPKERLSAAEVLS 323
D + + + + R SA E+L
Sbjct: 240 DFLGCIF-VEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 89/298 (29%), Positives = 133/298 (44%), Gaps = 55/298 (18%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSI----SSRKLINRDDVEDVRREVQ 119
++ N Y+ + +G G FG+ + T Q A K I S+ L R RE++
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKR-----TYRELK 61
Query: 120 IMHHLTGHRNIVELKGAY----EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR 175
++ HL H NI+ L + ED + V ++ G R++ ++
Sbjct: 62 LLKHLR-HENIISLSDIFISPLEDIYFVTELL-----GTDLHRLLTSRPLEKQFIQYFLY 115
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY 235
Q++ + Y HS GV+HRDLKP N L + E+ LK DFGL+ P V + Y
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILIN---ENCDLKICDFGLARIQDPQ--MTGYVSTRY 170
Query: 236 YVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL----------- 282
Y APE++ + Y E DIWSAG I +L G P F G+ + F I
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230
Query: 283 -----------------RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
R + FS + N SA D+++KML DP++R+SAAE L+
Sbjct: 231 NTICSENTLRFVQSLPKREPVPFSEK-FKNADPSAIDLLEKMLVFDPQKRISAAEALA 287
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 80/279 (28%), Positives = 131/279 (46%), Gaps = 12/279 (4%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
D + Y ++G+G G Y T Q+ A K ++ L + E + E+ +M
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRE 72
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
+ NIV +Y + ++M+ AGG L D ++ + E A +CR+ + + +
Sbjct: 73 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDF 130
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVL 242
HS V+HRD+K +N L D +K TDFG P + +VG+ Y++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 243 -RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
R+ YG + DIWS G++ ++ G PP+ E I +P +S+ +
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-ERLSAVFR 246
Query: 302 DIVKKMLHADPKERLSAAEVLSK-FLIPKKTLQTLADLL 339
D + + L D R SA E+L FL K L +L L+
Sbjct: 247 DFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLI 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 47/284 (16%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRNI 130
+G G +GV + +++T Q A K K + +D ++ RE++++ L H N+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLK-HPNL 62
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGV 189
V L + + ++L+ + C + + + E + Q + V++CH
Sbjct: 63 VNLIEVFRRKRKLHLVFEYC-DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAPEVL--RRNY 246
+HRD+KPEN L + + +K DFG + PGD + D V + +Y APE+L Y
Sbjct: 122 IHRDVKPENILITKQGQ---IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETE--------QSIFDAILRGHID-FSS------- 290
G D+W+ G + LL+G P + G+++ +++ D I R H FS+
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR-HQQIFSTNQFFKGL 237
Query: 291 ------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
+PNISS A +K L DP ERLS E+L
Sbjct: 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 75/249 (30%), Positives = 122/249 (48%), Gaps = 19/249 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG L K + FA K++ ++ DDVE E +++ + + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + + +M+ GG+L I KG + A ++V + + HS G+++RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-----LVGSAYYVAPEVLR-RNYGA 248
K +N + D +K DFG+ +VF D G+ Y+APE+L+ Y
Sbjct: 123 KLDNVMLD---RDGHIKIADFGMC----KENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175
Query: 249 EADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP-WPNISSSAKDIVKKM 307
D WS GV+LY +L G PF G+ E +F++I +D P W I+ +KDI++K+
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---RVDTPHYPRW--ITKESKDILEKL 230
Query: 308 LHADPKERL 316
DP RL
Sbjct: 231 FERDPTRRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 80/304 (26%), Positives = 132/304 (43%), Gaps = 63/304 (20%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQ--FACKSIS---SRKLINRDDVEDVRREVQIMHH 123
Y +ELG+G +G+ + +T ++ A K I+ S+K++ + + RE++++ H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLRH 57
Query: 124 LTGHRNIVEL-------KGAYEDRHSVNLIM--DLCAGGELFDRIIAKGH-YSERAAANL 173
GH+NI L G + + + +M DL II G ++ +
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQ-------IIRSGQPLTDAHFQSF 110
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-----FK 228
Q++ + Y HS V+HRDLKP N L ++ E LK DFGL+ F
Sbjct: 111 IYQILCGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGFSENPGENAGFMT 167
Query: 229 DLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR--- 283
+ V + +Y APE++ ++Y D+WS G IL LL P F G+ + IL+
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227
Query: 284 ----------------------GHIDFSSDPW--PNISSSAKDIVKKMLHADPKERLSAA 319
+I PN + A D+++K+L DP +R+S
Sbjct: 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVE 287
Query: 320 EVLS 323
E L
Sbjct: 288 EALE 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 70/257 (27%), Positives = 119/257 (46%), Gaps = 12/257 (4%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R LG+G FG + T + +ACK + +++ R E QI+ + R +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVS 64
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRI--IAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
L AYE + ++ L++ L GG+L I + + E A ++ + H ++
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV 124
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAE 249
+RDLKPEN L ++ +D GL+V G+ + VG+ Y+APEV++ Y
Sbjct: 125 YRDLKPENILLDDYGH---IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
D W G ++Y ++ G PF E+ + + R + + S +A+ I +++L
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 310 ADPKERL-----SAAEV 321
DP RL A EV
Sbjct: 242 KDPGFRLGCRGEGAEEV 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-24
Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 11/256 (4%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+++G G FG YL K + K I K+ ++ E ++EV ++ + H NIV
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMK-HPNIVT 63
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRI-IAKG-HYSERAAANLCRQMVTVVHYCHSMGVM 190
++++ + ++M+ C GG+L RI +G +SE + Q+ + + H ++
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKIL 123
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLR-RNYGA 248
HRD+K +N S + + K DFG++ ++ VG+ YY++PE+ + R Y
Sbjct: 124 HRDIKSQNIFLSKNGMVA--KLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181
Query: 249 EADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML 308
+ DIWS G +LY L + PF G + I +G+ S PN S + ++ ++
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS---PNFSRDLRSLISQLF 238
Query: 309 HADPKERLSAAEVLSK 324
P++R S +L +
Sbjct: 239 KVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-24
Identities = 67/247 (27%), Positives = 116/247 (46%), Gaps = 7/247 (2%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R LG+G FG + T + +ACK + +++ R E +I+ + R +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-RFVVS 64
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVM 190
L AYE + ++ L++ + GG+L I G+ + E+ A ++ + ++
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAE 249
+RDLKPEN L ++ +D GL+V G+ + VG+ Y+APEV+ Y
Sbjct: 125 YRDLKPENILLDDRGH---IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
D W G ++Y ++ G PF E+ + + R + + S AK I + +L
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
Query: 310 ADPKERL 316
+PKERL
Sbjct: 242 KNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-24
Identities = 68/265 (25%), Positives = 128/265 (48%), Gaps = 15/265 (5%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y F R +G+G +G LV H+ +Q+ K ++ R R+ + +E Q++ L H
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLK-HP 59
Query: 129 NIVELKGAYEDRHS-VNLIMDLCAGGELFDRII-AKGH-YSERAAANLCRQMVTVVHYCH 185
NIV + ++E + ++M C GG+L+ ++ KG E Q+ + Y H
Sbjct: 60 NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVL-R 243
++HRDLK +N + + + +K D G++ V D+ L+G+ YY++PE+
Sbjct: 120 EKHILHRDLKTQNVFLTRT---NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176
Query: 244 RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKD 302
+ Y ++D+W+ G +Y + + F + S+ I+ G + P P + S +
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL----PPMPKDYSPELGE 232
Query: 303 IVKKMLHADPKERLSAAEVLSKFLI 327
++ ML P++R S +L + I
Sbjct: 233 LIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-24
Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 16/273 (5%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
RE+G G FG Y T + A K +S + + +D+ +EV+ + + H N +E
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIE 89
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
KG Y H+ L+M+ C G + K E A + + + Y HS ++HR
Sbjct: 90 YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL----RRNYGA 248
D+K N L + E +K DFG + P + F VG+ Y++APEV+ Y
Sbjct: 150 DIKAGNILLT---EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYDG 203
Query: 249 EADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-DFSSDPWPNISSSAKDIVKKM 307
+ D+WS G+ L PP + S I + S+ W S ++ V
Sbjct: 204 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFRNFVDSC 260
Query: 308 LHADPKERLSAAEVLSKFLIPKKTLQT-LADLL 339
L P++R ++ E+L + ++ +T L DL+
Sbjct: 261 LQKIPQDRPTSEELLKHMFVLRERPETVLIDLI 293
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 66/189 (34%), Positives = 101/189 (53%), Gaps = 16/189 (8%)
Query: 143 VNLIMDLCAGGELFDRIIAKGH----YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198
+ L++D G+L I ++ + E A L Q++ VH+ HS ++HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 199 FLFSSSAEDSPLKATDFGLSVFFK---PGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWS 254
L S + +K DFG S + DV + G+ YYVAPE+ RR Y +AD++S
Sbjct: 174 ILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFS 230
Query: 255 AGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKDIVKKMLHADPK 313
GV+LY LL+ PF GE + + L G DP P +IS ++IV +L +DPK
Sbjct: 231 LGVLLYELLTLKRPFDGENMEEVMHKTLAGRY----DPLPPSISPEMQEIVTALLSSDPK 286
Query: 314 ERLSAAEVL 322
R S++++L
Sbjct: 287 RRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 5e-24
Identities = 64/283 (22%), Positives = 119/283 (42%), Gaps = 52/283 (18%)
Query: 73 RELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
++LG G FG Y L + A K++ + ++ +D +E ++M L GH N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKL-GHPN 57
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERA-------------AANLCRQ 176
+V L G + + L+++ GG+L D + A + +
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYY 236
M Y S +HRDL N L ED +K +DFGLS +D+ YY
Sbjct: 118 M----EYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLS---------RDVYDDDYY 161
Query: 237 V------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAIL 282
APE L+ + +++D+WS GV+L+ + + G P+ G + + + + +
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR 221
Query: 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325
+G+ P +++ DP++R + +E++ +
Sbjct: 222 KGY--RLPKP-EYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-24
Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 24/260 (9%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G +G+ Y T+ + A K I R + V+ + E+ + +L HRNIV+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYL 71
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSMGVMH 191
G+ + + M+ GG L + +K +E+ +Q++ + Y H ++H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLS---VFFKPGDVFKDLVGSAYYVAPEVL---RRN 245
RD+K +N L ++ + +K +DFG S P + G+ Y+APEV+ R
Sbjct: 132 RDIKGDNVLVNTYS--GVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRG 187
Query: 246 YGAEADIWSAGVILYILLSGVPPFW--GETEQSIFD-AILRGHIDFSSDPWPNISSSAKD 302
YGA ADIWS G + + +G PPF GE + ++F + + H + +S+ AK+
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES----LSAEAKN 243
Query: 303 IVKKMLHADPKERLSAAEVL 322
+ + DP +R SA ++L
Sbjct: 244 FILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 8e-24
Identities = 82/289 (28%), Positives = 122/289 (42%), Gaps = 53/289 (18%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED------VRREVQIMHHLTGH 127
++G G +GV Y +K T Q A K I R + E+ RE+ ++ L H
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKI-------RLESEEEGVPSTAIREISLLKELQ-H 58
Query: 128 RNIVELKGAYEDRHSVNLI-----MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
NIV L+ + LI MDL + D + + + Q++ +
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSMDL---KKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEV 241
+CHS V+HRDLKP+N L + +K DFGL+ F P V+ V + +Y APEV
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGV---IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172
Query: 242 L--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP----- 294
L Y DIWS G I + + P F G++E I R + D WP
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232
Query: 295 --------------------NISSSAKDIVKKMLHADPKERLSAAEVLS 323
N+ D+++KML DP +R+SA + L+
Sbjct: 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 8e-24
Identities = 79/308 (25%), Positives = 131/308 (42%), Gaps = 72/308 (23%)
Query: 66 RNTYIFGRELGR---GQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR------- 115
R+ + + L R G +GV Y K T + A K + K+ E +
Sbjct: 2 RSVDEYEK-LNRIEEGTYGVVYRARDKKTGEIVALKKL---KM------EKEKEGFPITS 51
Query: 116 -REVQIMHHLTGHRNIVELK----GAYEDRHSVNLIM-----DLCAGGELFDRIIAKGHY 165
RE+ I+ L H NIV +K G+ + + ++M DL + L + + K +
Sbjct: 52 LREINILLKL-QHPNIVTVKEVVVGS--NLDKIYMVMEYVEHDLKS---LMETM--KQPF 103
Query: 166 SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPG 224
+ L Q+++ V + H ++HRDLK N L ++ LK DFGL+ + P
Sbjct: 104 LQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI---LKICDFGLAREYGSPL 160
Query: 225 DVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL 282
+ LV + +Y APE+L + Y D+WS G I LL+ P F G++E + I
Sbjct: 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF 220
Query: 283 R-------------------GHIDFSSDP-------WPNISSSAK--DIVKKMLHADPKE 314
+ F+ P +P +S S D++ ++L DP +
Sbjct: 221 KLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAK 280
Query: 315 RLSAAEVL 322
R+SA + L
Sbjct: 281 RISAEDAL 288
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 8e-24
Identities = 73/261 (27%), Positives = 120/261 (45%), Gaps = 30/261 (11%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG V K+T + +ACK + ++L + + E +I+ + IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC---------- 184
A+E + + L+M L GG+L I + ER +M V+HY
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIY---NVGERGL-----EMERVIHYSAQITCGILHL 111
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
HSM +++RD+KPEN L + +D GL+V K G G+ Y+APE+L+
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGN---CRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE 168
Query: 245 N-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR----GHIDFSSDPWPNISSS 299
Y D ++ G +Y +++G PF E+ + + R + F N +
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEE 225
Query: 300 AKDIVKKMLHADPKERLSAAE 320
+KDI + L P++RL + E
Sbjct: 226 SKDICRLFLAKKPEDRLGSRE 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 9e-24
Identities = 76/271 (28%), Positives = 122/271 (45%), Gaps = 32/271 (11%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
LG G G K+T FA K+I++ N D + + RE++I IV+
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKS-CKSPYIVK 63
Query: 133 LKGAYEDRHS--VNLIMDLCAGGELFDRIIAK-----GHYSERAAANLCRQMVTVVHYCH 185
GA+ D S + + M+ C GG L D I K G E+ + ++ + Y H
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL----VGSAYYVAPEV 241
S ++HRD+KP N L + + +K DFG+S G++ L G+++Y+APE
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQ---VKLCDFGVS-----GELVNSLAGTFTGTSFYMAPER 174
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS------DPWP 294
++ + Y +D+WS G+ L + PF E E + L +I +P
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234
Query: 295 NI--SSSAKDIVKKMLHADPKERLSAAEVLS 323
I S KD +K+ L DP R + ++L
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-23
Identities = 84/299 (28%), Positives = 141/299 (47%), Gaps = 33/299 (11%)
Query: 37 PGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFA 96
P P SSS++S+++S K + ++ +G G G Y V H+ T + +A
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAKSLSELER----VNRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 97 CKSISSRKLINRDDVEDVR----REVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152
K I N +D VR RE++I+ + H N+V+ ++ + ++++ G
Sbjct: 104 LKVIYG----NHED--TVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEFMDG 156
Query: 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212
G L IA E+ A++ RQ+++ + Y H ++HRD+KP N L +S+ +K
Sbjct: 157 GSLEGTHIAD----EQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKI 209
Query: 213 TDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRR--NYGA----EADIWSAGVILYILLSG 265
DFG+S + + D VG+ Y++PE + N+GA DIWS GV + G
Sbjct: 210 ADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
Query: 266 VPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA--KDIVKKMLHADPKERLSAAEVL 322
PF G Q + A L I S P ++S + + L +P +R SA ++L
Sbjct: 270 RFPF-GVGRQGDW-ASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-23
Identities = 76/263 (28%), Positives = 127/263 (48%), Gaps = 22/263 (8%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSI----SSRKLINRDDVEDVRREVQIMHHLTGH 127
G+ LGRG FG YL DT ++ A K + S++ +V + E+Q++ +L H
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE--TSKEVNALECEIQLLKNLR-H 63
Query: 128 RNIVELKGAYED--RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH 185
IV+ G D +++ ++ GG + D++ A G +E RQ++ V Y H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS----VFFKPGDVFKDLVGSAYYVAPEV 241
S ++HRD+K N L S+ +K DFG S G K + G+ Y+++PEV
Sbjct: 124 SNMIVHRDIKGANILRDSAGN---VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSS 299
+ YG +AD+WS + +L+ PP W E E AI + + P +S +
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYEA--MAAIFKIATQPTKPMLPDGVSDA 237
Query: 300 AKDIVKKMLHADPKERLSAAEVL 322
+D +K++ + K R +A +L
Sbjct: 238 CRDFLKQIFVEE-KRRPTAEFLL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 2e-23
Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 61/303 (20%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG LV KDT + +A K++ ++ +D + V+ E ++ + +V L
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDSPWVVSLY 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++D + LIM+ GG+L +I +SE + V + H +G +HRD+
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLSV-FFKPGD--VFKDL--------------------- 230
KP+N L +K +DFGLS F K D ++ L
Sbjct: 128 KPDNILIDR---GGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184
Query: 231 ------------------------VGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSG 265
VG+ Y+APE+ L++ YG E D WS G I++ L G
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244
Query: 266 VPPFWGETEQSIFDAIL--RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL---SAAE 320
PPF E + I+ R + F D ++S A+D++++++ + + RL A E
Sbjct: 245 WPPFCSENSHETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLI-TNAENRLGRGGAHE 301
Query: 321 VLS 323
+ S
Sbjct: 302 IKS 304
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-23
Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 28/263 (10%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
ELG G FG Y +K+T A K I ++ + +++ED E+ I+ H NIV+L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILAS-CDHPNIVKL 67
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMH 191
A+ +++ ++++ CAGG + D ++ + +E +C+Q + ++Y H ++H
Sbjct: 68 LDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSV----FFKPGDVFKDLVGSAYYVAPEVLR---- 243
RDLK N LF+ D +K DFG+S + D F +G+ Y++APEV+
Sbjct: 127 RDLKAGNILFTL---DGDIKLADFGVSAKNTRTIQRRDSF---IGTPYWMAPEVVMCETS 180
Query: 244 --RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP--WPNISSS 299
R Y +AD+WS G+ L + PP + I + + P W SS
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---SSE 237
Query: 300 AKDIVKKMLHADPKERLSAAEVL 322
KD +KK L + R + ++L
Sbjct: 238 FKDFLKKCLEKNVDARWTTTQLL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 5e-23
Identities = 70/251 (27%), Positives = 130/251 (51%), Gaps = 28/251 (11%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVEL 133
+GRG FG +V K T++ +A K ++ +++ R + R E ++ + G + I L
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVL--VNGDCQWITTL 66
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR----QMVTVVHYCHSMGV 189
A++D + + L+MD GG+L +++K + +R ++ R +MV +H H +
Sbjct: 67 HYAFQDENYLYLVMDYYVGGDLLT-LLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLHY 123
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDL-VGSAYYVAPEVLRR--- 244
+HRD+KP+N L + ++ DFG + + G V + VG+ Y++PE+L+
Sbjct: 124 VHRDIKPDNVLLDMNGH---IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 245 ---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP----NIS 297
YG E D WS GV +Y +L G PF+ E+ + I+ F +P ++S
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHITDVS 237
Query: 298 SSAKDIVKKML 308
AKD++++++
Sbjct: 238 EEAKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 7e-23
Identities = 66/251 (26%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+++GRGQF Y T A K + L++ D +E+ ++ L H N+++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIK 66
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRII-----AKGHYSERAAANLCRQMVTVVHYCHSM 187
++ + + +N++++L G+L R+I K E+ Q+ + + + HS
Sbjct: 67 YYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR 125
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-FKDLVGSAYYVAPEVLRRN- 245
VMHRD+KP N +++ +K D GL FF LVG+ YY++PE + N
Sbjct: 126 RVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR-GHIDFSSDPWPNISSSAKDIV 304
Y ++DIWS G +LY + + PF+G+ + +++ + D+ P + S + +V
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 241
Query: 305 KKMLHADPKER 315
++ DP++R
Sbjct: 242 NMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 7e-23
Identities = 83/302 (27%), Positives = 132/302 (43%), Gaps = 46/302 (15%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L K + +V + Y +G G +G T ++ A K +S R + + RE
Sbjct: 6 LNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRE 64
Query: 118 VQIMHHLTGHRNIVELKGAY------EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA 171
++++ H+ H N++ L + ED V L+ L G +L + I+ S+
Sbjct: 65 LRLLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADL-NNIVKCQKLSDDHIQ 121
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
L Q++ + Y HS G++HRDLKP N + ED LK DFGL+ D V
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFGLAR--HTDDEMTGYV 176
Query: 232 GSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL------- 282
+ +Y APE++ +Y DIWS G I+ LL+G F G I+
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236
Query: 283 ------------RGHI---------DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
R +I DF + + + A D+++KML DP +R++AAE
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDF-KEVFSGANPLAIDLLEKMLVLDPDKRITAAEA 295
Query: 322 LS 323
L+
Sbjct: 296 LA 297
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 7e-23
Identities = 83/315 (26%), Positives = 131/315 (41%), Gaps = 66/315 (20%)
Query: 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REV 118
P D + Y ++G+G FG + HK TKQ A K + + N + + RE+
Sbjct: 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV---LMENEKEGFPITALREI 62
Query: 119 QIMHHLTGHRNIVEL--------KGAYEDRHSVNLIMDLC----AGGELFDRIIAKGHYS 166
+I+ L H N+V L + S L+ + C AG L K S
Sbjct: 63 KILQLLK-HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVKFTLS 119
Query: 167 ERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF----- 221
E + + ++ ++Y H ++HRD+K N L + +D LK DFGL+ F
Sbjct: 120 EIKK--VMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKN 174
Query: 222 -KPGDVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIF 278
KP + + + V + +Y PE+L R+YG D+W AG I+ + + P G TEQ
Sbjct: 175 SKP-NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL 233
Query: 279 DAI--LRGHIDFSSDPWPNI----------------------------SSSAKDIVKKML 308
I L G I + + WP + A D++ K+L
Sbjct: 234 TLISQLCGSI--TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLL 291
Query: 309 HADPKERLSAAEVLS 323
DP +R+ A L+
Sbjct: 292 VLDPAKRIDADTALN 306
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 9e-23
Identities = 68/250 (27%), Positives = 129/250 (51%), Gaps = 26/250 (10%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG +V K+ + FA K ++ +++ R + R E ++ + ++ I L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDNQWITTLH 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR----QMVTVVHYCHSMGVM 190
A++D +++ L+MD GG+L +++K + +R ++ R +MV + H + +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLT-LLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDL-VGSAYYVAPEVL------ 242
HRD+KP+N L + ++ DFG + + G V + VG+ Y++PE+L
Sbjct: 125 HRDIKPDNILMDMNGH---IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 243 RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP----NISS 298
+ YG E D WS GV +Y +L G PF+ E+ + I+ F +P ++S
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPAQVTDVSE 238
Query: 299 SAKDIVKKML 308
AKD++++++
Sbjct: 239 DAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 86/318 (27%), Positives = 127/318 (39%), Gaps = 66/318 (20%)
Query: 62 MEDVRNTYIF-GRELGRGQFGVTYLVTHKDTKQQFACK-----SISSRKLINRDDVEDV- 114
+ YI G LG G +G T + A K IS+ +R V
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 115 -----RREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSE 167
RE++IM+ + H NI+ L Y + +NL+MD+ A ++ DR I +E
Sbjct: 63 IHFTTLRELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI---RLTE 118
Query: 168 RAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
+ Q++ ++ H MHRDL P N +S K DFGL+ +
Sbjct: 119 SQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYS 175
Query: 228 KDL---------------VGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFW 270
L V + +Y APE+L Y D+WS G I LL+G P F
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235
Query: 271 GETE----QSIFDAILRG---------------HIDFS-------SDPWPNISSSAKDIV 304
GE E IF+ L G + +F+ +PN S A D++
Sbjct: 236 GENEIDQLGRIFE--LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLL 293
Query: 305 KKMLHADPKERLSAAEVL 322
+ +L +P ER+SA E L
Sbjct: 294 QSLLKLNPLERISAKEAL 311
|
Length = 335 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-22
Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 16/273 (5%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
RE+G G FG Y + A K +S + + +D+ +EV+ + L H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 79
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
+G Y H+ L+M+ C G + K E A + + + Y HS ++HR
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL----RRNYGA 248
D+K N L S E +K DFG + P + F VG+ Y++APEV+ Y
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193
Query: 249 EADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID-FSSDPWPNISSSAKDIVKKM 307
+ D+WS G+ L PP + S I + S W S ++ V
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 250
Query: 308 LHADPKERLSAAEVLS-KFLIPKKTLQTLADLL 339
L P++R ++ +L +F++ ++ + DL+
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-22
Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 18/243 (7%)
Query: 78 GQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM-HHLTG-HRNIVELKG 135
G+FG ++ HK T++ F K I ++ ++ M H L + N ++L
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNF----------NAIEPMVHQLMKDNPNFIKLYY 76
Query: 136 AYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLK 195
+ LIMD G+LFD + +G SE + RQ+V ++ H ++H D+K
Sbjct: 77 SVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIK 136
Query: 196 PENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE-VLRRNYGAEADIWS 254
EN L+ + + + D+GL K G+ Y +PE + NY D W+
Sbjct: 137 LENVLYDRAKDR--IYLCDYGLC---KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWA 191
Query: 255 AGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKE 314
GV+ Y LL+G PF + ++ + L N+S +A D V+ ML +
Sbjct: 192 VGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINY 251
Query: 315 RLS 317
RL+
Sbjct: 252 RLT 254
|
Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 46/284 (16%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE-DVRREVQIMHHLTGHRNIVEL 133
+G G +G+ Y + + A K + RD + RE+ ++ +L H NIVEL
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDN--ERDGIPISSLREITLLLNLR-HPNIVEL 71
Query: 134 KGAYEDRH--SVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGV 189
K +H S+ L+M+ C L D + +SE L Q++ + Y H +
Sbjct: 72 KEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHENFI 129
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL---VGSAYYVAPEVL--RR 244
+HRDLK N L + LK DFGL+ + G K + V + +Y APE+L
Sbjct: 130 IHRDLKVSNLLLTDKGC---LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLGCT 184
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI--LRG----HI--DFSSDP---- 292
Y D+W+ G IL LL+ P G++E D I L G I FS P
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244
Query: 293 --------------WPNISSSAKDIVKKMLHADPKERLSAAEVL 322
+P +S + ++ +L DPK+R +A E L
Sbjct: 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-22
Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 12/205 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G G +GV HK+TK+ A K + N + E RE++++ L NIVELK
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELK 66
Query: 135 GAYEDRHSVNLIMDLCAGG--ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
A+ R + L+ + EL + + G E+ + + Q++ +H+CH ++HR
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYI-YQLIKAIHWCHKNDIVHR 124
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD--VFKDLVGSAYYVAPEVLR-RNYGAE 249
D+KPEN L S + LK DFG + G + + V + +Y +PE+L YG
Sbjct: 125 DIKPENLLISH---NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 250 ADIWSAGVILYILLSGVPPFWGETE 274
D+WS G IL L G P F GE+E
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 5e-22
Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 49/293 (16%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y+ + +GRG +G+ + +T ++ A K I++ NR D + RE++++ HL H
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLD-HE 64
Query: 129 NIVELKG--------AYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
N++ +K A+ D + V +MD +L I + S+ Q++
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDT----DLHQIIRSSQTLSDDHCQYFLYQLLRG 120
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAP 239
+ Y HS V+HRDLKP N L +++ + LK DFGL+ + GD + V + +Y AP
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177
Query: 240 EVLRR--NYGAEADIWSAGVILYILLSGVPPFWG------------------ETEQSIFD 279
E+L Y D+WS G I LL P F G E +
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237
Query: 280 A-----ILRG-----HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
+R F + +P+ + A D+++KML DP +R++ E L
Sbjct: 238 NEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL 289
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 6e-22
Identities = 75/284 (26%), Positives = 118/284 (41%), Gaps = 46/284 (16%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-----VRREVQIMHHLTGHR 128
+LG G + Y ++ T + A K I D E+ RE+ +M L H
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEI-------HLDAEEGTPSTAIREISLMKELK-HE 58
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGG--ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
NIV L + + L+ + + D +G + Q++ + +CH
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVL--R 243
V+HRDLKP+N L + E LK DFGL+ F P + F + V + +Y AP+VL
Sbjct: 119 NRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 244 RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK-- 301
R Y DIWS G I+ +++G P F G + I R + WP IS +
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235
Query: 302 -----------------------DIVKKMLHADPKERLSAAEVL 322
D++ ++L +P+ R+SA + L
Sbjct: 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 6e-22
Identities = 74/264 (28%), Positives = 126/264 (47%), Gaps = 16/264 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG Y TK+ A K I + D++ED+++E+ ++ I
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY-ITRYY 68
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
G+Y + +IM+ GG D ++ G E A + R+++ + Y HS +HRD+
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLRRN-YGAEADI 252
K N L S E +K DFG++ + ++ VG+ +++APEV++++ Y +ADI
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP--WPNISSSAKDIVKKMLHA 310
WS G+ L G PP + I + +S P S K+ V+ L+
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVLFLIPK-----NSPPTLEGQYSKPFKEFVEACLNK 239
Query: 311 DPKERLSAAEVLSKFLIPKKTLQT 334
DP+ R +A E+L I + T +T
Sbjct: 240 DPRFRPTAKELLKHKFITRYTKKT 263
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-22
Identities = 70/262 (26%), Positives = 120/262 (45%), Gaps = 17/262 (6%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSI---SSRKLINRDDVEDVRREVQIMHHLTGHR 128
G LG+G +G Y + Q A K + +S L + E ++ EV ++ L H
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HV 62
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
NIV+ G D +++++ M+ GG + + G E +Q++ V Y H+
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFG-------LSVFFKPGDVFKDLVGSAYYVAPEV 241
V+HRD+K N + + +K DFG + + ++ K + G+ Y++APEV
Sbjct: 123 VVHRDIKGNNVMLMPNG---IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ + YG ++DIWS G ++ + +G PP + I P + S++A
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP-DSFSAAA 238
Query: 301 KDIVKKMLHADPKERLSAAEVL 322
D V L D ER SA ++L
Sbjct: 239 IDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-21
Identities = 79/293 (26%), Positives = 130/293 (44%), Gaps = 53/293 (18%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHLTGHRNIV 131
++G G +G Y KDT + A K + +L N + + RE++I+ L HRNIV
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKILRQLN-HRNIV 69
Query: 132 ELKGAYEDRH-SVNLIMDLCAGGELFDR-------IIAKG--HYSERAAANLCRQMVTVV 181
LK D+ +++ D A +F+ ++ G H+SE + +Q++ +
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGL 129
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV--FKDLVGSAYYVAP 239
+YCH +HRD+K N L ++ + +K DFGL+ + + + + V + +Y P
Sbjct: 130 NYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYTNKVITLWYRPP 186
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP--WPN 295
E+L YG D+WS G IL L + P F E + + I R + S P WP+
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR--LCGSPCPAVWPD 244
Query: 296 --------------------------ISSSAKDIVKKMLHADPKERLSAAEVL 322
I + A D++ ML DP +R +A E L
Sbjct: 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-21
Identities = 76/268 (28%), Positives = 126/268 (47%), Gaps = 34/268 (12%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
ELG+G +G Y V H+ T A K I R ++ + E+ I+H IV+
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEI--RLELDESKFNQIIMELDILHKAVSPY-IVDF 64
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMV-TVVHYCHSM----G 188
GA+ +V + M+ G L D++ A G +E ++ R++ VV +
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL----VGSAYYVAPEVLRR 244
++HRD+KP N L + + + +K DFG+S G++ L +G Y+APE ++
Sbjct: 124 IIHRDVKPTNVLVNGNGQ---VKLCDFGVS-----GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 245 -------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIF---DAILRGHIDFSSDPWP 294
Y ++D+WS G+ + + G P+ ET +IF AI+ G D + P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG--DPPTLP-S 232
Query: 295 NISSSAKDIVKKMLHADPKERLSAAEVL 322
S A+D V K L+ P R + A++L
Sbjct: 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-21
Identities = 57/183 (31%), Positives = 80/183 (43%), Gaps = 29/183 (15%)
Query: 167 ERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGD 225
+ + Q++ V +CH GVMHRDLKP+N L LK D GL F P
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG--LLKIADLGLGRAFSIPVK 166
Query: 226 VFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFD 279
+ + + +Y APEVL +Y DIWS G I + P F G++E IF
Sbjct: 167 SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226
Query: 280 AI-------------LRGHIDFS-------SDPWPNISSSAKDIVKKMLHADPKERLSAA 319
+ LR +F S P++S D+++KML DP +R+SA
Sbjct: 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK 286
Query: 320 EVL 322
L
Sbjct: 287 AAL 289
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 78/295 (26%), Positives = 121/295 (41%), Gaps = 66/295 (22%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED------VRREVQIMHHLTGH 127
++G G +GV Y +K T + A K I R D E RE+ ++ L H
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELN-H 58
Query: 128 RNIVELKGAYEDRHSVNLI-----------MDLCAGGELFDRIIAKGHYSERAAANLCRQ 176
NIV+L + + L+ MD + +I + Q
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK----------SYLFQ 108
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAY 235
++ + +CHS V+HRDLKP+N L + + +K DFGL+ F P + V + +
Sbjct: 109 LLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLW 165
Query: 236 YVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR--GHIDFSSD 291
Y APE+L + Y DIWS G I +++ F G++E I R G D
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225
Query: 292 P--------------W---------PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
P W P + +D++ +MLH DP +R+SA L+
Sbjct: 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 69/206 (33%), Positives = 104/206 (50%), Gaps = 18/206 (8%)
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA--KGH--YSERAAANLCRQMVTVVH 182
H IV+ ++ + LIM+ +GG+L +I K H + E L Q+V +
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD 183
Query: 183 YCHSMGVMHRDLKPEN-FLFSSSAEDSPLKATDFGLSVFFKPG---DVFKDLVGSAYYVA 238
HS +MHRDLK N FL + +K DFG S + DV G+ YY+A
Sbjct: 184 EVHSRKMMHRDLKSANIFLMPTGI----IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 239 PEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NI 296
PE+ R+ Y +AD+WS GVILY LL+ PF G +++ I +L G DP+P +
Sbjct: 240 PELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY----DPFPCPV 295
Query: 297 SSSAKDIVKKMLHADPKERLSAAEVL 322
SS K ++ +L +P R + ++L
Sbjct: 296 SSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 82/294 (27%), Positives = 117/294 (39%), Gaps = 66/294 (22%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED------VRREVQIMHHLTGHR 128
+G G +GV Y K T + A K I R + ED RE+ ++ L H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELN-HP 58
Query: 129 NIVELKGAYEDRHSVNLI-----------MDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
NIV L + + L+ MD L +I Y Q+
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY----------QL 108
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYY 236
+ + YCHS V+HRDLKP+N L + LK DFGL+ F P + V + +Y
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDR---EGALKLADFGLARAFGVPVRTYTHEVVTLWY 165
Query: 237 VAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAI--------- 281
APE+L R Y DIWS G I +++ P F G++E IF +
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP 225
Query: 282 -LRGHIDFSS-----------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ D+ PN+ D++ KML DP +R+SA L
Sbjct: 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-21
Identities = 80/294 (27%), Positives = 120/294 (40%), Gaps = 65/294 (22%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED------VRREVQIMHHLTGH 127
++G G +GV Y + T + A K I R + ED RE+ ++ + H
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKI-------RLEQEDEGVPSTAIREISLLKEMQ-H 60
Query: 128 RNIVELKGAYEDRHSVNLI-----------MDLCAGGELFDRIIAKGHYSERAAANLCRQ 176
NIV L+ + L+ MD R+I Y Q
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY----------Q 110
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAY 235
++ + YCHS V+HRDLKP+N L + LK DFGL+ F P F V + +
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLARAFGIPVRTFTHEVVTLW 168
Query: 236 YVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293
Y APE+L R+Y DIWS G I +++ P F G++E I R + + W
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228
Query: 294 PNISS-------------------------SAKDIVKKMLHADPKERLSAAEVL 322
P ++S + D++ KML DP +R++A L
Sbjct: 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282
|
Length = 294 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 83/307 (27%), Positives = 126/307 (41%), Gaps = 81/307 (26%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSI--SSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
++LG+G +G+ + + TK+ A K I + R N D + RE+ + L H NI
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR---NATDAQRTFREIMFLQELGDHPNI 69
Query: 131 VELKGAYE----------------DRHSV---NLIMDLCAGGELFDRIIAKGHYSERAAA 171
V+L + D H+V N++ D+ R I Y
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV------HKRYIM---Y------ 114
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD------ 225
Q++ + Y HS V+HRDLKP N L +S D +K DFGL+ +
Sbjct: 115 ----QLLKALKYIHSGNVIHRDLKPSNILLNS---DCRVKLADFGLARSLSELEENPENP 167
Query: 226 VFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWG------------ 271
V D V + +Y APE+L Y D+WS G IL +L G P F G
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227
Query: 272 --------ETEQ-------SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL 316
+ E ++ D++ + P S A D++KK+L +P +RL
Sbjct: 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL 287
Query: 317 SAAEVLS 323
+A E L
Sbjct: 288 TAEEALE 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 85/312 (27%), Positives = 125/312 (40%), Gaps = 72/312 (23%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISS--------RKLINRDDVEDV 114
DV Y +G G +G+ THK T + A K IS R L
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--------- 51
Query: 115 RREVQIMHHLTGHRNIVELK-----GAYEDRHSVNLI---M--DLCAGGELFDRIIAKGH 164
RE++I+ H NI+ + ++E + V ++ M DL ++I H
Sbjct: 52 -REIKILRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMETDLY-------KLIKTQH 102
Query: 165 YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
S Q++ + Y HS V+HRDLKP N L +++ + LK DFGL+ P
Sbjct: 103 LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPE 159
Query: 225 DVFK----DLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWG------- 271
+ V + +Y APE++ + Y DIWS G IL +LS P F G
Sbjct: 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL 219
Query: 272 ------------ETEQSIFDAILRGHID----FSSDPW----PNISSSAKDIVKKMLHAD 311
E I R +I PW PN A D++ KML +
Sbjct: 220 NLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFN 279
Query: 312 PKERLSAAEVLS 323
P +R++ E L+
Sbjct: 280 PHKRITVEEALA 291
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 4e-21
Identities = 69/264 (26%), Positives = 126/264 (47%), Gaps = 16/264 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG + T+Q A K I + D++ED+++E+ ++ + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY-VTKYY 68
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
G+Y + +IM+ GG D ++ G + E A + ++++ + Y HS +HRD+
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLRRN-YGAEADI 252
K N L S E +K DFG++ + ++ VG+ +++APEV++++ Y ++ADI
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW--PNISSSAKDIVKKMLHA 310
WS G+ L G PP + + I ++ P S K+ + L+
Sbjct: 185 WSLGITAIELAKGEPP-----NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK 239
Query: 311 DPKERLSAAEVLSKFLIPKKTLQT 334
DP R +A E+L I K +T
Sbjct: 240 DPSFRPTAKELLKHKFIVKNAKKT 263
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 5e-21
Identities = 68/252 (26%), Positives = 119/252 (47%), Gaps = 18/252 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG + T + +ACK ++ ++L R E E +I+ + R IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLA 59
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGH----YSERAAANLCRQMVTVVHYCHSMGVM 190
A++ + + L+M + GG+L I + E A Q+++ + + H ++
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DVFKDLVGSAYYVAPEVLR-RNYGA 248
+RDLKPEN L D ++ +D GL+V K G K G+ ++APE+L+ Y
Sbjct: 120 YRDLKPENVLLD---NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 249 EADIWSAGVILYILLSGVPPFWGETE----QSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
D ++ GV LY +++ PF E + + IL + + S ++K
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD----KFSPASKSFC 232
Query: 305 KKMLHADPKERL 316
+ +L DP++RL
Sbjct: 233 EALLAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 6e-21
Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 46/284 (16%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRN 129
++G G +G + +++T + A K + DD E V RE+ ++ L H+N
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLD-----DDDEGVPSSALREICLLKELK-HKN 60
Query: 130 IVELKGAYEDRHSVNLIMDLCAGG--ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM 187
IV L + L+ + C + FD G + Q++ + +CHS
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAPEVL--RR 244
V+HRDLKP+N L + + E LK DFGL+ F P + V + +Y P+VL +
Sbjct: 119 NVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 245 NYGAEADIWSAGVILYILL-SGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS------ 297
Y D+WSAG I L +G P F G I R + + WP +S
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235
Query: 298 -------------------SSAKDIVKKMLHADPKERLSAAEVL 322
S+ +D+++ +L +P +R+SA E L
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 7e-21
Identities = 74/275 (26%), Positives = 122/275 (44%), Gaps = 51/275 (18%)
Query: 96 ACKSISSRKLINRD--DVEDVRREVQIMHHLTGHRNIVELKGAY--------EDRHSVNL 145
K ++ +K++ D V+ RE++I+ L H NIV++ ED S+
Sbjct: 29 CDKRVAVKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSLTE 87
Query: 146 IMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLF 201
+ + E + ++ +G SE A Q++ + Y HS V+HRDLKP N
Sbjct: 88 LNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI 147
Query: 202 SSSAEDSPLKATDFGLSVFFKP-----GDVFKDLVGSAYYVAPEVL--RRNYGAEADIWS 254
++ ED LK DFGL+ P G + + LV + +Y +P +L NY D+W+
Sbjct: 148 NT--EDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWA 204
Query: 255 AGVILYILLSGVPPFWGETE----QSIFDAI------------------LRGHIDFSSDP 292
AG I +L+G P F G E Q I +++ +R P
Sbjct: 205 AGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRP 264
Query: 293 W----PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
P ++ A D ++++L +P +RL+A E L
Sbjct: 265 LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 9e-21
Identities = 80/276 (28%), Positives = 123/276 (44%), Gaps = 33/276 (11%)
Query: 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
P ED + + +G G +G Y + +T + A K I KL +D V++E+ I
Sbjct: 7 PQED----FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEI-I 58
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
M H NIV G+Y R + + M+ C GG L D G SE A + R+ +
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQG 118
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-FKDLVGSAYYVAP 239
++Y HS G MHRD+K N L + ++ +K DFG+S K +G+ Y++AP
Sbjct: 119 LYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
Query: 240 EVL----RRNYGAEADIWSAGVILYILLSGVPPFWG---------ETEQSIFDAILRGHI 286
EV + Y DIW+ G+ L PP + T+ + L+ +
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM 235
Query: 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
W N S VK L +PK+R +A ++L
Sbjct: 236 K-----WSN---SFHHFVKMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-20
Identities = 75/273 (27%), Positives = 123/273 (45%), Gaps = 44/273 (16%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHR 128
+LG G G V H T ++ ++K+++ VR RE+QIMH
Sbjct: 11 SDLGAGNGGSVSKVKHIPTG------TVMAKKVVHIGAKSSVRKQILRELQIMHECRSP- 63
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMV---TVVHYC 184
IV GA+ + +++ + M+ G L DRI K G + +V T ++
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS--VFFKPGDVFKDLVGSAYYVAPEVL 242
H +MHRD+KP N L +S + +K DFG+S + D F VG++ Y++PE +
Sbjct: 123 HR--IMHRDIKPSNILVNSRGQ---IKLCDFGVSGELINSIADTF---VGTSTYMSPERI 174
Query: 243 R-RNYGAEADIWSAGVILYILLSGVPPF-------WGETEQ-SIFDAILRGHIDFSSDPW 293
+ Y ++D+WS G+ + L G PF G+ + I D + + +P
Sbjct: 175 QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ----IVQEPP 230
Query: 294 PNISSS-----AKDIVKKMLHADPKERLSAAEV 321
P + SS +D V L DP ER + ++
Sbjct: 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-20
Identities = 71/263 (26%), Positives = 129/263 (49%), Gaps = 15/263 (5%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
++G+G FG + T++ A K I + D++ED+++E+ ++ + +
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY-VTKY 67
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
G+Y + +IM+ GG D ++ G E A + R+++ + Y HS +HRD
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRD 126
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLRRN-YGAEAD 251
+K N L S E +K DFG++ + ++ VG+ +++APEV++++ Y ++AD
Sbjct: 127 IKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 252 IWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311
IWS G+ L G PP + I + + N S K+ V+ L+ +
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG---NYSKPLKEFVEACLNKE 240
Query: 312 PKERLSAAEVLS-KFLI--PKKT 331
P R +A E+L KF++ KKT
Sbjct: 241 PSFRPTAKELLKHKFIVRFAKKT 263
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 77/263 (29%), Positives = 124/263 (47%), Gaps = 25/263 (9%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ +G G +G Y + T + A K I KL DD +++E+ ++ H NIV
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECK-HCNIVA 70
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
G+Y R + + M+ C GG L D G SE A +CR+ + + Y HS G MHR
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-FKDLVGSAYYVAPEV--LRRN--YG 247
D+K N L + + + +K DFG++ K +G+ Y++APEV + +N Y
Sbjct: 131 DIKGANILLTDNGD---VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 248 AEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHIDFSSDPWPNI------SSSA 300
DIW+ G+ L PP + +++F L +F P + SS+
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQP---PKLKDKTKWSSTF 241
Query: 301 KDIVKKMLHADPKERLSAAEVLS 323
+ VK L +PK+R +A +L+
Sbjct: 242 HNFVKISLTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-20
Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G G +G Y H T Q A K + + D+ E++++E+ ++ + HRNI
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHRNIATYY 69
Query: 135 GAYEDRH------SVNLIMDLCAGGELFDRII-AKGH-YSERAAANLCRQMVTVVHYCHS 186
GA+ ++ + L+M+ C G + D I KG+ E A +CR+++ + + H
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPEVLR-- 243
V+HRD+K +N L + +AE +K DFG+S + +G+ Y++APEV+
Sbjct: 130 HKVIHRDIKGQNVLLTENAE---VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 244 ----RNYGAEADIWSAGVILYILLSGVPPF 269
Y ++D+WS G+ + G PP
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-19
Identities = 65/212 (30%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 71 FGRELGRGQFGVTYLVTHK----DTKQQFACKSISSRKLINRDDVE----DVRREVQIMH 122
F ++LG G FG L + +T +Q A KS+ N E D RE++I+
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL------NHSGEEQHRSDFEREIEILR 61
Query: 123 HLTGHRNIVELKGAYEDRH--SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR---QM 177
L H NIV+ KG E S+ LIM+ G L R + H + L Q+
Sbjct: 62 TLD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQINLKRLLLFSSQI 118
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGS- 233
+ Y S +HRDL N L S + +K +DFGL+ K+ S
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVES---EDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 234 AYYVAPEVLR-RNYGAEADIWSAGVILYILLS 264
++ APE LR + + +D+WS GV LY L +
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-19
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G G +G Y H T Q A K + + D+ E+++ E+ ++ + HRNI
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHRNIATYY 79
Query: 135 GAYEDRHSVN------LIMDLCAGGELFDRII-AKGH-YSERAAANLCRQMVTVVHYCHS 186
GA+ + L+M+ C G + D + KG+ E A +CR+++ + + H+
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA 139
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLR-- 243
V+HRD+K +N L + +AE +K DFG+S ++ +G+ Y++APEV+
Sbjct: 140 HKVIHRDIKGQNVLLTENAE---VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196
Query: 244 ----RNYGAEADIWSAGVILYILLSGVPPF 269
Y +DIWS G+ + G PP
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 81/311 (26%), Positives = 122/311 (39%), Gaps = 72/311 (23%)
Query: 76 GRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRN 129
GRG +G Y K+ +++A K K + + RE+ ++ L H N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDK----EQYTGISQSACREIALLRELK-HEN 63
Query: 130 IVELKGAYEDRH--SVNLIMDLCAGGELFDRIIAKGHYSERAAA-------NLCRQMVTV 180
+V L + + SV L+ D A +L+ I K H + + +L Q++
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDY-AEHDLWQ--IIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGLS-VFFKPGDVFKDL---VGSAY 235
VHY HS V+HRDLKP N L E +K D GL+ +F P DL V + +
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 236 YVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE-------------QSIF-- 278
Y APE+L R+Y DIW+ G I LL+ P F G + IF
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 279 ----------------------DAILRGHIDFSS-----DPWPNISSSAKDIVKKMLHAD 311
+S + S D+++K+L D
Sbjct: 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYD 300
Query: 312 PKERLSAAEVL 322
P +R++A E L
Sbjct: 301 PTKRITAEEAL 311
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-19
Identities = 68/260 (26%), Positives = 123/260 (47%), Gaps = 21/260 (8%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
F +ELG GQFGV +L + K A K I + D +E E ++M L+ H N+
Sbjct: 8 FLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFIE----EAKVMMKLS-HPNL 61
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGV 189
V+L G + + ++ + A G L + + KG ++C + + Y S G
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---APEVLRRN- 245
+HRDL N L ED+ +K +DFGL+ + D + G+ + V PEV +
Sbjct: 122 IHRDLAARNCLVG---EDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSR 177
Query: 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS-SAKDI 303
+ +++D+WS GV+++ + S G P+ + + +++ G+ P ++ I
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR----LYRPKLAPTEVYTI 233
Query: 304 VKKMLHADPKERLSAAEVLS 323
+ H P++R + ++LS
Sbjct: 234 MYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 84/308 (27%), Positives = 132/308 (42%), Gaps = 59/308 (19%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
+ K + ++ Y +++G G +G K T ++ A K +S R + + RE
Sbjct: 6 VNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRE 64
Query: 118 VQIMHHLTGHRNIVEL------KGAYEDRHSVNLIM-----DLCAGGELFDRIIAKGHYS 166
+ ++ H+ H N++ L + ++ L+M DL + I S
Sbjct: 65 LTLLKHMQ-HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL--------QKIMGHPLS 115
Query: 167 ERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226
E L QM+ + Y HS G++HRDLKP N + ED LK DFGL+ + D
Sbjct: 116 EDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLA---RHADA 169
Query: 227 -FKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWG------------ 271
V + +Y APEV+ +Y DIWS G I+ +L+G F G
Sbjct: 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229
Query: 272 -------ETEQSIFDAILRGHI---------DFSSDPWPNISSSAKDIVKKMLHADPKER 315
E Q + D + +I DFS+ +P S A D+++KML D +R
Sbjct: 230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKR 288
Query: 316 LSAAEVLS 323
L+A E L
Sbjct: 289 LTATEALE 296
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-18
Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 16/221 (7%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
+E+G GQFG+ +L + K++ A K+I + ED E Q+M L+ H +
Sbjct: 8 LVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSE----EDFIEEAQVMMKLS-HPKL 61
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGV 189
V+L G +R + L+ + G L D + A +G +S+ +C + + Y S V
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV 121
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---APEVLR-RN 245
+HRDL N L E+ +K +DFG++ F D + G+ + V +PEV
Sbjct: 122 IHRDLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
Y +++D+WS GV+++ + S G P+ + + + I G
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF 218
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-18
Identities = 81/286 (28%), Positives = 119/286 (41%), Gaps = 46/286 (16%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE-DVRREVQIMHHLTG--HRNI 130
E+G G +G Y + A KS+ R N D + REV ++ L H NI
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSV--RVQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 131 VEL----KGAYEDRHS-VNLIM-----DLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
V L + DR + V L+ DL D++ G +E +L RQ +
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQDLRT---YLDKVPPPGLPAETIK-DLMRQFLRG 120
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 240
+ + H+ ++HRDLKPEN L +S + +K DFGL+ + +V + +Y APE
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 241 V-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQ----SIFDAI------------LR 283
V L+ Y D+WS G I + P F G +E IFD I
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237
Query: 284 GHIDFS-------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
FS P I S ++ +ML +P +R+SA L
Sbjct: 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 7e-18
Identities = 80/292 (27%), Positives = 128/292 (43%), Gaps = 53/292 (18%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G +GV T ++ A K I+ + D + RE++++ L H +IVE+K
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKIND-VFEHVSDATRILREIKLLRLLR-HPDIVEIK 65
Query: 135 G--------AYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
++D + V +M+ +L I A + Q++ + Y H+
Sbjct: 66 HIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFK--PGDVF-KDLVGSAYYVAPEV- 241
V HRDLKP+N L ++ D LK DFGL+ V F P +F D V + +Y APE+
Sbjct: 122 ANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 242 --LRRNYGAEADIWSAGVILYILLSGVPPFWG-------------------ETEQSIFDA 280
Y DIWS G I +L+G P F G ET + +
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238
Query: 281 ILRGH---------IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
R + + FS +PN A +++++L DPK+R +A E L+
Sbjct: 239 KARRYLSSMRKKQPVPFSQK-FPNADPLALRLLERLLAFDPKDRPTAEEALA 289
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 8e-18
Identities = 54/176 (30%), Positives = 76/176 (43%), Gaps = 41/176 (23%)
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL----SVFFKPGDVFKDLVGSAYYVA 238
YCH V+HRDLKP+N L S E LK DFGL SV P + + V + +Y
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSV---PSKTYSNEVVTLWYRP 171
Query: 239 PEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDPWPN 295
P+VL Y D+W G I Y + +G P F G T+ + I R + + WP
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231
Query: 296 ISS----------------------------SAKDIVKKMLHADPKERLSAAEVLS 323
+SS +++ K L +PK+R+SAAE +
Sbjct: 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 9e-18
Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 34/227 (14%)
Query: 74 ELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
+LG G FGV T A K + S KL D ++D +E IMH L H N+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLD-HENL 58
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRI--IAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+ L G H + ++ +L G L DR+ A GH+ + Q+ + Y S
Sbjct: 59 IRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV----------- 237
+HRDL N L +S D +K DFGL + +YV
Sbjct: 118 FIHRDLAARNILLAS---DDKVKIGDFGLMRALPQNE--------DHYVMEEHLKVPFAW 166
Query: 238 -APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAI 281
APE LR R + +D+W GV L+ + + G P+ G + I I
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 71/251 (28%), Positives = 118/251 (47%), Gaps = 19/251 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN---IV 131
+GRG FG Y DT + +A K + +K I E + +IM L + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLD-KKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+ A+ ++ I+DL GG+L + G +SE +++ + + H+ V++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFF---KPGDVFKDLVGSAYYVAPEVLRRN--Y 246
RDLKP N L E ++ +D GL+ F KP VG+ Y+APEVL++ Y
Sbjct: 121 RDLKPANILLD---EHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAY 173
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN-ISSSAKDIVK 305
+ AD +S G +L+ LL G PF + + I R + + + P+ S + +++
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVE-LPDSFSPELRSLLE 231
Query: 306 KMLHADPKERL 316
+L D RL
Sbjct: 232 GLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 72/312 (23%), Positives = 119/312 (38%), Gaps = 73/312 (23%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE----DVRREVQIMHHL 124
Y +LG G FG Y T + A K K++ ++ + RE++I+ L
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKKL 64
Query: 125 TGHRNIVEL--------KGAYEDRHSVNLIM-----DLCAGGELFDRIIAKGHYSERAAA 171
H N+V L + R SV ++ DL G L + + +E
Sbjct: 65 K-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSV---KLTESQIK 118
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFK-- 228
Q++ ++Y H ++HRD+K N L + LK DFGL+ + P K
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGI---LKIADFGLARPYDGPPPNPKGG 175
Query: 229 ---------DLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE--- 274
+LV + +Y PE+L R Y DIW G + + + P G+++
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235
Query: 275 -QSIFDAI----------------LRGHIDFSSDPWPNISSSAK-------DIVKKMLHA 310
IF G F++ P + D++ K+L
Sbjct: 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEERFGKLGPEGLDLLSKLLSL 294
Query: 311 DPKERLSAAEVL 322
DP +RL+A++ L
Sbjct: 295 DPYKRLTASDAL 306
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 4e-17
Identities = 80/301 (26%), Positives = 128/301 (42%), Gaps = 44/301 (14%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L K + +V Y +G G +G +Q+ A K +S R + RE
Sbjct: 6 LNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRE 64
Query: 118 VQIMHHLTGHRNIVELKGAY------EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA 171
++++ H+ H N++ L + E+ + V L+ +L G +L + I+ S+
Sbjct: 65 LRLLKHMK-HENVIGLLDVFTPATSIENFNEVYLVTNL-MGADL-NNIVKCQKLSDEHVQ 121
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
L Q++ + Y HS G++HRDLKP N + ED L+ DFGL+ + D V
Sbjct: 122 FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLAR--QADDEMTGYV 176
Query: 232 GSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289
+ +Y APE++ +Y DIWS G I+ LL G F G I+ S
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236
Query: 290 SDPWPNISSS---------------------------AKDIVKKMLHADPKERLSAAEVL 322
+ ISS A D+++KML D +R+SA+E L
Sbjct: 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296
Query: 323 S 323
+
Sbjct: 297 A 297
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-17
Identities = 71/260 (27%), Positives = 112/260 (43%), Gaps = 34/260 (13%)
Query: 72 GRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
GR +G GQFG Y ++ ++ K A K+ + + E +E IM H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKT--CKNCTSPSVREKFLQEAYIMRQFD-HP 67
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL--------CRQMVTV 180
+IV+L G + + V ++M+L GEL Y + +L Q+ T
Sbjct: 68 HIVKLIGVITE-NPVWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS--AYYVA 238
+ Y S +HRD+ N L SS +K DFGLS + + +K G ++A
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSP---DCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
Query: 239 PEVLR-RNYGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-N 295
PE + R + + +D+W GV ++ IL+ GV PF G + I G P P N
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG----ERLPMPPN 232
Query: 296 ISSSAKDIVKKMLHADPKER 315
+ ++ K DP +R
Sbjct: 233 CPPTLYSLMTKCWAYDPSKR 252
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 72/239 (30%), Positives = 102/239 (42%), Gaps = 46/239 (19%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH 127
+Y G +G G FGV Y DT ++ A K + D + RE+ IM +L H
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-------LQDPQYKNRELLIMKNLN-H 118
Query: 128 RNIVELKGAY--------EDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAA------ 171
NI+ LK Y E +N++M E + + K HY+ A
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVM------EFIPQTVHKYMKHYARNNHALPLFLV 172
Query: 172 -----NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226
LCR + Y HS + HRDLKP+N L + LK DFG + G
Sbjct: 173 KLYSYQLCRALA----YIHSKFICHRDLKPQNLLIDPNTHT--LKLCDFGSAKNLLAGQR 226
Query: 227 FKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR 283
+ S +Y APE++ NY D+WS G I+ ++ G P F G QS D ++R
Sbjct: 227 SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG---QSSVDQLVR 282
|
Length = 440 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-17
Identities = 77/277 (27%), Positives = 118/277 (42%), Gaps = 31/277 (11%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE-DVRREVQIMHHLTG 126
TYI +LG G + + K T+ A K I +L + + REV ++ L
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKDLK- 62
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK------GHYSERAAANLCRQMVTV 180
H NIV L S+ L+ E D+ + + S Q++
Sbjct: 63 HANIVTLHDIVHTDKSLTLVF------EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRG 116
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAP 239
+ YCH V+HRDLKP+N L + E LK DFGL+ P + + V + +Y P
Sbjct: 117 LAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPP 173
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
+VL Y + D+W G I + + SG P F G T + I R + + WP IS
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233
Query: 298 SS--------AKDIVKKMLHADPKERLSAAEVLSKFL 326
S+ K + +++ P+ E+L+KFL
Sbjct: 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFL 270
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-17
Identities = 70/288 (24%), Positives = 126/288 (43%), Gaps = 40/288 (13%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
D +T+ +G+G +G + V +K + A K + I+ E++ E I+
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKA 70
Query: 124 LTGHRNIVELKGAYEDRHSVN-----LIMDLCAGGELFDRIIAKG------HYSERAAAN 172
L+ H N+V+ G Y + N L+++LC GG + D + KG E A
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD--LVKGFLKRGERMEEPIIAY 128
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-V 231
+ + + + + H +HRD+K N L ++ + +K DFG+S + ++ V
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTSV 185
Query: 232 GSAYYVAPEV------LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285
G+ +++APEV L Y A D+WS G+ L G PP + +R
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP------MRAL 238
Query: 286 IDFSSDPWPNI------SSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327
+P P + S+ D ++K L D ++R + +++L I
Sbjct: 239 FKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 67/261 (25%), Positives = 126/261 (48%), Gaps = 25/261 (9%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
F +ELG GQFGV +L + + + A K+I+ + D +E E ++M L+ H +
Sbjct: 8 FMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIE----EAKVMMKLS-HPKL 61
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGV 189
V+L G + + ++ + G L + + + G S+ ++C+ + + Y
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---APEVLRRN- 245
+HRDL N L SS+ +K +DFG++ + D + G+ + V PEV +
Sbjct: 122 IHRDLAARNCLVSSTG---VVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 246 YGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
Y +++D+WS GV+++ + G PF ++ + + I RG + P ++S +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----PKLAS--MTVY 231
Query: 305 KKML---HADPKERLSAAEVL 322
+ M H P+ R + AE+L
Sbjct: 232 EVMYSCWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 80/308 (25%), Positives = 123/308 (39%), Gaps = 66/308 (21%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISS---------RKLINRDDVEDV 114
DV + Y +G G +GV + ++ A K I R L
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL--------- 52
Query: 115 RREVQIMHHLTGHRNIVELKGAY----EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAA 170
RE++I+ H H NI+ ++ D V ++MDL +L I + +E
Sbjct: 53 -RELKILRHFK-HDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHI 109
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL--SVFFKPGDV-- 226
Q++ + Y HS V+HRDLKP N L + E L+ DFG+ + P +
Sbjct: 110 RYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE---LRIGDFGMARGLSSSPTEHKY 166
Query: 227 -FKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVI-------------------LYILLS 264
+ V + +Y APE+L Y D+WS G I L ++LS
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS 226
Query: 265 --GVPPFWGETEQSIFDAILRGHI-DFSSD---PW----PNISSSAKDIVKKMLHADPKE 314
G P E I +R +I + PW P S A D++ +ML DP+E
Sbjct: 227 VLGSPS--EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEE 284
Query: 315 RLSAAEVL 322
R++ + L
Sbjct: 285 RITVEQAL 292
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 79/308 (25%), Positives = 127/308 (41%), Gaps = 51/308 (16%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE-DVRREVQIMHHLTG 126
TYI +LG G + Y K T A K I +L + + REV ++ L
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK- 62
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-----GHYSERAAANL-CRQMVTV 180
H NIV L S+ L+ E D+ + + G+ L Q++
Sbjct: 63 HANIVTLHDIIHTEKSLTLVF------EYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRG 116
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAP 239
++YCH V+HRDLKP+N L + E LK DFGL+ P + + V + +Y P
Sbjct: 117 LNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
++L +Y + D+W G I Y + +G P F G T + I R + + WP I
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233
Query: 298 SSAK--------------------------DIVKKMLHADPKERLSAAEVLSK--FLIPK 329
S+ + +++ K+L + ++R+SA E + F
Sbjct: 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293
Query: 330 KTLQTLAD 337
+ + L D
Sbjct: 294 ERIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 69/249 (27%), Positives = 105/249 (42%), Gaps = 33/249 (13%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE-DVRREVQIMHHLTG 126
TY+ +LG G + + K T+ A K I +L + + REV ++ +L
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKNLK- 61
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV------ 180
H NIV L + L+ E D + Y + + V +
Sbjct: 62 HANIVTLHDIIHTERCLTLVF------EYLDSDLK--QYLDNCGNLMSMHNVKIFMFQLL 113
Query: 181 --VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL----SVFFKPGDVFKDLVGSA 234
+ YCH ++HRDLKP+N L + E LK DFGL SV P + + V +
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSV---PTKTYSNEVVTL 167
Query: 235 YYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292
+Y P+VL Y D+W G ILY + +G P F G T + I R + +
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227
Query: 293 WPNISSSAK 301
WP I+S+ +
Sbjct: 228 WPGITSNEE 236
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 79/300 (26%), Positives = 131/300 (43%), Gaps = 46/300 (15%)
Query: 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ 119
K + +V + Y +++G G +G + T + A K + R + + RE++
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELR 66
Query: 120 IMHHLTGHRNIVELKGAY------EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL 173
++ H+ H N++ L + + H L+M G +++ SE L
Sbjct: 67 LLKHMK-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFL 123
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
QM+ + Y H+ G++HRDLKP N + ED LK DFGL+ + V +
Sbjct: 124 VYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLAR--QTDSEMTGYVVT 178
Query: 234 AYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGE--------------TEQSI 277
+Y APEV+ +Y DIWS G I+ +L+G P F G T
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238
Query: 278 FDAIL-----RGHI---------DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
F L + ++ DF S PN + A ++++KML D + R++AAE L+
Sbjct: 239 FVQKLQSEDAKNYVKKLPRFRKKDFRS-LLPNANPLAVNVLEKMLVLDAESRITAAEALA 297
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-16
Identities = 72/276 (26%), Positives = 117/276 (42%), Gaps = 52/276 (18%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRR----EVQIMHHLTGHR 128
++G+G FG Y K + A K+ S D++R E +I+ H
Sbjct: 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRS------TLPPDLKRKFLQEAEILKQYD-HP 52
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHYSERAAANLCRQMVTVVHYCHSM 187
NIV+L G + + ++M+L GG L + K + + + + Y S
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---------- 237
+HRDL N L E++ LK +DFG+S ++ G Y V
Sbjct: 113 NCIHRDLAARNCLVG---ENNVLKISDFGMS---------REEEGGIYTVSDGLKQIPIK 160
Query: 238 --APEVLRRNYG---AEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSD 291
APE L NYG +E+D+WS G++L+ S G P+ G + Q + I G+
Sbjct: 161 WTAPEAL--NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY------ 212
Query: 292 PWPNISSSAKDIVKKMLH---ADPKERLSAAEVLSK 324
P ++I + ML DP+ R S +E+ ++
Sbjct: 213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNE 248
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 80/290 (27%), Positives = 115/290 (39%), Gaps = 78/290 (26%)
Query: 91 TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150
T Q A K +S R N + RE+ +M L H+NI+ L + + S+ D+
Sbjct: 40 TGQNVAIKKLS-RPFQNVTHAKRAYRELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVY 97
Query: 151 AGGELFDRIIAKGHYSERAAANLCR----------------QMVTVVHYCHSMGVMHRDL 194
EL D ANLC+ QM+ + + HS G++HRDL
Sbjct: 98 LVMELMD-------------ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDL 144
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF--KDLVGSAYYVAPEV-LRRNYGAEAD 251
KP N + S D LK DFGL+ G F V + YY APEV L Y D
Sbjct: 145 KPSNIVVKS---DCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 199
Query: 252 IWSAGVILYILLSGVPPF--------W-------GETEQSIFDAI---LRGHID------ 287
IWS G I+ ++ G F W G + +R +++
Sbjct: 200 IWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYA 259
Query: 288 -------FSSDPWPNISSS--------AKDIVKKMLHADPKERLSAAEVL 322
F +P S S A+D++ KML DP++R+S + L
Sbjct: 260 GYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-16
Identities = 65/281 (23%), Positives = 120/281 (42%), Gaps = 49/281 (17%)
Query: 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRR---E 117
++++ G +G+G+FG L ++ Q+ A K + +DD + E
Sbjct: 4 NSKELK----LGATIGKGEFGDVMLGDYR--GQKVAVKCL-------KDDSTAAQAFLAE 50
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+M L H N+V+L G + + ++ + A G L D + ++G RA L +Q+
Sbjct: 51 ASVMTTLR-HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG----RAVITLAQQL 105
Query: 178 VTVVHYCHSM------GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
+ C M +HRDL N L S ED K +DFGL+ + +
Sbjct: 106 GFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLA-----KEASQGQD 157
Query: 232 GSAYYV---APEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286
V APE LR + ++D+WS G++L+ + S G P+ + + + +G+
Sbjct: 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR 217
Query: 287 DFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLSK 324
+ + P ++ K M DP +R + ++ +
Sbjct: 218 MEAPEGCP------PEVYKVMKDCWELDPAKRPTFKQLREQ 252
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 10/200 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN---IV 131
+GRG FG Y DT + +A K + +K I E + +IM L + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLD-KKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+ A+ + I+DL GG+L + G +SE+ +++ + + H+ V++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN--YGAE 249
RDLKP N L E ++ +D GL+ F VG+ Y+APEVL++ Y +
Sbjct: 121 RDLKPANILLD---EHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSS 176
Query: 250 ADIWSAGVILYILLSGVPPF 269
AD +S G +L+ LL G PF
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 69/265 (26%), Positives = 108/265 (40%), Gaps = 31/265 (11%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
E+G G G Y + K T A K + R+ N+++ + + ++ ++ IV+
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQM--RRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 134 KGAYEDRHSVNLIMDL---CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC-HSMGV 189
G + V + M+L C +L RI +G E + +V +HY GV
Sbjct: 80 YGYFITDSDVFICMELMSTCLD-KLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHGV 136
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL-----RR 244
+HRD+KP N L +S +K DFG+S G A Y+APE +
Sbjct: 137 IHRDVKPSNILLDASGN---VKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNP 193
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHIDFSSDPWP------NIS 297
Y AD+WS G+ L L +G P+ +TE + IL + P S
Sbjct: 194 KYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL-------QEEPPSLPPNEGFS 246
Query: 298 SSAKDIVKKMLHADPKERLSAAEVL 322
V L D ++R E+L
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 62/236 (26%), Positives = 101/236 (42%), Gaps = 21/236 (8%)
Query: 104 KLINRDDVED------VRREVQIMHHLTGHRNIVEL--KGAYEDRHSVNLIMDLCAGGEL 155
KL+ D E+ RRE + L H NIV L G + + + G L
Sbjct: 9 KLLRTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPPGL-LFAVFEYVPGRTL 66
Query: 156 FDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215
+ + A G L Q++ + H+ G++HRDLKP+N + S + K DF
Sbjct: 67 REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDF 126
Query: 216 GLSVF---FKPGDVFK-----DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGV 266
G+ + DV +++G+ Y APE LR +D+++ G+I L+G
Sbjct: 127 GIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
Query: 267 PPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
G + I L +D S PW +++K L+ DP++R ++A L
Sbjct: 187 RVVQGASVAEILYQQL-SPVDVSLPPWIA-GHPLGQVLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 73/265 (27%), Positives = 112/265 (42%), Gaps = 50/265 (18%)
Query: 102 SRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD---- 157
SR N+ + RE+ ++ H+NI+ L + + S+ D+ EL D
Sbjct: 55 SRPFQNQTHAKRAYREL-VLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLC 113
Query: 158 RIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217
++I ER + L QM+ + + HS G++HRDLKP N + S D LK DFGL
Sbjct: 114 QVIHMELDHERMSY-LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGL 169
Query: 218 SVFFKPGDVFKDLVGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQS 276
+ + V + YY APEV L Y DIWS G I+ L+ G F G
Sbjct: 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID 229
Query: 277 IFDAIL------------------RGHIDFSSDPWPNIS--------------------- 297
++ ++ R +++ + +P IS
Sbjct: 230 QWNKVIEQLGTPSAEFMNRLQPTVRNYVE-NRPQYPGISFEELFPDWIFPSESERDKLKT 288
Query: 298 SSAKDIVKKMLHADPKERLSAAEVL 322
S A+D++ KML DP +R+S E L
Sbjct: 289 SQARDLLSKMLVIDPDKRISVDEAL 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 41/286 (14%)
Query: 66 RNTYIFGRELGRGQFGVTY--LVTHKD---TKQQFACKSISSRKLINRDDVEDVRREVQI 120
R++ R LG G FG Y L +D + Q A K++ + + D D E I
Sbjct: 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALI 62
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA-------NL 173
M H+NIV L G +R ++++L AGG+L + ER ++
Sbjct: 63 MSKFN-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
R + Y +HRD+ N L + K DFG++ +D+ +
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRA 172
Query: 234 AYY------------VAPEV-LRRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFD 279
+YY + PE L + ++ D+WS GV+L+ + S G P+ G T Q + +
Sbjct: 173 SYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325
+ G DP I+ P++R + A +L +
Sbjct: 233 FVTGGG---RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ D +T+ +G+G +G Y VT+K A K + D E++ E I+
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNIL 72
Query: 122 HHLTGHRNIVELKGA-YEDRHSVN----LIMDLCAGG---ELFDRIIAKGH-YSERAAAN 172
L H N+V+ G Y+ V L+++LC GG EL ++ G E +
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-V 231
+ + + + H+ ++HRD+K N L ++ + +K DFG+S + ++ V
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 232 GSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPF 269
G+ +++APEV+ +Y A D+WS G+ L G PP
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 76/297 (25%), Positives = 111/297 (37%), Gaps = 56/297 (18%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR-------REVQIMHHLT 125
R +G+G G YL ++ A K I R+D+ + RE +I L
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKI-------REDLSENPLLKKRFLREAKIAADLI 60
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--------RIIAKGHYSERAAANLCRQM 177
H IV + D V M G L ++K + +
Sbjct: 61 -HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 178 VTV---VHYCHSMGVMHRDLKPENFLF---------------SSSAEDSPLKATDFGL-- 217
+ + Y HS GV+HRDLKP+N L E+ L D
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 218 ---SVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEA-DIWSAGVILYILLSGVPPFWGET 273
S PG + VG+ Y+APE L +E+ DI++ GVILY +L+ P+ +
Sbjct: 180 ICYSSMTIPGKI----VGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235
Query: 274 EQSIFDAILRGHIDFSSD--PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIP 328
+ I R I + P+ I I K L DP ER S+ + L + L P
Sbjct: 236 GRKI---SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289
|
Length = 932 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 79/298 (26%), Positives = 121/298 (40%), Gaps = 59/298 (19%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ +G G G+ ++ A K +S R N+ + RE+ +M H+NI+
Sbjct: 30 KPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMK-CVNHKNIIG 87
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
L + + S+ D+ EL D ++I ER + L QM+ + + HS G
Sbjct: 88 LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIKHLHSAG 146
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV-LRRNYG 247
++HRDLKP N + S D LK DFGL+ + V + YY APEV L Y
Sbjct: 147 IIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 248 AEADIWSAGVIL------YILLSGV----------------------------------- 266
DIWS G I+ +L G
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263
Query: 267 PPFWGETEQSIFDAILRGHIDFSSDPWPN--ISSSAKDIVKKMLHADPKERLSAAEVL 322
P + G + + +F +L F +D N +S A+D++ KML D +R+S E L
Sbjct: 264 PKYAGYSFEKLFPDVL-----FPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 45/142 (31%), Positives = 74/142 (52%), Gaps = 4/142 (2%)
Query: 77 RGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136
RG FG YL K+ + +A K + +IN++ V V+ E + L+ IV L +
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSPFIVHLYYS 72
Query: 137 YEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKP 196
+ ++V L+M+ GG++ + G++ E A ++ + Y H G++HRDLKP
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKP 132
Query: 197 ENFLFSSSAEDSPLKATDFGLS 218
+N L S+ +K TDFGLS
Sbjct: 133 DNMLISNEGH---IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 27/223 (12%)
Query: 66 RNTYIFGRELGRGQFG-----VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
RN FG+ LG G FG Y ++ D + A K + + + E + E++I
Sbjct: 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKI 91
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMV 178
M HL H NIV L GA + +I + C G+L + + K + + Q+
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD----LVGSA 234
+ + S +HRDL N L + +K DFGL+ D+ D + G+A
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHG---KIVKICDFGLA-----RDIMNDSNYVVKGNA 203
Query: 235 Y----YVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWG 271
++APE + Y E+D+WS G++L+ + S G P+ G
Sbjct: 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 1e-14
Identities = 77/294 (26%), Positives = 121/294 (41%), Gaps = 51/294 (17%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ +G G G+ + A K +S R N+ + RE+ +M H+NI+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMK-CVNHKNIIS 80
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
L + + S+ D+ EL D ++I ER + L QM+ + + HS G
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIKHLHSAG 139
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV-LRRNYG 247
++HRDLKP N + S D LK DFGL+ + V + YY APEV L Y
Sbjct: 140 IIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196
Query: 248 AEADIWSAGVIL------YILLSG-----------------VPPFWGETEQSIFDAILRG 284
DIWS G I+ IL G P F + + ++ + +
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV-EN 255
Query: 285 HIDFSSDPWPNI----------------SSSAKDIVKKMLHADPKERLSAAEVL 322
++ +P + +S A+D++ KML DP +R+S E L
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 73/296 (24%), Positives = 116/296 (39%), Gaps = 56/296 (18%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE-DVRREVQIMHHLTG 126
+Y+ +LG G + Y + Q A K IS + + V RE ++ L
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVIS---MKTEEGVPFTAIREASLLKGLK- 61
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR------QMVTV 180
H NIV L + ++ + E +A+ + Q++
Sbjct: 62 HANIVLLHDIIHTKETLTFVF------EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRG 115
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAP 239
+ Y H ++HRDLKP+N L S E LK DFGL+ P + V + +Y P
Sbjct: 116 LAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPP 172
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF---SSDPWP 294
+VL +Y + DIW AG I +L G P F G + +F+ + + + D WP
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS--DVFEQLEKIWTVLGVPTEDTWP 230
Query: 295 NISS----------------------------SAKDIVKKMLHADPKERLSAAEVL 322
+S A+D+ +ML PK+R+SA + L
Sbjct: 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 34/222 (15%)
Query: 70 IFGRELGRG--QFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRR---EVQIMHHL 124
+G+ + +L HK T A K I+ ++ ED++ E+ L
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKIN----LDSCSKEDLKLLQQEIITSRQL 56
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY----SERAAANLCRQMVTV 180
H NI+ ++ + ++ L A G D + K H+ E A A + + ++
Sbjct: 57 Q-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNA 113
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV---FFKPGDVFKDLVGSA--- 234
+ Y HS G +HR +K + L S K GL K G + +
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDG-----KVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 235 ----YYVAPEVLRRN---YGAEADIWSAGVILYILLSGVPPF 269
+++PEVL++N Y ++DI+S G+ L +G PF
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRN 129
ELG G GV V H+ + I +RKLI+ + +R RE++++H
Sbjct: 8 ELGAGNGGVVTKVLHRPSGL------IMARKLIHLEIKPAIRNQIIRELKVLHECNS-PY 60
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYC---H 185
IV GA+ +++ M+ GG L D+++ K G E + ++ + Y H
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL----VGSAYYVAPEV 241
+MHRD+KP N L +S E +K DFG+S G + + VG+ Y++PE
Sbjct: 120 K--IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPER 169
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
L+ Y ++DIWS G+ L + G P + +
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 63/260 (24%), Positives = 117/260 (45%), Gaps = 21/260 (8%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
F +ELG GQFGV + + A K I + + +E E ++M L+ H +
Sbjct: 8 FLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIE----EAKVMMKLS-HEKL 61
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAA-ANLCRQMVTVVHYCHSMGV 189
V+L G + + ++ + + G L + + G + + +C+ + + Y S
Sbjct: 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---APEVLRR-N 245
+HRDL N L +K +DFGLS + D + VGS + V PEVL
Sbjct: 122 IHRDLAARNCLVDD---QGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS-SAKDI 303
+ +++D+W+ GV+++ + S G P+ + + +G + P+++S I
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR----PHLASEKVYAI 233
Query: 304 VKKMLHADPKERLSAAEVLS 323
+ H +ER + ++LS
Sbjct: 234 MYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 79/301 (26%), Positives = 127/301 (42%), Gaps = 44/301 (14%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L K + +V Y +G G +G T + A K +S R + + RE
Sbjct: 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRE 66
Query: 118 VQIMHHLTGHRNIVEL------KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA 171
++++ H+ H N++ L + E+ + V L+ L G +L + I+ ++
Sbjct: 67 LRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQ 123
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
L Q++ + Y HS ++HRDLKP N + ED LK DFGL+ D V
Sbjct: 124 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLAR--HTDDEMTGYV 178
Query: 232 GSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289
+ +Y APE++ +Y DIWS G I+ LL+G F G ILR
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238
Query: 290 SDPWPNISSS---------------------------AKDIVKKMLHADPKERLSAAEVL 322
++ ISS A D+++KML D +R++AA+ L
Sbjct: 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298
Query: 323 S 323
+
Sbjct: 299 A 299
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 69/279 (24%), Positives = 121/279 (43%), Gaps = 32/279 (11%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSIS-SRKLINRD----DVEDVRRE 117
E R G+ LG G FG + + K ++ + K++ D D+ D+ E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR-- 175
+++M + H+NI+ L GA + ++++ + G L + + A+ + + C+
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 176 --------------QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221
Q+ + Y S +HRDL N L + ED+ +K DFGL+
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDV 184
Query: 222 KPGDVFKDLVGS---AYYVAPEVL-RRNYGAEADIWSAGVILY-ILLSGVPPFWGETEQS 276
D +K ++APE L R Y ++D+WS GV+L+ I G P+ G +
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244
Query: 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER 315
+F + GH D N + I+++ HA P +R
Sbjct: 245 LFKLLKEGH---RMDKPANCTHELYMIMRECWHAVPSQR 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 73 RELGRGQFGVTYLVTHK----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
R+LG G FG L + +T +Q A KS+ + + D+++E++I+ +L H
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HE 66
Query: 129 NIVELKGAYEDR--HSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCH 185
NIV+ KG + + + LIM+ G L + + K + + Q+ + Y
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD----VFKDLVGSAYYVAPEV 241
S +HRDL N L S + +K DFGL+ + V DL ++ APE
Sbjct: 127 SRQYVHRDLAARNVLVES---EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 242 L-RRNYGAEADIWSAGVILYILLS 264
L + + +D+WS GV LY LL+
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 6e-14
Identities = 68/279 (24%), Positives = 104/279 (37%), Gaps = 58/279 (20%)
Query: 75 LGRGQFGVTYLVTHKDT------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
LG G FG Y T D + A K++ RK + ++ +E +M + H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFN-HP 59
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA--------------NLC 174
NIV+L G +IM+L GG+L Y A ++C
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLL-------SYLRDARVERFGPPLLTLKELLDIC 112
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP--LKATDFGLSVFFKPGDVFKDLVG 232
+ Y M +HRDL N L S D+ +K DFGL+ +D+
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYK 163
Query: 233 SAYY------------VAPEVLRRN-YGAEADIWSAGVILY-ILLSGVPPFWGETEQSIF 278
S YY +APE L + ++D+WS GV+++ IL G P+ Q +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
Query: 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS 317
+ G N ++ DP ER +
Sbjct: 224 QHVTAGG---RLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 6e-14
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 73 RELGRGQFGVTYLV----THKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
R LG G FG L + T + A K++ + + ++E+ I+ L H
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HE 66
Query: 129 NIVELKGAYEDR--HSVNLIMDLCAGGELFDRIIAKGHYSERAAANL------CRQMVTV 180
NIV+ KG ++ + LIM+ G L D Y + NL +Q+
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLLLFAQQICEG 119
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD----VFKDLVGSAYY 236
+ Y HS +HRDL N L + D +K DFGL+ G V +D ++
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDN---DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 237 VAPEVLRRN-YGAEADIWSAGVILYILLS 264
A E L+ N + +D+WS GV LY LL+
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 69/282 (24%), Positives = 122/282 (43%), Gaps = 38/282 (13%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVT----HKDTKQQFACKSISSRKLINRD----DVEDV 114
E R+ + G+ LG G FG + K+ + ++ K++ D D+ D+
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAV---KMLKSDATEKDLSDL 70
Query: 115 RREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK------------ 162
E+++M + H+NI+ L GA + +I++ + G L + + A+
Sbjct: 71 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130
Query: 163 ----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218
S + + Q+ + Y S +HRDL N L + ED+ +K DFGL+
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA 187
Query: 219 VFFKPGDVFKDLVGS---AYYVAPEVL-RRNYGAEADIWSAGVILY-ILLSGVPPFWGET 273
D +K ++APE L R Y ++D+WS GV+L+ I G P+ G
Sbjct: 188 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247
Query: 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER 315
+ +F + GH D N ++ +++ HA P +R
Sbjct: 248 VEELFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQR 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 66/225 (29%), Positives = 110/225 (48%), Gaps = 30/225 (13%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRN 129
ELG G GV + V+HK + I +RKLI+ + +R RE+Q++H
Sbjct: 12 ELGAGNGGVVFKVSHKPSG------LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY- 64
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSM- 187
IV GA+ +++ M+ GG L D+++ K G E+ + ++ + Y
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 123
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL----VGSAYYVAPEVLR 243
+MHRD+KP N L +S E +K DFG+S G + + VG+ Y++PE L+
Sbjct: 124 KIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQ 175
Query: 244 -RNYGAEADIWSAGVILYILLSG---VPPFWGETEQSIFDAILRG 284
+Y ++DIWS G+ L + G +PP + + +F + G
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG 220
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 7e-14
Identities = 62/257 (24%), Positives = 109/257 (42%), Gaps = 20/257 (7%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R + R+LG GQFG + +T A K++ + D +D E QIM L
Sbjct: 5 RTSIQLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTM----DPKDFLAEAQIMKKLR 59
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHY 183
H +++L + ++ +L G L + + A ++ Q+ + + Y
Sbjct: 60 -HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPE 240
+ +HRDL N L E++ K DFGL+ K D+++ G+ + + APE
Sbjct: 119 LEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPE 174
Query: 241 VLRRN-YGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
N + ++D+WS G++L I+ G P+ G T + + +G + P
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG---YRMPCPPGCPK 231
Query: 299 SAKDIVKKMLHADPKER 315
DI+ DP +R
Sbjct: 232 ELYDIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 56/181 (30%), Positives = 82/181 (45%), Gaps = 37/181 (20%)
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL---VG 232
Q++ + Y HS G++HRD+KP N L +S + LK DFGL+ +P D K + V
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEP-DESKHMTQEVV 166
Query: 233 SAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL-------- 282
+ YY APE+L R+Y + DIWS G I LL F ++ D I
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226
Query: 283 ----------RGHIDFSSDPWPNISS----------SAKDIVKKMLHADPKERLSAAEVL 322
R HI P++ A ++ +ML DP +R+SAA+ L
Sbjct: 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
Query: 323 S 323
+
Sbjct: 287 A 287
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-14
Identities = 63/252 (25%), Positives = 108/252 (42%), Gaps = 36/252 (14%)
Query: 61 PMEDVRNTYIFGRELGRGQFGVTY-----LVTHKDTKQQFACKSISSRKLINRDDVEDVR 115
P+ VR F ELG G FG Y + + A K++ ++ ++ R
Sbjct: 3 PLSAVR----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL--KENAEPKVQQEFR 56
Query: 116 REVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA---- 171
+E ++M L H NIV L G ++ + A G+L + ++ +S+ A
Sbjct: 57 QEAELMSDLQ-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 172 ------------NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219
++ Q+ + Y S +HRDL N L E +K +DFGLS
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSR 172
Query: 220 FFKPGDVFKDLVGSAY---YVAPE-VLRRNYGAEADIWSAGVILYILLS-GVPPFWGETE 274
D ++ S ++ PE +L + E+DIWS GV+L+ + S G+ P++G +
Sbjct: 173 DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232
Query: 275 QSIFDAILRGHI 286
Q + + I +
Sbjct: 233 QEVIEMIRSRQL 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 64/273 (23%), Positives = 102/273 (37%), Gaps = 41/273 (15%)
Query: 73 RELGRGQFGVT---YLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
+ELG G FG + + + A K++ + ++ RE +M L H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA--GKKEFLREASVMAQLD-HPC 57
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGV 189
IV L G + + L+M+L G L + + L Q+ + Y S
Sbjct: 58 IVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-VGSAYY------------ 236
+HRDL N L + K +DFG+S + L GS YY
Sbjct: 117 VHRDLAARNVLLVN---RHQAKISDFGMS---------RALGAGSDYYRATTAGRWPLKW 164
Query: 237 VAPEVLRRNYG---AEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292
APE + NYG +++D+WS GV L+ S G P+ + + G
Sbjct: 165 YAPECI--NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE---RLPR 219
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325
I+ P++R + +E+ S F
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 48/234 (20%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRNI 130
LG+G FG + T KD K+ + K D ++++ E +I+ H NI
Sbjct: 3 LGKGNFGEVFKGTLKD-------KTPVAVKTCKEDLPQELKIKFLSEARILKQYD-HPNI 54
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG---------HYSERAAANLCRQMVTVV 181
V+L G R + ++M+L GG+ + K ++ AAA +
Sbjct: 55 VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMA------- 107
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS------VFFKPGDVFKDLVGSAY 235
Y S +HRDL N L E++ LK +DFG+S ++ G K +
Sbjct: 108 -YLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSG--LKQI--PIK 159
Query: 236 YVAPEVLRRNYG---AEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
+ APE L NYG +E+D+WS G++L+ S GV P+ G T Q + + +G+
Sbjct: 160 WTAPEAL--NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY 211
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 65/276 (23%), Positives = 121/276 (43%), Gaps = 32/276 (11%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSIS-SRKLINRD----DVEDVRREVQI 120
R+ G+ LG G FG + + ++++ + K++ D D+ D+ E+++
Sbjct: 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 73
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR----- 175
M + H+NI+ L GA + +I++ + G L + + A+ + ++ R
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 176 -----------QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
Q+ + Y S +HRDL N L + E++ +K DFGL+
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNI 190
Query: 225 DVFKDLVGS---AYYVAPEVL-RRNYGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFD 279
D +K ++APE L R Y ++D+WS GV+++ I G P+ G + +F
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER 315
+ GH D N ++ +++ HA P R
Sbjct: 251 LLKEGH---RMDKPANCTNELYMMMRDCWHAIPSHR 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 72 GRELGRGQFGVTYLVTHKDTK--QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
G ++GRG +G Y KD K +++A K I + RE+ ++ L H N
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELK-HPN 59
Query: 130 IVELKG---AYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERA-----------AANLCR 175
++ L+ ++ DR V L+ D A +L+ I K H + +A +L
Sbjct: 60 VIALQKVFLSHSDR-KVWLLFDY-AEHDLWH--IIKFHRASKANKKPMQLPRSMVKSLLY 115
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFL-FSSSAEDSPLKATDFGLSVFF----KPGDVFKDL 230
Q++ +HY H+ V+HRDLKP N L E +K D G + F KP +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 231 VGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPF 269
V + +Y APE+L R+Y DIW+ G I LL+ P F
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 31/253 (12%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G+FG L ++ K C + N + E +M L H N+V+L
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQLR-HSNLVQLL 65
Query: 135 GA-YEDRHSVNLIMDLCAGGELFD------RIIAKGHYSERAAANLCRQMVTVVHYCHSM 187
G E++ + ++ + A G L D R + G + + ++C M Y +
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM----EYLEAN 121
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG-SAYYVAPEVLR-RN 245
+HRDL N L S ED+ K +DFGL+ K +D + APE LR +
Sbjct: 122 NFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKK 175
Query: 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
+ ++D+WS G++L+ + S G P+ + + + +G+ + D P + D++
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPV---VYDVM 232
Query: 305 KKMLHADPKERLS 317
K+ H D R S
Sbjct: 233 KQCWHLDAATRPS 245
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 25/231 (10%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R + R+LG G FG + K+ + A K + S L+ + D + +EVQ + L
Sbjct: 5 REEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQ---KEVQALKRLR 60
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA--NLCRQMVTVVHY 183
H++++ L V +I +L G L + + A+ ++ Q+ + Y
Sbjct: 61 -HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY-------Y 236
+HRDL N L ED K DFGL+ + K+ V + +
Sbjct: 120 LEEQNSIHRDLAARNILV---GEDLVCKVADFGLA------RLIKEDVYLSSDKKIPYKW 170
Query: 237 VAPEVL-RRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + ++D+WS G++LY + + G P+ G ++D I G+
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY 221
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 72 GRELGRGQFGVTYLVTHKDTK--QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
G ++GRG +G Y KD K + +A K I + RE+ ++ L H N
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELK-HPN 59
Query: 130 IVELKG---AYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERA-----------AANLCR 175
++ L+ ++ DR V L+ D A +L+ I K H + +A +L
Sbjct: 60 VISLQKVFLSHADR-KVWLLFDY-AEHDLWH--IIKFHRASKANKKPVQLPRGMVKSLLY 115
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFL-FSSSAEDSPLKATDFGLSVFF----KPGDVFKDL 230
Q++ +HY H+ V+HRDLKP N L E +K D G + F KP +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 231 VGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPF 269
V + +Y APE+L R+Y DIW+ G I LL+ P F
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 7e-13
Identities = 66/245 (26%), Positives = 97/245 (39%), Gaps = 46/245 (18%)
Query: 116 REVQIMHHLTGHRNIVELKGAYEDRHSVNLIM-----DLCAGGELFDRIIAKGHYSERAA 170
RE ++ L H NIV L + ++ L+ DLC + D+ G
Sbjct: 52 REASLLKGLK-HANIVLLHDIIHTKETLTLVFEYVHTDLC---QYMDK--HPGGLHPENV 105
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKD 229
Q++ + Y H ++HRDLKP+N L S + E LK DFGL+ P + +
Sbjct: 106 KLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSN 162
Query: 230 LVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHI 286
V + +Y P+VL Y D+W G I ++ GV F G + Q + I
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLG 222
Query: 287 DFSSDPWPNISS----------------------------SAKDIVKKMLHADPKERLSA 318
+ D WP + S A+D+ K+L PK RLSA
Sbjct: 223 TPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA 282
Query: 319 AEVLS 323
LS
Sbjct: 283 QAALS 287
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 7e-13
Identities = 66/292 (22%), Positives = 126/292 (43%), Gaps = 51/292 (17%)
Query: 66 RNTYIFGRELGRGQFGVTYLVT-----HKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R+T + RELG G FG +L ++ K+ A K++ ++ + D +D RE ++
Sbjct: 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL--KETASNDARKDFEREAEL 61
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAAN-------- 172
+ + H NIV+ G + ++ + G+L + + G + +
Sbjct: 62 LTNF-QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 173 ------LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226
+ Q+ + + Y S +HRDL N L D +K DFG+S
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDLVVKIGDFGMS-------- 169
Query: 227 FKDLVGSAYY------------VAPE-VLRRNYGAEADIWSAGVILY-ILLSGVPPFWGE 272
+D+ + YY + PE ++ R + E+D+WS GV+L+ I G P++G
Sbjct: 170 -RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228
Query: 273 TEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324
+ + + + I +G + P S DI+ DP++R++ ++ +
Sbjct: 229 SNEEVIECITQGRLLQRPRTCP---SEVYDIMLGCWKRDPQQRINIKDIHER 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-13
Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 38/230 (16%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
+GRG FG + + A KS R+ + D +E +I+ + H NIV L
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKS--CRETLPPDLKAKFLQEARILKQYS-HPNIVRL 58
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKG---------HYSERAAANLCRQMVTVVHYC 184
G + + ++M+L GG+ + +G E AAA + Y
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGM--------EYL 110
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS------VFFKPGDVFKDLVGSAYYVA 238
S +HRDL N L + E + LK +DFG+S V+ G + + V + A
Sbjct: 111 ESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYASTGGMKQIPVK---WTA 164
Query: 239 PEVLRRNYG---AEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284
PE L NYG +E+D+WS G++L+ S G P+ + Q +AI +G
Sbjct: 165 PEAL--NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG 212
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL--INRDDVEDVRREVQIMHHLTGH 127
F ++LG+G FG L + D Q + ++ +KL + + D RE++I+ L H
Sbjct: 7 KFIQQLGKGNFGSVELCRY-DPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ-H 64
Query: 128 RNIVELKG-AYE-DRHSVNLIMDLCAGGELFDRIIAKGHYSERA-----AANLCRQMVTV 180
NIV+ KG Y R ++ L+M+ G L D + + A+ +C+ M
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM--- 121
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS----------VFFKPGDVFKDL 230
Y S +HRDL N L S ++ +K DFGL+ +PG+
Sbjct: 122 -EYLGSKRYVHRDLATRNILVES---ENRVKIGDFGLTKVLPQDKEYYKVREPGE----- 172
Query: 231 VGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLS 264
++ APE L + + +D+WS GV+LY L +
Sbjct: 173 -SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 61/293 (20%), Positives = 120/293 (40%), Gaps = 53/293 (18%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
E R RELG+G FG+ Y V + + + A K+++ + + + E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNE 59
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL---- 173
+M H ++V L G ++M+L A G+L + + E
Sbjct: 60 ASVMKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPP 116
Query: 174 --------CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225
++ + Y + +HRDL N + + ED +K DFG++
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMT------- 166
Query: 226 VFKDLVGSAYY------------VAPEVLRRN-YGAEADIWSAGVILY-ILLSGVPPFWG 271
+D+ + YY +APE L+ + ++D+WS GV+L+ + P+ G
Sbjct: 167 --RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG 224
Query: 272 ETEQSIFDAIL-RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ + + ++ GH+D + P+ ++++ +PK R + E++S
Sbjct: 225 LSNEEVLKFVIDGGHLDLPENC-PDK---LLELMRMCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 54/173 (31%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY 235
Q++ + + HS V+HRDLKP+N L +SS + +K DFGL+ + +V + +
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLW 174
Query: 236 YVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAI-LRGHID-- 287
Y APEV L+ +Y D+WS G I + P F G ++ I D I L G D
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234
Query: 288 ---------FSSDPW-------PNISSSAKDIVKKMLHADPKERLSAAEVLSK 324
F S +I KD++ K L +P +R+SA LS
Sbjct: 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 52/187 (27%), Positives = 86/187 (45%), Gaps = 25/187 (13%)
Query: 113 DVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAA 170
D E IM H NI+ L+G V ++ + G L D + K G ++
Sbjct: 51 DFLSEASIMGQFD-HPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQL 108
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230
+ R + + + Y MG +HRDL N L +S+ K +DFGLS V +D
Sbjct: 109 VGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL---VCKVSDFGLS------RVLEDD 159
Query: 231 VGSAY----------YVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIF 278
+AY + APE + R + + +D+WS G++++ ++S G P+W + Q +
Sbjct: 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219
Query: 279 DAILRGH 285
AI G+
Sbjct: 220 KAIEEGY 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRN 129
ELG G GV V HK + I +RKLI+ + +R RE+Q++H
Sbjct: 12 ELGAGNGGVVTKVQHKPSGL------IMARKLIHLEIKPAIRNQIIRELQVLHECNSPY- 64
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM-G 188
IV GA+ +++ M+ GG L + E + ++ + Y
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL----VGSAYYVAPEVLR- 243
+MHRD+KP N L +S E +K DFG+S G + + VG+ Y++PE L+
Sbjct: 125 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 176
Query: 244 RNYGAEADIWSAGVILYILLSG---VPPFWGETEQSIF 278
+Y ++DIWS G+ L L G +PP + ++IF
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 67/276 (24%), Positives = 115/276 (41%), Gaps = 32/276 (11%)
Query: 66 RNTYIFGRELGRGQFGVTYLV----THKDTKQQFACKSISSRKLINRD-DVEDVRREVQI 120
R+ + G+ LG G FG K Q ++ K D D+ D+ E+++
Sbjct: 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMEL 70
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK----------------GH 164
M + H+NI+ L G + +I++ A G L + + A+
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 165 YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
S + + Q+ + Y S +HRDL N L ED+ +K DFGL+
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV---TEDNVMKIADFGLARGVHDI 187
Query: 225 DVFKDLVGS---AYYVAPEVL-RRNYGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFD 279
D +K ++APE L R Y ++D+WS G++++ I G P+ G + +F
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER 315
+ GH D N + ++++ HA P +R
Sbjct: 248 LLREGH---RMDKPSNCTHELYMLMRECWHAVPTQR 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 34/97 (35%), Positives = 55/97 (56%), Gaps = 10/97 (10%)
Query: 230 LVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288
++G+ Y+APE+L + +G D W+ GV L+ L+G+PPF ET Q +F IL I
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI-- 597
Query: 289 SSDPWPN----ISSSAKDIVKKMLHADPKERLSAAEV 321
PWP +S +A++ ++ +L DP +R E+
Sbjct: 598 ---PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKEL 631
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 70/291 (24%), Positives = 123/291 (42%), Gaps = 54/291 (18%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R + RELG G FG +L ++ K A K++ L R +D +RE ++
Sbjct: 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR---KDFQREAEL 60
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELF--------DRII--------AKGH 164
+ +L H +IV+ G D + ++ + G+L D +I AKG
Sbjct: 61 LTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 165 YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
++ Q+ + + Y S +HRDL N L ++ +K DFG+S
Sbjct: 120 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL---VKIGDFGMS------ 170
Query: 225 DVFKDLVGSAYY------------VAPE-VLRRNYGAEADIWSAGVILY-ILLSGVPPFW 270
+D+ + YY + PE ++ R + E+D+WS GVIL+ I G P++
Sbjct: 171 ---RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
Query: 271 GETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
+ + + I +G + P DI+ +P++RL+ E+
Sbjct: 228 QLSNTEVIECITQGRVLERPRVCPK---EVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 73/300 (24%), Positives = 134/300 (44%), Gaps = 41/300 (13%)
Query: 63 EDVRNTYIFGRELGRGQFG--VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
ED++ F +G G FG + ++ K A K + ++ + +D D E+++
Sbjct: 2 EDIK----FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKML--KEFASENDHRDFAGELEV 55
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD-----RII------AKGH----- 164
+ L H NI+ L GA E+R + + ++ G L D R++ AK H
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 165 YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
+ + + T + Y +HRDL N L E+ K DFGLS +
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLS---RGE 169
Query: 225 DVF-KDLVGS--AYYVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFD 279
+V+ K +G ++A E L + Y ++D+WS GV+L+ ++S G P+ G T +++
Sbjct: 170 EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV---LSKFLIPKKTLQTLA 336
+ +G + + N +++++ P ER A++ LS+ L +K +A
Sbjct: 230 KLPQG---YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNMA 286
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 33/268 (12%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
ELGRG +GV + H T A K I R +N + + + ++ I V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVT 64
Query: 133 LKGAYEDRHSVNLIMDLCAGG--ELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHS-MG 188
GA V + M++ + + ++ KG E + +V + Y HS +
Sbjct: 65 FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV-----GSAYYVAPEVL- 242
V+HRD+KP N L + + + +K DFG+S G + + G Y+APE +
Sbjct: 125 VIHRDVKPSNVLINRNGQ---VKLCDFGIS-----GYLVDSVAKTIDAGCKPYMAPERIN 176
Query: 243 ----RRNYGAEADIWSAGVILYILLSGVPPF--WGETEQSIFDAILRGHIDFSSDPWPNI 296
++ Y ++D+WS G+ + L +G P+ W Q L+ ++ S P
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-----LKQVVEEPSPQLPAE 231
Query: 297 SSSA--KDIVKKMLHADPKERLSAAEVL 322
S +D V K L + KER + E+L
Sbjct: 232 KFSPEFQDFVNKCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 66/267 (24%), Positives = 107/267 (40%), Gaps = 33/267 (12%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT-----GHRN 129
LG G G Y H T++ A K +I D ++++ QIM L
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVK------VIPLDITVELQK--QIMSELEILYKCDSPY 60
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH---YCHS 186
I+ GA+ + +++ + GG L Y + L R V VV Y S
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSL-------DVYRKIPEHVLGRIAVAVVKGLTYLWS 113
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE-VLRRN 245
+ ++HRD+KP N L ++ + +K DFG+S + K VG+ Y+APE +
Sbjct: 114 LKILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQ 169
Query: 246 YGAEADIWSAGVILYILLSG---VPPFWGETEQSIFDAILRGHIDFSSDPWP--NISSSA 300
YG +D+WS G+ L G P + +L+ +D P S
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229
Query: 301 KDIVKKMLHADPKERLSAAEVLSKFLI 327
+ + + PKER + ++ I
Sbjct: 230 VHFITQCMRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 71/285 (24%), Positives = 123/285 (43%), Gaps = 33/285 (11%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
F +G G FG K + ++ ++DD D E++++ L H NI
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFD-----RIIAKG---HYSERAAANLCRQMVTV-- 180
+ L GA E R + L ++ G L D R++ + A+ L Q +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 181 ------VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-KDLVGS 233
+ Y +HRDL N L E+ K DFGLS + +V+ K +G
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS---RGQEVYVKKTMGR 184
Query: 234 --AYYVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFS 289
++A E L + Y +D+WS GV+L+ ++S G P+ G T +++ + +G +
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YR 241
Query: 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEV---LSKFLIPKKT 331
+ N D++++ P ER S A++ L++ L +KT
Sbjct: 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 26/225 (11%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKL-INRDDVEDVRREVQIMHHLTGHRNIVEL 133
+G G+FG + K ++ +I + K +D E IM + H NI+ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNIIRL 71
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+G +I + G L D+ + G +S + R + + Y M +H
Sbjct: 72 EGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY----------YVAPEV 241
RDL N L +S+ E K +DFGLS V +D Y + APE
Sbjct: 131 RDLAARNILVNSNLE---CKVSDFGLS------RVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 242 LR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284
+ R + + +D+WS G++++ ++S G P+W + + AI G
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 48/283 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL---INRDDVEDVRREVQIMH 122
R+ G+ LG G FG +++ + L D+ D+ E+++M
Sbjct: 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMK 70
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR------- 175
+ H+NI+ L G + ++++ A G L D + A+ E A+ + R
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 176 ---------QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226
Q+ + + S +HRDL N L + ED +K DFGL+
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLA-------- 179
Query: 227 FKDLVGSAYY------------VAPEVL-RRNYGAEADIWSAGVILY-ILLSGVPPFWGE 272
+D+ YY +APE L R Y ++D+WS GV+L+ I G P+ G
Sbjct: 180 -RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238
Query: 273 TEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER 315
+ +F + G+ + N + +++ H P +R
Sbjct: 239 PVEELFKLLKEGY---RMEKPQNCTQELYHLMRDCWHEVPSQR 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 49/197 (24%), Positives = 81/197 (41%), Gaps = 44/197 (22%)
Query: 168 RAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
A + +Q++ + Y H+ ++HRD+K EN + D D G + F F
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND--VDQVCIG-DLGAAQFPVVAPAF 213
Query: 228 KDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI 286
L G+ APEVL R+ Y ++ADIWSAG++L+ +L+ + + + + + H
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273
Query: 287 --------------DFSSDP---------------------WP-----NISSSAKDIVKK 306
+F DP +P N+ + +V K
Sbjct: 274 HLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHK 333
Query: 307 MLHADPKERLSAAEVLS 323
ML D R SA E+L+
Sbjct: 334 MLTFDAAMRPSAEEILN 350
|
Length = 357 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-11
Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 29/240 (12%)
Query: 85 LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144
LV T+Q F K + +R+ + + V M L H+ IV ED SV
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCL--HKYIVS-----ED--SVF 61
Query: 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS 204
L++ GG+L+ I + E +MV + H G++ RDL P N L
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR 121
Query: 205 AEDSPLKATDFGLSVFFKP---GDVFKDLVGSAYYVAPEVLRRNYGAEA-DIWSAGVILY 260
++ T F + G+ +++ Y APEV + EA D WS G IL+
Sbjct: 122 GH---IQLTYFSRWSEVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLGAILF 173
Query: 261 ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAE 320
LL+ G+T + + H + W +S A+ +++++L +P ERL A
Sbjct: 174 ELLT------GKTLVECHPSGINTHTTLNIPEW--VSEEARSLLQQLLQFNPTERLGAGV 225
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 69/264 (26%), Positives = 113/264 (42%), Gaps = 34/264 (12%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R + R+LG GQFG ++ T T + A K++ + E +E QIM L
Sbjct: 5 RESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTM----SPEAFLQEAQIMKKLR 59
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL------CRQMVT 179
H +V+L + + ++ + + G L D + E L Q+
Sbjct: 60 -HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL----KSGEGKKLRLPQLVDMAAQIAE 114
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---Y 236
+ Y S +HRDL N L E+ K DFGL+ + D + G+ + +
Sbjct: 115 GMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIED-DEYTAREGAKFPIKW 170
Query: 237 VAPEVLRRNYGA---EADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292
APE NYG ++D+WS G++L I+ G P+ G T + + + + RG+ P
Sbjct: 171 TAPEAA--NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY----RMP 224
Query: 293 WP-NISSSAKDIVKKMLHADPKER 315
P N D++ + DP+ER
Sbjct: 225 RPPNCPEELYDLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-11
Identities = 65/258 (25%), Positives = 115/258 (44%), Gaps = 35/258 (13%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDV--EDVRREVQIMHHLTGHR 128
G +G G+FG + T Q+ A K+I DV + E +M L H+
Sbjct: 10 LGEIIGEGEFGAVLQGEY--TGQKVAVKNIKC-------DVTAQAFLEETAVMTKLH-HK 59
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM- 187
N+V L G + + ++M+L + G L + + +G RA ++ + + + M
Sbjct: 60 NLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGME 114
Query: 188 -----GVMHRDLKPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEV 241
++HRDL N L S ED K +DFGL V D K V + APE
Sbjct: 115 YLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKLPVK---WTAPEA 168
Query: 242 LRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
L+ + +++D+WS GV+L+ + S G P+ + + + + + +G + +P +
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPAD 225
Query: 300 AKDIVKKMLHADPKERLS 317
++ +PK+R S
Sbjct: 226 VYVLMTSCWETEPKKRPS 243
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-11
Identities = 58/250 (23%), Positives = 114/250 (45%), Gaps = 42/250 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
R+ + RELG G FG +L + +Q ++ + K + + +D RE +++ +
Sbjct: 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTN 63
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL--FDR-------IIAKGH----YSERAA 170
L H +IV+ G + + ++ + G+L F R ++A+G+ ++
Sbjct: 64 LQ-HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230
++ +Q+ + Y S +HRDL N L E+ +K DFG+S +D+
Sbjct: 123 LHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMS---------RDV 170
Query: 231 VGSAYY------------VAPE-VLRRNYGAEADIWSAGVILY-ILLSGVPPFWGETEQS 276
+ YY + PE ++ R + E+D+WS GV+L+ I G P++ +
Sbjct: 171 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230
Query: 277 IFDAILRGHI 286
+ + I +G +
Sbjct: 231 VIECITQGRV 240
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 28/269 (10%)
Query: 69 YIFGRELGRGQFGV---TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+ GR LG+G+FG L + + Q+ A K + + + + D+E+ RE M
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA-DIFSSSDIEEFLREAACMKEFD 59
Query: 126 GHRNIVELKGAYEDRHSVN------LIMDLCAGGELFDRIIAKGHYSER---AAANLCRQ 176
H N+++L G + +I+ G+L ++ E L R
Sbjct: 60 -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 177 MVTV---VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
M+ + + Y S +HRDL N + E+ + DFGLS GD ++ S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 234 AY---YVAPEVLRRN-YGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDF 288
++A E L N Y +D+W+ GV ++ I+ G P+ G I++ +++G +
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG--NR 233
Query: 289 SSDPWPNISSSAKDIVKKMLHADPKERLS 317
P P+ +++ + +PK R S
Sbjct: 234 LKQP-PDCLEDVYELMCQCWSPEPKCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 86/379 (22%), Positives = 144/379 (37%), Gaps = 79/379 (20%)
Query: 17 TTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATS--------SSVGRVLGKPMED---- 64
D + K D S T AT S V +P E
Sbjct: 27 GGTDTSDSKDTTGD--KFDDCDELGDSDDVTHATDYDADEESLSPQTDVCQEPCETTSSS 84
Query: 65 -----VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFAC--KSISSRKLINRDDVEDVRRE 117
VR Y L G G ++ T +Q+ K+++ K RE
Sbjct: 85 DPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGRE 136
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL--CAGGELFDRIIAKGHYSERAAANLCR 175
+ I+ ++ HR I+ L AY + +V ++M C +LF + G A + R
Sbjct: 137 IDILKTIS-HRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQR 192
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV-----FFKPGDVFKDL 230
+++ + Y H G++HRD+K EN +F E++ L DFG + P
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTEN-IFLDEPENAVLG--DFGAACKLDAHPDTPQCY--GW 247
Query: 231 VGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWG---ETEQSIFDAILRG-- 284
G+ +PE+L + Y A+ DIWSAG++L+ + +G ++ S +I+R
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ 307
Query: 285 -H-IDFSSDPWPNI--------------------------SSSAKDIVKKMLHADPKERL 316
H ++F + N+ + ++ KML D + R
Sbjct: 308 VHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP 367
Query: 317 SAAEVLSKFLIPKKTLQTL 335
SA ++LS L K+ + L
Sbjct: 368 SAQDILSLPLFTKEPINLL 386
|
Length = 392 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 62/253 (24%), Positives = 109/253 (43%), Gaps = 26/253 (10%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
++LG GQFG ++ + ++ + A K++ + V+ E +M L H +V
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKLVR 65
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVM 190
L + +I + A G L D + + G + Q+ + Y +
Sbjct: 66 LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPEVLRRNYG 247
HRDL+ N L S S K DFGL+ + + + G+ + + APE + N+G
Sbjct: 126 HRDLRAANVLVSESLM---CKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAI--NFG 179
Query: 248 A---EADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKD 302
+ ++D+WS G++LY I+ G P+ G + + A+ RG+ P N D
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY----RMPRMENCPDELYD 235
Query: 303 IVKKMLHADPKER 315
I+K +ER
Sbjct: 236 IMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 63/292 (21%), Positives = 118/292 (40%), Gaps = 47/292 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLV--THKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
R + ELG G FG +L + +Q ++ + K + +D +RE +++
Sbjct: 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV 63
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL--FDR-------------IIAKGHYSER 168
L H++IV G + + ++ + G+L F R +A G +
Sbjct: 64 LQ-HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 169 AAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK 228
+ Q+ + + Y S+ +HRDL N L + +K DFG+S +
Sbjct: 123 QMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQGLVVKIGDFGMS---------R 170
Query: 229 DLVGSAYY------------VAPE-VLRRNYGAEADIWSAGVILY-ILLSGVPPFWGETE 274
D+ + YY + PE +L R + E+DIWS GV+L+ I G P++ +
Sbjct: 171 DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230
Query: 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326
+ I +G P I++ +P++R+ ++ S+
Sbjct: 231 TEAIECITQGRELERPRTCPP---EVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 66/279 (23%), Positives = 118/279 (42%), Gaps = 50/279 (17%)
Query: 75 LGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
LGRG+FG +L K + K++ K + + + RRE+ + L+ H+N
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKN 69
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGEL--FDRIIAKGHYSERAAANLCRQMVTVVH-YCHS 186
+V L G + +I++ G+L F R + +Q V +
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 187 MG------VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYY---- 236
M +HRDL N L SS E +K + LS KD+ S YY
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLS---------KDVYNSEYYKLRN 177
Query: 237 -------VAPEVLRRN-YGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHID 287
+APE ++ + + ++D+WS GV+++ + G PF+G +++ + + + G ++
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE 237
Query: 288 FSSDPWPNISSSAKDIVKKMLH---ADPKERLSAAEVLS 323
P + K M +PK+R S +E++S
Sbjct: 238 -----LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 65/263 (24%), Positives = 117/263 (44%), Gaps = 28/263 (10%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
+LG+G FG ++ T T + A K++ + E +E Q+M L H +V+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 66
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSER----AAANLCRQMVTVVHYCHSMGV 189
+ + ++ + + G L D + KG + ++ Q+ + + Y M
Sbjct: 67 YAVVSEE-PIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPE-VLRRN 245
+HRDL+ N L E+ K DFGL+ + + + G+ + + APE L
Sbjct: 124 VHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGR 179
Query: 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKDI 303
+ ++D+WS G++L L + G P+ G + + D + RG+ P P S D+
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----RMPCPPECPESLHDL 235
Query: 304 VKKMLHADPKERLSAAEVLSKFL 326
+ + +P+ER E L FL
Sbjct: 236 MCQCWRKEPEER-PTFEYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 16/218 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKL-INRDDVEDVRREVQIMHHLTGHRNIVEL 133
+G G+FG K ++ +I + K D E IM H NI+ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHL 70
Query: 134 KGAYEDRHSVNLIMDLCAGGEL--FDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+G V +I + G L F R G ++ + R + + Y M +H
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS------AYYVAPEVLR-R 244
RDL N L +S+ K +DFGLS F + S + APE + R
Sbjct: 130 RDLAARNILVNSNL---VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 245 NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAI 281
+ + +D+WS G++++ ++S G P+W + Q + +AI
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 59/247 (23%), Positives = 107/247 (43%), Gaps = 36/247 (14%)
Query: 61 PMEDVRNTYIFGRELGRGQFGVTY----LVTHKDTKQQFACKSISSRKLINRDDVEDVRR 116
P+ VR F ELG FG Y + D Q A K++ + + N + ++
Sbjct: 3 PLSAVR----FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQ 56
Query: 117 EVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAAN---- 172
E +M L H NIV L G V ++ + G+L + +I + +S+ ++
Sbjct: 57 EASLMAELH-HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115
Query: 173 -------------LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219
+ Q+ + Y S +H+DL N L E +K +D GLS
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLSR 172
Query: 220 FFKPGDVFKDLVGSAY---YVAPE-VLRRNYGAEADIWSAGVILYILLS-GVPPFWGETE 274
D ++ S ++ PE ++ + +++DIWS GV+L+ + S G+ P++G +
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232
Query: 275 QSIFDAI 281
Q + + +
Sbjct: 233 QEVIEMV 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 6e-10
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQF--ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
ELG G FG +K K+Q A K + + + +++ RE +IMH L + IV
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIV 58
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVM 190
+ G E ++ L+M++ +GG L + K + L Q+ + Y +
Sbjct: 59 RMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-VFKDLVGSAY---YVAPE-VLRRN 245
HRDL N L K +DFGLS D +K + + APE + R
Sbjct: 118 HRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 246 YGAEADIWSAGVILYILLS-GVPPF 269
+ + +D+WS G+ ++ S G P+
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 66/270 (24%), Positives = 119/270 (44%), Gaps = 34/270 (12%)
Query: 75 LGRGQFG--VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+G G FG + + + A K + ++ ++DD D E++++ L H NI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFD-----RII------AKGH-----YSERAAANLCRQ 176
L GA E R + L ++ G L D R++ A + S + +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-KDLVGS-- 233
+ + Y +HRDL N L E+ K DFGLS + +V+ K +G
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS---RGQEVYVKKTMGRLP 174
Query: 234 AYYVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSD 291
++A E L + Y +D+WS GV+L+ ++S G P+ G T +++ + +G + +
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLE 231
Query: 292 PWPNISSSAKDIVKKMLHADPKERLSAAEV 321
N D++++ P ER S A++
Sbjct: 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 67/291 (23%), Positives = 114/291 (39%), Gaps = 47/291 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVE-DVRREVQIMH 122
RN + R++G+G FG + + F ++ K D++ D +RE +M
Sbjct: 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 63
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL--FDRIIAKGHYSERAAANLCRQMVTV 180
H NIV+L G + L+ + A G+L F R H S RA +L +
Sbjct: 64 EFD-HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR-----HRSPRAQCSLSHSTSSA 117
Query: 181 VHY-------------CHSMGV------------MHRDLKPENFLFSSSAEDSPLKATDF 215
C + V +HRDL N L E+ +K DF
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADF 174
Query: 216 GLSVFFKPGDVFK----DLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLS-GVPPFW 270
GLS D +K D + + + Y E+D+W+ GV+L+ + S G+ P++
Sbjct: 175 GLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234
Query: 271 GETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
G + + + G++ D N ++++ P +R S A +
Sbjct: 235 GMAHEEVIYYVRDGNVLSCPD---NCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 65/282 (23%), Positives = 125/282 (44%), Gaps = 31/282 (10%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
E R RELG+G FG+ Y V + + + A K+++ + R+ +E + E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NE 59
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL---FDRIIAKGHYSERAAANLC 174
+M H ++V L G +IM+L G+L + + + A
Sbjct: 60 ASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118
Query: 175 RQMVTV-------VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
++M+ + + Y ++ +HRDL N + AED +K DFG++ D +
Sbjct: 119 KKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYY 175
Query: 228 ----KDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAI 281
K L+ +++PE L+ + +D+WS GV+L+ I P+ G + + + +
Sbjct: 176 RKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234
Query: 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ G + D P++ ++++ +PK R S E++S
Sbjct: 235 MEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 67/300 (22%), Positives = 126/300 (42%), Gaps = 63/300 (21%)
Query: 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL---INRDDVEDVRREVQIMHHLTG 126
+ G+ LG G+FG T K + +++ + L + ++ D+ E ++ +
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN- 61
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGEL--FDRIIAK-----------------GHYSE 167
H ++++L GA + LI++ G L F R K + E
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 168 RA---------AANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218
RA A + R M Y M ++HRDL N L AE +K +DFGLS
Sbjct: 122 RALTMGDLISFAWQISRGM----QYLAEMKLVHRDLAARNVLV---AEGRKMKISDFGLS 174
Query: 219 VFFKPGDVFKDLVGSAY-----------YVAPEVLRRN-YGAEADIWSAGVILYILLS-G 265
DV+++ +Y ++A E L + Y ++D+WS GV+L+ +++ G
Sbjct: 175 -----RDVYEE---DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 226
Query: 266 VPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325
P+ G + +F+ + G+ + N S +++ +P +R + A++ +
Sbjct: 227 GNPYPGIAPERLFNLLKTGY---RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 13/221 (5%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-DVEDVRREVQIMHHLTGHRNIV 131
+ +G G+FG K ++ +I + K + D D E IM H NI+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPNII 68
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGV 189
L+G V +I + G L D+ + + G ++ + R + + + Y M
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG---SAYYVAPEVLR-RN 245
+HRDL N L +S + K +DFGLS + + G + APE + R
Sbjct: 128 VHRDLAARNILVNS---NLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
+ + +D+WS G++++ ++S G P+W + Q + A+ G+
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 30/224 (13%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
E+GRG FG + HK + A K I S ++ + + + ++ ++ + IV+
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRS--TVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 134 KGAYEDRHSVNLIMDLCAGG-ELFDRII---AKGHYSERAAANLCRQMVTVVHYC-HSMG 188
GA + M+L + F + + K E + V ++Y +
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLS-----VFFKPGDVFKDLVGSAYYVAPEVL- 242
++HRD+KP N L + +K DFG+S K D G Y+APE +
Sbjct: 129 IIHRDVKPSNILLDRNGN---IKLCDFGISGQLVDSIAKTRDA-----GCRPYMAPERID 180
Query: 243 ---RRNYGAEADIWSAGVILYILLSGVPPF--WGETEQSIFDAI 281
R Y +D+WS G+ LY + +G P+ W S+FD +
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKW----NSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 54/240 (22%), Positives = 108/240 (45%), Gaps = 30/240 (12%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDV---EDVRREVQIMHH 123
+T F ELG +FG Y T ++++ + L ++ + E+ + E +
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSR 64
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAAN----------- 172
L H NIV L G +++I C+ +L + ++ + +S+ + +
Sbjct: 65 LQ-HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123
Query: 173 -----LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
+ Q+ + + S V+H+DL N L +K +D GL D +
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGLFREVYAADYY 180
Query: 228 KDLVGSAY----YVAPE-VLRRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAI 281
K L+G++ +++PE ++ + ++DIWS GV+L+ + S G+ P+ G + Q + + I
Sbjct: 181 K-LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 9e-09
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 17/223 (7%)
Query: 72 GRELGRGQFGVTY---LVTHKDT-KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH 127
+ LG G FG + + D+ K A K+I R R +++ + M L H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLD-H 68
Query: 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHS 186
IV L G S+ L+ L G L D + + + N C Q+ ++Y
Sbjct: 69 AYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPE-VL 242
++HR+L N L S DS ++ DFG++ P D + + ++A E +L
Sbjct: 128 HRMVHRNLAARNILLKS---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 243 RRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284
Y ++D+WS GV ++ ++S G P+ G + D + +G
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 59/232 (25%), Positives = 107/232 (46%), Gaps = 28/232 (12%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTH-KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
R + ++LG GQFG ++ T+ K TK A K++ + VE E +M L
Sbjct: 5 RESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSM----SVEAFLAEANVMKTL 58
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAA----ANLCRQMVTV 180
H +V+L A + + +I + A G L D + K + + Q+
Sbjct: 59 Q-HDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEG 114
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YV 237
+ + +HRDL+ N L S+S K DFGL+ + + + G+ + +
Sbjct: 115 MAFIEQRNYIHRDLRAANILVSASL---VCKIADFGLARVIEDNE-YTAREGAKFPIKWT 170
Query: 238 APEVLRRNYGA---EADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + N+G+ ++D+WS G++L +++ G P+ G + + A+ RG+
Sbjct: 171 APEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 220
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 24/272 (8%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
E R + ++LG GQFG ++ T + A K++ + E E QIM
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTM----SPESFLEEAQIMK 56
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRII-AKGHYSERAA-ANLCRQMVTV 180
L H +V+L A + ++ + + G L D + +G + ++ Q+
Sbjct: 57 KLR-HDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAG 114
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YV 237
+ Y M +HRDL+ N L K DFGL+ + + + G+ + +
Sbjct: 115 MAYIERMNYIHRDLRSANILVGDGL---VCKIADFGLARLIEDNE-YTARQGAKFPIKWT 170
Query: 238 APE-VLRRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP- 294
APE L + ++D+WS G++L L++ G P+ G + + + + RG+ P P
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY----RMPCPQ 226
Query: 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326
+ S +++ + DP+ER E L FL
Sbjct: 227 DCPISLHELMLQCWKKDPEER-PTFEYLQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 63/262 (24%), Positives = 115/262 (43%), Gaps = 26/262 (9%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
+LG+G FG ++ T T + A K++ ++ E +E QIM L H +V L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMP----EAFLQEAQIMKKLR-HDKLVPL 66
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSMGVM 190
+ + ++ + G L D + +G + ++ Q+ + Y M +
Sbjct: 67 YAVVSEE-PIYIVTEFMGKGSLLD-FLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPE-VLRRNY 246
HRDL+ N L ++ K DFGL+ + + + G+ + + APE L +
Sbjct: 125 HRDLRAANILV---GDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRF 180
Query: 247 GAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN-ISSSAKDIV 304
++D+WS G++L L++ G P+ G + + + + RG+ P P S +++
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY----RMPCPQGCPESLHELM 236
Query: 305 KKMLHADPKERLSAAEVLSKFL 326
K DP ER E + FL
Sbjct: 237 KLCWKKDPDER-PTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 63/258 (24%), Positives = 103/258 (39%), Gaps = 21/258 (8%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRN 129
ELG G FG +K K + K+++ + L N ++ ++ RE +M L +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSE---KTVAVKILKNDNNDPALKDELLREANVMQQLD-NPY 57
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGV 189
IV + G E S L+M+L G L + H +E+ L Q+ + Y
Sbjct: 58 IVRMIGICEAE-SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA----YYVAPEVLR-R 244
+HRDL N L + K +DFGLS + + + APE +
Sbjct: 117 VHRDLAARNVLLVTQHY---AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 245 NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303
+ +++D+WS GV+++ S G P+ G + I G + P D+
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG--ERMECP-QRCPPEMYDL 230
Query: 304 VKKMLHADPKERLSAAEV 321
+K ER A V
Sbjct: 231 MKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 27/260 (10%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R T ++LG GQFG ++ + + A KS+ + E E +M L
Sbjct: 5 RETLKLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSM----SPEAFLAEANLMKQLQ 59
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGH-YSERAAANLCRQMVTVVHY 183
H +V L A + + +I + G L D + +G + ++ Q+ + +
Sbjct: 60 -HPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPE 240
+HRDL+ N L S E K DFGL+ + + + G+ + + APE
Sbjct: 118 IERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 173
Query: 241 VLRRNYGA---EADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-N 295
+ NYG ++D+WS G++L I+ G P+ G T + + RG+ P P N
Sbjct: 174 AI--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY----RMPRPDN 227
Query: 296 ISSSAKDIVKKMLHADPKER 315
++++ P+ER
Sbjct: 228 CPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 66/292 (22%), Positives = 109/292 (37%), Gaps = 55/292 (18%)
Query: 70 IFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
G+ LG G+FG L ++ + A K++ + ++E+ E M
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL-DIHTYSEIEEFLSEAACMKDFD- 59
Query: 127 HRNIVELKGA---------------------YEDRHSVNLIMDLCAGGELFDRIIAKGHY 165
H N+++L G + D HS L L E
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKL--------- 110
Query: 166 SERAAANLCRQMVTV---VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
L + MV + + Y + +HRDL N + ED + DFGLS
Sbjct: 111 ---PLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIY 164
Query: 223 PGDVFKDLVGSAY---YVAPEVLRRN-YGAEADIWSAGVILY-ILLSGVPPFWGETEQSI 277
GD ++ + ++A E L Y +++D+W+ GV ++ I G P+ G I
Sbjct: 165 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI 224
Query: 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAA---EVLSKFL 326
+D + G+ P + D++ ADPK+R + EVL L
Sbjct: 225 YDYLRHGN--RLKQP-EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 21/226 (9%)
Query: 71 FGRELGRGQFGVTY----LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ LG G FG Y + + K A K + R+ + +++ E +M +
Sbjct: 11 KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REETSPKANKEILDEAYVMASV-D 67
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCH 185
H ++V L G V LI L G L D + K + + N C Q+ + Y
Sbjct: 68 HPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA-----YYVAPE 240
++HRDL N L + +K TDFGL+ + K+ ++A E
Sbjct: 127 EKRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLDVDE--KEYHAEGGKVPIKWMALE 181
Query: 241 -VLRRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284
+L R Y ++D+WS GV ++ L++ G P+ G I D + +G
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 12/190 (6%)
Query: 142 SVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200
+V L+ L G L D + K + N C Q+ + Y + ++HRDL N L
Sbjct: 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVL 141
Query: 201 FSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPE-VLRRNYGAEADIWSAG 256
S +K TDFGL+ + G ++A E +L R + ++D+WS G
Sbjct: 142 VKSPNH---VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYG 198
Query: 257 VILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER 315
V ++ L++ G P+ G + I D + +G + P P + I+ K D + R
Sbjct: 199 VTVWELMTFGAKPYDGIPAREIPDLLEKG--ERLPQP-PICTIDVYMIMVKCWMIDSECR 255
Query: 316 LSAAEVLSKF 325
E++ +F
Sbjct: 256 PRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK---PGDVFKD 229
+ RQ+++ + Y H G++HRD+K EN + + ED L DFG + F +
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFARGSWSTPFHYG 321
Query: 230 LVGSAYYVAPEVLRRN-YGAEADIWSAGVILY 260
+ G+ APEVL + Y DIWSAG++++
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 95 FACKSISSRK--LINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152
FAC + + +I E I+ + H +I++LKG + LI+
Sbjct: 109 FACIDNKTCEHVVIKAGQRGGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCLILPRYKT 167
Query: 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212
+L+ + AK + + + R ++ + Y H ++HRD+K EN + + +
Sbjct: 168 -DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD---VCL 223
Query: 213 TDFGLSVFFKPGDV----FKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSG 265
DFG + F P D+ + G+ APE+L R+ YG DIWSAG++L+ + +
Sbjct: 224 GDFGAACF--PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 65/280 (23%), Positives = 123/280 (43%), Gaps = 49/280 (17%)
Query: 73 RELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH 127
RELG+G FG+ Y +D + + A K+++ + R+ +E + E +M T H
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASVMKGFTCH 69
Query: 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSE----RAAANLCRQMVTV--- 180
++V L G ++M+L A G+L + + +E R L ++M+ +
Sbjct: 70 -HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL-QEMIQMAAE 127
Query: 181 ----VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYY 236
+ Y ++ +HRDL N + A D +K DFG++ +D+ + YY
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMV---AHDFTVKIGDFGMT---------RDIYETDYY 175
Query: 237 ------------VAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAIL 282
+APE L+ + +D+WS GV+L+ + S P+ G + + + ++
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235
Query: 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
G D N D+++ +PK R + E++
Sbjct: 236 DGG---YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 48/196 (24%), Positives = 92/196 (46%), Gaps = 29/196 (14%)
Query: 151 AGGELFDRIIAKGHYSERAAANLCRQMVTVVHY-CHSMGV------------MHRDLKPE 197
+ G + ++ ++ E +L ++++T+ C+S V +HRDL
Sbjct: 149 SSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAAR 208
Query: 198 NFLFSSSAEDSPLKATDFGLS--VFFKPGDVFK-DLVGSAYYVAPE-VLRRNYGAEADIW 253
N L S E++ +K DFGL+ ++ P V K D ++APE + R Y ++D+W
Sbjct: 209 NILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 265
Query: 254 SAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML---H 309
S GV+L+ + S G P+ G F L+ + P+ ++ ++ + ML H
Sbjct: 266 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTP--EMYQTMLDCWH 320
Query: 310 ADPKERLSAAEVLSKF 325
+P +R + +E++
Sbjct: 321 GEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL--VG 232
+Q++ V Y H ++HRD+K EN + D + DFG ++ F+ D VG
Sbjct: 274 KQLLCAVEYIHDKKLIHRDIKLENIFLNC---DGKIVLGDFGTAMPFEKEREAFDYGWVG 330
Query: 233 SAYYVAPEVLRRN-YGAEADIWSAGVILYILLS 264
+ +PE+L + Y DIWS G+IL +LS
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 53/231 (22%), Positives = 93/231 (40%), Gaps = 40/231 (17%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQF---------------ACKSISSRKLINRDD 110
R +LG GQFG +L + +F A K + R + +
Sbjct: 4 RQQLRLKEKLGEGQFGEVHLC-EAEGLAEFLGEGAPEFDGQPVLVAVKML--RADVTKTA 60
Query: 111 VEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAA 170
D +E++IM L + NI+ L G + +I + G+L + + S
Sbjct: 61 RNDFLKEIKIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 171 AN------------LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218
AN + Q+ + + Y S+ +HRDL N L + +K DFG+S
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT---IKIADFGMS 176
Query: 219 VFFKPGDVFKDLVGSAY----YVAPE-VLRRNYGAEADIWSAGVILYILLS 264
GD ++ + G A ++A E +L + +D+W+ GV L+ + +
Sbjct: 177 RNLYSGDYYR-IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 24/234 (10%)
Query: 71 FGRELGRGQFGVTY--LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
G+ LG G+FG + D+ + A K++ + R ++ED E M H
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKI-AICTRSEMEDFLSEAVCMKEFD-HP 60
Query: 129 NIVELKGA------YEDRHSVNLIMDLCAGGEL-----FDRIIAKGHY-SERAAANLCRQ 176
N++ L G E S +I+ G+L + R+ Y +
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY- 235
+ + + Y S +HRDL N + + E+ + DFGLS GD ++ +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 236 --YVAPEVLR-RNYGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGH 285
++A E L R Y ++D+WS GV ++ I G P+ G I+D + +G+
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 72/299 (24%), Positives = 108/299 (36%), Gaps = 61/299 (20%)
Query: 6 GLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGR---VLGKPM 62
S +T+ H A +++ PP + + A S G VLG+ +
Sbjct: 65 STDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVTYALPNQSREEGHFYVVLGEDI 124
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD------------- 109
+ + LG G FG + K+ A K + + RD
Sbjct: 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQ 184
Query: 110 -DVEDVRREVQIMHHL---TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY 165
D D ++I + TGH IV K G L D I+ G +
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMPK----------------YGPCLLDWIMKHGPF 228
Query: 166 SERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
S R A + Q + Y H+ + +MH DLKPEN L +S + T+ L P
Sbjct: 229 SHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETS-DTVVDPVTNRAL-----PP 282
Query: 225 DVFK----DL-------------VGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSG 265
D + DL V + +Y +PEV L + D+WS G I+Y L +G
Sbjct: 283 DPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 26/153 (16%)
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD----LV 231
Q+ + + S +HRDL N L S E++ +K DFGL+ D++KD
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLA-----RDIYKDPDYVRK 233
Query: 232 GSAY----YVAPE-VLRRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
GSA ++APE + + Y ++D+WS GV+L+ + S G P+ G F L+
Sbjct: 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK-- 291
Query: 286 IDFSSDPWPNISSSAKDIVKKML---HADPKER 315
D + P ++ I + ML DPKER
Sbjct: 292 -DGTRMRAPENATPE--IYRIMLACWQGDPKER 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 45/238 (18%)
Query: 66 RNTYIFGRELGRGQFGVTYLVT----HKDTKQQFACKSISSRKLI----------NRDDV 111
R +F +LG GQFG +L QF R L+ N++
Sbjct: 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR 63
Query: 112 EDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA 171
D +EV+I+ L NI+ L G D + +I + G+L ++ ++ H ++
Sbjct: 64 NDFLKEVKILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEEN 121
Query: 172 --------------------NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211
++ Q+ + + Y S+ +HRDL N L E+ +K
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIK 178
Query: 212 ATDFGLSVFFKPGDVFKDLVGSAY----YVAPE-VLRRNYGAEADIWSAGVILYILLS 264
DFG+S GD ++ + G A ++A E +L + +D+W+ GV L+ +L
Sbjct: 179 IADFGMSRNLYAGDYYR-IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 70/298 (23%), Positives = 110/298 (36%), Gaps = 65/298 (21%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLIN----RDDV----- 111
R F +LG GQFG +L + K + + L+ R D
Sbjct: 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 112 EDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM------DLCAGGELFDRIIAKGHY 165
ED +EV+I+ L+ NI L G + +IM DL L +
Sbjct: 64 EDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQ--FLQKHVAETSGL 120
Query: 166 SERAAA-------NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218
+ + + + Q+ + + Y S+ +HRDL N L + +K DFG+S
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT---IKIADFGMS 177
Query: 219 VFFKPGDVFKDLVGSAYY------VAP-------EVLRRNYGAEADIWSAGVILY-IL-L 263
++L S YY P VL + ++D+W+ GV L+ IL L
Sbjct: 178 ---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228
Query: 264 SGVPPFWGETEQSIFDAILRGHIDFSSD---PWPNISSSAKDIVKKML---HADPKER 315
P+ T+Q + + D P P KDI + ML D ++R
Sbjct: 229 CREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCP--KDIYELMLECWRRDEEDR 284
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 64/273 (23%), Positives = 120/273 (43%), Gaps = 39/273 (14%)
Query: 73 RELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
R +G+G FG Y L+ K A KS++ ++ + ++VE +E IM + H N
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN--RITDLEEVEQFLKEGIIMKDFS-HPN 57
Query: 130 IVELKG-AYEDRHSVNLIMDLCAGGELFDRIIAKGHY-SERAAANLCRQMVTVVHYCHSM 187
++ L G S +++ G+L + I ++ H + + Q+ + Y S
Sbjct: 58 VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYY----------- 236
+HRDL N + E +K DFGL+ +D+ YY
Sbjct: 118 KFVHRDLAARNCMLD---ESFTVKVADFGLA---------RDIYDKEYYSVHNHTGAKLP 165
Query: 237 ---VAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSD 291
+A E L+ + + ++D+WS GV+L+ L++ G PP+ I +L+G +
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPE 225
Query: 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324
P+ +++ H P+ R + +E++S+
Sbjct: 226 YCPD---PLYEVMLSCWHPKPEMRPTFSELVSR 255
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 37/164 (22%), Positives = 75/164 (45%), Gaps = 10/164 (6%)
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYC 184
H NIV L+G +++ ++ + + G L D + K G + + + + Y
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS--AYYVAPEVL 242
MG +H+ L L +S D K + F K ++ + G + APE +
Sbjct: 124 SEMGYVHKGLAAHKVLVNS---DLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 243 R-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284
+ ++ + +D+WS G++++ ++S G P+W + Q + A+ G
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 30/105 (28%), Positives = 50/105 (47%), Gaps = 7/105 (6%)
Query: 66 RNTYIFGRELGRGQFG-----VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R+ FG+ LG G FG + + +D + A K + + + D+ E + E++I
Sbjct: 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKI 94
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY 165
+ HL H+NIV L GA V +I + C G+L + + K
Sbjct: 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAET 139
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-06
Identities = 39/164 (23%), Positives = 62/164 (37%), Gaps = 22/164 (13%)
Query: 166 SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225
+E +C Q + + H L + L G SV FK +
Sbjct: 15 NEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL-----------DG-SVAFKTPE 62
Query: 226 VFKDLVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS-IFDAILR 283
Y++APEV+ ++Y +ADI+S G+ LY L P+ E E S I + +L
Sbjct: 63 ---QSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN 119
Query: 284 GHIDFSSDPWPNISS-----SAKDIVKKMLHADPKERLSAAEVL 322
G N+ S +D ++ P+ R +A L
Sbjct: 120 GMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYL 163
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 7/104 (6%)
Query: 66 RNTYIFGRELGRGQFG-----VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R+ + GR LG G FG + ++H + + A K + S + + + E++I
Sbjct: 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKI 93
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH 164
M HL H NIV L GA + +I + C G+L D + H
Sbjct: 94 MSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 41/232 (17%)
Query: 66 RNTYIFGRELGRGQFGVTYLV----THKDTKQQFACKSISSRKLI----------NRDDV 111
R F +LG GQFG +L K + F+ ++ ++ N++
Sbjct: 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR 63
Query: 112 EDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAA- 170
D +E++IM L NI+ L + +I + G+L ++ +++ E A
Sbjct: 64 NDFLKEIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEK 121
Query: 171 --------ANLC---RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219
+ L Q+ + + Y S+ +HRDL N L ++ +K DFG+S
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSR 178
Query: 220 FFKPGDVFKDLVGSAYYVAP-------EVLRRNYGAEADIWSAGVILYILLS 264
GD ++ + G A V P +L + +D+W+ GV L+ +L+
Sbjct: 179 NLYSGDYYR-IQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 50/191 (26%), Positives = 81/191 (42%), Gaps = 14/191 (7%)
Query: 142 SVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200
+V LI L G L D + K + + N C Q+ ++Y ++HRDL N L
Sbjct: 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVL 141
Query: 201 FSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPE-VLRRNYGAEADIWSAG 256
+ +K TDFGL+ + G ++A E +L R Y ++D+WS G
Sbjct: 142 VKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 198
Query: 257 VILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS-SAKDIVKKMLHADPKE 314
V ++ L++ G P+ G I + +G P P I + I+ K D
Sbjct: 199 VTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQPPICTIDVYMIMVKCWMIDADS 254
Query: 315 RLSAAEVLSKF 325
R E++ +F
Sbjct: 255 RPKFRELIIEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 27/70 (38%), Positives = 37/70 (52%), Gaps = 5/70 (7%)
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG-- 232
RQ++T + H +G++HRD+KPEN L + D +K DFG +V G F L G
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFGAAVDMCTGINFNPLYGML 372
Query: 233 SAYYVAPEVL 242
Y PE L
Sbjct: 373 DPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 15/219 (6%)
Query: 75 LGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
LG G FG Y V +T + I + + +VE E IM + H ++V
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMD-HPHLV 72
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVM 190
L G ++ L+ L G L D + K + + N C Q+ + Y ++
Sbjct: 73 RLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 131
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPEVLR-RNY 246
HRDL N L S + +K TDFGL+ + + + G ++A E + R +
Sbjct: 132 HRDLAARNVLVKSP---NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 247 GAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284
++D+WS GV ++ L++ G P+ G + I D + +G
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 18/92 (19%)
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD----LVGSAY----YVAPE- 240
+HRDL N L S E++ +K DFGL+ D++KD G A ++APE
Sbjct: 195 IHRDLAARNILLS---ENNVVKICDFGLA-----RDIYKDPDYVRKGDARLPLKWMAPES 246
Query: 241 VLRRNYGAEADIWSAGVILYILLS-GVPPFWG 271
+ + Y ++D+WS GV+L+ + S G P+ G
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 4e-04
Identities = 22/100 (22%), Positives = 36/100 (36%), Gaps = 6/100 (6%)
Query: 104 KLINRDDV-EDVRREVQIMHHLTGHRNIV-ELKGAYEDRHSVNLIMDLCAGGELFDRIIA 161
K+ + D REV I+ L V ++ + E L+M+ G L +
Sbjct: 27 KINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEE 86
Query: 162 KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLF 201
+ A L ++ H + + H DL P N L
Sbjct: 87 EKEDIAEQLAELLAKL----HQLPLLVLCHGDLHPGNILV 122
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 25/102 (24%)
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY 235
Q+ + Y H GV+H+D+ N + E+ +K TD LS +DL Y
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALS---------RDLFPMDY 172
Query: 236 ------------YVAPEVLRRN-YGAEADIWSAGVILYILLS 264
++A E L Y + +D+WS GV+L+ L++
Sbjct: 173 HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 47/161 (29%), Positives = 73/161 (45%), Gaps = 20/161 (12%)
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY----SERAAANLCRQMVT 179
L H NIV + + + + ++ A G D I H+ SE A A + + ++
Sbjct: 55 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMSELAIAYILQGVLK 112
Query: 180 VVHYCHSMGVMHRDLKPENFLFSS------SAEDSPLKATDFG--LSVFFKPGDVFKDLV 231
+ Y H MG +HR +K + L S S S L + G L V D K V
Sbjct: 113 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH---DFPKYSV 169
Query: 232 GSAYYVAPEVLRRN---YGAEADIWSAGVILYILLSGVPPF 269
+++PEVL++N Y A++DI+S G+ L +G PF
Sbjct: 170 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 42/154 (27%), Positives = 67/154 (43%), Gaps = 30/154 (19%)
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV-------- 237
S +HRDL N L + K DFGL+ +D+ + YV
Sbjct: 232 SKNCIHRDLAARNILLT---HGRITKICDFGLA---------RDIRNDSNYVVKGNARLP 279
Query: 238 ----APE-VLRRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILR-GHIDFSS 290
APE + Y E+D+WS G++L+ + S G P+ G S F +++ G+ S
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP 339
Query: 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324
+ P S DI+K ADP +R + +++
Sbjct: 340 ECAP---SEMYDIMKSCWDADPLKRPTFKQIVQL 370
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 70/269 (26%), Positives = 110/269 (40%), Gaps = 42/269 (15%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+ RG+ G +Y QF K I+ I ++ D+ + H NIV+L
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK--------LQHPNIVKLI 749
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH-YCHSMGVMHRD 193
G LI + G L + + R A + + +H C S V+ +
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRC-SPAVVVGN 808
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVL-RRNYGAE 249
L PE + +D P LS+ PG + K + SAY VAPE ++ +
Sbjct: 809 LSPEKIIID--GKDEP----HLRLSL---PGLLCTDTKCFISSAY-VAPETRETKDITEK 858
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG--------HIDFSSDP--WPNISSS 299
+DI+ G+IL LL+G P + E + +I+ H+D DP ++S +
Sbjct: 859 SDIYGFGLILIELLTGKSP--ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916
Query: 300 AKDIVKKM---LHA---DPKERLSAAEVL 322
+IV+ M LH DP R A +VL
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVL 945
|
Length = 968 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 22/153 (14%)
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD----LV 231
Q+ + + S +HRDL N L A+ +K DFGL+ D+ D
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLL---AQGKIVKICDFGLA-----RDIMHDSNYVSK 296
Query: 232 GSAY----YVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGE-TEQSIFDAILRG 284
GS + ++APE + N Y +D+WS G++L+ + S G P+ G + + ++ I G
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356
Query: 285 HIDFSSDPWPNISSSAKDIVKKMLHADPKERLS 317
+ D DI+ K +++P++R S
Sbjct: 357 YRMAKPDHATQ---EVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 19/68 (27%), Positives = 35/68 (51%), Gaps = 6/68 (8%)
Query: 154 ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213
E+F RI +++ N+ + M+T + Y H G+ H D+KPEN + + +
Sbjct: 115 EIFKRIKC---KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII--- 168
Query: 214 DFGLSVFF 221
D+G++ F
Sbjct: 169 DYGIASHF 176
|
Length = 294 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 38/121 (31%), Positives = 55/121 (45%), Gaps = 19/121 (15%)
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL-------SVFFKPGDVFK 228
Q+ + + S +HRDL N L E +K DFGL S + G F
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLI---CEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 229 DLVGSAYYVAPEVLRRN-YGAEADIWSAGVILY--ILLSGVP-PFWGETEQSIFDAILRG 284
L ++APE + N Y +D+WS G++L+ L G P P EQ ++AI RG
Sbjct: 304 PL----KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-FYNAIKRG 358
Query: 285 H 285
+
Sbjct: 359 Y 359
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 50/219 (22%), Positives = 93/219 (42%), Gaps = 36/219 (16%)
Query: 74 ELGRGQFGVT--YLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
E+GRG +T YL H T + I+ + + ++ ++ EV ++ H H NI+
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEV-VLSHFFRHPNIM 62
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM----VTVVHYCHSM 187
+ + +I A G + K ++ E + L + + ++Y H
Sbjct: 63 TSWTVFTTGSWLWVISPFMAYGSA--NSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN 120
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF---KPGDVFKDLVGSAY--------- 235
G +HR++K + L S D + + GLS + + G K Y
Sbjct: 121 GYIHRNIKASHILIS---GDGLVSLS--GLSHLYSLVRNGQKAK----VVYDFPQFSTSV 171
Query: 236 --YVAPEVLRRN---YGAEADIWSAGVILYILLSGVPPF 269
+++PE+LR++ Y ++DI+S G+ L +G PF
Sbjct: 172 LPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 350 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.6 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.6 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.59 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.56 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.52 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.46 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.36 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.29 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.29 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.26 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.23 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.22 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.14 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.97 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.85 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.79 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.79 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.74 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.68 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.65 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.64 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.62 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.53 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.52 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.45 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.45 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.41 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.22 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.22 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.2 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.13 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.09 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.0 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.93 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.88 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.86 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.78 | |
| PLN02236 | 344 | choline kinase | 97.75 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.7 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.68 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.63 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.57 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.52 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.49 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.38 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.35 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.26 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.16 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.01 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.98 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.91 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.8 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.66 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.57 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.53 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.51 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.39 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.15 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.12 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.9 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-62 Score=425.50 Aligned_cols=276 Identities=39% Similarity=0.654 Sum_probs=252.3
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChh----hHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD----DVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
..+.+.|.+.+.||+|+||.|-+|..+.+|+.||||++.++...... ....+.+|+++|++|. |||||+++++|+
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFE 246 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeee
Confidence 44678899999999999999999999999999999999877654422 2345789999999999 999999999999
Q ss_pred cCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
..++.|+||||++||.|++.+-.++.+.+.....+++||+.|+.|||+.||+||||||+|||++.+.++..+||.|||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999999999999999999999999999999999999999999999999999988778889999999999
Q ss_pred ccccCCCccccCCcCcccccccccccc----CCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCCCCC
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLRRN----YGAEADIWSAGVILYILLSGVPPFWGETEQS-IFDAILRGHIDFSSDPW 293 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 293 (350)
+.........+.+|||.|.|||++.+. +..+.|+||+||++|-+++|.+||....... ..+.+.++...+....|
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 998888888899999999999998632 4458999999999999999999998877666 88899999999999999
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHHHh
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLADLL 339 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~~~ 339 (350)
..++.+..+||.+||..||++|||+.|+|+|+||+...++..++.+
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s~~~~l 452 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLSKQDIL 452 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccchHHHH
Confidence 9999999999999999999999999999999999999877765544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-58 Score=418.92 Aligned_cols=261 Identities=34% Similarity=0.559 Sum_probs=244.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
.+|..++.||+|||+.||++++..+|+.||+|++.+.........+++.+|+++.++|. |||||+++++|++.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence 78999999999999999999999999999999999887777788899999999999999 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-C
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-D 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~-~ 225 (350)
.|+|+.++|..++++++.++|.+++.+++||+.||.|||+++|+|||||..|+|+ +++.+|||+|||+|...... .
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCccc
Confidence 9999999999999999999999999999999999999999999999999999999 66777999999999998744 6
Q ss_pred ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
...+.+|||.|.|||++. ..++..+||||+||+||.|+.|++||...+-.+.+..+.......|. .++.++++||
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI 249 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI 249 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence 778899999999999886 45899999999999999999999999999999999999999888876 5799999999
Q ss_pred HHhcccCccCCCCHHHHHhccCCCCCchhhH
Q 018786 305 KKMLHADPKERLSAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~ 335 (350)
.++|+.||.+|||+.+||.|.||.....+.-
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhhhCCCcCCC
Confidence 9999999999999999999999966655443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-57 Score=394.87 Aligned_cols=261 Identities=27% Similarity=0.395 Sum_probs=232.3
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc-e
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS-V 143 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~-~ 143 (350)
...+...++.||+|..|+||++.++.+++.+|+|++... .+....+++.+|+++++.+. ||+||.+|+.|...+. +
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCceE
Confidence 345777889999999999999999999999999999533 35566788999999999997 9999999999998885 9
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
.|+||||+||+|.++++..+++++..+..++.++++||.|||+ ++||||||||+|||+ +..|.|||+|||.+..+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILV 230 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhh
Confidence 9999999999999999998999999999999999999999995 999999999999999 456679999999999887
Q ss_pred CCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 223 PGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE-----TEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
+. ..++.+||..|||||.+.+ .|+.++||||||++++|+.+|++||... ..-+.+..+..+..+-.+.. .+
T Consensus 231 nS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~--~f 307 (364)
T KOG0581|consen 231 NS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG--EF 307 (364)
T ss_pred hh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc--cC
Confidence 66 6688999999999999986 5999999999999999999999999774 56677888887655444332 48
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
++++++||..||++||.+|||+.|+|+|+|+.+...+.
T Consensus 308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~ 345 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN 345 (364)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence 99999999999999999999999999999999765433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-56 Score=385.04 Aligned_cols=267 Identities=33% Similarity=0.623 Sum_probs=245.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+++.||+|+||+||.++.+++++.||+|++++.........+....|..+|.++. ||.||+++..|++.+.+|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEE
Confidence 578999999999999999999999999999999999988777777889999999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc-cCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~-~~~ 224 (350)
|+||+.||.|+-+|++.+.|++..++-++..|+.||.|||++|||||||||+|||+ +.+|+++|+|||+++.. ..+
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCC
Confidence 99999999999999999999999999999999999999999999999999999999 88899999999999864 444
Q ss_pred CccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
....+.+||+.|||||++. ..++..+|.||||+++|+|++|.+||.+.+..+..+++..+....+.. -++.+.+++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---~ls~~ardl 256 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---YLSEEARDL 256 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---cCCHHHHHH
Confidence 5556689999999999865 569999999999999999999999999999999999999988444432 378999999
Q ss_pred HHHhcccCccCCC----CHHHHHhccCCCCCchhhHHHHh
Q 018786 304 VKKMLHADPKERL----SAAEVLSKFLIPKKTLQTLADLL 339 (350)
Q Consensus 304 i~~~L~~dp~~Rp----s~~~iL~~~~~~~~~~~~~~~~~ 339 (350)
|+++|+.||++|. .+.++-+|+||.+..|+.+....
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~ 296 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKK 296 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcC
Confidence 9999999999995 78999999999999998876543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-55 Score=395.51 Aligned_cols=267 Identities=33% Similarity=0.613 Sum_probs=246.0
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
.....+|.+++.||+|+|++|++|+++.+++.||||++.++....+....-+.+|-.+|.+|.+||+|++++-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34458999999999999999999999999999999999887776666677789999999999889999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+|+|+||+++|+|.+++++.+.|++...+.++.+|+.||+|||++|||||||||+|||+ +++++++|.|||.|+.+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCC
Confidence 99999999999999999999999999999999999999999999999999999999999 788899999999998764
Q ss_pred CCCc--------------cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Q 018786 223 PGDV--------------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID 287 (350)
Q Consensus 223 ~~~~--------------~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 287 (350)
+... ..+.+||..|.+||++.. ..+..+|+|+|||++|.|+.|.+||.+..+-.+++.+..-...
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE 305 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence 3211 144789999999999874 5889999999999999999999999999999999999998888
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHH
Q 018786 288 FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~ 336 (350)
++. ++++.+++||+++|..||.+|+|+.+|-+|+||.+..|+.+-
T Consensus 306 fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw 350 (604)
T KOG0592|consen 306 FPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW 350 (604)
T ss_pred CCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence 886 679999999999999999999999999999999999998843
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-55 Score=381.74 Aligned_cols=265 Identities=35% Similarity=0.648 Sum_probs=239.6
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|.+.+.||.|+|++||+|+++.++..||||.+.+... +...++-+..|+.+|+.++ |||||.+++++...+++|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEE
Confidence 34789999999999999999999999999999999987665 5667788999999999999 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCC---CCeEEeecCCcccc
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED---SPLKATDFGLSVFF 221 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~---~~vkl~Dfg~a~~~ 221 (350)
+|||||.||+|.++++.++.+++.+++.++.||+.||++||+++||||||||.|||++....+ ..+||+|||+|+..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999875333 67999999999999
Q ss_pred cCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 222 KPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
.++....+.+|++.|||||++. .+|+.|+|+||+|+++|+|++|+.||...+..+.+..+.++.-..+... ..++..+
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~ 244 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNPL 244 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCch
Confidence 9998889999999999999985 6799999999999999999999999999999888887776654433222 2356677
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.+++...|+.++.+|.+..+-+.|+++.....
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~ 276 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDHPFLAANPQ 276 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence 79999999999999999999999999988764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-56 Score=363.09 Aligned_cols=267 Identities=39% Similarity=0.748 Sum_probs=248.7
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.+.|.+-+.||+|.|++|+++.+..+|+.+|+|++....+ +....+++.+|+.+-+.|. ||||+++.+.+...+..
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~-~~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH 85 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh-ccccHHHHHHHHHHHHhcC-CCcEeehhhhhccccee
Confidence 456789999999999999999999999999999999876555 3346688999999999999 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
|+|+|++.|++|..-+-.+.-+++..+-++++||+.+|+|+|.+||||||+||+|+++-..+....+||+|||+|....+
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 99999999999987776667789999999999999999999999999999999999998777778899999999999998
Q ss_pred CCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
+.....++|||.|||||++++ +++..+|||+.|++||-|+.|.+||.+.+...+++.+..+...++...|+.++++.++
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 888888999999999999875 5999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
||++||..||.+|+|+.|+|+|+|+++...
T Consensus 246 LvrrML~~dP~kRIta~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEALKHPWICNRER 275 (355)
T ss_pred HHHHHhccChhhhccHHHHhCCchhcchHH
Confidence 999999999999999999999999998753
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-53 Score=355.74 Aligned_cols=263 Identities=30% Similarity=0.589 Sum_probs=246.5
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||.|+||.|.+++.+.+|..+|+|++.+.......+.+...+|..+|+.+. ||.++++++.+.+.+.+++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEE
Confidence 478999999999999999999999999999999999888777778889999999999999 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||||.+||.|++++++.++|++..++-++.||+.||+|||+++|++|||||+|||+ +.+|.+||.|||.|+.....
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc-
Confidence 99999999999999999999999999999999999999999999999999999999 78888999999999997655
Q ss_pred ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
..+.+|||.|+|||.+. ++++.++|.|+||+++|||+.|.+||.......+++++..+...+|. -++.++++||
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl 272 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLL 272 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHH
Confidence 46789999999999876 56999999999999999999999999999999999999999999887 4799999999
Q ss_pred HHhcccCccCCC-----CHHHHHhccCCCCCchhhHHHH
Q 018786 305 KKMLHADPKERL-----SAAEVLSKFLIPKKTLQTLADL 338 (350)
Q Consensus 305 ~~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~~~ 338 (350)
..+|+.|-.+|. ...+|-.|+||.+..|..+...
T Consensus 273 ~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r 311 (355)
T KOG0616|consen 273 KKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQR 311 (355)
T ss_pred HHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhc
Confidence 999999999993 6779999999999999876543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-54 Score=361.64 Aligned_cols=257 Identities=28% Similarity=0.517 Sum_probs=224.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|..+.++|+|+||+||+++++++|+.||||.+..+.. ++...+-..+|+++|++|. |+|+|.+++.|.....+++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEE
Confidence 468888999999999999999999999999999975543 3444566899999999999 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CC
Q 018786 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PG 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~ 224 (350)
||||+. ++.+.++.. ..++...+..+++|++.|+.|+|++++|||||||+|||+ ..++.+||||||+|+... ++
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCc
Confidence 999965 766777664 458999999999999999999999999999999999999 677889999999999887 77
Q ss_pred CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------------
Q 018786 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF-------------- 288 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------- 288 (350)
...+..+.|..|+|||.+.+ +|+...|||++||++.||++|.+.|.+..+-+++..+......+
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 78889999999999998765 59999999999999999999999999999888877665422111
Q ss_pred -------------CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 289 -------------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 289 -------------~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
.+..+++++..+.++++.||+.||.+|++.+|+|.|++|.+
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 11124567788999999999999999999999999999943
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=380.66 Aligned_cols=260 Identities=38% Similarity=0.684 Sum_probs=234.9
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCC--hhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN--RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
....++|.+++.||+|+||+|+.|.+..++..||+|++....... ....+.+.+|+.+++++..||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 345689999999999999999999999999999999776542211 123567789999999998899999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCC-CCeEEeecCCcc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED-SPLKATDFGLSV 219 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~-~~vkl~Dfg~a~ 219 (350)
..+++||||+.||+|++++...+++.+..++.+++||+.|++|||++||+||||||+|||++ .+ +.+||+|||++.
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSDFGLSA 169 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEecccccc
Confidence 99999999999999999999999999999999999999999999999999999999999995 44 789999999999
Q ss_pred cc-cCCCccccCCcCcccccccccccc--C-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 220 FF-KPGDVFKDLVGSAYYVAPEVLRRN--Y-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 220 ~~-~~~~~~~~~~gt~~y~aPE~~~~~--~-~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. .......+.+||+.|+|||++.+. | ..++||||+|++||.|++|..||........+..+..+.+.++..
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~---- 245 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY---- 245 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC----
Confidence 88 466677889999999999998753 4 588999999999999999999999998888999999988888763
Q ss_pred C-CHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 296 I-SSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 296 ~-~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
+ +.+++.||.+||..||.+|+|+.+++.|+||+.
T Consensus 246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 246 LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 4 999999999999999999999999999999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-53 Score=379.04 Aligned_cols=268 Identities=30% Similarity=0.540 Sum_probs=242.5
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+++.||+|+||.||+|+.+.+|..||+|+++++.......++.++.|-.+|.... ++.||+++..|++.+++|+
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d-s~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD-SPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC-CCcEEEEEEEecCCCeeEE
Confidence 478999999999999999999999999999999999999888889999999999999965 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC--
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-- 223 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~-- 223 (350)
||||++||++..+|.+.+.+++..++.++.+++.|++.||+.|+|||||||+|+|| |..|++||.|||++.-...
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999 8889999999999843210
Q ss_pred --------------------C--C------------------------ccccCCcCcccccccccc-ccCCcchhHHHHH
Q 018786 224 --------------------G--D------------------------VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAG 256 (350)
Q Consensus 224 --------------------~--~------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG 256 (350)
. . ...+.+|||.|+|||++. ..|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 0 011247999999999875 4699999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCC---HHHHHhccCCCCCchh
Q 018786 257 VILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS---AAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 257 ~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps---~~~iL~~~~~~~~~~~ 333 (350)
|||||||.|.+||...+..+.+.++.++...+..+.-..++.++.+||.+||. ||++|.. +.||-+||||.+..|.
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 99999999999999999999999999988666555545778999999999998 9999994 9999999999999998
Q ss_pred hHHHH
Q 018786 334 TLADL 338 (350)
Q Consensus 334 ~~~~~ 338 (350)
.+-..
T Consensus 455 ~l~~~ 459 (550)
T KOG0605|consen 455 HLREM 459 (550)
T ss_pred hhhcC
Confidence 76544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=388.76 Aligned_cols=260 Identities=35% Similarity=0.653 Sum_probs=243.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
+-|++++.||.|+.|.|-+|++..||+..|||++.+...........+.+|+-+|+.+. |||++++++.++...++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEEE
Confidence 55999999999999999999999999999999998876556666788999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
.||++||.|++++..++++++.+++++++||+.|+.|+|..+|+||||||+|+|+ +..+.+||+|||.|..-.++..
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCcc
Confidence 9999999999999999999999999999999999999999999999999999999 5566699999999999888888
Q ss_pred cccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
..+.||+|.|.+||++.+ ..+.++||||+|+|||.|++|..||.++....++.++..+.+..+. +++.++++||
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs----~Is~eaQdLL 243 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS----NISSEAQDLL 243 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----cCCHHHHHHH
Confidence 999999999999998865 3688999999999999999999999999999999999999999885 6899999999
Q ss_pred HHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 305 KKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
.+||..||++|+|.+||+.|+|+.+..-..
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 999999999999999999999999876433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-52 Score=382.47 Aligned_cols=268 Identities=28% Similarity=0.508 Sum_probs=247.4
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
....+|.+.+.||+|.||+|+++..+.+++.||||++++......+.++....|-.++....+||.++.++.+|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34588999999999999999999999999999999999999888899999999999999998899999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK- 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~- 222 (350)
++||||+.||++.. +...+.|++..++-++..++.||.|||++|||+||||.+|||+ |.+|++||+|||+++.--
T Consensus 445 ~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCC
Confidence 99999999999543 4445689999999999999999999999999999999999999 778889999999998754
Q ss_pred CCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 223 PGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.+....+.+|||.|+|||++.+ .|+..+|.||||++||||+.|..||.+++++++.+.|....+.+|. .++.+..
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~ 596 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAI 596 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHH
Confidence 5667788999999999999875 5999999999999999999999999999999999999999988887 5899999
Q ss_pred HHHHHhcccCccCCCC-----HHHHHhccCCCCCchhhHHHHh
Q 018786 302 DIVKKMLHADPKERLS-----AAEVLSKFLIPKKTLQTLADLL 339 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~~~~ 339 (350)
++++++|..||++|.. +.+|..|+||....|..++.-.
T Consensus 597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~ 639 (694)
T KOG0694|consen 597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRR 639 (694)
T ss_pred HHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhcc
Confidence 9999999999999995 5889999999999998877643
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=372.23 Aligned_cols=268 Identities=59% Similarity=1.016 Sum_probs=251.9
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
.......|.+.+.||.|.||+||+++.+.+|+.+|+|++.+.........+.+.+|+.+|+++.+||||+.+++.|++..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 34566889999999999999999999999999999999998877666667899999999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCC-CCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE-DSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-~~~vkl~Dfg~a~~ 220 (350)
.+++|||++.||.|++.+... .+++..+..++.|++.+++|||+.||+||||||+|+|+....+ ++.+|++|||++..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999999877 4999999999999999999999999999999999999986544 46899999999999
Q ss_pred ccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHH
Q 018786 221 FKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (350)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
...+......+||+.|+|||++. ..++..+||||+|+++|.|++|..||.+..+......+..+.+.+....|+.++..
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 88877788899999999999998 67999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
+.++|..||..||.+|+|+.++|+|||+...
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999999999999999999999999975
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-53 Score=375.31 Aligned_cols=261 Identities=29% Similarity=0.462 Sum_probs=227.6
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC-ce
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-SV 143 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-~~ 143 (350)
+-++|.+.++||.|+||.||+|+.+.++..||||.+++.- ...+.. .-.||+..|+++..||||+++.+.+.+.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-ccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 4578999999999999999999999999999999997543 233332 24689999999999999999999998887 99
Q ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||||| ..+|.++++.+ +.|++..++.|+.||++||+|+|.+|+.|||+||+|||+. ....|||+|||+|+...
T Consensus 86 ~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAREVR 161 (538)
T ss_pred eeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEecccccccccc
Confidence 9999999 55999999875 4599999999999999999999999999999999999994 45679999999999999
Q ss_pred CCCccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC--------
Q 018786 223 PGDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP-------- 292 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 292 (350)
.....+..+.|..|+|||++- +.|+.+.|+|++||+++|+++-++.|.+..+.+++.++..-........
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 999999999999999999763 5699999999999999999999999999998888777655322222111
Q ss_pred ------------------CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 293 ------------------WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 293 ------------------~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.++++.++.++|.+||.+||++|||+.++|+|+||+...
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 235689999999999999999999999999999998764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-53 Score=349.94 Aligned_cols=267 Identities=35% Similarity=0.654 Sum_probs=243.6
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEeccccc-----CChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL-----INRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
.+-++|.-.+.||.|..++|.++.++.+|+.+|+|++..... ......+.-..|+.+|+++.+||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 344678888999999999999999999999999999864321 112234567889999999999999999999999
Q ss_pred cCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
....+++|+|.|+.|.|+|++...-.++++..+.|++|++.|+.|||.++||||||||+|||+ +++..+||+|||++
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa 170 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFA 170 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEecccee
Confidence 999999999999999999999999899999999999999999999999999999999999999 67777999999999
Q ss_pred ccccCCCccccCCcCcccccccccc-------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLR-------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
+.+..+......+|||.|.|||.+. ..|+...|+|++|++||.|+.|.+||+.....-++..+..+...+..+
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 9999999999999999999999874 247889999999999999999999999999889999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
.|.+++...++||.+||+.||.+|+|++|+|+|+||++...+
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 999999999999999999999999999999999999654443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=357.55 Aligned_cols=265 Identities=29% Similarity=0.425 Sum_probs=232.4
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.-...|.+.+.||.|..++||+|+...++..||||++..+.+.+. .+.+.+|+..+..+. ||||++++..|..+..+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLID-HPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcC-CCCcceEEEEEEeccee
Confidence 445889999999999999999999999999999999987776433 788999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 144 NLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
|+||.+|.+|++.++++.. ..+++..++.|++++++||.|||++|.||||||+.|||| +.+|.|||+|||.+..+
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASL 176 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeee
Confidence 9999999999999999874 449999999999999999999999999999999999999 78889999999987654
Q ss_pred cC-CCcc----ccCCcCcccccccccc---ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC---
Q 018786 222 KP-GDVF----KDLVGSAYYVAPEVLR---RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS--- 290 (350)
Q Consensus 222 ~~-~~~~----~~~~gt~~y~aPE~~~---~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 290 (350)
.+ +... ...+||++|||||++. ..|+.|+||||||++..||.+|..||......+.+-.-+++.++.+.
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence 32 2211 4568999999999954 35999999999999999999999999999888888777777765332
Q ss_pred ---CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 291 ---DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 291 ---~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
.....++..++++|..||++||.+|||+.++|.|.||++..-..
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 22335678899999999999999999999999999999887543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=372.20 Aligned_cols=255 Identities=31% Similarity=0.552 Sum_probs=234.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+... .......+.+|+++++.++ ||||+.++++|+....+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEE
Confidence 579999999999999999999999999999999987654 3445677999999999999 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
.||+.| +|+.++..++.++++.++.++.+++.||.|||+++|.|||+||.|||+ +.++++|++|||+|+....+.
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce
Confidence 999977 999999999999999999999999999999999999999999999999 888999999999999876554
Q ss_pred ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
......|||.|||||+.. +.|+..+|+|||||++||+++|++||......+..+.|......++. +++..+..++
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f~nfl 231 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSFVNFL 231 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHHHHHH
Confidence 446678999999999876 46999999999999999999999999999888888888887776665 6899999999
Q ss_pred HHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 305 KKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
..+|++||.+|.|..+++.|+|.++..
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhhhh
Confidence 999999999999999999999988764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=347.86 Aligned_cols=248 Identities=29% Similarity=0.535 Sum_probs=216.4
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEe--EEEcCC
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKG--AYEDRH 141 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~--~~~~~~ 141 (350)
....+|+|.++||.|+||.||++.+..+|..+|.|.+..... +....+.+..|+.+|++|+ |||||++++ +.++..
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNE 93 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccch
Confidence 345789999999999999999999999999999999985544 5566778999999999999 999999998 335556
Q ss_pred ceEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--CEeecCCCCceEeecCCCCCCeEEe
Q 018786 142 SVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHS--MG--VMHRDLKPENFLFSSSAEDSPLKAT 213 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~--~~--ivH~Dlkp~NIl~~~~~~~~~vkl~ 213 (350)
.++||||+|.+|+|...++. ++.+++..+|.++.|++.||..+|+ .. |+||||||.|||+ +.+|.|||+
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLG 170 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLG 170 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeec
Confidence 69999999999999988864 3559999999999999999999998 44 9999999999999 678889999
Q ss_pred ecCCcccccCCC-ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 018786 214 DFGLSVFFKPGD-VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 214 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
|||+++.+.... ...+.+|||+||+||++. .+|+.++||||+||++|||+.-+.||.+..-...-.++.++..+..+.
T Consensus 171 DfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 171 DFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred cchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence 999999986554 345679999999999886 569999999999999999999999999998888888888886542221
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCH
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSA 318 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~ 318 (350)
.-++.++..+|..|+..||++||+.
T Consensus 251 --~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 --EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred --HHhhhHHHHHHHHHccCCcccCCCc
Confidence 2578999999999999999999984
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=362.06 Aligned_cols=263 Identities=28% Similarity=0.489 Sum_probs=227.7
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC--
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR-- 140 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-- 140 (350)
....+.|..+++||+|+||.||+|++..+|+.||+|.+..+.. ......-..+||.+|++|. ||||+++.+...+.
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLS 190 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcC-CCcccceeeEEEecCC
Confidence 3445789999999999999999999999999999999987664 3344456789999999999 99999999987665
Q ss_pred CceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
+.+|+|||||+. +|..++... -+|++.++..+++||+.||+|||++||+|||||.+|||| +++|.+||+|||+|+
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLAR 266 (560)
T ss_pred ceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEecccccee
Confidence 789999999965 888877663 469999999999999999999999999999999999999 778889999999999
Q ss_pred cccCCC--ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC-
Q 018786 220 FFKPGD--VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP- 294 (350)
Q Consensus 220 ~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 294 (350)
.+.... ..+..+-|..|+|||++.+ .|+...|+||.||||.||+.|++.|.+.++-+++..|.+.........|+
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 776443 4678889999999998764 59999999999999999999999999999999998887654444333333
Q ss_pred ------------------------CCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 295 ------------------------NISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 295 ------------------------~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.++....+|+..+|..||.+|.|+.++|.+.||....
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence 4578889999999999999999999999999994443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=335.23 Aligned_cols=261 Identities=31% Similarity=0.517 Sum_probs=226.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
.+|...+.||+|.||+||+|++..+|+.||||.++..+..+ .......+|++.|+.+. |+||+.+++.|...+.+.+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEE
Confidence 47888999999999999999999999999999998765432 23356789999999999 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
+||++ .+|+..++.+ ..++..++..++.++++||+|||++.|+||||||+|+|+ +.+|.+||+|||+|+.+....
T Consensus 80 fEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 80 FEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCC
Confidence 99995 4998888764 458999999999999999999999999999999999999 677889999999999876443
Q ss_pred c-cccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC--------
Q 018786 226 V-FKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-------- 294 (350)
Q Consensus 226 ~-~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------- 294 (350)
. ....+.|..|+|||.+- +.|+...|+||.||++.||+.|.+.|.+.++.+++..+.+.........|+
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 3 33347899999999764 459999999999999999999999999999999988887755555444444
Q ss_pred ----------------CCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 295 ----------------NISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 295 ----------------~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
..+.++.+|+..||..||.+|+++.|+|+|.||.....+
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 346788999999999999999999999999999976544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-51 Score=357.85 Aligned_cols=259 Identities=33% Similarity=0.546 Sum_probs=215.2
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC--ce
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH--SV 143 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~--~~ 143 (350)
..+|..++.||+|+||.||++.+..+|..+|||.+.... ....+.+.+|+.+|.+++ |||||++++...... .+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeee
Confidence 356888899999999999999999999999999986542 222677999999999999 999999999754444 69
Q ss_pred EEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+++|||+++|+|.++++..+ .+++..++.+.+||++||.|||++|||||||||+|||++.+ ++.+||+|||.+....
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~--~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS--NGDVKLADFGLAKKLE 169 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC--CCeEEeccCccccccc
Confidence 99999999999999999877 79999999999999999999999999999999999999532 5679999999998766
Q ss_pred C----CCccccCCcCcccccccccccc--CCcchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCC
Q 018786 223 P----GDVFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGE-TEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 223 ~----~~~~~~~~gt~~y~aPE~~~~~--~~~~~Dv~slG~vl~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
. ........||+.|||||++... ...++|||||||++.||+||..||... ...+....+.... ..+ .....
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P-~ip~~ 247 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP-EIPDS 247 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC-CCCcc
Confidence 3 1223457899999999998743 334999999999999999999999873 3333233333322 111 22336
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
++.+++++|.+|++.||++|||+.++|.|+|+.+...
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 8999999999999999999999999999999987654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=364.55 Aligned_cols=261 Identities=31% Similarity=0.591 Sum_probs=232.0
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||+|+||.||+|+++.+++.||+|++...........+.+.+|+.+++++. |+||+++++.+...+..++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEEEE
Confidence 478999999999999999999999999999999997655444455677899999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCCc
Confidence 99999999999999988889999999999999999999999999999999999999 667789999999998764332
Q ss_pred ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
....|++.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+..+...++. .++..+.+||
T Consensus 173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li 246 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRARDLV 246 (329)
T ss_pred --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHHHHH
Confidence 34578999999998764 5789999999999999999999999988888888888777655543 3688999999
Q ss_pred HHhcccCccCCCC-----HHHHHhccCCCCCchhhHH
Q 018786 305 KKMLHADPKERLS-----AAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 305 ~~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~ 336 (350)
.+||+.||.+|++ +.+++.|+||.+..|..+.
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~ 283 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLY 283 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 9999999999997 7999999999998776554
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-50 Score=359.35 Aligned_cols=261 Identities=28% Similarity=0.522 Sum_probs=230.5
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||.||+|.++.+++.||+|++...........+.+.+|+.+++++. ||||+++++.+.+.+.+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEE
Confidence 46899999999999999999999999999999997554333344567899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
|||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC--
Confidence 9999999999999988889999999999999999999999999999999999999 56678999999999876433
Q ss_pred cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 305 (350)
.....|++.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+...++. .++..+.++|.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~ 230 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIK 230 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHHHHH
Confidence 234578999999998764 4889999999999999999999999998888888888877665544 46889999999
Q ss_pred HhcccCccCCCC-----HHHHHhccCCCCCchhhHHH
Q 018786 306 KMLHADPKERLS-----AAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 306 ~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~~ 337 (350)
+||+.||.+|++ +.++++|+||....|.....
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~ 267 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQ 267 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhc
Confidence 999999999995 99999999999887765543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=366.03 Aligned_cols=256 Identities=29% Similarity=0.528 Sum_probs=224.3
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
...|...++||+|+.|.||.|....+++.||||.+..+. ....+-+.+|+.+|+.+. |+|||.+++.|..++.+|+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLH-HPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhcc-chHHHHHHHHhcccceeEE
Confidence 357888899999999999999999999999999996553 234467999999999999 9999999999988899999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||||++||+|.+.+... .+++.+++.+++.+++||+|||.+||+|||||.+|||+ +.++.+||+|||++..+....
T Consensus 348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeecccccc
Confidence 99999999999977654 49999999999999999999999999999999999999 667779999999998876554
Q ss_pred -ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCCCCHHHHH
Q 018786 226 -VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR-GHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~ 302 (350)
...+.+|||+|||||+.. +.|+.+.||||||++++||+-|.+||........+..+.. +.+.+.. ...++..+++
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~--~~klS~~~kd 501 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN--PEKLSPELKD 501 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC--ccccCHHHHH
Confidence 456789999999999886 5699999999999999999999999997766555555544 3333333 3478999999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
|+.+||+.|+++|+++.|+|+|+||....
T Consensus 502 FL~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 99999999999999999999999996554
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=362.08 Aligned_cols=256 Identities=32% Similarity=0.575 Sum_probs=225.5
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||.||++.++.+|+.||+|++.............+.+|+.+++++. |+||+++++.+...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997654444455567889999999998 99999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CCCccccCC
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLV 231 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 231 (350)
++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.... .........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCccccee
Confidence 9999999888889999999999999999999999999999999999999 567789999999987632 222334567
Q ss_pred cCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 232 GSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 232 gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
||+.|+|||++. ..++.++|||||||++|+|++|..||...........+......++. .++.++.++|.+||+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~ 232 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHccC
Confidence 999999999886 45899999999999999999999999988887777777766655543 5799999999999999
Q ss_pred CccCCC-----CHHHHHhccCCCCCchhhHH
Q 018786 311 DPKERL-----SAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 311 dp~~Rp-----s~~~iL~~~~~~~~~~~~~~ 336 (350)
||++|| ++.++++|+||.+..|....
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~ 263 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFASINWQDVV 263 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 999999 89999999999998776654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-50 Score=354.62 Aligned_cols=262 Identities=32% Similarity=0.586 Sum_probs=227.4
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh-----------hhHHHHHHHHHHHHHccCCCCe
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-----------DDVEDVRREVQIMHHLTGHRNI 130 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~h~~i 130 (350)
.....+.|.+.+.||+|.||.|-+|.+..+++.||||++.+...... ...+++.+||.+|++|. |+||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nV 170 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNV 170 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCe
Confidence 34456899999999999999999999999999999999976543221 22568999999999999 9999
Q ss_pred eEeEeEEEc--CCceEEEEecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCC
Q 018786 131 VELKGAYED--RHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (350)
Q Consensus 131 v~~~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 207 (350)
|+++++..+ .+.+|+|+|||..|.+.. .-..+. +++.+++.++++++.||+|||.+|||||||||.|+|+ +.+
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~ 246 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSD 246 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCC
Confidence 999999864 568999999999887743 333444 8999999999999999999999999999999999999 677
Q ss_pred CCeEEeecCCcccccCC------CccccCCcCccccccccccc-----cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 018786 208 SPLKATDFGLSVFFKPG------DVFKDLVGSAYYVAPEVLRR-----NYGAEADIWSAGVILYILLSGVPPFWGETEQS 276 (350)
Q Consensus 208 ~~vkl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~ 276 (350)
++|||+|||.+.....+ ......+|||.|+|||.+.+ ..+.+.||||+|++||.|+.|++||.+....+
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 89999999999876322 22344789999999998754 24678899999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.+.+|.+....++..+ .+..++++||.+||.+||++|++..+|-.|+|..+.
T Consensus 327 l~~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 327 LFDKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9999999988887754 678999999999999999999999999999999876
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=353.06 Aligned_cols=267 Identities=27% Similarity=0.454 Sum_probs=223.3
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
.|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.++.++. |++|+++++.+...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEEE
Confidence 3788999999999999999999999999999987554333334456789999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCC
Confidence 999999998877643 358999999999999999999999999999999999999 567789999999998765554
Q ss_pred ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
......|+..|+|||++. ..++.++||||||+++|+|++|+.||...........+..............++.++.+||
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 445667999999999876 4689999999999999999999999987654322222222111111122235789999999
Q ss_pred HHhcccCccCCCC-----HHHHHhccCCCCCchhhHHHH
Q 018786 305 KKMLHADPKERLS-----AAEVLSKFLIPKKTLQTLADL 338 (350)
Q Consensus 305 ~~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~~~ 338 (350)
++||+.||.+||+ +.++++|+||.+..++.++..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 275 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN 275 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhC
Confidence 9999999999997 899999999999998887754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=343.92 Aligned_cols=263 Identities=31% Similarity=0.548 Sum_probs=238.9
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
-.+.|++++.||.|.-|+||+++.+.++..+|+|++.+..........++..|-++|..+. ||.++.+|..|+...+.+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKYSC 153 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccceeE
Confidence 3478999999999999999999999999999999999887777777888999999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 145 LIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||||+||+|..+++++ +.|++..++-++..++.||+|||-.|||+|||||+|||| .++|+|.|+||.++....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCC
Confidence 999999999999988875 459999999999999999999999999999999999999 788899999999864321
Q ss_pred C---------------------------------C-C-----------------------ccccCCcCcccccccccccc
Q 018786 223 P---------------------------------G-D-----------------------VFKDLVGSAYYVAPEVLRRN 245 (350)
Q Consensus 223 ~---------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~~ 245 (350)
- . . ...+.+||..|.|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 01225799999999999864
Q ss_pred -CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCC----HHH
Q 018786 246 -YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS----AAE 320 (350)
Q Consensus 246 -~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps----~~~ 320 (350)
.+.++|.|+||+++|||+.|..||.+....+.+.+++.....++... .++..+++||+++|.+||.+|.. +.|
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHH
Confidence 89999999999999999999999999999999999999988888765 67899999999999999999998 999
Q ss_pred HHhccCCCCCchh
Q 018786 321 VLSKFLIPKKTLQ 333 (350)
Q Consensus 321 iL~~~~~~~~~~~ 333 (350)
|=+|+||.+..|.
T Consensus 389 IK~HpFF~gVnWa 401 (459)
T KOG0610|consen 389 IKRHPFFEGVNWA 401 (459)
T ss_pred hhcCccccCCChh
Confidence 9999999999997
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=337.87 Aligned_cols=260 Identities=37% Similarity=0.673 Sum_probs=235.2
Q ss_pred ccccceeeee-eeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE----
Q 018786 64 DVRNTYIFGR-ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE---- 138 (350)
Q Consensus 64 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~---- 138 (350)
.+.++|++.. +||-|-.|.|..+.++.+++.+|+|++..+ .+.++|++..-...+|+|||.++++|+
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 4567888764 679999999999999999999999998532 578899998888888999999999874
Q ss_pred cCCceEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
....+.+|||.++||.|++.+..++. |++.++..|++||..|+.|||+.+|.||||||+|+|......+-.+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 45678899999999999999988765 9999999999999999999999999999999999999988888899999999
Q ss_pred CcccccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCCC
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET----EQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~ 291 (350)
+|+.........+.+-||+|.|||+++. .|+...|+||+|++||-|++|.+||.... .......+..+...++.+
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 9999776677788899999999999975 59999999999999999999999997654 345667889999999999
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.|..++++.+++|+.+|..+|.+|.|+.++++|+|+.+..
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 9999999999999999999999999999999999998765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=351.74 Aligned_cols=259 Identities=33% Similarity=0.637 Sum_probs=243.3
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
...+..+|.+.+.||+|.||.|-+|.....|+.||||.++++...+.+..-.+++|+++|..|+ ||||+.++++|+..+
T Consensus 48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFENkd 126 (668)
T KOG0611|consen 48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFENKD 126 (668)
T ss_pred ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcCCc
Confidence 3456789999999999999999999999999999999999999888888889999999999999 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.+.|||||..+|.|.+++.+++.+++..++++++||..|+.|+|.++++|||||.+|||+ +.++.+||+|||++..+
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLY 203 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999 77778999999999999
Q ss_pred cCCCccccCCcCcccccccccccc--CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHH
Q 018786 222 KPGDVFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (350)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.......+++|+|.|.+||++++. -++..|.||||++||.|..|..||++.+...+..++.++..--+. -+.+
T Consensus 204 ~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~PSd 278 (668)
T KOG0611|consen 204 ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----TPSD 278 (668)
T ss_pred ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----CCch
Confidence 999999999999999999999864 478899999999999999999999999999999999988765544 4788
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
...||+.||..||++|.|+.|+-.|-|+.=
T Consensus 279 A~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 279 ASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred HHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 999999999999999999999999999753
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-50 Score=340.24 Aligned_cols=267 Identities=26% Similarity=0.394 Sum_probs=229.2
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE--cCCce
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE--DRHSV 143 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~--~~~~~ 143 (350)
-+.|..++.|++|+||+||+|+++.+++.||+|.++.+..... .--...+||++|.+++ |||||.+.++.. .-+.+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G-FPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG-FPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC-CcchhHHHHHHHHhcC-CCCeeeeEEEEecccccee
Confidence 3679999999999999999999999999999999987663222 2234678999999999 999999988765 44679
Q ss_pred EEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
|+|||||+. +|.++++..+ +|...++.-++.|++.||+|||.+.|+|||||++|+|+ .+.|.+||+|||+|+.+.
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREYG 228 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhhc
Confidence 999999965 9999998765 79999999999999999999999999999999999999 677889999999999986
Q ss_pred CC-CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC----
Q 018786 223 PG-DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN---- 295 (350)
Q Consensus 223 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---- 295 (350)
.. ...+..+-|..|+|||.+-+ .|+...|+||+|||+.||+++.+.|.+..+.++++.+.+.........|++
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 54 44567788999999998754 599999999999999999999999999999999988876544444444432
Q ss_pred ------------------------CCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHHH
Q 018786 296 ------------------------ISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLADL 338 (350)
Q Consensus 296 ------------------------~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~~ 338 (350)
++....+|++.+|..||.+|.|+.|.|.|.||.....+...++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~ 375 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSM 375 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhh
Confidence 3477889999999999999999999999999999877655443
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-49 Score=361.89 Aligned_cols=265 Identities=27% Similarity=0.475 Sum_probs=225.2
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.++.++. |++|+++++.+.+...+++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEEEE
Confidence 46899999999999999999999999999999997654434445567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
|||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCccccccccc
Confidence 9999999999999988899999999999999999999999999999999999999 567789999999987543210
Q ss_pred -----------------------------------ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCC
Q 018786 226 -----------------------------------VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPF 269 (350)
Q Consensus 226 -----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf 269 (350)
.....+||+.|+|||++. ..++.++|||||||++|||++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 012357999999999875 45899999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcc---CCCCHHHHHhccCCCCCchhhHH
Q 018786 270 WGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPK---ERLSAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~---~Rps~~~iL~~~~~~~~~~~~~~ 336 (350)
.+....+....+.........+....++.++.++|.+++. +|. .||++.|+++|+||.+..|+.+.
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~ 305 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIR 305 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHH
Confidence 9888888887777643332222223478999999998764 444 46899999999999999888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=359.47 Aligned_cols=264 Identities=30% Similarity=0.466 Sum_probs=229.3
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++.++. |+||+++++.+...+..++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEE
Confidence 46999999999999999999999999999999997654433445567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
|||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... .
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--c
Confidence 9999999999999888889999999999999999999999999999999999999 6677899999999987543 2
Q ss_pred cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC----CCCCHHHH
Q 018786 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW----PNISSSAK 301 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~ 301 (350)
.....||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.........+.. ..++.++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 345679999999998764 5899999999999999999999999988877777666554322222211 25689999
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCCCCCchhhHH
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~ 336 (350)
++|.+||+.+|++||++.++++|+||.+..|....
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~~~ 269 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELR 269 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCCCCHHHHh
Confidence 99999999999999999999999999998776554
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=363.86 Aligned_cols=266 Identities=28% Similarity=0.518 Sum_probs=228.5
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|+||+||+|++..+++.||||++.............+.+|+.+++.+. |+||+++++.+...+.+++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEE
Confidence 47999999999999999999999999999999997654434445567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
|||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceecccccc
Confidence 9999999999999888889999999999999999999999999999999999999 667789999999986542211
Q ss_pred --------------------------------------ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCC
Q 018786 226 --------------------------------------VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGV 266 (350)
Q Consensus 226 --------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~ 266 (350)
.....+||+.|+|||++. ..++.++|||||||++|+|++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 011246999999999875 45899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCC---HHHHHhccCCCCCchhhHHH
Q 018786 267 PPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS---AAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps---~~~iL~~~~~~~~~~~~~~~ 337 (350)
.||......+....+.........+....+++++.++|.+||. +|.+|++ +.++++|+||.+..|+.+.+
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~ 309 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRE 309 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHhh
Confidence 9999888877777776654433333333578999999999996 9999998 99999999999988876543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=356.38 Aligned_cols=259 Identities=23% Similarity=0.375 Sum_probs=210.2
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
...+|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+++++++. |+||+++++++...+.++
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEE
Confidence 3477899999999999999999999999999999986432 2334567899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+||||+++++|.+. ...++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceecccc
Confidence 99999999988642 345788889999999999999999999999999999999 56778999999999875433
Q ss_pred C-ccccCCcCccccccccccc------cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 225 D-VFKDLVGSAYYVAPEVLRR------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 225 ~-~~~~~~gt~~y~aPE~~~~------~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
. ......||..|+|||++.. ..+.++||||||+++|+|++|+.||......+...................++
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS 301 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence 2 2345679999999998742 24568999999999999999999997443222221111111111122223678
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
.++.+||.+||+.||++|||+.|+|+|+||.+....
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~ 337 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG 337 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence 999999999999999999999999999999998543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=354.13 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=214.6
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcE-EEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC-ce
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQ-FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-SV 143 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-~~ 143 (350)
.....+.+.||.|+||+||+|.++. .. ||||++......... .+.+.+|+.+|.+++ |||||++++.+.+.. ..
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSL 115 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCce
Confidence 3555667789999999999999975 44 999999765543333 779999999999999 999999999998887 79
Q ss_pred EEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcC-CEeecCCCCceEeecCCCCC-CeEEeecCCcc
Q 018786 144 NLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMG-VMHRDLKPENFLFSSSAEDS-PLKATDFGLSV 219 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~-ivH~Dlkp~NIl~~~~~~~~-~vkl~Dfg~a~ 219 (350)
.+||||+++|+|.+++.. .+.++...+..++.||+.|+.|||+++ ||||||||+|||+ +.+. ++||+|||+++
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSR 192 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccce
Confidence 999999999999999987 678999999999999999999999999 9999999999999 5564 89999999998
Q ss_pred cccCC-CccccCCcCccccccccccc---cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 220 FFKPG-DVFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 220 ~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... .......||+.|||||++.+ .++.++||||||+++|||++|+.||...........+.........+ ..
T Consensus 193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~ 270 (362)
T KOG0192|consen 193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KE 270 (362)
T ss_pred eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--cc
Confidence 76544 33444789999999999984 49999999999999999999999999998866665554333222221 13
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
+++.+..++.+||+.||++||++.+++..+-
T Consensus 271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 271 CPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 7999999999999999999999999986543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=355.41 Aligned_cols=256 Identities=32% Similarity=0.573 Sum_probs=224.7
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||.||++.+..+|+.||+|++.............+.+|+.+++++. ||||+++++.+...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence 47999999999999999999999999997654434445567888999999998 99999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CCCccccCC
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLV 231 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 231 (350)
++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... .........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 567789999999987632 222334467
Q ss_pred cCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 232 GSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 232 gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
|++.|+|||++. ..++.++||||||+++|+|++|..||...........+......++. .+++++.++|.+||+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~ 232 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccC
Confidence 999999999875 45899999999999999999999999988887777777766655443 5789999999999999
Q ss_pred CccCCC-----CHHHHHhccCCCCCchhhHH
Q 018786 311 DPKERL-----SAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 311 dp~~Rp-----s~~~iL~~~~~~~~~~~~~~ 336 (350)
||++|+ ++.++++|+||.+..|+...
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 263 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 263 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 999998 99999999999998887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=356.22 Aligned_cols=257 Identities=30% Similarity=0.558 Sum_probs=224.9
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++++. |+||+++++.+...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999997654444455677889999999998 99999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC-CCccccCC
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLV 231 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 231 (350)
++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..... ........
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccccccc
Confidence 9999999888889999999999999999999999999999999999999 5677799999999876332 22334457
Q ss_pred cCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 232 GSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 232 gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+......++. .++.++.++|.+||+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~ 232 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIK 232 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC----CCCHHHHHHHHHHcCC
Confidence 999999999876 45899999999999999999999999888877777777666555443 5789999999999999
Q ss_pred CccCCC-----CHHHHHhccCCCCCchhhHHH
Q 018786 311 DPKERL-----SAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 311 dp~~Rp-----s~~~iL~~~~~~~~~~~~~~~ 337 (350)
||++|+ ++.++++|+||.+..|+...+
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~ 264 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYD 264 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence 999997 899999999999988876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=356.75 Aligned_cols=262 Identities=30% Similarity=0.535 Sum_probs=230.3
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCC-cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTK-QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
..++|.+.+.||+|+||.||+|.++.++ ..||+|++...........+.+.+|+.+++.+. ||||+++++++...+..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYL 106 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEE
Confidence 4478999999999999999999976654 689999997654444445677889999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecCC
Confidence 9999999999999999988899999999999999999999999999999999999999 6677899999999987543
Q ss_pred CCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
. .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+...++. .++..+.+
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ 257 (340)
T PTZ00426 184 R--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKH 257 (340)
T ss_pred C--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHH
Confidence 2 245579999999998764 4889999999999999999999999998888888888877665543 46899999
Q ss_pred HHHHhcccCccCCC-----CHHHHHhccCCCCCchhhHH
Q 018786 303 IVKKMLHADPKERL-----SAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 303 li~~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~ 336 (350)
+|++||+.||.+|+ ++.++++|+||.+..|....
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~ 296 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLL 296 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 99999999999995 89999999999998776544
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=353.11 Aligned_cols=264 Identities=27% Similarity=0.511 Sum_probs=229.9
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|.+.+.||+|+||.||+|.++.+++.||||++.+.........+.+..|..++..+..|++|+.+++++...+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58899999999999999999999999999999976544344456778889999999985567889999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CCCc
Q 018786 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDV 226 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~~~ 226 (350)
||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCc
Confidence 999999999999888889999999999999999999999999999999999999 567789999999987532 2223
Q ss_pred cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 305 (350)
.....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+....+....+......++. .++.++.++|.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~ 233 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICK 233 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHH
Confidence 345679999999998764 5889999999999999999999999998888888888776655543 57899999999
Q ss_pred HhcccCccCCCCH-----HHHHhccCCCCCchhhHHHH
Q 018786 306 KMLHADPKERLSA-----AEVLSKFLIPKKTLQTLADL 338 (350)
Q Consensus 306 ~~L~~dp~~Rps~-----~~iL~~~~~~~~~~~~~~~~ 338 (350)
+||+.||.+|++. .++++|+||.+..|..+...
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~ 271 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERR 271 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence 9999999999976 89999999999888766543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=343.23 Aligned_cols=268 Identities=31% Similarity=0.500 Sum_probs=226.7
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc---
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--- 139 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--- 139 (350)
..+...|...+.||.|+||.|..+.++.+|+.||+|.+. +.+......++..+|+++|+.++ |+||+.+.+.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~-~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL-NPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSR 95 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhh-hhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccccc
Confidence 445677888899999999999999999999999999985 23445667789999999999999 9999999998754
Q ss_pred --CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 140 --RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 140 --~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
-..+|+|+|+| +.+|...++.+..+++..+..+++||++||+|+|+.||+||||||.|++++. +-.+||+|||+
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~---~c~lKI~DFGL 171 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNA---DCDLKICDFGL 171 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeecc---CCCEEeccccc
Confidence 45799999999 6689988888878999999999999999999999999999999999999954 44589999999
Q ss_pred cccccC---CCccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------
Q 018786 218 SVFFKP---GDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH------- 285 (350)
Q Consensus 218 a~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~------- 285 (350)
|+.... ....+..+.|..|+|||++. ..|+...||||.||+|.||++|++.|.+.+.-.++..+..-.
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 998753 44457788999999999764 469999999999999999999999998877666555443322
Q ss_pred ----------------CCCCCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHH
Q 018786 286 ----------------IDFSSD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 286 ----------------~~~~~~----~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~ 336 (350)
+..+.. .+++.++.+.+|+.+||..||.+|+|++|+|+|||+....-...+
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE 322 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE 322 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC
Confidence 222221 256789999999999999999999999999999999877654443
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=353.37 Aligned_cols=257 Identities=28% Similarity=0.519 Sum_probs=224.6
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||+||+|+++.+++.||+|++.+.........+.+..|..++..+..|+||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654434445667888999988876699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CCCccccCC
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLV 231 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 231 (350)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... .........
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 667789999999987642 223334567
Q ss_pred cCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......+. .++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~L~~ 233 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILKAFMTK 233 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccc
Confidence 9999999998764 5889999999999999999999999999888888888776655443 4789999999999999
Q ss_pred CccCCCCH------HHHHhccCCCCCchhhHH
Q 018786 311 DPKERLSA------AEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 311 dp~~Rps~------~~iL~~~~~~~~~~~~~~ 336 (350)
||++|+++ .+++.|+||....|..+.
T Consensus 234 dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~ 265 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRHPFFKELDWEKLN 265 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 99999998 999999999988776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=352.09 Aligned_cols=253 Identities=29% Similarity=0.557 Sum_probs=221.7
Q ss_pred eeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCCC
Q 018786 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (350)
Q Consensus 75 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~s 154 (350)
||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++. |+||+++++.+...+..++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 699999999999999999999999997654434455677889999999998 9999999999999999999999999999
Q ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC-CCccccCCcC
Q 018786 155 LFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLVGS 233 (350)
Q Consensus 155 L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt 233 (350)
|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ........||
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCC
Confidence 99999888889999999999999999999999999999999999999 6677899999999876432 2233446799
Q ss_pred ccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 018786 234 AYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312 (350)
Q Consensus 234 ~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp 312 (350)
+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++. .++.++.++|.+||+.||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHcCCCH
Confidence 99999998764 5899999999999999999999999988888888777776555443 578999999999999999
Q ss_pred cCCC---CHHHHHhccCCCCCchhhH
Q 018786 313 KERL---SAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 313 ~~Rp---s~~~iL~~~~~~~~~~~~~ 335 (350)
.+|| ++.++|.|+||.+..+...
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~~~~~~~ 258 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQLSWKKL 258 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCCCCHHHH
Confidence 9997 5899999999998765443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=362.57 Aligned_cols=265 Identities=27% Similarity=0.496 Sum_probs=224.1
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+++.||+|+||.||++.+..+++.||||++.+.........+.+.+|+++++++. |+||+++++++.+...+++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeEEE
Confidence 46999999999999999999999999999999987654434455677899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
|||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeecccccccccccc
Confidence 9999999999999888889999999999999999999999999999999999999 567789999999986321100
Q ss_pred -----------------------------------------------ccccCCcCcccccccccc-ccCCcchhHHHHHH
Q 018786 226 -----------------------------------------------VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGV 257 (350)
Q Consensus 226 -----------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~ 257 (350)
.....+||+.|+|||++. ..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 001246999999999875 45899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCC---CCHHHHHhccCCCCCchhh
Q 018786 258 ILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER---LSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 258 vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~R---ps~~~iL~~~~~~~~~~~~ 334 (350)
++|||++|..||......+.+..+.........+....++.++.++|.+||. +|.+| +++.+++.|+||.+..|..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~ 315 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDT 315 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 9999999999998888777777766543333222223578999999999997 77775 5999999999999887765
Q ss_pred HH
Q 018786 335 LA 336 (350)
Q Consensus 335 ~~ 336 (350)
+.
T Consensus 316 ~~ 317 (377)
T cd05629 316 IR 317 (377)
T ss_pred Hc
Confidence 54
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=359.87 Aligned_cols=265 Identities=34% Similarity=0.594 Sum_probs=229.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.++..+. |+||+++++.+.+.+.+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEE
Confidence 47999999999999999999999999999999997655444455677899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
|||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccCc
Confidence 9999999999999888889999999999999999999999999999999999999 667789999999987754332
Q ss_pred -----------------------------ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 018786 226 -----------------------------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ 275 (350)
Q Consensus 226 -----------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~ 275 (350)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 2234579999999998764 5899999999999999999999999988877
Q ss_pred HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCC-HHHHHhccCCCCCchhhHH
Q 018786 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS-AAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps-~~~iL~~~~~~~~~~~~~~ 336 (350)
.....+.........+....+++++.++|.+||. ||.+|++ +.++|+|+||.+..|....
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~~~ 297 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLR 297 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHHHh
Confidence 7777777633322222233579999999999997 9999999 9999999999998776544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=359.91 Aligned_cols=264 Identities=28% Similarity=0.488 Sum_probs=222.9
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
.|.+++.||+|+||+||+|.++.+++.||+|++...........+.+.+|+.+++++. |+||+++++.+.+.+.+++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEE
Confidence 5889999999999999999999999999999997655445555678999999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC---
Q 018786 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG--- 224 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~--- 224 (350)
||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 56778999999987532100
Q ss_pred ---------------------------------------------CccccCCcCcccccccccc-ccCCcchhHHHHHHH
Q 018786 225 ---------------------------------------------DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVI 258 (350)
Q Consensus 225 ---------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~v 258 (350)
......+||+.|+|||++. ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0012347999999999875 458999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhc--ccCccCCCCHHHHHhccCCCCCchhhH
Q 018786 259 LYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML--HADPKERLSAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 259 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L--~~dp~~Rps~~~iL~~~~~~~~~~~~~ 335 (350)
+|||++|..||......+....+.........+....+++++.++|.+|+ ..++..|+++.++++|+||.+..|...
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~~ 316 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSD 316 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhHH
Confidence 99999999999887776666555543333333333467999999999954 556666999999999999998776543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=351.24 Aligned_cols=264 Identities=27% Similarity=0.494 Sum_probs=230.5
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|.+.+.||+|+||.||+|.++.+++.||+|++.+.........+.+..|..++..+..|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 48899999999999999999999999999999976544344445667788888888876899999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CCCc
Q 018786 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDV 226 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~~~ 226 (350)
||+++++|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCc
Confidence 999999999999888889999999999999999999999999999999999999 667789999999987643 2223
Q ss_pred cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 305 (350)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||...........+......++. .++.++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~ 233 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICK 233 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHHHHHHH
Confidence 34567999999999876 45899999999999999999999999998888888888877665543 57899999999
Q ss_pred HhcccCccCCCC-----HHHHHhccCCCCCchhhHHHH
Q 018786 306 KMLHADPKERLS-----AAEVLSKFLIPKKTLQTLADL 338 (350)
Q Consensus 306 ~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~~~ 338 (350)
+||+.||++|++ ..++++|+||....|....+.
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~ 271 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERK 271 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence 999999999998 489999999999888766543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-50 Score=325.80 Aligned_cols=256 Identities=33% Similarity=0.602 Sum_probs=236.3
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+++.||+|.||.||.|+.+.++-.||+|++.++..........+.+|+++-..|+ ||||++++++|-+...+|+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEE
Confidence 478999999999999999999999999999999998877666666778999999999999 9999999999999999999
Q ss_pred EEecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 146 IMDLCAGGELFDRII--AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 146 v~e~~~~~sL~~~l~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||..+|++...+. ...++++...+.++.|++.||.|+|.++++||||||+|+|+ +-.+.+||+|||.+....
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceeecC-
Confidence 999999999999998 56779999999999999999999999999999999999999 666779999999998865
Q ss_pred CCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
.....+.+||..|.+||+..+ .++...|+|++|++.||++.|.+||......+.+..+.+-...++. .++.++.+
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~----~is~~a~d 251 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS----TISGGAAD 251 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc----ccChhHHH
Confidence 444577899999999998875 5899999999999999999999999999999999999998888774 68999999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
+|.+||..+|.+|.+..|++.|+|+...
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHHHHhc
Confidence 9999999999999999999999998753
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=351.84 Aligned_cols=258 Identities=26% Similarity=0.493 Sum_probs=226.1
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||.||+|+++.+++.||+|++...........+.+..|.+++..+.+|+||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999997654444455567888999998876699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC-CCccccCC
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLV 231 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 231 (350)
++|...+...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... ........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccc
Confidence 9999999888889999999999999999999999999999999999999 6677899999999876432 22334457
Q ss_pred cCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+.......+. .++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKAFMTK 233 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhcc
Confidence 8999999998764 5899999999999999999999999999988888888876655443 4689999999999999
Q ss_pred CccCCC-------CHHHHHhccCCCCCchhhHHH
Q 018786 311 DPKERL-------SAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 311 dp~~Rp-------s~~~iL~~~~~~~~~~~~~~~ 337 (350)
||++|+ ++.++++|+||....|..++.
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~ 267 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQ 267 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence 999999 999999999999988876654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=360.26 Aligned_cols=264 Identities=29% Similarity=0.519 Sum_probs=224.7
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++++. |+||+++++.+.+++.+++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999997544333344567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC--
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-- 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~-- 224 (350)
|||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|..+...
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCcccccccc
Confidence 9999999999999888889999999999999999999999999999999999999 66778999999997532100
Q ss_pred ------------------------------------------CccccCCcCccccccccccc-cCCcchhHHHHHHHHHH
Q 018786 225 ------------------------------------------DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYI 261 (350)
Q Consensus 225 ------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ 261 (350)
......+||+.|+|||++.+ .++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 00113469999999998764 58999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCC---CHHHHHhccCCCCCchhhH
Q 018786 262 LLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL---SAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 262 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp---s~~~iL~~~~~~~~~~~~~ 335 (350)
|++|..||......+....+..............++.++.++|.+|+ .+|.+|+ ++.++++|+||.+..+...
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~~ 312 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASL 312 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHHHH
Confidence 99999999988877666666554444433334568999999999977 5999999 9999999999998766554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=359.23 Aligned_cols=262 Identities=31% Similarity=0.539 Sum_probs=224.5
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|.+++.||+|+||+||+|++..+++.||+|++.............+.+|+.+++++. |+||+++++.+.+.+.+++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEEEEE
Confidence 5899999999999999999999999999999997654434455678899999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC---
Q 018786 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG--- 224 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~--- 224 (350)
||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 66778999999997532100
Q ss_pred ---------------------------------------------CccccCCcCcccccccccc-ccCCcchhHHHHHHH
Q 018786 225 ---------------------------------------------DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVI 258 (350)
Q Consensus 225 ---------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~v 258 (350)
......+||+.|+|||++. ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0012346899999999875 458999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCC---HHHHHhccCCCCCchhh
Q 018786 259 LYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS---AAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 259 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps---~~~iL~~~~~~~~~~~~ 334 (350)
+|||++|..||......+....+.........+....+++++.++|.+|+ .+|.+|++ +.++++|+||.+..+..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~ 315 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFSS 315 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChHH
Confidence 99999999999988877766666655444444444568999999999987 59999997 99999999999877654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-48 Score=349.02 Aligned_cols=257 Identities=30% Similarity=0.533 Sum_probs=220.9
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||+||+|.+..+++.||+|+++..........+.+..|..++..+.+|+||+++++.+..++.+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654333344556677777777765699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-CccccCC
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DVFKDLV 231 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~ 231 (350)
++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...... .......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 56778999999999764322 2334567
Q ss_pred cCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+.......+. .++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR----WISKEAKDCLSKLFER 233 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHccC
Confidence 9999999998764 5889999999999999999999999998888888777766554443 4789999999999999
Q ss_pred CccCCCCH-HHHHhccCCCCCchhhHH
Q 018786 311 DPKERLSA-AEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 311 dp~~Rps~-~~iL~~~~~~~~~~~~~~ 336 (350)
||++||++ .++++|+||....|...+
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~~~~~~~ 260 (316)
T cd05592 234 DPTKRLGVDGDIRQHPFFRGIDWERLE 260 (316)
T ss_pred CHHHcCCChHHHHcCcccCCCCHHHHH
Confidence 99999986 488899999998776554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=352.96 Aligned_cols=256 Identities=31% Similarity=0.569 Sum_probs=223.9
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||.||++.+..+++.||+|++.............+.+|+++++.+. |+||+++++.+...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997654444445567888999999998 99999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CCCccccC
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDL 230 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~ 230 (350)
++|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||++.... ........
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccc
Confidence 9999998888889999999999999999999997 799999999999999 667789999999987533 22233456
Q ss_pred CcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 018786 231 VGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309 (350)
Q Consensus 231 ~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 309 (350)
.||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......++. .+++++.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~ 232 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLK 232 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhh
Confidence 7999999999875 45899999999999999999999999988887777777766655543 578999999999999
Q ss_pred cCccCCC-----CHHHHHhccCCCCCchhhHH
Q 018786 310 ADPKERL-----SAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 310 ~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~ 336 (350)
.||++|+ ++.++++|+||.+..|+...
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~ 264 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVY 264 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 9999997 99999999999998877554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-48 Score=355.77 Aligned_cols=265 Identities=30% Similarity=0.480 Sum_probs=227.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|.+.+.||+|+||.||++++..+++.||+|++.+.........+.+.+|+.+++.+. |+||+++++++.+...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEE
Confidence 34578999999999999999999999999999999997544333344556788999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||++|++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccC
Confidence 999999999999988765 468999999999999999999999999999999999999 6678899999999987543
Q ss_pred CC--ccccCCcCccccccccccc-----cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 224 GD--VFKDLVGSAYYVAPEVLRR-----NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 224 ~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........+..+.........+....+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 32 2234579999999998743 3788999999999999999999999988887777777765443333333467
Q ss_pred CHHHHHHHHHhcccCccC--CCCHHHHHhccCCCCCchh
Q 018786 297 SSSAKDIVKKMLHADPKE--RLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~--Rps~~~iL~~~~~~~~~~~ 333 (350)
+.++.++|.+||+.+|.+ |+++.++++|+||.+..|.
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 999999999999999988 9999999999999987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=353.23 Aligned_cols=266 Identities=29% Similarity=0.467 Sum_probs=227.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||+||++.++.+++.||+|+++............+.+|+.+++.+. |+||+++++.+.+.+.+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEEEE
Confidence 46999999999999999999999999999999998655434445667889999999887 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence 9999999999999875 679999999999999999999999999999999999999 667789999999998765433
Q ss_pred c--cccCCcCcccccccccc-------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 226 V--FKDLVGSAYYVAPEVLR-------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 226 ~--~~~~~gt~~y~aPE~~~-------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. .....||+.|+|||++. ..++.++||||||+++|+|++|..||........+..+.........+..+.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 2 22346899999999874 24678999999999999999999999888877777776654322222223467
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHH
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~ 337 (350)
+.++.+||..||+ ||.+|||+.+++.|+||.+..|....+
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~~~ 276 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNIRN 276 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHHhh
Confidence 8999999999998 999999999999999999987766543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=353.25 Aligned_cols=256 Identities=29% Similarity=0.477 Sum_probs=227.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
..|+..+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.++.+++ ++||.++|+.+..+..++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHHH
Confidence 56888899999999999999999999999999997554 3455788999999999999 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
||||.||++.+.++..+.+++..+.-++++++.||.|||..+.+|||||+.||++. .++.|||+|||.+........
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechhh
Confidence 99999999999999888889999999999999999999999999999999999994 457799999999988765543
Q ss_pred -cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 227 -FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 227 -~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
..+.+||+.|||||++.. .|+.++||||||++.+||.+|.+|+........+..+-+..++.... .+++.+++||
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~---~~S~~~kEFV 243 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG---DFSPPFKEFV 243 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc---ccCHHHHHHH
Confidence 377899999999999875 69999999999999999999999998887755555555554443332 6789999999
Q ss_pred HHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 305 KKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
..||++||+.||++.++|.|.|++..+
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred HHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 999999999999999999999999865
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=347.73 Aligned_cols=257 Identities=28% Similarity=0.538 Sum_probs=223.8
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||+||+|.++.+++.||+|++++...........+.+|..+++.+.+|+||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998654444455667888999998886699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CCCccccCC
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLV 231 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 231 (350)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.... .........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCccccee
Confidence 9999999888889999999999999999999999999999999999999 667789999999987532 222234456
Q ss_pred cCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 232 GSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 232 gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
|++.|+|||++. ..++.++||||||+++|+|++|..||...........+.......+. .++.++.++|.+||+.
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~ 233 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSFLTK 233 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHccC
Confidence 899999999876 45899999999999999999999999988887777777766555443 4789999999999999
Q ss_pred CccCCCCH-----HHHHhccCCCCCchhhHH
Q 018786 311 DPKERLSA-----AEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 311 dp~~Rps~-----~~iL~~~~~~~~~~~~~~ 336 (350)
||++||++ .++++|+||....|....
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~ 264 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFFREIDWDKLE 264 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 99999999 999999999998775443
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=341.37 Aligned_cols=266 Identities=27% Similarity=0.462 Sum_probs=222.8
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++++. |+||+++++.+...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEEEEE
Confidence 4889999999999999999999999999999997544333333456788999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ ++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence 999999999887653 458999999999999999999999999999999999999 667789999999998765544
Q ss_pred ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
......|+..|+|||++. ..++.++||||+|+++|++++|..||.+.........+..............++..+.++|
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 445567899999999875 4588999999999999999999999987665433333322211111222235789999999
Q ss_pred HHhcccCccCCC-----CHHHHHhccCCCCCchhhHHH
Q 018786 305 KKMLHADPKERL-----SAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 305 ~~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~~ 337 (350)
.+||+.||++|| ++.+++.|+||.+..|+....
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~ 274 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA 274 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhh
Confidence 999999999999 999999999999998887764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=349.05 Aligned_cols=257 Identities=28% Similarity=0.526 Sum_probs=218.1
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||.||+|.+..+++.||+|+++............+.+|..++.++.+||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999998654444455667889999999996699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc-cCCCccccCC
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLV 231 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~ 231 (350)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++... ..........
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcccccc
Confidence 9999999888899999999999999999999999999999999999999 56778999999998753 2333344567
Q ss_pred cCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE---------TEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
||+.|+|||++.+ .++.++|+||||+++|+|++|+.||... ........+.......+. .++.++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~----~~~~~~~ 233 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAS 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC----CCCHHHH
Confidence 9999999998764 5889999999999999999999999531 112234445555444433 4789999
Q ss_pred HHHHHhcccCccCCCC------HHHHHhccCCCCCchhhHH
Q 018786 302 DIVKKMLHADPKERLS------AAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps------~~~iL~~~~~~~~~~~~~~ 336 (350)
++|.+||+.||.+|++ +.++++|+||....|...+
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~ 274 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLE 274 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHH
Confidence 9999999999999987 7999999999987776554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=341.80 Aligned_cols=254 Identities=27% Similarity=0.430 Sum_probs=211.3
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||.|+||.||+|.++.+++.||+|+++.... ......+.+|+.+++++. |+||+++++++...+..++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEE
Confidence 679999999999999999999999999999999865432 223356789999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-
Q 018786 147 MDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~- 224 (350)
|||+.+ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC
Confidence 999975 8988887654 47999999999999999999999999999999999999 56677999999998764322
Q ss_pred CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC------------
Q 018786 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS------------ 290 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------ 290 (350)
.......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+.......+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 22344578999999998753 4889999999999999999999999887766555444322111000
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 291 --------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 291 --------------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
...+.++.++.+||.+||+.||.+|||+.|+|+|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=355.02 Aligned_cols=266 Identities=29% Similarity=0.510 Sum_probs=226.3
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||.||++.++.+++.||+|++.............+.+|+.++.++. |++|+++++.+.+.+.+++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence 36899999999999999999999999999999997544434455677889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
|||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCcccccccc
Confidence 9999999999999888889999999999999999999999999999999999999 667789999999986542110
Q ss_pred -----------------------------------ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCC
Q 018786 226 -----------------------------------VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPF 269 (350)
Q Consensus 226 -----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf 269 (350)
.....+||+.|+|||++. ..++.++|||||||++|+|++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 012347999999999875 45899999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCC---CHHHHHhccCCCCCchhhHHH
Q 018786 270 WGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL---SAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp---s~~~iL~~~~~~~~~~~~~~~ 337 (350)
...........+.........+....++.++.++|.+++. ||.+|+ ++.++++|+||.+..|..+.+
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~ 306 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHIRE 306 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHHhc
Confidence 9888877777776543222222222478999999999874 999998 489999999999998877643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=346.42 Aligned_cols=257 Identities=27% Similarity=0.485 Sum_probs=220.5
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||.||+|.++.+|+.||+|+++..........+....|..++....+|++|+++++.+...+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999999999999999997654323334566778888888765699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC-CCccccCC
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLV 231 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 231 (350)
++|..++...+.+++..+..++.||+.||+|||++||+||||||+||++ +.++.++|+|||++..... ........
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccC
Confidence 9999999888889999999999999999999999999999999999999 5677899999999875322 22334567
Q ss_pred cCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 232 GSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 232 gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+.......+. .++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~ 233 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEKLFER 233 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHccC
Confidence 999999999876 45899999999999999999999999988888777777665544443 4689999999999999
Q ss_pred CccCCCCH-HHHHhccCCCCCchhhHH
Q 018786 311 DPKERLSA-AEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 311 dp~~Rps~-~~iL~~~~~~~~~~~~~~ 336 (350)
||++|+++ .++++|+||.+..+..+.
T Consensus 234 dP~~R~~~~~~~~~h~~f~~~~~~~~~ 260 (316)
T cd05620 234 DPTRRLGVVGNIRGHPFFKTINWTALE 260 (316)
T ss_pred CHHHcCCChHHHHcCCCcCCCCHHHHH
Confidence 99999998 588899999998776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=346.04 Aligned_cols=258 Identities=30% Similarity=0.519 Sum_probs=221.0
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHH---HccCCCCeeEeEeEEEcCCceEE
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH---HLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~---~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
|++.+.||+|+||.||+|.+..+++.||||+++..........+.+.+|+.++. ++. |+||+++++++...+..++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-HPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC-CCChhceeeEEEcCCEEEE
Confidence 678999999999999999999999999999997654333444566777776654 445 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC-C
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-G 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~-~ 224 (350)
||||+++++|...+.. +.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... .
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence 9999999999877654 579999999999999999999999999999999999999 5667899999999875332 2
Q ss_pred CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
.......|++.|+|||.+.+ .++.++||||||+++|+|++|..||.+....+....+.......+. .++.++.++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l 231 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISI 231 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence 23345679999999998764 5889999999999999999999999998888888887776655443 578999999
Q ss_pred HHHhcccCccCCC-----CHHHHHhccCCCCCchhhH
Q 018786 304 VKKMLHADPKERL-----SAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 304 i~~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~ 335 (350)
|.+||+.||++|| ++.++++|+||.+..+...
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~ 268 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHH
Confidence 9999999999999 7999999999998776554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=340.66 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=211.2
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||.||+|+++.+++.+|+|++..... .....+.+.+|+.+++++. |+||+++++.+...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEE
Confidence 479999999999999999999999999999999975433 2334567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
|||++++++..+......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccccccc
Confidence 9999887665544445679999999999999999999999999999999999999 566789999999998764332
Q ss_pred -ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC---------------
Q 018786 226 -VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF--------------- 288 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 288 (350)
......|++.|+|||++. ..++.++||||||+++|+|++|+.||......+....+.....+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 223457899999999875 458899999999999999999999998776544433322211100
Q ss_pred ----CCC---------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 289 ----SSD---------PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 289 ----~~~---------~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
+.. ....++.++.+||.+||+.||++|||+.++|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 012367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=344.58 Aligned_cols=263 Identities=26% Similarity=0.510 Sum_probs=228.3
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|.+.+.||+|+||.||+|.++.+++.||+|++.+.........+.+..|..++..+.+|++|+++++++...+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47788999999999999999999999999999976544344455678889999988876788899999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-Cc
Q 018786 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DV 226 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~-~~ 226 (350)
||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCcc
Confidence 999999999999888889999999999999999999999999999999999999 66778999999998764322 22
Q ss_pred cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 305 (350)
.....||+.|+|||++. ..++.++||||||+++|+|++|..||...........+.......+. .++.++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~ 233 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICK 233 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHH
Confidence 33456899999999876 45889999999999999999999999998888888888776665543 57899999999
Q ss_pred HhcccCccCCCC-----HHHHHhccCCCCCchhhHHH
Q 018786 306 KMLHADPKERLS-----AAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 306 ~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~~ 337 (350)
+||+.||.+|++ ..++++|+||....|....+
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~ 270 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLEN 270 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhc
Confidence 999999999997 57999999999988766654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=352.06 Aligned_cols=265 Identities=28% Similarity=0.466 Sum_probs=223.8
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|++.+.||+|+||.||++.++.+++.+|+|++.+...........+.+|+.+++.+. ||||+++++.+..++.+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEE
Confidence 34578999999999999999999999999999999997544333344566888999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||+++++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceeccc
Confidence 9999999999999988654 68999999999999999999999999999999999999 6677899999999987643
Q ss_pred CCc--cccCCcCccccccccccc-----cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 224 GDV--FKDLVGSAYYVAPEVLRR-----NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 224 ~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||........+..+.........+....+
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 274 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI 274 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccC
Confidence 322 235679999999998753 2788999999999999999999999988887777777664433332223357
Q ss_pred CHHHHHHHHHhcccCccC--CCCHHHHHhccCCCCCchh
Q 018786 297 SSSAKDIVKKMLHADPKE--RLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~--Rps~~~iL~~~~~~~~~~~ 333 (350)
+..+.++|..||..++.+ |+++.++++|+||....|.
T Consensus 275 s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~ 313 (370)
T cd05621 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN 313 (370)
T ss_pred CHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence 899999999999865544 8999999999999886543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=346.54 Aligned_cols=258 Identities=27% Similarity=0.521 Sum_probs=217.8
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||.||+|.++.+++.||+|++++...........+.+|+.++.++.+|+||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998654444455667889999998886699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CCCccccCC
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLV 231 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 231 (350)
++|..++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.... .........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 667789999999987532 223334567
Q ss_pred cCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 232 GSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGE---------TEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 232 gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
||+.|+|||++. ..++.++||||||+++|+|++|..||... ........+......++. .++.++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~~~~~~ 233 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC----CCCHHHH
Confidence 999999999876 45889999999999999999999999521 122234444554444443 5789999
Q ss_pred HHHHHhcccCccCCCC------HHHHHhccCCCCCchhhHHH
Q 018786 302 DIVKKMLHADPKERLS------AAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps------~~~iL~~~~~~~~~~~~~~~ 337 (350)
++|.+||+.||++|++ +.++++|+||....|.....
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~ 275 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQ 275 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHc
Confidence 9999999999999998 58999999999987765543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=348.43 Aligned_cols=262 Identities=29% Similarity=0.534 Sum_probs=218.9
Q ss_pred ceeeeeeeeccCceEEEEEEEc---cCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 68 TYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
+|.+.+.||+|+||+||++++. .+++.||+|++.+.... .....+.+.+|+.+++++.+|++|+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999999874 46899999999754322 2233567889999999997799999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccccc
Confidence 9999999999999999888889999999999999999999999999999999999999 5667899999999876533
Q ss_pred CC--ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCCCCCCC
Q 018786 224 GD--VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGET----EQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 224 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.... .......+.......+ ..
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~ 233 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----SF 233 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC----CC
Confidence 22 2234579999999998864 37889999999999999999999996432 2333444444433332 35
Q ss_pred CCHHHHHHHHHhcccCccCCC-----CHHHHHhccCCCCCchhhHH
Q 018786 296 ISSSAKDIVKKMLHADPKERL-----SAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~ 336 (350)
++..+.++|.+||+.||++|| ++.++++|+||.+..|....
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 279 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALA 279 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 789999999999999999999 88999999999987765544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=342.88 Aligned_cols=258 Identities=27% Similarity=0.474 Sum_probs=220.4
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||+||+|.+..+++.||+|+++..........+....|..++..+.+||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997654323334566777888888765599999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC-CCccccCC
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLV 231 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 231 (350)
++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeec
Confidence 9999999888889999999999999999999999999999999999999 5667799999999875322 22334567
Q ss_pred cCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......+. .++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~ 233 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR----WLTREAKDILVKLFVR 233 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHHhcc
Confidence 8999999998764 5899999999999999999999999988877777776655443332 4789999999999999
Q ss_pred CccCCCCHH-HHHhccCCCCCchhhHHH
Q 018786 311 DPKERLSAA-EVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 311 dp~~Rps~~-~iL~~~~~~~~~~~~~~~ 337 (350)
||++|+++. ++++|+||....|..+..
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~~~~~~~~ 261 (316)
T cd05619 234 EPERRLGVKGDIRQHPFFREIDWSALEE 261 (316)
T ss_pred CHhhcCCChHHHHcCcccCCCCHHHHHh
Confidence 999999996 899999999988766544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=344.41 Aligned_cols=255 Identities=33% Similarity=0.582 Sum_probs=220.5
Q ss_pred eeeeccCceEEEEEEEc---cCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEe
Q 018786 73 RELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
+.||+|+||.||++++. .+++.||+|+++..... .......+.+|+.+++++. |+||+++++.+..++.+++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEEe
Confidence 68999999999999874 46889999999754321 2233456789999999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC-CCcc
Q 018786 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVF 227 (350)
Q Consensus 149 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~-~~~~ 227 (350)
|+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCcc
Confidence 99999999999888889999999999999999999999999999999999999 6677899999999875432 2223
Q ss_pred ccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 018786 228 KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306 (350)
Q Consensus 228 ~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 306 (350)
....|++.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+....+. .++.++.++|.+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~ 233 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP----YLTPEARDLLKK 233 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence 44579999999998764 5788999999999999999999999998888888888777655443 578999999999
Q ss_pred hcccCccCCC-----CHHHHHhccCCCCCchhhH
Q 018786 307 MLHADPKERL-----SAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 307 ~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~ 335 (350)
||+.||++|| ++.++++|+||....|...
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~ 267 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL 267 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 9999999999 8999999999998876554
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=345.60 Aligned_cols=256 Identities=28% Similarity=0.562 Sum_probs=218.1
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHH-HHHccCCCCeeEeEeEEEcCCceEEEEecCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI-MHHLTGHRNIVELKGAYEDRHSVNLIMDLCA 151 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~-l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~ 151 (350)
+.||+|+||+||+|.++.+|+.||+|++.............+.+|... ++.+. |+||+++++.+...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 479999999999999999999999999975543333334455566554 46676 9999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC-CCccccC
Q 018786 152 GGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDL 230 (350)
Q Consensus 152 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 230 (350)
+++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccc
Confidence 99999999888889999999999999999999999999999999999999 6677899999999875422 2233445
Q ss_pred CcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 018786 231 VGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309 (350)
Q Consensus 231 ~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 309 (350)
.||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+........ +.++.++.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ 232 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhh
Confidence 79999999998764 588999999999999999999999998888887777776654443 3579999999999999
Q ss_pred cCccCCCCH----HHHHhccCCCCCchhhHH
Q 018786 310 ADPKERLSA----AEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 310 ~dp~~Rps~----~~iL~~~~~~~~~~~~~~ 336 (350)
.||.+||++ .+++.|+||....|+.+.
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~ 263 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSSINWDDLV 263 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCCCCHHHHh
Confidence 999999987 699999999988776553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=339.41 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=209.7
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||+|+||.||+|.++.+++.||+|++..... ......+.+|+.+++++. |+||+++++++......++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEE
Confidence 4789999999999999999999999999999999865432 222346778999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVP 156 (303)
T ss_pred EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCC
Confidence 999995 5787877654 568999999999999999999999999999999999999 56778999999998754322
Q ss_pred -CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCC-------------
Q 018786 225 -DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHID------------- 287 (350)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~~------------- 287 (350)
.......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+..+ .+.+..+......
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 22344578999999998753 478899999999999999999999976543 2222222110000
Q ss_pred -CCCCC------------C--CCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 288 -FSSDP------------W--PNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 288 -~~~~~------------~--~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
..... + ..++.++.+||.+||+.||.+|||+.|+|+|+||.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 00000 0 124578899999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=329.53 Aligned_cols=262 Identities=28% Similarity=0.450 Sum_probs=223.3
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCC-eeEeEeEEEcCC---
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN-IVELKGAYEDRH--- 141 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-iv~~~~~~~~~~--- 141 (350)
...|..+++||+|+||+||+|+.+.+|+.||+|.+...... +..-....+|+.+++.++ |+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeeccccc
Confidence 35688889999999999999999999999999999765432 223345789999999999 999 999999987766
Q ss_pred ---ceEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEee
Q 018786 142 ---SVNLIMDLCAGGELFDRIIAKG----HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 142 ---~~~iv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
..++||||+ ..+|..++.... .++...++.+++||+.||+|||+++|+||||||.||++ +.+|.+||+|
T Consensus 88 ~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLAD 163 (323)
T ss_pred ccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeec
Confidence 899999999 459999998754 47888999999999999999999999999999999999 5688899999
Q ss_pred cCCccccc-CCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 018786 215 FGLSVFFK-PGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 215 fg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
||+|+.+. +.+..+..++|..|+|||++-+ .|+...||||+||++.||++++..|.+..+.+++..+-+-.......
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 99999776 5555778889999999998653 59999999999999999999999999999988887776543333333
Q ss_pred CCC--------------------------CCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 292 PWP--------------------------NISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 292 ~~~--------------------------~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
.|+ +.+.+..+++.+||+.+|.+|.|++.+|.|+||....-+
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 332 223588999999999999999999999999999987544
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=341.90 Aligned_cols=263 Identities=25% Similarity=0.361 Sum_probs=219.4
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||+|+||.||++++..++..+|+|++.... .....+++.+|+++++++. |+||+++++++...+..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEE
Confidence 478999999999999999999999999999999986432 3344567999999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||||+++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence 999999999999998888899999999999999999999986 59999999999999 56677999999998765433
Q ss_pred CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----------------
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID---------------- 287 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------- 287 (350)
......|++.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+......
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2345578999999998764 5899999999999999999999999766554433222110000
Q ss_pred ----------------------------CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhH
Q 018786 288 ----------------------------FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 288 ----------------------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~ 335 (350)
.+......++.++++||.+||+.||++|||+.++|+|+|+.....+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~ 312 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEEV 312 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccccc
Confidence 000011246789999999999999999999999999999988765433
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-47 Score=348.94 Aligned_cols=265 Identities=29% Similarity=0.473 Sum_probs=224.0
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
....++|.+.+.||+|+||.||++.++.+++.+|+|++.+...........+.+|+.+++.+. ||||+++++.+...+.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRY 117 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCE
Confidence 344589999999999999999999999999999999997544333344566788999999988 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcC
Confidence 9999999999999998865 458999999999999999999999999999999999999 567789999999998764
Q ss_pred CCC--ccccCCcCccccccccccc-----cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 223 PGD--VFKDLVGSAYYVAPEVLRR-----NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 223 ~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... ......||+.|+|||++.. .++.++||||||+++|+|++|..||........+..+.........+....
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence 332 2235679999999998753 278899999999999999999999998888777777776544333333446
Q ss_pred CCHHHHHHHHHhcccCccC--CCCHHHHHhccCCCCCch
Q 018786 296 ISSSAKDIVKKMLHADPKE--RLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~--Rps~~~iL~~~~~~~~~~ 332 (350)
++.++.++|.+||..++.+ |+++.++++|+||.+..+
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 8999999999999844433 789999999999988654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=315.48 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=223.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++..++..||.|+.|+|++++.+.+|...|||.+.... +.+...++...+.++....++|+||+.+++|..+..++|.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 44556778999999999999999999999999997543 5666788999999888877799999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||.| ..-+..+++. .+++++..+-++...++.||.||-++ ||+|||+||+|||+ |+.|.+||||||.+.++.+.
T Consensus 170 MelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 170 MELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeecc
Confidence 9998 4455565554 56799999999999999999999864 79999999999999 78888999999999999999
Q ss_pred CccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCCCCHH
Q 018786 225 DVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGE-TEQSIFDAILRGHIDFSSDPWPNISSS 299 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
...+...|.+.|||||.+. ..|+.++||||||++++||.||+.||.+. .+-+.+..+.+..++..... .+++++
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~-~gFSp~ 324 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGH-MGFSPD 324 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcc-cCcCHH
Confidence 9889999999999999985 34899999999999999999999999875 45677777777655443332 248999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
+++++..||++|+.+||...++|+|+|+....
T Consensus 325 F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 325 FQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 99999999999999999999999999987654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=355.48 Aligned_cols=261 Identities=23% Similarity=0.348 Sum_probs=205.6
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc-----CCCCeeEeEeEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT-----GHRNIVELKGAY 137 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~iv~~~~~~ 137 (350)
+...++|++.+.||+|+||+||+|.+..+++.||||+++... ........|+.+++.+. .|.+++++++++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344688999999999999999999999999999999986422 12344566787777775 244588888888
Q ss_pred EcC-CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCC---------
Q 018786 138 EDR-HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAE--------- 206 (350)
Q Consensus 138 ~~~-~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~--------- 206 (350)
... ..+++||+++ |++|.+++...+.+++..++.++.||+.||+|||+ .|||||||||+|||++.++.
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 654 5788999988 77999999888889999999999999999999998 59999999999999964321
Q ss_pred ----CCCeEEeecCCcccccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 018786 207 ----DSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI 281 (350)
Q Consensus 207 ----~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~ 281 (350)
...+||+|||.+..... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+.+..+
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred cCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 22599999998765322 2345689999999998764 5899999999999999999999999887765554443
Q ss_pred HcCCCCCCCC------------------------------------CCC--CCCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 282 LRGHIDFSSD------------------------------------PWP--NISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 282 ~~~~~~~~~~------------------------------------~~~--~~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
......++.. .+. ..+..+.+||.+||+.||.+|||+.|+|+
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 3221111000 000 01356789999999999999999999999
Q ss_pred ccCCCCC
Q 018786 324 KFLIPKK 330 (350)
Q Consensus 324 ~~~~~~~ 330 (350)
|+||.+.
T Consensus 438 Hp~~~~~ 444 (467)
T PTZ00284 438 HPYVLKY 444 (467)
T ss_pred Ccccccc
Confidence 9999875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=334.54 Aligned_cols=259 Identities=30% Similarity=0.451 Sum_probs=218.9
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC---
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 140 (350)
...-.|.-.+.+|.|+||+||.|....+++.||||.+-.+.. --.+|+++|+++. |||||++.-+|...
T Consensus 21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~-HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLD-HPNIVRLLYFFSSSTES 92 (364)
T ss_pred ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcC-CcCeeeEEEEEEecCCC
Confidence 344568888999999999999999999999999998864432 2347999999998 99999998877422
Q ss_pred --CceEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEee
Q 018786 141 --HSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 141 --~~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
-+..+||||++. +|.+.++. +.+++...++-+.+||++||.|||+.||+||||||.|+|++ .+.+.+||||
T Consensus 93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicD 169 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICD 169 (364)
T ss_pred chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEecc
Confidence 245699999954 99888874 56799999999999999999999999999999999999997 4468899999
Q ss_pred cCCcccccCCCccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---
Q 018786 215 FGLSVFFKPGDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS--- 289 (350)
Q Consensus 215 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--- 289 (350)
||.|+....+....+...|..|+|||.+- ..|+.+.||||.|||+.||+-|++.|.+.+..+++..+.+-.....
T Consensus 170 FGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 170 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred CCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99999998888888889999999999875 4699999999999999999999999999888887776654221111
Q ss_pred -----------------CC-----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 290 -----------------SD-----PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 290 -----------------~~-----~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
.. .....++++.+|+.++|+.+|.+|.++.|+|.|+||.....+
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 01 123568999999999999999999999999999999876543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=344.43 Aligned_cols=259 Identities=28% Similarity=0.446 Sum_probs=210.4
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC-----Cc
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR-----HS 142 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-----~~ 142 (350)
+|++.+.||+|+||.||+|.+..+++.||||.+..... ......++.+|++++++++ ||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence 58999999999999999999999999999999864321 2233457889999999998 99999999987533 34
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+++||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccc
Confidence 899999994 6899999888889999999999999999999999999999999999999 667789999999987643
Q ss_pred CCC----ccccCCcCcccccccccc---ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------------
Q 018786 223 PGD----VFKDLVGSAYYVAPEVLR---RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR------------ 283 (350)
Q Consensus 223 ~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~------------ 283 (350)
... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||.+.........+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 123457899999999875 3588999999999999999999999977654333221111
Q ss_pred ---------------CCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 284 ---------------GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 284 ---------------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.........++.++.++.++|.+||+.||++|||+.|+|+|+||.+...
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0111111123467889999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=335.80 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=212.2
Q ss_pred eeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCCC
Q 018786 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (350)
Q Consensus 75 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~s 154 (350)
||+|+||+||++.++.+++.+|+|.+...........+.+..|+.+++++. |+||+++.+++......++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 699999999999999999999999987554433344567788999999998 9999999999999999999999999999
Q ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc-ccc
Q 018786 155 LFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-FKD 229 (350)
Q Consensus 155 L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~-~~~ 229 (350)
|...+.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||.+........ ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccc
Confidence 9887743 3468999999999999999999999999999999999999 5677799999999876544322 234
Q ss_pred CCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhc
Q 018786 230 LVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML 308 (350)
Q Consensus 230 ~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 308 (350)
..|++.|+|||++. ..++.++||||||+++|+|++|+.||...........+..............++..+.+++.+||
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 57899999999876 45889999999999999999999999765432222122111111111122357899999999999
Q ss_pred ccCccCCC-----CHHHHHhccCCCCCchhhHHH
Q 018786 309 HADPKERL-----SAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 309 ~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~~ 337 (350)
+.||++|| +++++++|+||.+..|+.++.
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~ 270 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEA 270 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhh
Confidence 99999999 889999999999988776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=341.84 Aligned_cols=258 Identities=28% Similarity=0.508 Sum_probs=218.6
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++.++..|++|+.+++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999998655444455677889999999987799999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc-cCCCccccCC
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLV 231 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~ 231 (350)
++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++... ..........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceeccc
Confidence 9999999888889999999999999999999999999999999999999 56677999999998753 2233344567
Q ss_pred cCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 232 GSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGE-------TEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 232 gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
||+.|+|||++. ..++.++||||||+++|+|++|..||... ........+.......+. .++..+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~l 233 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHV 233 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence 999999999875 45889999999999999999999999532 122334444444333332 478999999
Q ss_pred HHHhcccCccCCCC------HHHHHhccCCCCCchhhHHH
Q 018786 304 VKKMLHADPKERLS------AAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 304 i~~~L~~dp~~Rps------~~~iL~~~~~~~~~~~~~~~ 337 (350)
|.+||+.||.+|++ +.++++|+||....|..+..
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~ 273 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEK 273 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHh
Confidence 99999999999997 57999999999988876653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=340.71 Aligned_cols=266 Identities=26% Similarity=0.501 Sum_probs=222.8
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|+||+||++.+..+++.||+|++.+.........+.+.+|+.+++.+. |+||+++++++...+.+++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEEEE
Confidence 47999999999999999999999999999999997544334445567889999999987 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||++|++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence 999999999999976 4579999999999999999999999999999999999999 667789999999987654332
Q ss_pred cc--ccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCC
Q 018786 226 VF--KDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH--IDFSSDPWPN 295 (350)
Q Consensus 226 ~~--~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~ 295 (350)
.. ....||+.|+|||++. +.++.++||||||+++|+|++|+.||......+....+.... ...+. ....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~ 235 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP-DVTD 235 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCC-ccCC
Confidence 21 2346899999999875 246889999999999999999999998887777666665433 22222 2235
Q ss_pred CCHHHHHHHHHhcccCcc--CCCCHHHHHhccCCCCCchhhHHH
Q 018786 296 ISSSAKDIVKKMLHADPK--ERLSAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~--~Rps~~~iL~~~~~~~~~~~~~~~ 337 (350)
++.+++++|++||..+++ .|+++.+++.|+||.+..|.....
T Consensus 236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~ 279 (331)
T cd05597 236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRN 279 (331)
T ss_pred CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHHhh
Confidence 799999999998865444 388999999999999988776654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=334.13 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=208.1
Q ss_pred cceeeeeeeeccCceEEEEEEEcc-CCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc--CCCCeeEeEeEEE-----
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKD-TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYE----- 138 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~----- 138 (350)
.+|.+.+.||+|+||+||+|.+.. +++.||+|.+...... ......+.+|+.+++++. .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 469999999999999999999854 4788999998754322 222345667887777764 3999999999874
Q ss_pred cCCceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg 155 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 155 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEcccc
Confidence 3456899999996 5898888753 458999999999999999999999999999999999999 566789999999
Q ss_pred CcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC----
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD---- 291 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 291 (350)
++.............|++.|+|||++. ..++.++||||||+++|+|++|..||.+....+.+..+..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 998765554445667899999999875 468899999999999999999999999888776666654322111100
Q ss_pred -------------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 292 -------------------PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 292 -------------------~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
..+.++..+.++|.+||+.||++|||+.++|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 123567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=324.79 Aligned_cols=263 Identities=35% Similarity=0.617 Sum_probs=231.2
Q ss_pred ccceeee-eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 66 RNTYIFG-RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 66 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
.+-|++. +.||+|+|+.|-.+....+|..||||++.+... -.+.++.+|++++.++.+|+||+++++||++++..|
T Consensus 76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY 152 (463)
T KOG0607|consen 76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY 152 (463)
T ss_pred HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence 3445544 578999999999999999999999999976632 345789999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+|||.+.||+|..++..++.|++.++..+.++|+.||++||.+||.||||||+|||...-+.-..|||+||.++......
T Consensus 153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 99999999999999999999999999999999999999999999999999999999965444456899999987654322
Q ss_pred --------CccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCC---------------HH
Q 018786 225 --------DVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGET---------------EQ 275 (350)
Q Consensus 225 --------~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~---------------~~ 275 (350)
....+.+|+..|||||+.. ..|+.+.|.||||+++|-|++|.+||.+.. ..
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence 1234567889999999752 248999999999999999999999996532 34
Q ss_pred HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
..++.|..+...++...|..++.+..++|+.+|..|+.+|.++.++++|||+....
T Consensus 313 ~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 313 KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 67889999999999999999999999999999999999999999999999998765
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=345.36 Aligned_cols=256 Identities=30% Similarity=0.530 Sum_probs=218.1
Q ss_pred eeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc--CCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 75 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
||+|+||+||+|+++.+++.||+|++.+..............|..++.++. +||+|+++++.+.....+++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999997544333333445566777776653 599999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CCCccccCC
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLV 231 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 231 (350)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.... .........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 9999999888889999999999999999999999999999999999999 566779999999987643 222334567
Q ss_pred cCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 018786 232 GSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309 (350)
Q Consensus 232 gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 309 (350)
||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+..+...++.. .++.++.++|.+||+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~~~~~~li~~~L~ 234 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVKGLLN 234 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc---cCCHHHHHHHHHHcC
Confidence 9999999998753 47899999999999999999999999888877777777666555432 468999999999999
Q ss_pred cCccCCC----CHHHHHhccCCCCCchhhHH
Q 018786 310 ADPKERL----SAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 310 ~dp~~Rp----s~~~iL~~~~~~~~~~~~~~ 336 (350)
.||.+|| ++.++++|+||....|....
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~ 265 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFADIDWDLLS 265 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccCCCHHHHH
Confidence 9999998 79999999999987665443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=342.24 Aligned_cols=256 Identities=28% Similarity=0.528 Sum_probs=217.8
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHH-HHHccCCCCeeEeEeEEEcCCceEEEEecCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI-MHHLTGHRNIVELKGAYEDRHSVNLIMDLCA 151 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~-l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~ 151 (350)
+.||+|+||+||+|.++.+|+.+|+|++.............+..|... ++.+. |+||+++++.+...+..++||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEcCCC
Confidence 469999999999999999999999999976543333444556666654 45566 9999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CCCccccC
Q 018786 152 GGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDL 230 (350)
Q Consensus 152 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~ 230 (350)
+++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.... ........
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccc
Confidence 99999999888889999999999999999999999999999999999999 667789999999987532 22233456
Q ss_pred CcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 018786 231 VGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309 (350)
Q Consensus 231 ~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 309 (350)
.|++.|+|||++.+ .++.++||||||+++|+|++|..||......+....+........ +..+..+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhc
Confidence 79999999998764 588999999999999999999999998888777777776554433 3578999999999999
Q ss_pred cCccCCCCH----HHHHhccCCCCCchhhHH
Q 018786 310 ADPKERLSA----AEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 310 ~dp~~Rps~----~~iL~~~~~~~~~~~~~~ 336 (350)
.||.+||++ .+++.|+||....|....
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~ 263 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFESLSWTDLE 263 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 999999976 599999999988775544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=342.53 Aligned_cols=255 Identities=29% Similarity=0.514 Sum_probs=220.6
Q ss_pred eeeeccCceEEEEEEEc---cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEec
Q 018786 73 RELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~ 149 (350)
+.||+|+||.||++++. .+|+.+|+|++..... .......+.+|+++++++. |+||+++++.+...+.+++||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence 67999999999999873 5689999999975433 2223456788999999998 99999999999999999999999
Q ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-Cccc
Q 018786 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DVFK 228 (350)
Q Consensus 150 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~-~~~~ 228 (350)
+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...... ....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCcee
Confidence 9999999999888889999999999999999999999999999999999999 56677999999998765433 2334
Q ss_pred cCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 018786 229 DLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307 (350)
Q Consensus 229 ~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 307 (350)
...|++.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+.......+. .++.++.++|.+|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~ 232 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRAL 232 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHH
Confidence 5678999999998764 5788999999999999999999999988888888777776655443 4789999999999
Q ss_pred cccCccCCCC-----HHHHHhccCCCCCchhhHH
Q 018786 308 LHADPKERLS-----AAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 308 L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~ 336 (350)
|+.||++||+ ..+++.|+||....|+.+.
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLY 266 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHH
Confidence 9999999999 7889999999988776544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=349.26 Aligned_cols=262 Identities=27% Similarity=0.421 Sum_probs=218.1
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccC-----CCCeeEeEeEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG-----HRNIVELKGAY 137 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-----h~~iv~~~~~~ 137 (350)
+.+..+|.+.+.||+|+||.|.+|.+..+++.||||+++... ....+...|+.+|..++. .-|+|+++++|
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 444568999999999999999999999999999999998644 345667789999999983 34899999999
Q ss_pred EcCCceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeec
Q 018786 138 EDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (350)
Q Consensus 138 ~~~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Df 215 (350)
.-.++.+||+|.+ +.+|.++++.+ ..++...++.++.||+.||.+||+.||||+||||+|||+..-+ ...|||+||
T Consensus 258 ~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~-r~~vKVIDF 335 (586)
T KOG0667|consen 258 YFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK-RSRIKVIDF 335 (586)
T ss_pred ccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC-cCceeEEec
Confidence 9999999999999 66999999875 3589999999999999999999999999999999999997533 347999999
Q ss_pred CCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----
Q 018786 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS----- 289 (350)
Q Consensus 216 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----- 289 (350)
|.++....... +.+-+..|+|||++- .+|+.+.||||||||+.||++|.+.|.+..+.+++..+..-....+
T Consensus 336 GSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 336 GSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred ccccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99998654432 677889999999865 5799999999999999999999999999888777665543110000
Q ss_pred ----------C--------------------------------CCCC------------CCCHHHHHHHHHhcccCccCC
Q 018786 290 ----------S--------------------------------DPWP------------NISSSAKDIVKKMLHADPKER 315 (350)
Q Consensus 290 ----------~--------------------------------~~~~------------~~~~~l~~li~~~L~~dp~~R 315 (350)
. ...+ .-...+.++|.+||++||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 0 0000 113567999999999999999
Q ss_pred CCHHHHHhccCCCCCch
Q 018786 316 LSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 316 ps~~~iL~~~~~~~~~~ 332 (350)
+|+.++|+|+|+.+...
T Consensus 494 ~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 494 ITPAQALNHPFLTGTSL 510 (586)
T ss_pred CCHHHHhcCcccccccc
Confidence 99999999999996543
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=340.41 Aligned_cols=256 Identities=27% Similarity=0.559 Sum_probs=215.9
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHH-HHHHccCCCCeeEeEeEEEcCCceEEEEecCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ-IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCA 151 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~ 151 (350)
+.||+|+||+||+|++..+++.||+|++.............+..|.. +++.+. |+||+++++.+...+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEeCCC
Confidence 47999999999999999999999999997543322233344555554 456676 9999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CCCccccC
Q 018786 152 GGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDL 230 (350)
Q Consensus 152 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~ 230 (350)
+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ........
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccc
Confidence 99999999888889999999999999999999999999999999999999 566789999999987643 22233456
Q ss_pred CcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 018786 231 VGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309 (350)
Q Consensus 231 ~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 309 (350)
.||+.|+|||++.+ .++.++||||||+++|+|++|..||......+.+..+........ +.++.++.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQ 232 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----CCCCHHHHHHHHHHcc
Confidence 79999999998764 588999999999999999999999998888777777766544332 3679999999999999
Q ss_pred cCccCCCCHH----HHHhccCCCCCchhhHH
Q 018786 310 ADPKERLSAA----EVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 310 ~dp~~Rps~~----~iL~~~~~~~~~~~~~~ 336 (350)
.||.+|+++. ++++|+|+....|..+.
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~ 263 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSPINWDDLI 263 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCCCCHHHHH
Confidence 9999999876 89999999888776553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=339.72 Aligned_cols=256 Identities=27% Similarity=0.542 Sum_probs=216.4
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHH-HHHHccCCCCeeEeEeEEEcCCceEEEEecCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ-IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCA 151 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~ 151 (350)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|.. +++.+. |+||+++++.+...+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEcCCC
Confidence 47999999999999999999999999997544323333445556655 466676 9999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CCCccccC
Q 018786 152 GGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDL 230 (350)
Q Consensus 152 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~ 230 (350)
+++|...+.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.... ........
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccc
Confidence 99999988888889999999999999999999999999999999999999 667789999999987632 22233445
Q ss_pred CcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 018786 231 VGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309 (350)
Q Consensus 231 ~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 309 (350)
.||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+.......+. ..+.++.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~ 232 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG----GKTVAACDLLVGLLH 232 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHcc
Confidence 78999999998764 5889999999999999999999999988877777777766544432 568899999999999
Q ss_pred cCccCCCCH----HHHHhccCCCCCchhhHH
Q 018786 310 ADPKERLSA----AEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 310 ~dp~~Rps~----~~iL~~~~~~~~~~~~~~ 336 (350)
.||.+|+++ .++++|+||....|..+.
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSPINWDDLY 263 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCCCCHHHHh
Confidence 999999875 599999999988776543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=346.04 Aligned_cols=258 Identities=24% Similarity=0.426 Sum_probs=218.9
Q ss_pred cCCcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 58 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
....++...+...+++.||+|.||+||+|++.. .||||++..... +.+..+.|++|+.++++-+ |.||+-+.|++
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~ 457 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTR-HENILLFMGAC 457 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcc-hhhheeeehhh
Confidence 346677778888999999999999999999965 499999976554 5568899999999999999 99999999999
Q ss_pred EcCCceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 138 EDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 138 ~~~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
..... .||..+|+|.+|+.+++- ..+|.....+.|++||++|+.|||.++|||||||.+|||+ .+++.|||+|||
T Consensus 458 ~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFG 533 (678)
T KOG0193|consen 458 MNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFG 533 (678)
T ss_pred cCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEeccc
Confidence 87776 899999999999999975 4569999999999999999999999999999999999999 667889999999
Q ss_pred Ccccc---cCCCccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 018786 217 LSVFF---KPGDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289 (350)
Q Consensus 217 ~a~~~---~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 289 (350)
++... ..........|...|||||+++ .+|+..+||||||+|+|||++|..||.....+.++..+-++.....
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd 613 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD 613 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc
Confidence 98653 3334445567889999999875 3599999999999999999999999997666666655555522221
Q ss_pred -CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 290 -SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 290 -~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
.....++++++.+|+..||+.++++||.+.++|..
T Consensus 614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~ 649 (678)
T KOG0193|consen 614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSK 649 (678)
T ss_pred chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHH
Confidence 11234678899999999999999999999999983
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=324.86 Aligned_cols=266 Identities=30% Similarity=0.554 Sum_probs=247.4
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
.-++|..++.||+|.||.|.+++.+.+++.||+|++++......+....-..|-++|+.++ ||.+..+...|+..+.++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEE
Confidence 3478999999999999999999999999999999999988878888888899999999999 999999998999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc-ccC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF-FKP 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~-~~~ 223 (350)
+||||..||.|+-++.+.+.|++...+.+...|+.||.|||+++||.||||.+|+|+ +.+|++||.|||+++. +..
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhcccc
Confidence 999999999999999888889999999999999999999999999999999999999 8899999999999976 456
Q ss_pred CCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
+....+.+|||.|.|||++. ..|++..|.|.+|++||||++|+.||...+....+..+..+...++. .++++.+.
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAkt 397 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKT 397 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHH
Confidence 66678899999999999987 56999999999999999999999999999999999999999988887 58999999
Q ss_pred HHHHhcccCccCCC-----CHHHHHhccCCCCCchhhHHHH
Q 018786 303 IVKKMLHADPKERL-----SAAEVLSKFLIPKKTLQTLADL 338 (350)
Q Consensus 303 li~~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~~~ 338 (350)
|+..+|.+||.+|. .+.|+.+|.||....|+..-+.
T Consensus 398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~K 438 (516)
T KOG0690|consen 398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRK 438 (516)
T ss_pred HHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHh
Confidence 99999999999997 5899999999999999876543
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=331.12 Aligned_cols=261 Identities=29% Similarity=0.496 Sum_probs=217.3
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
.|++.+.||+|+||.||++.+..+++.+|+|.+.............+.+|+.+++++. |++++.+++.+...+..++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEEE
Confidence 3778899999999999999999999999999987654433344456788999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence 999999999888653 358999999999999999999999999999999999999 566779999999987765444
Q ss_pred ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQ---SIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
......|+..|+|||++. ..++.++||||||+++|+|++|..||...... .......... .......+++++.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 233 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---QEEYSEKFSPDAR 233 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---hhhcCccCCHHHH
Confidence 444567999999999875 45889999999999999999999999765432 1222221111 1112235789999
Q ss_pred HHHHHhcccCccCCCC-----HHHHHhccCCCCCchhhH
Q 018786 302 DIVKKMLHADPKERLS-----AAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~ 335 (350)
+++.+||+.||++||| +.|+++|+||.+..+...
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~ 272 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRL 272 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHH
Confidence 9999999999999999 999999999998766644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=329.02 Aligned_cols=265 Identities=28% Similarity=0.476 Sum_probs=221.9
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
.|+..+.||.|+||+||++.+..+++.+|+|.+.............+.+|++++++++ |++++.+.+.+..++..+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEEE
Confidence 3778899999999999999999999999999987554333334456788999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence 999999998888653 369999999999999999999999999999999999999 556779999999987765444
Q ss_pred ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
......|+..|+|||.+. ..++.++|+||||+++|+|++|..||...........+............+.++.++.+++
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 445567899999999875 4588999999999999999999999987765544333333222222222346789999999
Q ss_pred HHhcccCccCCCC-----HHHHHhccCCCCCchhhHH
Q 018786 305 KKMLHADPKERLS-----AAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 305 ~~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~ 336 (350)
..||+.||++||+ +.+++.|+||....+...+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 273 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLE 273 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHh
Confidence 9999999999999 8999999999998877553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=351.03 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=206.8
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC----
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR---- 140 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~---- 140 (350)
...+|.+++.||+|+||+||+|.+..+++.||||.+.... ....+|+.+++++. |+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeeccccc
Confidence 4578999999999999999999999999999999885332 23457999999998 99999998876322
Q ss_pred ----CceEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEE
Q 018786 141 ----HSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212 (350)
Q Consensus 141 ----~~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl 212 (350)
..+++||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--~~~~vkL 212 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--NTHTLKL 212 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC--CCCceee
Confidence 246799999965 77776643 456899999999999999999999999999999999999952 3446999
Q ss_pred eecCCcccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----
Q 018786 213 TDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI---- 286 (350)
Q Consensus 213 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~---- 286 (350)
+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+.+..+.....
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99999987765555556788999999998743 589999999999999999999999988776655544432111
Q ss_pred -------------CCCCCC--------CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 287 -------------DFSSDP--------WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 287 -------------~~~~~~--------~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.++... ....+.++.+||.+||+.||.+|||+.|+|+|+||...
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 001000 01357899999999999999999999999999998653
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=338.33 Aligned_cols=267 Identities=24% Similarity=0.479 Sum_probs=223.7
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||.||+++++.+++.||+|++.+...........+.+|..++..+. |++|+++++++...+..++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999997543333334456888999998887 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||++|++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 999999999999987 4679999999999999999999999999999999999999 566779999999987754332
Q ss_pred cc--ccCCcCccccccccccc------cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCCC
Q 018786 226 VF--KDLVGSAYYVAPEVLRR------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS-SDPWPNI 296 (350)
Q Consensus 226 ~~--~~~~gt~~y~aPE~~~~------~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 296 (350)
.. ....|++.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+........ ...+..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 21 23569999999998753 478899999999999999999999998887777776665432222 1223457
Q ss_pred CHHHHHHHHHhcccCccC--CCCHHHHHhccCCCCCchhhHHH
Q 018786 297 SSSAKDIVKKMLHADPKE--RLSAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~--Rps~~~iL~~~~~~~~~~~~~~~ 337 (350)
+.++.++|.+||..++.+ |++++++++|+||....|.....
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~~~ 279 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRN 279 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHHhh
Confidence 899999999999876654 56999999999999988876644
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=328.57 Aligned_cols=256 Identities=27% Similarity=0.477 Sum_probs=212.8
Q ss_pred eeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCCC
Q 018786 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (350)
Q Consensus 75 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~s 154 (350)
||+|+||.||++.++.+|+.||+|.+.............+..|+++++++. |+||+++++.+......++||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 699999999999999999999999997544333333345667999999997 9999999999999999999999999999
Q ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccCCc
Q 018786 155 LFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232 (350)
Q Consensus 155 L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 232 (350)
|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.............|
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCC
Confidence 998886543 48899999999999999999999999999999999999 5677799999999987665544455678
Q ss_pred Ccccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 018786 233 SAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQ----SIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307 (350)
Q Consensus 233 t~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 307 (350)
+..|+|||++. ..++.++||||||+++|+|++|..||...... .............. ...++.++.++|.+|
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~ 233 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDICRLF 233 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHHHHH
Confidence 99999999875 45899999999999999999999999764332 22233333222221 235789999999999
Q ss_pred cccCccCCCCH----HHHHhccCCCCCchhhHHH
Q 018786 308 LHADPKERLSA----AEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 308 L~~dp~~Rps~----~~iL~~~~~~~~~~~~~~~ 337 (350)
|+.||++||++ .+++.|+||....|+..+.
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~ 267 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEA 267 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCCHHHHhc
Confidence 99999999999 6788999999988877664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=337.35 Aligned_cols=267 Identities=24% Similarity=0.465 Sum_probs=223.3
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||.||++.++.+++.+|+|++.+...........+.+|+.++..+. |++|+++++.+.+.+.+++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEEE
Confidence 46999999999999999999999999999999986543333334456888999998887 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence 999999999999976 4678999999999999999999999999999999999999 567789999999987653322
Q ss_pred --ccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCC
Q 018786 226 --VFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS-DPWPNI 296 (350)
Q Consensus 226 --~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 296 (350)
......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+....+......... .....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 123357999999999874 34788999999999999999999999988877777777654332221 123467
Q ss_pred CHHHHHHHHHhcccCccC--CCCHHHHHhccCCCCCchhhHHH
Q 018786 297 SSSAKDIVKKMLHADPKE--RLSAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~--Rps~~~iL~~~~~~~~~~~~~~~ 337 (350)
+.++.++|.+||..++++ |+++.++++|+||.+..|....+
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~~ 279 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRN 279 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHhh
Confidence 999999999999665544 78999999999999988876654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=328.86 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=206.5
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc--CCCCeeEeEeEEEc-----C
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYED-----R 140 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~~-----~ 140 (350)
+|.+.+.||+|+||+||+|.++.+++.||+|.+...... ......+.+|+.+++++. +|+||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 589999999999999999999999999999998754321 122234567777777663 39999999998753 3
Q ss_pred CceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
..++++||++.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcc
Confidence 458999999965 888888764 348999999999999999999999999999999999999 56677999999999
Q ss_pred ccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----------
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID---------- 287 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------- 287 (350)
.............++..|+|||++. ..++.++||||||+++|+|++|.+||......+....+......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 8765544445567899999999875 45899999999999999999999999887766555444321100
Q ss_pred -CC------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 288 -FS------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 288 -~~------------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.+ ....+.++..+.++|.+||+.||++|||+.|++.|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 01123568889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=341.73 Aligned_cols=278 Identities=32% Similarity=0.560 Sum_probs=245.8
Q ss_pred cceeee--eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 67 NTYIFG--RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 67 ~~y~~~--~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
.-|+|. +.||.|-||+||-|+++.+|+.||||++.+..+...+ ...+++|+.+|+++. ||+||.+...|+..+.++
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~-HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLH-HPGIVNLECMFETPERVF 639 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcC-CCCeeEEEEeecCCceEE
Confidence 345443 6899999999999999999999999999877664443 478999999999999 999999999999999999
Q ss_pred EEEecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 145 LIMDLCAGGELFDRII--AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+|||.+.| ++.+.+. +.+++++.....++.||+.||+|||.+||||+||||+|||+...+.-..+||||||+|+.+.
T Consensus 640 VVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg 718 (888)
T KOG4236|consen 640 VVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG 718 (888)
T ss_pred EEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence 99999976 5555554 36789999999999999999999999999999999999999877777789999999999998
Q ss_pred CCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 223 PGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
+.....+.+|||.|.|||++. +.|.+.-|+||.|+++|--++|..||..+ +++.+++.+..+.++.++|..++.+..
T Consensus 719 EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~Ai 796 (888)
T KOG4236|consen 719 EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAI 796 (888)
T ss_pred hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHH
Confidence 887778899999999999886 56999999999999999999999999644 557788999999999999999999999
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCCCCCc-hhhHHHHhhHHHHhhhccC
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLIPKKT-LQTLADLLYSQIFARFLTG 350 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 350 (350)
+||+.+|+..-.+|.|.+..|.|+|+++.+ |..+-.+. -++=++||||
T Consensus 797 dlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE-~~igeRyiTh 845 (888)
T KOG4236|consen 797 DLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELE-VRIGERYITH 845 (888)
T ss_pred HHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHH-HhhCcceecC
Confidence 999999999999999999999999999987 44555554 5566788876
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=327.14 Aligned_cols=261 Identities=33% Similarity=0.627 Sum_probs=230.3
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|++|.||++.+..+++.+|+|++...........+.+.+|+++++++. |+||+++++.+..+..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEE
Confidence 47999999999999999999999999999999997655444455678999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
|||+++++|.+++...+.+++..+..++.||+.||.+||++||+|+||+|.||++ +.++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--
Confidence 9999999999999888889999999999999999999999999999999999999 56678999999998876544
Q ss_pred cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 305 (350)
.....+++.|+|||.+. ...+.++|+||||+++|+|++|..||...........+..+....+. .++..+.++|.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~ 230 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIR 230 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc----cCCHHHHHHHH
Confidence 33456889999999875 45788999999999999999999999888776667666666555443 46899999999
Q ss_pred HhcccCccCCC-----CHHHHHhccCCCCCchhhHHH
Q 018786 306 KMLHADPKERL-----SAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 306 ~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~~ 337 (350)
+||+.||.+|+ +++|+++|+||....|..+..
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~ 267 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQ 267 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhh
Confidence 99999999999 999999999999988776653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=337.79 Aligned_cols=252 Identities=27% Similarity=0.446 Sum_probs=217.2
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
..++.-...+++.+.||+|-||.||.|....+ ..||+|.++.... ..+.+.+|+++|++|+ |++||++++++..
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM----SPEAFLREAQIMKKLR-HEKLVKLYGVCTK 272 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc----ChhHHHHHHHHHHhCc-ccCeEEEEEEEec
Confidence 34455567788899999999999999999864 4699999975433 2356889999999999 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 140 RHSVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
++.++||||||+.|+|.++|.. ...+.....+.++.||++|++||+++++|||||...|||| +++..+||+|||+
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGL 349 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEccccc
Confidence 8899999999999999999987 4568999999999999999999999999999999999999 7788899999999
Q ss_pred cccccCCCcccc--CCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 218 SVFFKPGDVFKD--LVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 218 a~~~~~~~~~~~--~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
|+...++..... ..-...|.|||++. +.++.++||||||++|||++| |+.||.+....+.++.+.++..-..+
T Consensus 350 Ar~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P--- 426 (468)
T KOG0197|consen 350 ARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP--- 426 (468)
T ss_pred ccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC---
Confidence 996544432222 22345699999886 679999999999999999998 99999999999999999987654443
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
..+|+++.+++..||+.+|++|||+..+..
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 368999999999999999999999996653
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=334.39 Aligned_cols=260 Identities=25% Similarity=0.366 Sum_probs=216.2
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|++.+.||+|+||.||++.+..++..+|+|++.... .....+.+.+|+++++++. |+||+++++++...+.++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEE
Confidence 3578999999999999999999999999999999986432 2334567899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
+||||+.+++|.+++...+.+++..+..++.|++.||.|||++ +|+|+||||+|||+ +.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhh
Confidence 9999999999999998888899999999999999999999985 79999999999999 5567799999999876533
Q ss_pred CCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------------
Q 018786 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL-------------------- 282 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~-------------------- 282 (350)
. ......|+..|+|||++.+ .++.++||||||+++|+|++|+.||...........+.
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 157 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred h-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 2 2244578999999998864 58899999999999999999999997655433322110
Q ss_pred ------------------------cCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 283 ------------------------RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 283 ------------------------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
....+ ......++.++.+||.+||+.||++|||+.|++.|+||.....+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~ 308 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPP--KLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAE 308 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCc--cCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCccc
Confidence 00000 00011357889999999999999999999999999999877543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=339.43 Aligned_cols=256 Identities=32% Similarity=0.556 Sum_probs=229.7
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc-eEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS-VNL 145 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~-~~i 145 (350)
++|..++.+|+|+||.+++++++.+++.+|+|.+.......+ ..+...+|+.++.++. |||||.+.+.|..++. .+|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEE
Confidence 679999999999999999999999999999999976654333 3457889999999998 9999999999988877 999
Q ss_pred EEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 146 IMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
||+||+||++.+.+++.+ .|+++.+..|+.||+.|+.|||+++|+|||||+.|||+ ..++.|+|+|||+|+...+
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhhhcCC
Confidence 999999999999998754 48999999999999999999999999999999999999 5566689999999999887
Q ss_pred CC-ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 224 GD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 224 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.. ...+.+||+.|+.||++.+ +|+.++|||||||++|||++-+++|...+-.....++.+....... ..++.+++
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el~ 235 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSELR 235 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHHH
Confidence 76 6778899999999999875 6999999999999999999999999999999999898888744333 26799999
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.+|..||..+|..||++.++|.++.+...
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 99999999999999999999999776643
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=341.64 Aligned_cols=253 Identities=21% Similarity=0.328 Sum_probs=206.3
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
...+|.+.+.||+|+||.||++.+..+++.||+|... ...+.+|+++++++. ||||+++++++......+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAIN-HPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeE
Confidence 3468999999999999999999999999999999753 134678999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+|+|++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCcccccccc
Confidence 9999994 6898988888889999999999999999999999999999999999999 56677999999998754322
Q ss_pred --CccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCC---------
Q 018786 225 --DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGET-------EQSIFDAILRGH--------- 285 (350)
Q Consensus 225 --~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~-------~~~~~~~~~~~~--------- 285 (350)
.......||+.|+|||++. ..++.++||||||+++|+|++|..||.... ....+..+....
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 2233467999999999876 458999999999999999999998875422 111111111100
Q ss_pred -----------------CCCC--CCC---CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 286 -----------------IDFS--SDP---WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 286 -----------------~~~~--~~~---~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
...+ ... ...++.++.+||.+||+.||++|||+.|+|+|+||....
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 0000 000 113467899999999999999999999999999998754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=336.68 Aligned_cols=258 Identities=28% Similarity=0.423 Sum_probs=208.6
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC--
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-- 141 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-- 141 (350)
.+.++|.+.+.||+|+||.||++.+..+|+.||+|++..... ......++.+|+.+++.+. |+||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCc
Confidence 356899999999999999999999999999999999865422 3344567889999999998 999999999886443
Q ss_pred ----ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 142 ----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 142 ----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
.+++||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCC
Confidence 57999999965 6666654 358899999999999999999999999999999999999 5677899999999
Q ss_pred cccccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG------------ 284 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~------------ 284 (350)
+.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+....+..+...
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 987554444455678999999998764 5889999999999999999999999877654433222111
Q ss_pred ----------CCCCCC----------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 285 ----------HIDFSS----------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 285 ----------~~~~~~----------------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
....+. ......+.++.+||.+||+.||++|||+.|+|+|+|+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 111100 001123578899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=333.30 Aligned_cols=258 Identities=28% Similarity=0.431 Sum_probs=212.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||.||+|.++.+++.+|+|.+..... ......+.+|+++++++. |+||+++++++...+..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEE
Confidence 679999999999999999999999999999999865432 222346778999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPT 158 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCc
Confidence 999965 888887664 448999999999999999999999999999999999999 566779999999987643222
Q ss_pred -ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Q 018786 226 -VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI---------------- 286 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~---------------- 286 (350)
......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||......+....+.....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 2234567899999998743 478999999999999999999999987766554443322110
Q ss_pred ---CCCC-------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 287 ---DFSS-------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 287 ---~~~~-------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
..+. ...+.++.++.++|.+||+.||.+|||+.|+|+|+||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0000 11235788999999999999999999999999999999755
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=326.49 Aligned_cols=254 Identities=36% Similarity=0.628 Sum_probs=211.9
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEe
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
|++++.||+|+||+||++.+..+++.+|+|++....... .......+|+.+++++. |+||+++++++......+++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhcccccc-cccccccccccccccccccccc
Confidence 789999999999999999999999999999997654322 22233456999999997 9999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc-cCCCcc
Q 018786 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVF 227 (350)
Q Consensus 149 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~-~~~~~~ 227 (350)
++.+++|.+++...+.+++..++.++.||+.||.+||++||+|+||||+||++ +.++.++|+|||.+... ......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTSEB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999 66777999999999763 333444
Q ss_pred ccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 228 KDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETE---QSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 228 ~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
....++..|+|||++. ...+.++||||||+++|+|++|..||..... ......................+.++.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 5677899999999876 5689999999999999999999999988732 2333333322222111111122489999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCC
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
+|.+||+.||++||++.++++|+||
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=335.29 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=210.5
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC---
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 140 (350)
.+.++|.+.+.||+|+||.||++.+..+++.||||++..... .......+.+|+.+++.+. |+||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL 98 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcC-CCCccccceeecccccc
Confidence 356899999999999999999999999999999999864322 3334567889999999998 99999999877533
Q ss_pred ---CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 141 ---HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 141 ---~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
..+++||||+.+ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~ 172 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 172 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCC
Confidence 357999999965 77776643 48899999999999999999999999999999999999 5677899999999
Q ss_pred cccccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID--------- 287 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------- 287 (350)
+.............+|..|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+.+..+......
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 987655544455678999999998764 5889999999999999999999999887766555444321110
Q ss_pred -------------CCC----------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 288 -------------FSS----------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 288 -------------~~~----------------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
... ......+.++++||.+||+.||.+|||+.|+|+|+||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 000 000113467899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=346.26 Aligned_cols=259 Identities=30% Similarity=0.503 Sum_probs=218.9
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC-
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH- 141 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~- 141 (350)
....++|.+.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+..+..+. |+|++++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceecccc
Confidence 3445799999999999999999999999999999999875443 3445567889999999998 999999987664322
Q ss_pred -------ceEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCe
Q 018786 142 -------SVNLIMDLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (350)
Q Consensus 142 -------~~~iv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~v 210 (350)
.+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCE
Confidence 368999999999999988653 468999999999999999999999999999999999999 556789
Q ss_pred EEeecCCcccccCC---CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Q 018786 211 KATDFGLSVFFKPG---DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI 286 (350)
Q Consensus 211 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~ 286 (350)
||+|||++...... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+..+..
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999998765422 12234679999999998864 589999999999999999999999998887777777766544
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
... .+.+++++.++|.+||+.||.+||++.++++|+|+..
T Consensus 263 ~~~---~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 263 DPL---PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 322 2367899999999999999999999999999998654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.19 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=217.5
Q ss_pred ccceeeeeeeeccCceEEEEEEEccC-CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDT-KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
...|.+.+.||+|++|.||+|.+..+ ++.+|+|.+... .......+.+|+.+++++. ||||+++++++...+.++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEEE
Confidence 34599999999999999999998877 788999976432 3344467888999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 145 LIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
+||||++|++|.+++.. ..++++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCcee
Confidence 99999999999987753 3468999999999999999999999999999999999999 5677899999999987
Q ss_pred ccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 221 FKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 221 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
...... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||......+....+..+...... ..+
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~ 295 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP---CPV 295 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---ccC
Confidence 654321 34457999999999876 45899999999999999999999999988887777777665443221 257
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
+.++.++|.+||+.||++||++.++|.++|+..
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 899999999999999999999999999988853
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=318.05 Aligned_cols=255 Identities=28% Similarity=0.481 Sum_probs=214.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCC--hhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN--RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
++|.+.+.||+|++|.||++.+..+++.+|+|.+....... ......+.+|+++++++. |+||+++++++...+..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCeEE
Confidence 46899999999999999999999999999999987543221 223467899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+++||+++++|.+++...+.+++..+..++.|++.||.+||+.||+|+||+|+||++ +.++.++|+|||.+......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecccc
Confidence 999999999999999888889999999999999999999999999999999999999 55677999999998765332
Q ss_pred Ccc----ccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHH
Q 018786 225 DVF----KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (350)
Q Consensus 225 ~~~----~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
... ....++..|+|||.+.+ .++.++||||||+++|++++|+.||.................... ....++.+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ--LPSHVSPD 235 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC--CCccCCHH
Confidence 111 23467889999998764 488999999999999999999999987665544444433322211 12357899
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
+.++|.+||..+|++|||+.++|+|+||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=337.76 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=212.6
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC-----c
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-----S 142 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-----~ 142 (350)
+|.+.+.||+|+||.||++.+..+++.||+|.+.... .......++.+|+.+++.++ |+||+++++++...+ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccce
Confidence 4778899999999999999999999999999986432 23334567889999999998 999999999987766 7
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
.++|+||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecc
Confidence 899999995 5888888877889999999999999999999999999999999999999 667789999999987653
Q ss_pred CCC--ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Q 018786 223 PGD--VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG-------------- 284 (350)
Q Consensus 223 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~-------------- 284 (350)
... ......+++.|+|||.+.+ .++.++|||||||++|+|++|+.||.+......+..+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 322 2234567899999998754 4789999999999999999999999887765554443221
Q ss_pred ---------CCCCCC-----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 285 ---------HIDFSS-----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 285 ---------~~~~~~-----~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
....+. ......+.++.+||.+||+.||++|||+.|+|+|+||.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 000000 11234578999999999999999999999999999998854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=334.55 Aligned_cols=259 Identities=28% Similarity=0.407 Sum_probs=209.5
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC---
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 140 (350)
...++|++.+.||+|+||.||++.+..+++.+|+|.+..... .......+.+|+.+++.+. |+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccccc
Confidence 355899999999999999999999999999999999864332 3344567889999999998 99999999987543
Q ss_pred ---CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 141 ---HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 141 ---~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
...++||||+++ ++.+.+.. .+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCcc
Confidence 357899999965 67666643 58899999999999999999999999999999999999 5677899999999
Q ss_pred cccccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH----------- 285 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~----------- 285 (350)
+.............||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+....+.+..+....
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 987655544456679999999998764 58899999999999999999999998776544333222110
Q ss_pred -----------CCC----------------CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 286 -----------IDF----------------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 286 -----------~~~----------------~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
... ........+.++.++|.+||+.||++|||+.|+|+|+||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 000 000011235678999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=325.83 Aligned_cols=264 Identities=32% Similarity=0.566 Sum_probs=225.8
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|++|.||+|.+..+++.+|+|.+.............+.+|++.++++. |+||+++++.+......+++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEE
Confidence 36999999999999999999999999999999997665443345677999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 147 MDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
|||+.+++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhccccc
Confidence 9999999999988754 568999999999999999999999999999999999999 55677999999998654321
Q ss_pred C------------------------------ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 018786 225 D------------------------------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET 273 (350)
Q Consensus 225 ~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~ 273 (350)
. ......|+..|+|||++.+ .++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1 1112467889999998754 58889999999999999999999998888
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCC----HHHHHhccCCCCCchhhHH
Q 018786 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS----AAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps----~~~iL~~~~~~~~~~~~~~ 336 (350)
....+..+......++.. ..++.++.++|.+||+.||++||| +.++|.|+||.+..|....
T Consensus 237 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~ 301 (316)
T cd05574 237 RDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIR 301 (316)
T ss_pred hHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcc
Confidence 777776666555444432 237899999999999999999999 9999999999998876554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=356.28 Aligned_cols=266 Identities=32% Similarity=0.545 Sum_probs=219.5
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
...+...++|.+++.||.|+||+||+|.+..+++.+|+|++..... .......+..|+.+++++. ||||++++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~d 83 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDRFLN 83 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEe
Confidence 3455667899999999999999999999999999999999875443 3344577899999999998 9999999998754
Q ss_pred --CCceEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc-------CCEeecCCCCceEeecC--
Q 018786 140 --RHSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSM-------GVMHRDLKPENFLFSSS-- 204 (350)
Q Consensus 140 --~~~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~-------~ivH~Dlkp~NIl~~~~-- 204 (350)
...++|||||+.+++|.+++.. ...+++..++.|+.||+.||.|||+. +||||||||+|||++..
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 4578999999999999998865 35699999999999999999999985 49999999999999642
Q ss_pred ------------CCCCCeEEeecCCcccccCCCccccCCcCcccccccccc---ccCCcchhHHHHHHHHHHHHhCCCCC
Q 018786 205 ------------AEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR---RNYGAEADIWSAGVILYILLSGVPPF 269 (350)
Q Consensus 205 ------------~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Dv~slG~vl~~ll~g~~pf 269 (350)
+....+||+|||++.............||+.|+|||++. ..++.++|||||||+||+|++|..||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 123468999999998765544445567999999999874 34789999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 270 WGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
........+..........+ ....+.++.+||..||+.+|.+||++.|+|.|+|+...
T Consensus 244 ~~~~~~~qli~~lk~~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 76655444333333332222 23568999999999999999999999999999999744
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=331.02 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=201.0
Q ss_pred cccceeeeeeeeccCceEEEEEEEc-----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
..++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.++.++.+|+||+++++.+..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 4578999999999999999999852 345789999986432 233456789999999999559999999998765
Q ss_pred -CCceEEEEecCCCCCHHHHHHHc--------------------------------------------------------
Q 018786 140 -RHSVNLIMDLCAGGELFDRIIAK-------------------------------------------------------- 162 (350)
Q Consensus 140 -~~~~~iv~e~~~~~sL~~~l~~~-------------------------------------------------------- 162 (350)
.+.++++|||+++++|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 44688999999999999988652
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc---cccCCcC
Q 018786 163 ------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGS 233 (350)
Q Consensus 163 ------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt 233 (350)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........ .....++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 236778889999999999999999999999999999999 5567799999999976533221 1223456
Q ss_pred cccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 234 AYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 234 ~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
..|+|||++. ..++.++||||||+++|||++ |..||......+ ....+..+..... ...++.++.++|.+||+.
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~ 316 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA---PENATPEIYRIMLACWQG 316 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHccC
Confidence 7899999875 458999999999999999997 999998755433 3333333322111 235789999999999999
Q ss_pred CccCCCCHHHHHhc
Q 018786 311 DPKERLSAAEVLSK 324 (350)
Q Consensus 311 dp~~Rps~~~iL~~ 324 (350)
||++|||+.++++.
T Consensus 317 dp~~RPs~~el~~~ 330 (338)
T cd05102 317 DPKERPTFSALVEI 330 (338)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=322.08 Aligned_cols=266 Identities=30% Similarity=0.545 Sum_probs=226.1
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||.||++.+..+++.|++|.+.............+.+|+++++.+. |+||+++++.+..++.+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEEE
Confidence 46899999999999999999999999999999987554333444567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
|||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||.+.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCcc
Confidence 9999999999999888889999999999999999999999999999999999999 567789999999876321000
Q ss_pred ---------------ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 018786 226 ---------------VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289 (350)
Q Consensus 226 ---------------~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 289 (350)
......++..|+|||.+. ..++.++|+||||+++|++++|..||.+....+.......+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 011235788899999865 4589999999999999999999999998887777777666654444
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCC---HHHHHhccCCCCCchhhHHH
Q 018786 290 SDPWPNISSSAKDIVKKMLHADPKERLS---AAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 290 ~~~~~~~~~~l~~li~~~L~~dp~~Rps---~~~iL~~~~~~~~~~~~~~~ 337 (350)
... ..++.++.++|.+||+.||++||+ +.++|+|+||....+....+
T Consensus 237 ~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~ 286 (305)
T cd05609 237 EGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLR 286 (305)
T ss_pred Ccc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhh
Confidence 332 257899999999999999999997 79999999998887766543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=328.54 Aligned_cols=262 Identities=35% Similarity=0.578 Sum_probs=238.3
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
..+.+-|.+.+.||+|-|++|-+|++.-+|..||||++.+.++... ....+..|++.|+.+. |||||++|++......
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQTK 91 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhc-CcCeeeeeehhcccce
Confidence 3556789999999999999999999999999999999988776433 3456889999998887 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
+|+|+|+-.+|+|++++.++ ..+.+..+.++++||+.|+.|+|+..+|||||||+||.+. ..-|.|||.|||++..+
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccC
Confidence 99999999999999999664 5699999999999999999999999999999999999886 45678999999999999
Q ss_pred cCCCccccCCcCcccccccccccc--CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHH
Q 018786 222 KPGDVFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (350)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.++....+.+|+..|-|||++.+. ..++.||||||++||.|.+|+.||....+.+.+..+.......+. -++.+
T Consensus 170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~e 245 (864)
T KOG4717|consen 170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSKE 245 (864)
T ss_pred CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhHH
Confidence 999999999999999999987653 457889999999999999999999999999999999988887765 57999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.++||..||..||.+|.+.++|..+.|++...-
T Consensus 246 CrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 246 CRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 999999999999999999999999999998753
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=317.78 Aligned_cols=254 Identities=28% Similarity=0.462 Sum_probs=211.4
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
..+|.+.+.||+|+||.||+|.+..+++.+|+|++.... ......+.+|+.+++++. |+||+++++.+...+.+++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEEE
Confidence 468999999999999999999999999999999986432 233456889999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||+|+||++ +.++.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecccc
Confidence 99999999999999888889999999999999999999999999999999999999 566779999999998754322
Q ss_pred -ccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCCCHH
Q 018786 226 -VFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD-PWPNISSS 299 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 299 (350)
......++..|+|||.+. ..++.++|+||||+++|+|++|..||...........+.......+.. ....++..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 223456888999999863 347789999999999999999999997655433332222222221111 11246889
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
+.++|++||+.||++|||+.++|+|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=330.40 Aligned_cols=260 Identities=26% Similarity=0.427 Sum_probs=210.2
Q ss_pred cccccceeeeeeeeccCceEEEEEEEc--cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHK--DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
.....+|.+.+.||+|+||.||++... .+++.||+|.+... ....+|+++++++. |+||+++++.+...
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~ 158 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWK 158 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeC
Confidence 345678999999999999999999764 34678999988532 23568999999998 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
...+++||++. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++..
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACK 234 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccc
Confidence 99999999995 5888988777889999999999999999999999999999999999999 6677899999999876
Q ss_pred ccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcC----CCC--
Q 018786 221 FKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETE---QSIFDAILRG----HID-- 287 (350)
Q Consensus 221 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~---~~~~~~~~~~----~~~-- 287 (350)
...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+... ...+..+.+. ...
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 543322 23457999999999886 4589999999999999999999999976432 1122221110 000
Q ss_pred ---------------------CCCCC---CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhH
Q 018786 288 ---------------------FSSDP---WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 288 ---------------------~~~~~---~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~ 335 (350)
+..+. -..++.++.++|.+||..||++|||+.|+|.|+||.+..++.+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~ 386 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLL 386 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhh
Confidence 00000 0134678899999999999999999999999999999887654
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=316.54 Aligned_cols=270 Identities=29% Similarity=0.483 Sum_probs=226.3
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||.|++|.||+|.+..+++.+|+|++.... .......+.+|+++++.+. |+||+++++.+.+....++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEE
Confidence 46889999999999999999999999999999986543 2334567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-C
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-D 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~-~ 225 (350)
+||+.+++|.+++... ++++..++.++.|++.||.+||+++++|+||+|+||++ +.++.++|+|||++...... .
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc
Confidence 9999999999988765 78999999999999999999999999999999999999 56777999999999876543 2
Q ss_pred ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+.....+.... ..++.++.+++
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 231 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG--NKFSKPFKDFV 231 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcc--cccCHHHHHHH
Confidence 2344568889999998754 58999999999999999999999998766555554444443222211 12788999999
Q ss_pred HHhcccCccCCCCHHHHHhccCCCCCchhhHHHHhhHHHHhh
Q 018786 305 KKMLHADPKERLSAAEVLSKFLIPKKTLQTLADLLYSQIFAR 346 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~~~~~~~~~~ 346 (350)
.+||..||++|||+.+++.|+|+.+......-+.+ .+++.|
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~~~~-~~~~~~ 272 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLL-IERIKK 272 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCCCcccHHHHH-HHHHHh
Confidence 99999999999999999999999998877655555 444444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=322.07 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=212.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++++. |+||+++++++...+..++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEE
Confidence 3679999999999999999999999999999999865432 223346778999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++......
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIP 157 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCC
Confidence 999996 4898888754 568999999999999999999999999999999999999 56677999999998764322
Q ss_pred C-ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------------
Q 018786 225 D-VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID-------------- 287 (350)
Q Consensus 225 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------- 287 (350)
. ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...+..+....+......
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 2 2234567889999998753 4788999999999999999999999887765554433221110
Q ss_pred -----CCC-------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 288 -----FSS-------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 288 -----~~~-------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.+. ...+.++.++.++|.+||+.||.+|||+.|+|+|+||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 01135688999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=345.51 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=215.4
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEe-EEE
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKG-AYE 138 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~-~~~ 138 (350)
.....-..+++|.+.|.+|||+.||+|.+...|..||+|++... ++...+.+.+|+++|++|.+|+|||.+++ ...
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 33445567899999999999999999999998899999998543 66778899999999999999999999999 331
Q ss_pred ---c---CCceEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeecCCCCceEeecCCCCC
Q 018786 139 ---D---RHSVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 139 ---~---~~~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~ 208 (350)
. .-.+.++||||.|+.|.+++.. ...|++.++++|++++++|+.+||... |||||||-+|||| ..++
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g 183 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADG 183 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCC
Confidence 1 1357799999999999999975 455999999999999999999999998 9999999999999 6677
Q ss_pred CeEEeecCCcccccCCC-cc---------ccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Q 018786 209 PLKATDFGLSVFFKPGD-VF---------KDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETE 274 (350)
Q Consensus 209 ~vkl~Dfg~a~~~~~~~-~~---------~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~ 274 (350)
..||||||.|....... .. -....|+.|++||++. ..++.|+|||+|||+||-|+....||.....
T Consensus 184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 89999999987643222 11 1135799999999874 3589999999999999999999999976543
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCC
Q 018786 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
-+|+++.+.++.. +.++..+.+||+.||+.||++||++.+++.+.+..
T Consensus 264 ----laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 264 ----LAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ----eeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 3466777777664 58999999999999999999999999999765543
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=321.73 Aligned_cols=260 Identities=26% Similarity=0.370 Sum_probs=214.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|+||.||++.+..++..+|+|.+.... ......++.+|+++++++. |+||+++++.+...+.+++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999986432 2344567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++|+||||+||++ +.++.++|+|||++......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCccccccc-
Confidence 9999999999999888889999999999999999999998 589999999999999 55677999999998765332
Q ss_pred ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----------------
Q 018786 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF---------------- 288 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 288 (350)
......++..|+|||.+.+ .++.++|+||||+++|+|++|+.||...........+.......
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 2244578899999998754 47889999999999999999999997655333322221111000
Q ss_pred ------------------CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 289 ------------------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 289 ------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
+..+...++.++.++|.+||..||++|||+.+++.|+||.+...+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 296 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence 000112367889999999999999999999999999999886544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=318.56 Aligned_cols=243 Identities=18% Similarity=0.249 Sum_probs=206.9
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc----CCceEEEEe
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED----RHSVNLIMD 148 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----~~~~~iv~e 148 (350)
..||+|+++.||+|.. +|+.||||.+...........+.+.+|+.+++++. ||||+++++++.+ ...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence 5689999999999988 57899999997654434344577889999999998 9999999998866 457899999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCcc
Q 018786 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227 (350)
Q Consensus 149 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~ 227 (350)
|+++++|.+++...+.+++.....++.+++.||.+||+. +++||||||+||++ ++++.+||+|||++.......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--
Confidence 999999999998888899999999999999999999984 99999999999999 667789999999988654322
Q ss_pred ccCCcCcccccccccc---ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 228 KDLVGSAYYVAPEVLR---RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 228 ~~~~gt~~y~aPE~~~---~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
....|+..|+|||++. ..++.++||||||+++|||++|..||......+....+.........+ ..++.++.+++
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li 255 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV 255 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence 3456889999999875 368999999999999999999999999888777777765544333221 25789999999
Q ss_pred HHhcccCccCCCCHHHHHhcc
Q 018786 305 KKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+||+.||++|||+.+++..+
T Consensus 256 ~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred HHHhcCCcccCcCHHHHHHHH
Confidence 999999999999999998654
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=317.71 Aligned_cols=256 Identities=27% Similarity=0.489 Sum_probs=212.0
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|++|.||+|.++.+++.||+|++..... .....+.+.+|+.+++++. |+|++++++.+......++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEE
Confidence 479999999999999999999999999999999865432 2223456789999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
|||+++++|..+......+++..++.++.||+.+|.|||+.||+|+||||+||++ +.++.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence 9999998887777666779999999999999999999999999999999999999 566779999999998765433
Q ss_pred ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------
Q 018786 226 VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI----------------- 286 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~----------------- 286 (350)
......++..|+|||.+.+ .++.++|+||||+++|+|++|..||.+....+....+.....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 2234567889999998753 478899999999999999999999987765544433321100
Q ss_pred --CCCC--------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 287 --DFSS--------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 287 --~~~~--------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
..+. ..++.++..+.++|.+||+.||++||++.+++.|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000 0123568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=313.38 Aligned_cols=253 Identities=29% Similarity=0.494 Sum_probs=213.2
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh------hhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR------DDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
+|.+.+.||.|++|.||+|.+..+++.+|+|.+........ ...+.+.+|+.+++++. |+||+++++++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence 47888999999999999999998899999998865433221 22356889999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
..+++|||+++++|.+++...+.+++..+..++.|++.||.+||++|++||||+|+||++ +.++.++|+|||.+...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCccc
Confidence 999999999999999999888889999999999999999999999999999999999999 56777999999998776
Q ss_pred cCCC-------ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 222 KPGD-------VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 222 ~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.... ......|+..|+|||.+. ..++.++|+||||+++|+|++|..||...........+.....+. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 233 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE---IP 233 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCc---CC
Confidence 4221 112345788999999875 457889999999999999999999998776655444443322211 12
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
..++..+.++|.+||+.||++||++.++++|+||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 3578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=316.19 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=212.9
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||+|+||.||+|.+..+++.+|+|+++... ......+.+|+.+++.+. |+||+++++.+...+.+++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEE
Confidence 468999999999999999999999999999999986442 233456788999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
+|||+++++|.+++...+.+++..++.++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCcc
Confidence 99999999999999888899999999999999999999999999999999999999 566779999999987654322
Q ss_pred -ccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCCCHH
Q 018786 226 -VFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS-DPWPNISSS 299 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 299 (350)
......|+..|+|||++. +.++.++|+||||+++|+|++|..||...................+. .....++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 223457899999999863 34788999999999999999999999765544433333333222221 111246789
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
+.++|.+||+.||++||++.++++|+|
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=310.23 Aligned_cols=252 Identities=24% Similarity=0.455 Sum_probs=217.4
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|.+.+.||+|++|.||+|.+..+++.|++|.+..... .......+.+|+.++++++ |+||+++++.+...+..++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEE
Confidence 48889999999999999999999999999999875443 3344577899999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||+|+||++ +.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCcc
Confidence 999999999998764 568999999999999999999999999999999999999 556779999999988765433
Q ss_pred c-cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 226 V-FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 226 ~-~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
. .....|++.|+|||++. +.++.++|+||||+++++|++|..||...........+..+..+.... .++.++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ---MYSQQLAQL 232 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc---ccCHHHHHH
Confidence 2 23446888999999875 457899999999999999999999998888777666666554433221 578999999
Q ss_pred HHHhcccCccCCCCHHHHHhccCC
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
|.+||+.+|++||++.+++.++|+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=316.88 Aligned_cols=254 Identities=29% Similarity=0.425 Sum_probs=207.9
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|++.+.||+|++|.||+|.++.+++.||+|.+..... .......+.+|+.+++++. |+||+++++++..+...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEE
Confidence 58899999999999999999999999999999865432 2334467889999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 148 DLCAGGELFDRIIAK---GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 148 e~~~~~sL~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||++ ++|.+++... ..+++..++.++.||+.||.|||++||+|+||+|+||++ +.++.++|+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCC
Confidence 9997 5888887642 468999999999999999999999999999999999999 56778999999998764322
Q ss_pred C-ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------------
Q 018786 225 D-VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF------------- 288 (350)
Q Consensus 225 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------- 288 (350)
. ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.+.........+.......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 1 2233467889999998753 47889999999999999999999998776544333222111000
Q ss_pred ------------CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 289 ------------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 289 ------------~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.......++.++.++|.+||+.||++|||+.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 001123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=325.82 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=211.4
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
..+..|.+.++||.||.+.||++...+. +.||+|.+.... .+.+....+.+|+..|.+|.+|.+|++++++-..++++
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 4467899999999999999999998764 456666654333 25566788999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
|+|||+- ..+|..+|..... ++...++.+..||+.|+.++|++||||.||||.|+|+- .|.+||+|||.|..+.
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQ 510 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcccC
Confidence 9999986 5589988887655 44468889999999999999999999999999999984 6779999999998876
Q ss_pred CCC---ccccCCcCccccccccccc------------cCCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCC
Q 018786 223 PGD---VFKDLVGSAYYVAPEVLRR------------NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHI 286 (350)
Q Consensus 223 ~~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~Dv~slG~vl~~ll~g~~pf~~~~-~~~~~~~~~~~~~ 286 (350)
... ...+.+||+.||+||++.. ..++++|||||||+||+|+.|+.||..-. ....+..+.....
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~ 590 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH 590 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence 553 3456789999999998731 15788999999999999999999997554 2333444444433
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
....+..+. ..+++++++.||+.||.+|||+.++|+|+|+.....
T Consensus 591 ~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i 635 (677)
T KOG0596|consen 591 EIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI 635 (677)
T ss_pred cccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence 333222222 234999999999999999999999999999998544
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=330.43 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=210.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC---
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 140 (350)
.+.++|.+.+.||.|+||+||+|.+..+++.||||.+..... .......+.+|+.+++++. |+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccccc
Confidence 456889999999999999999999999999999999864322 2233456788999999998 99999999877432
Q ss_pred ---CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 141 ---HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 141 ---~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
...+++++++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~ 164 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGL 164 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCcc
Confidence 4578999988 778977665 4579999999999999999999999999999999999999 5677799999999
Q ss_pred cccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI--------- 286 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~--------- 286 (350)
+...... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......+.+..+.....
T Consensus 165 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 165 ARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9875433 245578999999998754 478999999999999999999999987665444433322110
Q ss_pred --------------CCCC----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 287 --------------DFSS----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 287 --------------~~~~----~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
..+. ..+...++.+.+||.+||+.||++|||+.|+|+|+||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 0000 012245677899999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=334.68 Aligned_cols=256 Identities=27% Similarity=0.476 Sum_probs=225.2
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
..|.=+..||.|+||.||-|++..+.+.||||.+..+.....+.+..+..|+.+|++++ |||++.+.++|..+...|+|
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchHHHH
Confidence 34666689999999999999999999999999998776666677889999999999999 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||||-| +-.|++.- ++++.+-.+..|..+.+.||+|||+.+.||||||..|||+ .+.|.|||+|||.|....+.
T Consensus 105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcCch-
Confidence 999955 88888864 5679999999999999999999999999999999999999 77888999999999886543
Q ss_pred ccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCCCCHHH
Q 018786 226 VFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG-HIDFSSDPWPNISSSA 300 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 300 (350)
++++|||+|||||++. +.|+-++||||||++..||.-.++|+........+..|..+ .+.+.. +.++..+
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs---~eWS~~F 254 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS---NEWSDYF 254 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC---chhHHHH
Confidence 6789999999999863 67999999999999999999999998877766555555544 444443 3568899
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
+.||..||++-|.+|||++++|.|.|+....-.
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKHRFVLRERPP 287 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence 999999999999999999999999999887643
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=314.25 Aligned_cols=255 Identities=25% Similarity=0.447 Sum_probs=210.9
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc----
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED---- 139 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~---- 139 (350)
...+.|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++.+|+||+++++.+..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 34578999999999999999999999999999999986432 2345788999999998669999999998864
Q ss_pred --CCceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeec
Q 018786 140 --RHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (350)
Q Consensus 140 --~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Df 215 (350)
...++++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+|+||+|+||++ ++++.++|+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Df 155 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDF 155 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccC
Confidence 24689999999999999988763 358999999999999999999999999999999999999 56677999999
Q ss_pred CCcccccCC-CccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Q 018786 216 GLSVFFKPG-DVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288 (350)
Q Consensus 216 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 288 (350)
|++...... .......|+..|+|||++. ..++.++||||||+++|+|++|..||................ .
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~ 233 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--A 233 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--C
Confidence 998765432 2234457899999999874 247889999999999999999999997666544444333322 1
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 289 ~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.......++.++.+++.+||+.||.+|||+.+++.|+||
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 111223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=312.91 Aligned_cols=254 Identities=30% Similarity=0.497 Sum_probs=214.6
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||.|++|.||+|.+..+++.||+|++.+...........+..|..++....+|+|++++++.+..++.+++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999999999999999987544322333344556665555554599999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccCCc
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 232 (350)
++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||++..... .....+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cccCCC
Confidence 9999999888889999999999999999999999999999999999999 5567799999998876433 234467
Q ss_pred Cccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 018786 233 SAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311 (350)
Q Consensus 233 t~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 311 (350)
+..|++||.+.+ .++.++||||||+++|+|++|..||...........+.......+......++.++.++|.+||+.|
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 889999998754 4788999999999999999999999888877777776666555554444568999999999999999
Q ss_pred ccCCC---CHHHHHhccCCCCCch
Q 018786 312 PKERL---SAAEVLSKFLIPKKTL 332 (350)
Q Consensus 312 p~~Rp---s~~~iL~~~~~~~~~~ 332 (350)
|++|| ++.|+|.|+||.+..|
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HHHccCCCcHHHHHcChHhhcCCC
Confidence 99999 5579999999988766
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=316.28 Aligned_cols=258 Identities=31% Similarity=0.497 Sum_probs=214.0
Q ss_pred eeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCCC
Q 018786 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (350)
Q Consensus 75 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~s 154 (350)
||+|+||+||++.+..+|+.||+|++.............+.+|++++++++ |+||+++++.+...+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 689999999999999999999999997644333344556788999999998 9999999999999999999999999999
Q ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccCCc
Q 018786 155 LFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232 (350)
Q Consensus 155 L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 232 (350)
|.+++...+ .+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.............+
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccC
Confidence 999987755 68999999999999999999999999999999999999 5667899999999877654444445567
Q ss_pred Ccccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 018786 233 SAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311 (350)
Q Consensus 233 t~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 311 (350)
+..|++||.+. +.++.++||||||+++|+|++|..||...........+............+.+++.+.++|.+||+.|
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 88999999875 44888999999999999999999999766542222222222222222223457899999999999999
Q ss_pred ccCCC-----CHHHHHhccCCCCCchhhHH
Q 018786 312 PKERL-----SAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 312 p~~Rp-----s~~~iL~~~~~~~~~~~~~~ 336 (350)
|++|| ++.+++.|+||....|....
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~ 266 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKDLNWRRLE 266 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhcCChhhhh
Confidence 99999 89999999999988776553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=308.80 Aligned_cols=252 Identities=25% Similarity=0.525 Sum_probs=212.7
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc-CCceEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-RHSVNLI 146 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~-~~~~~iv 146 (350)
+|++.+.||.|++|.||++.++.+++.+|+|.+..... .....+.+.+|++++++++ |+|++++++.+.. ...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEE
Confidence 48999999999999999999999999999999864332 3334567889999999998 9999999988764 4468999
Q ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 147 MDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
|||+++++|.+++... ..+++.+++.++.+++.||.+||++||+|+||+|+||++ +.++.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEeccc
Confidence 9999999999988763 458999999999999999999999999999999999999 56778999999998765432
Q ss_pred -CccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 225 -DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
.......+++.|+|||++. ..++.++||||||++++++++|..||...+.......+..+..... ...++.++.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM---PKDYSPELGE 232 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHHH
Confidence 2233456889999999875 4578899999999999999999999987776666555555443222 1357899999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCC
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
+|.+||+.||++||++.+++.|+||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=326.24 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=199.6
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
..+|.+.+.||+|+||.||+|.+..+++.||+|+.... ....|+.+++++. |+||+++++++......++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCeeEE
Confidence 35799999999999999999999999999999985322 2346899999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
|||++. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||.+......
T Consensus 135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccC
Confidence 999995 588888765 4669999999999999999999999999999999999999 56677999999999765444
Q ss_pred CccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCC-CCCCHH---------HHHHHHHcC-C---CCCC
Q 018786 225 DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPF-WGETEQ---------SIFDAILRG-H---IDFS 289 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf-~~~~~~---------~~~~~~~~~-~---~~~~ 289 (350)
.......||..|+|||++. ..++.++||||||+++|||+++..++ ...... ..+..+... . ..++
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 4444567999999999875 45899999999999999999865554 321110 111111110 0 0000
Q ss_pred C--------------------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 290 S--------------------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 290 ~--------------------------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
. ....+++.++.++|.+||+.||.+|||+.|+|+|+||.+
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0 001145677888999999999999999999999999975
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=314.69 Aligned_cols=252 Identities=31% Similarity=0.540 Sum_probs=217.8
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|.+.+.||.|+||.||+|.+..+++.||+|++...........+.+.+|+++++++. ||||+++++.+......++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEEEEE
Confidence 5899999999999999999999899999999997655444455678999999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCcc
Q 018786 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~ 227 (350)
||+.|++|.+++....++++..+..++.||+.||.|||++|++|+||+|+||++ ++++.++|+|||.+.........
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCccc
Confidence 999999999999887789999999999999999999999999999999999999 56677999999998876555444
Q ss_pred ccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 228 KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE---QSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 228 ~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
....|+..|+|||.+.. .++.++|+||||+++|+|++|..||..... ..............+ +.++.++.++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 232 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP----ATWSTEAIDA 232 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCc----ccCcHHHHHH
Confidence 55678889999998764 478999999999999999999999987763 333333222222222 3578999999
Q ss_pred HHHhcccCccCCCCH--HHHHhccCC
Q 018786 304 VKKMLHADPKERLSA--AEVLSKFLI 327 (350)
Q Consensus 304 i~~~L~~dp~~Rps~--~~iL~~~~~ 327 (350)
|.+||+.||.+||++ .|+++|+||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=309.28 Aligned_cols=253 Identities=25% Similarity=0.455 Sum_probs=217.0
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|.+.+.||+|++|.||++.+..+++.+|+|.+..... .......+.+|+++++++. |+|++++++.+...+..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEE
Confidence 58999999999999999999999999999999875443 3344678999999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||+++++|.+++... ..+++..+..++.+++.+|.+||++|++|+||+|+||+++. ++..++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK--HKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEccCCCceecCCCc
Confidence 999999999999764 34899999999999999999999999999999999999952 34568999999998776554
Q ss_pred ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
......++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+......... ..++.++.++|
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li 233 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS---DRYSPDLRQLI 233 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCC---CCcCHHHHHHH
Confidence 4455678899999998764 4788999999999999999999999887766666555544332211 24789999999
Q ss_pred HHhcccCccCCCCHHHHHhccCC
Q 018786 305 KKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.+||+.||++|||+.|+++|+|+
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=311.77 Aligned_cols=255 Identities=28% Similarity=0.464 Sum_probs=215.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||.|++|+||+|....++..+++|++...... .....+.+|+..++.+. |+|++++++.+...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEE
Confidence 4699999999999999999999888999999998654332 25578999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 147 MDLCAGGELFDRIIAK---GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
+|++++++|.+++... ..+++..++.++.||+.||.+||++||+|+||+|+||++ ++++.++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhcc
Confidence 9999999999998764 458999999999999999999999999999999999999 5567799999999876554
Q ss_pred CCcc-----ccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CC
Q 018786 224 GDVF-----KDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP--WP 294 (350)
Q Consensus 224 ~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~ 294 (350)
.... ....++..|++||.+.. .++.++|+||||+++|+|++|..||....................... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence 3221 33468889999998753 588999999999999999999999987776655555554433222211 23
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.++.++.+++.+||+.||++||++.+++.|+||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 678999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=316.05 Aligned_cols=265 Identities=23% Similarity=0.421 Sum_probs=223.5
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
+-|.++++||+|+||.||+|.++.+|+.+|+|.+... ...+++..|+.+++++. .+++|++|+.|.....+|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEee
Confidence 4588999999999999999999999999999988543 45688999999999999 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||||..|++.+.+.. ++++++.++..+++..++||+|||...=+|||||..|||+ +.+|..||+|||.|..+.+..
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhH
Confidence 999999999998875 5779999999999999999999999999999999999999 556779999999998876654
Q ss_pred c-cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 226 V-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 226 ~-~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
. .++..|||.|||||++.. .|+.++||||||++..||.-|++||..-.....+..+-...++ .......++.++.++
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPP-TF~KPE~WS~~F~DF 262 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPP-TFKKPEEWSSEFNDF 262 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCC-CCCChHhhhhHHHHH
Confidence 3 356789999999999875 5899999999999999999999999766543322222222111 111112467899999
Q ss_pred HHHhcccCccCCCCHHHHHhccCCCCCchhhHHHHhhH
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLIPKKTLQTLADLLYS 341 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~~~~~ 341 (350)
|+.||-++|++|-|+.++++|+|++...-=...++++.
T Consensus 263 i~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~ 300 (502)
T KOG0574|consen 263 IRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLMIQ 300 (502)
T ss_pred HHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHHHH
Confidence 99999999999999999999999998764444444433
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=314.10 Aligned_cols=263 Identities=29% Similarity=0.458 Sum_probs=219.2
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|++.+.||.|+||.||+|.+..+++.+++|++... .....+.+.+|+.+++++. |+||+++++.+...+.+++
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEEE
Confidence 36799999999999999999999999999999998643 3445677889999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||||+++++|..++.. ...+++..+..++.||+.+|.+||++|++||||||+||++ +.++.++|+|||.+......
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceecccc
Confidence 9999999999887754 4568999999999999999999999999999999999999 55677999999988764322
Q ss_pred -CccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 225 -DVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.......+++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+.....+.. .....++
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 242 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-SQPSKWS 242 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccC-CCCcccC
Confidence 1223456888999999873 2367899999999999999999999987765555555443322211 1123568
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHH
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~ 336 (350)
.++.++|.+||+.||++||++.++++|+|+....+....
T Consensus 243 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~ 281 (292)
T cd06644 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPL 281 (292)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchhH
Confidence 899999999999999999999999999999887665533
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=307.57 Aligned_cols=252 Identities=29% Similarity=0.507 Sum_probs=218.7
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|++.+.||.|+||.||.+++..+++.+++|.+..... .......+.+|+++++++. |+||+++++++.+.+..+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEEEEE
Confidence 58999999999999999999999999999999865432 3344567889999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||+++++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||++ ++++.+||+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEccccc
Confidence 999999999999765 458999999999999999999999999999999999999 556679999999987754333
Q ss_pred -ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 226 -VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
......+++.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+..+...... ..++.++.++
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELISL 232 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence 2344578999999998754 4788999999999999999999999888777777777665443322 4578999999
Q ss_pred HHHhcccCccCCCCHHHHHhccCC
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
|.+||..+|++||++.++|+++|+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=322.74 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=192.7
Q ss_pred eeeeeccCceEEEEEEEc--cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc--CCceEEEE
Q 018786 72 GRELGRGQFGVTYLVTHK--DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHSVNLIM 147 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~~~iv~ 147 (350)
+++||+|+||+||+|.++ .+++.+|+|.+.... ....+.+|+++++++. |+||+++++.+.. ...++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence 368999999999999976 367899999986432 1245778999999998 9999999998853 45688999
Q ss_pred ecCCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecC-CCCCCeEEeecCC
Q 018786 148 DLCAGGELFDRIIAK---------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS-AEDSPLKATDFGL 217 (350)
Q Consensus 148 e~~~~~sL~~~l~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~~~vkl~Dfg~ 217 (350)
||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +.++.+||+|||+
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 9995 5888877532 248999999999999999999999999999999999999643 3467899999999
Q ss_pred cccccCCC----ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHH
Q 018786 218 SVFFKPGD----VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQ---------SIFDAIL 282 (350)
Q Consensus 218 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~---------~~~~~~~ 282 (350)
+....... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98754321 2234678999999998753 4889999999999999999999999654321 1111111
Q ss_pred cCCCCC----------------------------------CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 283 RGHIDF----------------------------------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 283 ~~~~~~----------------------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
...... ........+.++.+||.+||+.||.+|||++|+|+|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 100000 000001235678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=312.37 Aligned_cols=258 Identities=22% Similarity=0.359 Sum_probs=212.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|++|.||+|.+..+++.+|+|++.... .......+.+|+++++++. |+||+++++.+...+..+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEEEE
Confidence 36888999999999999999999999999999986432 2334567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
|||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++...... .
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~ 149 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-I 149 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-c
Confidence 999999988543 357899999999999999999999999999999999999 56778999999999765433 2
Q ss_pred cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 227 FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETE-------QSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.....++..|+|||.+. ..++.++|+||||+++|+|++|..||..... ......+...... ......++.
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 227 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP--VLPVGQFSE 227 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC--CCCCCcCCH
Confidence 34567899999999876 4588999999999999999999999965321 1122222222211 111235788
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHH
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~ 337 (350)
++.++|.+||+.||++||++.++++|+|+.....+....
T Consensus 228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~~~ 266 (279)
T cd06619 228 KFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEV 266 (279)
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcCcccccccCccHHH
Confidence 999999999999999999999999999999887665544
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=310.63 Aligned_cols=253 Identities=32% Similarity=0.581 Sum_probs=216.9
Q ss_pred eeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCCC
Q 018786 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (350)
Q Consensus 75 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~s 154 (350)
||.|++|.||++.+..+++.+|+|++...........+.+.+|+.+++++. |+||+++++.+.++...++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 689999999999999889999999997655444455678999999999998 9999999999999999999999999999
Q ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccCCcCc
Q 018786 155 LFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA 234 (350)
Q Consensus 155 L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~ 234 (350)
|.+++.....+++..+..++.||+.||+|||++|++|+||+|+||++ +.++.++|+|||.+.............+++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCc
Confidence 99999888789999999999999999999999999999999999999 556789999999998776544334457889
Q ss_pred ccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 018786 235 YYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGET--EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311 (350)
Q Consensus 235 ~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 311 (350)
.|++||.+. ..++.++|+||||+++|++++|..||.... ..+....+.........+ ...+.++.++|.+||+.|
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHccCC
Confidence 999999875 458899999999999999999999998776 555555555322222211 134889999999999999
Q ss_pred ccCCCC-----HHHHHhccCCCCCchh
Q 018786 312 PKERLS-----AAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 312 p~~Rps-----~~~iL~~~~~~~~~~~ 333 (350)
|++||+ +.|+++|+||..-.|+
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 999999 9999999999987664
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=329.37 Aligned_cols=251 Identities=23% Similarity=0.374 Sum_probs=202.6
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
..+|.+.+.||+|+||.||++.+..+++.||||... ...+.+|+++++++. |+||+++++++..++..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEE
Confidence 468999999999999999999999999999999642 134568999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
|||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccc
Confidence 999995 5888888664 469999999999999999999999999999999999999 55677999999999765432
Q ss_pred Cc---cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCCCC-----
Q 018786 225 DV---FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE--------TEQSIFDAILRGHID----- 287 (350)
Q Consensus 225 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~--------~~~~~~~~~~~~~~~----- 287 (350)
.. .....||..|+|||++.+ .++.++|||||||++|||++|..++... ........+......
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 21 223569999999998764 5899999999999999999987655322 122233322221111
Q ss_pred ----------------------CCCCCC---CCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 288 ----------------------FSSDPW---PNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 288 ----------------------~~~~~~---~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.....| ..++.++.+||.+||+.||.+|||+.|+|+|+||..+
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~~ 461 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQSK 461 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCCC
Confidence 001111 1345689999999999999999999999999999763
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=314.90 Aligned_cols=258 Identities=27% Similarity=0.467 Sum_probs=215.4
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
...+|.+.+.||+|++|.||+|.+..+++.+++|.+..... ...+.+.+|+.+++.+. |+||+++++.+......+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDELW 93 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCEEE
Confidence 34789999999999999999999999999999999865432 23467889999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhcccc
Confidence 99999999999998764 468999999999999999999999999999999999999 56678999999998765433
Q ss_pred Cc-cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 225 DV-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 225 ~~-~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
.. .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.................. .......++..+.+
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 248 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD 248 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC-CCCCccccCHHHHH
Confidence 21 233468899999998764 4789999999999999999999999877654443333322211 11112357889999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
+|.+||..||++||++.++++|+|+....
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 99999999999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=327.30 Aligned_cols=261 Identities=34% Similarity=0.593 Sum_probs=239.0
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...+.|.+.+.||.|.|++|.+|.+..++..||+|++.+... +......+.+|+++++.+. |||||+++.+......+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLN-HPNIVKLFSVIETEATL 130 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcC-Ccceeeeeeeeeeccee
Confidence 345789999999999999999999999999999999988765 4444566999999999999 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
|+||||+.++.+++++.+++.+.+..++.++.|+..|++|||+++|||||||.+|||+ +.+..+||+|||++..+..
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeecc
Confidence 9999999999999999999999999999999999999999999999999999999999 6677799999999999998
Q ss_pred CCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
+....+++|++.|.|||++.+ ...+.+|+||+|+++|.|++|.+||.+..-.+.-...+.+.+..+.. ++.+..
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~----ms~dce 283 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY----MSCDCE 283 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce----eechhH
Confidence 888899999999999999875 36789999999999999999999999988877777777777776663 688999
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
++|+++|..+|.+|++.++++.|.|+....-.
T Consensus 284 ~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 284 DLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 99999999999999999999999999876544
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=313.25 Aligned_cols=257 Identities=32% Similarity=0.492 Sum_probs=218.0
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||.|++|.||++.+..+++.+|+|++... .....+.+.+|+++++++. |+||+++++.+......++|
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEEE
Confidence 5799999999999999999999888999999998643 3344567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||+++++|.+++... ..+++..++.++.|++.||.|||++||+|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhcccc
Confidence 9999999999988764 569999999999999999999999999999999999999 667789999999887643322
Q ss_pred -ccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 226 -VFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
......+++.|++||.+. ..++.++|+||||+++|+|++|..||...........+.....+... ....++.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD-QPSKWSS 236 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC-CcccCCH
Confidence 223456889999999863 23678999999999999999999999887766655555544332211 1235789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
++.++|.+||+.||++||++.++|+|+|+.+..
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 999999999999999999999999999998873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=312.16 Aligned_cols=262 Identities=27% Similarity=0.454 Sum_probs=218.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
+-|++.+.||.|+||.||+|.+..++..+++|.+... .....+.+.+|+++++.+. |+|++++++.+...+..++|
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEEE
Confidence 3478889999999999999999999999999998543 2344567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
+||+.+++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccccc
Confidence 999999999887765 4578999999999999999999999999999999999999 556779999999987643221
Q ss_pred -ccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 226 -VFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
......++..|+|||++. ..++.++||||||+++|+|++|..||......+....+......... ....++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC-CccccCH
Confidence 223456889999999873 23678999999999999999999999877766655555444332211 1235789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHH
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~ 336 (350)
++.++|.+||+.||++||++.++++|+|+....-....
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~ 274 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIR 274 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEeccCCCCHH
Confidence 99999999999999999999999999999977655433
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=317.30 Aligned_cols=254 Identities=26% Similarity=0.478 Sum_probs=205.8
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|.+.+.||.|++|.||+|.+..+|+.+|+|.+..... .......+.+|+.+++++. |+||+++++++.+.+..++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEE
Confidence 58899999999999999999999999999999875432 2223356788999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 148 DLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
||+.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC
Confidence 99964 88887765 5679999999999999999999999999999999999999 556779999999987654322
Q ss_pred ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--------------C-
Q 018786 226 VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHI--------------D- 287 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~-~~~~~~~~~~~~~~~--------------~- 287 (350)
......++..|+|||++.+ .++.++||||||+++|+|++|..|+.. ....+.+..+.+... .
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2234567889999998754 368899999999999999999888643 333333333221100 0
Q ss_pred --C---C-----CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 288 --F---S-----SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 288 --~---~-----~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
. . ....+.++.++.++|.+||+.||.+|||+.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0 01123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=313.74 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=211.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCC-----cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTK-----QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
++|++.+.||+|+||.||+|.+...+ ..+|+|.+.... .......+.+|+..+.++. |+||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence 57899999999999999999986554 679999886432 3344567899999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC
Q 018786 142 SVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 205 (350)
..+++|||+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||++ +
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence 999999999999999999764 457889999999999999999999999999999999999 5
Q ss_pred CCCCeEEeecCCcccccCCC---ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 018786 206 EDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDA 280 (350)
Q Consensus 206 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~ 280 (350)
+++.++|+|||++....... ......+++.|+|||.+. +.++.++||||||+++|||++ |..||.+....+....
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 56779999999987643222 123345678899999765 568999999999999999998 9999998888777777
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+........ ...++.++.+++.+||+.||++||++.++++++
T Consensus 239 i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 239 IRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred HHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 665543322 236799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=317.11 Aligned_cols=262 Identities=28% Similarity=0.459 Sum_probs=215.3
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccC--ChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
+|.+.+.||.|++|.||+|.+..+++.||+|.+...... .......+..|+++++++. |+||+++++++.+.+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence 488899999999999999999988999999999765432 1223456778999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||++ +.++.++|+|||++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCC
Confidence 99999 889999998766 79999999999999999999999999999999999999 55677999999999876443
Q ss_pred C-ccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------------
Q 018786 225 D-VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS------------ 289 (350)
Q Consensus 225 ~-~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 289 (350)
. ......++..|+|||.+. ..++.++||||||+++|+|++|..+|......+....+........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 2 223345678899999874 3478899999999999999999888877665554444332110000
Q ss_pred ------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 290 ------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 290 ------------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
...+...+.++.++|.+||+.||++|||+.|+|.|+||.+.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 001234578899999999999999999999999999999977654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=333.98 Aligned_cols=258 Identities=28% Similarity=0.471 Sum_probs=223.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
+-|.|+..||.|+||.||+|.++.++...|-|++.. ...+..+.+.-||++|..|. ||+||++++.|..++.+||+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCceEEE
Confidence 568899999999999999999999988888898843 35567788999999999999 99999999988888999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CC
Q 018786 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PG 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~ 224 (350)
.|+|.||-+...+.. ...+.+.++..+++|++.||.|||+++|||||||..|||+ .-+|.|+|+|||.+.... ..
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccchhHH
Confidence 999999988777665 4569999999999999999999999999999999999999 556669999999976643 22
Q ss_pred CccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 225 DVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
....+++|||+|||||+.. .+|++++||||||++|.||..+.+|.........+-.+.+..++....+ ..++.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP-S~Ws~ 263 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP-SHWSR 263 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc-chhhh
Confidence 3346789999999999752 4699999999999999999999999999988888877776655544332 35688
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.+.+++.+||.+||..||++.++|.|+|+....-
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 9999999999999999999999999999996643
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=327.28 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=203.3
Q ss_pred ccceeeeeeeeccCceEEEEEEE-----ccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTH-----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
.++|++.+.||+|+||.||+|.+ ..++..||||+++... .....+.+.+|+.++..+..||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 46899999999999999999974 3456789999986433 2234467889999999995599999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHcC---------------------------------------------------------
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKG--------------------------------------------------------- 163 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~--------------------------------------------------------- 163 (350)
+..++||||+++++|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886432
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 164 ------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 164 ------------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCcc
Confidence 36788899999999999999999999999999999999 456679999999998654332
Q ss_pred cc---ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCCCCHH
Q 018786 226 VF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSS 299 (350)
Q Consensus 226 ~~---~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.. ....++..|+|||++. ..++.++||||||+++|+|++ |..||....... ....+..+... .. ....+.+
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 345 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-LS--PECAPSE 345 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-CC--CCCCCHH
Confidence 11 1223456799999875 458999999999999999998 899997765433 33333333221 11 1245789
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+.++|.+||+.||++|||+.|+++.+
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~l 371 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQLI 371 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHH
Confidence 99999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=313.14 Aligned_cols=257 Identities=27% Similarity=0.474 Sum_probs=216.5
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
..+|++.+.||.|++|.||+|.+..+++.|++|.+.... ....+.+.+|+..++.+. |+|++++++++.....+++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELK-NPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcC-CCceeeeeeeEecCceEEE
Confidence 367999999999999999999999999999999986432 233467889999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|+||+.+++|.+++.. ..+++..+..++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhccccc
Confidence 9999999999987764 468999999999999999999999999999999999999 567789999999987654332
Q ss_pred c-cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 226 V-FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 226 ~-~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
. .....++..|+|||.+. ..++.++||||||+++|++++|..||...........+....... ......++..+.++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 248 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSPIFRDF 248 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc-cCCcccCCHHHHHH
Confidence 2 23346888999999876 458899999999999999999999998877655444443322211 11223678999999
Q ss_pred HHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
|.+||..||++||++.+++.|+|+....
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=309.13 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=210.7
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEeccccc---CChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL---INRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
+|++.+.||.|+||.||+|.+. +++.+|+|.+..... ........+.+|++.+++++ |+||+++++++.+.+..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence 4788999999999999999874 678899998864322 12233467899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC-
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP- 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~- 223 (350)
+++||+++++|.+++....++++..+..++.|++.||.|||+.+|+|+||+|+||++ +.++.++|+|||.+.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhhc
Confidence 999999999999999887889999999999999999999999999999999999999 5667899999999876421
Q ss_pred ------CCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 224 ------GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 224 ------~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
........++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+.......+ .....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 234 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RLPDSF 234 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC-CCCCCC
Confidence 111234568899999998764 478899999999999999999999987665444333333211111 122357
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
+.++.++|.+||+.+|++||++.++|.|+||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=307.28 Aligned_cols=254 Identities=30% Similarity=0.495 Sum_probs=214.9
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||.|++|.||+|.+..+++.+++|++.... ....+.+.+|+.++++++ |+||+++++.+..++.+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEEEE
Confidence 367999999999999999999999889999999996543 235578999999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+|||+.+++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||++ +.++.++|+|||.+......
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhh
Confidence 99999999999988775 789999999999999999999999999999999999999 56677999999998775433
Q ss_pred C-ccccCCcCcccccccccc-c---cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCCCH
Q 018786 225 D-VFKDLVGSAYYVAPEVLR-R---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS-DPWPNISS 298 (350)
Q Consensus 225 ~-~~~~~~gt~~y~aPE~~~-~---~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 298 (350)
. ......++..|+|||.+. . .++.++|+||||+++|+|++|..||...........+......... .....++.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence 2 223456788999999874 3 5788999999999999999999999887765555544444222111 11224578
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
++.++|.+||+.||.+|||+.+++.|+|
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 8999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=308.92 Aligned_cols=250 Identities=18% Similarity=0.320 Sum_probs=208.6
Q ss_pred ccceeeeeeeeccCceEEEEEEEc---cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
.++|++.+.||+|+||.||+|.++ ..+..||+|.++... .....+.+.+|+..+++++ |+||+++++++...+.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCC
Confidence 467999999999999999999875 346789999987532 2334467889999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.++||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||++ +.++.++++|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence 99999999999999988764 578999999999999999999999999999999999999 56778999999987654
Q ss_pred cCCCccc--cCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 222 KPGDVFK--DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 222 ~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
....... ...++..|+|||.+. ..++.++||||||+++|++++ |..||......+....+..+.... ....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 234 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP---APRNCP 234 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCC
Confidence 3222111 223457899999875 568999999999999999775 999999888877777666543221 224678
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
..+.+++.+||+.+|++||++.++++.
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~~ 261 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHSI 261 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHHH
Confidence 999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=312.95 Aligned_cols=255 Identities=29% Similarity=0.524 Sum_probs=212.5
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|++.+.||.|++|.||+|.+..+++.||+|++..... .......+.+|+.+++++. |+||+++++++......++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEe
Confidence 58999999999999999999998899999999875432 2233567899999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 148 DLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
||+ +++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||.+.......
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC
Confidence 999 9999998865 4568999999999999999999999999999999999999 556779999999988764432
Q ss_pred -ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------------
Q 018786 226 -VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID--------------- 287 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------------- 287 (350)
......++..|+|||.+.+ .++.++||||||+++|+|++|.++|........+..+......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 2334568899999998743 4688999999999999999998888777665554443321110
Q ss_pred ----CCC-------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCC
Q 018786 288 ----FSS-------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 288 ----~~~-------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
++. ...++.+.++.++|.+||+.||++|||+.++|.|+||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 000 11235678999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=311.98 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=203.4
Q ss_pred eeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHc--cCCCCeeEeEeEEEcCCceEEEEecCC
Q 018786 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL--TGHRNIVELKGAYEDRHSVNLIMDLCA 151 (350)
Q Consensus 74 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l--~~h~~iv~~~~~~~~~~~~~iv~e~~~ 151 (350)
.||+|+||.||++.+..+++.+|+|++...............+|..+++.+ ..|++|+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998755432222223344454444433 249999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccCC
Q 018786 152 GGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231 (350)
Q Consensus 152 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 231 (350)
+++|.+++..++.+++..+..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-ccCcC
Confidence 99999999888889999999999999999999999999999999999999 566789999999987654332 23456
Q ss_pred cCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 018786 232 GSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQ--SIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307 (350)
Q Consensus 232 gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 307 (350)
|+..|+|||.+. ..++.++|+||||+++|+|++|..||...... ....... ........+.++.++.++|.+|
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTVNVELPDSFSPELKSLLEGL 233 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---hcCCcCCccccCHHHHHHHHHH
Confidence 899999999874 34789999999999999999999999654321 1111111 1111122235789999999999
Q ss_pred cccCccCCC-----CHHHHHhccCCCCCchhh
Q 018786 308 LHADPKERL-----SAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 308 L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~ 334 (350)
|+.||++|+ ++.++++|+||.+..+..
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence 999999999 699999999999977554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=309.46 Aligned_cols=253 Identities=26% Similarity=0.493 Sum_probs=209.7
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||.||+|.+..+++.||||.+.............+.+|+.+++++. |+||+++++++...+..+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence 57999999999999999999999999999999887544445555667899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 147 MDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence 999999999888753 3448999999999999999999999999999999999999 556779999999988754
Q ss_pred CCCc-cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 223 PGDV-FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETE--QSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 223 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.... .....+++.|+|||.+. ..++.++|+||||+++|+|++|..||..... ......+.... .+......++.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE 235 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence 3321 23356888999999875 4588899999999999999999999965532 23333333322 22222235678
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+.++|.+||+.+|++||++.++++.+
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=306.91 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=213.2
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|++.+.||+|++|.||+|.+..+++.+++|.++..... ....+.+.+|+.+++++. |+||+++++.+...+.+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEE
Confidence 589999999999999999999988999999999765432 346678999999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc-
Q 018786 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV- 226 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~- 226 (350)
||+++++|.+++.....+++..+..++.+++.||.|||++||+|+||+|+||++ +.++.+||+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence 999999999999887778999999999999999999999999999999999999 5577899999999887643322
Q ss_pred ----cccCCcCccccccccccc-c---CCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCCCC
Q 018786 227 ----FKDLVGSAYYVAPEVLRR-N---YGAEADIWSAGVILYILLSGVPPFWGETEQS-IFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 227 ----~~~~~gt~~y~aPE~~~~-~---~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.....++..|++||.+.+ . .+.++||||||++++++++|..||....... ....+.. ......+....++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLS 234 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccC
Confidence 123467889999998753 2 6889999999999999999999997654322 2222222 2222222233568
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
..+.++|.+||+.||++||++.+++.|+|+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=309.43 Aligned_cols=256 Identities=27% Similarity=0.459 Sum_probs=212.5
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCC-------hhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-------RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
+|.+.+.||.|++|.||+|.+..+++.+|+|.++...... ....+.+.+|+.+++++. |+|++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence 5889999999999999999999889999999886422111 112356888999999998 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
+..++||||+.+++|.+++...+.+++..+..++.||+.||.+||++|++|+||+|+||++ +.++.++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecccccc
Confidence 9999999999999999999888889999999999999999999999999999999999999 5677899999999876
Q ss_pred ccCCC---ccccCCcCccccccccccc---cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCC
Q 018786 221 FKPGD---VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG--HIDFSSDP 292 (350)
Q Consensus 221 ~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~ 292 (350)
..... ......++..|+|||.+.. .++.++|+||||+++|++++|..||...........+... ....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 53221 1233467889999998753 3788999999999999999999999765554433333222 22233333
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.+.++.++.++|.+||+.||++|||+.++|+|+|+
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 45678999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=326.80 Aligned_cols=254 Identities=25% Similarity=0.387 Sum_probs=204.8
Q ss_pred ccccceeeeeeeeccCceEEEEEEEcc-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
...++|.+.+.||+|+||.||+|.+.. ++..||+|+++... .....+.+.+|+++++.+.+|+||+++++.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 335689999999999999999998643 34579999996543 23345678899999999955999999999999
Q ss_pred cCCceEEEEecCCCCCHHHHHHHc--------------------------------------------------------
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAK-------------------------------------------------------- 162 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~-------------------------------------------------------- 162 (350)
..+..++||||+.+++|.+++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999999999988542
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCcc-
Q 018786 163 --------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF- 227 (350)
Q Consensus 163 --------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~- 227 (350)
.++++..++.++.||+.||.|||++||+||||||+|||+ ++++.+||+|||++.........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCccee
Confidence 236788899999999999999999999999999999999 55677999999998765433211
Q ss_pred --ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 228 --KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 228 --~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
....++..|+|||++. ..++.++||||||+++|+|++ |..||...................... ..++.++.++
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l 347 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSI 347 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC--CCCCHHHHHH
Confidence 1223456799999865 568999999999999999997 999997765544444444333222221 2468999999
Q ss_pred HHHhcccCccCCCCHHHHHhc
Q 018786 304 VKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~ 324 (350)
|.+||+.||++|||+.++++.
T Consensus 348 i~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=314.53 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=202.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEcc----------------CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKD----------------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 129 (350)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++.++. |+|
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence 4789999999999999999998642 34579999986432 3344567899999999998 999
Q ss_pred eeEeEeEEEcCCceEEEEecCCCCCHHHHHHHc-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCE
Q 018786 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-------------------GHYSERAAANLCRQMVTVVHYCHSMGVM 190 (350)
Q Consensus 130 iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~-------------------~~~~~~~~~~i~~~i~~~l~~lH~~~iv 190 (350)
|+++++++...+..++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999999999999999999999999988653 1367788999999999999999999999
Q ss_pred eecCCCCceEeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh--
Q 018786 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-- 264 (350)
Q Consensus 191 H~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-- 264 (350)
||||||+|||+ +.++.+||+|||++........ .....++..|+|||++. +.++.++||||||+++|+|++
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999 5667799999999976543321 12334577899999865 568999999999999999986
Q ss_pred CCCCCCCCCHHHHHHHHHc----CCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 265 GVPPFWGETEQSIFDAILR----GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
+..||......+....... ..........+.++..+.+++.+||+.||++|||+.++.+.
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~ 301 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAF 301 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 6678877666555443321 11111111123578999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.86 Aligned_cols=252 Identities=27% Similarity=0.567 Sum_probs=216.4
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++++. |+||+++++++...+..++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEE
Confidence 58999999999999999999999999999999865432 2334567899999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 148 DLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||+.+++|.+.+.... .+++..+..++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcch
Confidence 9999999999887643 57899999999999999999999999999999999999 556679999999987754332
Q ss_pred c-cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 226 V-FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 226 ~-~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
. .....|++.|+|||.+. ...+.++|+||||++++++++|..||......+....+..+...... ..++.++.++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 232 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVS---SHYSYDLRNL 232 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCc---ccCCHHHHHH
Confidence 2 22345788899999875 45788999999999999999999999888777777666655543222 3578999999
Q ss_pred HHHhcccCccCCCCHHHHHhccCC
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
|.+||+.+|++||++.+++.|+||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=315.91 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=214.2
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC--Cce
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HSV 143 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~ 143 (350)
.++|++.+.||.|+||.||+|.++.+|+.||+|.++..... ......+.+|+.+++++. |+||+++++++... +.+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeE
Confidence 47799999999999999999999999999999998654321 122234668999999998 99999999988654 568
Q ss_pred EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||++ +.++.+||+|||.+....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecC
Confidence 999999965 88888875 4668999999999999999999999999999999999999 566789999999988765
Q ss_pred CCC-ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-----------
Q 018786 223 PGD-VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF----------- 288 (350)
Q Consensus 223 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------- 288 (350)
... ......++..|+|||.+.+ .++.++||||||+++|+|++|..||......+.+..+.......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 332 2233346788999998753 47899999999999999999999998888776666554421110
Q ss_pred --------CCCC-------CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 289 --------SSDP-------WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 289 --------~~~~-------~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
.... ....++++.++|.+||+.||++|||+.++|.|+||.+.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~ 300 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC 300 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCC
Confidence 0000 123578899999999999999999999999999999887653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=331.09 Aligned_cols=253 Identities=24% Similarity=0.457 Sum_probs=222.6
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEEEEeccccc-CChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc--eEEEE
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL-INRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS--VNLIM 147 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~--~~iv~ 147 (350)
..+.||+|+|-+||+|.|..+|..||--.++.+.. ......+++..|+.+|+.|. |+||+++++.|.+... +.+|+
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCceeeeee
Confidence 45789999999999999999999988666654433 23445689999999999999 9999999998876554 88999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|++..|+|..++++.++++.+.+..|++||++||.|||++. |+|||||.+||||+ +..|.|||+|.|+|.......
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhccc
Confidence 99999999999999999999999999999999999999986 99999999999997 667889999999999876554
Q ss_pred ccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
. ...+|||.|||||++...|+...||||||+.|+||.|+.+||..... ..+++++..+..+......+ .++++++|
T Consensus 201 a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~--dPevr~fI 277 (632)
T KOG0584|consen 201 A-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK--DPEVREFI 277 (632)
T ss_pred c-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC--CHHHHHHH
Confidence 4 44899999999999999999999999999999999999999987654 56677788877666555443 68999999
Q ss_pred HHhcccCccCCCCHHHHHhccCCCCC
Q 018786 305 KKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.+||.. .++|+|+.|+|.|+||...
T Consensus 278 ekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 278 EKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHhcC-chhccCHHHHhhChhhccc
Confidence 999988 9999999999999999886
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=311.70 Aligned_cols=255 Identities=26% Similarity=0.439 Sum_probs=209.8
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE-----
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE----- 138 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~----- 138 (350)
...+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++.+|+||+++++++.
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 34578999999999999999999999999999999985432 234568899999999966999999999874
Q ss_pred -cCCceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeec
Q 018786 139 -DRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (350)
Q Consensus 139 -~~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Df 215 (350)
....++++|||+.+++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+||++ ++++.++|+||
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~df 165 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDF 165 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeC
Confidence 346789999999999999988753 358899999999999999999999999999999999999 56677999999
Q ss_pred CCcccccCC-CccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Q 018786 216 GLSVFFKPG-DVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288 (350)
Q Consensus 216 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 288 (350)
|++...... .......|++.|+|||.+. ..++.++||||||+++|+|++|..||...........+.....
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-- 243 (282)
T cd06636 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP-- 243 (282)
T ss_pred cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--
Confidence 998765322 2234456899999999864 2477899999999999999999999977665444433332211
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 289 ~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.......++.++.++|.+||+.||.+||++.|+|.|+||
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 111223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=318.68 Aligned_cols=256 Identities=22% Similarity=0.310 Sum_probs=204.2
Q ss_pred eeeeeecc--CceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEe
Q 018786 71 FGRELGRG--QFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 71 ~~~~lg~G--~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
+++.||+| +|++||++.++.+|+.||+|.+..... .....+.+.+|+.+++.+. ||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEEEEe
Confidence 46789999 678999999999999999999865433 2334567888999999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 149 LCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 149 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
|+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||++ +.++.+++.||+.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhccccccc
Confidence 99999999988653 458999999999999999999999999999999999999 556679999998654322111
Q ss_pred -------ccccCCcCccccccccccc---cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------
Q 018786 226 -------VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS------ 289 (350)
Q Consensus 226 -------~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------ 289 (350)
......++..|+|||++.+ .++.++||||||+++|+|++|..||.................+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0112346778999998753 478999999999999999999999976554443333222211100
Q ss_pred ------------------------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 290 ------------------------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 290 ------------------------------------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
......+++++.++|.+||+.||++|||+.++|+|+||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 000113467899999999999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=307.28 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=208.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccC--ChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc--CCc
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--NRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHS 142 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~ 142 (350)
.+|.+.+.||+|+||.||+|.+..+++.+++|.+...... .......+.+|+.++++++ |+||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCE
Confidence 4789999999999999999999999999999998654321 2234567899999999998 9999999998765 467
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
.++++||+++++|.+++...+.+++..++.++.||+.||.|||+++|+|+||+|+||++ +.++.++|+|||++....
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccccc
Confidence 88999999999999999888889999999999999999999999999999999999999 556679999999987643
Q ss_pred CC----CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 223 PG----DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 223 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.. .......++..|+|||.+.+ .++.++||||||+++|+|++|+.||.................. ......++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN--PQLPSHIS 235 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC--CCCchhcC
Confidence 21 11223457889999998764 4889999999999999999999999876654444433322211 11112467
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCC
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
..+.++| +||..+|++||+++|++.|+||.
T Consensus 236 ~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 236 EHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 8889999 57778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=305.55 Aligned_cols=254 Identities=29% Similarity=0.470 Sum_probs=215.4
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEeccccc--CChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL--INRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
+|+..+.||+|++|.||+|.+..+++.|++|.+..... ...+..+.+.+|+.+++++. |+||+++++++.....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCeEEE
Confidence 47788999999999999999998899999999865432 22345578999999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
++||+++++|.+++...+.+++..++.++.||+.||.+||+.||+|+||+|+||++ +.++.+||+|||.+.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceeccccc
Confidence 99999999999999888889999999999999999999999999999999999999 567789999999988765444
Q ss_pred ccccCCcCccccccccccc-c-CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLRR-N-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~-~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
......++..|++||.+.. . ++.++|+||||+++|++++|..||...........+..... . ....+.++.++.++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~l 234 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-L-PPIPDHLSDEAKDF 234 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-C-CCcCCCcCHHHHHH
Confidence 3455678899999997653 3 78999999999999999999999977665444444333111 1 11123578999999
Q ss_pred HHHhcccCccCCCCHHHHHhccCC
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
+.+||+.+|++||++.++|.|+|+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=297.90 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=209.0
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE----
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE---- 138 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~---- 138 (350)
..-.++|++.+.||+|||+.||+++...+++.||+|.+... ..+..+...+|++..+++. |||+++++++..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEK 92 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhc
Confidence 34468999999999999999999999999999999999654 3466788999999999999 999999988653
Q ss_pred -cCCceEEEEecCCCCCHHHHHHHc---C-CCCHHHHHHHHHHHHHHHHHHHHcC--CEeecCCCCceEeecCCCCCCeE
Q 018786 139 -DRHSVNLIMDLCAGGELFDRIIAK---G-HYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLK 211 (350)
Q Consensus 139 -~~~~~~iv~e~~~~~sL~~~l~~~---~-~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~vk 211 (350)
.....|++++|...|+|.+.+... + .+++.+++.|+.+|++||++||+.. ++||||||.||++ .+.+.++
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl---s~~~~~v 169 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL---SDSGLPV 169 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe---cCCCceE
Confidence 334599999999999999988652 3 5899999999999999999999999 9999999999999 5567799
Q ss_pred EeecCCccccc----CCC------ccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-
Q 018786 212 ATDFGLSVFFK----PGD------VFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQS- 276 (350)
Q Consensus 212 l~Dfg~a~~~~----~~~------~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~- 276 (350)
|.|||.+.... ... .......|..|+|||.++ ...+.++|||||||++|+|+.|..||.......
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 99999987642 111 122345789999999885 247899999999999999999999995432211
Q ss_pred -HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 277 -IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 277 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..-++.++...++... .+++.+.++|+.||+.||.+||++.+++.+.
T Consensus 250 SlaLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~~ 297 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSKL 297 (302)
T ss_pred eEEEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 1122344455555544 3899999999999999999999999999764
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=309.00 Aligned_cols=255 Identities=23% Similarity=0.370 Sum_probs=211.6
Q ss_pred cccceeeeeeeeccCceEEEEEEEcc-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
..++|.+.+.||+|++|.||+|.+.. ++..|++|.+.... .......+.+|+.++++++ |+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFE 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcc
Confidence 35789999999999999999999987 67889999885332 2333456889999999998 9999999999998
Q ss_pred CCceEEEEecCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEE
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKG-------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl 212 (350)
.+..+++|||+.|++|.+++...+ .+++..+..++.||+.||.|||+++++|+||||+||+++.++.+..+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 899999999999999999997653 4889999999999999999999999999999999999976555567999
Q ss_pred eecCCcccccCCCcc---ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCC
Q 018786 213 TDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHID 287 (350)
Q Consensus 213 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 287 (350)
+|||.+......... .....+..|+|||++. ..++.++||||||+++|+|++ |..||......+....+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 999999875332211 1223356799999875 558999999999999999997 99999888777766665543222
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 288 FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.. ...++..+.+++.+||+.||++|||+.++++++
T Consensus 241 ~~---~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 241 DP---PKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred CC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 11 235789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=314.15 Aligned_cols=256 Identities=26% Similarity=0.472 Sum_probs=211.1
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|++|.||+|.++.+++.+|+|++..... .....+.+.+|+++++++. |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEEE
Confidence 469999999999999999999998899999999865433 2234567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
+||+++++|..+......+++..+..++.||+.||.|||+.||+|+||+|+||++ +.++.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence 9999998888777666679999999999999999999999999999999999999 567789999999987754332
Q ss_pred ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------
Q 018786 226 VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI----------------- 286 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~----------------- 286 (350)
......++..|+|||.+.+ .++.++||||||+++|+|++|..||......+....+.....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2234567889999998753 467899999999999999999999976665433322221000
Q ss_pred --CCCC--------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 287 --DFSS--------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 287 --~~~~--------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
..+. ..++.++..+.+++.+||+.||++||++.++++|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000 1134678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=305.97 Aligned_cols=252 Identities=29% Similarity=0.516 Sum_probs=215.5
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE--cCCceEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE--DRHSVNL 145 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~--~~~~~~i 145 (350)
+|.+.+.||.|++|.||++.+..+++.+|+|++..... .....+++.+|+++++++. |+||+++++++. .+...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEE
Confidence 58899999999999999999999999999999875443 3445577899999999998 999999999775 4456899
Q ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 146 IMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCH-----SMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH-----~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
+|||+++++|.+++.. ...+++..++.++.||+.||.+|| +.+++|+||+|+||++ +.++.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccc
Confidence 9999999999998865 356899999999999999999999 8999999999999999 556789999999
Q ss_pred CcccccCCCc-cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 217 LSVFFKPGDV-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 217 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.+........ .....+++.|+|||.+.+ .++.++|+||||+++++|++|..||...........+......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 232 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIP---Y 232 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCc---c
Confidence 9987654433 344578999999998764 4788999999999999999999999888766666666655443222 2
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.++..+.+++.+||+.+|++||++.++++|+|+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=313.66 Aligned_cols=260 Identities=25% Similarity=0.359 Sum_probs=214.0
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|+||.||++.+..+++.+|+|.+... ........+.+|+.+++++. |+||+++++.+...+..++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEEEE
Confidence 3688999999999999999999989999999988643 23344578899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 147 MDLCAGGELFDRIIAK---GHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
|||+++++|..++... ..+++..+..++.||+.||.|||+ .||+|+||||+||++ +.++.++|+|||.+....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCccccc
Confidence 9999999998888763 368999999999999999999997 599999999999999 556779999999987654
Q ss_pred CCCccccCCcCccccccccccc-------cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 223 PGDVFKDLVGSAYYVAPEVLRR-------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+............+.
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 155 ASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred CCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 322 234467889999998742 257899999999999999999999976554444333222111112222335
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
++.++.++|.+||+.+|++||++.+++.|+|+....-.
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 78999999999999999999999999999999776544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=305.64 Aligned_cols=255 Identities=28% Similarity=0.491 Sum_probs=209.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEeccccc--CChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc--CCc
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL--INRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHS 142 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~ 142 (350)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+.+|+.+++++. |+||+++++++.+ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence 579999999999999999999999999999998864321 12234567899999999998 9999999998765 356
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++++|||+++++|.+++...+.+++..+..++.|++.||.+||+++|+|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccccccc
Confidence 88999999999999999887789999999999999999999999999999999999999 566789999999987643
Q ss_pred CC----CccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 223 PG----DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 223 ~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.. .......++..|+|||++. ..++.++||||||+++|+|++|+.||.................. ......++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PVLPPHVS 235 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC--CCCchhhC
Confidence 21 1123346888999999875 45889999999999999999999999876555444443322211 11123567
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCC
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
..+.++|.+|+ .+|++||++.++++|+|+.
T Consensus 236 ~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 236 DHCRDFLKRIF-VEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence 88999999999 4999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=309.70 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=209.1
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||.||++.++.+|+.||+|++..... .....++..|+..+.+..+|+||+++++++...+..+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 468999999999999999999999999999999865432 222345666777655555599999999999999999999
Q ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 147 MDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
|||++ ++|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+||++ +.++.+||+|||++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeeccccccc
Confidence 99996 588777754 24589999999999999999999997 99999999999999 56778999999999876
Q ss_pred cCCCccccCCcCccccccccccc-----cCCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcC-CCCCCCCCCC
Q 018786 222 KPGDVFKDLVGSAYYVAPEVLRR-----NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRG-HIDFSSDPWP 294 (350)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Dv~slG~vl~~ll~g~~pf~~~~-~~~~~~~~~~~-~~~~~~~~~~ 294 (350)
..........++..|+|||.+.+ .++.++|+||||+++|+|++|..||.... ..+........ ....+. .
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~ 231 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA---E 231 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc---c
Confidence 54433344568889999998743 36789999999999999999999996532 22333333332 222221 2
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
.++.++.++|.+||..+|++||++.+++.|+||.+...+
T Consensus 232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 478999999999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=306.23 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=212.3
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||.|++|.||+|.+..+++.+++|.+.... ..+.+.+|+++++++. |+||+++++.+......+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcEEEE
Confidence 67999999999999999999999889999999986432 1578999999999997 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
+|++.+++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCc
Confidence 999999999999875 4568999999999999999999999999999999999999 556779999999988765443
Q ss_pred -ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 226 -VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
......++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+....... ......++.++.++
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEFNDF 232 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCC-CCchhhcCHHHHHH
Confidence 2234457889999998764 58889999999999999999999998766544443332221111 11122467899999
Q ss_pred HHHhcccCccCCCCHHHHHhccCC
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
|.+||+.||++|||+.|+|.|+||
T Consensus 233 i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=313.65 Aligned_cols=259 Identities=27% Similarity=0.456 Sum_probs=215.1
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
...+|++.+.||.|++|.||++.+..+++.||+|.+..... ...+.+.+|+.+++.+. |+||+++++.+...+..+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDELW 92 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCEEE
Confidence 34889999999999999999999998999999999865432 23466889999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+||||+++++|.+++.. ..+++..+..++.|++.+|.|||+.||+|+||||+|||+ +.++.++|+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEccCC
Confidence 99999999999998864 458999999999999999999999999999999999999 56778999999998765433
Q ss_pred Cc-cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 225 DV-FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 225 ~~-~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
.. .....+++.|++||.+. ..++.++|+||||+++|++++|..||...........+...... .......++..+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 247 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPERLSAVFRD 247 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC-CCCCccccCHHHHH
Confidence 22 23456888999999875 45889999999999999999999999776543333222222111 11112357889999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
+|.+||+.||++||++.+++.|+||.....
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 999999999999999999999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=309.93 Aligned_cols=258 Identities=25% Similarity=0.417 Sum_probs=209.2
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE---
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE--- 138 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~--- 138 (350)
.....++|.+.+.||+|+||.||++.+..+++.+|+|++.... .....+.+|+.+++++.+|+||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3456689999999999999999999999999999999875422 123567889999999956999999999873
Q ss_pred --cCCceEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEE
Q 018786 139 --DRHSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212 (350)
Q Consensus 139 --~~~~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl 212 (350)
.++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++|+||||||+||++ +.++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCEEE
Confidence 45678999999999999987753 3468899999999999999999999999999999999999 55667999
Q ss_pred eecCCcccccCCC-ccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Q 018786 213 TDFGLSVFFKPGD-VFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285 (350)
Q Consensus 213 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~ 285 (350)
+|||++....... ......|+..|+|||.+. ..++.++||||||+++|+|++|..||................
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 9999987654332 223456899999999874 237889999999999999999999998766544443332221
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
... ......++.++.++|.+||+.||++|||+.|+++|+||
T Consensus 246 ~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 PPT-LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCc-ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 111 11112357899999999999999999999999999996
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=314.48 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=204.8
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcE--EEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQ--FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
++|.+.+.||+|+||.||+|.++.++.. +++|.++. .........+.+|+.++.++.+|+||+++++++...+.++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 6899999999999999999999877754 46666542 2233445678899999999955999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCC
Q 018786 145 LIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~ 208 (350)
+||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||++ +.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCC
Confidence 9999999999999987542 47899999999999999999999999999999999999 5667
Q ss_pred CeEEeecCCcccccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Q 018786 209 PLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286 (350)
Q Consensus 209 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 286 (350)
.+||+|||++.............++..|+|||.+.+ .++.++||||||+++|+|++ |..||......+....+.....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 241 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc
Confidence 799999999864322111122234567999998754 47899999999999999998 9999987776666655544321
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
. .....++.++.++|.+||+.+|++||++.++|..+.
T Consensus 242 ~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 242 L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1 111246889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=311.34 Aligned_cols=259 Identities=27% Similarity=0.477 Sum_probs=216.1
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
...+|.+.+.||+|++|.||+|.+..+++.||+|++.............+.+|+.+++.+. |+||+++++++...+..+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHTAW 91 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCeEE
Confidence 3467999999999999999999999889999999986554444445567899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 145 LIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
+|+||+.| ++.+.+.. ...+++..+..++.||+.||.|||++||+|+||+|+||++ +.++.++|+|||++.....
T Consensus 92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecCC
Confidence 99999964 77776654 4568999999999999999999999999999999999999 6677899999999876543
Q ss_pred CCccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
. ....++..|+|||++. +.++.++||||||+++|+|++|..||...........+........ ....++..
T Consensus 168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 242 (307)
T cd06607 168 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL--SSNDWSDY 242 (307)
T ss_pred C---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--CchhhCHH
Confidence 3 3456788999999863 3478899999999999999999999987766554444433222111 11246789
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
+.++|.+||+.||++||++.+++.|+|+......
T Consensus 243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 276 (307)
T cd06607 243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPP 276 (307)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcccCCc
Confidence 9999999999999999999999999999887643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=311.36 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=207.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc----
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS---- 142 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~---- 142 (350)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++..|+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 469999999999999999999999999999999865432 222345688899999999867999999998876655
Q ss_pred -eEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 143 -VNLIMDLCAGGELFDRIIAK-----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 143 -~~iv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
.+++|||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||+|+||+++. .++.+||+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~--~~~~~kl~dfg 156 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK--QKGLLKIADLG 156 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec--CCCeEEEeecc
Confidence 8999999976 888887642 35799999999999999999999999999999999999952 26779999999
Q ss_pred CcccccCC-CccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----
Q 018786 217 LSVFFKPG-DVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS---- 289 (350)
Q Consensus 217 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---- 289 (350)
.+...... .......+++.|+|||.+. ..++.++|+||||+++|+|++|..||.+....+....+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98765322 1223345688899999764 3478999999999999999999999987766554443322110000
Q ss_pred --------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCC
Q 018786 290 --------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 290 --------------------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
....+.++.++.++|.+||+.||.+||++.|+|.|+||.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 011235788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=308.50 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=211.2
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC---
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 140 (350)
...++|.+.+.||+|+||.||++.+..+++.+|+|++.... .....+.+|+.+++++.+|+|++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 34688999999999999999999999999999999986432 22356788999999995699999999987643
Q ss_pred --CceEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEee
Q 018786 141 --HSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 141 --~~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
+..++||||+++++|.++++. ...+++..++.++.|++.||++||++||+|+||||+||++ +.++.++|+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEee
Confidence 468999999999999988753 4568999999999999999999999999999999999999 5567799999
Q ss_pred cCCcccccCCC-ccccCCcCccccccccccc------cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Q 018786 215 FGLSVFFKPGD-VFKDLVGSAYYVAPEVLRR------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID 287 (350)
Q Consensus 215 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 287 (350)
||++....... ......|+..|+|||.+.. .++.++||||||+++|+|++|+.||...........+......
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 251 (291)
T cd06639 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP 251 (291)
T ss_pred cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence 99988754332 2234468889999998742 2578999999999999999999999877665555554443222
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCC
Q 018786 288 FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
... ....++..+.++|.+||+.||++||++.++++|+||+
T Consensus 252 ~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 TLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 111 1124678899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=308.88 Aligned_cols=257 Identities=26% Similarity=0.457 Sum_probs=217.0
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
..|+..+.||.|+||.||+|.+..++..+|+|++.... .......+.+|+.+++++. |+||+++++.+.+....++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEEE
Confidence 56888899999999999999999889999999986432 2344577899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
|||+++++|.+++.. +++++..+..++.|++.||.+||+++++|+||+|+||++ +.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCcc
Confidence 999999999998764 568999999999999999999999999999999999999 5567799999999877543332
Q ss_pred -cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 227 -FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 227 -~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
.....++..|+|||.+. ..++.++|+||||+++|+|++|..||...........+.....+ .....++..+.++|
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li 233 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP---TLTGEFSKPFKEFI 233 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC---CCchhhhHHHHHHH
Confidence 23346788899999875 45889999999999999999999999877665554444332221 12234678999999
Q ss_pred HHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 305 KKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
.+||+.+|++||++.+++.|+|+.....+
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 234 DACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred HHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 99999999999999999999999988764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=309.25 Aligned_cols=258 Identities=26% Similarity=0.475 Sum_probs=210.5
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCC---hhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN---RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
+|+..+.||+|++|.||++.+..+++.+|+|++....... ....+.+.+|+..+++++ |+||+++++++.+.+.++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEE
Confidence 4788899999999999999999999999999986433211 223567899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+|+||+++++|.+++...+.+++..+..++.||+.||.+||++|++|+||+|+||+++. .+..++|+|||.+......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEcccccccccccc
Confidence 99999999999999988888999999999999999999999999999999999999942 2335999999998775432
Q ss_pred C-----ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCCCC
Q 018786 225 D-----VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH-IDFSSDPWPNIS 297 (350)
Q Consensus 225 ~-----~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 297 (350)
. ......++..|+|||.+. ..++.++|+||||++++++++|..||...........+.... ........+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1 112346788999999875 457899999999999999999999996544322222221110 111111223578
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCC
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
.++.+++.+||+.||++||++.+++.|+||.
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=311.75 Aligned_cols=266 Identities=26% Similarity=0.397 Sum_probs=217.3
Q ss_pred CCcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCC-----CCeeEe
Q 018786 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-----RNIVEL 133 (350)
Q Consensus 59 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-----~~iv~~ 133 (350)
....+.+.++|.+++.+|+|.||.|..+.+..++..||||+++.-.. -.+..+-|+++++++..+ --++++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 34557778999999999999999999999999999999999974332 235567799999999522 247888
Q ss_pred EeEEEcCCceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC------
Q 018786 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA------ 205 (350)
Q Consensus 134 ~~~~~~~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~------ 205 (350)
.+||+..++++||+|.+ |.|+.+++.++ .+++..+++.+++||++++.+||+.+++|.||||+||++..++
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 89999999999999998 88999999875 4589999999999999999999999999999999999986321
Q ss_pred -----------CCCCeEEeecCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 018786 206 -----------EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGET 273 (350)
Q Consensus 206 -----------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~ 273 (350)
++..|+|+|||.|..... .....+.|..|+|||++. -.|+.++||||+||+|+|+++|...|...+
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 245699999999987433 336778899999999865 589999999999999999999999998888
Q ss_pred HHHHHHHHHcCCCCCCCC----------------CCCC--------------------------CCHHHHHHHHHhcccC
Q 018786 274 EQSIFDAILRGHIDFSSD----------------PWPN--------------------------ISSSAKDIVKKMLHAD 311 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~----------------~~~~--------------------------~~~~l~~li~~~L~~d 311 (350)
+.+.+..+.+-..++|.. .|++ .-.++.+||++||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 776554443322222110 0110 1245789999999999
Q ss_pred ccCCCCHHHHHhccCCCCCc
Q 018786 312 PKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 312 p~~Rps~~~iL~~~~~~~~~ 331 (350)
|.+|+|+.|+|.|+||....
T Consensus 394 P~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 394 PARRITLREALSHPFFARLT 413 (415)
T ss_pred ccccccHHHHhcCHHhhcCC
Confidence 99999999999999998753
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=309.52 Aligned_cols=252 Identities=28% Similarity=0.467 Sum_probs=205.7
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC--CceEEE
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HSVNLI 146 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~~iv 146 (350)
|++.+.||+|+||.||+|.+..+++.+|+|.++.... .. ......+|+..+.++.+|+|++++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999999865422 21 2233457888899887799999999999877 889999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||+.+ +|.+.+... ..+++..++.++.||+.||.|||++|++||||+|+||+++ . +.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCC
Confidence 999965 888877763 5689999999999999999999999999999999999994 4 789999999998765554
Q ss_pred ccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------------
Q 018786 226 VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH------------------ 285 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~------------------ 285 (350)
......++..|+|||.+. +.++.++||||||+++|+|++|..||...+..+....+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 445566889999999753 347889999999999999999999998776554443332211
Q ss_pred CCCCCC-------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 286 IDFSSD-------PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 286 ~~~~~~-------~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
..++.. ..+.++.++.++|.+||+.||++||++.+++.|+||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 011100 012568999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=318.32 Aligned_cols=268 Identities=28% Similarity=0.471 Sum_probs=234.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...+.|+....||+||||.||-++.+.+|+.||+|.+.+.............+|-.+|+++. .+.||.+-..|+..+.+
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDAL 260 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCce
Confidence 34578888999999999999999999999999999987654444444556788999999998 89999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 144 NLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
++|+..|+||+|.-++.+.+ .|++..++-++.+|+.||++||+.+||.||+||+|||+ |+.|+|+|+|.|+|..+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEec
Confidence 99999999999988887755 69999999999999999999999999999999999999 88899999999999999
Q ss_pred cCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCCCCCCCCC
Q 018786 222 KPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIF----DAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 296 (350)
..+......+||..|||||++++ .|+...|.|||||++|||+.|+.||....+..-. ..+......++ .++
T Consensus 338 ~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~----~kF 413 (591)
T KOG0986|consen 338 PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS----DKF 413 (591)
T ss_pred CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----ccc
Confidence 99988888899999999999874 5999999999999999999999999766554333 33444444444 478
Q ss_pred CHHHHHHHHHhcccCccCCCC-----HHHHHhccCCCCCchhhHHHHh
Q 018786 297 SSSAKDIVKKMLHADPKERLS-----AAEVLSKFLIPKKTLQTLADLL 339 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~~~~ 339 (350)
+++++++.+.+|++||++|.. +.++-+|+||....|+.++--+
T Consensus 414 S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagm 461 (591)
T KOG0986|consen 414 SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGM 461 (591)
T ss_pred CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccC
Confidence 999999999999999999984 5699999999999999887543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=349.41 Aligned_cols=267 Identities=29% Similarity=0.505 Sum_probs=235.2
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|.|++.||+|+||.|.+++++.+++.||+|++.+..........-|+.|-.+|.... .+=|++++-.|.++.++
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYL 150 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccce
Confidence 34589999999999999999999999999999999998755544555567888888887766 88899999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK- 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~- 222 (350)
|+||||++||+|..++-+..+++++.++.++..|+-||+.||+.|+|||||||+|||+ |..|++||+|||.+..+.
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCC
Confidence 9999999999999999888899999999999999999999999999999999999999 788899999999998876
Q ss_pred CCC-ccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCC
Q 018786 223 PGD-VFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG--HIDFSSDPW 293 (350)
Q Consensus 223 ~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~ 293 (350)
++. .....+|||.|.+||++. +.|++.+|.||+|+++|||+.|..||+...--+.+-+|.+. .+.+| .-
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~ 305 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DE 305 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--cc
Confidence 333 234568999999999873 35899999999999999999999999999988889888876 55555 23
Q ss_pred CCCCHHHHHHHHHhcccCccCCCC---HHHHHhccCCCCCchhhHHH
Q 018786 294 PNISSSAKDIVKKMLHADPKERLS---AAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps---~~~iL~~~~~~~~~~~~~~~ 337 (350)
..+|.++++||++.+ -+|+.|.. +.++-.|+||.+..|.++-+
T Consensus 306 ~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~ 351 (1317)
T KOG0612|consen 306 TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRE 351 (1317)
T ss_pred cccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhh
Confidence 369999999999988 68899998 99999999999999965543
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=331.92 Aligned_cols=267 Identities=21% Similarity=0.287 Sum_probs=197.5
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCC-cEEEEE--------------EecccccCChhhHHHHHHHHHHHHHccCC
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTK-QQFACK--------------SISSRKLINRDDVEDVRREVQIMHHLTGH 127 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~avK--------------~~~~~~~~~~~~~~~~~~e~~~l~~l~~h 127 (350)
..+.++|++++.||+|+||+||++..+... ...+.| .+.+...........+.+|+.+++++. |
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-H 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-C
Confidence 445688999999999999999998765322 112222 111111112234456889999999998 9
Q ss_pred CCeeEeEeEEEcCCceEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEee
Q 018786 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFS 202 (350)
Q Consensus 128 ~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~ 202 (350)
+||+++++++...+..+++++++. ++|.+++... .......++.++.||+.||.|||++||+||||||+|||+
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl- 300 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL- 300 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-
Confidence 999999999999999999999984 5777776542 234467788999999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCcccccCCCc--cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCC-CCC--CHHH
Q 018786 203 SSAEDSPLKATDFGLSVFFKPGDV--FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPF-WGE--TEQS 276 (350)
Q Consensus 203 ~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf-~~~--~~~~ 276 (350)
+.++.+||+|||++..+..... .....||..|+|||++.+ .++.++|||||||++|||++|..++ ... ....
T Consensus 301 --~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 301 --NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred --CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 5667799999999987654322 234679999999998764 5899999999999999999987644 322 1222
Q ss_pred HHHHHHcCCC----CCCC------------------CC------CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCC
Q 018786 277 IFDAILRGHI----DFSS------------------DP------WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 277 ~~~~~~~~~~----~~~~------------------~~------~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
.+..+..... .++. .. ...++.++.++|.+||+.||.+|||+.|+|+|+||.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~ 458 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS 458 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence 2222111100 0000 00 013567788899999999999999999999999998
Q ss_pred CCchhh
Q 018786 329 KKTLQT 334 (350)
Q Consensus 329 ~~~~~~ 334 (350)
....+.
T Consensus 459 ~~~~~~ 464 (501)
T PHA03210 459 AEEEEE 464 (501)
T ss_pred cCCchH
Confidence 875443
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=303.11 Aligned_cols=249 Identities=30% Similarity=0.536 Sum_probs=212.9
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|.+.+.||.|+||.||++.+..+++.+|+|.+.... .....+.+.+|+.+++++. |+||+++++.+...+.++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence 5889999999999999999999999999999986433 2334567889999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||+++++|.+++... ..+++..+..++.||+.||.+||++||+|+||||+||++ +.++.++|+|||.+.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccc
Confidence 999999999988653 358999999999999999999999999999999999999 567779999999987654332
Q ss_pred -ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 226 -VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
......+++.|+|||++.+ .++.++|+||||+++|+|++|..||...........+..+...... ..++..+.++
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 231 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYELRSL 231 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHHHHH
Confidence 2234568899999998764 5889999999999999999999999887776666666555443222 2578899999
Q ss_pred HHHhcccCccCCCCHHHHHhcc
Q 018786 304 VKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~ 325 (350)
|.+||+.||++|||+.+++..-
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhcc
Confidence 9999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=340.81 Aligned_cols=252 Identities=28% Similarity=0.365 Sum_probs=204.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||.||+|.+..+++.||+|++...........+++.+|+++++++. ||||+++++++.+.+..+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence 57999999999999999999999999999999997544334445578999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeec
Q 018786 147 MDLCAGGELFDRIIAK-----------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Df 215 (350)
|||++|++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++ +.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence 9999999999988641 234567788999999999999999999999999999999 66677999999
Q ss_pred CCcccccCCC-------------------ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 018786 216 GLSVFFKPGD-------------------VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQ 275 (350)
Q Consensus 216 g~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~ 275 (350)
|++....... .....+||+.|+|||++. ..++.++||||||+++|+|++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9997652110 112246999999999875 45899999999999999999999999875544
Q ss_pred HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
......... .+........+++.+.+++.+||+.||++|++..+.|.
T Consensus 238 ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 238 KISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 333221111 11111223467899999999999999999987766554
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=311.67 Aligned_cols=265 Identities=22% Similarity=0.298 Sum_probs=212.8
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
.+|...+.||+|+||.||++.+..+++.+|+|.+..... ......+.+|+..+.++.+|+||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 456777899999999999999999999999999875432 234567889999999997799999999999988999999
Q ss_pred EecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 147 MDLCAGGELFDRII-----AKGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 147 ~e~~~~~sL~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
||++. .++.++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.++|+|||++..
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQ 157 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHH
Confidence 99985 46555432 235699999999999999999999975 99999999999999 5567799999999977
Q ss_pred ccCCCccccCCcCccccccccccc----cCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCC-CCCCCCCCC
Q 018786 221 FKPGDVFKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGH-IDFSSDPWP 294 (350)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~-~~~~~~~~~ 294 (350)
...........|+..|+|||++.+ .++.++||||||+++|+|++|..||..... .+....+.... .........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 654444444568899999998753 478999999999999999999999976542 12222222221 122222223
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHH
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~ 337 (350)
.++.++.+||.+||+.||++|||+.+++.|+||.+..+++...
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~~~~ 280 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDV 280 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcchhH
Confidence 5789999999999999999999999999999999877766554
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=308.95 Aligned_cols=255 Identities=29% Similarity=0.421 Sum_probs=213.1
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||.|++|.||++.++.+++.+|+|.+.... ......++.+|+++++++. |+||+++++.+...+..+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEE
Confidence 36888899999999999999999999999999987543 2244567899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+|++.+++|.+++... ..+++..+..++.|++.+|.+||+ .|++|+||+|+||++ +.++.++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHH
Confidence 9999999999999876 789999999999999999999999 999999999999999 55777999999998765433
Q ss_pred CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET-----EQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
... ...++..|+|||.+.+ .++.++||||||+++|+|++|..||.... ..+....+......... ...++.
T Consensus 155 ~~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 231 (265)
T cd06605 155 LAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP--SGKFSP 231 (265)
T ss_pred Hhh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC--hhhcCH
Confidence 222 2678889999998754 58899999999999999999999996542 22333333333221111 112788
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
++.++|.+||..||++|||+.+++.|+||++.
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 99999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=307.15 Aligned_cols=257 Identities=30% Similarity=0.502 Sum_probs=214.1
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc--CCCCeeEeEeEEEcCCceEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~~~~~~~i 145 (350)
.|++.+.||.|+||.||+|.+..+++.+|+|.+.... .....+.+.+|+.+++++. .|+|++++++.+..+...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5788899999999999999999999999999986432 2334567889999999986 59999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
+|||+++++|.+++.. +.+++..++.++.|++.||.+||+.||+|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCc
Confidence 9999999999988765 478999999999999999999999999999999999999 557789999999988765433
Q ss_pred -ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 226 -VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
......|+..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+..... +......++.++.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP--PRLEDNGYSKLLRE 233 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCC--CCCCcccCCHHHHH
Confidence 2234568889999998753 368899999999999999999999987665444433322211 11111237889999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
++.+||+.||++||++.+++.++|+.....
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 999999999999999999999999987663
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=312.46 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=209.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC--CceE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HSVN 144 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~~ 144 (350)
++|.+.+.||.|++|.||+|.+..+++.+++|.++..... ......+.+|+.+++++. |+||+++++++... ...+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence 5799999999999999999999999999999999754332 223345778999999998 99999999988777 8999
Q ss_pred EEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 145 LIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
+|+||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence 99999965 9988887644 58999999999999999999999999999999999999 5667799999999887654
Q ss_pred C-CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 018786 224 G-DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID------------- 287 (350)
Q Consensus 224 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------- 287 (350)
. .......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||......+....+......
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 3 23344567889999998753 3688999999999999999999999877665554443221100
Q ss_pred -------------CCCCCCCC--CCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 288 -------------FSSDPWPN--ISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 288 -------------~~~~~~~~--~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.....++. ++..+.++|.+||+.||++|||+.|+|.|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00111222 47889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=331.21 Aligned_cols=251 Identities=27% Similarity=0.473 Sum_probs=213.6
Q ss_pred eeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCC
Q 018786 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGG 153 (350)
Q Consensus 74 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 153 (350)
.||+|.||+||.|++..+...+|||.+... +....+-+..||...++|+ |.|||+++|.+..++++-|.||..+||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 589999999999999999999999998543 3344567899999999999 999999999999999999999999999
Q ss_pred CHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-cccc
Q 018786 154 ELFDRIIAK-GHY--SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-VFKD 229 (350)
Q Consensus 154 sL~~~l~~~-~~~--~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~ 229 (350)
+|.+++... +++ .+.++..+.+||++||.|||++.|||||||-+|||++ .-.|.+||+|||.++....-. ...+
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccc
Confidence 999999875 566 7889999999999999999999999999999999997 457889999999998865433 3456
Q ss_pred CCcCcccccccccc---ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 018786 230 LVGSAYYVAPEVLR---RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306 (350)
Q Consensus 230 ~~gt~~y~aPE~~~---~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 306 (350)
..||..|||||++. ..|+.++|||||||++.||.||++||...... +......+.+..-++....++.+.+.+|.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-qAAMFkVGmyKvHP~iPeelsaeak~Filr 814 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-QAAMFKVGMYKVHPPIPEELSAEAKNFILR 814 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-hHhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence 78999999999985 24999999999999999999999999766542 222333333333333333578899999999
Q ss_pred hcccCccCCCCHHHHHhccCCCCCc
Q 018786 307 MLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 307 ~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
|+.+||.+||++.++|..+|++...
T Consensus 815 cFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HcCCCcccCccHHHhccCcccccCC
Confidence 9999999999999999999998774
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=309.86 Aligned_cols=254 Identities=33% Similarity=0.669 Sum_probs=220.8
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||.|++|.||++.+..+++.||+|++..+........+.+.+|+.+++++.+|+||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999997655444455577889999999997799999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
||++++++|.+++...+.+++..++.++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCccc
Confidence 9999999999999988889999999999999999999999999999999999999 5677899999999876543221
Q ss_pred ---------------------cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 018786 227 ---------------------FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG 284 (350)
Q Consensus 227 ---------------------~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~ 284 (350)
.....++..|++||.+. ...+.++|+||||++++++++|..||........+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 12345788999999865 45788999999999999999999999888776666666654
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCH----HHHHhccCC
Q 018786 285 HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSA----AEVLSKFLI 327 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~----~~iL~~~~~ 327 (350)
....+. .+++.+.++|.+||+.||++||++ .++++|+||
T Consensus 238 ~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 444443 568999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=306.43 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=210.7
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC---
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH--- 141 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~--- 141 (350)
..++|.+.+.||.|++|.||+|.++.+++.+++|++..... ..+.+.+|+.+++++.+|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 35889999999999999999999998899999999865432 34678999999999966999999999986544
Q ss_pred ---ceEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEee
Q 018786 142 ---SVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 142 ---~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
.+++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECC
Confidence 58999999999999998865 3578999999999999999999999999999999999999 5567799999
Q ss_pred cCCcccccCCC-ccccCCcCccccccccccc------cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Q 018786 215 FGLSVFFKPGD-VFKDLVGSAYYVAPEVLRR------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID 287 (350)
Q Consensus 215 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 287 (350)
||.+....... ......++..|+|||.+.. .++.++||||||+++|+|++|..||...........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 99987654322 2234568899999998642 3678899999999999999999999866555555444443222
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 288 FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
... ....++.++.++|.+||..||++|||+.++++|+|+
T Consensus 237 ~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 TLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 111 112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=306.26 Aligned_cols=254 Identities=22% Similarity=0.385 Sum_probs=208.2
Q ss_pred cccccceeeeeeeeccCceEEEEEEEcc-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
+...++|++.+.||+|++|.||+|.++. ++..+|+|.+.... .......+.+|+.+++.+. |+||+++++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~ 78 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVV 78 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEE
Confidence 3456889999999999999999998752 35679999885432 2233456889999999998 99999999999
Q ss_pred EcCCceEEEEecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCC
Q 018786 138 EDRHSVNLIMDLCAGGELFDRIIAKG----------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (350)
Q Consensus 138 ~~~~~~~iv~e~~~~~sL~~~l~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 207 (350)
..+...++||||+++++|.+++.... .++...+..++.|++.||.|||++|++|+||||+||++ +.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~ 155 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AED 155 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCC
Confidence 99999999999999999999886532 25678899999999999999999999999999999999 567
Q ss_pred CCeEEeecCCcccccCCCcc---ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 018786 208 SPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAIL 282 (350)
Q Consensus 208 ~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~ 282 (350)
+.++|+|||++......... ....++..|+|||.+. +.++.++||||||+++|+|++ |..||......+....+.
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 78999999998764332211 1234567899999876 458999999999999999998 789998887777766665
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
........ ..++..+.+++.+||+.||++|||+.|+++.+
T Consensus 236 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 236 EGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred cCCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 54432221 25788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=325.23 Aligned_cols=243 Identities=26% Similarity=0.433 Sum_probs=213.7
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCC
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCA 151 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~ 151 (350)
++-||.|+.|.||+|+.++ +.||||.++ +.-..+|+-|++|+ |+||+.+.++|.....++||||||.
T Consensus 129 LeWlGSGaQGAVF~Grl~n--etVAVKKV~----------elkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHN--ETVAVKKVR----------ELKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeeeccC--ceehhHHHh----------hhhhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccc
Confidence 4679999999999999875 789999874 22346889999999 9999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccCC
Q 018786 152 GGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231 (350)
Q Consensus 152 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 231 (350)
.|.|...|+....+....+..|..+|+.|+.|||.+.|||||||.-||||. .+..|||+|||.++...+....-.+.
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999995 45569999999999887766666788
Q ss_pred cCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
||..|||||++++ +.+.|+||||||+|||||+||..||...+...++.-+-.+...++-+ ..+|+.++-||++||+-
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP--stcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP--STCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc--ccCchHHHHHHHHHHhc
Confidence 9999999999875 58999999999999999999999998887766665555544444432 36899999999999999
Q ss_pred CccCCCCHHHHHhccCCCCCch
Q 018786 311 DPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 311 dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.|..||++.++|.|+=+.+..+
T Consensus 351 KpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 351 KPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred CCCCCccHHHHHHHHhhcCHHH
Confidence 9999999999999998777653
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=319.87 Aligned_cols=260 Identities=28% Similarity=0.410 Sum_probs=209.6
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC---
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 140 (350)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++++. |+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCc
Confidence 456889999999999999999999999999999999864322 3334567888999999998 99999999987543
Q ss_pred ---CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 141 ---HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 141 ---~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
...++||||+.+ +|.+.+... +++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||.
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~ 164 (353)
T cd07850 91 EEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 164 (353)
T ss_pred cccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCcc
Confidence 357999999954 888877654 8999999999999999999999999999999999999 5667899999999
Q ss_pred cccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID--------- 287 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------- 287 (350)
+.............++..|+|||.+. ..++.++||||||+++|+|++|+.||...+....+..+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 98765544444556889999999875 45899999999999999999999999876654443333211100
Q ss_pred -------------CCCC-----------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 288 -------------FSSD-----------------PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 288 -------------~~~~-----------------~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.... .....+..+.++|.+||+.||++|||+.|+|.|+|+.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 0000 0112456789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=308.41 Aligned_cols=251 Identities=25% Similarity=0.455 Sum_probs=211.3
Q ss_pred ccceeeeeeeeccCceEEEEEEEcc-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.+.... ..+..+.+.+|+++++++. |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQ-HENIVKFYGVCTEG 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcC-CCCchheeeEEecC
Confidence 3679999999999999999998753 36789999986432 2334578999999999998 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCC
Q 018786 141 HSVNLIMDLCAGGELFDRIIAK--------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE 206 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 206 (350)
...+++|||+++++|.+++... ..+++..+..++.||+.||.+||++|++||||||+||++ +.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cC
Confidence 9999999999999999999754 237888999999999999999999999999999999999 56
Q ss_pred CCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 018786 207 DSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAI 281 (350)
Q Consensus 207 ~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~ 281 (350)
++.++|+|||++........ .....+++.|+|||++. +.++.++||||||+++|+|++ |..||......+....+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 67899999999876432221 12334567899999875 458899999999999999998 99999888877777777
Q ss_pred HcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..+...... ..++..+.+++.+||+.||++||++.|+++.+
T Consensus 238 ~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 238 TQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred HcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 765544332 35789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=309.26 Aligned_cols=254 Identities=28% Similarity=0.432 Sum_probs=207.8
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|++.+.||.|++|.||+|.++.+++.+|||.+..... .......+.+|++++++++ |+||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEe
Confidence 48899999999999999999999999999999865432 2233457889999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 148 DLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||+. ++|.+++.. ...+++..++.++.|++.||+|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCc
Confidence 9995 588888865 3568999999999999999999999999999999999999 566779999999987654322
Q ss_pred -ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Q 018786 226 -VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS------------- 289 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 289 (350)
......++..|+|||.+.+ .++.++||||||+++|+|++|..||....+......+........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 2233456888999998753 368899999999999999999999987766544433322111000
Q ss_pred ------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 290 ------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 290 ------------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
....+.++.++.++|.+||+.||++|||+.++|.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=306.42 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=205.7
Q ss_pred eeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHH---HHccCCCCeeEeEeEEEcCCceEEEEecC
Q 018786 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM---HHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (350)
Q Consensus 74 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l---~~l~~h~~iv~~~~~~~~~~~~~iv~e~~ 150 (350)
.||+|+||.||+|.+..+++.||+|++................|...+ +... |++|+.+++.+...+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCEEEEEEecC
Confidence 489999999999999999999999998754332222222233444333 3334 999999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccC
Q 018786 151 AGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230 (350)
Q Consensus 151 ~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 230 (350)
.|++|.+++...+.+++..++.++.|++.||.|||+++|+||||||+||++ +.++.++|+|||++....... ....
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~-~~~~ 155 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHAS 155 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-CcCc
Confidence 999999999888889999999999999999999999999999999999999 566789999999987654332 2345
Q ss_pred CcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 018786 231 VGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGET---EQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (350)
Q Consensus 231 ~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 305 (350)
.|+..|+|||.+.+ .++.++|+||+|+++|+|++|..||.... ...............+ ..++.++.++|.
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~li~ 231 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLE 231 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCC----CcCCHHHHHHHH
Confidence 78999999998753 47899999999999999999999997663 2232222322222222 246899999999
Q ss_pred HhcccCccCCC-----CHHHHHhccCCCCCchhhHH
Q 018786 306 KMLHADPKERL-----SAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 306 ~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~ 336 (350)
+||..||.+|| ++.++++|+||.+..|....
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~ 267 (278)
T cd05606 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVF 267 (278)
T ss_pred HHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhh
Confidence 99999999999 99999999999998876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=309.13 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=210.2
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||.|++|.||+|.++.+++.||+|.+..... .....+.+.+|+++++++. |+||+++++++......++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEEEE
Confidence 579999999999999999999999999999999865432 2233466889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 147 MDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
|||++ ++|.+++..... +++..++.++.||+.||.|||++|++|+||+|+||+++. .++.+||+|||++......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIP 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEcccccccccCCC
Confidence 99995 588887765443 578889999999999999999999999999999999953 3456999999999765332
Q ss_pred -CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-----------
Q 018786 225 -DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS----------- 290 (350)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 290 (350)
.......+++.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+.........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 22234467889999998753 4788999999999999999999999877665544443221100000
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 291 --------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 291 --------------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
...+.++.++.++|.+||+.||++||++.+++.|+||.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0123568899999999999999999999999999999764
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=313.24 Aligned_cols=260 Identities=29% Similarity=0.494 Sum_probs=216.6
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+..++++. |+||+++++.+...+..++
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDELWV 96 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeEEE
Confidence 456666788999999999999999889999999985432 334567889999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 97 v~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 97 VMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhccccc
Confidence 9999999999887754 568999999999999999999999999999999999999 556779999999987643222
Q ss_pred -ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 226 -VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
......++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+........ .....++..+.++
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 251 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-KDSHKVSSVLRGF 251 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-ccccccCHHHHHH
Confidence 2234568899999998754 588999999999999999999999988776655555443322211 1122468899999
Q ss_pred HHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
|.+||..||++|||+.++++|+||.....+.
T Consensus 252 i~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred HHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 9999999999999999999999999776555
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=303.49 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=217.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||.|++|.||+|.+..+++.|++|++..... ......+.+|+..+.++. |+|++++++++......+++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEE
Confidence 368899999999999999999999999999999865432 144578999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||+++++|.+++.....+++..+..++.||+.||.+||+ +|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCC
Confidence 9999999999999888889999999999999999999999 999999999999999 567779999999988765443
Q ss_pred cc-ccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCC-CCHH
Q 018786 226 VF-KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET---EQSIFDAILRGHIDFSSDPWPN-ISSS 299 (350)
Q Consensus 226 ~~-~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~-~~~~ 299 (350)
.. ....++..|+|||.+.. .++.++|+||||+++|+|++|..||.... ..+....+......... .. ++..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 231 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLP---AEEFSPE 231 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCC---cccCCHH
Confidence 32 24567889999998764 57889999999999999999999997763 34444444433222211 23 7899
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
+.++|.+||+.+|++||++.++++|+|++..
T Consensus 232 l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 232 FRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=309.69 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=205.5
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCc--EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQ--QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
++|++.+.||+|+||.||+|..+.++. .+++|.++.. ......+.+.+|+.++.++..||||+++++++...+.++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877664 4688877532 233345678999999999955999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCC
Q 018786 145 LIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~ 208 (350)
+++||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||++ +.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCC
Confidence 9999999999999986532 47889999999999999999999999999999999999 5667
Q ss_pred CeEEeecCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Q 018786 209 PLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286 (350)
Q Consensus 209 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 286 (350)
.+||+|||++..............+..|+|||.+. ..++.++||||||+++|+|++ |..||......+....+.....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 79999999986533221111222345699999875 458899999999999999997 9999988887777766655432
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
... ...++.++.++|.+||+.||.+||++.++++.+
T Consensus 237 ~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 237 MEK---PRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111 135789999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=309.53 Aligned_cols=256 Identities=32% Similarity=0.522 Sum_probs=210.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+.+|+++++++. |+||+++++++...+..+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEE
Confidence 479999999999999999999999999999999865432 3344578899999999999 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
|||++++.+..+......+++..+..++.||+.||.|||++|++|+||+|+||++ ++++.+||+|||.+.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCcc
Confidence 9999886666655556679999999999999999999999999999999999999 567789999999988765443
Q ss_pred -ccccCCcCcccccccccc-c-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------------
Q 018786 226 -VFKDLVGSAYYVAPEVLR-R-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID--------------- 287 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~-~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------------- 287 (350)
......++..|+|||++. . .++.++||||||+++|+|++|..||......+....+......
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 334456788999999875 3 5788999999999999999999999876654443332211000
Q ss_pred ----CCCC--------CCC-CCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 288 ----FSSD--------PWP-NISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 288 ----~~~~--------~~~-~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.+.. .++ .++.++.++|.+||+.||++|||+.+++.|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 011 247889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=309.05 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=215.5
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|++.+.||+|++|+||++.+..+++.||+|++.... .......+.+|+++++.+. |+||+++++.+.....+++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEE
Confidence 367999999999999999999999999999999986432 2334577899999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||||+++++|.+++...+.+++..+..++.+++.+|.|||+ .+++|+||+|+||++ ++++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh
Confidence 99999999999998888889999999999999999999997 689999999999999 56677999999998764322
Q ss_pred CccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHcCCCCCCCCC
Q 018786 225 DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQ-----------SIFDAILRGHIDFSSDP 292 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~ 292 (350)
. .....|+..|+|||++. +.++.++|+||||+++|++++|..||...... +....+....... ..
T Consensus 158 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 234 (284)
T cd06620 158 I-ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR--LP 234 (284)
T ss_pred c-cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCC--CC
Confidence 2 23457899999999874 56889999999999999999999999765432 2222222221111 11
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
...++.++.++|.+||+.||++|||+.|+++++||.+....
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~ 275 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRA 275 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 12367899999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=305.87 Aligned_cols=252 Identities=34% Similarity=0.590 Sum_probs=217.5
Q ss_pred eeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCCC
Q 018786 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (350)
Q Consensus 75 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~s 154 (350)
||.|++|.||++.+..+++.+++|++...........+.+.+|++.++++. |+||+++++.+..+...++++||+.+++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999999889999999997655444455678999999999998 9999999999999999999999999999
Q ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC---------
Q 018786 155 LFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD--------- 225 (350)
Q Consensus 155 L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~--------- 225 (350)
|.+++...+.+++..+..++.||+.||.+||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccc
Confidence 99999887789999999999999999999999999999999999999 566779999999987643321
Q ss_pred ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
......++..|++||... ...+.++||||||+++|++++|..||......+....+..+...++.. ..++..+.++|
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i 234 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence 223346788899999875 447889999999999999999999998888877777776655444332 13589999999
Q ss_pred HHhcccCccCCCCH---HHHHhccCCCCCch
Q 018786 305 KKMLHADPKERLSA---AEVLSKFLIPKKTL 332 (350)
Q Consensus 305 ~~~L~~dp~~Rps~---~~iL~~~~~~~~~~ 332 (350)
.+||+.+|.+|||+ .++|.|+||.+..|
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 99999999999999 99999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=305.54 Aligned_cols=249 Identities=26% Similarity=0.426 Sum_probs=200.6
Q ss_pred ccceeeeeee--eccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 66 RNTYIFGREL--GRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 66 ~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.++|.+.+.+ |.|+||.||++.++.++..+|+|++....... .|+.....+.+|+||+++++.+...+..
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3567777776 99999999999999999999999986543211 1222222233599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCC-CeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS-PLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~-~vkl~Dfg~a~~~~ 222 (350)
++||||+++++|.+++.....+++..++.++.||+.||.+||+.|++||||||+||+++. ++ .++|+|||.+....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~---~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR---AKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC---CCCeEEEecCccceecC
Confidence 999999999999999988888999999999999999999999999999999999999953 34 79999999987654
Q ss_pred CCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHcCCCCCCCCCCCCCCHHH
Q 018786 223 PGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIF-DAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l 300 (350)
.. ....++..|+|||++. ..++.++||||||+++|+|++|..||......... ....... .......+.++..+
T Consensus 162 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (267)
T PHA03390 162 TP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNA 237 (267)
T ss_pred CC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHH
Confidence 33 2346788999999876 45888999999999999999999999765443321 1111111 22222334689999
Q ss_pred HHHHHHhcccCccCCCC-HHHHHhccCCCC
Q 018786 301 KDIVKKMLHADPKERLS-AAEVLSKFLIPK 329 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps-~~~iL~~~~~~~ 329 (350)
.++|.+||+.||.+|++ ++++|+|+||..
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 99999999999999996 699999999963
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=310.67 Aligned_cols=258 Identities=28% Similarity=0.453 Sum_probs=214.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
..|+..+.||+|+||.||+|.+..+++.+|+|.+.... .....+.+.+|+.+++++. |+||+++++.+......++|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEEE
Confidence 56888899999999999999999889999999986443 2234567899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
+||+++++|.+++.. ..+++..++.++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcch
Confidence 999999999987754 568999999999999999999999999999999999999 5567799999999877543322
Q ss_pred -cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 227 -FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 227 -~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
.....++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+........ ...++.++.++|
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li 233 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTL---EGQYSKPFKEFV 233 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCC---CcccCHHHHHHH
Confidence 223467889999998764 578899999999999999999999976655444444333322111 124688999999
Q ss_pred HHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 305 KKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
.+||+.+|++||++.++++|+|+.......
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 263 (277)
T cd06642 234 EACLNKDPRFRPTAKELLKHKFITRYTKKT 263 (277)
T ss_pred HHHccCCcccCcCHHHHHHhHHHHHHhhhH
Confidence 999999999999999999999997665433
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=313.23 Aligned_cols=248 Identities=27% Similarity=0.448 Sum_probs=191.1
Q ss_pred eeeeccCceEEEEEEEcc--CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE--cCCceEEEEe
Q 018786 73 RELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE--DRHSVNLIMD 148 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~--~~~~~~iv~e 148 (350)
.+||+|+||.||+|.++. ++..+|+|.+.... ....+.+|+++++++. |+||+++++++. .....+++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEEe
Confidence 589999999999999754 56889999886432 2345788999999998 999999999874 4567899999
Q ss_pred cCCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecC-CCCCCeEEeecCCc
Q 018786 149 LCAGGELFDRIIAK---------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS-AEDSPLKATDFGLS 218 (350)
Q Consensus 149 ~~~~~sL~~~l~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~~~vkl~Dfg~a 218 (350)
|+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++..+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9854 787777421 247899999999999999999999999999999999999543 34678999999999
Q ss_pred ccccCCC----ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHc
Q 018786 219 VFFKPGD----VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQ---------SIFDAILR 283 (350)
Q Consensus 219 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~---------~~~~~~~~ 283 (350)
....... ......+|+.|+|||++.+ .++.++||||||+++|+|++|..||....+. .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 8754332 1234568999999998753 4789999999999999999999999654321 11111110
Q ss_pred CCC--------------CCC--------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 284 GHI--------------DFS--------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 284 ~~~--------------~~~--------------------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
... .++ .......+..+.+||.+||+.||.+|||+.|+|+|+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 000 00001235678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=302.10 Aligned_cols=249 Identities=22% Similarity=0.394 Sum_probs=209.6
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
...+|.+.+.||+|++|.||+|.++.+++.+|+|++.... .....+.+|+++++++. |+||+++++++...+.++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFY 78 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcE
Confidence 3467999999999999999999999989999999986432 23467889999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 145 LIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||++ ++++.+||+|||.+....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccc
Confidence 999999999999998754 358999999999999999999999999999999999999 567789999999988765
Q ss_pred CCCccc--cCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 223 PGDVFK--DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 223 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
...... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||.+....+....+...... .....++.
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 232 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM---ERPEGCPP 232 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC---CCCCCCCH
Confidence 432211 123356799999875 458899999999999999998 99999887776666666553221 12235789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
++.++|.+||+.||++|||+.++++.
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHH
Confidence 99999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=310.08 Aligned_cols=257 Identities=27% Similarity=0.445 Sum_probs=203.8
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC---
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH--- 141 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~--- 141 (350)
.-++|.+.+.||+|++|.||+|.+..+++.||||.+..... .......+.+|+++++++. |+||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKATPY 87 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCC-CCCccceEEEEecccccc
Confidence 34679999999999999999999999999999999864332 2222345678999999998 999999999876543
Q ss_pred -----ceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeec
Q 018786 142 -----SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (350)
Q Consensus 142 -----~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Df 215 (350)
..++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++|++|+||||+||++ +.++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~df 163 (310)
T cd07865 88 NRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADF 163 (310)
T ss_pred cCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcC
Confidence 45999999954 888877654 368999999999999999999999999999999999999 66778999999
Q ss_pred CCcccccCCCc-----cccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Q 018786 216 GLSVFFKPGDV-----FKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288 (350)
Q Consensus 216 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 288 (350)
|.+........ .....++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99876543221 123457788999998653 36889999999999999999999998776654443333211111
Q ss_pred CCCCC----------------------------CCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 289 SSDPW----------------------------PNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 289 ~~~~~----------------------------~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
+...+ ...+..+.++|.+||+.||++|||++++|+|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 11000 0124677899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=306.96 Aligned_cols=255 Identities=29% Similarity=0.444 Sum_probs=203.9
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||.|++|.||+|.++.+++.||+|.+..... ......+.+|+++++++. |+||+++++++...+..++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEE
Confidence 3689999999999999999999998899999999865432 122245678999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVP 156 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCC
Confidence 9999975 898888764 468999999999999999999999999999999999999 56677999999998754321
Q ss_pred -CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCC-------------
Q 018786 225 -DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHID------------- 287 (350)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~-~~~~~~~~~~~~~~------------- 287 (350)
.......++..|+|||.+.+ .++.++||||||+++|+|++|..||.... ..+....+.+....
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 11223356888999998753 47889999999999999999999997654 22222222111000
Q ss_pred --------CC-----CCCCCCCC--HHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 288 --------FS-----SDPWPNIS--SSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 288 --------~~-----~~~~~~~~--~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.. ....+.++ .++.++|.+||+.||++|||+.++|.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 00011234 788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=307.77 Aligned_cols=262 Identities=30% Similarity=0.538 Sum_probs=217.5
Q ss_pred ceeeeeeeeccCceEEEEEEEc---cCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 68 TYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
+|++.+.||.|+||.||++.+. .+|+.||+|++...... .....+.+.+|+++++++.+|+||+.+++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999985 46899999998654322 2233467889999999997799999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++|+||+++++|.+++.....+++..+..++.||+.||.|||++|++||||+|+||++ +.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceeccc
Confidence 9999999999999999888889999999999999999999999999999999999999 5677899999999877543
Q ss_pred CC--ccccCCcCccccccccccc---cCCcchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCC
Q 018786 224 GD--VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 224 ~~--~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~ 294 (350)
.. ......|+..|++||.+.. .++.++||||||+++|+|++|..||..... .+....+.....+.+ +
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~ 233 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----Q 233 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC----c
Confidence 32 2234568899999998753 367899999999999999999999964322 333333333333332 2
Q ss_pred CCCHHHHHHHHHhcccCccCCC-----CHHHHHhccCCCCCchhhHH
Q 018786 295 NISSSAKDIVKKMLHADPKERL-----SAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~ 336 (350)
.++..+.+++.+||+.||++|| ++.+++.|+||.+..|+...
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 280 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA 280 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHh
Confidence 5789999999999999999997 89999999999999886653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=308.55 Aligned_cols=261 Identities=26% Similarity=0.469 Sum_probs=218.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
...|...+.||+|+||.||++.+..++..+|+|.+.............+.+|+++++++. |+|++++++++......++
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeEEE
Confidence 355888999999999999999999899999999987654444445567899999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||||+.| +|.+.+.. ...+++..+..++.||+.||.|||++||+|+||+|+||++ +.++.++|+|||++......
T Consensus 103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASPA 178 (317)
T ss_pred EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCCc
Confidence 9999975 77777654 5568999999999999999999999999999999999999 55677999999998764432
Q ss_pred CccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
....++..|+|||.+. +.++.++||||||+++|+|++|..||...........+......... ...++..+
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l 253 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWSDYF 253 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC--CccccHHH
Confidence 3456888999999863 35788999999999999999999999887766656555544332221 23568899
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHH
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~ 336 (350)
.++|.+||+.+|.+||++.++++|+|+.....+...
T Consensus 254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~ 289 (317)
T cd06635 254 RNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVL 289 (317)
T ss_pred HHHHHHHccCCcccCcCHHHHHhChhhhccCcccch
Confidence 999999999999999999999999999877665543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=304.49 Aligned_cols=261 Identities=22% Similarity=0.371 Sum_probs=211.4
Q ss_pred cccccceeeeeeeeccCceEEEEEEEcc-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
+...++|.+.+.||+|+||.||+|.++. .+..+|+|.+.... .......+.+|+.+++++. |+||+++++++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~ 78 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVV 78 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEE
Confidence 3456889999999999999999997653 35579999876432 2233456788999999998 99999999999
Q ss_pred EcCCceEEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCC
Q 018786 138 EDRHSVNLIMDLCAGGELFDRIIAK----------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (350)
Q Consensus 138 ~~~~~~~iv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 207 (350)
...+..++||||+.+++|.+++... ..++...+..++.||+.||.|||+++|+||||||+||++ +.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~ 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHD 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCC
Confidence 9999999999999999999999753 224667889999999999999999999999999999999 556
Q ss_pred CCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 018786 208 SPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAIL 282 (350)
Q Consensus 208 ~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~ 282 (350)
+.++|+|||++........ .....++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+....+.
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 7799999999876433221 12234567799999875 458999999999999999998 788998887777666665
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHh------ccCCCCCch
Q 018786 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS------KFLIPKKTL 332 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~------~~~~~~~~~ 332 (350)
........ ...+..+.+++.+||+.||++|||+.++++ |+||.+..|
T Consensus 236 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 236 DGGYLDQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred cCCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 54332211 245789999999999999999999999987 777776544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=306.38 Aligned_cols=253 Identities=26% Similarity=0.453 Sum_probs=208.0
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|++.+.||.|++|.||+|.+..+|+.||+|++..... ....+.+.+|+.+++++. |+||+++++++...+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEE
Confidence 58899999999999999999999999999999875432 223466788999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 148 DLCAGGELFDRIIAK---GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 148 e~~~~~sL~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||+.+ +|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCC
Confidence 99975 888888654 358999999999999999999999999999999999999 56677999999998765332
Q ss_pred C-ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-----------
Q 018786 225 D-VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS----------- 290 (350)
Q Consensus 225 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 290 (350)
. ......++..|++||++.+ .++.++||||||+++|++++|..||.+....+....+.+.......
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1 2234467889999998753 4688999999999999999999999877665554443321100000
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 291 --------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 291 --------------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
...+.++.++.++|.+||+.||.+||++.++++|+||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0012457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=319.65 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=204.8
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccC-----CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
++.-.++|.+++.||+|+||.||+|.+... +..||||++.... .....+.+.+|++++.++..||||++++++
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 344468899999999999999999987432 3469999986432 333456799999999999669999999999
Q ss_pred EEcCCceEEEEecCCCCCHHHHHHHc------------------------------------------------------
Q 018786 137 YEDRHSVNLIMDLCAGGELFDRIIAK------------------------------------------------------ 162 (350)
Q Consensus 137 ~~~~~~~~iv~e~~~~~sL~~~l~~~------------------------------------------------------ 162 (350)
+...+..++||||+++++|.+++..+
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 99999999999999999999887542
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceE
Q 018786 163 ------------------------------------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200 (350)
Q Consensus 163 ------------------------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl 200 (350)
..+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 13677888999999999999999999999999999999
Q ss_pred eecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 018786 201 FSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQ 275 (350)
Q Consensus 201 ~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~ 275 (350)
+ +.++.+||+|||++........ .....++..|+|||.+. ..++.++||||||+++|+|++ |..||......
T Consensus 270 l---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 270 L---AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred E---eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9 5566799999999876543221 22345677899999875 458999999999999999997 99999765443
Q ss_pred H-HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 276 S-IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 276 ~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
. ....+..+ .... ....++.++.+++.+||+.||++||++.++.+.
T Consensus 347 ~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 347 STFYNKIKSG-YRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred HHHHHHHhcC-CCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 3 33333333 2221 123578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=316.73 Aligned_cols=261 Identities=28% Similarity=0.465 Sum_probs=211.5
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC----
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR---- 140 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~---- 140 (350)
+.++|.+.+.||+|+||+||+|.+..+++.||||.+..... .......+.+|+.+++.+. |+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREA 80 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCccchHHheecccccc
Confidence 45789999999999999999999999999999999865322 2333456788999999998 99999999977543
Q ss_pred -CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 141 -HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 141 -~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
...++++||+. ++|.+++...+.+++..+..++.||+.||.|||+++++|+||||+||++ +.++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR 156 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccc
Confidence 35899999995 6899988888889999999999999999999999999999999999999 556779999999998
Q ss_pred cccCC-CccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Q 018786 220 FFKPG-DVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG------------ 284 (350)
Q Consensus 220 ~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~------------ 284 (350)
..... .......++..|+|||.+. ..++.++||||||+++|+|++|..||.+.........+...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 76433 2223456788999999764 35889999999999999999999999766543322222110
Q ss_pred -----------CCCCC----CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 285 -----------HIDFS----SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 285 -----------~~~~~----~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
..... ....+.++.++.++|.+||+.||++|||+.++|+|+||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00000 111346789999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=305.63 Aligned_cols=250 Identities=24% Similarity=0.445 Sum_probs=209.3
Q ss_pred ccceeeeeeeeccCceEEEEEEEc-----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
+.+|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+++++++. |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Confidence 468999999999999999999863 34567899988543 2334567899999999998 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCC
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKG-------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 207 (350)
+.++++|||+++++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+||++ +.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccC
Confidence 99999999999999999987543 38999999999999999999999999999999999999 567
Q ss_pred CCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 018786 208 SPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAIL 282 (350)
Q Consensus 208 ~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~ 282 (350)
+.++|+|||++........ .....++..|+|||.+. ..++.++||||||+++|+|++ |..||......+....+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 7899999999876533221 12233567899999876 458899999999999999998 999998888777777776
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+...... ..++.++.+++.+||+.||.+|||+.++++.+
T Consensus 237 ~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l 276 (288)
T cd05093 237 QGRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276 (288)
T ss_pred cCCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 65533222 25788999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=305.10 Aligned_cols=251 Identities=26% Similarity=0.494 Sum_probs=207.8
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||.|++|.||++.+..+++.+|||.+.............+.+|+.+++++. |+||+++++++...+..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeEEEE
Confidence 56889999999999999999999899999999887544434445578899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 147 MDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence 999999999998864 3458999999999999999999999999999999999999 556779999999987654
Q ss_pred CCC-ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 223 PGD-VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETE--QSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 223 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
... ......++..|+|||.+. ..++.++|+||||+++|+|++|..||..... ......+.... .+......++.
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSE 235 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCCCcccccH
Confidence 332 223456889999999875 4578899999999999999999999975543 22333333222 22222235788
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHh
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
.+.++|.+||+.||++|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999997765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=309.09 Aligned_cols=270 Identities=27% Similarity=0.492 Sum_probs=245.9
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
....+|.++..||+|+||.|.+|..+.+.+.||||+++++.....+..+--..|-++|.....-|.+++++.+|+.-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34578999999999999999999999999999999999988877777777778888887766678899999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc-c
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-K 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~-~ 222 (350)
|+||||+.||+|.=.++.-+++.+..+.-++..|+.||=+||++||+.||||.+|||+ +.+|++||+|||.++.- -
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeeccccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999 77888999999999763 3
Q ss_pred CCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 223 PGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
++....+.+|||.|+|||++. .+|+...|.||+|++||||+.|+.||.+.++.+....+......++. .++.++.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv 578 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAV 578 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHH
Confidence 445567789999999999876 67999999999999999999999999999999999999999999887 4799999
Q ss_pred HHHHHhcccCccCCCCH-----HHHHhccCCCCCchhhHHHHhh
Q 018786 302 DIVKKMLHADPKERLSA-----AEVLSKFLIPKKTLQTLADLLY 340 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~-----~~iL~~~~~~~~~~~~~~~~~~ 340 (350)
++....|.+.|.+|... .+|-.|+||....|..+++..+
T Consensus 579 ~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~ei 622 (683)
T KOG0696|consen 579 AICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREI 622 (683)
T ss_pred HHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccC
Confidence 99999999999999853 6888999999999999887654
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=304.71 Aligned_cols=257 Identities=30% Similarity=0.506 Sum_probs=216.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
..|...+.||.|++|.||++.+..+++.+++|.+... .....+.+.+|+.+++++. |+||+++++++...+..+++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEEEE
Confidence 4566668999999999999999988999999988533 2233466889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
+||+.+++|.+++.. +++++..+..++.||+.||.+||++||+||||+|+||++ +.++.++|+|||.+.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc
Confidence 999999999998877 678999999999999999999999999999999999999 567789999999876543322
Q ss_pred ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
......|++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+......... ....++..+.++|
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li 249 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRLRSFL 249 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHHHHHH
Confidence 2233568899999998764 5889999999999999999999999887766666655554322222 1224789999999
Q ss_pred HHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 305 KKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.+||+.||++||++.++++|+|+.+...
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHcccChhhCcCHHHHccCcccccCCC
Confidence 9999999999999999999999988764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=299.34 Aligned_cols=247 Identities=24% Similarity=0.465 Sum_probs=207.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|+||.||++..+. +..+|+|.+..... ..+.+.+|+.+++++. |+||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEE
Confidence 568999999999999999998865 56799998764322 2356889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+|+||||+||++ +.++.+||+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCc
Confidence 999999999998875 3568999999999999999999999999999999999999 566779999999987654322
Q ss_pred cc--ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 226 VF--KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 226 ~~--~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.. ....++..|+|||.+. ..++.++|+||||+++|+|++ |+.||......+....+..+...... ...+..+.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVY 231 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHH
Confidence 21 1223456799999876 458899999999999999999 99999888877777777665433222 23578999
Q ss_pred HHHHHhcccCccCCCCHHHHHhcc
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+++.+||+.||++||++.++++.+
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=299.88 Aligned_cols=244 Identities=25% Similarity=0.395 Sum_probs=201.9
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||.||+|.++.+++.+|+|.+... ...+....+.+|+++++++. |+||+++++++......++||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEeeccC
Confidence 4699999999999999989999999987533 23444577999999999998 99999999999999999999999999
Q ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccc---
Q 018786 153 GELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK--- 228 (350)
Q Consensus 153 ~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~--- 228 (350)
++|.+++...+ .+++..++.++.|++.||.|||++||+|+||||+||++ +.++.+||+|||.+..........
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccccCC
Confidence 99999987644 58999999999999999999999999999999999999 556779999999987654322111
Q ss_pred cCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 018786 229 DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306 (350)
Q Consensus 229 ~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 306 (350)
...++..|+|||.+. +.++.++||||||+++|++++ |..||...........+....... ....++..+.+++.+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~ 231 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP---CPELCPDAVYRLMER 231 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC---CcccCCHHHHHHHHH
Confidence 112345699999875 458899999999999999997 899998777666555555432221 123568999999999
Q ss_pred hcccCccCCCCHHHHHhcc
Q 018786 307 MLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 307 ~L~~dp~~Rps~~~iL~~~ 325 (350)
||+.||++|||+.++++.+
T Consensus 232 ~l~~~p~~Rps~~~~~~~l 250 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQEL 250 (252)
T ss_pred HcCCChhhCcCHHHHHHHH
Confidence 9999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=301.19 Aligned_cols=253 Identities=26% Similarity=0.504 Sum_probs=213.4
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|.+.+.||.|+||.||++.++.+|..+|+|.+..... .....+.+.+|++++++++ |+||+++++.+......++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEE
Confidence 58899999999999999999999999999999865432 2234467889999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 148 DLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||+.+++|.+++.... .+++..+..++.|++.||.|||+++++|+||+|+||+++. ++..++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC--CCCeEEecccccchhccCCc
Confidence 9999999999887643 4799999999999999999999999999999999999953 22357999999987765433
Q ss_pred c-cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 226 V-FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 226 ~-~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
. .....|++.|+|||.+. ..++.++|+||||++++++++|..||......+............. .+.++.++.++
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 233 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI---SPNFSRDLRSL 233 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCC---CCCCCHHHHHH
Confidence 2 22346888999999875 4588999999999999999999999987776665555554433322 23578899999
Q ss_pred HHHhcccCccCCCCHHHHHhccCC
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
|.+||+.+|++|||+.++++|+||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.97 Aligned_cols=251 Identities=22% Similarity=0.389 Sum_probs=209.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEccC---CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
.++|++.+.||+|+||+||+|.++.+ ...+|+|.+.... .......+.+|+.++++++ |+||+++++++...+.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCc
Confidence 36799999999999999999998654 4579999886432 3344567889999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.+++|||+++++|.+++... +.+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRL 156 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhcc
Confidence 99999999999999998764 468999999999999999999999999999999999999 56677999999999876
Q ss_pred cCCC-ccc--cCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 222 KPGD-VFK--DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 222 ~~~~-~~~--~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... ... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||......+....+........ ...+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 233 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP---PMDC 233 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---CCCC
Confidence 4211 111 223456799999876 458899999999999999998 9999988777777766665432211 1357
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+..+.+++.+||+.+|++||++.++++++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 89999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=306.17 Aligned_cols=253 Identities=29% Similarity=0.441 Sum_probs=208.0
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEe
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
|++.+.||.|++|.||+|.++.+|+.||+|++..... .......+.+|++.+++++ |+|++++++++.+.+..+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEe
Confidence 6778999999999999999999999999999875432 2233456888999999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 149 LCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 149 ~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
|+. ++|.+++.... .+++..+..++.|++.||.|||+++++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCCcc
Confidence 995 58999887765 68999999999999999999999999999999999999 557789999999987653222
Q ss_pred ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------
Q 018786 226 VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI----------------- 286 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~----------------- 286 (350)
......++..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+.+...
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 2233456888999997753 468899999999999999999999987765444333222100
Q ss_pred --------CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 287 --------DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 287 --------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.......+.++..+.++|.+||+.||.+|||+.|++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01111134577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=303.85 Aligned_cols=247 Identities=29% Similarity=0.485 Sum_probs=202.4
Q ss_pred eeeeeeeccCceEEEEEEEc----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 70 IFGRELGRGQFGVTYLVTHK----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.+.+.||.|.||.||+|... ..+..|+||.++.. ...+..+.+.+|++.+++++ |+||+++++++...+..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccc-ccccccccccccccccccc
Confidence 46789999999999999998 44678999999532 24445788999999999996 9999999999998888999
Q ss_pred EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 146 IMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
|+||+++++|.+++... ..+++..+..++.||+.||.|||+++++|+||+++||++ +.++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence 99999999999999886 679999999999999999999999999999999999999 5566799999999987632
Q ss_pred CC---ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 224 GD---VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 224 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ..........|+|||.+.. .++.++||||||+++||+++ |+.||......+....+.++...... ..++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIP---DNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSB---TTSBH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceec---cchhH
Confidence 21 1223446778999998864 48999999999999999999 78999888888877777655443222 25799
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+.++|.+||+.||++|||+.++++.+
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 999999999999999999999998753
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=303.71 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=207.3
Q ss_pred cceeeeeeeeccCceEEEEEEEc----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHK----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
.+|++.+.||+|+||+||+|.+. .+++.+++|.+.... .......+.+|+.+++++. |+||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence 57899999999999999999853 356789999986432 3344567889999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC
Q 018786 143 VNLIMDLCAGGELFDRIIAK-----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~-----------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 205 (350)
.+++|||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++ +
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence 99999999999999988532 237888999999999999999999999999999999999 5
Q ss_pred CCCCeEEeecCCcccccCCC---ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 018786 206 EDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDA 280 (350)
Q Consensus 206 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~ 280 (350)
.++.+||+|||++....... ......++..|+|||.+. ..++.++||||||+++|+|++ |..||.+.........
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 56779999999997653322 123344567799999875 558999999999999999998 9999988776666666
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+....... ....++..+.+++.+||+.||++||++.++++++
T Consensus 239 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 239 VRKRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 65443222 1235789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=299.53 Aligned_cols=244 Identities=25% Similarity=0.344 Sum_probs=201.9
Q ss_pred eeeeccCceEEEEEEE--ccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecC
Q 018786 73 RELGRGQFGVTYLVTH--KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~ 150 (350)
+.||+|+||.||+|.+ ..+++.+|+|+++... ......+.+.+|+.+++++. |+||+++++++. .+..++||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~~ 77 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMELA 77 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEecC
Confidence 3689999999999965 4567899999986433 23445678899999999998 999999999875 45678999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc----
Q 018786 151 AGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---- 226 (350)
Q Consensus 151 ~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~---- 226 (350)
++++|.+++...+.+++..+..++.|++.||.+||++||+||||||.||++ +.++.+||+|||.+........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeee
Confidence 999999999888889999999999999999999999999999999999999 5567799999999877543321
Q ss_pred cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
.....++..|+|||.+. ..++.++|+||||+++|||++ |..||......+....+..+..... ...++.++.++|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li 231 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC---PQRCPPEMYDLM 231 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHH
Confidence 11223457899999876 457889999999999999998 9999988777777777665443211 235789999999
Q ss_pred HHhcccCccCCCCHHHHHhcc
Q 018786 305 KKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+||+.||++||++.+|...+
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 232 KLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred HHHhccCchhCcCHHHHHHHH
Confidence 999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=309.69 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=204.6
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcE----EEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQ----FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
..+|++.+.||+|+||.||+|.+..++.. ||+|.+.... .....+++.+|+.+++.+. |+||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-
Confidence 36799999999999999999998665554 8999986322 2344567889999999998 99999999988764
Q ss_pred ceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..+++++|+++++|.+++... ..++...+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 158 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEcccccccc
Confidence 567999999999999999874 458899999999999999999999999999999999999 5667799999999987
Q ss_pred ccCCCcc---ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 221 FKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 221 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
....... ....++..|++||.+. ..++.++||||||+++|||++ |..||.+....+....+.... ..+. .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~ 235 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQ--PPI 235 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-CCCC--CCC
Confidence 6533221 1223456799999875 458999999999999999997 999998877665554444332 2222 135
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
++.++.+++.+||+.||++||++.+++.++.
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~ 266 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIEFS 266 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 6889999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=302.02 Aligned_cols=257 Identities=26% Similarity=0.442 Sum_probs=216.1
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
+-|++.+.||.|+||.||+|.+..+++.+|+|++..... ......+.+|+..+.++. |+||+++++.+..++..++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEEE
Confidence 457888999999999999999988899999999864332 234567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
|||+.+++|.+++.. ..+++..+..++.|++.++.+||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh
Confidence 999999999988764 468999999999999999999999999999999999999 566779999999987654332
Q ss_pred ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
......++..|+|||.+. ..++.++|+||||+++|+|++|..||...........+....... ....++.++.++|
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i 233 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLKEFV 233 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC---CCcccCHHHHHHH
Confidence 223346788999999875 457889999999999999999999998766655555544332221 1125789999999
Q ss_pred HHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 305 KKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
.+||+.+|++||++.+++.|+|+.+...+
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~ 262 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKHKFIVRFAKK 262 (277)
T ss_pred HHHccCChhhCcCHHHHHhCHHHhhhhhc
Confidence 99999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=300.45 Aligned_cols=253 Identities=26% Similarity=0.494 Sum_probs=209.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|++|.||+|.+..+|+.+|+|.++..........+.+.+|+++++++. |++++++++.+...+..+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeEEEE
Confidence 57999999999999999999999899999999987544444455678999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 147 MDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
|||+++++|.+++.. ...+++..+..++.+|+.||.+||+.||+|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence 999999999998864 3458999999999999999999999999999999999999 566779999999987654
Q ss_pred CCC-ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 223 PGD-VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETE--QSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 223 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
... ......++..|+|||.+. ..++.++|+||||+++|+|++|..||..... .+....+..+.... .....++.
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP--LPADHYSE 235 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCC--CChhhcCH
Confidence 332 223456888999999875 4588899999999999999999999965432 23333333332221 11225788
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++.++|.+||+.+|++|||+.++++.+
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=298.04 Aligned_cols=252 Identities=31% Similarity=0.575 Sum_probs=217.7
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|.+.+.||.|++|.||++.+..+++.+++|++..... .......+.+|++++++++ |+|++++.+.+...+..++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEE
Confidence 58899999999999999999998899999999875433 3345577899999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 148 DLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 148 e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
|++++++|.+++... ..+++..+..++.+++.||.+||++|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeeccc
Confidence 999999999988764 679999999999999999999999999999999999999 5567799999999887654
Q ss_pred CC-ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 224 GD-VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 224 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.. ......|++.|+|||.+. ..++.++|+||+|+++++|++|..||..................... ..++.++.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 232 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP---SQYSSELR 232 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence 43 233456889999999765 45788999999999999999999999887766666666554433222 25789999
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCC
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
+++.+||+.+|++|||+.++|.|+||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.86 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=208.4
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCC----------------cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTK----------------QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 129 (350)
..+|.+.+.||+|+||.||+|.+...+ ..+|+|.+.... .....+.+.+|+++++++. |+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLS-DPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcC-CCC
Confidence 468999999999999999999876543 568999986443 2345678899999999998 999
Q ss_pred eeEeEeEEEcCCceEEEEecCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCc
Q 018786 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG-----------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (350)
Q Consensus 130 iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~N 198 (350)
|+++++++..++..+++||++.+++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999987755 68999999999999999999999999999999999
Q ss_pred eEeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh--CCCCCCCC
Q 018786 199 FLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS--GVPPFWGE 272 (350)
Q Consensus 199 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~--g~~pf~~~ 272 (350)
|++ +.++.++|+|||++........ .....++..|+|||.+. +.++.++||||||+++|+|++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999 5567899999999876533321 12344677899999875 468999999999999999998 77888777
Q ss_pred CHHHHHHHHHcC----CCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 273 TEQSIFDAILRG----HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 273 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.....+...... .........+.++.++.++|.+||+.||++|||+.++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 766665555432 11111111235678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=313.77 Aligned_cols=259 Identities=30% Similarity=0.485 Sum_probs=206.4
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC----
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR---- 140 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~---- 140 (350)
+.++|.+.+.||+|++|.||+|.+..+|+.||+|++.... ......++.+|+.++++++ |+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFES 79 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccc
Confidence 4578999999999999999999999999999999985322 2234466888999999998 99999999876543
Q ss_pred -CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 141 -HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 141 -~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
...++++||+.+ +|.+.+. ...+++..++.++.||+.||.+||++||+||||||+||++ +.++.+||+|||++.
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLAR 154 (336)
T ss_pred cceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECccccee
Confidence 357999999964 8877664 4579999999999999999999999999999999999999 667779999999987
Q ss_pred cccCCC----ccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------
Q 018786 220 FFKPGD----VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI------- 286 (350)
Q Consensus 220 ~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~------- 286 (350)
...... ......|+..|+|||.+. ..++.++||||||+++|+|++|+.||.+.........+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 653322 113356889999999764 3588999999999999999999999976554332222211000
Q ss_pred ---------------CCC-C----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 287 ---------------DFS-S----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 287 ---------------~~~-~----~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
... . ...+..+.++.++|.+||+.||++|||+.++++|+||....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000 0 01235678899999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=329.49 Aligned_cols=252 Identities=28% Similarity=0.503 Sum_probs=218.4
Q ss_pred cccccceeeeeeeeccCceEEEEEEEcc-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
+....+....+.||+|+||+||+|+... ....||||.++... +.+...+|++|++++..+. |||||+++|.+
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVrLlGVC 558 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVRLLGVC 558 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEE
Confidence 3445677788999999999999998642 35679999997543 4446789999999999999 99999999999
Q ss_pred EcCCceEEEEecCCCCCHHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeec
Q 018786 138 EDRHSVNLIMDLCAGGELFDRIIAKG--------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS 203 (350)
Q Consensus 138 ~~~~~~~iv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~ 203 (350)
..++.+++|+|||..|+|.++|..+. +++..+.++|+.||+.|+.||-++.+|||||..+|+||
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV-- 636 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV-- 636 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee--
Confidence 99999999999999999999997531 27889999999999999999999999999999999999
Q ss_pred CCCCCCeEEeecCCcccccCCCccc---cCCcCccccccccc-cccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 018786 204 SAEDSPLKATDFGLSVFFKPGDVFK---DLVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIF 278 (350)
Q Consensus 204 ~~~~~~vkl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~-~~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~ 278 (350)
+++..|||+|||+++..-..+.+. ...-..+|||||.+ -+.++.++||||||++|||+++ |..||.+...++.+
T Consensus 637 -ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 637 -GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred -ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 788889999999998754333221 23446789999976 5789999999999999999998 99999999999999
Q ss_pred HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
+.+..+.. ++.+ .++|.++.+|+..||+.+|.+||++.||=.
T Consensus 716 e~i~~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 716 ECIRAGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred HHHHcCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999887 4433 378999999999999999999999999854
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=304.47 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=202.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|++.+.||+|+||.||+|.++.+++.+|+|++..... ......+.+|+.+++++. |+||+++++++..++..++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEE
Confidence 3789999999999999999999999999999999865432 222345778999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||||+. +++.+.+.. ...+++..+..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++......
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIP 156 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCC
Confidence 999995 577776654 3567888999999999999999999999999999999999 56677999999998764322
Q ss_pred -CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCC--------------
Q 018786 225 -DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHI-------------- 286 (350)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~-------------- 286 (350)
.......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...... +.+..+.....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 12234457889999998753 4788999999999999999999999765432 22222211000
Q ss_pred CCCC------------CCCC--CCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 287 DFSS------------DPWP--NISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 287 ~~~~------------~~~~--~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.... ..+. ..+.++.+++.+||+.||.+|||+.|++.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 0000 125788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=308.99 Aligned_cols=257 Identities=29% Similarity=0.512 Sum_probs=215.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
..|.....||+|+||.||++.+..+++.||+|++..... ...+.+.+|+..++.+. |+|++++++.+..++..+++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEEE
Confidence 445566789999999999999998899999999864332 33467889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
+||+++++|.+++.. ..+++..++.++.|++.||.+||++||+|+||+|+||++ +.++.++|+|||++.......
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccccc
Confidence 999999999886654 568999999999999999999999999999999999999 667789999999987654322
Q ss_pred ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
......++..|+|||.+. ..++.++||||||+++|+|++|..||...........+...... .......++..+.++|
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~i 251 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVLRDFL 251 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHHHHHH
Confidence 223456889999999876 45889999999999999999999999877766665555433222 2222346788999999
Q ss_pred HHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 305 KKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.+||+.+|++||++.++++|+|+.+...
T Consensus 252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 252 ERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred HHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 9999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=303.96 Aligned_cols=253 Identities=30% Similarity=0.478 Sum_probs=209.6
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC--CceEEE
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HSVNLI 146 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~~iv 146 (350)
|.+.+.||.|++|.||+|.+..+++.+|+|.+.... ........+.+|+++++++. |+|++++++++... +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEE
Confidence 678899999999999999999999999999997654 23334467889999999998 99999999999887 899999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
+||+.+ +|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||++ ++++.++|+|||.+.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCC
Confidence 999965 888888665 579999999999999999999999999999999999999 667789999999988765443
Q ss_pred --ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC---------
Q 018786 226 --VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP--------- 292 (350)
Q Consensus 226 --~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------- 292 (350)
......++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+...........
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 2234456888999997643 478999999999999999999999988776655554443211111110
Q ss_pred -----------------CCC-CCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 293 -----------------WPN-ISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 293 -----------------~~~-~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
... ++..+.++|.+||+.||++||++.+++.++||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 112 27889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=299.19 Aligned_cols=248 Identities=23% Similarity=0.388 Sum_probs=208.2
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|++.++||+|++|.||+|.+.. +..+|+|.+.... ...+.+.+|+.+++++. |+||+++++.+...+..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcE
Confidence 45789999999999999999999754 5679999876432 23467899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 145 LIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++|||+++++|.+++... ..+++..+..++.|++.||+|||+++++|+||||+||++ +.++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIE 154 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecC
Confidence 999999999999998753 458899999999999999999999999999999999999 567789999999998764
Q ss_pred CCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 223 PGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 223 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.... .....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+...... +....++.
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM---PRMENCPD 231 (261)
T ss_pred CCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCH
Confidence 4321 12234567799999875 458889999999999999998 99999887777766666554321 22246789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
++.+++.+||+.||++||+++++++.
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~~ 257 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQSV 257 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=296.14 Aligned_cols=252 Identities=30% Similarity=0.494 Sum_probs=216.3
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|.+.+.||+|++|.||++.+..+++.+++|.+..... .....+.+.+|+++++++. |+|++++++++...+..+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Confidence 58899999999999999999998899999999976543 2345678999999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc-
Q 018786 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV- 226 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~- 226 (350)
|++++++|.+++.....+++..++.++.|++.+|.+||++||+|+||+|+||++ +.++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCCCccc
Confidence 999999999999888889999999999999999999999999999999999999 5567899999999987654432
Q ss_pred cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 305 (350)
.....++..|++||...+ ..+.++|||+||+++|+|++|..||................... ....++..+.++|.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP---LPEGISPELKDFLM 232 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCC---CCCCCCHHHHHHHH
Confidence 234567889999998753 47889999999999999999999998766555444444322221 12357899999999
Q ss_pred HhcccCccCCCCHHHHHhccCC
Q 018786 306 KMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 306 ~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
+||+.+|++|||+.+++.++||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=299.53 Aligned_cols=249 Identities=28% Similarity=0.478 Sum_probs=203.0
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEe
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
......||+|+||.||+|.+..++..|++|.+... .....+.+.+|+.++++++ |+||+++++++..++..++++|
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEe
Confidence 33446899999999999999988999999988643 2334567899999999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 149 LCAGGELFDRIIAK-GHY--SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 149 ~~~~~sL~~~l~~~-~~~--~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|+++++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. .++.++|+|||.+.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~--~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCeEEEecchhheecccCC
Confidence 99999999998764 445 88889999999999999999999999999999999952 24579999999987654322
Q ss_pred -ccccCCcCccccccccccc---cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH--HcCCCCCCCCCCCCCCH
Q 018786 226 -VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSI-FDAI--LRGHIDFSSDPWPNISS 298 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~ 298 (350)
......+++.|+|||.+.+ .++.++||||||+++|+|++|..||........ .... ....... ...++.
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 239 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI----PESLSA 239 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCC----CcccCH
Confidence 2234468899999998743 378899999999999999999999975443221 1111 1111111 125788
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
++.+++.+||+.+|++|||+.+++.|+||
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999999999996
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=313.36 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=202.0
Q ss_pred ccccceeeeeeeeccCceEEEEEEEcc-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
.-.++|++.+.||.|+||.||+|.... +++.||+|++.... .....+.+.+|+.++.++.+|+||+++++++.
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 345789999999999999999997543 45789999986432 22344678889999999955999999999775
Q ss_pred -cCCceEEEEecCCCCCHHHHHHHc-------------------------------------------------------
Q 018786 139 -DRHSVNLIMDLCAGGELFDRIIAK------------------------------------------------------- 162 (350)
Q Consensus 139 -~~~~~~iv~e~~~~~sL~~~l~~~------------------------------------------------------- 162 (350)
.+..++++|||+++++|.+++...
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 456788999999999999888542
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc---cccCCcC
Q 018786 163 ------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGS 233 (350)
Q Consensus 163 ------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt 233 (350)
..+++..+..++.||+.||.|||++||+||||||+|||+ ++++.++|+|||++........ .....++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 257889999999999999999999999999999999999 5567799999999987543221 1223456
Q ss_pred cccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 234 AYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIF-DAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 234 ~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
..|+|||++. ..++.++|||||||++|+|++ |..||.+....+.. ..+......... ...+.++.+++.+||+.
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP---EYATPEIYSIMLDCWHN 315 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCC---ccCCHHHHHHHHHHccC
Confidence 7899999764 568999999999999999998 99999765443333 333332222111 25688999999999999
Q ss_pred CccCCCCHHHHHhcc
Q 018786 311 DPKERLSAAEVLSKF 325 (350)
Q Consensus 311 dp~~Rps~~~iL~~~ 325 (350)
+|++||++.++++++
T Consensus 316 ~p~~RPs~~ell~~l 330 (337)
T cd05054 316 NPEDRPTFSELVEIL 330 (337)
T ss_pred ChhhCcCHHHHHHHH
Confidence 999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=298.17 Aligned_cols=254 Identities=27% Similarity=0.459 Sum_probs=210.7
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccc--cCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC--Cc
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRK--LINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HS 142 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~ 142 (350)
.+|.+.+.||+|++|.||+|.+..+++.+|+|.+.... .........+.+|+++++++. |+||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence 57999999999999999999999999999999875432 122344568899999999998 99999999988654 46
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+++++||+++++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccccc
Confidence 88999999999999999887889999999999999999999999999999999999999 556679999999987653
Q ss_pred CC----CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 223 PG----DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 223 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.. .......++..|+|||.+.+ .++.++|+||||+++|++++|+.||......+....+..... .......++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~ 235 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLPDGVS 235 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCCcccC
Confidence 21 12234568899999998764 478999999999999999999999987765554444432211 111224678
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
+.+.++|.+||+ +|..||++.+++.|+|.
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 999999999998 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=298.12 Aligned_cols=247 Identities=22% Similarity=0.409 Sum_probs=207.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|++|+||+|.+.. +..+|+|.+..... ..+.+.+|+.+++++. ||||+++++++......+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEE
Confidence 679999999999999999998765 45699998864322 2356899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||+.+++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||++ +.++.+||+|||.+.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCc
Confidence 9999999999998764 468999999999999999999999999999999999999 566789999999987654332
Q ss_pred cc--ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 226 VF--KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 226 ~~--~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.. ....++..|++||.+. ..++.++||||||+++|+|++ |..||......+....+......... ...+..+.
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVY 231 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence 21 1223456799999876 458899999999999999998 99999887777777766665433222 24588999
Q ss_pred HHHHHhcccCccCCCCHHHHHhcc
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+++.+||+.||++||++.+++..+
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHhh
Confidence 999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=299.09 Aligned_cols=244 Identities=25% Similarity=0.432 Sum_probs=209.7
Q ss_pred eeeeccCceEEEEEEEccC---CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEec
Q 018786 73 RELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~ 149 (350)
+.||+|+||.||+|.+... +..+++|.+..... ....+.+.+|++.++.+. |+|++++++++.....++++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence 4789999999999999866 88999999975432 224678999999999999 99999999999999999999999
Q ss_pred CCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 150 CAGGELFDRIIAK---------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 150 ~~~~sL~~~l~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
+++++|.+++... ..+++..++.++.||+.||.+||++|++|+||+|+||++ +.++.++|+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence 9999999999875 679999999999999999999999999999999999999 5667899999999987
Q ss_pred ccCCC---ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 221 FKPGD---VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 221 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... ......++..|+|||.+.. .++.++||||||+++|+|++ |..||...........+........ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK---PEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence 65432 2234457888999998764 58899999999999999999 6999998887777777765332211 235
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++.++.+++.+||+.||++|||+.|+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=296.07 Aligned_cols=253 Identities=32% Similarity=0.533 Sum_probs=214.3
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC--CceEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HSVNL 145 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~~i 145 (350)
+|++.+.||+|++|.||+|.+..+++.+++|++..... .....+.+.+|+..++++. |+||+++++.+... ..+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEE
Confidence 47889999999999999999998899999999865443 2345678999999999999 99999999999888 89999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
++|++++++|.+++.....+++..++.++.|++.+|.|||++|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEeccccc
Confidence 99999999999999887789999999999999999999999999999999999999 556779999999988866554
Q ss_pred c---cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 226 V---FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 226 ~---~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
. .....++..|++||.+.. ..+.++||||||+++++|++|..||.... .......+... .........++..+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 233 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS--GEPPEIPEHLSEEA 233 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc--CCCcCCCcccCHHH
Confidence 3 345678899999998764 48899999999999999999999997765 22222222211 11111123568999
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.++|.+||+.||++||++.+++.|+||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=295.31 Aligned_cols=251 Identities=30% Similarity=0.525 Sum_probs=213.0
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|.+.+.||.|++|.||++.+..+++.+++|++..... .....+.+|+.+++++. |++++++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEE
Confidence 47889999999999999999998899999999965432 35578999999999999 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 148 DLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 148 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
||+++++|.+++... ..+++..+..++.|++.+|.+||++|++|+||+|+||++ ++++.++|+|||.+........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc
Confidence 999999999988776 579999999999999999999999999999999999999 5567799999999988665443
Q ss_pred cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 305 (350)
.....++..|++||.+.+ ..+.++|+||||+++|+|++|..||...................... ...++..+.++|.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRN-PEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCc-ccccCHHHHHHHH
Confidence 345678899999998763 47889999999999999999999998775544444433322211111 1134889999999
Q ss_pred HhcccCccCCCCHHHHHhccC
Q 018786 306 KMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 306 ~~L~~dp~~Rps~~~iL~~~~ 326 (350)
+||+.||++|||+.++|.|+|
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=305.29 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=210.7
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccC-----CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
+....++|++.+.||+|++|.||++..... ...+|+|.+.... .......+.+|+.+++++.+|+||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 344558899999999999999999998643 3789999986432 233456788999999999559999999999
Q ss_pred EEcCCceEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceE
Q 018786 137 YEDRHSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200 (350)
Q Consensus 137 ~~~~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl 200 (350)
+...+.++++|||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 99999999999999999999998642 45889999999999999999999999999999999999
Q ss_pred eecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 018786 201 FSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQ 275 (350)
Q Consensus 201 ~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~ 275 (350)
+ ++++.+||+|||++........ .....++..|+|||++. ..++.++||||||+++|++++ |..||......
T Consensus 165 ~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 165 V---TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred E---cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 9 5677899999999987543321 12223456799999865 458899999999999999997 99999887777
Q ss_pred HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+....+....... ....++.++.+++.+||+.||++|||+.++++++
T Consensus 242 ~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 242 ELFKLLKEGYRME---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred HHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 6666665543221 1125689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=315.60 Aligned_cols=264 Identities=27% Similarity=0.423 Sum_probs=213.4
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE----cC
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE----DR 140 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~----~~ 140 (350)
+..+|.+.+.||.|++|.||+|.++.+++.||+|++..... .......+.+|+.+++++. |+||+++++++. ..
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCC
Confidence 34789999999999999999999999999999999875432 2234567888999999998 999999998775 34
Q ss_pred CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
...++||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARG 156 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEeccccccee
Confidence 56899999995 5899988877789999999999999999999999999999999999999 6677899999999876
Q ss_pred ccCCCc-----cccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------
Q 018786 221 FKPGDV-----FKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG--------- 284 (350)
Q Consensus 221 ~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~--------- 284 (350)
...... .....++..|+|||.+.+ .++.++||||||+++|+|++|+.||...........+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 543221 124578899999998743 4789999999999999999999999766543332221110
Q ss_pred --------------CCCCCCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 285 --------------HIDFSSD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 285 --------------~~~~~~~----~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
....... ..+..+.++.++|.+||+.||++||++.+++.|+||.+...+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 0000000 1245689999999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=301.21 Aligned_cols=253 Identities=22% Similarity=0.360 Sum_probs=209.2
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccC-----CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
...++|.+.+.||+|+||.||+|.++.. +..+|+|.+.... .......+.+|+.+++++. |+||+++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~ 79 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVS 79 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEc
Confidence 3457899999999999999999998643 4789999985432 2233457889999999998 999999999999
Q ss_pred cCCceEEEEecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCC
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAKG----------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~ 208 (350)
.....++||||+++++|.+++.... .+++..+..++.||+.||.|||+++|+||||||+||++ +.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCC
Confidence 9999999999999999999986532 36788999999999999999999999999999999999 6677
Q ss_pred CeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHc
Q 018786 209 PLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILR 283 (350)
Q Consensus 209 ~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~ 283 (350)
.+||+|||++........ .....++..|+|||.+. +.++.++||||||+++|++++ |..||...........+..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 899999999876543321 12334677899999875 558899999999999999998 9999988877777666664
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
....... ..++.++.++|.+||+.+|++|||+.++++.+
T Consensus 237 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 275 (277)
T cd05032 237 GGHLDLP---ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275 (277)
T ss_pred CCCCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence 3322111 24689999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=301.61 Aligned_cols=260 Identities=27% Similarity=0.409 Sum_probs=209.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc--CCceE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHSVN 144 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~~~ 144 (350)
++|...+.||.|++|.||++.+..+++.+|+|.+.... ......++.+|+++++++. |+||+++++++.. ...++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEE
Confidence 46889999999999999999999999999999986442 2244577899999999998 9999999998754 34689
Q ss_pred EEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 145 LIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeecccccc
Confidence 99999999999887653 3458999999999999999999999999999999999999 5566799999999876
Q ss_pred ccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCCCCC-CCC
Q 018786 221 FKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGE-----TEQSIFDAILRGHIDFSS-DPW 293 (350)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~-----~~~~~~~~~~~~~~~~~~-~~~ 293 (350)
...... ....++..|++||.+. ..++.++||||||+++|+|++|..||... ...+....+......... ...
T Consensus 155 ~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 155 LVNSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred cccccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 543321 2345788899999875 45889999999999999999999999765 223333333332211111 111
Q ss_pred --CCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 294 --PNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 294 --~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
..+++.+.++|.+||+.||++|||+.|++.|+|+.+..-+
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 1346789999999999999999999999999999665544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=297.39 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=207.6
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|++.+.||+|++|.||+|.+.. ++.||+|.++.... ..+.+.+|+.+++++. |+||+++++++...+..+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCCee
Confidence 45779999999999999999999765 57899999865332 2466889999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 145 LIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||++.+++|.+++.... .+++..+..++.|++.||.+||++||+|+||||+||++ +.++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIK 154 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEcc
Confidence 9999999999999987654 68999999999999999999999999999999999999 566779999999988765
Q ss_pred CCCcc--ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 223 PGDVF--KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 223 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
..... .....+..|+|||.+. ..++.++||||||+++|+|++ |+.||.+.........+..... .+. ...++.
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~ 231 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-MPC--PPGCPK 231 (261)
T ss_pred CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCC--CCcCCH
Confidence 33211 1112235799999876 458899999999999999999 9999988877766666654422 111 235789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+.+++.+||+.||++||++.+++..+
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~~l 258 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQWKL 258 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=304.99 Aligned_cols=250 Identities=22% Similarity=0.385 Sum_probs=209.0
Q ss_pred cceeeeeeeeccCceEEEEEEEccC-----CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
.+|.+.+.||+|+||.||+|.+..+ ++.||+|++.... .....+.+.+|+.++.++. |+||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCC
Confidence 5688999999999999999987543 5789999986432 2334567889999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC
Q 018786 142 SVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 205 (350)
..++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||.||++ +
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---F 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---c
Confidence 999999999999999988532 347888899999999999999999999999999999999 5
Q ss_pred CCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 018786 206 EDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDA 280 (350)
Q Consensus 206 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~ 280 (350)
+++.+||+|||++........ .....+++.|+|||.+. +.++.++||||||+++|||++ |..||.+....+....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 567799999999876533221 22344677899999864 568999999999999999998 8889988888777777
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+......... ..++.++.+++.+||+.+|++||++.++++.+
T Consensus 239 i~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 239 IRNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred HHcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 7766543222 36789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=302.99 Aligned_cols=266 Identities=24% Similarity=0.343 Sum_probs=214.7
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
....++|.+.+.||.|++|.||+|.+..+++.+|||.++... .......+..|+.++.+..+|+||+++++++.....
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 344578999999999999999999999889999999996543 222345667788777777679999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 143 VNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.+++|||+. +++.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||++ ++++.++|+|||.+..
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGR 164 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchh
Confidence 999999985 477777655 4578999999999999999999997 599999999999999 5677899999999887
Q ss_pred ccCCCccccCCcCccccccccccc-----cCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCC
Q 018786 221 FKPGDVFKDLVGSAYYVAPEVLRR-----NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 294 (350)
...........++..|+|||.+.+ .++.++|+||||+++|+|++|+.||..... .+.+..+......... ...
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 243 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP-PNE 243 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC-CCC
Confidence 654444444567889999998753 378899999999999999999999975432 3344444443322111 112
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhH
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~ 335 (350)
.++.++.++|.+||+.||++||++.+++.|+|+........
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~ 284 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHH
Confidence 47899999999999999999999999999999988654433
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=305.50 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=208.0
Q ss_pred cccccceeeeeeeeccCceEEEEEEEcc-------CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEe
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKD-------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKG 135 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~ 135 (350)
+...++|.+.+.||+|+||.||++.+.. +...+|+|.+.... .......+.+|+.+++++.+|+||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3445789999999999999999998743 23569999986432 23345678889999999955999999999
Q ss_pred EEEcCCceEEEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCce
Q 018786 136 AYEDRHSVNLIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (350)
Q Consensus 136 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NI 199 (350)
++...+..++||||+.+++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999997642 478899999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecCCcccccCCCcc---ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 018786 200 LFSSSAEDSPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETE 274 (350)
Q Consensus 200 l~~~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~ 274 (350)
++ +.++.+||+|||.+......... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.....
T Consensus 172 ll---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 172 LV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred EE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99 56678999999998765432211 1123456799999875 458899999999999999998 8899987776
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+....+...... .....++.++.++|.+||+.+|++|||+.++++++
T Consensus 249 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 249 EELFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred HHHHHHHHcCCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 6666655544321 11235789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=310.60 Aligned_cols=264 Identities=30% Similarity=0.420 Sum_probs=213.8
Q ss_pred cccceee-eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChh-----------hHHHHHHHHHHHHHccCCCCeeE
Q 018786 65 VRNTYIF-GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-----------DVEDVRREVQIMHHLTGHRNIVE 132 (350)
Q Consensus 65 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~~h~~iv~ 132 (350)
+.++|.. .+.||.|+||+||+|.+..+++.||||++......... ....+.+|+++++++. |+||++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~ 84 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMG 84 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccceee
Confidence 4567764 57799999999999999999999999998654321110 1124778999999998 999999
Q ss_pred eEeEEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEE
Q 018786 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212 (350)
Q Consensus 133 ~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl 212 (350)
+++++..++..+++|||+. ++|.+++.....+++..+..++.||+.||++||++||+|+||+|+||++ +.++.++|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~~~kl 160 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGICKI 160 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCCCEEE
Confidence 9999999999999999996 5999999888889999999999999999999999999999999999999 56678999
Q ss_pred eecCCcccccCC---------------CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 018786 213 TDFGLSVFFKPG---------------DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQ 275 (350)
Q Consensus 213 ~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~ 275 (350)
+|||.+...... .......++..|+|||.+.+ .++.++|+||||+++|+|++|..||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999998765411 11123356788999998753 3688999999999999999999999888776
Q ss_pred HHHHHHHcCCCCCCCC------------------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 276 SIFDAILRGHIDFSSD------------------------PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
+.+..+.......... ..+..+.++.++|.+||+.||++|||+.|+|.|+||....
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 6555443311111000 1134578899999999999999999999999999999876
Q ss_pred hh
Q 018786 332 LQ 333 (350)
Q Consensus 332 ~~ 333 (350)
.+
T Consensus 321 ~~ 322 (335)
T PTZ00024 321 LP 322 (335)
T ss_pred CC
Confidence 54
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=302.83 Aligned_cols=262 Identities=31% Similarity=0.490 Sum_probs=220.6
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...+.|.+.+.||.|++|.||+|.+..+++.+++|++..... ..+.+.+|++.++++. |+|++++++.+......
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECCEE
Confidence 355779999999999999999999998899999999964332 4567889999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++++||+++++|.+++.... .+++..+..++.|++.||.+||+.||+|+||+|+||++ +.++.++|+|||.+....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhc
Confidence 99999999999999998876 89999999999999999999999999999999999999 556779999999887654
Q ss_pred CCC-ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 223 PGD-VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 223 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
... ......++..|++||.+. ..++.++|+||||+++|+|++|..||...........+....... ......++.++
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l 246 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP-LKNPEKWSPEF 246 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CcchhhCCHHH
Confidence 322 223345788999999875 458899999999999999999999998776655444443332221 11123478999
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
.++|.+||+.+|.+||++.+++.|+|+.+.++..
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 280 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKE 280 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhhChHhhccCchH
Confidence 9999999999999999999999999999976643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=304.13 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=207.5
Q ss_pred cccccceeeeeeeeccCceEEEEEEE-----ccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTH-----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
....++|.+.+.||+|+||.||++.+ ..++..+|+|+++... .....+.+.+|+.+++++.+|+||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 34457899999999999999999985 2345689999986432 2334567899999999995599999999999
Q ss_pred EcCCceEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeec
Q 018786 138 EDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (350)
Q Consensus 138 ~~~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Df 215 (350)
...+..+++|||+.+++|.+++.... .+++..+..++.||+.||.|||+++|+|+||||+||++ +.++.++|+||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~df 185 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDF 185 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCC
Confidence 99999999999999999999987643 38999999999999999999999999999999999999 56677999999
Q ss_pred CCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCC
Q 018786 216 GLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSS 290 (350)
Q Consensus 216 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 290 (350)
|++........ .....++..|+|||.+. +.++.++||||||+++|++++ |..||......+..............
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 99876543221 12234567899999875 458899999999999999998 99999776654444333332222211
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 291 ~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
....+.++.+++.+||+.+|++|||+.++++.+
T Consensus 266 --~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l 298 (302)
T cd05055 266 --PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298 (302)
T ss_pred --CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 124688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=302.96 Aligned_cols=250 Identities=24% Similarity=0.431 Sum_probs=208.2
Q ss_pred ccceeeeeeeeccCceEEEEEEEcc-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
..+|.+.+.||+|+||.||+|.+.. ++..+++|.+... .......+.+|++.++++. |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDG 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccC
Confidence 3679999999999999999998643 4567899987533 2233467889999999998 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecC
Q 018786 141 HSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS 204 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 204 (350)
+..++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~--- 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV--- 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---
Confidence 9999999999999999998753 237899999999999999999999999999999999999
Q ss_pred CCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 018786 205 AEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFD 279 (350)
Q Consensus 205 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~ 279 (350)
+.++.++|+|||++........ .....++..|+|||.+. ..++.++||||||+++|+|++ |..||......+...
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 5667899999999876543221 12344678899999875 458889999999999999998 999998888777776
Q ss_pred HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+..+...... ..++..+.+++.+||+.||++|||+.++++.+
T Consensus 237 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 237 CITQGRVLERP---RVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred HHhCCCCCCCC---ccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 66655443222 24688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=299.69 Aligned_cols=249 Identities=23% Similarity=0.380 Sum_probs=202.4
Q ss_pred eeeeeeeeccCceEEEEEEEccCCc--EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc------C
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQ--QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED------R 140 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~------~ 140 (350)
+.+++.||+|+||.||+|.+..++. .+|+|.++.... .....+.+.+|+.++++++ |+||+++++.+.. .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCC
Confidence 3567899999999999999877665 689998865432 3445678899999999998 9999999987632 2
Q ss_pred CceEEEEecCCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEee
Q 018786 141 HSVNLIMDLCAGGELFDRIIA------KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
...+++|||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECC
Confidence 357899999999999988743 1347899999999999999999999999999999999999 5677899999
Q ss_pred cCCcccccCCCcc---ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCC
Q 018786 215 FGLSVFFKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFS 289 (350)
Q Consensus 215 fg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 289 (350)
||++......... ....+++.|++||.+. ..++.++||||||+++|+|++ |..||...........+..+.....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ 235 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9999876433211 1223567899999876 458999999999999999999 8999988777777766665433221
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 290 ~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+.++..+.++|.+||+.||++|||+.++++++
T Consensus 236 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 236 ---PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred ---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 235788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=300.99 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=211.7
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
....+|++.+.||.|++|.||+|.+.. ++.+++|++.... ......+.+|+.+++.++ |+||+++++++......
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPV 77 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCe
Confidence 345779999999999999999999988 8889999986543 223467889999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 144 NLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||++ ++++.+||+|||.+...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLI 154 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhc
Confidence 9999999999999999753 458999999999999999999999999999999999999 56677999999999776
Q ss_pred cCCCc-cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 222 KPGDV-FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 222 ~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
..... .....++..|++||.+. +.++.++||||||+++|+|++ |..||......+....+...... +. ...++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~ 231 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-PC--PAKCPQ 231 (261)
T ss_pred CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-CC--CCCCCH
Confidence 43321 12334567799999875 458889999999999999998 89999888777777766644222 11 236789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+.++|.+||+.||++|||+.++++.+
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 232 EIYKIMLECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=309.00 Aligned_cols=258 Identities=29% Similarity=0.477 Sum_probs=203.4
Q ss_pred ceeeeeeeeccCceEEEEEEEcc--CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC--Cce
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HSV 143 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~ 143 (350)
+|.+.+.||+|++|.||+|.+.. +++.||+|.+...........+.+.+|+.++.++. |+||+++++++... ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence 58899999999999999999988 89999999997644223334467888999999998 99999999999888 889
Q ss_pred EEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeec-CCCCCCeEEeecCC
Q 018786 144 NLIMDLCAGGELFDRIIAK-----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS-SAEDSPLKATDFGL 217 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~-~~~~~~vkl~Dfg~ 217 (350)
++||||+++ ++.+++... ..+++..++.++.||+.||.|||+++|+||||||+||+++. ++.++.+||+|||+
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999999965 777766432 26899999999999999999999999999999999999954 22278899999999
Q ss_pred cccccCCCc----cccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHH
Q 018786 218 SVFFKPGDV----FKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQS---------IFDAIL 282 (350)
Q Consensus 218 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~---------~~~~~~ 282 (350)
+........ .....++..|+|||.+.+ .++.++||||||+++++|++|+.||....... .+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 887543321 233467888999997653 47899999999999999999999997554321 111110
Q ss_pred cCCC---------------------CCCCCCCC------------CCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 283 RGHI---------------------DFSSDPWP------------NISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 283 ~~~~---------------------~~~~~~~~------------~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.... .......+ ..+.++.++|.+||+.||++|||+.|++.|+||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0000 00000111 456789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=316.69 Aligned_cols=261 Identities=23% Similarity=0.406 Sum_probs=219.9
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCc---E-EEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEe
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQ---Q-FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKG 135 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~ 135 (350)
..++..-++..+.++||+|+||.||+|..+..+. . ||+|..+...........++.+|++++++++ |+|||+++|
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yG 228 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYG 228 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEE
Confidence 3344445667777999999999999999876422 3 8999987655556778889999999999998 999999999
Q ss_pred EEEcCCceEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEee
Q 018786 136 AYEDRHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 136 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
+......+++|||+|.||+|.++|+..+ .++..+...++.+.+.||+|||+++++||||-.+|||+ ..+..+||+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISD 305 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISD 305 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCc
Confidence 9999999999999999999999999877 49999999999999999999999999999999999999 5666689999
Q ss_pred cCCcccccCCCccc-cCCcCccccccccccc-cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 018786 215 FGLSVFFKPGDVFK-DLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 215 fg~a~~~~~~~~~~-~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
||+++.-....... ...-...|+|||.+.. -++.++||||||+++||+++ |..||.+....+....+.......+.+
T Consensus 306 FGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 306 FGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP 385 (474)
T ss_pred cccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC
Confidence 99987743111111 1224567999999874 59999999999999999998 889999999998888885554444433
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
. ..+.++..++.+|+..||++||++.++.+.+-
T Consensus 386 ~--~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 386 S--KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred C--CCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence 2 56889999999999999999999999976543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=302.56 Aligned_cols=256 Identities=28% Similarity=0.467 Sum_probs=214.2
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
+.|...+.||+|++|+||+|.+..+++.+++|.+.............+.+|++++++++ |+|++++++++.+....++|
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEEEE
Confidence 44777889999999999999999999999999997654444445567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||+. +++.+.+.. ...+++..+..++.||+.+|.|||++|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 100 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 100 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC--
Confidence 99995 477777765 4568999999999999999999999999999999999999 5667799999999865332
Q ss_pred ccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.....|+..|+|||.+. +.++.++||||||+++|+|++|..||...........+.....+. ...+.++..+.
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 250 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT--LQSNEWTDSFR 250 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCccccCHHHH
Confidence 23457889999999863 457889999999999999999999998776555554444332221 12235678899
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
+++.+||+.+|.+||++.+++.|+||.....
T Consensus 251 ~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 251 GFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=304.70 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=209.4
Q ss_pred cccccceeeeeeeeccCceEEEEEEEcc-------CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEe
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKD-------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKG 135 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~ 135 (350)
+...++|.+.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++++.+|+||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3445789999999999999999998632 34579999986432 23345678899999999966999999999
Q ss_pred EEEcCCceEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCce
Q 018786 136 AYEDRHSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (350)
Q Consensus 136 ~~~~~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NI 199 (350)
++...+.++++|||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999999999999999999999999653 2478899999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 018786 200 LFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETE 274 (350)
Q Consensus 200 l~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~ 274 (350)
++ ++++.+||+|||.+........ .....++..|+|||++. +.++.++||||||+++|++++ |..||.....
T Consensus 166 ll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 166 LV---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EE---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99 5567799999999986543221 11223446799999875 458899999999999999999 8999988877
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
.+....+....... ....++.++.++|.+||+.||++|||+.++++.+.
T Consensus 243 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 243 EELFKLLREGHRMD---KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred HHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 77776665543211 12357889999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.25 Aligned_cols=257 Identities=28% Similarity=0.474 Sum_probs=213.5
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||+|+||.||++.+..+++.|++|.+.... ....+.+.+|+.+++++. |+|++++++.+...+..++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-HPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcEEE
Confidence 478999999999999999999998889999999985432 223467889999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|+||+++++|.+++... .+++..+..++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecccccc
Confidence 99999999999987653 58899999999999999999999999999999999999 556779999999887654332
Q ss_pred -ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 226 -VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
......+++.|++||.+. +.++.++|+||||+++|++++|..||...........+..... ........++..+.++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l 248 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRDF 248 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccCHHHHHH
Confidence 223446888999999875 4588999999999999999999999987655443333222211 1111223467899999
Q ss_pred HHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
|.+||+.+|++||++.+++.|+||....
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=299.87 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=204.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCc----EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQ----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
..+|.+.+.||.|+||+||+|.+..+++ .||+|++.... .......+.+|+.+++.+. |+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLT-S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-C
Confidence 4689999999999999999999876665 48999886432 3344567889999999998 9999999998865 4
Q ss_pred ceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..+++++++++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||++ ++++.+||+|||++..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGLARL 158 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCceee
Confidence 57799999999999999876 4568999999999999999999999999999999999999 5566799999999987
Q ss_pred ccCCCcc---ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 221 FKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 221 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
....... ....++..|++||.+. ..++.++||||||+++|||++ |..||...........+........ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 235 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ---PPI 235 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---Ccc
Confidence 6433221 1223467799999875 458899999999999999998 9999987776665555554332221 235
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++.++.++|.+||+.||++||++.+++..+
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l 265 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVDEF 265 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 789999999999999999999999999653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=299.12 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=204.4
Q ss_pred eeeeeeeeccCceEEEEEEEccC---CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc---
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS--- 142 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~--- 142 (350)
|++++.||+|+||.||+|....+ +..+|+|.++.... .....+.+.+|+..++.+. |+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence 56889999999999999997653 47899999875332 3344567899999999998 9999999998765443
Q ss_pred ---eEEEEecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEe
Q 018786 143 ---VNLIMDLCAGGELFDRIIAK------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (350)
Q Consensus 143 ---~~iv~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~ 213 (350)
.++++||+++++|..++... ..+++..++.++.|++.||.|||+++|+||||||+||++ ++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence 78999999999999888542 358999999999999999999999999999999999999 566789999
Q ss_pred ecCCcccccCCCcc---ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCC
Q 018786 214 DFGLSVFFKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDF 288 (350)
Q Consensus 214 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 288 (350)
|||++......... ....++..|+|||.+. ..++.++||||||+++|||++ |..||......+....+.......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99998875433211 1223466799999875 458899999999999999999 999998887777776666543322
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 289 ~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
. ...++.++.+++.+||+.||++|||+.+++.++
T Consensus 236 ~---~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 236 Q---PEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred C---CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2 235789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=313.22 Aligned_cols=263 Identities=24% Similarity=0.339 Sum_probs=207.9
Q ss_pred ccccCCcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeE
Q 018786 55 GRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134 (350)
Q Consensus 55 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~ 134 (350)
..+.........++|.-...||+|+||.||+|...+. ..||||.+....... ..+|.+|+.++.+++ |+|+|+++
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~Nlv~Ll 137 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HPNLVKLL 137 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-CcCcccEE
Confidence 3344455566678999999999999999999999774 889999875433211 355999999999999 99999999
Q ss_pred eEEEcCC-ceEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CEeecCCCCceEeecCCCCC
Q 018786 135 GAYEDRH-SVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMG---VMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 135 ~~~~~~~-~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~ 208 (350)
|||.+.+ ...+|+||++.|+|.+++.... .++|..+.+|+.++++||+|||... |||||||++|||+ |++.
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~ 214 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDF 214 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCC
Confidence 9999888 4999999999999999998755 8999999999999999999999854 9999999999999 7788
Q ss_pred CeEEeecCCcccccC-CCccccC-CcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---
Q 018786 209 PLKATDFGLSVFFKP-GDVFKDL-VGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGET---EQSIFD--- 279 (350)
Q Consensus 209 ~vkl~Dfg~a~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~---~~~~~~--- 279 (350)
..||+|||+|..... ....... .||..|++||.+. +..+.++||||||++|+|+++|+.+..... ......
T Consensus 215 ~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 215 NAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred CEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 899999999976554 3333333 8999999999875 679999999999999999999998876432 111111
Q ss_pred -HHHcC-CCCCCCCCC--CCCC-----HHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 280 -AILRG-HIDFSSDPW--PNIS-----SSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 280 -~~~~~-~~~~~~~~~--~~~~-----~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+.++ ...+.++.. ...+ ..+..+..+|++.+|.+||++.|+++.+
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 11121 111112111 1223 2356788899999999999999987766
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=296.22 Aligned_cols=245 Identities=36% Similarity=0.687 Sum_probs=214.6
Q ss_pred eeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCCC
Q 018786 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (350)
Q Consensus 75 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~s 154 (350)
||.|++|.||++.+..+++.+|+|++...........+.+.+|+.+++++. |+||+++++.+..+...+++||++.+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 689999999999999889999999997765544556678999999999998 9999999999999999999999999999
Q ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-CccccCCcC
Q 018786 155 LFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DVFKDLVGS 233 (350)
Q Consensus 155 L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt 233 (350)
|.+++.....+++..+..++.|++.||.+||+.+++|+||+|+||++ +.++.++|+|||.+...... .......++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCC
Confidence 99999888889999999999999999999999999999999999999 55677999999998876443 223445688
Q ss_pred ccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 018786 234 AYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312 (350)
Q Consensus 234 ~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp 312 (350)
..|++||...+ ..+.++|+||||+++|++++|..||...........+.......+. .++..+.++|.+||..||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLLQKDP 232 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhcCCH
Confidence 89999998754 4788999999999999999999999888776666666664444433 458999999999999999
Q ss_pred cCCCCH---HHHHhccCC
Q 018786 313 KERLSA---AEVLSKFLI 327 (350)
Q Consensus 313 ~~Rps~---~~iL~~~~~ 327 (350)
++||++ .+++.|+||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=298.64 Aligned_cols=245 Identities=26% Similarity=0.370 Sum_probs=199.1
Q ss_pred eeeeccCceEEEEEEEccCCc--EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQ--QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~ 150 (350)
+.||+|+||.||+|.+..++. .+++|.++.. ......+.+.+|+++++++..|+||+++++++...+..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999987765 4688877532 233445678899999999966999999999999999999999999
Q ss_pred CCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEee
Q 018786 151 AGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 151 ~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||++ +.++.+||+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECC
Confidence 9999999987542 47889999999999999999999999999999999999 6677899999
Q ss_pred cCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 018786 215 FGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292 (350)
Q Consensus 215 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
||++..............+..|+|||.+. ..++.++||||||+++|+|++ |..||......+....+...... ..
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~ 232 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL---EK 232 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC---CC
Confidence 99986432211111223356799999875 458899999999999999997 99999887776666665543211 11
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
...++.++.+++.+||+.||.+|||+.+++..+
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 124688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=296.45 Aligned_cols=251 Identities=27% Similarity=0.476 Sum_probs=215.8
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|++.+.||+|++|.||++.+..+++.+++|.+..... ......++.+|+..++++. |+||+++++++......++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEe
Confidence 58899999999999999999999999999999875443 2334567888999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 148 DLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 148 e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
||+++++|.+++.. ...+++..+..++.|++.||.+||++|++|+||+|+||+++ .++.+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhcc
Confidence 99999999998865 35689999999999999999999999999999999999994 466799999999987654
Q ss_pred CCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
. ......++..|++||.+.+ .++.++|+||||+++|+|++|..||......+....+......... ..++.++.+
T Consensus 156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (256)
T cd08530 156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP---PIYSQDLQN 231 (256)
T ss_pred C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---hhhCHHHHH
Confidence 4 3334568889999998754 4788999999999999999999999888777666666555443222 257899999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCC
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
+|.+||+.+|++||++.++++||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=296.49 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=203.9
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|.+.+.||+|++|.||+|.+..+ ..+|+|++..... ..+.+.+|+++++++. |+||+++++.+. ....+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEEC-CCCcE
Confidence 357899999999999999999998765 4599999864322 2357889999999998 999999999874 45688
Q ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 145 LIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+||||+.+++|.+++... ..+++..+..++.|++.||.+||+++|+|+||||+||++ ++++.++|+|||.+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIE 153 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeecc
Confidence 999999999999999763 357899999999999999999999999999999999999 556779999999997654
Q ss_pred CCCcc--ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 223 PGDVF--KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 223 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
..... ....++..|+|||... ..++.++||||||+++|++++ |..||...........+...... + ....++.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~ 230 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-P--CPPECPE 230 (262)
T ss_pred ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-C--CccccCH
Confidence 33221 2234567799999765 568999999999999999999 88899888777666666544321 1 1235789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
.+.++|.+||+.||++||++.++++.
T Consensus 231 ~l~~li~~~l~~~p~~Rp~~~~~~~~ 256 (262)
T cd05071 231 SLHDLMCQCWRKEPEERPTFEYLQAF 256 (262)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHH
Confidence 99999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=318.26 Aligned_cols=267 Identities=28% Similarity=0.487 Sum_probs=246.3
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
..+++++..||-||||.|-++........+|+|++++.........+.+..|-++|..++ .+.||++|..|.+..++|+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhh
Confidence 466778889999999999999988766679999999888878888899999999999999 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
+||-|-||.|+..+..++.|++.+.+.++..+++|++|||++|||.|||||+|+++ +.+|-+||+|||+|+.+..+.
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCC
Confidence 99999999999999999999999999999999999999999999999999999999 778889999999999999888
Q ss_pred ccccCCcCccccccccc-cccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~-~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
...+.+|||.|.|||++ ++..+.++|+||||+++|||++|.+||.+.+....+..++++.-.+..+ ..++....+||
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Li 652 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLI 652 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHH
Confidence 88899999999999965 6779999999999999999999999999999999999999986555444 36889999999
Q ss_pred HHhcccCccCCCC-----HHHHHhccCCCCCchhhHHHH
Q 018786 305 KKMLHADPKERLS-----AAEVLSKFLIPKKTLQTLADL 338 (350)
Q Consensus 305 ~~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~~~ 338 (350)
++++..+|.+|.. +.||-.|-||.+-.|+.+...
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~ 691 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSR 691 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhc
Confidence 9999999999986 899999999999999877543
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=302.70 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=209.9
Q ss_pred cccccceeeeeeeeccCceEEEEEEEc-------cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEe
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHK-------DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKG 135 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~ 135 (350)
+....+|.+.+.||+|+||.||+|.+. .++..+|+|.+.... .......+.+|+.+++.+.+|+||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 345688999999999999999999753 234579999886432 23445678999999999955999999999
Q ss_pred EEEcCCceEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCce
Q 018786 136 AYEDRHSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (350)
Q Consensus 136 ~~~~~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NI 199 (350)
++......+++|||+.+++|.+++... ..++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999998763 2467888999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 018786 200 LFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETE 274 (350)
Q Consensus 200 l~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~ 274 (350)
++ +.++.+||+|||.+........ .....++..|+|||++. ..++.++||||||+++|++++ |..||.....
T Consensus 169 li---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 169 LV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 99 5667799999999987543221 12234567899999875 458899999999999999998 8889988877
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+....+........ ...++.++.++|.+||+.+|++|||+.++++.+
T Consensus 246 ~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 246 EELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred HHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 777776655432211 235789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=270.60 Aligned_cols=258 Identities=27% Similarity=0.508 Sum_probs=219.1
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+|.-.++||+|.||+||+|+++++++.||+|.+..+.. ++..-....+|+-+++.+. |.|||++++....+..+.+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelk-hknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeH
Confidence 46777899999999999999999999999999976543 3333457889999999999 999999999999999999999
Q ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-C
Q 018786 148 DLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-D 225 (350)
Q Consensus 148 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~-~ 225 (350)
|+| ..+|..+... ++.++...++.++.|++.||.++|++++.|||+||.|.++ +.+|.+||+|||+++.+.-. .
T Consensus 81 e~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 81 EFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCceE
Confidence 999 4588888875 6779999999999999999999999999999999999999 56677999999999886533 2
Q ss_pred ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC--------
Q 018786 226 VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP-------- 294 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------- 294 (350)
..+..+.|..|++|.++-+ -|+...|+||-||++.|+.. |++.|.+.+-.+++..+........+..|+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 4566778999999998754 38999999999999999987 788888888888887776654444444333
Q ss_pred -----------------CCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 295 -----------------NISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 295 -----------------~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
++...-+++++++|.-+|.+|++++++|+|++|....
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 2345568999999999999999999999999997653
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=304.60 Aligned_cols=258 Identities=28% Similarity=0.478 Sum_probs=209.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC--
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-- 141 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-- 141 (350)
...++|++.+.||+|++|.||+|.++.+++.||+|.++.... .......+.+|++++++++ |+||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchh
Confidence 455789999999999999999999999999999999865432 2223356778999999998 999999999886544
Q ss_pred --------ceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEE
Q 018786 142 --------SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212 (350)
Q Consensus 142 --------~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl 212 (350)
.+++++||+++ ++.+.+... ..+++..++.++.||+.||.|||++||+|+||+|+||++ ++++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl 157 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKL 157 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEe
Confidence 78999999976 777777653 468999999999999999999999999999999999999 66778999
Q ss_pred eecCCcccccCCC--ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Q 018786 213 TDFGLSVFFKPGD--VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288 (350)
Q Consensus 213 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 288 (350)
+|||.+....... ......++..|+|||.+.+ .++.++||||||+++|+|++|+.||......+.+..+.......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999988764332 1223356778999998753 47889999999999999999999998776655544443321100
Q ss_pred C--------------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 289 S--------------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 289 ~--------------------------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
. ...+..++..+.++|.+||+.||++||++.+++.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0 01123468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=295.68 Aligned_cols=247 Identities=25% Similarity=0.449 Sum_probs=205.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
.+|++.+.||+|++|.||++.++. +..+|+|++..... ....+.+|+++++++. |+||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEE
Confidence 568899999999999999998864 56799999864322 2356788999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+....+..
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccc
Confidence 9999999999998764 468999999999999999999999999999999999999 567789999999987654322
Q ss_pred ccc--cCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 226 VFK--DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 226 ~~~--~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
... ...++..|+|||.+. ..++.++|+||||+++|++++ |..||......+....+...... .. ...++.++.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~ 231 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL-YR--PKLAPTEVY 231 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC-CC--CCCCCHHHH
Confidence 111 112345799999875 568899999999999999998 89999887777776666544221 11 135789999
Q ss_pred HHHHHhcccCccCCCCHHHHHhcc
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+++.+||+.+|++|||+.++++.+
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=297.10 Aligned_cols=249 Identities=23% Similarity=0.408 Sum_probs=207.0
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCc---EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQ---QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
++|++.+.||+|+||.||+|.++.+++ .||+|++.... .......+..|+.+++++. |+||+++++++..+...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCce
Confidence 568999999999999999999887654 59999986432 3445678999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||||+++++|.+++.. .+.+++..++.++.|++.||+|||++|++|+||||+||++ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCccccccc
Confidence 999999999999998876 4568999999999999999999999999999999999999 566779999999987654
Q ss_pred CCCcccc---CC---cCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 223 PGDVFKD---LV---GSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 223 ~~~~~~~---~~---gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
....... .. .+..|+|||.+. ..++.++||||||+++||+++ |..||......+....+.... ..+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-~~~--~~~ 234 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-RLP--PPM 234 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-cCC--Ccc
Confidence 3322111 11 134699999875 458899999999999999886 999998887776666664432 212 123
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
.++..+.+++.+||+.+|++||++.+++..
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=299.55 Aligned_cols=254 Identities=28% Similarity=0.438 Sum_probs=206.9
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc--CCCCeeEeEeEEEcCCc----
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYEDRHS---- 142 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~~~~~---- 142 (350)
|++.+.||.|++|.||+|+++.+++.+|+|.+..... .......+.+|+.+++++. .|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6788999999999999999998899999999975433 2222345667888777764 39999999999987776
Q ss_pred -eEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 143 -VNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 143 -~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
++++||++.+ +|.+++.... .+++..++.++.||+.||.+||+++++|+||+|+||++ +.++.++|+|||.+.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcce
Confidence 9999999965 8988887643 48999999999999999999999999999999999999 556789999999998
Q ss_pred cccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----CC----
Q 018786 220 FFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID-----FS---- 289 (350)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~---- 289 (350)
............++..|+|||.+. ..++.++|+||||+++|+|++|..||......+....+...... ++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 765444444456788999999875 45888999999999999999999999888776665555432110 00
Q ss_pred --------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 290 --------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 290 --------------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
....+.++..+.++|.+||+.||++||++.+++.|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00112356788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=300.65 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=203.9
Q ss_pred ceeeeeeeeccCceEEEEEEEcc-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .....+.+.+|+.+++++. ||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence 47889999999999999998753 23568888886432 2334567899999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCc
Q 018786 143 VNLIMDLCAGGELFDRIIAK------------------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~N 198 (350)
.++++||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999988642 247888999999999999999999999999999999
Q ss_pred eEeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 018786 199 FLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGET 273 (350)
Q Consensus 199 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~ 273 (350)
|++ ++++.+||+|||++........ .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+..
T Consensus 158 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999 5567899999999876533221 12234567899999765 458899999999999999998 999998887
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
............. .. ....++.++.+++.+||+.||++||++.++++.+
T Consensus 235 ~~~~~~~~~~~~~-~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 235 PERLFNLLKTGYR-ME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred HHHHHHHHhCCCC-CC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 7776665554322 11 1235789999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=311.61 Aligned_cols=260 Identities=30% Similarity=0.458 Sum_probs=216.9
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC-----c
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-----S 142 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-----~ 142 (350)
+|++.+.||.|++|.||+|.+..+++.||+|.+..... .....+.+.+|+.+++++. |+||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence 58999999999999999999998899999999864321 2344567899999999998 999999999887665 7
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
.+++|||+. ++|.+++.....+++..++.++.||+.||.+||++||+|+||||.||++ +.++.++|+|||.+....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeec
Confidence 899999996 4898888887789999999999999999999999999999999999999 556789999999998765
Q ss_pred CCC----ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-----
Q 018786 223 PGD----VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD----- 291 (350)
Q Consensus 223 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 291 (350)
... ......++..|+|||.+.+ .++.++|+||||+++|+|++|..||......+....+..........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 443 2344568889999998753 57889999999999999999999998877666555544322111100
Q ss_pred ----------------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 292 ----------------------PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 292 ----------------------~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
..+.++.++.++|.+||+.||++||++.+++.|+||.+...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 113467899999999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=305.89 Aligned_cols=258 Identities=25% Similarity=0.393 Sum_probs=210.5
Q ss_pred cccccccceeeeeeeeccCceEEEEEEEccC-------CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEe
Q 018786 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDT-------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133 (350)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~ 133 (350)
.++....+|++++.||+|+||.||+|.+... +..+|+|.+.... .....+.+.+|+++++++.+|+||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3455567899999999999999999986432 2368999886432 233456789999999999559999999
Q ss_pred EeEEEcCCceEEEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCC
Q 018786 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPE 197 (350)
Q Consensus 134 ~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~ 197 (350)
++++...+..++++||+.+++|.+++.... .++...+..++.||+.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999987532 3678889999999999999999999999999999
Q ss_pred ceEeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 018786 198 NFLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGE 272 (350)
Q Consensus 198 NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~ 272 (350)
||++ +.++.+||+|||++........ .....++..|+|||++. ..++.++||||||+++|+|++ |..||...
T Consensus 164 Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 164 NVLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred eEEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9999 5567799999999876543321 12223456799999875 458899999999999999998 88999888
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 273 TEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
...+....+........ ...++.++.++|.+||+.+|++|||+.++++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 241 PVEELFKLLKEGHRMDK---PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred CHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 87777766655432211 2356889999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=299.00 Aligned_cols=250 Identities=22% Similarity=0.410 Sum_probs=207.2
Q ss_pred ccceeeeeeeeccCceEEEEEEEc-----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
..+|.+.+.||+|+||.||++... .++..+++|.+... .......+.+|++.++++. |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQ-HQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecC
Confidence 467889999999999999999753 34668999987533 3344567999999999998 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKG---------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 205 (350)
+..+++|||+.+++|.+++...+ .+++..+..++.||+.||.|||++||+|+||||+||++ +
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---G 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---c
Confidence 99999999999999999987642 47899999999999999999999999999999999999 5
Q ss_pred CCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 018786 206 EDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDA 280 (350)
Q Consensus 206 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~ 280 (350)
+++.+||+|||++........ .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||......+....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 677899999999876533221 12233567899999775 458999999999999999998 9999988777776666
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+..+..... ...++..+.++|.+||+.||++||++.++++.+
T Consensus 237 ~~~~~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 237 ITQGRELER---PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred HHcCccCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 655433211 235789999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=294.46 Aligned_cols=243 Identities=23% Similarity=0.360 Sum_probs=201.3
Q ss_pred eeeeccCceEEEEEEEccCC---cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEec
Q 018786 73 RELGRGQFGVTYLVTHKDTK---QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~ 149 (350)
+.||+|+||.||+|.....+ ..+|+|.+...... ...+.+.+|+.+++++. |+||+++++++. ....++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEe
Confidence 47999999999999876544 78999998754432 34567899999999998 999999999875 4568999999
Q ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCcc--
Q 018786 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-- 227 (350)
Q Consensus 150 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~-- 227 (350)
+++++|.+++.....+++..+..++.|++.||.+||+++++|+||||+||++ +.++.+||+|||.+.........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcccc
Confidence 9999999999888889999999999999999999999999999999999999 56677999999998876433221
Q ss_pred --ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 228 --KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 228 --~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
....++..|+|||.+. ..++.++||||||+++|++++ |..||......+....+....... ....++..+.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l 230 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP---RPEECPQEIYSI 230 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC---CCCCCCHHHHHH
Confidence 1112345799999875 458899999999999999998 999998877766666665543221 223578999999
Q ss_pred HHHhcccCccCCCCHHHHHhcc
Q 018786 304 VKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~ 325 (350)
|.+||+.||++||++.++++.+
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred HHHHhcCChhhCcCHHHHHHHH
Confidence 9999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=330.41 Aligned_cols=149 Identities=29% Similarity=0.526 Sum_probs=137.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.++..+. |+||+++++.+.....+++|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEEE
Confidence 68999999999999999999999999999999997665555555678999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
|||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9999999999999888889999999999999999999999999999999999999 556789999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=309.83 Aligned_cols=261 Identities=29% Similarity=0.462 Sum_probs=208.5
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC----
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR---- 140 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~---- 140 (350)
+..+|.+.+.||.|+||.||+|.++.+++.||+|.+..... ...+.+.+|++++++++ |+||+++++.+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcC-CCcchhhHhhhccccccc
Confidence 45899999999999999999999999999999999865432 34567889999999998 99999998765443
Q ss_pred ----------CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCe
Q 018786 141 ----------HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (350)
Q Consensus 141 ----------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~v 210 (350)
...++||||+. ++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||+++. .++.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--CCceE
Confidence 35789999996 48887765 356899999999999999999999999999999999999952 45568
Q ss_pred EEeecCCcccccCCC----ccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 018786 211 KATDFGLSVFFKPGD----VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG 284 (350)
Q Consensus 211 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~ 284 (350)
+|+|||.+....... ......++..|+|||.+. ..++.++||||||+++|+|++|+.||......+....+...
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999987653221 112345788999999764 34788999999999999999999999876654444333221
Q ss_pred CCC----------------------CC----CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 285 HID----------------------FS----SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 285 ~~~----------------------~~----~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
... .. ....+.++.++.++|.+||+.||++|||+.++|.|+||....++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 100 00 00123578899999999999999999999999999999865544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=293.27 Aligned_cols=245 Identities=22% Similarity=0.384 Sum_probs=208.0
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||.|++|.||+|... |+.+|+|.+..... ...++.+|+.+++++. |+||+++++++...+..++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEE
Confidence 467999999999999999999875 68899999864421 4577899999999998 9999999999998999999
Q ss_pred EEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 146 IMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||++ +.++.++|+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEccccccccccc
Confidence 999999999999997765 68999999999999999999999999999999999999 5677799999999987643
Q ss_pred CCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
... ....+..|+|||.+. +.++.++||||||+++|++++ |..||...........+...... .....+++.+.
T Consensus 155 ~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 229 (256)
T cd05039 155 GQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM---EAPEGCPPEVY 229 (256)
T ss_pred ccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC---CCccCCCHHHH
Confidence 322 334456799999875 568889999999999999997 99999888776666655543221 11235789999
Q ss_pred HHHHHhcccCccCCCCHHHHHhcc
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++|.+||+.+|++|||+.++++.+
T Consensus 230 ~li~~~l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 230 KVMKDCWELDPAKRPTFKQLREQL 253 (256)
T ss_pred HHHHHHhccChhhCcCHHHHHHHH
Confidence 999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=295.84 Aligned_cols=250 Identities=22% Similarity=0.393 Sum_probs=207.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCC---cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTK---QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
..+|++.+.||+|+||.||+|.++.++ ..+|+|.++... .....+.+.+|+.+++++. ||||+++++++...+.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCc
Confidence 367999999999999999999986443 379999886432 2334568899999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.+++|||+++++|.+++... +.+++..+..++.|++.||.+||++|++||||||+||++ +.++.++|+|||.+...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 156 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCccccc
Confidence 99999999999999998764 468999999999999999999999999999999999999 55677999999999876
Q ss_pred cCCCcc----ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 222 KPGDVF----KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 222 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
...... ....++..|++||.+. ..++.++|+||||+++|++++ |..||......+....+..... .+. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~ 233 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-LPA--PMD 233 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-CCC--CCC
Confidence 433211 1122356799999876 468999999999999999886 9999988777666666665422 221 235
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
++..+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 262 (267)
T cd05066 234 CPAALHQLMLDCWQKDRNERPKFEQIVSI 262 (267)
T ss_pred CCHHHHHHHHHHcccCchhCCCHHHHHHH
Confidence 78999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=306.65 Aligned_cols=259 Identities=29% Similarity=0.459 Sum_probs=207.2
Q ss_pred ceeeeeeeeccCceEEEEEEEccC--CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE----cCC
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDT--KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE----DRH 141 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~----~~~ 141 (350)
+|.+.+.||+|+||.||++.+..+ +..||+|.+.... ........+.+|+.+++++.+|+||+++++... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 588999999999999999999887 8999999986432 122334668889999999977999999998643 234
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.++++++++. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceec
Confidence 5788999985 6899998888889999999999999999999999999999999999999 56677999999999765
Q ss_pred cCCC-----ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------
Q 018786 222 KPGD-----VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-------- 286 (350)
Q Consensus 222 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~-------- 286 (350)
.... ......|+..|+|||.+.+ .++.++|+||||+++|++++|..||...........+.....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 4322 1233568999999997643 478999999999999999999999977654433332221100
Q ss_pred ---------------CCC----CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 287 ---------------DFS----SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 287 ---------------~~~----~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
..+ ....+.++..+.+++.+||+.||++|||+.+++.|+|+.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 000 111235688999999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=297.29 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=202.0
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCc----EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQ----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
.+|++.+.||+|+||+||+|.+..+++ .+++|.+... .......++..|+..+.++. |+||+++++++. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP-GAS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC-CCc
Confidence 678999999999999999999977766 4667766422 12233467788888888888 999999999875 455
Q ss_pred eEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.++++||+++++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||++ ++++.+||+|||.+...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence 7789999999999999976 4568999999999999999999999999999999999999 56778999999999765
Q ss_pred cCCC---ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 222 KPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 222 ~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... ......++..|++||.+. +.++.++||||||+++||+++ |..||.+.........+..+...... ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 236 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP---QIC 236 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---CCC
Confidence 3322 122344667899999875 568999999999999999998 99999887766655555544332222 235
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+.++.+++.+||..||++|||+.|+++.+
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~~l 265 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELANEF 265 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 78899999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=299.84 Aligned_cols=253 Identities=30% Similarity=0.473 Sum_probs=208.4
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEe
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
|.+.+.||.|++|+||+|....+++.+++|.+..... ........+|+..++++.+|+|++++++++..++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999998899999999864332 12223456789999999879999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 149 LCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 149 ~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
|+ +++|.+.+.... .+++..+..++.|++.+|.|||++|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC
Confidence 99 779999887764 68999999999999999999999999999999999999 5677799999999987765555
Q ss_pred cccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Q 018786 227 FKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS--------------- 289 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 289 (350)
.....++..|+|||.+. ..++.++|+||||+++++|++|..||......+....+........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 55667889999999874 3478999999999999999999999977665544433322111000
Q ss_pred -----------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 290 -----------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 290 -----------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
....+..+.++.++|.+||+.||++|||+.|++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00012336889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=294.19 Aligned_cols=251 Identities=22% Similarity=0.386 Sum_probs=207.9
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCc---EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQ---QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
.++|+..+.||+|++|.||+|.++.+++ .+|+|.+.... .....+.+.+|+++++++. |+|++++.+++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCC
Confidence 4678999999999999999999876554 79999886432 2334567899999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.++||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++|+||||+||++ +.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVL 157 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceec
Confidence 99999999999999998764 578999999999999999999999999999999999999 55677999999998765
Q ss_pred cCCCccc----cCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 222 KPGDVFK----DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 222 ~~~~~~~----~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
....... ....+..|+|||.+. +.++.++||||||+++|++++ |..||......+....+..... .+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~-~~--~~~~ 234 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR-LP--APMD 234 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC-CC--CCCC
Confidence 4322111 112345699999875 458899999999999999997 9999988777777766665422 11 1235
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++.++.+++.+||+.+|++||++.++++.+
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l 264 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=300.78 Aligned_cols=254 Identities=21% Similarity=0.311 Sum_probs=203.0
Q ss_pred ccceeeeeeeeccCceEEEEEEEccC--------------CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCee
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDT--------------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv 131 (350)
.++|++.+.||+|+||.||++.+..+ ...||+|.+.... .....+.+.+|+++++++. |+|++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcC
Confidence 46899999999999999999987543 2358999986432 3344567999999999998 99999
Q ss_pred EeEeEEEcCCceEEEEecCCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCce
Q 018786 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (350)
Q Consensus 132 ~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NI 199 (350)
++++++...+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999886532 367889999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh--CCCCCCCCC
Q 018786 200 LFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS--GVPPFWGET 273 (350)
Q Consensus 200 l~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~--g~~pf~~~~ 273 (350)
++ +.++.+||+|||++........ .....++..|+|||.+. +.++.++||||||+++|+|++ |..||....
T Consensus 161 ll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 161 LV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99 5566799999999876533221 12234567899999765 568999999999999999988 678888776
Q ss_pred HHHHHHHHHcC----CCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 274 EQSIFDAILRG----HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 274 ~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..+........ .........+.++..+.++|.+||+.||++|||+.++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 65554443221 11111111234689999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=301.14 Aligned_cols=262 Identities=30% Similarity=0.523 Sum_probs=214.5
Q ss_pred ceeeeeeeeccCceEEEEEEEc---cCCcEEEEEEecccccCC-hhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 68 TYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLIN-RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
+|.+.+.||+|++|.||++++. .++..||||++++..... ......+.+|+.++.++.+|++|+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 357889999987543222 223456889999999997799999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||+.+++|.+++.....+++..++.++.|++.+|.|||+.|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECcccccccc
Confidence 9999999999999999877789999999999999999999999999999999999999 5667799999999876543
Q ss_pred CCc--cccCCcCcccccccccccc---CCcchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCCCCCC
Q 018786 224 GDV--FKDLVGSAYYVAPEVLRRN---YGAEADIWSAGVILYILLSGVPPFWGET----EQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 224 ~~~--~~~~~gt~~y~aPE~~~~~---~~~~~Dv~slG~vl~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~ 294 (350)
... .....|+..|++||.+.+. .+.++||||||+++|+|++|..||.... ..+....+.......+ .
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~ 233 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP----K 233 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCC----c
Confidence 321 2234688899999987532 6789999999999999999999996432 2233333333333322 2
Q ss_pred CCCHHHHHHHHHhcccCccCCCC---HHHHHhccCCCCCchhhHH
Q 018786 295 NISSSAKDIVKKMLHADPKERLS---AAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps---~~~iL~~~~~~~~~~~~~~ 336 (350)
.++.++.++|.+||+.||++||| +.++|+|+||....|..++
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~ 278 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLA 278 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHh
Confidence 47889999999999999999998 5677999999999886554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=301.41 Aligned_cols=258 Identities=25% Similarity=0.445 Sum_probs=214.4
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
...|...+.||+|++|.||+|.++.+++.+|+|.+............++.+|+++++++. |+|++++++++......++
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCeeEE
Confidence 356888899999999999999999999999999986543334444567889999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||||+. +++.+.+.. ...+++..+..++.|++.||.|||+++++||||+|+||++ +.++.++|+|||++......
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecCc
Confidence 999996 578777654 4568999999999999999999999999999999999999 55678999999998765432
Q ss_pred CccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
....++..|+|||.+. +.++.++||||||+++|+|++|..||...........+........ ....++..+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 243 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYF 243 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--CcccccHHH
Confidence 3346788999999863 3478899999999999999999999977665544444444332221 123578899
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
.++|.+||+.+|++||++.+++.|+|+.+....
T Consensus 244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred HHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=293.26 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=206.8
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
+...++|+++++||+|+||.||+|..+. ++.+|+|.+..... ..+.+.+|+.+++++. |+||+++++++. .+.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~ 74 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QEP 74 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC----cHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cCC
Confidence 3456889999999999999999998765 67899999864332 2467889999999998 999999999864 456
Q ss_pred eEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 143 VNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.+++||++.+++|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||++ +.++.++|+|||.+..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceee
Confidence 89999999999999988753 458999999999999999999999999999999999999 6677899999999877
Q ss_pred ccCCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 221 FKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 221 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
...... .....++..|+|||.+. ..++.++||||||+++|++++ |+.||......+....+....... ....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 228 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP---RPDNC 228 (260)
T ss_pred cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC---CCCCC
Confidence 652221 12334567899999876 457889999999999999999 999998877766666655443221 12357
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+.++.++|.+||+.+|++||++.+++..+
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 229 PEELYELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence 88999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=293.66 Aligned_cols=249 Identities=22% Similarity=0.377 Sum_probs=204.6
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|++.+.||+|++|.||+|.+.. +..+|+|.+..... ..+.+.+|+.++++++ |++++++++++. ....
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~~ 75 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQLYAVVS-EEPI 75 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC----CHHHHHHHHHHHHhcC-CCceEEEEeEEC-CCCc
Confidence 345789999999999999999998764 56799999865332 2356899999999998 999999999875 4568
Q ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 144 NLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
+++|||+.+++|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||++ ++++.++|+|||.+...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLI 152 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeec
Confidence 8999999999999988763 358999999999999999999999999999999999999 55677999999999775
Q ss_pred cCCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 222 KPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 222 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
..... .....++..|+|||.+. ..++.++|+||||+++|+|++ |..||......+....+...... + .....+
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~ 229 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-P--CPQDCP 229 (260)
T ss_pred cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-C--CCCcCC
Confidence 43321 12233556799999865 458899999999999999999 89999887777767666554221 1 123578
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..+.+++.+||+.||++|||+.++++.+
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 9999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=311.31 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=205.6
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEc-----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
++...++|.+.+.||+|+||.||+|.+. ..++.||+|++.... .....+.+.+|+.++.++..|+||+++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 3444578999999999999999999964 345689999996432 223345788999999999779999999999
Q ss_pred EEcCCceEEEEecCCCCCHHHHHHHcC-----------------------------------------------------
Q 018786 137 YEDRHSVNLIMDLCAGGELFDRIIAKG----------------------------------------------------- 163 (350)
Q Consensus 137 ~~~~~~~~iv~e~~~~~sL~~~l~~~~----------------------------------------------------- 163 (350)
+...+..++||||+.+++|.+++...+
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986532
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCc
Q 018786 164 ---------------------------------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (350)
Q Consensus 164 ---------------------------------------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~N 198 (350)
.+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 25667788899999999999999999999999999
Q ss_pred eEeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 018786 199 FLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGET 273 (350)
Q Consensus 199 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~ 273 (350)
|++ ++++.+||+|||++........ .....++..|+|||.+. ..++.++||||||+++|||++ |..||....
T Consensus 270 iLl---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 270 VLI---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred EEE---eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999 5567799999999876432211 12335678899999875 458899999999999999998 899997765
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..+............. ....++.++.+++.+||+.+|++||++.|++..+
T Consensus 347 ~~~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 347 MNEQFYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred chHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 5444433333222111 1235789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=298.35 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=207.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEcc-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
.++|.+.+.||+|+||.||+|.+.. ++..+|+|++.... .......+.+|+.++.++. |+||+++++++..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-HPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC
Confidence 4789999999999999999998753 57889999986432 2334567889999999998 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKG----------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~----------------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~N 198 (350)
...+++|||+.+++|.+++.... .+++..++.++.||+.||.+||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999987432 36788899999999999999999999999999999
Q ss_pred eEeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 018786 199 FLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGET 273 (350)
Q Consensus 199 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~ 273 (350)
|++ +.++.++|+|||.+........ ......+..|+|||.+. ..++.++||||||+++|+|++ |..||.+..
T Consensus 161 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999 5677899999999876432211 12233466799999765 568999999999999999997 888998877
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..+....+..+...... ..++.++.++|.+||+.||++|||+.|+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l 286 (288)
T cd05050 238 HEEVIYYVRDGNVLSCP---DNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286 (288)
T ss_pred HHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 77777666655432211 25789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=300.42 Aligned_cols=257 Identities=28% Similarity=0.485 Sum_probs=213.8
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEe
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
|.....||+|+||.||++....+++.+|+|.+... .......+.+|+.+++++. |+|++++++.+...+..+++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEEe
Confidence 34447899999999999999999999999988532 2234567899999999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-cc
Q 018786 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-VF 227 (350)
Q Consensus 149 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-~~ 227 (350)
|+++++|.+++. ...+++..++.++.|++.+|.|||++|++|+||+|+||++ +.++.++|+|||.+....... ..
T Consensus 98 ~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 98 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccccc
Confidence 999999988664 4568999999999999999999999999999999999999 566779999999887654322 22
Q ss_pred ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 018786 228 KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306 (350)
Q Consensus 228 ~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 306 (350)
....++..|++||.+. ..++.++|+||||+++|+|++|..||...........+...... .......++..+.+++.+
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 252 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-KLKNLHKVSPSLKGFLDR 252 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc-ccCCcccCCHHHHHHHHH
Confidence 3356888999999875 45788999999999999999999999877665555544433221 111234578999999999
Q ss_pred hcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 307 MLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 307 ~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
||+.||.+||++.++|.|+||.+...++
T Consensus 253 ~l~~~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 253 LLVRDPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred HHhCCcccCcCHHHHhcChHHhccCCCc
Confidence 9999999999999999999999887544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=292.38 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=208.8
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|.+.+.||+|++|.||+|.+.. ++.+|||.+..... ..+.+.+|+.+++++. |+||+++++++......
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCce
Confidence 456889999999999999999999764 57799999864332 3467899999999998 99999999999998999
Q ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 144 NLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
+++||++++++|.+++... ..+++..+..++.+|+.||.|||++|++|+||||+||++ +.++.++|+|||.+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLI 153 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceec
Confidence 9999999999999999764 368999999999999999999999999999999999999 56678999999998775
Q ss_pred cCCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 222 KPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 222 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
..... .....++..|+|||.+. ...+.++|+||||+++|++++ |+.||.+.........+........ ....+
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 230 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---PPNCP 230 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCC
Confidence 43211 11223456799999876 458889999999999999998 9999988887777777665432211 12468
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
.++.+++.+||+.||++||+++++++.
T Consensus 231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~~ 257 (261)
T cd05034 231 EELYDLMLQCWDKDPEERPTFEYLQSF 257 (261)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=307.93 Aligned_cols=256 Identities=21% Similarity=0.302 Sum_probs=202.3
Q ss_pred eeeecc--CceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecC
Q 018786 73 RELGRG--QFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (350)
Q Consensus 73 ~~lg~G--~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~ 150 (350)
+.||.| +||+||++.+..+|+.||+|++..... .....+.+.+|+.+++.+. |+||+++++++..++..++|+||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEecc
Confidence 456666 999999999999999999999875433 3344578899999999898 999999999999999999999999
Q ss_pred CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc--
Q 018786 151 AGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-- 226 (350)
Q Consensus 151 ~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~-- 226 (350)
.+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||++ +.++.++++||+.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccc
Confidence 999999988764 348999999999999999999999999999999999999 5567799999986543221110
Q ss_pred ------cccCCcCccccccccccc---cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--------
Q 018786 227 ------FKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS-------- 289 (350)
Q Consensus 227 ------~~~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 289 (350)
.....++..|++||++.+ .++.++||||||+++|+|++|..||...................+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 011234567999998754 368899999999999999999999987665444333322111000
Q ss_pred -----------------------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 290 -----------------------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 290 -----------------------------------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
......++..+.+||++||+.||++|||+.++|+|+||.....+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 00012356789999999999999999999999999999776543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=306.24 Aligned_cols=260 Identities=28% Similarity=0.424 Sum_probs=211.1
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC-
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH- 141 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~- 141 (350)
..+.++|++.+.||+|++|.||++.+..+++.||||++.... ........+.+|+.+++++. |+||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLS 88 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCcc
Confidence 346788999999999999999999999999999999986432 12333456889999999998 999999999886543
Q ss_pred -----ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 142 -----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 142 -----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
.+++|||++ +++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~dfg 163 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFG 163 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecc
Confidence 458999998 778887765 4579999999999999999999999999999999999999 556779999999
Q ss_pred CcccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF------ 288 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------ 288 (350)
.+...... .....+++.|++||.+.+ .++.++|+||||+++|++++|..||...........+.......
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 164 LARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98875432 234467889999998754 47889999999999999999999998776544443332211110
Q ss_pred -----------------C----CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 289 -----------------S----SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 289 -----------------~----~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
. ...++.++.++.++|.+||+.||++|||+.+++.|+||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0 011235788899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=291.88 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=204.2
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|.+.+.||+|++|.||+|.+..+ ..+|+|.+.... ...+.+.+|+.+++++. |+|++++++++. .+..+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKLR-HDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhCC-CCCeeeEEEEEc-CCCcE
Confidence 347799999999999999999998765 459999875432 22356889999999998 999999999875 45688
Q ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 145 LIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++|||+.+++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+||++ ++++.++|+|||.+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEcc
Confidence 999999999999999764 347899999999999999999999999999999999999 667789999999997654
Q ss_pred CCC--ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 223 PGD--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 223 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
... ......++..|+|||... ...+.++|+||||+++|+|++ |..||......+....+...... + .....+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~ 230 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM-P--CPQGCPE 230 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCcccCH
Confidence 332 112234567899999875 458899999999999999999 99999888777766666554221 1 1235789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+.+++.+||+.||++||++.++++.+
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 231 SLHELMKLCWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=309.86 Aligned_cols=263 Identities=28% Similarity=0.435 Sum_probs=214.4
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
..+.++|.+.+.||+|++|.||+|.+..+++.||+|++.... ........+.+|+.+++++. |+|++++++++...+.
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPASS 88 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcccc
Confidence 345788999999999999999999999999999999986432 12334466788999999998 9999999987765544
Q ss_pred ------eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 143 ------VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 143 ------~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
.++|+|++ +++|.+++.. ..+++..++.++.||+.||.+||++||+|+||+|+||++ +.++.++|+|||
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg 163 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFG 163 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEcccc
Confidence 89999999 6699887765 569999999999999999999999999999999999999 556779999999
Q ss_pred CcccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS----- 289 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----- 289 (350)
.+...... .....++..|+|||.+.+ .++.++||||||+++|++++|+.||........+..+.......+
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 164 LARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred cccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 99875433 234567888999998753 478899999999999999999999987766555544433211100
Q ss_pred ------------------C----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 290 ------------------S----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 290 ------------------~----~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
. .....++.++.++|.+||+.||++|||+.+++.|+||.+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence 0 01124588999999999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=291.83 Aligned_cols=246 Identities=27% Similarity=0.474 Sum_probs=208.7
Q ss_pred eeeeeeeccCceEEEEEEEccCC----cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 70 IFGRELGRGQFGVTYLVTHKDTK----QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.+.+.||.|+||.||++.+...+ ..+|+|.+.... .......+..|+..++++. |+||+++++++...+..++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeEE
Confidence 56789999999999999998766 899999986443 2225678999999999996 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 146 IMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
+||++++++|.+++..... +++..+..++.||+.||.+||++|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceeccc
Confidence 9999999999999976544 9999999999999999999999999999999999999 5666899999999987654
Q ss_pred CCccc--cCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHH
Q 018786 224 GDVFK--DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (350)
Q Consensus 224 ~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
..... ...++..|++||.+. ..++.++|+||||+++++|++ |..||...........+......... ..++.+
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 232 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP---ENCPPE 232 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCHH
Confidence 42222 123678899999875 458899999999999999998 88999887777777776665443322 247899
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhc
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 233 IYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HHHHHHHHCcCChhhCcCHHHHHhh
Confidence 9999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.47 Aligned_cols=245 Identities=34% Similarity=0.534 Sum_probs=212.5
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
....|.+...+|.|+|+.|-.+.+..+++.+++|++.+.. ....+|+.++.+..+|+||+++.+.+.++...|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 5678999999999999999999999999999999997652 224467777888888999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+|||.+.|+-+.+.+...+.+. ..+..|+++|+.|+.|||++|+|||||||+|||+. +..++++|+|||.+......
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchh
Confidence 9999999998888887766555 77888999999999999999999999999999996 46778999999999987655
Q ss_pred CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
....+-|..|.|||++.. .++.++|+||||++||+|++|+.||...... ++...+..+.+. ..++.++++
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AKd 541 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAKD 541 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHHH
Confidence 344466888999999874 5999999999999999999999999776655 455555444333 368999999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCC
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
||++||+.||.+|+++.+++.|+|+
T Consensus 542 Ll~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 542 LLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999999
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=292.02 Aligned_cols=243 Identities=23% Similarity=0.400 Sum_probs=202.3
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE-EcCCceEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY-EDRHSVNL 145 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~-~~~~~~~i 145 (350)
.+|++.+.||+|++|.||++... +..+|+|.++.. ...+.+.+|+.+++++. |+|++++++++ ...+..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEE
Confidence 57999999999999999999765 678999998532 22457889999999998 99999999865 45567899
Q ss_pred EEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 146 IMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
+|||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++ ++++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccc
Confidence 999999999999987643 37899999999999999999999999999999999999 6677899999999876543
Q ss_pred CCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.. ....++..|+|||++.+ .++.++||||||+++|+|++ |..||...........+..+... ...+.++..+.
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 229 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPVVY 229 (256)
T ss_pred cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCCHHHH
Confidence 22 23344567999998764 58889999999999999997 99999877766666666554322 22246789999
Q ss_pred HHHHHhcccCccCCCCHHHHHhcc
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++|.+||+.||++|||+.++++.+
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~~l 253 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLREQL 253 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHH
Confidence 999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=308.18 Aligned_cols=263 Identities=29% Similarity=0.466 Sum_probs=211.4
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC--C
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--H 141 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~ 141 (350)
.+.++|.+.+.||+|+||.||+|.+..+++.+|+|.+..... .......+.+|+.+++++.+|+||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 456889999999999999999999998899999998864322 2233456778999999993499999999987643 4
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
..++||||+. ++|..++... .+++..+..++.||+.||.|||++||+|+||+|+||++ +.++.+||+|||.+...
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhcc
Confidence 6899999996 4898888765 78899999999999999999999999999999999999 66778999999998765
Q ss_pred cCCC------ccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------
Q 018786 222 KPGD------VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH-------- 285 (350)
Q Consensus 222 ~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~-------- 285 (350)
.... ......|+..|+|||.+. ..++.++||||||+++|+|++|+.||......+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 3322 223356888999999764 347889999999999999999999997665544333322111
Q ss_pred -------------------CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 286 -------------------IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 286 -------------------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
........+.++.++.++|.+||+.||++|||+.++++|+|+.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 11111223457899999999999999999999999999999977643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=302.77 Aligned_cols=256 Identities=24% Similarity=0.386 Sum_probs=203.9
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC-----
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR----- 140 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~----- 140 (350)
.++|.+.+.||.|++|.||+|.++.+++.+|+|++....... .....+.+|++++++++ |+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence 588999999999999999999999999999999986543211 12245678999999998 99999999876433
Q ss_pred ---CceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 141 ---HSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 141 ---~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
..+++|+||+.+ ++...+.. ...+++..+..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCc
Confidence 356999999965 77776654 4579999999999999999999999999999999999999 667789999999
Q ss_pred CcccccCCCc------------cccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 018786 217 LSVFFKPGDV------------FKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL 282 (350)
Q Consensus 217 ~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~ 282 (350)
++........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9876532211 122356888999998653 47889999999999999999999998777665554433
Q ss_pred cCCCCCCC--------------------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 283 RGHIDFSS--------------------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 283 ~~~~~~~~--------------------------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
........ ..+..+...+.++|.+||+.||++|||+.+++.|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 21110000 0112345788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=295.47 Aligned_cols=252 Identities=22% Similarity=0.431 Sum_probs=210.6
Q ss_pred cceeeeeeeeccCceEEEEEEEcc-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
++|++.+.||.|+||.||+|+.+. ..+.+++|.+.... .....+.+.+|+++++++. |+||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence 679999999999999999999753 35679999885432 2234577999999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEE
Q 018786 142 SVNLIMDLCAGGELFDRIIAKG---------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl 212 (350)
..++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence 9999999999999999998755 68999999999999999999999999999999999999 55677999
Q ss_pred eecCCcccccCCC--ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCC
Q 018786 213 TDFGLSVFFKPGD--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDF 288 (350)
Q Consensus 213 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 288 (350)
+|||++....... ......++..|++||.+. ..++.++||||||+++|++++ |..||..................+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999986543221 223345677899999865 457889999999999999998 888998777777776666555443
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 289 ~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
... ..++..+.+++.+||+.||++|||+.++++.+.
T Consensus 239 ~~~--~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 PVP--EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCC--CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 322 357899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=306.61 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=199.8
Q ss_pred cccceeeeeeeeccCceEEEEEEE-----ccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTH-----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
..++|++.+.||+|+||+||+|.+ ..+++.||||+++... .......+.+|+.++.++.+|+||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 347899999999999999999985 3457899999986433 223456788999999999769999999997754
Q ss_pred -CCceEEEEecCCCCCHHHHHHHc--------------------------------------------------------
Q 018786 140 -RHSVNLIMDLCAGGELFDRIIAK-------------------------------------------------------- 162 (350)
Q Consensus 140 -~~~~~iv~e~~~~~sL~~~l~~~-------------------------------------------------------- 162 (350)
+...+++|||+++++|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 45688999999999999988642
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc---cc
Q 018786 163 -----------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---FK 228 (350)
Q Consensus 163 -----------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~ 228 (350)
..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........ ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcC
Confidence 135778888999999999999999999999999999999 5667899999999876532211 11
Q ss_pred cCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 018786 229 DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQ-SIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (350)
Q Consensus 229 ~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 305 (350)
...++..|+|||.+. ..++.++||||||+++|+|++ |..||...... .....+..+.. .... ..+++++.+++.
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~ 316 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAP--DYTTPEMYQTML 316 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-CCCC--CCCCHHHHHHHH
Confidence 233566799999764 458899999999999999997 99999765433 23333333322 1111 135789999999
Q ss_pred HhcccCccCCCCHHHHHhcc
Q 018786 306 KMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 306 ~~L~~dp~~Rps~~~iL~~~ 325 (350)
.||+.||++|||+.++++++
T Consensus 317 ~cl~~~p~~Rps~~eil~~l 336 (343)
T cd05103 317 DCWHGEPSQRPTFSELVEHL 336 (343)
T ss_pred HHccCChhhCcCHHHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=291.22 Aligned_cols=242 Identities=24% Similarity=0.377 Sum_probs=197.9
Q ss_pred eeeccCceEEEEEEEc--cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCC
Q 018786 74 ELGRGQFGVTYLVTHK--DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCA 151 (350)
Q Consensus 74 ~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~ 151 (350)
.||+|+||.||+|.++ ..+..+|+|++.... .....+.+.+|+.+++++. |+||+++++++. ....++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-CCCeEEEEEeCC
Confidence 4899999999999875 445679999986442 3344567999999999998 999999999875 457899999999
Q ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCcc---
Q 018786 152 GGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF--- 227 (350)
Q Consensus 152 ~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~--- 227 (350)
+++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||++ +.++.+||+|||++.........
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccceec
Confidence 9999998875 4568999999999999999999999999999999999999 55677999999998765433211
Q ss_pred -ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 228 -KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 228 -~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
....++..|+|||.+. ..++.++||||||+++|++++ |..||......+....+..+..... .+..+.++.++|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li 231 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC---PAECPPEMYALM 231 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHH
Confidence 1122356799999875 458889999999999999996 9999988877776666655432221 135689999999
Q ss_pred HHhcccCccCCCCHHHHHhcc
Q 018786 305 KKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+||..||++||++.++.+.+
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~~l 252 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEERM 252 (257)
T ss_pred HHHcCCChhhCcCHHHHHHHH
Confidence 999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=343.76 Aligned_cols=258 Identities=28% Similarity=0.466 Sum_probs=222.0
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.-+|..+..||.|.||.||.|.+.++|...|+|.++..... ......+.+|+.++..+. |||+|+++++-...+..+|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceeecHHHHHH
Confidence 45777888999999999999999999999999998765543 455677899999999999 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
.||||+||+|.+.+...+..++....-+-.|++.|+.|||+.|||||||||.||++ +.+|.+|++|||.|..+.+..
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCch
Confidence 99999999999999888778888888999999999999999999999999999999 677789999999998876442
Q ss_pred -----ccccCCcCccccccccccc----cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCC-CCCCCCCCC
Q 018786 226 -----VFKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGH-IDFSSDPWP 294 (350)
Q Consensus 226 -----~~~~~~gt~~y~aPE~~~~----~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~-~~~~~~~~~ 294 (350)
.....+||+.|||||++.+ ....+.||||||||+.||+||+.||...+.. ++...+-.+. +++|.
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~---- 1464 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE---- 1464 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch----
Confidence 2355789999999999853 3678999999999999999999999766543 3444444443 33333
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.++.+..++|..||+.||.+|+++.|+|+|-|-....-
T Consensus 1465 ~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1465 RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence 38999999999999999999999999999998766543
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=291.58 Aligned_cols=244 Identities=27% Similarity=0.427 Sum_probs=202.9
Q ss_pred eeeeccCceEEEEEEEcc-CC--cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEec
Q 018786 73 RELGRGQFGVTYLVTHKD-TK--QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~-~~--~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~ 149 (350)
+.||+|++|.||+|.+.. .+ ..+|+|.+...... ...+.+.+|+..++++. |+||+++++.+.. ...++++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence 468999999999999865 33 36999998754432 45678999999999998 9999999999888 889999999
Q ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc-
Q 018786 150 CAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV- 226 (350)
Q Consensus 150 ~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~- 226 (350)
+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.+||+|||.+........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc
Confidence 99999999997754 68999999999999999999999999999999999999 5567899999999887643211
Q ss_pred ---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 227 ---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 227 ---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.....++..|+|||.+. ..++.++||||||+++|+|++ |..||......+....+......... ...++..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER--PEACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCC--CccCCHHHH
Confidence 11234677899999876 458899999999999999998 99999887777766666543322222 125689999
Q ss_pred HHHHHhcccCccCCCCHHHHHhcc
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+++.+||+.+|++||++.++++.+
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~~l 255 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALREFL 255 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHHHh
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=301.25 Aligned_cols=265 Identities=31% Similarity=0.483 Sum_probs=212.8
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc-CCc
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-RHS 142 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~-~~~ 142 (350)
...++|.+.+.||.|+||.||+|.+..+++.+|+|++..... .....+.+.+|+.+++++. ||||+++++++.. ...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLED 84 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCCc
Confidence 457889999999999999999999999999999998864322 2334567889999999998 9999999998865 567
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
.++++||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+|+||+|.||++ +.++.++|+|||.+....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccC
Confidence 89999998 5688876653 468899999999999999999999999999999999999 567789999999987643
Q ss_pred CCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------------
Q 018786 223 PGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH--------------- 285 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~--------------- 285 (350)
.. .....++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+.+..
T Consensus 160 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 160 PQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred CC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 32 234567889999998653 58899999999999999999999997665433222111100
Q ss_pred -----------CCCC-CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHH
Q 018786 286 -----------IDFS-SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 286 -----------~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~ 337 (350)
...+ ....+.++..+.++|.+||+.+|++||++.+++.|+|+...+.+..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~ 301 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP 301 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcccc
Confidence 0000 111235788999999999999999999999999999998877664443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=297.69 Aligned_cols=253 Identities=31% Similarity=0.508 Sum_probs=208.9
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEe
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
|.+.+.||.|++|.||++.+..+++.+++|.+..... .......+.+|+.+++++. |+||+++++++..+...++++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEe
Confidence 6678999999999999999998999999999865433 2234567889999999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-c
Q 018786 149 LCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-V 226 (350)
Q Consensus 149 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-~ 226 (350)
|+++ +|.+++.. ...+++..+..++.||+.||.+||++||+|+||+|+||++ +.++.++|+|||.+....... .
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCccc
Confidence 9965 88887766 4578999999999999999999999999999999999999 556779999999987765433 2
Q ss_pred cccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----------------
Q 018786 227 FKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF---------------- 288 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 288 (350)
.....++..|+|||.+.+ .++.++|+||||+++|++++|+.||......+....+.......
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 334567888999998653 57889999999999999999999997776554443332211100
Q ss_pred ---C-------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 289 ---S-------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 289 ---~-------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
+ ....+.++.++.++|.+||+.||.+||++.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0 01123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=297.69 Aligned_cols=253 Identities=30% Similarity=0.496 Sum_probs=209.6
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEe
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
|++.+.||+|++|.||+|.+..+++.+|+|++.... ......+.+.+|+.+++++. |+|++++++++...+..++|+|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEec
Confidence 567889999999999999999999999999997654 22334467788999999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-c
Q 018786 149 LCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-V 226 (350)
Q Consensus 149 ~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-~ 226 (350)
++. ++|.+++... ..+++..+..++.|++.||.+||++||+|+||+|+||++ ++++.++|+|||.+....... .
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCccc
Confidence 997 5999999876 579999999999999999999999999999999999999 567789999999987754332 2
Q ss_pred cccCCcCcccccccccc-c-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------
Q 018786 227 FKDLVGSAYYVAPEVLR-R-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI------------------ 286 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~-~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~------------------ 286 (350)
.....++..|+|||.+. . .++.++||||||+++|++++|..||......+.+..+.....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 23345678899999864 3 578899999999999999999999987765554443322110
Q ss_pred CC-------CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 287 DF-------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 287 ~~-------~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.+ ....++.++..+.++|.+||+.||++||++.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00 001233557899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=291.24 Aligned_cols=265 Identities=29% Similarity=0.459 Sum_probs=211.2
Q ss_pred ccceeeeeeeeccCceEEEEEEEccC----CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc-C
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDT----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-R 140 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~-~ 140 (350)
...|.+.+.||+|.||.||+|..+++ .+.+|+|.++..+..+ .......+|+.+++.+. |+|++.+..++.. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELK-HPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhc-CCcchhHHHHHhccC
Confidence 36799999999999999999976554 2379999997664422 23356789999999999 9999999987765 7
Q ss_pred CceEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecC-CCCCCeEEee
Q 018786 141 HSVNLIMDLCAGGELFDRIIAK-----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS-AEDSPLKATD 214 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~~~vkl~D 214 (350)
..+++++||.+. +|...++-. +.++...+..|+.||+.|+.|||++-|+||||||.|||+..+ .+.|.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 889999999965 888888632 458999999999999999999999999999999999999643 2358999999
Q ss_pred cCCcccccCCC----ccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHH
Q 018786 215 FGLSVFFKPGD----VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQ---------SIFD 279 (350)
Q Consensus 215 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~---------~~~~ 279 (350)
+|+++.+.+.- ..+..+.|..|+|||.+- ..|+.+.|||+.||++.||++-.+.|.+.... +++.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999875432 235567899999999875 35999999999999999999998888654322 3344
Q ss_pred HHHcCCCCCCCCCCCC---------------------------------CCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 280 AILRGHIDFSSDPWPN---------------------------------ISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~---------------------------------~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
.+..-........|+. -++...+|+.++|+.||-+|+|+.++|+|.|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 4433322223333321 1344779999999999999999999999999
Q ss_pred CCCCchh
Q 018786 327 IPKKTLQ 333 (350)
Q Consensus 327 ~~~~~~~ 333 (350)
|....++
T Consensus 340 F~~d~lp 346 (438)
T KOG0666|consen 340 FTEDPLP 346 (438)
T ss_pred cccCCCC
Confidence 9988654
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=295.96 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=195.8
Q ss_pred cce-eeeeeeeccCceEEEEEE----EccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc--
Q 018786 67 NTY-IFGRELGRGQFGVTYLVT----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-- 139 (350)
Q Consensus 67 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~-- 139 (350)
++| ++.+.||+|+||+||++. ...+++.+|+|.+.... .......+.+|+++++++. |+||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 455 899999999999998765 34568899999986432 2234567889999999998 9999999998764
Q ss_pred CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
....+++|||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~ 155 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 155 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeeccccc
Confidence 34688999999999999988764 59999999999999999999999999999999999999 556779999999988
Q ss_pred cccCCCc----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHH
Q 018786 220 FFKPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQS--------------IFDA 280 (350)
Q Consensus 220 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~--------------~~~~ 280 (350)
....... .....++..|+|||.+. ..++.++||||||+++|+|++|..||....... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 7543321 12234566799999875 458899999999999999999999986443210 0000
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
........+ ....++.++.+++.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~ 277 (283)
T cd05080 236 LLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPI 277 (283)
T ss_pred hhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 111111111 123568999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=297.22 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=201.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEcc----------------CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKD----------------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 129 (350)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+.... .......+.+|+++++++. |+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence 4679999999999999999986532 34568999986432 2334567899999999998 999
Q ss_pred eeEeEeEEEcCCceEEEEecCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCc
Q 018786 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG-----------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (350)
Q Consensus 130 iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~N 198 (350)
|+++++++...+..+++|||+.+++|.+++.... .+++..+..++.||+.||+|||++||+|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999987642 36678899999999999999999999999999999
Q ss_pred eEeecCCCCCCeEEeecCCcccccCCCc---cccCCcCccccccccc-cccCCcchhHHHHHHHHHHHHh--CCCCCCCC
Q 018786 199 FLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLS--GVPPFWGE 272 (350)
Q Consensus 199 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~-~~~~~~~~Dv~slG~vl~~ll~--g~~pf~~~ 272 (350)
|++ +.++.++|+|||++........ .....++..|++||.. .+.++.++||||||+++|||++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999 5567799999999876543321 1223346789999965 4568999999999999999998 77899776
Q ss_pred CHHHHHHHHHc----CCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 273 TEQSIFDAILR----GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 273 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
...+....... .......+....++..+.+++.+||+.||++||++.++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 65554433221 101111111235689999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=292.94 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=207.0
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCc----EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQ----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
..+|++.+.||+|+||+||+|.++.+|+ .+|+|.+.... .......+.+|+..++++. |+||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVD-HPHVVRLLGICLS-S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-C
Confidence 4789999999999999999999876654 58999876443 2344567899999999998 9999999998877 7
Q ss_pred ceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..+++|||+++++|.+++... ..+++..+..++.||+.||+|||++||+|+||||+||++ +.++.+||+|||.+..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 158 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccccc
Confidence 889999999999999998764 468999999999999999999999999999999999999 5567799999999987
Q ss_pred ccCCCccc---cCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 221 FKPGDVFK---DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 221 ~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
........ ...++..|++||.+. ..++.++|+||||+++|++++ |..||......+....+......... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 235 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP---PI 235 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCC---CC
Confidence 65332211 122356799999875 568899999999999999998 99999888877777666654322211 24
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+.++.+++.+||..||++||++.++++.+
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l 265 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELINEF 265 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 678999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=304.69 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=208.3
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC--
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR-- 140 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-- 140 (350)
....++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++ |+||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARS 90 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcC-CCcccceeeeeeeccc
Confidence 4566899999999999999999999999999999999865322 2223466888999999998 99999999987533
Q ss_pred ----CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 141 ----HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 141 ----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
...+++++++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg 165 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFG 165 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEeccc
Confidence 3467888887 7799876654 469999999999999999999999999999999999999 566779999999
Q ss_pred CcccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-------- 286 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~-------- 286 (350)
++...... .....++..|+|||.+.+ .++.++||||||+++|+|++|+.||...........+.....
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 166 LARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred cccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 98765332 234567889999998653 478899999999999999999999976655443333222110
Q ss_pred ---------------CCCC----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 287 ---------------DFSS----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 287 ---------------~~~~----~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
..+. ..+...+.++.++|.+||+.||.+||++.+++.|+||.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 0000 01124578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=292.02 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=205.9
Q ss_pred cccceeeeeeeeccCceEEEEEEEccC---CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
...+|.+.+.||+|+||.||+|.+... ...+++|.+.... .....+.+.+|+.+++++. |+||+++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~ 79 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-N 79 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-C
Confidence 346799999999999999999997643 4568999885432 2345578999999999998 9999999998875 4
Q ss_pred ceEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRY 156 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeee
Confidence 5679999999999999997643 58999999999999999999999999999999999999 5566799999999876
Q ss_pred ccCCCccc--cCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 221 FKPGDVFK--DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 221 ~~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
........ ...++..|+|||.+. ..++.++||||||+++|++++ |..||......+....+.++.... ....+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~ 233 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP---MPPNC 233 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC---CCCCC
Confidence 54432211 223446799999875 458899999999999999986 999998888777666665543222 12367
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+..+.++|.+|+..+|++|||+.++++.+
T Consensus 234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~~l 262 (270)
T cd05056 234 PPTLYSLMTKCWAYDPSKRPRFTELKAQL 262 (270)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 89999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=293.11 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=206.9
Q ss_pred cccceeeeeeeeccCceEEEEEEEcc----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc-
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKD----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED- 139 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~- 139 (350)
..++|.+.+.||+|+||.||+|.+.. ++..+++|.+... ......+.+.+|+..++++. |+||+++++++..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~ 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLS-HQNILPILHVCIED 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecC
Confidence 45789999999999999999999876 3578999987532 23445677899999999997 9999999998655
Q ss_pred CCceEEEEecCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeE
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAK--------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vk 211 (350)
....+++++|+.+++|.+++... ..+++..++.++.||+.||.|||+++++|+||||+||++ ++++.+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~k 157 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVK 157 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEE
Confidence 57789999999999999988653 358899999999999999999999999999999999999 5667899
Q ss_pred EeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Q 018786 212 ATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286 (350)
Q Consensus 212 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 286 (350)
|+|||+++.+..... .....++..|+|||++. ..++.++||||||+++|++++ |..||......+....+..+..
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 237 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR 237 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC
Confidence 999999986543321 12234567799999875 458899999999999999998 9999988776665555554322
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
... ...++.++.+++.+||..||++|||+.++++.+
T Consensus 238 -~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 238 -LAQ--PINCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred -CCC--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 211 235689999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=286.67 Aligned_cols=243 Identities=26% Similarity=0.399 Sum_probs=200.5
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||+|+||.||+|... +++.+|+|.+.... .......+.+|+++++++. |+||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEECCCC
Confidence 46899999999999865 57889999986432 2333457889999999998 99999999999999999999999999
Q ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccc--c
Q 018786 153 GELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK--D 229 (350)
Q Consensus 153 ~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~--~ 229 (350)
++|.+++... ..+++..+..++.|++.+|.|||++|++|+||+|+||++ +.++.++|+|||++.......... .
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccccCCC
Confidence 9999988754 458999999999999999999999999999999999999 566779999999987644332111 1
Q ss_pred CCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 018786 230 LVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307 (350)
Q Consensus 230 ~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 307 (350)
..++..|+|||++. +.++.++||||||+++|++++ |..||...........+...... .....++..+.+++.+|
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVMQRC 230 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHH
Confidence 23456799999876 458889999999999999998 99999887766666555543221 11235789999999999
Q ss_pred cccCccCCCCHHHHHhcc
Q 018786 308 LHADPKERLSAAEVLSKF 325 (350)
Q Consensus 308 L~~dp~~Rps~~~iL~~~ 325 (350)
|+.+|++||++.++++.+
T Consensus 231 l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 231 WDYKPENRPKFSELQKEL 248 (250)
T ss_pred cccCcccCCCHHHHHHHh
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=303.96 Aligned_cols=259 Identities=29% Similarity=0.451 Sum_probs=207.8
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC---
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 140 (350)
.+..+|.+.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++++. |+||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSG 89 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcC-CCCccchhheecccccC
Confidence 345789999999999999999999998999999999865322 2233456889999999998 99999999988644
Q ss_pred ---CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 141 ---HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 141 ---~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
..+++|+||+.. +|.++. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||+
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~ 163 (342)
T cd07879 90 DEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGL 163 (342)
T ss_pred CCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCC
Confidence 246899999854 676554 3468999999999999999999999999999999999999 5677899999999
Q ss_pred cccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH---------- 285 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~---------- 285 (350)
+...... .....++..|+|||.+.+ .++.++||||||+++|+|++|+.||.+......+..+....
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 164 ARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 8764322 234567889999998754 47889999999999999999999998776544443332210
Q ss_pred -------------CCCCCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 286 -------------IDFSSD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 286 -------------~~~~~~----~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
...+.. .++..+.++.++|.+||+.||++||++.+++.|+||.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000110 12356788999999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=287.77 Aligned_cols=247 Identities=26% Similarity=0.490 Sum_probs=206.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
.+|++.+.||+|++|.||++.+.. +..+|+|.+..... ....+.+|+++++++. |++++++++++......+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC----CHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceEEE
Confidence 578999999999999999998864 67899998864332 2356889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||+.+++|.+++... ..+++..++.++.|++.+|.+||+++++|+||||+||++ +.++.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCc
Confidence 9999999999988764 468999999999999999999999999999999999999 566779999999987654332
Q ss_pred cc--ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 226 VF--KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 226 ~~--~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.. ....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+..+...... ...+..+.
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVY 231 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHH
Confidence 11 1223456799999876 558889999999999999998 99999887777777766554322221 23588999
Q ss_pred HHHHHhcccCccCCCCHHHHHhcc
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+++.+||+.+|++|||+.++++.+
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=287.77 Aligned_cols=270 Identities=28% Similarity=0.484 Sum_probs=223.9
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE-----
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE----- 138 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~----- 138 (350)
...+.|.-..+||+|.||.||+|+.+++|+.||+|.+-...... ..-....+|+.+|..|. |+|++.+++.|.
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lk-Henv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKATP 91 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCC
Confidence 34577888899999999999999999999999999775433211 22245678999999999 999999988763
Q ss_pred ---cCCceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEee
Q 018786 139 ---DRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 139 ---~~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
+...+|+||.+|+. +|..++-.. -+++..++..++.+++.||.|+|++.|+|||+|+.|+|| +.++.+||+|
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklAD 167 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLAD 167 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeec
Confidence 34468999999965 888877654 569999999999999999999999999999999999999 7888999999
Q ss_pred cCCcccccCC-----CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Q 018786 215 FGLSVFFKPG-----DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID 287 (350)
Q Consensus 215 fg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 287 (350)
||+++.+... ...+.++.|..|++||.+-+ .++++.|||..||+|.||++|.+.+.++++...+..+..-...
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs 247 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS 247 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence 9999665322 23455678999999998754 5999999999999999999999999999999888887665555
Q ss_pred CCCCCCCCC-------------------------------CHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh--h
Q 018786 288 FSSDPWPNI-------------------------------SSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ--T 334 (350)
Q Consensus 288 ~~~~~~~~~-------------------------------~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~--~ 334 (350)
...+.||++ +++..+|+..+|..||.+|+++.++|+|.||.+...+ .
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqan 327 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQAN 327 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchhh
Confidence 555555532 3477899999999999999999999999999988765 4
Q ss_pred HHHHh
Q 018786 335 LADLL 339 (350)
Q Consensus 335 ~~~~~ 339 (350)
+.+++
T Consensus 328 l~~ml 332 (376)
T KOG0669|consen 328 LQDML 332 (376)
T ss_pred HHHHH
Confidence 45554
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=287.23 Aligned_cols=243 Identities=26% Similarity=0.396 Sum_probs=201.2
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
+.||.|++|.||++.+.. ++.|++|.+..... ......+.+|+++++++. |+||+++++++......++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 478999999999999987 89999999865432 234567999999999998 99999999999999999999999999
Q ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCcc---c
Q 018786 153 GELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF---K 228 (350)
Q Consensus 153 ~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~---~ 228 (350)
++|.+++... ..+++..+..++.+++.+|.+||+++++||||+|+||++ +.++.++|+|||.+......... .
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccc
Confidence 9999998663 468999999999999999999999999999999999999 56677999999998765422211 1
Q ss_pred cCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 018786 229 DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306 (350)
Q Consensus 229 ~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 306 (350)
....+..|+|||.+. +.++.++|+||||+++|+|++ |..||...........+..... .. ....++.++.+++.+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~ 230 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR-MP--APQLCPEEIYRLMLQ 230 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-CC--CCccCCHHHHHHHHH
Confidence 122356699999875 458899999999999999998 8899987776665555544321 11 123578999999999
Q ss_pred hcccCccCCCCHHHHHhcc
Q 018786 307 MLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 307 ~L~~dp~~Rps~~~iL~~~ 325 (350)
||+.+|++|||+.|+++.+
T Consensus 231 ~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 231 CWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred HhccChhhCcCHHHHHHHh
Confidence 9999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.50 Aligned_cols=250 Identities=22% Similarity=0.381 Sum_probs=205.6
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
+...++|++.+.||+|+||.||++.+.. +..+|+|.+.... ...+.+.+|+.+++++. |+||+++++.+.. ..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~ 74 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EP 74 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh----hHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CC
Confidence 3456889999999999999999998654 5569999886432 23467889999999998 9999999999877 77
Q ss_pred eEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 143 VNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.+++|||+++++|.+++... ..+++..+..++.||+.||.+||++|++|+||+|+||++ +.++.+||+|||.+..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~ 151 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARV 151 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceee
Confidence 89999999999999998763 357888999999999999999999999999999999999 5677899999999876
Q ss_pred ccCCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 221 FKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 221 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
...... .....++..|+|||++. +.++.++|+||||+++|++++ |..||...........+...... + .....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~ 228 (260)
T cd05073 152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-P--RPENC 228 (260)
T ss_pred ccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-C--CcccC
Confidence 543321 12233556799999876 458889999999999999998 99999887776666655544222 1 22357
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+.++.+++.+||+.||++||++.++++.+
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L 257 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFEYIQSVL 257 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 89999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=293.29 Aligned_cols=241 Identities=18% Similarity=0.300 Sum_probs=193.1
Q ss_pred eeeeccCceEEEEEEEccCCc-------EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 73 RELGRGQFGVTYLVTHKDTKQ-------QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~-------~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
+.||.|+||.||+|.++..+. .+++|.+... .....+.+.+|+.+++.+. |+||+++++++......++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence 469999999999999865443 3888877432 2234467888999999998 9999999999999899999
Q ss_pred EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCC-----CCCeEEeecCCcc
Q 018786 146 IMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE-----DSPLKATDFGLSV 219 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-----~~~vkl~Dfg~a~ 219 (350)
||||+.+++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++. .+.++++|||.+.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999997654 5899999999999999999999999999999999999965432 1247999999987
Q ss_pred cccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 220 FFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGV-PPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
..... ....++..|+|||.+.+ .++.++||||||+++|+|++|. .||.......... ........+. ..
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~----~~ 228 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPA----PK 228 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCC----CC
Confidence 65432 23457888999998864 4788999999999999999984 6666555444332 2222333322 34
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+.++.++|.+||+.||++|||+.++++.+
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 67899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=289.78 Aligned_cols=253 Identities=28% Similarity=0.504 Sum_probs=209.0
Q ss_pred ceeeeeeeeccCceEEEEEEEcc-CCcEEEEEEeccccc-------CChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKD-TKQQFACKSISSRKL-------INRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~-------~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
.|++.+.||+|+||.||+|.+.. .++.+|+|.+..... .......++.+|+.++.+..+|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999999987 688999998864321 1223345677888888764449999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCCCCCeEEee
Q 018786 140 RHSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
.+..+++|||+++++|.+++.. ...+++..++.++.|++.+|.+||+ .+++|+||+|+||++ +.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence 9999999999999999988743 3468999999999999999999996 789999999999999 6677899999
Q ss_pred cCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 215 FGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 215 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
||.+.............++..|++||.+. +.++.++|+||||+++|+|++|..||...........+..........
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 235 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE-- 235 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCc--
Confidence 99998765554445567899999999875 458899999999999999999999998777666555555544332221
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..++.++.++|.+||+.||++||++.|+.+++
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 24689999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=292.69 Aligned_cols=250 Identities=25% Similarity=0.421 Sum_probs=198.7
Q ss_pred cceeeeeeeeccCceEEEEEEE----ccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC--
Q 018786 67 NTYIFGRELGRGQFGVTYLVTH----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR-- 140 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-- 140 (350)
..|++.+.||+|+||.||++.. ..+++.||+|.+.... .......+.+|+++++++. |+|++++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCC
Confidence 4578999999999999999984 4568899999986432 3344567999999999998 99999999988764
Q ss_pred CceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
...++||||++|++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||++ +.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTK 157 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCcccc
Confidence 5789999999999999998764 358999999999999999999999999999999999999 556779999999988
Q ss_pred cccCCCc----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHH
Q 018786 220 FFKPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETE---------------QSIFD 279 (350)
Q Consensus 220 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~---------------~~~~~ 279 (350)
....... .....++..|+|||.+. ..++.++||||||+++|+|+++..|+..... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 7543321 12345677899999765 4588999999999999999998766432111 11111
Q ss_pred HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+..... .+ ....++..+.++|.+||+.||++|||+.++++++
T Consensus 238 ~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 238 VLEEGKR-LP--RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred HHHcCcc-CC--CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 1222211 11 2246789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=324.31 Aligned_cols=248 Identities=26% Similarity=0.442 Sum_probs=212.0
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCc-----EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQ-----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
..+..+...||+|.||.||.|....... .||+|.+++ ..+.+....|.+|..+|..+. |||||+++|++.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCC
Confidence 4667788999999999999999865433 388888754 335667789999999999999 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEe
Q 018786 141 HSVNLIMDLCAGGELFDRIIAK-------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~ 213 (350)
+..+|++|||+||+|..+|++. ..++..+++.++.||++|+.||+++++|||||..+|+|+ +....|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEc
Confidence 9999999999999999999875 348899999999999999999999999999999999999 666889999
Q ss_pred ecCCcccccCCCccc--c-CCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CC
Q 018786 214 DFGLSVFFKPGDVFK--D-LVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH-ID 287 (350)
Q Consensus 214 Dfg~a~~~~~~~~~~--~-~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~-~~ 287 (350)
|||+|+.+-...... . ..-...|||||.+. +.++.++||||||+++||+++ |..||...+..+.+..+.++. .+
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD 924 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC
Confidence 999999543332211 1 13346799999886 669999999999999999999 899999999988888655544 33
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 288 FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
.+ ..++..+.+++..||+.+|++||++.+++.
T Consensus 925 ~P----~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PP----SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CC----CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 33 368999999999999999999999999998
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=324.86 Aligned_cols=257 Identities=30% Similarity=0.486 Sum_probs=206.3
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE-----
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE----- 138 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~----- 138 (350)
....+|..++.||+||||.||+++++-+|+.||||.+.... ......++.+|+..+.+|. |||||+++..|.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCc
Confidence 45577888999999999999999999999999999997654 4556678999999999999 999999986540
Q ss_pred -------------------------------------------------------------------------c------
Q 018786 139 -------------------------------------------------------------------------D------ 139 (350)
Q Consensus 139 -------------------------------------------------------------------------~------ 139 (350)
+
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence 0
Q ss_pred ---------------------------C--------CceEEEEecCCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHH
Q 018786 140 ---------------------------R--------HSVNLIMDLCAGGELFDRIIAKGHY-SERAAANLCRQMVTVVHY 183 (350)
Q Consensus 140 ---------------------------~--------~~~~iv~e~~~~~sL~~~l~~~~~~-~~~~~~~i~~~i~~~l~~ 183 (350)
+ ..+||-||||+..++.+++..+... .....++++++|++||.|
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence 0 2467999999886666666554433 477899999999999999
Q ss_pred HHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-------------------CCCccccCCcCccccccccccc
Q 018786 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-------------------PGDVFKDLVGSAYYVAPEVLRR 244 (350)
Q Consensus 184 lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~ 244 (350)
+|+.|||||||||.|||+ +.+..|||+|||+|.... +....+..+||..|+|||++.+
T Consensus 713 IH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 999999999999999999 566779999999998721 1113456789999999999852
Q ss_pred ----cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHH
Q 018786 245 ----NYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAA 319 (350)
Q Consensus 245 ----~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~ 319 (350)
.|+.|+|+||||+||+||+. ||...-+. ..+..+.++.++.+..-+.+--+.-..+|+.||+.||++|||+.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence 58999999999999999995 67655443 44555555555555222233345667899999999999999999
Q ss_pred HHHhccCCCC
Q 018786 320 EVLSKFLIPK 329 (350)
Q Consensus 320 ~iL~~~~~~~ 329 (350)
|+|.+-|+..
T Consensus 867 eLL~s~llpp 876 (1351)
T KOG1035|consen 867 ELLNSELLPP 876 (1351)
T ss_pred HHhhccCCCc
Confidence 9999999983
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=289.74 Aligned_cols=250 Identities=25% Similarity=0.414 Sum_probs=196.7
Q ss_pred cceeeeeeeeccCceEEEEEEE----ccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE--cC
Q 018786 67 NTYIFGRELGRGQFGVTYLVTH----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE--DR 140 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~--~~ 140 (350)
.+|++.+.||+|+||.||++.. ..+++.||+|.+... .....+.+.+|+++++++. |+||+++++++. +.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence 5789999999999999999974 456889999998643 2344567899999999998 999999998764 34
Q ss_pred CceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
..+++|+||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccc
Confidence 5689999999999999998764 468999999999999999999999999999999999999 566779999999998
Q ss_pred cccCCCcc----ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---------------HHH
Q 018786 220 FFKPGDVF----KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQS---------------IFD 279 (350)
Q Consensus 220 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~---------------~~~ 279 (350)
........ ....++..|+|||.+. ..++.++||||||+++|||++|..++....... .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 75433211 1122345699999875 458899999999999999999877654332110 011
Q ss_pred HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.........+ ....++.++.++|.+||+.+|++|||+.++++.+
T Consensus 237 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 237 ELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred HHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 1111111111 1235789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=289.30 Aligned_cols=252 Identities=30% Similarity=0.511 Sum_probs=207.6
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccC--ChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
+|.+.+.||+|+||.||++.+...+..+++|+++..... .......+..|+.+++++. ||||+++++++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence 589999999999999999999887777777777543221 2223345778899999998 9999999999998999999
Q ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 146 IMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
++||+++++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++ ++.++|+|||.+...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence 9999999999888753 35689999999999999999999999999999999999994 245999999998775
Q ss_pred cCCC-ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHH
Q 018786 222 KPGD-VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (350)
Q Consensus 222 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.... ......+++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+........ ...++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 232 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL---PETYSRQ 232 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC---cchhcHH
Confidence 4332 223456888999999875 4578899999999999999999999987666555555544332222 1357889
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
+.++|.+||+.||++||++.++++|+||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=287.60 Aligned_cols=246 Identities=21% Similarity=0.323 Sum_probs=193.2
Q ss_pred eeeeccCceEEEEEEEc--cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecC
Q 018786 73 RELGRGQFGVTYLVTHK--DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~ 150 (350)
+.||+|+||.||+|... .++..+|+|.+.... .......+.+|+.++++++ |+||+++++.+.+....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECC
Confidence 36899999999999864 345679999886443 2233457888999999998 999999999999999999999999
Q ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 151 AGGELFDRIIAKG-----HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 151 ~~~sL~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||.+.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcc
Confidence 9999999986532 35677888999999999999999999999999999999 556789999999987543222
Q ss_pred c---cccCCcCccccccccccc--------cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Q 018786 226 V---FKDLVGSAYYVAPEVLRR--------NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAIL-RGHIDFSSDP 292 (350)
Q Consensus 226 ~---~~~~~gt~~y~aPE~~~~--------~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 292 (350)
. .....++..|+|||++.+ .++.++|+||||+++|+|++ |..||......+...... ..........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 1 123456788999998752 24789999999999999996 999998766555443332 2222222221
Q ss_pred C-CCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 293 W-PNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 293 ~-~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
. ...+..+.+++..|+ .+|++|||+.+++..+
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 1 235788999999998 6899999999998653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=287.48 Aligned_cols=241 Identities=18% Similarity=0.263 Sum_probs=191.0
Q ss_pred eeeeccCceEEEEEEEccC------------CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 73 RELGRGQFGVTYLVTHKDT------------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~------------~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
+.||+|+||.||+|..... ...+++|++.... ......+.+|+.++..+. ||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVS-HKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 4689999999999985322 3358888875432 233457888999999998 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCC----CCCeEEeec
Q 018786 141 HSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE----DSPLKATDF 215 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~----~~~vkl~Df 215 (350)
...+++|||+++++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. ...++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999999888765 356899999999999999999999999999999999999964321 123899999
Q ss_pred CCcccccCCCccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 018786 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILL-SGVPPFWGETEQSIFDAILRGHIDFSSDP 292 (350)
Q Consensus 216 g~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
|++...... ....++..|+|||.+. ..++.++||||||+++|+|+ +|..||......+... .........
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~--- 229 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLV--- 229 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCC---
Confidence 998765322 3345788899999875 45889999999999999997 5888887665443332 222222211
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
...+.++.++|.+||+.||++||++.+++++.
T Consensus 230 -~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 230 -TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 12467899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=285.78 Aligned_cols=242 Identities=25% Similarity=0.411 Sum_probs=201.8
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|+||.||++.. +++.+|+|.+.... ..+.+.+|+.+++++. |+|++++++++...+ .+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~-~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLH-HKNLVRLLGVILHNG-LYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCC-CCCcCeEEEEEcCCC-cEEE
Confidence 6799999999999999999864 57789999985432 2357889999999998 999999999886554 7899
Q ss_pred EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 147 MDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
|||+.+++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||++ +.++.++|+|||.+......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceecccc
Confidence 99999999999987643 47999999999999999999999999999999999999 55677999999998764332
Q ss_pred CccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
......+..|+|||.+. +.++.++|+||||+++|+|++ |..||......+....+..+.... ....++..+.+
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 228 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME---PPEGCPADVYV 228 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC---CCCcCCHHHHH
Confidence 12334456799999875 568899999999999999997 999998887776666665543222 12367899999
Q ss_pred HHHHhcccCccCCCCHHHHHhcc
Q 018786 303 IVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++.+||+.+|++||++.+++..+
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~~l 251 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLREKL 251 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=285.47 Aligned_cols=260 Identities=21% Similarity=0.276 Sum_probs=219.1
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
.+.+=+..||.|+||+|++..++.+|+..|||.+..... .....+++.|.+..++-.++||||++++....++..||-
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 344455789999999999999999999999999976543 445678999999999888899999999999999999999
Q ss_pred EecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 147 MDLCAGGELFDRII-----AKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 147 ~e~~~~~sL~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
||+| ..+|..+-+ .+..+++.-+.+|.-..+.||+||-. .+|+||||||+|||+ +..|.|||||||.+..
T Consensus 142 MELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 142 MELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQ 217 (361)
T ss_pred HHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHh
Confidence 9999 557644332 24569999999999999999999985 579999999999999 6677799999999999
Q ss_pred ccCCCccccCCcCcccccccccc---ccCCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCCCCCC--C
Q 018786 221 FKPGDVFKDLVGSAYYVAPEVLR---RNYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDFSSDPW--P 294 (350)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~--~ 294 (350)
+.++-..+.-.|...|||||.+. ..|+.++||||||++|||+.||..|+..-. --+++..+..+.++...... -
T Consensus 218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence 88877777788999999999985 348999999999999999999999996543 34666677777666543332 2
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.++..+..+|..||.+|-+.||...+++.++|......
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 47899999999999999999999999999999876543
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=287.28 Aligned_cols=246 Identities=21% Similarity=0.347 Sum_probs=194.0
Q ss_pred eeeeccCceEEEEEEEcc--CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecC
Q 018786 73 RELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~ 150 (350)
+.||+|+||.||+|.... ....+++|.+.... .......+.+|+..++.+. |+||+++++.+......++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEeC
Confidence 368999999999997543 34578888775332 2334467889999999998 999999999999999999999999
Q ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 151 AGGELFDRIIAKG-----HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 151 ~~~sL~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
++++|.+++.... ..++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccch
Confidence 9999999987643 24678889999999999999999999999999999999 567789999999986543221
Q ss_pred c---cccCCcCcccccccccc--------ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCC-
Q 018786 226 V---FKDLVGSAYYVAPEVLR--------RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG-HIDFSSD- 291 (350)
Q Consensus 226 ~---~~~~~gt~~y~aPE~~~--------~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~- 291 (350)
. .....++..|+|||++. ..++.++||||||+++|+|++ |..||......+........ ....+..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 1 12334567799999863 246789999999999999999 78899877766665554433 2222222
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
....++..+.+++..|+ .||++|||++++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 12357888999999998 5999999999998754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=285.66 Aligned_cols=244 Identities=24% Similarity=0.377 Sum_probs=193.9
Q ss_pred eeeeccCceEEEEEEEcc---CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE-cCCceEEEEe
Q 018786 73 RELGRGQFGVTYLVTHKD---TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE-DRHSVNLIMD 148 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~-~~~~~~iv~e 148 (350)
+.||+|+||.||+|.+.. .+..+|+|.+.... .....+.+.+|+.+++.+. |+||+++++++. .++..+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence 468999999999998753 34579999875322 3334567889999999998 999999999764 5667889999
Q ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc-
Q 018786 149 LCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV- 226 (350)
Q Consensus 149 ~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~- 226 (350)
|+.+++|.+++... ..+++..+..++.||+.||.|||+++++||||||+||++ +.++.+||+|||++........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence 99999999998764 346788889999999999999999999999999999999 5567799999999876533211
Q ss_pred ----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 227 ----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSG-VPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 227 ----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
.....++..|+|||.+. ..++.++||||||+++|||++| ..||......+....+..+...... ..++..+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP---EYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCHHH
Confidence 11234567899999875 5688999999999999999994 6677666666655555544322211 2468899
Q ss_pred HHHHHHhcccCccCCCCHHHHHhcc
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+++.+||+.+|++||++.+++..+
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHH
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.86 Aligned_cols=239 Identities=19% Similarity=0.252 Sum_probs=191.7
Q ss_pred eeeeccCceEEEEEEEccCC----------cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 73 RELGRGQFGVTYLVTHKDTK----------QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~----------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
+.||+|+||.||+|.+..++ ..+++|.+..... ....+.+|+.+++++. |+||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence 46899999999999998766 3577887653321 1577889999999998 9999999998877 77
Q ss_pred eEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC----CCCCeEEeecCC
Q 018786 143 VNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA----EDSPLKATDFGL 217 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~----~~~~vkl~Dfg~ 217 (350)
.++||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++ ....+||+|||.
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 899999999999999998765 789999999999999999999999999999999999996433 112699999999
Q ss_pred cccccCCCccccCCcCccccccccccc---cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
+..... .....++..|+|||++.+ .++.++||||||+++|+|++ |..||......+........ ...+.
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~~--- 227 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-HRLPM--- 227 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-CCCCC---
Confidence 887543 223456778999998754 48899999999999999999 57888766543333333221 11111
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.....+.++|.+||+.+|++|||+.++++.+
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 228 -PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1237899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.91 Aligned_cols=240 Identities=17% Similarity=0.234 Sum_probs=191.2
Q ss_pred eeeccCceEEEEEEEccC------------------------CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCC
Q 018786 74 ELGRGQFGVTYLVTHKDT------------------------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129 (350)
Q Consensus 74 ~lg~G~~g~V~~~~~~~~------------------------~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 129 (350)
.||+|+||.||+|....+ ...|++|++.... ......+.+|+.+++++. |+|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence 689999999999985321 2458888885332 233456888999999998 999
Q ss_pred eeEeEeEEEcCCceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC---
Q 018786 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--- 205 (350)
Q Consensus 130 iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--- 205 (350)
|+++++++......++||||+++++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+||+++..+
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888865 56789999999999999999999999999999999999996422
Q ss_pred -CCCCeEEeecCCcccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHH
Q 018786 206 -EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILL-SGVPPFWGETEQSIFDAI 281 (350)
Q Consensus 206 -~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll-~g~~pf~~~~~~~~~~~~ 281 (350)
....++++|||.+...... ....++..|+|||.+.+ .++.++||||||+++||++ +|..||......+.....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 234 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 2335899999987654322 23457888999998753 4789999999999999985 699999876654443322
Q ss_pred HcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
. .....+. ..+..+.++|.+||+.+|++|||+.++|+++
T Consensus 235 ~-~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 235 E-KKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred H-hccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 2 2222222 2467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.42 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=196.6
Q ss_pred CceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCCCHHHH
Q 018786 79 QFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDR 158 (350)
Q Consensus 79 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~ 158 (350)
+++.||.++...+++.||||++..... .....+.+.+|+..+++++ |+||+++++.+...+..+++|||+++++|.++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence 445666667777899999999975432 3445678999999999998 99999999999999999999999999999998
Q ss_pred HHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC--------ccc
Q 018786 159 IIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD--------VFK 228 (350)
Q Consensus 159 l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~--------~~~ 228 (350)
+... ..+++..+..++.||+.||.|||+++|+||||||+||++ +.++.+||+|||.+....... ...
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeeccccccccccccccc
Confidence 8763 458999999999999999999999999999999999999 556779999999886543211 112
Q ss_pred cCCcCccccccccccc---cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------C---------
Q 018786 229 DLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF-------S--------- 289 (350)
Q Consensus 229 ~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------~--------- 289 (350)
...++..|+|||++.. .++.++|+||||+++|+|++|..||..............+.... +
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS 246 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcc
Confidence 3457778999998754 47889999999999999999999998766544332222211100 0
Q ss_pred --------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 290 --------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 290 --------------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
......++.++.+++.+||+.||++|||+.++|+|+||.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000012346788999999999999999999999999998664
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=292.26 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=202.6
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCc----EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQ----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++++. |+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-
Confidence 3678899999999999999999877665 46888875432 2333456889999999998 99999999988654
Q ss_pred ceEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..++++||+++++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++..
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARL 158 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEcccccccc
Confidence 4678999999999999987644 58999999999999999999999999999999999999 5566799999999987
Q ss_pred ccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 221 FKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 221 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
...... .....++..|++||.+. ..++.++||||||+++|++++ |..||.+.........+..... .+. .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~ 235 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER-LPQ--PPI 235 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CCC--CCC
Confidence 543321 12234567899999875 458899999999999999997 8999987765555444443322 221 235
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
++..+.+++.+||..+|++||++.++++.+.
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 6889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=287.87 Aligned_cols=247 Identities=24% Similarity=0.390 Sum_probs=199.8
Q ss_pred eeeeccCceEEEEEEEccCC------cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 73 RELGRGQFGVTYLVTHKDTK------QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
+.||+|+||.||+|.++... +.+|+|.+.... .......+.+|+.+++++. |+||+++++++...+..+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence 36899999999999986543 679999885432 2234567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC--CCCCeEEeecCC
Q 018786 147 MDLCAGGELFDRIIAK-------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--EDSPLKATDFGL 217 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~~~vkl~Dfg~ 217 (350)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++ ....++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999998642 2378899999999999999999999999999999999996533 233799999999
Q ss_pred cccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 018786 218 SVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292 (350)
Q Consensus 218 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
+........ .....++..|+|||.+. +.++.++||||||+++|+|++ |..||......+....+....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ---K 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccC---C
Confidence 876533221 12234567899999875 458999999999999999998 999998777666655554332111 1
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
...++..+.++|.+||..+|++||++.++++.+
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 235789999999999999999999999998754
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=280.78 Aligned_cols=266 Identities=26% Similarity=0.502 Sum_probs=236.7
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
-.++|.++..||+|+|++|..++.+.+.+.||+|++++...+..+.++=+..|-.+..+..+||.+|-++.+|..+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 45789999999999999999999999999999999998887777777778889999999888999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc-ccC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF-FKP 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~-~~~ 223 (350)
+|.||.+||+|.-++..+++++++.++.+...|+-||.|||++||+.||||.+|+|+ +..|++||.|+|.++. +.+
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCC
Confidence 999999999999889999999999999999999999999999999999999999999 6778899999999976 456
Q ss_pred CCccccCCcCcccccccccccc-CCcchhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHcCCCCCCCCCCC
Q 018786 224 GDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWG--------ETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~Dv~slG~vl~~ll~g~~pf~~--------~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
+...++.+|||.|.|||++++. |....|.|+||++|+||+.|+.||.- +++.-.++.++...+..+.
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr---- 480 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR---- 480 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----
Confidence 6777889999999999999864 99999999999999999999999942 2333455556666666665
Q ss_pred CCCHHHHHHHHHhcccCccCCC------CHHHHHhccCCCCCchhhHHH
Q 018786 295 NISSSAKDIVKKMLHADPKERL------SAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rp------s~~~iL~~~~~~~~~~~~~~~ 337 (350)
.++-....+++..|++||.+|. .+.++-.|+||....|..++.
T Consensus 481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq 529 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ 529 (593)
T ss_pred eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh
Confidence 3577788899999999999996 468999999999999987764
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=285.90 Aligned_cols=249 Identities=22% Similarity=0.386 Sum_probs=200.0
Q ss_pred eeeeeeeeccCceEEEEEEEcc---CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC----
Q 018786 69 YIFGRELGRGQFGVTYLVTHKD---TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH---- 141 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~---- 141 (350)
|.+.+.||+|+||.||+|.++. +++.+|||++..... .....+.+.+|++.++++. |+||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence 5678899999999999998653 578899999865432 3344677889999999998 999999999875432
Q ss_pred --ceEEEEecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEe
Q 018786 142 --SVNLIMDLCAGGELFDRIIAK------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (350)
Q Consensus 142 --~~~iv~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~ 213 (350)
..+++++|+.+++|.+++... ..++...++.++.||+.||.|||++||+||||||+||++ +.++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence 246889999999998877532 247889999999999999999999999999999999999 556779999
Q ss_pred ecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCC
Q 018786 214 DFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDF 288 (350)
Q Consensus 214 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 288 (350)
|||++........ .....+++.|++||.+. ..++.++||||||+++|+|++ |..||......+....+.......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9999886543221 12234567899999875 457889999999999999999 899998777766666555443211
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 289 ~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
. .+..+..+.+++.+||+.+|++|||+.++++.+
T Consensus 236 ~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 236 Q---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred C---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1 135688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=290.07 Aligned_cols=251 Identities=16% Similarity=0.192 Sum_probs=187.2
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccC---CcEEEEEEecccccCChhhH--------HHHHHHHHHHHHccCCCCeeE
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDV--------EDVRREVQIMHHLTGHRNIVE 132 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~--------~~~~~e~~~l~~l~~h~~iv~ 132 (350)
...++|++.+.||+|+||+||+|.+..+ +..+|+|+............ .....++..+..+. |+++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~ 87 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIPK 87 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCCc
Confidence 4457899999999999999999999877 66778886543221110000 01122233344455 999999
Q ss_pred eEeEEEcCC----ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCC
Q 018786 133 LKGAYEDRH----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 133 ~~~~~~~~~----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~ 208 (350)
+++++.... ..+++++++ ..++.+.+......++..+..++.||+.||.|||+++|+||||||+|||+ +.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGNN 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCC
Confidence 998764433 346788887 44777777666567899999999999999999999999999999999999 5567
Q ss_pred CeEEeecCCcccccCCC--------ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHH-
Q 018786 209 PLKATDFGLSVFFKPGD--------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE-QSI- 277 (350)
Q Consensus 209 ~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~-~~~- 277 (350)
.++|+|||+|....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ...
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 79999999997653211 1123469999999998764 589999999999999999999999977632 221
Q ss_pred -------HHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 278 -------FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 278 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
...+..... ..+..++++.+++..|++.+|++||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~ 292 (294)
T PHA02882 244 HAAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKI 292 (294)
T ss_pred HHhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHh
Confidence 122222211 223568999999999999999999999999864
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=310.21 Aligned_cols=204 Identities=31% Similarity=0.498 Sum_probs=179.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC-----
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH----- 141 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~----- 141 (350)
..|..-+.||+||||.||+++++.+|+.||||.+.... .....++..+|++++++++ |+|||++++.-+...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCccc
Confidence 34555689999999999999999999999999997543 4455788999999999999 999999999755433
Q ss_pred -ceEEEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC-CCCCeEEeecC
Q 018786 142 -SVNLIMDLCAGGELFDRIIA---KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFG 216 (350)
Q Consensus 142 -~~~iv~e~~~~~sL~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~~~vkl~Dfg 216 (350)
...++||||.||+|+..+.. ...+++..++.++.++..||.|||++||+||||||.||++.... .....||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 56799999999999999864 45699999999999999999999999999999999999997533 34456999999
Q ss_pred CcccccCCCccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGET 273 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~ 273 (350)
.|+...++....+.+||+.|.+||++. +.|+..+|.||||+++|++.||..||....
T Consensus 170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 999999998899999999999999876 668999999999999999999999996543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=288.28 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=201.2
Q ss_pred cceeeeeeeeccCceEEEEEEEcc----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc--C
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKD----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--R 140 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~ 140 (350)
..|++.+.||+|+||.||+|.... +++.+|+|++...... ...+.+.+|++.++++. |+||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence 568888999999999999998653 4789999999754321 34578999999999998 9999999998876 6
Q ss_pred CceEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
...+++|||+++++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||.+.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence 67999999999999999997654 58999999999999999999999999999999999999 556789999999998
Q ss_pred cccCCCcc----ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHH
Q 018786 220 FFKPGDVF----KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQS--------------IFDA 280 (350)
Q Consensus 220 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~--------------~~~~ 280 (350)
........ ....++..|++||.+. ..++.++||||||+++++|++|..|+....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532211 1224456799999775 458889999999999999999999986542211 1112
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
........+. ...++.++.+++.+||+.+|++|||+.|+++.+
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 238 LLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred HHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 2222222221 235678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=301.26 Aligned_cols=265 Identities=30% Similarity=0.534 Sum_probs=229.2
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
..-|..++.||-|+||.|.+++..++...||+|.+.+...........++.|-.+|.... ++-||++|-.|.+.+.+|+
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEE
Confidence 356778899999999999999999999999999998877777777888999999999988 8999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc----
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF---- 221 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~---- 221 (350)
||+|++||++..+|-+.+-|.+..++.++..+.+|++++|..|+|||||||+|||| |.+|++||.|||++.-+
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceecc
Confidence 99999999999999999999999999999999999999999999999999999999 78889999999998532
Q ss_pred -----cCCC----------------------------------ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHH
Q 018786 222 -----KPGD----------------------------------VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYI 261 (350)
Q Consensus 222 -----~~~~----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ 261 (350)
..+. .....+||+.|+|||++. ..++.-+|.||.|++|||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 1110 011247999999999876 569999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCC---CHHHHHhccCCCCCchhhH
Q 018786 262 LLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL---SAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 262 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp---s~~~iL~~~~~~~~~~~~~ 335 (350)
|+.|+.||......+.-..+.++.-.+......+++++..++|.+++ .+++.|. .++|+-+|+||++..|..+
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfssl 939 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSSL 939 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHhh
Confidence 99999999888876666666666555555555689999999998876 5777887 5677999999999988664
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=269.99 Aligned_cols=256 Identities=27% Similarity=0.532 Sum_probs=211.8
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC--Cc
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HS 142 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~ 142 (350)
..++|++.+++|+|.++.||.|.+..+.+.++||+++..+ ..++.+|+.+|+.|.+++||+++++...+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 4588999999999999999999998889999999997543 378999999999999999999999987654 45
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
..+++||.+..+...+ -..++...++.++.+++.||+|+|+.||+|||+||.|+|++. +...++|+|||+|.++-
T Consensus 110 paLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh--~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech--hhceeeeeecchHhhcC
Confidence 7799999987655443 346888999999999999999999999999999999999963 34569999999999999
Q ss_pred CCCccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHc-------------CCC
Q 018786 223 PGDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFW-GETEQSIFDAILR-------------GHI 286 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~-~~~~~~~~~~~~~-------------~~~ 286 (350)
++...+-++.+..|--||.+. ..++..-|+|||||++..|+..+.||. +.+..+++..+.+ -..
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 998888899999999999875 458999999999999999999888874 4444444333321 111
Q ss_pred CCC-----------CCCC---------CCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 287 DFS-----------SDPW---------PNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 287 ~~~-----------~~~~---------~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.++ ...| --+++++.+|+.++|..|..+|+|+.|+++|+||....
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 111 1111 12468999999999999999999999999999997654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=280.22 Aligned_cols=228 Identities=24% Similarity=0.335 Sum_probs=187.2
Q ss_pred cCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCCCHHH
Q 018786 78 GQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD 157 (350)
Q Consensus 78 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~ 157 (350)
|.+|.||+++++.+++.||+|.+.... ...+|...+.... |+||+++++++......+++|||+++++|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999999999999999996542 1233444444555 9999999999999999999999999999999
Q ss_pred HHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccCCcCcccc
Q 018786 158 RIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237 (350)
Q Consensus 158 ~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~ 237 (350)
++.....+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||.+...... .....++..|+
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcCcccc
Confidence 99887789999999999999999999999999999999999999 56677999999987665433 23345677899
Q ss_pred cccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCC
Q 018786 238 APEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL 316 (350)
Q Consensus 238 aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp 316 (350)
|||.+. ..++.++|+||+|+++|+|++|..|+........ .......+ +.++..+.++|.+||+.||++||
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIP----EWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCc----ccCCHHHHHHHHHHccCCHHHhc
Confidence 999876 4588899999999999999999988754322100 00011111 24688999999999999999999
Q ss_pred CH-----HHHHhccCC
Q 018786 317 SA-----AEVLSKFLI 327 (350)
Q Consensus 317 s~-----~~iL~~~~~ 327 (350)
++ .++++|+||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=280.04 Aligned_cols=246 Identities=17% Similarity=0.304 Sum_probs=192.6
Q ss_pred eeeeccCceEEEEEEEccC--CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecC
Q 018786 73 RELGRGQFGVTYLVTHKDT--KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~ 150 (350)
+.||+|+||.||++..... ...+++|.+.... .....+.+.+|+..++.+. ||||+++++.+......++||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEecC
Confidence 3699999999999976433 3346677664332 2234568999999999998 999999999999999999999999
Q ss_pred CCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 151 AGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 151 ~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
++++|.+++... ..++...+..++.||+.||.|||+++++||||||+|||+ +.++.++|+|||++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchh
Confidence 999999998753 335677888999999999999999999999999999999 566779999999976432111
Q ss_pred --ccccCCcCccccccccccc--------cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCC-
Q 018786 226 --VFKDLVGSAYYVAPEVLRR--------NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH-IDFSSDP- 292 (350)
Q Consensus 226 --~~~~~~gt~~y~aPE~~~~--------~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~- 292 (350)
......++..|+|||++.. .++.++||||||+++|||++ |..||......+.+..+.... .....+.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 1234467889999998632 25678999999999999996 577888777766666554332 2222221
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
...++..+.+++..|+ .+|++||++.++++.+
T Consensus 235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 2346889999999999 6899999999998765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=303.00 Aligned_cols=258 Identities=25% Similarity=0.424 Sum_probs=220.3
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE-----cC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE-----DR 140 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~-----~~ 140 (350)
.+.|.|.+.||.|.+|.||+++++.+++..|+|+..... +..+++..|.++++.+..|||++.++++|. .+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 467999999999999999999999999999999986544 344778899999999999999999999874 46
Q ss_pred CceEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 141 HSVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
+.+|+|||||.|||..|+++. ..++.|..+..|++.++.||.+||.+.++|||||-.|||+ ..++.|||+|||.+
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVS 170 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeeeee
Confidence 789999999999999999976 3568999999999999999999999999999999999999 55666999999998
Q ss_pred ccccCCC-ccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 018786 219 VFFKPGD-VFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 219 ~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
....... ..++.+||+.|||||++. ..|+.++|+||||++..||--|.+|+........+-.+-++.++ ...
T Consensus 171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPP-kLk 249 (953)
T KOG0587|consen 171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP-KLK 249 (953)
T ss_pred eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCc-ccc
Confidence 8875443 346778999999999985 23788999999999999999999999877765554444333222 222
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.+.+++.++.++|..||.+|-++||+..++|+|+|+....
T Consensus 250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 3456789999999999999999999999999999999554
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=287.26 Aligned_cols=254 Identities=22% Similarity=0.370 Sum_probs=211.0
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
-.....++++||+|-||.|.++.... +..||||.++... +......|.+|+++|.+|+ ||||+.+++.|...+.++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLC 611 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchH
Confidence 35678899999999999999998765 6889999997554 3444688999999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 145 LIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+++||++.|+|.+++.++. ....+....++.||+.|++||.+.++|||||.++|||+ ++++++||+|||.++.+-
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccc
Confidence 9999999999999998863 34556667799999999999999999999999999999 888899999999998654
Q ss_pred CCCcc---ccCCcCcccccccc-ccccCCcchhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHcCCCCCCC----CC
Q 018786 223 PGDVF---KDLVGSAYYVAPEV-LRRNYGAEADIWSAGVILYILL--SGVPPFWGETEQSIFDAILRGHIDFSS----DP 292 (350)
Q Consensus 223 ~~~~~---~~~~gt~~y~aPE~-~~~~~~~~~Dv~slG~vl~~ll--~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~ 292 (350)
.+... ...+-...|||+|. +.+.++.++|||+||+++||++ +...||....+++..+....-...-.. ..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence 44322 23456788999996 4688999999999999999976 478999988887777665432222111 12
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+-++..+.+++.+|+..|-++||+++++..++
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 235789999999999999999999999986543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=289.41 Aligned_cols=247 Identities=27% Similarity=0.466 Sum_probs=209.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccC----CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDT----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
....+.+.||.|-||.||+|....- .--||||..+.+- ..+..+.|..|.-+++++. ||||++++|++.+ ..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfd-HphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVE-QP 464 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCC-Ccchhheeeeeec-cc
Confidence 3444567899999999999997542 3358889887543 4455789999999999999 9999999999865 46
Q ss_pred eEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.|||||+++-|.|..+++.+ ..++...+..++.||+.||.|||++.+|||||...|||+ ....-|||+|||+++.+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV---sSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV---SSPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee---cCcceeeecccchhhhc
Confidence 89999999999999999875 458999999999999999999999999999999999999 45566999999999998
Q ss_pred cCCCccccCCc--Ccccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 222 KPGDVFKDLVG--SAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 222 ~~~~~~~~~~g--t~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
++........| ...|||||.++ ..++.++|||.||+.|||+++ |..||.+....+.+-.+.++.....+ +++|
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P---~nCP 618 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP---PNCP 618 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC---CCCC
Confidence 87766555444 34599999987 569999999999999999987 99999998888777777766543333 3789
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
+.+..|+.+||..+|.+||++.++-.
T Consensus 619 p~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 619 PALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred hHHHHHHHHHhccCcccCCcHHHHHH
Confidence 99999999999999999999998865
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=301.45 Aligned_cols=257 Identities=21% Similarity=0.329 Sum_probs=177.2
Q ss_pred cccceeeeeeeeccCceEEEEEEEccC----CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE----
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDT----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA---- 136 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~---- 136 (350)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .+...++ .++... +.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~-~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRAC-PNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhc-hhhHHHHHHhhhcc
Confidence 357899999999999999999999988 89999998753221 1111111 111111 2222222111
Q ss_pred --EEcCCceEEEEecCCCCCHHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCEeecC
Q 018786 137 --YEDRHSVNLIMDLCAGGELFDRIIAKGH--------------------YSERAAANLCRQMVTVVHYCHSMGVMHRDL 194 (350)
Q Consensus 137 --~~~~~~~~iv~e~~~~~sL~~~l~~~~~--------------------~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dl 194 (350)
......+++|+||+.+++|.+++..... .....+..++.||+.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2456679999999999999998865321 123456789999999999999999999999
Q ss_pred CCCceEeecCCCCCCeEEeecCCcccccCCC--ccccCCcCcccccccccc-c----------------------cCCcc
Q 018786 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGD--VFKDLVGSAYYVAPEVLR-R----------------------NYGAE 249 (350)
Q Consensus 195 kp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~----------------------~~~~~ 249 (350)
||+|||++. +++.+||+|||+|....... ......+++.|+|||.+. . .+..+
T Consensus 282 KP~NILl~~--~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 282 KPQNIIFSE--GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CHHHEEEeC--CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999999952 35679999999998654322 234567899999999652 1 13345
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHcCCCCC-------CC----------CCCCCCCHHHHHHHHHhcccC
Q 018786 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDA-ILRGHIDF-------SS----------DPWPNISSSAKDIVKKMLHAD 311 (350)
Q Consensus 250 ~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~-------~~----------~~~~~~~~~l~~li~~~L~~d 311 (350)
+|||||||++|||+++..++... ...+.. +....... .. ..+........+||.+||+.|
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 69999999999999976664322 111111 11111000 00 000112334568999999999
Q ss_pred ccCCCCHHHHHhccCCCCCchh
Q 018786 312 PKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 312 p~~Rps~~~iL~~~~~~~~~~~ 333 (350)
|++|||+.++|+|+||.+..+.
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCcc
Confidence 9999999999999999987654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=284.58 Aligned_cols=269 Identities=26% Similarity=0.442 Sum_probs=222.8
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhh----HHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD----VEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~----~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
-..+.++|-++..||+|||+.||+|.+....++||||+-...+.+..+. .....+|..+.+.|. ||.||++|++|
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDyf 536 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDYF 536 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeeee
Confidence 3456789999999999999999999999999999999987654433322 345788999999998 99999999988
Q ss_pred E-cCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeecCCCCceEeecCCCCCCeEEee
Q 018786 138 E-DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 138 ~-~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
. +.+..+-|+|||+|-+|.-+++.++-+++++++.|+.||+.||.||.+.. |||-||||.|||+.+...-|.+||.|
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 5 66778899999999999889999999999999999999999999999775 99999999999998766678899999
Q ss_pred cCCcccccCCCc--------cccCCcCcccccccccc-c----cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Q 018786 215 FGLSVFFKPGDV--------FKDLVGSAYYVAPEVLR-R----NYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDA 280 (350)
Q Consensus 215 fg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~----~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~-~~~~~ 280 (350)
||+++.+.+... .....||..|.+||.+. + ..+.++||||.|+++|.++.|+.||..+... +++..
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 999998764432 23457999999999763 2 3789999999999999999999999876543 33322
Q ss_pred --HHc-CCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 281 --ILR-GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 281 --~~~-~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
+++ ....++.. |.++.+..++|++||+..-++|....++-.+++|.--..+
T Consensus 697 NTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rr 750 (775)
T KOG1151|consen 697 NTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRR 750 (775)
T ss_pred hchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhh
Confidence 222 23334433 4689999999999999999999999999999998764433
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=300.07 Aligned_cols=252 Identities=23% Similarity=0.397 Sum_probs=219.8
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCC---cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTK---QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
-.+..+|.+.||.|.||.|++|+.+..| ..||||.++.. ..+..+..|+.|+.+|-++. ||||+++.+......
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSK 703 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCc
Confidence 3467788999999999999999987654 56999999743 35566788999999999999 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.+.||.|||++|+|..+|.. .++|+..++..+++.|+.|++||-+.|+|||||...|||+ +.+..+|++|||+++.
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRV 780 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceee
Confidence 99999999999999999975 5789999999999999999999999999999999999999 6677899999999998
Q ss_pred ccCCCc-c-ccCCc--Ccccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 221 FKPGDV-F-KDLVG--SAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 221 ~~~~~~-~-~~~~g--t~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.+++.. . ++.-| ...|.|||.+. ..++.++||||+|++|||.++ |..||.....++.++.+..+..-.++.
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm--- 857 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM--- 857 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC---
Confidence 765541 1 12212 35699999986 679999999999999999886 999999999999999999876544443
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++|..|.+|+..||++|-.+||.+.+|+..+
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 6899999999999999999999999998743
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=267.41 Aligned_cols=242 Identities=41% Similarity=0.721 Sum_probs=205.9
Q ss_pred CceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCCCHHHH
Q 018786 79 QFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDR 158 (350)
Q Consensus 79 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~ 158 (350)
+||.||+|.+..+++.+|+|++........ .+.+.+|++.++++. |+|++++++++......++++|++.+++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 589999999998899999999975443221 578999999999997 99999999999998999999999999999999
Q ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccCCcCccccc
Q 018786 159 IIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVA 238 (350)
Q Consensus 159 l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~a 238 (350)
+.....++...++.++.+++.++.+||+.+++|+||+|.||++ +.++.++|+|||.+.............++..|++
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence 8877668999999999999999999999999999999999999 4557799999999988765544556678889999
Q ss_pred ccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCC
Q 018786 239 PEVLR-RNYGAEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL 316 (350)
Q Consensus 239 PE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp 316 (350)
||.+. ..++.++|||+||++++++++|..||.. .................... ...++.++.+++.+||..+|++||
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP-EWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc-cccCCHHHHHHHHHHccCCchhcc
Confidence 99875 5588899999999999999999999987 44444555444444333221 122789999999999999999999
Q ss_pred CHHHHHhccCC
Q 018786 317 SAAEVLSKFLI 327 (350)
Q Consensus 317 s~~~iL~~~~~ 327 (350)
++.++++++||
T Consensus 234 ~~~~~~~~~~~ 244 (244)
T smart00220 234 TAEEALQHPFF 244 (244)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=294.35 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=212.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccC---CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
+..++.++||+|.||+|++|.++.. ...||||++....... ....|.+|+.+|.+|. |+|++++|++..+ ..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhcc-CcceeEEeeeecc-chh
Confidence 4566779999999999999998743 3469999998665432 6788999999999999 9999999999876 678
Q ss_pred EEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 144 NLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.+|||+++.|+|.+.|.+ +..|....+..++.||+.|+.||.++++|||||...|+++ -....|||+|||+.+.+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll---asprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL---ASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee---cccceeeeecccceecc
Confidence 899999999999999987 3458889999999999999999999999999999999999 44667999999999887
Q ss_pred cCCCcccc----CCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 222 KPGDVFKD----LVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 222 ~~~~~~~~----~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..+..... ..-...|+|||.++ ..++.++|||+||+++|||++ |..||.+.....+++.+..+.. ++.+ +.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er-LpRP--k~ 339 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER-LPRP--KY 339 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-CCCC--CC
Confidence 65543322 22355699999886 579999999999999999998 8899999999999988874432 2222 36
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhccCCC
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
+++++.+++..||..+|++|||+..|-+..++.
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 899999999999999999999999997655544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=274.88 Aligned_cols=264 Identities=26% Similarity=0.453 Sum_probs=203.1
Q ss_pred ccccc-cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccC-------CCCeeEe
Q 018786 62 MEDVR-NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG-------HRNIVEL 133 (350)
Q Consensus 62 ~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-------h~~iv~~ 133 (350)
++.+. ++|.+.++||.|-|++||++.+....+.||+|+.+...- -.+....||++|++++. ...||++
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 45566 899999999999999999999999999999999874322 23567889999999863 3369999
Q ss_pred EeEEE----cCCceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCC-
Q 018786 134 KGAYE----DRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSA- 205 (350)
Q Consensus 134 ~~~~~----~~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~- 205 (350)
++.|. .+.++++|+|++ |.+|..+++.. +.++...+++|++||+.||+|||. .||||.||||+|||+...+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~ 226 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEI 226 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecccc
Confidence 99885 567899999999 88999999864 569999999999999999999995 6999999999999984220
Q ss_pred --------------------------------------------------------------------------------
Q 018786 206 -------------------------------------------------------------------------------- 205 (350)
Q Consensus 206 -------------------------------------------------------------------------------- 205 (350)
T Consensus 227 ~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~ 306 (590)
T KOG1290|consen 227 DPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNE 306 (590)
T ss_pred chhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccc
Confidence
Q ss_pred ------------------------------C-------------------------------------------------
Q 018786 206 ------------------------------E------------------------------------------------- 206 (350)
Q Consensus 206 ------------------------------~------------------------------------------------- 206 (350)
.
T Consensus 307 ~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~ 386 (590)
T KOG1290|consen 307 PRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPL 386 (590)
T ss_pred cCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCC
Confidence 0
Q ss_pred ---CCCeEEeecCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCC------CHHH
Q 018786 207 ---DSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGE------TEQS 276 (350)
Q Consensus 207 ---~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~------~~~~ 276 (350)
+..|||+|||.|+... ...+.-+-|..|++||++- ..|+..+||||++|+++||.||.+.|... .+++
T Consensus 387 ~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 387 PECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred CccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 0125666777666632 2234446788999999865 57999999999999999999999999543 2334
Q ss_pred HHHHHHcCCCCCCCC-------------------------CCC---------CC----CHHHHHHHHHhcccCccCCCCH
Q 018786 277 IFDAILRGHIDFSSD-------------------------PWP---------NI----SSSAKDIVKKMLHADPKERLSA 318 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~-------------------------~~~---------~~----~~~l~~li~~~L~~dp~~Rps~ 318 (350)
.+..+..-....|.. .|+ .+ ..++.+|+.-||+.+|++|||+
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA 544 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTA 544 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccH
Confidence 443332211111100 111 11 2567899999999999999999
Q ss_pred HHHHhccCCCCCch
Q 018786 319 AEVLSKFLIPKKTL 332 (350)
Q Consensus 319 ~~iL~~~~~~~~~~ 332 (350)
.+.|+|+|+.....
T Consensus 545 ~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 545 AQCLKHPWLNPVAG 558 (590)
T ss_pred HHHhcCccccCCCC
Confidence 99999999996544
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=285.93 Aligned_cols=252 Identities=23% Similarity=0.413 Sum_probs=218.5
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
..++.-..+.....+||.|-||.||.|.++.-.-.||||.++.+. -..++|..|..+|+.+. |||+|+++++|..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeik-HpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTH 334 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhc-CccHHHHhhhhcc
Confidence 345555667777889999999999999999888889999987543 35688999999999999 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
+...|||.|||..|+|.++|.+..+ ++.-.++.++.||..|++||..+++|||||...|+|+ +++..|||+|||+
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGL 411 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGL 411 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccch
Confidence 9999999999999999999987543 6777888999999999999999999999999999999 8888999999999
Q ss_pred cccccCCCccccCCc---Ccccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 018786 218 SVFFKPGDVFKDLVG---SAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292 (350)
Q Consensus 218 a~~~~~~~~~~~~~g---t~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
++.+.... ++...| ...|.|||-+. +.++.++|||+||++|||+.| |.-||.+.+-...+..+.++......
T Consensus 412 sRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~P-- 488 (1157)
T KOG4278|consen 412 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGP-- 488 (1157)
T ss_pred hhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCC--
Confidence 99986543 333333 45699999876 569999999999999999988 89999999988888888876544333
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
..+++.+.+|++.||+++|.+||++.|+-+
T Consensus 489 -eGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 489 -EGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred -CCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 378999999999999999999999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=249.51 Aligned_cols=218 Identities=24% Similarity=0.352 Sum_probs=185.6
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
.+...+....+..||+|++|.|-+.++..+|...|+|.+...- +.+...+..+|+.+.++...+|.+|.+++.+..++
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 3444566667789999999999999999999999999997443 45566789999999999888999999999999999
Q ss_pred ceEEEEecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 142 SVNLIMDLCAGGELFDRI----IAKGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l----~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
.++|.||.| ..||..+- +..+.+++..+-+++..+.+||.|||++ .++|||+||+|||+ +.+|.||+||||
T Consensus 119 dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFG 194 (282)
T KOG0984|consen 119 DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFG 194 (282)
T ss_pred cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccc
Confidence 999999999 44775443 3356799999999999999999999976 79999999999999 677889999999
Q ss_pred CcccccCCCccccCCcCcccccccccc-----ccCCcchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR-----RNYGAEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGH 285 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~Dv~slG~vl~~ll~g~~pf~~-~~~~~~~~~~~~~~ 285 (350)
.+..+.++...+-..|...|||||.+. ..|+.++||||||+++.||.++++||.. .++-+++.++....
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence 999988777666678999999999875 2589999999999999999999999964 45566777766543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=286.61 Aligned_cols=261 Identities=23% Similarity=0.387 Sum_probs=216.1
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccC-----CCCeeEeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG-----HRNIVELKGA 136 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-----h~~iv~~~~~ 136 (350)
++.+..+|.+....|+|-|++|.+|.+...|..||||++..... -...=..|+++|++|.. --++++++..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 46677899999999999999999999999999999999975432 23456789999999973 3478999999
Q ss_pred EEcCCceEEEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEe
Q 018786 137 YEDRHSVNLIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (350)
Q Consensus 137 ~~~~~~~~iv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~ 213 (350)
|...+++|+|||-+ ..+|.+.|+..+. +....++.++.||+-||..|-.+||+|.||||.|||++. ....+|||
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE--~k~iLKLC 579 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE--SKNILKLC 579 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc--Ccceeeec
Confidence 99999999999988 5599999987553 889999999999999999999999999999999999973 45679999
Q ss_pred ecCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 018786 214 DFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292 (350)
Q Consensus 214 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
|||.|....+... +.+..+..|+|||++. -.|+...|+||.||+||||+||+..|.+.+...++.........++..-
T Consensus 580 DfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 580 DFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred cCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 9999998765543 3445566799999765 5799999999999999999999999999888777665544333222110
Q ss_pred C-------------------------------------------------CCC-------CHHHHHHHHHhcccCccCCC
Q 018786 293 W-------------------------------------------------PNI-------SSSAKDIVKKMLHADPKERL 316 (350)
Q Consensus 293 ~-------------------------------------------------~~~-------~~~l~~li~~~L~~dp~~Rp 316 (350)
+ +.+ -..+.+|+..||..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 0 011 14578999999999999999
Q ss_pred CHHHHHhccCCCCC
Q 018786 317 SAAEVLSKFLIPKK 330 (350)
Q Consensus 317 s~~~iL~~~~~~~~ 330 (350)
|..++|.||||+++
T Consensus 739 t~nqAL~HpFi~~k 752 (752)
T KOG0670|consen 739 TVNQALKHPFITEK 752 (752)
T ss_pred CHHHHhcCCcccCC
Confidence 99999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=283.83 Aligned_cols=259 Identities=23% Similarity=0.311 Sum_probs=186.7
Q ss_pred cccceeeeeeeeccCceEEEEEEEc----------------cCCcEEEEEEecccccCCh-----------hhHHHHHHH
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHK----------------DTKQQFACKSISSRKLINR-----------DDVEDVRRE 117 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~~avK~~~~~~~~~~-----------~~~~~~~~e 117 (350)
..++|.+.++||+|+||+||+|... ..++.||||.+........ ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3579999999999999999999752 2356799999864321100 011233456
Q ss_pred HHHHHHccCCCCe-----eEeEeEEEc--------CCceEEEEecCCCCCHHHHHHHc----------------------
Q 018786 118 VQIMHHLTGHRNI-----VELKGAYED--------RHSVNLIMDLCAGGELFDRIIAK---------------------- 162 (350)
Q Consensus 118 ~~~l~~l~~h~~i-----v~~~~~~~~--------~~~~~iv~e~~~~~sL~~~l~~~---------------------- 162 (350)
+.++.++. |.++ +++++++.. .+..++|+||+++++|.++++..
T Consensus 223 ~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 77777776 4443 566666532 45689999999999999988642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCcccc--CCcCccccc
Q 018786 163 --GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD--LVGSAYYVA 238 (350)
Q Consensus 163 --~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~gt~~y~a 238 (350)
..+++..++.++.|++.+|.|||+++|+||||||+||++ +.++.+||+|||++........... ..+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 123567788999999999999999999999999999999 5567799999999976544332222 234789999
Q ss_pred ccccccc---------------------C--CcchhHHHHHHHHHHHHhCCC-CCCCCC-----------HHHHHHHHHc
Q 018786 239 PEVLRRN---------------------Y--GAEADIWSAGVILYILLSGVP-PFWGET-----------EQSIFDAILR 283 (350)
Q Consensus 239 PE~~~~~---------------------~--~~~~Dv~slG~vl~~ll~g~~-pf~~~~-----------~~~~~~~~~~ 283 (350)
||.+... + ..+.||||+||++|+|++|.. ||.... ....+..+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 9976421 1 124699999999999999876 664321 1111122222
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCc---cCCCCHHHHHhccCCCC
Q 018786 284 GHIDFSSDPWPNISSSAKDIVKKMLHADP---KERLSAAEVLSKFLIPK 329 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp---~~Rps~~~iL~~~~~~~ 329 (350)
....+ ..++..++...+|+.+||..+| .+|+|+.|+|+|+||..
T Consensus 459 ~~~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QKYDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cCCCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 22222 2355678999999999999866 68999999999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=267.31 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=203.8
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC-----CceEEE
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR-----HSVNLI 146 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-----~~~~iv 146 (350)
-+.||.|+||+||.+.+..+|+.||+|.+.. ...+.....++.+|+++|.-++ |.|++..+++.... ..+|++
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHHHHH
Confidence 3689999999999999999999999998753 2223344578999999999999 99999888876432 346788
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC--
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-- 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~-- 224 (350)
.|++ ..+|+.++-.-..++.+.+.-+++||+.||+|||+.+|.||||||.|.|+ +.+-.+||+|||+++..+..
T Consensus 136 TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccchhhh
Confidence 8888 45888888777789999999999999999999999999999999999999 55667999999999876533
Q ss_pred CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------------
Q 018786 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH----------------- 285 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~----------------- 285 (350)
...+..+.|.+|+|||.+.+ .|+.+.||||.||++.|++..+..|......+.++.+..-.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 33455678999999998764 59999999999999999999999997776665555443311
Q ss_pred ------CCCCCC-C------CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 286 ------IDFSSD-P------WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 286 ------~~~~~~-~------~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
...+.. . ......+...++..+|..||++|.+..+++.|+++.....
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 111100 0 0122356788999999999999999999999999877653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=291.52 Aligned_cols=250 Identities=29% Similarity=0.427 Sum_probs=199.0
Q ss_pred eeeeeeeeccCce-EEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 69 YIFGRELGRGQFG-VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 69 y~~~~~lg~G~~g-~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
|.-.+.+|.|+.| .||+|... |+.||||.+-. +....+.+|+..|+....||||+++++.-.+....||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 3344678999876 59999885 57999998843 334678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcC-C---CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC--CCCCeEEeecCCcccc
Q 018786 148 DLCAGGELFDRIIAKG-H---YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--EDSPLKATDFGLSVFF 221 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~-~---~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~~~vkl~Dfg~a~~~ 221 (350)
|.| ..+|.++++... . ......+.++.|++.||++||+.+||||||||.||||...+ ...+++|+|||+++.+
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 559999998741 1 11145678999999999999999999999999999998643 3457899999999987
Q ss_pred cCCCc----cccCCcCcccccccccccc-CCcchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 222 KPGDV----FKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSG-VPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 222 ~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~Dv~slG~vl~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..+.. .....||.+|+|||++... -+.++|||||||++|+.++| .+||...... -.+++++......-.. .
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~-~ 738 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEP-L 738 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeecc-C
Confidence 65542 3456799999999998753 56689999999999999985 8999766543 2335555444332110 1
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
...++.+||.+|++.+|..||++.++|.||+|=..
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 12289999999999999999999999999998554
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=264.19 Aligned_cols=256 Identities=29% Similarity=0.449 Sum_probs=211.0
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc----
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED---- 139 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~---- 139 (350)
+...+|.-++.+|.|+- .|..+.+.-.+++||+|..... ..+....++..+|...+..+. |+||++++.+|.-
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccH
Confidence 45678988999999998 7888999989999999988654 556677889999999999998 9999999998853
Q ss_pred --CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 140 --RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 140 --~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
....|+|||+| ..+|...+. -.++..++..++.|+++|+++||+.||+||||||+||++ ..+..+||.|||+
T Consensus 91 ~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 91 EEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGL 164 (369)
T ss_pred HHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchh
Confidence 34678999999 458888776 347889999999999999999999999999999999999 6677799999999
Q ss_pred cccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID--------- 287 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------- 287 (350)
|+.....-..+..+.|..|+|||++- -.+...+||||+||++.||++|...|.+.+..+++.++......
T Consensus 165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred hcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 99876665667788999999999864 35899999999999999999999999877666555443321110
Q ss_pred ----------------------CCCCCCC-------CCCHHHHHHHHHhcccCccCCCCHHHHHhccCCC
Q 018786 288 ----------------------FSSDPWP-------NISSSAKDIVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 288 ----------------------~~~~~~~-------~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
++...|+ .-...+++++.+||..||++|.|++++|+|||+.
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1111111 1135678999999999999999999999999996
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=261.08 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=192.1
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHH--ccCCCCeeEeEeEEEc
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH--LTGHRNIVELKGAYED 139 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~--l~~h~~iv~~~~~~~~ 139 (350)
..++.....+.+.||+|-||.||+|.++ |+.||||++.... .+.+.+|.++++. |+ |+||+.+++.-..
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLR-HENILgFIaaD~~ 276 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLR-HENILGFIAADNK 276 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhc-cchhhhhhhcccc
Confidence 3566788999999999999999999997 5789999996443 3668888888876 56 9999999876432
Q ss_pred C----CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCEeecCCCCceEeecCCCC
Q 018786 140 R----HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM--------GVMHRDLKPENFLFSSSAED 207 (350)
Q Consensus 140 ~----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~ivH~Dlkp~NIl~~~~~~~ 207 (350)
. ..+|+|.+|.+.|||+|+|.+ ..++.....+++..++.||.+||-. .|.|||||+.|||| ..+
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn 352 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKN 352 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccC
Confidence 2 368999999999999999988 5799999999999999999999942 49999999999999 778
Q ss_pred CCeEEeecCCcccccCCC-----ccccCCcCccccccccccccCC-------cchhHHHHHHHHHHHHhC----------
Q 018786 208 SPLKATDFGLSVFFKPGD-----VFKDLVGSAYYVAPEVLRRNYG-------AEADIWSAGVILYILLSG---------- 265 (350)
Q Consensus 208 ~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-------~~~Dv~slG~vl~~ll~g---------- 265 (350)
+++-|+|+|+|....... ..+..+||.+|||||++..... ..+||||||.|+||+...
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 889999999998865442 2356799999999999864322 358999999999998752
Q ss_pred CCCCCCC-----CHHHHHHHHHc-CCCCCCCCCCCCCC--HHHHHHHHHhcccCccCCCCHHHH
Q 018786 266 VPPFWGE-----TEQSIFDAILR-GHIDFSSDPWPNIS--SSAKDIVKKMLHADPKERLSAAEV 321 (350)
Q Consensus 266 ~~pf~~~-----~~~~~~~~~~~-~~~~~~~~~~~~~~--~~l~~li~~~L~~dp~~Rps~~~i 321 (350)
++||.+. ..+++.+-+.. ...+..++.|...+ ..+.++++.||..||.-|.|+..+
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 4677542 22233322222 22233333444322 346788999999999999999877
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.79 Aligned_cols=242 Identities=23% Similarity=0.284 Sum_probs=183.7
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
..+...+.||+|+||.||+|.++.+++.||||.+..... ....|++.+++++ ||||+++++++...+..++|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQ-HPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCC-CCCcceEEEEEEcCCCCEEE
Confidence 345566789999999999999998899999999853321 1234688889998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH---SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
|||+++++|.++++ .+++..+..++.||+.||+||| +.+|+||||||+||+++ .+...++. ||.......
T Consensus 762 ~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~---~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC---CCCceEEE-ecccccccc
Confidence 99999999999885 3789999999999999999999 67999999999999994 44445654 555443221
Q ss_pred CCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHH--HHHHcCC--------CCCCC
Q 018786 224 GDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETE--QSIF--DAILRGH--------IDFSS 290 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~--~~~~--~~~~~~~--------~~~~~ 290 (350)
. ....+++.|+|||++. ..++.++||||||+++|||++|+.||..... .... ....... .....
T Consensus 835 ~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 D---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred C---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1 2346789999999876 4589999999999999999999999853221 0111 1100000 00000
Q ss_pred C--CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 291 D--PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 291 ~--~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
. .......++.+++.+||+.||++|||+.|+++.+-
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 949 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHH
Confidence 0 00011235678999999999999999999998764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=281.33 Aligned_cols=256 Identities=24% Similarity=0.413 Sum_probs=212.2
Q ss_pred cccccccceeeeeeeeccCceEEEEEEEcc-------CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEe
Q 018786 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKD-------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133 (350)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~ 133 (350)
.++...++..+.+.||+|.||.|++|.... ....||||.++.... ....+.+..|+++++.+..|+||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 355556667788899999999999998541 145799999875443 35678899999999999999999999
Q ss_pred EeEEEcCCceEEEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCC
Q 018786 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPE 197 (350)
Q Consensus 134 ~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~ 197 (350)
++.+...+.+++|+||+..|+|.+++..++ .++..++..++.||+.|++||+++++|||||..+
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998765 3888999999999999999999999999999999
Q ss_pred ceEeecCCCCCCeEEeecCCcccccCCCcccc--CCc--Cccccccccccc-cCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 018786 198 NFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD--LVG--SAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWG 271 (350)
Q Consensus 198 NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~g--t~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~-g~~pf~~ 271 (350)
|||+ .++..+||+|||+|+...+...... ..+ ...|||||.+.. .++.++||||||++|||+++ |..||.+
T Consensus 448 NVLi---~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 448 NVLI---TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hEEe---cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999 6677899999999997554443321 122 344999998875 59999999999999999998 8899987
Q ss_pred CC-HHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 272 ET-EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 272 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
.. ..+.++.+..+.....+. .++.++.++++.||+.+|++||++.++...
T Consensus 525 ~~~~~~l~~~l~~G~r~~~P~---~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 525 IPPTEELLEFLKEGNRMEQPE---HCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred CCcHHHHHHHHhcCCCCCCCC---CCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 55 566666566554433322 569999999999999999999999998753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=257.63 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=189.7
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc-CCCCeeEeEeEEEcCC----
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT-GHRNIVELKGAYEDRH---- 141 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~iv~~~~~~~~~~---- 141 (350)
....+.+.+|+|.||.||+|+..+ +.||||++. .+..+.+.+|-++..... .|+||+++++.-+.+.
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC--ceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 345677899999999999998865 899999994 344577888887776532 3999999999876555
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---------cCCEeecCCCCceEeecCCCCCCeEE
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS---------MGVMHRDLKPENFLFSSSAEDSPLKA 212 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~---------~~ivH~Dlkp~NIl~~~~~~~~~vkl 212 (350)
.+++|++|.+.|+|.++|+.+ .+++....+++..|+.||+|||+ ..|+|||||+.|||| ..|+++.|
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccI 357 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCI 357 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEe
Confidence 899999999999999999875 68999999999999999999995 359999999999999 77888999
Q ss_pred eecCCcccccCCCcc---ccCCcCccccccccccccC--C-----cchhHHHHHHHHHHHHhCCC------------CCC
Q 018786 213 TDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLRRNY--G-----AEADIWSAGVILYILLSGVP------------PFW 270 (350)
Q Consensus 213 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~--~-----~~~Dv~slG~vl~~ll~g~~------------pf~ 270 (350)
+|||+|..+..+... ...+||.+|||||++.+.. . .+.||||+|.||||+++.-. ||.
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 999999988755432 3478999999999986532 2 35899999999999998532 231
Q ss_pred -----CCCHHHHHHH--HHcCCCCCCCCCCC-CCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 271 -----GETEQSIFDA--ILRGHIDFSSDPWP-NISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 271 -----~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
...-+++.+. ..+.++.++..... .....+++.+..||+.|++-|.|+.=+.+..
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 1111222222 23344444433221 1235678999999999999999987665433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=263.81 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=204.5
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEcc---CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKD---TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
...+.+.|.++++||+|.|++||++.+.. ..+.||+|.+... +.-.++.+|+++|..+.++.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhc
Confidence 34556889999999999999999999877 7889999988543 344679999999999999999999999999
Q ss_pred cCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
.++...+|+||++..+..++.. .++...++.+++.++.||.++|.+|||||||||+|++.+. ..+.-.|+|||+|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~--~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR--RTQRGVLVDFGLA 180 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc--ccCCceEEechhH
Confidence 9999999999999888877654 4679999999999999999999999999999999999974 4556789999998
Q ss_pred cccc-----------------C--CC--------------------------ccccCCcCcccccccccc--ccCCcchh
Q 018786 219 VFFK-----------------P--GD--------------------------VFKDLVGSAYYVAPEVLR--RNYGAEAD 251 (350)
Q Consensus 219 ~~~~-----------------~--~~--------------------------~~~~~~gt~~y~aPE~~~--~~~~~~~D 251 (350)
...+ . +. ....+.||++|+|||++. +.-++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7221 0 00 001246999999999875 45788999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH--------------HcCC-------------------CCC---------
Q 018786 252 IWSAGVILYILLSGVPPFWGETEQ-SIFDAI--------------LRGH-------------------IDF--------- 288 (350)
Q Consensus 252 v~slG~vl~~ll~g~~pf~~~~~~-~~~~~~--------------~~~~-------------------~~~--------- 288 (350)
|||.|+++..++++++||....++ ..+..+ .-+. ...
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999999543221 000000 0000 000
Q ss_pred -----CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 289 -----SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 289 -----~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
........+..+.+|+.+||..||.+|+|++++|.|+||...
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 000111235588999999999999999999999999999854
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=272.54 Aligned_cols=258 Identities=27% Similarity=0.465 Sum_probs=224.6
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
+.+|.+...+|.|+||.||+++++.+++..|+|+++... ......+..|+-+++.++ |+||+.+++.+......||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCC-CcChHHHHhhhhhhcCcEE
Confidence 478999999999999999999999999999999996543 455677889999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
.||||.|++|.+.-+-.+++++.++..+.+..+++|+|||+.|=+|||||-.||++ .+.+.||++|||.+..+....
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchhhhhhhh
Confidence 99999999999988888999999999999999999999999999999999999999 556669999999988765332
Q ss_pred c-cccCCcCccccccccc----cccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCCCHH
Q 018786 226 V-FKDLVGSAYYVAPEVL----RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD-PWPNISSS 299 (350)
Q Consensus 226 ~-~~~~~gt~~y~aPE~~----~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 299 (350)
. .....||++|||||+- ++.|...+|||++|++..|+---+.|.........+..+.+..+..+.- .--.+++.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 2 2457899999999963 4679999999999999999988888887777776666666655544422 22256788
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
+-+|++.+|.++|.+||+++-+|.|+|+...
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 9999999999999999999999999999887
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=263.52 Aligned_cols=201 Identities=31% Similarity=0.545 Sum_probs=177.2
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh-----hhHHHHHHHHHHHHHcc--CCCCeeEeEeEEEc
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-----DDVEDVRREVQIMHHLT--GHRNIVELKGAYED 139 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~~ 139 (350)
.+|...+.+|.|+||.|++|.++.+...|+||.+.+...... ...-.+-.||++|.++. .|+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 569999999999999999999999999999999876543221 12234667999999986 49999999999999
Q ss_pred CCceEEEEecC-CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 140 RHSVNLIMDLC-AGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 140 ~~~~~iv~e~~-~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
.+++|++||-. +|.+|+++++.+..+++.++..|++|++.|+++||+.||||||||-+|+.+ +.+|-+||+|||.|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence 99999999976 466899999999999999999999999999999999999999999999999 77788999999999
Q ss_pred ccccCCCccccCCcCcccccccccccc--CCcchhHHHHHHHHHHHHhCCCCCCC
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWG 271 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Dv~slG~vl~~ll~g~~pf~~ 271 (350)
.....+. ....+||..|.|||++++. .+..-|||+||++||.+.....||..
T Consensus 718 a~~ksgp-fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGP-FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCC-cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9876654 5778999999999999864 67788999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=229.18 Aligned_cols=211 Identities=42% Similarity=0.730 Sum_probs=184.2
Q ss_pred eeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCCC
Q 018786 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (350)
Q Consensus 75 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~s 154 (350)
||+|++|.||++.+..+++.+++|++....... ..+.+.+|++.++.+. |++++++++++......++++|++.+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 689999999999998889999999997543211 3467999999999998 8999999999999899999999999899
Q ss_pred HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-ccccCCc
Q 018786 155 LFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-VFKDLVG 232 (350)
Q Consensus 155 L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~g 232 (350)
|.+++... ..++...+..++.+++.+|.+||++|++|+||+|.||+++.. ++.++|+|||.+....... ......+
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD--NGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC--CCcEEEecCCceEEccCCcchhhcccC
Confidence 99998775 578999999999999999999999999999999999999531 5679999999998765432 1234557
Q ss_pred Cccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 233 SAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 233 t~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
...|++||.+.. ..+.+.|+|++|++++++ ..+.+++..|++.
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhC
Confidence 888999998765 678899999999999998 6899999999999
Q ss_pred CccCCCCHHHHHhcc
Q 018786 311 DPKERLSAAEVLSKF 325 (350)
Q Consensus 311 dp~~Rps~~~iL~~~ 325 (350)
||++||++.++++++
T Consensus 201 ~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 DPEKRPSAKEILEHL 215 (215)
T ss_pred CcccCcCHHHHhhCC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=264.27 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=205.6
Q ss_pred eeeeeeeeccCceEEEEEEEccCC----cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTK----QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
.+..++||.|+||+||+|.+-..| -+||+|++.... ..+...++.+|+-+|.++. |+|++++++++.... +.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-HH
Confidence 334578999999999999986554 468888875433 3444578999999999999 999999999987665 78
Q ss_pred EEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 145 LIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
||++|+++|+|.++++. +.++-....+.|..||++|+.|||.+++|||||-.+|||| .....||+.|||+++....
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCc
Confidence 99999999999999976 4668999999999999999999999999999999999999 5566799999999998654
Q ss_pred CC-cccc--CCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 224 GD-VFKD--LVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 224 ~~-~~~~--~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. .... ..-.+.|||-|.+. ..++.++||||||+++||++| |..|+.+...+++-+.+..+.. ++.+ +.++-
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqP--piCti 927 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQP--PICTI 927 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCC--CCccH
Confidence 32 2222 22345699999775 569999999999999999998 9999999999999888887765 3332 46889
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHh
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
++.-++.+||..|++.||+++++..
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999999999865
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=233.55 Aligned_cols=257 Identities=24% Similarity=0.384 Sum_probs=201.4
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEe-EEEcCCc
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKG-AYEDRHS 142 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~-~~~~~~~ 142 (350)
.+.+.|.|.+.||+|-||.+.++.++.+...+|+|.+.... .....|.+|...--.|+.|.||+.-|+ .|+..+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 45688999999999999999999999999999999986432 345778899887777777999998776 5677889
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+++++||++.|+|.+.+... .+-+.....++.|+++||.|||++++||||||.+||||-+.+ ...|||+|||......
T Consensus 97 YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeecccccccC
Confidence 99999999999999877664 478888999999999999999999999999999999997643 4489999999987643
Q ss_pred CCCccccCCcCcccccccccc----c--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCCCC
Q 018786 223 PGDVFKDLVGSAYYVAPEVLR----R--NYGAEADIWSAGVILYILLSGVPPFWGETEQ----SIFDAILRGHIDFSSDP 292 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~----~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~ 292 (350)
... ....-+..|.+||... + ...+.+|+|.||+++|.+++|.+||...... -.+.+.......-.+..
T Consensus 175 ~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 175 TTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred cee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 222 1122345689999652 2 2567899999999999999999999743321 12233333333333334
Q ss_pred CCCCCHHHHHHHHHhcccCccCC---CCHHHHHhccCCC
Q 018786 293 WPNISSSAKDIVKKMLHADPKER---LSAAEVLSKFLIP 328 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~R---ps~~~iL~~~~~~ 328 (350)
+.-+++.+..++++-|..++++| .+++.....+|..
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 55678999999999999999999 6666666666654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-31 Score=226.76 Aligned_cols=211 Identities=43% Similarity=0.739 Sum_probs=180.4
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEe
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
|.+.+.||.|++|.||++.+..+++.+++|.+...... ...+.+.+|++.++++. |+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEEEEe
Confidence 56789999999999999999988899999999754322 24578999999999997 9999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC--
Q 018786 149 LCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-- 225 (350)
Q Consensus 149 ~~~~~sL~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-- 225 (350)
++.+++|.+++..... +++..+..++.+++.+|.+||+++++|+||+|.||++ +.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccc
Confidence 9999999999988766 8999999999999999999999999999999999999 445779999999988765443
Q ss_pred ccccCCcCccccccccc-c-ccCCcchhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHcCC
Q 018786 226 VFKDLVGSAYYVAPEVL-R-RNYGAEADIWSAGVILYILLSGVPPFWG--ETEQSIFDAILRGH 285 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~--~~~~~~~~~~~~~~ 285 (350)
......++..|++||.+ . ..++.++|+|+||+++++|++|+.||.. .......+.+..+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 33445678889999987 3 3477799999999999999999999977 33345566666554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=231.54 Aligned_cols=251 Identities=20% Similarity=0.256 Sum_probs=203.4
Q ss_pred cccceeeeeeeeccCceEEEEEEEccC-----CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE-E
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY-E 138 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~-~ 138 (350)
.+.++++...+-+|.||.||.|.+++. .+.+-+|.++... ..-+...+..|...+..+. |+|+..+.+.. +
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~s-H~nll~V~~V~ie 358 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIE 358 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCc-CCCccceeEEEee
Confidence 356788888999999999999976543 3445666665332 3334567888888888888 99999998865 5
Q ss_pred cCCceEEEEecCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCe
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAK--------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~v 210 (350)
+.+..++++.++.-++|..++... ..++..++..++.|++.|++|||+.|+||.||..+|++| ++...|
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeE
Confidence 667788899999889999988721 236777888999999999999999999999999999999 677889
Q ss_pred EEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 018786 211 KATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285 (350)
Q Consensus 211 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~ 285 (350)
||+|-.+++..-+... -........||+||.+. ..|+.++||||||++||||+| |+.|+..-+..+....+.++.
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy 515 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY 515 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence 9999998887644331 12334567799999886 569999999999999999998 999999999988888887764
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
.-..+ -++|+++..++..||..+|++||++.|+...
T Consensus 516 RlaQP---~NCPDeLf~vMacCWallpeeRPsf~Qlv~c 551 (563)
T KOG1024|consen 516 RLAQP---FNCPDELFTVMACCWALLPEERPSFSQLVIC 551 (563)
T ss_pred eecCC---CCCcHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence 43222 2789999999999999999999999999754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=221.54 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=199.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.++-.|+++++||+|+||+++.|++..++++||||.-.. .+....++.|....+.|.+.++|+.++-+..++-+.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 456789999999999999999999999999999997642 234577999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeec--CCCCCCeEEeecCCccc
Q 018786 144 NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS--SAEDSPLKATDFGLSVF 220 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~--~~~~~~vkl~Dfg~a~~ 220 (350)
.+|+|++ |.+|+|++.- .++|+.++++.++.|++.-++++|++.+|.|||||+|+||.. +.+...|.++|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999998 8899999975 567999999999999999999999999999999999999964 22345799999999998
Q ss_pred ccCCC--------ccccCCcCcccccccc-ccccCCcchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCC
Q 018786 221 FKPGD--------VFKDLVGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGET---EQSIFDAILRGHIDF 288 (350)
Q Consensus 221 ~~~~~--------~~~~~~gt~~y~aPE~-~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~ 288 (350)
+.+.. ...+..||..||+-.. +....+++.|+-|||-++++++-|..||.+.. ..+.+++|-......
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 76553 2345679999999775 44568999999999999999999999997754 344444443322222
Q ss_pred C-CCCCCCCCHHHHHHHHHhcccCccCCCCH
Q 018786 289 S-SDPWPNISSSAKDIVKKMLHADPKERLSA 318 (350)
Q Consensus 289 ~-~~~~~~~~~~l~~li~~~L~~dp~~Rps~ 318 (350)
+ ...+.++|.++...+.-.-..+-.+-|..
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence 1 22234566677666665544454455543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=263.73 Aligned_cols=197 Identities=19% Similarity=0.236 Sum_probs=144.2
Q ss_pred CCeeEeEeEE-------EcCCceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCce
Q 018786 128 RNIVELKGAY-------EDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (350)
Q Consensus 128 ~~iv~~~~~~-------~~~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NI 199 (350)
+||+.+++++ .....+++++|++ +.+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 4666666655 2234577888887 6699999975 34599999999999999999999999999999999999
Q ss_pred EeecC----------------CCCCCeEEeecCCcccccCCC-----------------ccccCCcCcccccccccc-cc
Q 018786 200 LFSSS----------------AEDSPLKATDFGLSVFFKPGD-----------------VFKDLVGSAYYVAPEVLR-RN 245 (350)
Q Consensus 200 l~~~~----------------~~~~~vkl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~-~~ 245 (350)
|++.. +.++.+|++|||+++...... .....+||+.|+|||++. ..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 99531 234567788888776421100 011246889999999875 46
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 246 ~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++.++|||||||+||||++|..|+..... ....+..... +.... ........++.+||+.||.+||++.|+|+|+
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVL--PPQIL-LNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhc--Chhhh-hcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 89999999999999999999888753321 2222221111 11111 1245667899999999999999999999999
Q ss_pred CCCCC
Q 018786 326 LIPKK 330 (350)
Q Consensus 326 ~~~~~ 330 (350)
||...
T Consensus 267 ~~~~~ 271 (793)
T PLN00181 267 FINEP 271 (793)
T ss_pred hhhhh
Confidence 99764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=205.97 Aligned_cols=252 Identities=22% Similarity=0.281 Sum_probs=205.8
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
.....++|+++++||.|+||.+|.|....+|..||||+-..... ...+.-|..+.+.|.+..+|+.+..+..++.
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 34557899999999999999999999999999999998754332 2457789999999998899999999999999
Q ss_pred ceEEEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRII-AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
+..+||+++ |.+|++++. +.+.|+.++++.++.|++.-++|+|.++++||||||+|+|..-+.....+.|+|||+|+.
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 999999998 889999886 467799999999999999999999999999999999999997655667799999999988
Q ss_pred ccCCC--------ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCC
Q 018786 221 FKPGD--------VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETE---QSIFDAILRGHIDF 288 (350)
Q Consensus 221 ~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~ 288 (350)
+.+.. ......||..|.+--+.- -..+++.|+-|+|.++.++.-|..||.+... .+.++.+.......
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 65432 224467999999876544 3468899999999999999999999987643 34455555544443
Q ss_pred CC-CCCCCCCHHHHHHHHHhcccCccCCCCHH
Q 018786 289 SS-DPWPNISSSAKDIVKKMLHADPKERLSAA 319 (350)
Q Consensus 289 ~~-~~~~~~~~~l~~li~~~L~~dp~~Rps~~ 319 (350)
+. ..+..+|.++.-.+.-|-..--++-|...
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 32 23567889999888888766666666543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=216.82 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=194.7
Q ss_pred ceeeeeeeeccCceEEEEEEEccCC-cEEEEEEecccccCChhhHHHHHHHHHHHHHcc---CCCCeeEeEeEE-EcCCc
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTK-QQFACKSISSRKLINRDDVEDVRREVQIMHHLT---GHRNIVELKGAY-EDRHS 142 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~---~h~~iv~~~~~~-~~~~~ 142 (350)
+|.+.+.||+|+||.||.+.+..++ ..+|+|+......... ..+..|..++..+. +..++..+++.+ ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998764 6789998765432111 25778888888887 346999999998 58889
Q ss_pred eEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCC--CCCeEEeecCCc
Q 018786 143 VNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE--DSPLKATDFGLS 218 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~~~vkl~Dfg~a 218 (350)
.++||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.|++||||||.|+++..... ...++|+|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 88999988654 57999999999999999999999999999999999999965431 256999999999
Q ss_pred c--cccCCC--------c-cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Q 018786 219 V--FFKPGD--------V-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI 286 (350)
Q Consensus 219 ~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~ 286 (350)
+ .+.... . .....||..|+++.+..+ ..+++.|+||++.++.+++.|..||...........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 321111 1 123459999999998764 589999999999999999999999976553222222222111
Q ss_pred CCCCC-CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 287 DFSSD-PWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 287 ~~~~~-~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
..... .....+.++..+...+-..+..++|....+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 11111 122346788888888888899999998887655
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=202.11 Aligned_cols=162 Identities=26% Similarity=0.342 Sum_probs=126.8
Q ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccCC
Q 018786 153 GELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231 (350)
Q Consensus 153 ~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 231 (350)
|+|.+++..+ ..+++..++.++.||+.||.|||+++ ||+||++ +.++.+|+ ||.+....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence 5899999874 45999999999999999999999999 9999999 66677888 99988754332 26
Q ss_pred cCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCCC---CCCCCCCH--HHHHHH
Q 018786 232 GSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSS---DPWPNISS--SAKDIV 304 (350)
Q Consensus 232 gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~--~l~~li 304 (350)
||+.|+|||++. ..++.++||||||+++|||++|+.||..... ......+......... .....++. ++.++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 889999999876 4589999999999999999999999976543 2233333322221111 01112333 699999
Q ss_pred HHhcccCccCCCCHHHHHhccCCCC
Q 018786 305 KKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
.+||+.||++||++.+++.|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-25 Score=202.68 Aligned_cols=255 Identities=38% Similarity=0.595 Sum_probs=207.0
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCC-CeeEeEeEEEcCCceEEEE
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-NIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~~~~~~~~~iv~ 147 (350)
|.+.+.||.|+|+.||++.+. ..+++|.+.............+.+|+..+..+. |+ +++++.+.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEEE
Confidence 788899999999999999998 678999998665544335678999999999999 66 7999999998777789999
Q ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCC-CeEEeecCCcccccC
Q 018786 148 DLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS-PLKATDFGLSVFFKP 223 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~-~vkl~Dfg~a~~~~~ 223 (350)
+++.++++.+++.... .++......++.|++.++.++|+.+++|||+||+||+++ ... .++++|||.+.....
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCC
Confidence 9999999997777664 799999999999999999999999999999999999994 444 699999999876543
Q ss_pred CC-------ccccCCcCccccccccccc----cCCcchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCC-
Q 018786 224 GD-------VFKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAILRGHID- 287 (350)
Q Consensus 224 ~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~----~~~~~~~~~~~~~- 287 (350)
.. ......|+..|++||.+.+ ......|+|++|++++++++|..||..... ......+......
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 32 2456789999999998754 578899999999999999999999877653 4444444444433
Q ss_pred CCCCCCCCC----CHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 288 FSSDPWPNI----SSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 288 ~~~~~~~~~----~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
......... ...+.+++..++..+|..|.+..+...+.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 222211111 2578999999999999999999998887544443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=211.92 Aligned_cols=169 Identities=18% Similarity=0.217 Sum_probs=131.1
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEcc-CCcEEEEEEeccccc--CChhhHHHHHHHHHHHHHccCCCCeeE-eEe
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKD-TKQQFACKSISSRKL--INRDDVEDVRREVQIMHHLTGHRNIVE-LKG 135 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~-~~~ 135 (350)
.+...+.++|.+.+.||+|+||+||+|.++. +++.+|||++..... ......+.+.+|+++++++. |+|++. +++
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~ 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLA 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEE
Confidence 4445667889999999999999999999876 677789998753211 12234567999999999998 999885 443
Q ss_pred EEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecC-CCCceEeecCCCCCCeEEee
Q 018786 136 AYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL-KPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 136 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dl-kp~NIl~~~~~~~~~vkl~D 214 (350)
. +..++||||++|++|.. +. ... ...++.+++.+|.|||++||+|||| ||+|||+ +.++.+||+|
T Consensus 90 ~----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiD 155 (365)
T PRK09188 90 T----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVID 155 (365)
T ss_pred c----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEE
Confidence 2 45799999999999963 21 111 1568899999999999999999999 9999999 5566799999
Q ss_pred cCCcccccCCCc---------cccCCcCcccccccccc
Q 018786 215 FGLSVFFKPGDV---------FKDLVGSAYYVAPEVLR 243 (350)
Q Consensus 215 fg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~ 243 (350)
||+|........ .....+++.|++||.+.
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 999987643321 13456888899999885
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-28 Score=235.51 Aligned_cols=261 Identities=27% Similarity=0.437 Sum_probs=197.7
Q ss_pred cce-eeeeeeeccCceEEEEEEEccCCcEEEEEEeccc--ccCChhhH-HHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 67 NTY-IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSR--KLINRDDV-EDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 67 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~-~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
..| .....+|.|++|.|+.+......+.++.|.+... ........ ..+..|+-+-.++. |+|++..+..+.+...
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEIDG 395 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhccc
Confidence 334 3557889999998888888776666777765421 11111111 22566776777777 9999887776666665
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+...||||++ +|+.++...+.+....+.-++.||+.||+|+|+.||.|||+|++|+++ ..++.+||+|||.+....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVFR 471 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceeec
Confidence 6666999999 999999888889999999999999999999999999999999999999 667789999999987654
Q ss_pred CC-----CccccCCcCccccccccccc-cCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHcC---CCCCCC
Q 018786 223 PG-----DVFKDLVGSAYYVAPEVLRR-NYG-AEADIWSAGVILYILLSGVPPFWGETEQSIF--DAILRG---HIDFSS 290 (350)
Q Consensus 223 ~~-----~~~~~~~gt~~y~aPE~~~~-~~~-~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~--~~~~~~---~~~~~~ 290 (350)
.. ......+|+..|+|||++.+ .|+ +..||||.|++++.|.+|+.||......+.. ...... ...-+.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 22 23356789999999998864 455 4579999999999999999999655433221 111111 111112
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 291 ~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
..+..++..-+.+|.+||+.||.+|.|+++|++..||+....
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 223457888999999999999999999999999999988754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=199.78 Aligned_cols=235 Identities=25% Similarity=0.364 Sum_probs=155.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccC---------CCCeeEeEeEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG---------HRNIVELKGAY 137 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~---------h~~iv~~~~~~ 137 (350)
..+..++.||.|+++.||.+.+..+++.+|||++..........++.+++|.-....+.+ |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 457788999999999999999999999999999986665455567788887765555432 22333222222
Q ss_pred ---------EcC---C-----ceEEEEecCCCCCHHHHHHH---cCCC----CHHHHHHHHHHHHHHHHHHHHcCCEeec
Q 018786 138 ---------EDR---H-----SVNLIMDLCAGGELFDRIIA---KGHY----SERAAANLCRQMVTVVHYCHSMGVMHRD 193 (350)
Q Consensus 138 ---------~~~---~-----~~~iv~e~~~~~sL~~~l~~---~~~~----~~~~~~~i~~~i~~~l~~lH~~~ivH~D 193 (350)
... . ..+++|+.+ .++|.+.+.. .... .......+..|+++.+++||+.|+||+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 111 1 236788888 4588776542 2222 1222344558999999999999999999
Q ss_pred CCCCceEeecCCCCCCeEEeecCCcccccCCCccccCCcCccccccccccc---------cCCcchhHHHHHHHHHHHHh
Q 018786 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR---------NYGAEADIWSAGVILYILLS 264 (350)
Q Consensus 194 lkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~Dv~slG~vl~~ll~ 264 (350)
|+|+|+++ +.+|.++|+||+........... ...+..|.+||.... .++.+.|.|+||+++|.|+|
T Consensus 171 i~~~nfll---~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLL---DQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE----TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEE---cCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999 67788999999887764433221 345577999996532 36788999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCC
Q 018786 265 GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER 315 (350)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~R 315 (350)
|+.||........... ....+.++|+.++.||..+|+.||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999976543211111 122233689999999999999999998
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=220.85 Aligned_cols=250 Identities=28% Similarity=0.474 Sum_probs=215.2
Q ss_pred eeeccCceEEEEEEE---ccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecC
Q 018786 74 ELGRGQFGVTYLVTH---KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (350)
Q Consensus 74 ~lg~G~~g~V~~~~~---~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~ 150 (350)
.+|.|+||.|+++.. .+.|+.+|+|+.++......... ....|-.++..+.+|+.++++...++.....++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 378999999998654 34578899999887655444333 56667778888878999999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccC
Q 018786 151 AGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230 (350)
Q Consensus 151 ~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 230 (350)
.|+.|...+.....+.+.....+...++-+++++|+.+|+|||+|++||++ +.+|++++.|||+++..-..+..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc---
Confidence 999999888888889999999999999999999999999999999999999 77888999999999886555433
Q ss_pred CcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 231 VGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 231 ~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
+||..|||||+++ ......|.||||+++++|++|..||.. +....+.+.....+. .++..+++++..++..
T Consensus 154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKR 224 (612)
T ss_pred ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhh
Confidence 8999999999998 567889999999999999999999987 667777776666665 4688999999999999
Q ss_pred CccCCCCH-----HHHHhccCCCCCchhhHHHHh
Q 018786 311 DPKERLSA-----AEVLSKFLIPKKTLQTLADLL 339 (350)
Q Consensus 311 dp~~Rps~-----~~iL~~~~~~~~~~~~~~~~~ 339 (350)
+|.+|... .++.+|.||....|..+....
T Consensus 225 ~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~ 258 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEIKQHEFFQSIDWNELEARS 258 (612)
T ss_pred CHHHHhccCcchhHHHhccchheeeeHhhHhhcC
Confidence 99999855 789999999999998776544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=182.90 Aligned_cols=143 Identities=20% Similarity=0.212 Sum_probs=111.2
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhh-----------------------HHHHHHHHHHHHHccCCC
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD-----------------------VEDVRREVQIMHHLTGHR 128 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~-----------------------~~~~~~e~~~l~~l~~h~ 128 (350)
.+.||+|++|.||+|.+. +|+.||||+++......... .....+|++.+.++. ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence 468999999999999997 79999999997542211110 122345999999997 77
Q ss_pred CeeEeEeEEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCCEeecCCCCceEeecCCCC
Q 018786 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC-HSMGVMHRDLKPENFLFSSSAED 207 (350)
Q Consensus 129 ~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~ivH~Dlkp~NIl~~~~~~~ 207 (350)
++.....+... ..++||||++|+++.........+++..+..++.|++.+|.++ |+.||+||||||+||+++ +
T Consensus 80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----~ 153 (190)
T cd05147 80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----D 153 (190)
T ss_pred CCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----C
Confidence 76443333222 2379999999877765555567899999999999999999999 799999999999999995 2
Q ss_pred CCeEEeecCCccccc
Q 018786 208 SPLKATDFGLSVFFK 222 (350)
Q Consensus 208 ~~vkl~Dfg~a~~~~ 222 (350)
+.++|+|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 569999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=185.27 Aligned_cols=176 Identities=15% Similarity=0.173 Sum_probs=134.6
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHH------HHHHHHHHHHccCCCCeeEeEeE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED------VRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~------~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
..+.++|++.+.||.|+||.||++.+ ++..+|+|++.......+....+ +.+|+..+.++. |+||..+.++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~ 103 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDF 103 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEe
Confidence 34679999999999999999999765 35679999997554433333334 689999999998 9999999888
Q ss_pred EEcC--------CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCC
Q 018786 137 YEDR--------HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 137 ~~~~--------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~ 208 (350)
+... +..+++|||++|.+|.++. .+++ ..+.+++.+|..+|+.|++|||++|+||+++ .++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~---~~g 172 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS---KNG 172 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---CCC
Confidence 6533 3578999999999997763 2333 3466999999999999999999999999994 445
Q ss_pred CeEEeecCCcccccCCCccccCCcCccccccccccccCCcchhHHHHHHHHHHHH
Q 018786 209 PLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILL 263 (350)
Q Consensus 209 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll 263 (350)
++|+|||............. | ++...+..++|+|+||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~d~------~----vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAKDR------I----DLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhHHH------H----HHHhHhcccccccceeEeehHHH
Confidence 99999998776533222111 0 12334667899999999988755
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=174.72 Aligned_cols=145 Identities=17% Similarity=0.174 Sum_probs=113.4
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChh-----------------------hHHHHHHHHHHHHHccCC
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-----------------------DVEDVRREVQIMHHLTGH 127 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~~h 127 (350)
+.+.||+|++|.||+|.+. +|+.||||++......... ......+|...+.++. +
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~ 78 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-E 78 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-h
Confidence 3578999999999999987 7999999999764211000 0123467899999998 8
Q ss_pred CCeeEeEeEEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCC
Q 018786 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAE 206 (350)
Q Consensus 128 ~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~ 206 (350)
+++.....+.... .++||||++|+++.........++...+..++.|++.+|.++|+ +||+||||||+||+++
T Consensus 79 ~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~---- 152 (190)
T cd05145 79 AGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH---- 152 (190)
T ss_pred CCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----
Confidence 8875544433332 47999999887654443445678889999999999999999999 9999999999999995
Q ss_pred CCCeEEeecCCcccccC
Q 018786 207 DSPLKATDFGLSVFFKP 223 (350)
Q Consensus 207 ~~~vkl~Dfg~a~~~~~ 223 (350)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 46699999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-23 Score=171.42 Aligned_cols=188 Identities=22% Similarity=0.277 Sum_probs=141.2
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChh-hHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEec
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-DVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~ 149 (350)
+...|++|+||+||.+.. .+..++.+.+......... ....+.+|+++|++|.+++++++++++ +..+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 457899999999997665 4677887777654432221 223588999999999867899999886 346899999
Q ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecC-CCCceEeecCCCCCCeEEeecCCcccccCCCcc-
Q 018786 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL-KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF- 227 (350)
Q Consensus 150 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dl-kp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~- 227 (350)
+.|.+|...... . ...++.|++.+|.++|++||+|||| ||+|||+ +.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcchHH
Confidence 999888653321 1 2357889999999999999999999 7999999 55667999999999865433210
Q ss_pred -------------ccCCcCcccccccccc--ccCC-cchhHHHHHHHHHHHHhCCCCCCCCCH
Q 018786 228 -------------KDLVGSAYYVAPEVLR--RNYG-AEADIWSAGVILYILLSGVPPFWGETE 274 (350)
Q Consensus 228 -------------~~~~gt~~y~aPE~~~--~~~~-~~~Dv~slG~vl~~ll~g~~pf~~~~~ 274 (350)
.....++.|+.|+... ...+ ...+.++.|.-+|.++|+..++..+.+
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0123577788887532 2233 567899999999999999998866543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=210.92 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=177.6
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccc-cCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRK-LINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
.|...+.||.+-|=+|.+|++.. |. |+||++.+.. ........+-..|++ ...+ .+||++.+.-+.......|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHHHHH
Confidence 78888999999999999999876 44 9999997654 333333344444555 3333 499999998877777778888
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc--c-C
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF--K-P 223 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~--~-~ 223 (350)
-+|.. -+|+|.+-.+.-+...+.+=|+.||+.||.-+|..||+|||||.+|||+ ..-+.+.|.||-..+-. . +
T Consensus 100 Rqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi---TSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI---TSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE---eeechhhhhcccccCCccCCCC
Confidence 88884 4999988777667777778899999999999999999999999999999 55667899999876431 1 1
Q ss_pred CCc-----cccCCcCccccccccccc-----------c-CCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 018786 224 GDV-----FKDLVGSAYYVAPEVLRR-----------N-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285 (350)
Q Consensus 224 ~~~-----~~~~~gt~~y~aPE~~~~-----------~-~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~ 285 (350)
... ..+...-.+|.|||.+.. . .+++.||||+||++.||++ |+++|. ..++-++..+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~ 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGN 251 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccC
Confidence 111 122334567999998632 1 4678999999999999998 788883 11122222221
Q ss_pred CCCCCCCCCC-CCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 286 IDFSSDPWPN-ISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 286 ~~~~~~~~~~-~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
-..+...+.+ -+..++.+|..|++.||++|.++++.|+.
T Consensus 252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111000001 14578999999999999999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-24 Score=207.31 Aligned_cols=228 Identities=32% Similarity=0.553 Sum_probs=180.1
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
..+|..++.|..|+||.||.++++.+.+.+|+|+-+ ... -+++ ++... ++|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-------ilRn---ilt~a-~npfvv-------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-------ILRN---ILTFA-GNPFVV-------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-------hhhc---ccccc-CCccee--------------
Confidence 477889999999999999999999999999996532 211 0111 12122 244443
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~- 224 (350)
|+=...++.-++++... +.+++|||+.||+|||+||+|.+| ..-|++|+.|||+++.....
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhc
Confidence 23334455555555543 788999999999999999999999 56777999999997653111
Q ss_pred ---------------CccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Q 018786 225 ---------------DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288 (350)
Q Consensus 225 ---------------~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 288 (350)
-.....+||+.|.|||++. ..|+..+|.|++|+++|+++.|..||.+++.++++..+....+.+
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 0123458999999999865 569999999999999999999999999999999999999999888
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCC---CHHHHHhccCCCCCchhhHHHH
Q 018786 289 SSDPWPNISSSAKDIVKKMLHADPKERL---SAAEVLSKFLIPKKTLQTLADL 338 (350)
Q Consensus 289 ~~~~~~~~~~~l~~li~~~L~~dp~~Rp---s~~~iL~~~~~~~~~~~~~~~~ 338 (350)
++..+ .++++++++|.++|+.+|..|. .+.++-+|.||+...|..+-+.
T Consensus 278 pE~de-a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRq 329 (1205)
T KOG0606|consen 278 PEEDE-ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQ 329 (1205)
T ss_pred cccCc-CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhh
Confidence 88854 5799999999999999999997 5677788999999999866554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-23 Score=202.10 Aligned_cols=200 Identities=22% Similarity=0.325 Sum_probs=161.9
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
+.-+..|.|.+.||+|+||.||+|.+.+ |+.||+|+-+....+.--...+++..++ ++- -+.|..+...+...+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~---~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQM---LPSIMHISSAHVFQNA 768 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hhh---hcchHHHHHHHccCCc
Confidence 3346789999999999999999999988 9999999987554333222233333333 111 2456666666666677
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeec----CCCCCCeEEeecCCc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS----SAEDSPLKATDFGLS 218 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~----~~~~~~vkl~Dfg~a 218 (350)
-++|+||.+.|||.+++...+.+++..+..+..||+..++.||..+|||+||||+|+|+.. +.+...++|+|||.+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 7899999999999999998888999999999999999999999999999999999999963 233557999999998
Q ss_pred ccc---cCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCC
Q 018786 219 VFF---KPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVP 267 (350)
Q Consensus 219 ~~~---~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~ 267 (350)
..+ .++......++|..+-.+|+..+ .|+++.|.|.|+.+++.|+.|++
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 654 45556677889999999998865 69999999999999999999854
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-23 Score=180.20 Aligned_cols=189 Identities=26% Similarity=0.387 Sum_probs=140.9
Q ss_pred CCCCeeEeEeEEE---------------------------cCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHH
Q 018786 126 GHRNIVELKGAYE---------------------------DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMV 178 (350)
Q Consensus 126 ~h~~iv~~~~~~~---------------------------~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~ 178 (350)
.|||||.+...|. ....+|+||..+ ..+|..++-.+ ..+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 5999999988762 234678999988 45999888654 457778888999999
Q ss_pred HHHHHHHHcCCEeecCCCCceEeecCCC-CCCeEEeecCCcccccC-------CCccccCCcCccccccccccc---c--
Q 018786 179 TVVHYCHSMGVMHRDLKPENFLFSSSAE-DSPLKATDFGLSVFFKP-------GDVFKDLVGSAYYVAPEVLRR---N-- 245 (350)
Q Consensus 179 ~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-~~~vkl~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~-- 245 (350)
+|+.|||++||.|||+|++|||+.-+++ -..++|+|||.+-.-+. .......-|+-.-||||+... +
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 9999999999999999999999975433 34679999997654221 112233457888999998752 2
Q ss_pred --CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHH
Q 018786 246 --YGAEADIWSAGVILYILLSGVPPFWGETEQSI--FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAE 320 (350)
Q Consensus 246 --~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~ 320 (350)
.-.++|.|+.|.+.||++....||+...+... ........+..+ ..+++.+++++..+|+.||++|++..-
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp----~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALP----SRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCc----ccCChHHHHHHHHHhcCCccccCCccH
Confidence 13479999999999999999999987443211 111122222222 257899999999999999999998643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-23 Score=171.16 Aligned_cols=238 Identities=18% Similarity=0.261 Sum_probs=186.2
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
...+..+|.+.-.|..|+|++..+ .++.|++..+.. .....+.|..|.-.|+-+. ||||+.+++.+.......++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~-t~risrdfneefp~lrifs-hpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREV-TARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhccCCCcccccccccCc--chhhhhhhhhhc-chhhcchhhhhCcceeeec-CCchhhhhhhccCCCCceEee
Confidence 345667888999999999999754 578888876554 3334467888999998888 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcC--CEeecCCCCceEeecCCCCCCeEE--eecCCcccc
Q 018786 148 DLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKA--TDFGLSVFF 221 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~vkl--~Dfg~a~~~ 221 (350)
.||+-++|+..++.... .+..++.+++.+|+.|+.|||+.. |.---|+...+++ +++.+.+| +|-.++..-
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfqe 343 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQE 343 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeeec
Confidence 99999999999987654 578899999999999999999876 5556788999999 55544443 343333221
Q ss_pred cCCCccccCCcCcccccccccccc----CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCCC
Q 018786 222 KPGDVFKDLVGSAYYVAPEVLRRN----YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG--HIDFSSDPWPN 295 (350)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~ 295 (350)
....-.|.||+||.+... .-+.+|+|||++++||+.|...||......+.-.++.-+ +...+ |+
T Consensus 344 ------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip----pg 413 (448)
T KOG0195|consen 344 ------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP----PG 413 (448)
T ss_pred ------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC----CC
Confidence 223457889999988642 345789999999999999999999988776655444322 22232 37
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHH
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVL 322 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL 322 (350)
++..+..|++-|++.||.+||.++.++
T Consensus 414 is~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 414 ISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 899999999999999999999988765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-21 Score=162.59 Aligned_cols=138 Identities=22% Similarity=0.270 Sum_probs=107.5
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc----CCCCeeEeEeEEEcCC---c-e
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT----GHRNIVELKGAYEDRH---S-V 143 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~iv~~~~~~~~~~---~-~ 143 (350)
.+.||+|++|.||. +..++.. +||++..... ...+.+.+|+..++.+. .|+||++++++++... . +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 47899999999995 6655554 6898865322 23467999999999994 3899999999998763 4 3
Q ss_pred EEEEec--CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHHcCCEeecCCCCceEeecCC-CCCCeEEeecCCc
Q 018786 144 NLIMDL--CAGGELFDRIIAKGHYSERAAANLCRQMVTVV-HYCHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGLS 218 (350)
Q Consensus 144 ~iv~e~--~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~ivH~Dlkp~NIl~~~~~-~~~~vkl~Dfg~a 218 (350)
.+|+|| +.+++|.+++... .+++. ..++.+++.++ +|||+++|+||||||+|||++..+ .+..++|+||+-+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 478999 4578999999653 46666 36678888777 999999999999999999997543 3457999995433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=165.27 Aligned_cols=148 Identities=16% Similarity=0.144 Sum_probs=115.6
Q ss_pred ccceeeeeeeeccCceEEEEEE-EccCCcEEEEEEecccccCCh-----------------h----hHHHHHHHHHHHHH
Q 018786 66 RNTYIFGRELGRGQFGVTYLVT-HKDTKQQFACKSISSRKLINR-----------------D----DVEDVRREVQIMHH 123 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~~avK~~~~~~~~~~-----------------~----~~~~~~~e~~~l~~ 123 (350)
+..|.+.+.||+|++|.||+|. +..+|+.||+|++........ . ....+.+|+..+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3468899999999999999999 667899999999975432100 0 11346789999999
Q ss_pred ccCCCC--eeEeEeEEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC-CEeecCCCCceE
Q 018786 124 LTGHRN--IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG-VMHRDLKPENFL 200 (350)
Q Consensus 124 l~~h~~--iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-ivH~Dlkp~NIl 200 (350)
+. +.+ +++++++ ...++||||+.|.+|.........+....+..++.||+.+|.+||++| |+||||||+||+
T Consensus 107 L~-~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 107 LY-EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred HH-hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 97 433 3444443 235799999999888765544556677778899999999999999999 999999999999
Q ss_pred eecCCCCCCeEEeecCCccccc
Q 018786 201 FSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 201 ~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++ ++.++|+|||.+....
T Consensus 182 i~----~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH----DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE----CCCEEEEEChhhhccC
Confidence 95 4569999999987644
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-21 Score=175.04 Aligned_cols=176 Identities=30% Similarity=0.472 Sum_probs=134.7
Q ss_pred CCceEEEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
..+.+|.|++|...+|.+|+..+.. .+....+.++.|++.+++| +|.+|+|+||.||+.. .+..+||+|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhh
Confidence 3468899999999999999986543 5778899999999999999 9999999999999994 44569999999
Q ss_pred CcccccCCC-------ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCC
Q 018786 217 LSVFFKPGD-------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHID 287 (350)
Q Consensus 217 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 287 (350)
+........ ..+...||..||+||.+.+ .|+.++|||+||++|+|++. -..+|. ....+..+..+.++
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIP 478 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCC
Confidence 987765444 4466789999999999875 59999999999999999997 222221 22233334444433
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 288 FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
+..+.+ -++-..|+.++|...|.+||++.+.-.|.|+
T Consensus 479 --~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 479 --PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred --hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 111122 2445689999999999999977776655554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-20 Score=169.68 Aligned_cols=221 Identities=24% Similarity=0.353 Sum_probs=166.9
Q ss_pred HHccCCCCeeEeEeEEEcCCceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCC-EeecCCCCce
Q 018786 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGV-MHRDLKPENF 199 (350)
Q Consensus 122 ~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i-vH~Dlkp~NI 199 (350)
+.+. |.|+.++++.+.++...++|.+||..|+|.|.+.. .-+++......++++|+.||.|||+..| .|+.+++.|+
T Consensus 2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4566 99999999999999999999999999999999987 4568888899999999999999998876 9999999999
Q ss_pred EeecCCCCCCeEEeecCCcccccCC---CccccCCcCcccccccccccc--------CCcchhHHHHHHHHHHHHhCCCC
Q 018786 200 LFSSSAEDSPLKATDFGLSVFFKPG---DVFKDLVGSAYYVAPEVLRRN--------YGAEADIWSAGVILYILLSGVPP 268 (350)
Q Consensus 200 l~~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~Dv~slG~vl~~ll~g~~p 268 (350)
++ +....+||.|||+....... ...........|.|||.++.. .+.+.|+||||++++|+++...|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 67788999999998776421 111222345569999988642 46779999999999999999999
Q ss_pred CCCCC----HHHHHHHHHc-CCCCCCCCCC--CCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch---hhHHHH
Q 018786 269 FWGET----EQSIFDAILR-GHIDFSSDPW--PNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL---QTLADL 338 (350)
Q Consensus 269 f~~~~----~~~~~~~~~~-~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~---~~~~~~ 338 (350)
|.... ..+....+.+ +...+.+..+ ...++++..++..||..+|++||+++++-...-...... ..+.|+
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~~~~nl~D~ 237 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGSSKGNLMDS 237 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccccccchhHHH
Confidence 96522 2344555555 2222222111 145668999999999999999999999976554444432 255555
Q ss_pred hhHHHHhhh
Q 018786 339 LYSQIFARF 347 (350)
Q Consensus 339 ~~~~~~~~~ 347 (350)
+ ..++++|
T Consensus 238 m-~~~le~Y 245 (484)
T KOG1023|consen 238 L-FRMLESY 245 (484)
T ss_pred H-HHHHHHH
Confidence 5 3344444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-19 Score=153.44 Aligned_cols=137 Identities=25% Similarity=0.348 Sum_probs=112.5
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChh-----hHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-----DVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-----~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
+.||+|++|.||+|.+ .|..+++|........... ...++.+|+.++..+. |++++....++...+..+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence 5789999999999987 4677999986543321111 2346788999999998 888877776666777889999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
||++|.+|.+++..... ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 99999999998865432 7889999999999999999999999999999995 45699999998876
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.1e-19 Score=150.07 Aligned_cols=134 Identities=21% Similarity=0.280 Sum_probs=105.8
Q ss_pred eeeccCceEEEEEEEccCCcEEEEEEecccccCCh-----hhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEe
Q 018786 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-----DDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 74 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
.||+|++|.||+|.. ++..+++|.......... ...+++.+|++++..+. ++++.....++......+++||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence 479999999999985 467899998654332111 12356789999999998 7765554444456666789999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 149 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
|++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+...
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence 9999999887754321 7899999999999999999999999999995 566999999988763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.7e-19 Score=149.59 Aligned_cols=141 Identities=16% Similarity=0.196 Sum_probs=107.9
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh-------------------hhHHHHHHHHHHHHHccCCC
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-------------------DDVEDVRREVQIMHHLTGHR 128 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-------------------~~~~~~~~e~~~l~~l~~h~ 128 (350)
.|.+.+.||+|+||.||++... +|+.+|||++........ ........|+.++..+. +.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 93 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EE 93 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-Hc
Confidence 4888899999999999999885 689999998764321000 01123677889998887 66
Q ss_pred --CeeEeEeEEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCC
Q 018786 129 --NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE 206 (350)
Q Consensus 129 --~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 206 (350)
.++..++ .+..+++|||++|++|.+... ......++.+++.++.++|+.||+|+||+|+||++ ++
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~ 160 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DD 160 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cC
Confidence 3444443 244689999999988866432 13456788999999999999999999999999999 55
Q ss_pred CCCeEEeecCCcccccC
Q 018786 207 DSPLKATDFGLSVFFKP 223 (350)
Q Consensus 207 ~~~vkl~Dfg~a~~~~~ 223 (350)
++.++|+|||.+.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 77899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-18 Score=165.99 Aligned_cols=141 Identities=21% Similarity=0.265 Sum_probs=111.5
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccC-----ChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-----NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
...|...+.||+|+||+||++..... .+++|+....... .....+++.+|+++++++. |++++....++...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~ 408 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVDP 408 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEeC
Confidence 34556788999999999999987653 3444543221111 1122456889999999998 99998877777777
Q ss_pred CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
...++||||++|++|.+++. ....++.+++.+|.+||+.||+||||||+||+++ ++.++|+|||++..
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFGla~~ 476 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFGLGKY 476 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCccccc
Confidence 77889999999999998775 3567899999999999999999999999999993 34699999999876
Q ss_pred c
Q 018786 221 F 221 (350)
Q Consensus 221 ~ 221 (350)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-20 Score=182.12 Aligned_cols=259 Identities=30% Similarity=0.482 Sum_probs=206.8
Q ss_pred cceeeeeeeeccCceEEEEEEEcc-CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKD-TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
..|.+.+.||+|+++.|-...... ....+|+|.+.... ......+.+..|..+-..+.+|.|++.+++.....+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 446677789999999999888743 34556666664332 2334456677788888888779999999999999999999
Q ss_pred EEecCCCCCHHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-HcCCEeecCCCCceEeecCCCCC-CeEEeecCCcccc
Q 018786 146 IMDLCAGGELFDRI-IAKG-HYSERAAANLCRQMVTVVHYCH-SMGVMHRDLKPENFLFSSSAEDS-PLKATDFGLSVFF 221 (350)
Q Consensus 146 v~e~~~~~sL~~~l-~~~~-~~~~~~~~~i~~~i~~~l~~lH-~~~ivH~Dlkp~NIl~~~~~~~~-~vkl~Dfg~a~~~ 221 (350)
++++..|+++.+.+ +... ..+......++.|+..++.|+| ..++.|+||||+|.+++ ..+ .+++.|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhccc
Confidence 99999999999888 5554 5778888899999999999999 99999999999999994 444 7999999999876
Q ss_pred cC-C---CccccCCc-Cccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHcCCCCCCCCCC
Q 018786 222 KP-G---DVFKDLVG-SAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIF-DAILRGHIDFSSDPW 293 (350)
Q Consensus 222 ~~-~---~~~~~~~g-t~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~ 293 (350)
.. . ......+| ++.|+|||...+ ......|+||.|+++..+++|..|+......... .........+....|
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence 55 2 23345678 999999998765 4678899999999999999999999765544322 222222223334456
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
..++....+++.+++..+|+.|.+.+++-.++|+..
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccCChhhhhcccccccCCchhccccccccccccccc
Confidence 788999999999999999999999999999999988
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-18 Score=142.72 Aligned_cols=140 Identities=17% Similarity=0.224 Sum_probs=99.7
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHH---------------------HHHHHHHHHHHccCCC--
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE---------------------DVRREVQIMHHLTGHR-- 128 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~---------------------~~~~e~~~l~~l~~h~-- 128 (350)
.+.||+|+||+||+|.+. +++.||||++............ ....|...+.++. +.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY-EAGV 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH-HcCC
Confidence 568999999999999987 6899999998754321111111 1145667777765 33
Q ss_pred CeeEeEeEEEcCCceEEEEecCCCCCHHH-HHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCC
Q 018786 129 NIVELKGAYEDRHSVNLIMDLCAGGELFD-RIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAE 206 (350)
Q Consensus 129 ~iv~~~~~~~~~~~~~iv~e~~~~~sL~~-~l~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~ 206 (350)
.+++.++. ...+++|||++++++.. .+... ... ..+..++.+++.++.++|+ .||+|+||||+||+++
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~---- 149 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD---- 149 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----
Confidence 24444443 23689999998854321 11111 111 6678899999999999999 9999999999999995
Q ss_pred CCCeEEeecCCcccccC
Q 018786 207 DSPLKATDFGLSVFFKP 223 (350)
Q Consensus 207 ~~~vkl~Dfg~a~~~~~ 223 (350)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 56799999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.7e-17 Score=141.46 Aligned_cols=138 Identities=17% Similarity=0.245 Sum_probs=102.7
Q ss_pred eeee-ccCceEEEEEEEccCCcEEEEEEeccccc----------CChhhHHHHHHHHHHHHHccCCCCe--eEeEeEEEc
Q 018786 73 RELG-RGQFGVTYLVTHKDTKQQFACKSISSRKL----------INRDDVEDVRREVQIMHHLTGHRNI--VELKGAYED 139 (350)
Q Consensus 73 ~~lg-~G~~g~V~~~~~~~~~~~~avK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~~h~~i--v~~~~~~~~ 139 (350)
..|| .||.|+||.+... +..++||.+..... .......++.+|++++.++. |+++ +..+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeee
Confidence 4677 8888889988774 57799998853211 11223467889999999998 7775 566665432
Q ss_pred -CCc---eEEEEecCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEee
Q 018786 140 -RHS---VNLIMDLCAG-GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 140 -~~~---~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
... .++|||+++| .+|.+++.. ..+++.. +.+|+.+|.+||++||+|+||||.|||++ .++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEEEEE
Confidence 222 3599999997 688887654 3455543 57899999999999999999999999994 445799999
Q ss_pred cCCcccc
Q 018786 215 FGLSVFF 221 (350)
Q Consensus 215 fg~a~~~ 221 (350)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=153.43 Aligned_cols=259 Identities=24% Similarity=0.294 Sum_probs=202.6
Q ss_pred ccccceeeeeeeec--cCceEEEEEEE--ccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 64 DVRNTYIFGRELGR--GQFGVTYLVTH--KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 64 ~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
.....+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.- ........+-.+|+...+++..|++.++.+..++.
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCccccc
Confidence 34567778899999 99999999999 888999999974321 11112223445677777888889999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHH----HHHHHHHcCCEeecCCCCceEeecCCCC-CCeEEe
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVT----VVHYCHSMGVMHRDLKPENFLFSSSAED-SPLKAT 213 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~i~~----~l~~lH~~~ivH~Dlkp~NIl~~~~~~~-~~vkl~ 213 (350)
.+..++-.|++ +.+|.++...... ++...++....+... ||.++|+.+|+|-|+||.||+. ..+ ..+++.
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~---~~~~~s~~~~ 265 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFT---TSDWTSCKLT 265 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheec---ccccceeecC
Confidence 99999999999 5788888877555 899999999999999 9999999999999999999999 445 779999
Q ss_pred ecCCcccccCCCcc------ccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Q 018786 214 DFGLSVFFKPGDVF------KDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID 287 (350)
Q Consensus 214 Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 287 (350)
|||+...+.++... ....|...|++||..++-++...|+|++|.++.+..++..++...... .+..+....
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~-- 342 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGY-- 342 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC-Ccccccccc--
Confidence 99998887655422 122578889999999999999999999999999999887766443110 111111111
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 288 FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.+.+-+...+.++...+..|++.+|-.|+++..++++.++...
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 2222233457778889999999999999999999999888744
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=128.25 Aligned_cols=133 Identities=24% Similarity=0.317 Sum_probs=110.8
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCC-CCeeEeEeEEEcCCceEEEEec
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVELKGAYEDRHSVNLIMDL 149 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~iv~~~~~~~~~~~~~iv~e~ 149 (350)
+++.||.|.++.||++.... ..+++|....... ...+.+|+..++.+..+ .++++++.+....+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999999855 6799999854321 35788999999999833 6889999888888889999999
Q ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM---GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 150 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
+.|..+..+ +......++.+++.+|..||.. +++|+|++|+||+++ +.+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence 988777543 5667778899999999999985 799999999999995 356799999998865
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.9e-17 Score=157.47 Aligned_cols=266 Identities=28% Similarity=0.402 Sum_probs=214.5
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
..+.+.+.+..|+++.++.+.-..+|...+.|+............+.+..+-+++..-. +|-++...--+......+++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCCCcchh
Confidence 45667778889999999999988888888888876655555545555555544443333 55566554445677788999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc----
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK---- 222 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~---- 222 (350)
++|..+++|...++..+..+....+.++..+..++++||+..+.|+|++|.|++. ..+++.++.|||......
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccccccccC
Confidence 9999999999999988888888888899999999999999999999999999999 677889999998432210
Q ss_pred --CC--------------------------CccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 018786 223 --PG--------------------------DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGET 273 (350)
Q Consensus 223 --~~--------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~ 273 (350)
+. .......||+.|.+||... ......+|.|++|+++++.++|..||....
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 00 0112356999999999765 457889999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHH---HHHhccCCCCCchhhHHH
Q 018786 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAA---EVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~---~iL~~~~~~~~~~~~~~~ 337 (350)
.+...+.+.+...+++.-.. ..+.+.++++...|..+|.+|..+. ++-.|+||+...|..+..
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~-~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPE-EGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred hhhhhhccccCCCCCCCCcc-ccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccc
Confidence 99999999998888776543 4688999999999999999999888 888999999999987754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.3e-14 Score=132.68 Aligned_cols=143 Identities=17% Similarity=0.195 Sum_probs=97.5
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCC--------------------------h-hh----H------HHHH
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN--------------------------R-DD----V------EDVR 115 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--------------------------~-~~----~------~~~~ 115 (350)
+.||.|++|.||+|+.+ +|+.||||+.+...... . .. . -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999986 58999999986431100 0 00 0 0244
Q ss_pred HHHHHHHHcc----CCCCeeEeEeEEEcCCceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHH-HHHHHHHcCC
Q 018786 116 REVQIMHHLT----GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVT-VVHYCHSMGV 189 (350)
Q Consensus 116 ~e~~~l~~l~----~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~-~l~~lH~~~i 189 (350)
+|...+.++. +++++.-..-+....+..++||||++|.+|.+..... ...+ ...++..++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 5555555553 2344332222233345578999999999998766432 1222 3445666655 4788999999
Q ss_pred EeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 190 vH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+|+|++|.||++ +.++.++|+|||.+....
T Consensus 279 ~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 999999999999 566789999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3e-14 Score=118.18 Aligned_cols=144 Identities=13% Similarity=0.130 Sum_probs=103.8
Q ss_pred eeeeeccCceEEEEEEEcc------CCcEEEEEEeccccc--C-----------------ChhhHHHH----HHHHHHHH
Q 018786 72 GRELGRGQFGVTYLVTHKD------TKQQFACKSISSRKL--I-----------------NRDDVEDV----RREVQIMH 122 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~--~-----------------~~~~~~~~----~~e~~~l~ 122 (350)
...||.|.-+.||.|.... .+..+|||+++.... . .......+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998654 357899998853211 0 01112233 38999999
Q ss_pred HccCC-CCeeEeEeEEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCCEeecCCCCceE
Q 018786 123 HLTGH-RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC-HSMGVMHRDLKPENFL 200 (350)
Q Consensus 123 ~l~~h-~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~ivH~Dlkp~NIl 200 (350)
++... -++++.+++ ...++||||+.+..+......+..++......+..+++.+|..| |+.||||+||++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 99732 356666654 45779999997644432222233456667788899999999998 8999999999999999
Q ss_pred eecCCCCCCeEEeecCCcccccC
Q 018786 201 FSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 201 ~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
+. ++.++|+|||.+....+
T Consensus 158 ~~----~~~v~iIDF~qav~~~h 176 (197)
T cd05146 158 WH----DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EE----CCcEEEEECCCceeCCC
Confidence 95 24599999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.8e-15 Score=140.79 Aligned_cols=155 Identities=20% Similarity=0.298 Sum_probs=99.5
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccC--------------------------C-h----
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--------------------------N-R---- 108 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--------------------------~-~---- 108 (350)
.+.+..-..|.. +.||.|++|+||+|+.+.+|+.||||+.++.... + .
T Consensus 113 ~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~ 191 (537)
T PRK04750 113 GPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA 191 (537)
T ss_pred CCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence 344444456766 7899999999999999988999999999743210 0 0
Q ss_pred hhHHH------HHHHHHHHHHcc---CCCCeeEeEeEE-EcCCceEEEEecCCCCCHHHH--HHHcC----CCCHHHHHH
Q 018786 109 DDVED------VRREVQIMHHLT---GHRNIVELKGAY-EDRHSVNLIMDLCAGGELFDR--IIAKG----HYSERAAAN 172 (350)
Q Consensus 109 ~~~~~------~~~e~~~l~~l~---~h~~iv~~~~~~-~~~~~~~iv~e~~~~~sL~~~--l~~~~----~~~~~~~~~ 172 (350)
+..+. +.+|+..+.++. .+...+.+-..+ +-.+..++||||++|+.+.+. +...+ .+.+..+..
T Consensus 192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~ 271 (537)
T PRK04750 192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV 271 (537)
T ss_pred HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence 01111 344555555543 122233333322 335667899999999999764 23332 133333444
Q ss_pred HHHHHHHHHHHHHHcCCEeecCCCCceEeecCC-CCCCeEEeecCCccccc
Q 018786 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGLSVFFK 222 (350)
Q Consensus 173 i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~~~vkl~Dfg~a~~~~ 222 (350)
++.|+ ...|++|+|++|.||+++.++ .++.++++|||.+....
T Consensus 272 ~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 272 FFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 44444 468999999999999996432 23489999999987754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.2e-15 Score=126.78 Aligned_cols=241 Identities=16% Similarity=0.193 Sum_probs=161.9
Q ss_pred EEEEEEEccCCcEEEEEEecccccCChh-hHHHHHHHHHHHHHccCCCCeeEeEeEEEcC-----CceEEEEecCCCCCH
Q 018786 82 VTYLVTHKDTKQQFACKSISSRKLINRD-DVEDVRREVQIMHHLTGHRNIVELKGAYEDR-----HSVNLIMDLCAGGEL 155 (350)
Q Consensus 82 ~V~~~~~~~~~~~~avK~~~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-----~~~~iv~e~~~~~sL 155 (350)
.||++.++..|.+|+--.+......+.. .-++.+.-...+-++. |.||++++.++.+. ....++.||+..+++
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 4777777777766554433322211111 1223333445566677 99999999988544 457899999999999
Q ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeecCCCCceEeecCCCCCCeEEeecCCcccc---c--CC
Q 018786 156 FDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF---K--PG 224 (350)
Q Consensus 156 ~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~---~--~~ 224 (350)
..+|++ ...+......+|+.||+.||.|||+.. |+|+++..+.|++ ..++-+|++----.... . ..
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~ 236 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTRE 236 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEecccCccccchhhhhhhH
Confidence 999975 345888999999999999999999885 9999999999999 56777776532111100 0 00
Q ss_pred CccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
.......+.++|.+||.=. .+.+.++|||+||+...+|..+...-.... .-..-..+.+-.+... ...-++
T Consensus 237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~ 309 (458)
T KOG1266|consen 237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRG 309 (458)
T ss_pred hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccC
Confidence 1112234678899998643 446778999999999999988765432221 1111122222222111 223456
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
+|.+||+-.|+.||+++++|.|+.+......
T Consensus 310 ~i~kcl~~eP~~rp~ar~llfHpllfeVhsl 340 (458)
T KOG1266|consen 310 SITKCLEGEPNGRPDARLLLFHPLLFEVHSL 340 (458)
T ss_pred cCcccccCCCCCCcchhhhhcCceeeecchH
Confidence 8999999999999999999999998877643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.6e-13 Score=127.55 Aligned_cols=183 Identities=16% Similarity=0.176 Sum_probs=135.9
Q ss_pred eeeeeeeeccCceEEE-EEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 69 YIFGRELGRGQFGVTY-LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~-~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
|.+ +...-++.+ +| .|..+.++.++.|..++.+.. ...+.+.+.++.|+.++ ||+|+++++.++..+..|+|+
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvT 88 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVT 88 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEe
Confidence 444 444444444 44 577778889999999875543 44567888999999999 999999999999999999999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH-SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
|.+. .|...+++.+ ...+..-++||+.||.||| +++++|++|....|++ +..|.+||++|.++........
T Consensus 89 ErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~ 160 (690)
T KOG1243|consen 89 ERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNA 160 (690)
T ss_pred eccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCc
Confidence 9974 5666666543 6777788999999999997 6789999999999999 6677799999998866443221
Q ss_pred -cccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCC
Q 018786 227 -FKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGV 266 (350)
Q Consensus 227 -~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~ 266 (350)
......--.|..|+.+... .-..|.|.||+++++++.|.
T Consensus 161 ~~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 161 PAKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ccccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCcc
Confidence 1111112235555543221 13469999999999999983
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.1e-14 Score=114.46 Aligned_cols=129 Identities=18% Similarity=0.176 Sum_probs=95.5
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCC
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCA 151 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~ 151 (350)
.+.|+.|.++.||++... ++.|++|+...... ....+.+|+.+++.+.....+++++.+.. ...++|||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 367899999999999865 67899999754321 12345789999998873333455655533 33579999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCC-----EeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 152 GGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGV-----MHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 152 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i-----vH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
|.++.+. ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 9887542 11123467899999999999985 9999999999995 34599999998765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.6e-13 Score=107.66 Aligned_cols=148 Identities=18% Similarity=0.193 Sum_probs=112.3
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEEEEec-ccc----cCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSIS-SRK----LINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~-~~~----~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
..+.|-+|+-+.|+++.+. |+.++||.=. +.. ....-...+..+|++.+.++. --+|.--.-++.+...-.|
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence 5678999999999999875 5667777422 111 111122456789999999998 5677665556667777889
Q ss_pred EEecCCC-CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 146 IMDLCAG-GELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 146 v~e~~~~-~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
+|||.+| .++.+++... ..........++++|-+.+.-||.++|+|+||.++||++.+.+....+.++|||++...
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9999977 4777777653 22333334789999999999999999999999999999998777777899999998663
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.2e-14 Score=131.47 Aligned_cols=255 Identities=20% Similarity=0.189 Sum_probs=184.5
Q ss_pred ccccceeeeeeeeccCceEEEEEEEc-cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHK-DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
....+|..+..||.|.|+.|+....+ .++..|++|.+........+ ...-..|+.+...+.-|.+++.++..|.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-DIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh-hhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34577889999999999999988765 66888999987654432222 23345677777777779999998887777777
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
.++--|||+++++.......-.+++...+.+..|++.++.++|++.++|+|++|+||++..++ +..+++|||.+..+.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLA 418 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccccc
Confidence 789999999988876665445578888999999999999999999999999999999996432 678999999886421
Q ss_pred CCCccccCCcCcccc-cccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHH
Q 018786 223 PGDVFKDLVGSAYYV-APEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~-aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
-. .........+. ..|.+. ..+..+.|++|||..+.+.+++...-.... ....+..+..+.. ++...+
T Consensus 419 ~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p~~----~~~~~~ 489 (524)
T KOG0601|consen 419 FS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTPNL----PGLKLQ 489 (524)
T ss_pred ee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeecccccCC----CchHHh
Confidence 11 01112233344 244443 347789999999999999998754322211 1222223322222 234578
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
+..+.+.++..++..|+.+.++..+.-+...
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 8899999999999999999999887766544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.9e-12 Score=104.00 Aligned_cols=135 Identities=21% Similarity=0.283 Sum_probs=100.7
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChh-----hHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEE
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-----DVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-----~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~ 147 (350)
..+++|+-+.+|.+... |..+++|.=.+.....++ ..++-.+|+.++.++. -.+|..-.-+..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence 45789999999999663 345677743322222222 2356788999999988 567665555556777788999
Q ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 148 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
||.+|..|.+.+... ...+++.+-.-+.-||.+||+|+||.++||++.. +.+.++|||++...
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~----~~i~~IDfGLg~~s 141 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG----GRIYFIDFGLGEFS 141 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeC----CcEEEEECCccccc
Confidence 999998888887665 2566777777788899999999999999999952 22999999998763
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.4e-11 Score=107.85 Aligned_cols=241 Identities=17% Similarity=0.178 Sum_probs=162.0
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE------E-EcCCce
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA------Y-EDRHSV 143 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~------~-~~~~~~ 143 (350)
.+..||+|+-+.+|..-... ..+-|+++.... ....+ .+..|.....||-+-.=+.| . .....+
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Ppp---a~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPP---AAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCc---hHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 45689999999999764433 245688865432 11122 22333344445543321111 1 223347
Q ss_pred EEEEecCCCCC-HHHHHH---H---cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 144 NLIMDLCAGGE-LFDRII---A---KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 144 ~iv~e~~~~~s-L~~~l~---~---~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
.++|....|.. +..+.. + .....+..+.++++.|+.+...||..|.+-+|++++|+|+ .+++.|.|+|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEccc
Confidence 88999987752 333221 1 1336788999999999999999999999999999999999 667779999987
Q ss_pred CcccccCCCccccCCcCcccccccccc-c-----cCCcchhHHHHHHHHHHHHhC-CCCCCCCCH-----HHHHHHHHc-
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR-R-----NYGAEADIWSAGVILYILLSG-VPPFWGETE-----QSIFDAILR- 283 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~Dv~slG~vl~~ll~g-~~pf~~~~~-----~~~~~~~~~- 283 (350)
......++...-..+|.+.|.+||.-+ + .-+...|.|.||+++++++.| ++||.+... ......|..
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 766656666667788999999999654 2 246678999999999999986 999965321 001111111
Q ss_pred ----------CCCCC-CCCCCCCCCHHHHHHHHHhccc--CccCCCCHHHHHh
Q 018786 284 ----------GHIDF-SSDPWPNISSSAKDIVKKMLHA--DPKERLSAAEVLS 323 (350)
Q Consensus 284 ----------~~~~~-~~~~~~~~~~~l~~li~~~L~~--dp~~Rps~~~iL~ 323 (350)
+..+. ...+|.-++++++.|+.+|+.. ++.-|||++..+.
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~a 295 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVA 295 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHH
Confidence 12222 2234556889999999999965 3568999987764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.9e-11 Score=104.70 Aligned_cols=143 Identities=25% Similarity=0.396 Sum_probs=103.1
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCC-CCeeEeEeEEEcC---CceEEEEe
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVELKGAYEDR---HSVNLIMD 148 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~iv~~~~~~~~~---~~~~iv~e 148 (350)
+.|+.|..+.||++...+ |+.+++|+....... .....+.+|+++++.+..+ ..+++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 578999999999998754 678999997543321 1235688999999999732 3456777766553 36789999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 018786 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS------------------------------------------ 186 (350)
Q Consensus 149 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~------------------------------------------ 186 (350)
+++|.++.+.+.. ..++......++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999887664321 345666666777777777777763
Q ss_pred --------------cCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 187 --------------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 187 --------------~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..++|+|+++.||+++.+ .++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 246899999999999542 145689999998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.6e-10 Score=104.71 Aligned_cols=210 Identities=18% Similarity=0.245 Sum_probs=153.5
Q ss_pred ceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE----cCCceEEEEecCCC-CC
Q 018786 80 FGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE----DRHSVNLIMDLCAG-GE 154 (350)
Q Consensus 80 ~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~----~~~~~~iv~e~~~~-~s 154 (350)
-.+.|++....+|..|++|+++....... ...-.-+++++++. |.|+|++.+.+. ....+++|++|+++ ++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 36799999999999999999954433222 23345578889998 999999998775 44578899999875 46
Q ss_pred HHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 155 LFDRIIAK---------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 155 L~~~l~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
|.++--.. ...++..+|.++.||..||.++|+.|+..+-|.+.+|++ .++.+++|...|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEeccccee
Confidence 76654221 246789999999999999999999999999999999999 445578988888877
Q ss_pred cccCCCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCC-CCCCCHHHH-HHHHHcCCCCCCCCCCCCCC
Q 018786 220 FFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPP-FWGETEQSI-FDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~p-f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 297 (350)
....... |-+. .-.+.|.-.||.+++.|.+|..- +........ +..+.. .++
T Consensus 442 vl~~d~~-------------~~le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~-----------~yS 495 (655)
T KOG3741|consen 442 VLQEDPT-------------EPLE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITT-----------TYS 495 (655)
T ss_pred eecCCCC-------------cchh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhh-----------hhh
Confidence 6554430 1111 12467999999999999998543 222222222 233322 578
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
.+++++|.-+...++++ -++.+++.
T Consensus 496 ~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 496 TDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred HHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 89999999888888876 66777664
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.6e-10 Score=101.31 Aligned_cols=143 Identities=20% Similarity=0.129 Sum_probs=99.1
Q ss_pred eeccCceEEEEEEEccCCcEEEEEEecccccC----C----hhhHHHHHHHHHHHHHccCCCCee--EeEeEEEc-----
Q 018786 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLI----N----RDDVEDVRREVQIMHHLTGHRNIV--ELKGAYED----- 139 (350)
Q Consensus 75 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~----~~~~~~~~~e~~~l~~l~~h~~iv--~~~~~~~~----- 139 (350)
+-......|++... .|+.|.||........ . ......+.+|...+.+|. ..+|. ..+.+.+.
T Consensus 30 v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 30 FRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCc
Confidence 33333344556543 4678899976432210 0 001124789999998886 44443 33444432
Q ss_pred CCceEEEEecCCCC-CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecC----CCCCCeEE
Q 018786 140 RHSVNLIMDLCAGG-ELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS----AEDSPLKA 212 (350)
Q Consensus 140 ~~~~~iv~e~~~~~-sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~----~~~~~vkl 212 (350)
....++|+|++++. +|.+++.. ....+......++.+++..+.-||++||+|+|+++.|||++.+ +++..+.|
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 23578999999876 78888754 3456677888999999999999999999999999999999742 34567999
Q ss_pred eecCCccc
Q 018786 213 TDFGLSVF 220 (350)
Q Consensus 213 ~Dfg~a~~ 220 (350)
+||+.+..
T Consensus 187 IDl~r~~~ 194 (268)
T PRK15123 187 IDLHRAQI 194 (268)
T ss_pred EECCcccc
Confidence 99998754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.7e-11 Score=97.86 Aligned_cols=129 Identities=18% Similarity=0.177 Sum_probs=82.2
Q ss_pred EEEEEEEccCCcEEEEEEecccccC------------C-----------hhhHHHHHHHHHHHHHccCCC--CeeEeEeE
Q 018786 82 VTYLVTHKDTKQQFACKSISSRKLI------------N-----------RDDVEDVRREVQIMHHLTGHR--NIVELKGA 136 (350)
Q Consensus 82 ~V~~~~~~~~~~~~avK~~~~~~~~------------~-----------~~~~~~~~~e~~~l~~l~~h~--~iv~~~~~ 136 (350)
.||.|...+ |..+|||+++..... . ........+|.+.|.++. .. ++++.+++
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~-~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLY-EAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCC-CTT-SS--EEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHH-HCCccCCcEEEE
Confidence 388888754 779999988532110 0 011345788999999998 44 46777755
Q ss_pred EEcCCceEEEEecCC--CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH-HHHHcCCEeecCCCCceEeecCCCCCCeEEe
Q 018786 137 YEDRHSVNLIMDLCA--GGELFDRIIAKGHYSERAAANLCRQMVTVVH-YCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (350)
Q Consensus 137 ~~~~~~~~iv~e~~~--~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~-~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~ 213 (350)
. ...+||||++ |..+..+.... ++......++.+++..+. .+|..||+|+|+.+.||+++. + .+.|+
T Consensus 79 ~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~---~-~~~iI 148 (188)
T PF01163_consen 79 N----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDD---G-KVYII 148 (188)
T ss_dssp E----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEET---T-CEEE-
T ss_pred e----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeec---c-eEEEE
Confidence 2 3569999998 65554433222 224455667777877444 468999999999999999953 2 69999
Q ss_pred ecCCccccc
Q 018786 214 DFGLSVFFK 222 (350)
Q Consensus 214 Dfg~a~~~~ 222 (350)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.6e-12 Score=119.21 Aligned_cols=154 Identities=20% Similarity=0.309 Sum_probs=112.2
Q ss_pred HHHHHHHHH-cCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCcc-----c-----cCCcCccccccccccc-c
Q 018786 178 VTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-----K-----DLVGSAYYVAPEVLRR-N 245 (350)
Q Consensus 178 ~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~-----~-----~~~gt~~y~aPE~~~~-~ 245 (350)
+.|+.++|. .++||++|.|++|.+ +.++.+||+.|+.+....+.... + -......|.|||.+.. .
T Consensus 109 ~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 109 ADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 389999995 589999999999999 66777999999998776542211 1 1234567999998765 4
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCC-CCCCCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP-WPNISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 246 ~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
.+.++|+||+|+++|.+.. |+..+........+ ............. ..+++.++++-+.+++..+..-||++..++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 6789999999999999994 55555433222111 1111111111111 1378999999999999999999999999999
Q ss_pred ccCCCCCchhhH
Q 018786 324 KFLIPKKTLQTL 335 (350)
Q Consensus 324 ~~~~~~~~~~~~ 335 (350)
.+||.+.....+
T Consensus 265 ~~ff~D~~~~aL 276 (700)
T KOG2137|consen 265 IPFFSDPGLKAL 276 (700)
T ss_pred ccccCCchhhhh
Confidence 999999886554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.6e-10 Score=98.49 Aligned_cols=142 Identities=17% Similarity=0.224 Sum_probs=105.2
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEeccccc---------------CC----hhhHHHHHHHHHHHHHccCC-
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL---------------IN----RDDVEDVRREVQIMHHLTGH- 127 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------------~~----~~~~~~~~~e~~~l~~l~~h- 127 (350)
-+.+++.||.|.-|.||.|.+.. |.++|||.-..-.. .. --......+|.++|++|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 45578899999999999999874 78999996532100 00 01234578999999999743
Q ss_pred CCeeEeEeEEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCC
Q 018786 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (350)
Q Consensus 128 ~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 207 (350)
-.+++.+++ +...+|||+.+|..|... +++......++..|+.-+..+=..||||+|+++-||++ +++
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~d 238 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TED 238 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecC
Confidence 367777765 567899999998766542 22355566677777777777779999999999999999 566
Q ss_pred CCeEEeecCCccccc
Q 018786 208 SPLKATDFGLSVFFK 222 (350)
Q Consensus 208 ~~vkl~Dfg~a~~~~ 222 (350)
+.++++||-.+....
T Consensus 239 g~~~vIDwPQ~v~~~ 253 (304)
T COG0478 239 GDIVVIDWPQAVPIS 253 (304)
T ss_pred CCEEEEeCcccccCC
Confidence 779999998876644
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.6e-10 Score=94.14 Aligned_cols=110 Identities=22% Similarity=0.271 Sum_probs=87.5
Q ss_pred HHHHHHHHHHHHHccCCCCe--eEeEeEEEcC----CceEEEEecCCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 018786 111 VEDVRREVQIMHHLTGHRNI--VELKGAYEDR----HSVNLIMDLCAGG-ELFDRIIAKGHYSERAAANLCRQMVTVVHY 183 (350)
Q Consensus 111 ~~~~~~e~~~l~~l~~h~~i--v~~~~~~~~~----~~~~iv~e~~~~~-sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~ 183 (350)
..+..+|...+.+|. ..+| +..+.+.+.. ...++|+|++++. +|.+++......+......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~-~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLR-EAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHH-HcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 457888999888886 4444 3455554432 2457999999874 798888875557788889999999999999
Q ss_pred HHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 184 lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
||++||+|+|+++.|||++.+++...+.|+||+.+...
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999976655568999999987763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.8e-08 Score=84.00 Aligned_cols=141 Identities=13% Similarity=0.118 Sum_probs=99.9
Q ss_pred eeccCceEEEEEEEccCCcEEEEEEecccc---cCChhhHHHHHHHHHHHHHccCCCC--eeEeEeEEE-c----CCceE
Q 018786 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRK---LINRDDVEDVRREVQIMHHLTGHRN--IVELKGAYE-D----RHSVN 144 (350)
Q Consensus 75 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~~e~~~l~~l~~h~~--iv~~~~~~~-~----~~~~~ 144 (350)
-|+||.+-|++..... +.+-+|.-...- ...+--...+.+|+..+++|. ..+ ++++. ++. . .-..+
T Consensus 26 ~~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~-~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 26 YRRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELE-RAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred cCCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHH-HcCCCCCccc-eeeeeccCCceEEE
Confidence 3668888899876543 357888764211 111224578999999999987 333 34444 322 1 22467
Q ss_pred EEEecCCC-CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 145 LIMDLCAG-GELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 145 iv~e~~~~-~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
||+|-+.| .+|.+++... .+.+......++.+++.++.-||+.|+.|+|+.+.||+++.++ ...+.++||.-++.
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~ 179 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR 179 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence 89997753 5888877552 3467788889999999999999999999999999999996432 33599999986654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.3e-08 Score=82.79 Aligned_cols=143 Identities=19% Similarity=0.226 Sum_probs=91.6
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHH------HHHHHHHHHHHcc--CCCCeeEeEe
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE------DVRREVQIMHHLT--GHRNIVELKG 135 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~------~~~~e~~~l~~l~--~h~~iv~~~~ 135 (350)
.+.++|.+.+.+-.....-|.+..- +|+.+++|.............. ...+++....++. +......++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3467888888888777666666544 4678999988643321111111 1244455455554 1223333222
Q ss_pred E-----EEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCe
Q 018786 136 A-----YEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (350)
Q Consensus 136 ~-----~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~v 210 (350)
. +.-....+++|||++|..|.+... +++ .++..|.+++.-||+.|++|+|..|.|++++. +.+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~----~~i 173 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN----NGI 173 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC----CcE
Confidence 2 223345678999999988866432 222 35567788899999999999999999999952 239
Q ss_pred EEeecCCccc
Q 018786 211 KATDFGLSVF 220 (350)
Q Consensus 211 kl~Dfg~a~~ 220 (350)
+++||+-...
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999976543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.1e-07 Score=88.51 Aligned_cols=145 Identities=19% Similarity=0.196 Sum_probs=94.9
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCC---------------------------hhhH----H------HHH
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN---------------------------RDDV----E------DVR 115 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---------------------------~~~~----~------~~~ 115 (350)
+.|+.++-|.||+|+.+. |+.||||+.+..-... .... + .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 578999999999999987 8999999885322100 0001 1 134
Q ss_pred HHHHHHHHcc----CCCCeeEeEeEEEcCCceEEEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHcCCE
Q 018786 116 REVQIMHHLT----GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRII-AKGHYSERAAANLCRQMVTVVHYCHSMGVM 190 (350)
Q Consensus 116 ~e~~~l~~l~----~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~iv 190 (350)
+|...+.++. +.+++.--.-+++-.+.-.++|||++|..+.+... ....++.+.+...+.++. +..+=..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 4555555543 34444333334455666789999999988887642 223456444443332221 2333447999
Q ss_pred eecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 191 H~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
|.|..|.||++ ..++.+.+.|||......+
T Consensus 288 HaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILV---RSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence 99999999999 5567899999999877653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.6e-07 Score=80.61 Aligned_cols=73 Identities=21% Similarity=0.250 Sum_probs=54.8
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCC-CeeEeEeEEEcCCceEEEEecCC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-NIVELKGAYEDRHSVNLIMDLCA 151 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~~~~~~~~~iv~e~~~ 151 (350)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+.... .+++.+.+....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999983 24468899885322 2355789999999987332 25778888877888889999999
Q ss_pred CCC
Q 018786 152 GGE 154 (350)
Q Consensus 152 ~~s 154 (350)
|.+
T Consensus 78 G~~ 80 (226)
T TIGR02172 78 GKR 80 (226)
T ss_pred Ccc
Confidence 863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.3e-07 Score=80.16 Aligned_cols=141 Identities=16% Similarity=0.140 Sum_probs=93.0
Q ss_pred eeeccCceEEEEEEEccCCcEEEEEEecccccCChh----------------hHH-----HHHHHHHHHHHccCCC--Ce
Q 018786 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD----------------DVE-----DVRREVQIMHHLTGHR--NI 130 (350)
Q Consensus 74 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----------------~~~-----~~~~e~~~l~~l~~h~--~i 130 (350)
.|..|..+.||+|... ++..+|+|+++........ ... =..+|+..|+++. .. .+
T Consensus 55 ~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~-eAGVrv 132 (268)
T COG1718 55 CISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAY-EAGVRV 132 (268)
T ss_pred eecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHH-HcCCCC
Confidence 5667778899999874 3788999999643321111 011 1366888888886 33 34
Q ss_pred eEeEeEEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCCCCC
Q 018786 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSP 209 (350)
Q Consensus 131 v~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~ 209 (350)
++-+.+. ...+|||++.......-....-++.......+..++++.+.-|=. .++||+||+.-|||+. ++.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~----~~~ 204 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH----DGE 204 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----CCe
Confidence 4555442 356999998543111100111223333677778888888887766 9999999999999994 566
Q ss_pred eEEeecCCcccccCC
Q 018786 210 LKATDFGLSVFFKPG 224 (350)
Q Consensus 210 vkl~Dfg~a~~~~~~ 224 (350)
+.++|||.|....+.
T Consensus 205 p~iID~~QaV~~~hp 219 (268)
T COG1718 205 PYIIDVSQAVTIDHP 219 (268)
T ss_pred EEEEECccccccCCC
Confidence 999999999876543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.5e-06 Score=71.96 Aligned_cols=129 Identities=21% Similarity=0.260 Sum_probs=90.4
Q ss_pred cceeeeeeeeccCc-eEEEEEEEccCCcEEEEEEecc---ccc-------CCh--------hhHHHHHHHHHHHHHccC-
Q 018786 67 NTYIFGRELGRGQF-GVTYLVTHKDTKQQFACKSISS---RKL-------INR--------DDVEDVRREVQIMHHLTG- 126 (350)
Q Consensus 67 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~~avK~~~~---~~~-------~~~--------~~~~~~~~e~~~l~~l~~- 126 (350)
.+++.++.||.|.- |.||+++.. |+.||+|++.. ... ... ....-|..|.++.-+|..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 77899999999999 999999875 57999999432 110 000 112357888888888762
Q ss_pred -CCCe--eEeEeEEEcC------------------CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 018786 127 -HRNI--VELKGAYEDR------------------HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH 185 (350)
Q Consensus 127 -h~~i--v~~~~~~~~~------------------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH 185 (350)
+.++ +++++|..-. ....||.||.+... .+... -+.+|++-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence 4455 8888886211 12357777765533 12233 3456777788899
Q ss_pred HcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 186 ~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
..||+-+|+++.|..= -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccC--------CEEEecccC
Confidence 9999999999999963 399999964
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.65 E-value=6e-07 Score=90.26 Aligned_cols=209 Identities=20% Similarity=0.211 Sum_probs=149.9
Q ss_pred HHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc----eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Q 018786 111 VEDVRREVQIMHHLTGHRNIVELKGAYEDRHS----VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186 (350)
Q Consensus 111 ~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~----~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~ 186 (350)
+.....|+..+.+.. |+|++.++.+...... ..+..+++.+.++...+..-...+....+.+..++.+||.++|+
T Consensus 226 i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344556667777777 9999999888654433 23456788888999999988899999999999999999999999
Q ss_pred cCCEeecCCCCceEeecCCCCCCeEEe--ecCCcccccCCCccccCCcCcccccccccccc---CCcchhHHHHHHHHHH
Q 018786 187 MGVMHRDLKPENFLFSSSAEDSPLKAT--DFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN---YGAEADIWSAGVILYI 261 (350)
Q Consensus 187 ~~ivH~Dlkp~NIl~~~~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~Dv~slG~vl~~ 261 (350)
....|.-+...-..-...+..+.+... ||+......+.........+..+.++|....+ .+...|+|.+|..+..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 976666666554443333556667777 88888776555444444556668888876533 3445799999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 262 LLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 262 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
+..|..+-.... ....++.. .....+.+.+.+|+..+.++|+++.+++.|+|..-...-
T Consensus 385 ~~~~~~i~~~~~---~~~~~l~~----------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~ 443 (1351)
T KOG1035|consen 385 LSQGEDISEKSA---VPVSLLDV----------LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDN 443 (1351)
T ss_pred hhhcCccccccc---chhhhhcc----------ccchhhhhhhhhhcchhhhhccchhhhhhchhccccccc
Confidence 998765432111 11111110 112278889999999999999999999999998876543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.5e-07 Score=78.97 Aligned_cols=76 Identities=18% Similarity=0.183 Sum_probs=55.3
Q ss_pred eeeccCc-eEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 74 ELGRGQF-GVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 74 ~lg~G~~-g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
.|..|.. +.||+.... +..++||+..... ...+.+|+++++.+..+-.+++++++....+..++||++++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 4444544 789998754 3578889875332 245778999998887665667888887777778999999999
Q ss_pred CCHHH
Q 018786 153 GELFD 157 (350)
Q Consensus 153 ~sL~~ 157 (350)
.++..
T Consensus 77 ~~l~~ 81 (244)
T cd05150 77 VPAAA 81 (244)
T ss_pred ccHhH
Confidence 77754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.1e-07 Score=77.28 Aligned_cols=79 Identities=27% Similarity=0.303 Sum_probs=56.8
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCC-CeeEeEeEE---EcCCceEEEE
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-NIVELKGAY---EDRHSVNLIM 147 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~~---~~~~~~~iv~ 147 (350)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+..+. .+++++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4689999999999999876 47999997432 34567889999998887332 355666543 2334578999
Q ss_pred ecCCCCCHHH
Q 018786 148 DLCAGGELFD 157 (350)
Q Consensus 148 e~~~~~sL~~ 157 (350)
++++|.++..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999887766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1e-06 Score=70.69 Aligned_cols=131 Identities=21% Similarity=0.251 Sum_probs=92.4
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEe
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
....+.|++|.+|.||++.++. ..+|+|+-..+ +....+..|+++|..+.+..--.+++.+.. .++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRG--GEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeeccC--ceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhh
Confidence 3456789999999999999874 57899986432 335679999999999985555667776633 335699
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCC-CC-ceEeecCCCCCCeEEeecCCcccc
Q 018786 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLK-PE-NFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 149 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlk-p~-NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
|..|..|.++.... +..++ ..+++.-.-|-..||-|..|. |. ||+++ +..+.|+||..|...
T Consensus 93 ~i~G~~L~~~~~~~---~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~----~~~~~iIDFd~At~k 156 (201)
T COG2112 93 YIDGRPLGKLEIGG---DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVN----DRDVYIIDFDSATFK 156 (201)
T ss_pred hhcCcchhhhhhcc---cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEec----CCcEEEEEccchhhc
Confidence 99998887654321 23333 344445555777899999996 33 55552 335999999998853
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=8.3e-09 Score=97.22 Aligned_cols=245 Identities=17% Similarity=0.186 Sum_probs=164.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCC-eeEeEeEEEcCCceEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN-IVELKGAYEDRHSVNL 145 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-iv~~~~~~~~~~~~~i 145 (350)
..|......++|+++.+++.+...+... ..+.+... ....-++++|.+++ ||| .+..++-++.+.+.++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL-~h~fvs~~--------l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLL-QHPFVSQT--------LSRRLAIELLDKVN-NPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhe-eceeeccc--------hhhHHHHHHHHHcc-CCCCcccccccCCcccccch
Confidence 4455566789999999999988776443 36665322 44667889999998 999 6677777788889999
Q ss_pred EEecCCCC-CHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 146 IMDLCAGG-ELFDRI-IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 146 v~e~~~~~-sL~~~l-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
.++++.++ +..... ...-.+.+-....+.+.-+.+++++|+.-=+|+| ||+.. .+.++..||+....+..
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQLTR 383 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCcccCc
Confidence 99999776 221111 1112244455566777788999999998778999 77763 35589999999888776
Q ss_pred CCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCC-CCCCCCCHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG--HIDFSS-DPWPNISSS 299 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~ 299 (350)
........+++.+++||+.. +.+....|+|++|.-..++--|.+|-..... ....+-.+ .+.... ..|. +..
T Consensus 384 ~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~aw~--~~~ 459 (829)
T KOG0576|consen 384 TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSAWS--PVF 459 (829)
T ss_pred ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhhcC--ccc
Confidence 65566778999999999765 5688899999999877777767666433110 00000000 000000 0110 111
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
-.++...|+...|..|+....++.+.+|.+-.++
T Consensus 460 ~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~ 493 (829)
T KOG0576|consen 460 HRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLR 493 (829)
T ss_pred ccCCcccccCCCCCCCcchhhHHHHHHhccCccc
Confidence 1246677888888888888888887777765543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.45 E-value=8.4e-06 Score=68.12 Aligned_cols=134 Identities=19% Similarity=0.266 Sum_probs=95.3
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEeccccc-------------CChhhHHHHHHHHHHHHHcc-----CCCCeeEeE
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKL-------------INRDDVEDVRREVQIMHHLT-----GHRNIVELK 134 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------------~~~~~~~~~~~e~~~l~~l~-----~h~~iv~~~ 134 (350)
..||+|+.-.||.--+ .....||+...... .......+..+|+.....+. .+..|.+++
T Consensus 7 ~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5789999999995332 33468899876540 01123456677777665554 367899999
Q ss_pred eEEEcCCceEEEEecCC------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCC
Q 018786 135 GAYEDRHSVNLIMDLCA------GGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 135 ~~~~~~~~~~iv~e~~~------~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~ 208 (350)
|+.+...-..+|+|... ..||.+++.. +.++. . +...+-.-.++|-+++|+.+|++|.||++...+++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 99999888999999863 2468777744 34555 3 334444555678899999999999999998766555
Q ss_pred -CeEEee
Q 018786 209 -PLKATD 214 (350)
Q Consensus 209 -~vkl~D 214 (350)
.++|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 788888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.9e-06 Score=81.90 Aligned_cols=147 Identities=14% Similarity=0.126 Sum_probs=92.3
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCC----------------------------hhhHHH------HHHHH
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN----------------------------RDDVED------VRREV 118 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~----------------------------~~~~~~------~~~e~ 118 (350)
+.||..+.|.||+|+.++ |+.||||+-+..-... .+..+. |.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999999988 9999999875432111 000111 33344
Q ss_pred HHHHHcc---CCCC------eeEeEeEEEcCCceEEEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 018786 119 QIMHHLT---GHRN------IVELKGAYEDRHSVNLIMDLCAGGELFDRII-AKGHYSERAAANLCRQMVTVVHYCHSMG 188 (350)
Q Consensus 119 ~~l~~l~---~h~~------iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 188 (350)
+...++. .|-+ |++++ +.....-.++|||++|..+.|.-. .+..++...+..-+.+... +.|=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 3333332 1333 33333 233455779999999987765432 1233555544433333222 2233568
Q ss_pred CEeecCCCCceEeecCC-CCCCeEEeecCCcccccCC
Q 018786 189 VMHRDLKPENFLFSSSA-EDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 189 ivH~Dlkp~NIl~~~~~-~~~~vkl~Dfg~a~~~~~~ 224 (350)
++|+|-.|.||++..+. .+..+.+.|||+.....+.
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 99999999999997543 4678999999998876544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.7e-06 Score=85.06 Aligned_cols=81 Identities=21% Similarity=0.343 Sum_probs=57.4
Q ss_pred eeeeeccCceEEEEEEEccCC--cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCe--eEeEeEEEcC---CceE
Q 018786 72 GRELGRGQFGVTYLVTHKDTK--QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI--VELKGAYEDR---HSVN 144 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i--v~~~~~~~~~---~~~~ 144 (350)
.+.++.|.++.+|+......+ ..+++|+....... .....+.+|+++++.+..|.++ ++++.++.+. +..+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 577899999999998765432 46788876432211 1234688999999999645554 7777776654 4678
Q ss_pred EEEecCCCCC
Q 018786 145 LIMDLCAGGE 154 (350)
Q Consensus 145 iv~e~~~~~s 154 (350)
+|||+++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999998864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.22 E-value=9.9e-06 Score=70.13 Aligned_cols=73 Identities=16% Similarity=0.145 Sum_probs=46.3
Q ss_pred eeeeccCce-EEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCC--CeeEeEeEEEcC---CceEEE
Q 018786 73 RELGRGQFG-VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR--NIVELKGAYEDR---HSVNLI 146 (350)
Q Consensus 73 ~~lg~G~~g-~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~--~iv~~~~~~~~~---~~~~iv 146 (350)
+.|+.|+.. .||+.. ..+++|+..... ....+.+|.+++..+..+- .++++++..... ...+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 567766665 599762 247888764321 2357889999998887332 344555443322 245889
Q ss_pred EecCCCCCH
Q 018786 147 MDLCAGGEL 155 (350)
Q Consensus 147 ~e~~~~~sL 155 (350)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999988766
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.22 E-value=6.2e-05 Score=69.68 Aligned_cols=80 Identities=13% Similarity=0.153 Sum_probs=56.1
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEeccccc---CC-hhhHHHHHHHHHHHHHccCC--CCeeEeEeEEEcCCceEEE
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKL---IN-RDDVEDVRREVQIMHHLTGH--RNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~-~~~~~~~~~e~~~l~~l~~h--~~iv~~~~~~~~~~~~~iv 146 (350)
+.||.|..+.||++.....++.++||.-..... .. .-..++...|.+.|+.+..+ ..+++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 679999999999999875446899997531110 00 12456788888888887533 457778776 44567899
Q ss_pred EecCCCCC
Q 018786 147 MDLCAGGE 154 (350)
Q Consensus 147 ~e~~~~~s 154 (350)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99987643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.8e-05 Score=68.39 Aligned_cols=76 Identities=18% Similarity=0.271 Sum_probs=49.8
Q ss_pred eeeeeccCceEEEEEEEcc-CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecC
Q 018786 72 GRELGRGQFGVTYLVTHKD-TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~ 150 (350)
++.|..|-.+.+|++.... .++.|++|+...... ..-...+|+.+++.+..+.-.++++..... .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 4678888889999987653 346788998753211 111234788888888644445566554332 3799999
Q ss_pred CCCCH
Q 018786 151 AGGEL 155 (350)
Q Consensus 151 ~~~sL 155 (350)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 88765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.7e-06 Score=74.79 Aligned_cols=143 Identities=16% Similarity=0.164 Sum_probs=99.5
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEeccc-----------------ccCChhh--HHHHHHHHHHHHHccCCC
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSR-----------------KLINRDD--VEDVRREVQIMHHLTGHR 128 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~-----------------~~~~~~~--~~~~~~e~~~l~~l~~h~ 128 (350)
-+.+++.||-|.-+-||.+.+.. |.++++|.-..- ....+-. +-...+|+..|+.|..|.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 46688999999999999998875 788899954311 0000111 123567888888887443
Q ss_pred C-eeEeEeEEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCC
Q 018786 129 N-IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (350)
Q Consensus 129 ~-iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 207 (350)
. +++.++ .+..++|||++.|..|...-+ ...+..+...++.-+--|-.+|+||+|++--||++ .++
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd 238 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV---KDD 238 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEE---ecC
Confidence 2 444543 456789999999887754221 22334455666666777889999999999999999 556
Q ss_pred CCeEEeecCCcccccCC
Q 018786 208 SPLKATDFGLSVFFKPG 224 (350)
Q Consensus 208 ~~vkl~Dfg~a~~~~~~ 224 (350)
..++++||-.+....+.
T Consensus 239 ~~i~vIDFPQmvS~sh~ 255 (465)
T KOG2268|consen 239 DKIVVIDFPQMVSTSHP 255 (465)
T ss_pred CCEEEeechHhhccCCC
Confidence 67999999977655433
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.7e-05 Score=69.67 Aligned_cols=134 Identities=18% Similarity=0.157 Sum_probs=76.0
Q ss_pred eeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCC
Q 018786 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGG 153 (350)
Q Consensus 74 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 153 (350)
.+..|-.+.+|+... +++.+++|....... ...-...+|..+++.+..+.-.++++.... -++|+||++|.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 456677889998873 456788998643221 100124678888888874323345554432 36899999886
Q ss_pred CHHH--------------HHH---Hc----CCCCHH-HHHHHHHHH---------HHHHHHHHH--------cCCEeecC
Q 018786 154 ELFD--------------RII---AK----GHYSER-AAANLCRQM---------VTVVHYCHS--------MGVMHRDL 194 (350)
Q Consensus 154 sL~~--------------~l~---~~----~~~~~~-~~~~i~~~i---------~~~l~~lH~--------~~ivH~Dl 194 (350)
.+.. .+. .. .+++.. .+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6431 111 11 111211 122222111 111222222 24899999
Q ss_pred CCCceEeecCCCCCCeEEeecCCccc
Q 018786 195 KPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 195 kp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.|.||+++ +++ +.|+||+.+..
T Consensus 154 ~~~Nil~~---~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVT---PQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEe---CCC-CEEEeccccCc
Confidence 99999995 333 78999998765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.4e-05 Score=67.48 Aligned_cols=146 Identities=19% Similarity=0.222 Sum_probs=98.5
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEEEEecccccCC---------------------hhhH-H-HHHHHHHHHHHccCC
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN---------------------RDDV-E-DVRREVQIMHHLTGH 127 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---------------------~~~~-~-~~~~e~~~l~~l~~h 127 (350)
+-..|..|.-+.||.|...+ |..+|||+++-+-+.. +... . =...|++.|.++. .
T Consensus 148 inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~ 225 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-N 225 (520)
T ss_pred cccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-h
Confidence 44567889999999988765 7779999986432211 0001 1 1456888899987 5
Q ss_pred CCeeEeEeEEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCCEeecCCCCceEeecCCC
Q 018786 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC-HSMGVMHRDLKPENFLFSSSAE 206 (350)
Q Consensus 128 ~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~ivH~Dlkp~NIl~~~~~~ 206 (350)
.+|+----+.. ....+||+++.+.....-....-.++...+..+-.+++.-+.-| |.+++||.||.--|+|+.
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh---- 299 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH---- 299 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE----
Confidence 66543222211 22568999985433322223345577777888777777777665 578999999999999984
Q ss_pred CCCeEEeecCCcccccCC
Q 018786 207 DSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 207 ~~~vkl~Dfg~a~~~~~~ 224 (350)
+|.+.++|.+.+......
T Consensus 300 dG~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHDHP 317 (520)
T ss_pred CCEEEEEEccccccCCCh
Confidence 567999999988775543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00012 Score=65.61 Aligned_cols=138 Identities=17% Similarity=0.178 Sum_probs=81.3
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCC-CeeEeEe------EEEcCCceE
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-NIVELKG------AYEDRHSVN 144 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~------~~~~~~~~~ 144 (350)
.+.|..|....+|+.... +..+++|++.. ...+.+..|+.++..+..+. .+++++. +....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 456778888899988653 34689998753 12345777888888876221 2444433 123345678
Q ss_pred EEEecCCCCCHHH----HH----------HHc-CCCCH--------HHH------------HHHHHHHHHHHHHHHH---
Q 018786 145 LIMDLCAGGELFD----RI----------IAK-GHYSE--------RAA------------ANLCRQMVTVVHYCHS--- 186 (350)
Q Consensus 145 iv~e~~~~~sL~~----~l----------~~~-~~~~~--------~~~------------~~i~~~i~~~l~~lH~--- 186 (350)
+|+++++|..+.. .. +.. ..+.. .-. ......+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999998866421 01 110 00100 000 0011122334444443
Q ss_pred ----cCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 187 ----MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 187 ----~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.+++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFD---GDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEe---CCceEEEeehhhhcC
Confidence 4699999999999994 445568999997765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00014 Score=65.46 Aligned_cols=76 Identities=16% Similarity=0.216 Sum_probs=49.7
Q ss_pred eeeeeccCceEEEEEEEcc------CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 72 GRELGRGQFGVTYLVTHKD------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
++.|..|-...+|++.... .++.+++|+..... .......+|..++..+..+.-.++++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3567778888999987643 25789999975432 1123457788888888744334566665542 35
Q ss_pred EEecCCCCCH
Q 018786 146 IMDLCAGGEL 155 (350)
Q Consensus 146 v~e~~~~~sL 155 (350)
|++|++|.++
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 7899887665
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.86 E-value=7.2e-05 Score=62.19 Aligned_cols=99 Identities=17% Similarity=0.222 Sum_probs=77.0
Q ss_pred HHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 018786 115 RREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDR---IIAKGHYSERAAANLCRQMVTVVHYCHS---MG 188 (350)
Q Consensus 115 ~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~---l~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ 188 (350)
.+|.-+++.+.+.+++++++|.|- .+++.||...+++... +..-...++..+.+++.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888899986679999999862 3468899875555321 1112346899999999999999999997 45
Q ss_pred CEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 189 ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
+.-.|++++|+-+ .+++.+|++|.+.+..
T Consensus 83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEE---eCCCcEEEEechhcch
Confidence 8899999999999 5567799999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00041 Score=63.00 Aligned_cols=77 Identities=12% Similarity=0.077 Sum_probs=51.0
Q ss_pred eeeccCceEEEEEEEccCCcEEEEEEeccccc----CChhhHHHHHHHHHHHHHccC-CC-CeeEeEeEEEcCCceEEEE
Q 018786 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKL----INRDDVEDVRREVQIMHHLTG-HR-NIVELKGAYEDRHSVNLIM 147 (350)
Q Consensus 74 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~e~~~l~~l~~-h~-~iv~~~~~~~~~~~~~iv~ 147 (350)
.||.|....||++.+...++.++||.-..-.. .-+-..++..-|.+.|+.... .| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999864446799996532111 112234667778888877653 23 46666655 555667999
Q ss_pred ecCCC
Q 018786 148 DLCAG 152 (350)
Q Consensus 148 e~~~~ 152 (350)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00033 Score=64.18 Aligned_cols=141 Identities=11% Similarity=0.142 Sum_probs=83.1
Q ss_pred eeeeeeeccCceEEEEEEEcc----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 70 IFGRELGRGQFGVTYLVTHKD----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.-.+.|..|-...+|++.... .++.|++|+..... .....+ .+|..+++.+..+.--+++++.+..+ .
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~ 110 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----R 110 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence 344566678889999987532 24679999885432 122232 67888888887444455677766433 4
Q ss_pred EEecCCCCCHHHH----------H-------HHcC-C----C-CHHHHHHHHHHH-----------------HHHHHHHH
Q 018786 146 IMDLCAGGELFDR----------I-------IAKG-H----Y-SERAAANLCRQM-----------------VTVVHYCH 185 (350)
Q Consensus 146 v~e~~~~~sL~~~----------l-------~~~~-~----~-~~~~~~~i~~~i-----------------~~~l~~lH 185 (350)
|.+|+++.++... + +... + . ....+..++.++ ...+..|.
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 7888877665311 0 1101 0 1 122333333221 11122221
Q ss_pred --------HcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 186 --------SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 186 --------~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
...++|+|+++.||+++. +++.+.|+||..+..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~--~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDE--ETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeC--CCCcEEEEeehhccc
Confidence 225899999999999962 245699999988765
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00039 Score=62.73 Aligned_cols=139 Identities=18% Similarity=0.243 Sum_probs=79.0
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCC-CeeEeEeE------EEcCCceE
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-NIVELKGA------YEDRHSVN 144 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~------~~~~~~~~ 144 (350)
.+.++.|....+|++... +| .+++|++.... ..+.+..|++++..|..+. .+++++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEeC-CC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 456777777899988653 33 58889875321 1244566777777775211 13444331 12345678
Q ss_pred EEEecCCCCCHH----H-------H---HHH-cCCC--------CHHH-----HH----------HHHHHHHHHHHHHHH
Q 018786 145 LIMDLCAGGELF----D-------R---IIA-KGHY--------SERA-----AA----------NLCRQMVTVVHYCHS 186 (350)
Q Consensus 145 iv~e~~~~~sL~----~-------~---l~~-~~~~--------~~~~-----~~----------~i~~~i~~~l~~lH~ 186 (350)
++++|++|..+. + . ++. ...+ .... .. .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885421 1 1 111 0111 0000 00 011223344555542
Q ss_pred -------cCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 187 -------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 187 -------~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.+++|+|+++.||+++ +++.+.|+||+.+..
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFACT 217 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEE---CCceEEEeecccccC
Confidence 5799999999999995 344568999998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00061 Score=61.03 Aligned_cols=79 Identities=14% Similarity=0.171 Sum_probs=47.2
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCC-CCeeEeEeEEEcCC--ceEEEE
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVELKGAYEDRH--SVNLIM 147 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~iv~~~~~~~~~~--~~~iv~ 147 (350)
+++.+..|-...+|..... ++.++++ .. .............+|+.+++.+... --+...++.+.++. ..+.||
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P-~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KP-PRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cC-CccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 3444444444456655554 6778888 22 1122334456778899998887631 23334455554444 679999
Q ss_pred ecCCCC
Q 018786 148 DLCAGG 153 (350)
Q Consensus 148 e~~~~~ 153 (350)
+|.+|.
T Consensus 105 ~~veGe 110 (321)
T COG3173 105 EWVEGE 110 (321)
T ss_pred EEecce
Confidence 999884
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00074 Score=61.54 Aligned_cols=141 Identities=14% Similarity=0.158 Sum_probs=80.7
Q ss_pred eeeeeeeccCceEEEEEEEccC---CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 70 IFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
..++.|..|-...+|+...... +..|++|+...... ... .-.+|..+++.+..+.--+++++++. ++ +|
T Consensus 17 i~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i 88 (330)
T PLN02421 17 FSVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MI 88 (330)
T ss_pred eEEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---Ee
Confidence 3445666688889999875432 34799998754321 111 23568888888874433456666653 22 57
Q ss_pred EecCCCCCHHH----------HH-------HHcC-C----CC-HHHHHHHHHHH----------------------HHHH
Q 018786 147 MDLCAGGELFD----------RI-------IAKG-H----YS-ERAAANLCRQM----------------------VTVV 181 (350)
Q Consensus 147 ~e~~~~~sL~~----------~l-------~~~~-~----~~-~~~~~~i~~~i----------------------~~~l 181 (350)
.+|++|.++.. .+ +... + ++ ...+..+..++ ...+
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 88887765421 01 1101 0 11 22233332222 1112
Q ss_pred HHHHH----c----CCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 182 HYCHS----M----GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 182 ~~lH~----~----~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..+.. . -++|.|+.+.||+++. +++.++++||..|..
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~--~~~~l~lID~EYag~ 213 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNE--DEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeC--CCCcEEEEcccccCC
Confidence 22221 1 2789999999999952 345699999998865
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0012 Score=59.91 Aligned_cols=74 Identities=15% Similarity=0.201 Sum_probs=44.1
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCC-CCeeEeEe------EEEcCCceEE
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVELKG------AYEDRHSVNL 145 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~iv~~~~------~~~~~~~~~i 145 (350)
+.|+.|....+|+..... | .+++|++. . .. .+.+..|+.++..|..+ -.+++++. +....+..++
T Consensus 28 ~~l~~G~~n~~y~v~t~~-g-~~vLK~~~-~--~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~ 99 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQ-G-EYVLTLFE-R--LT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA 99 (319)
T ss_pred chhccccccceEEEEeCC-C-cEEEEEec-c--CC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence 456778878999987543 3 68999874 1 11 23444566666665411 11333332 1233566789
Q ss_pred EEecCCCCC
Q 018786 146 IMDLCAGGE 154 (350)
Q Consensus 146 v~e~~~~~s 154 (350)
++++++|..
T Consensus 100 l~~~l~G~~ 108 (319)
T PRK05231 100 IVTFLEGKW 108 (319)
T ss_pred EEEecCCCC
Confidence 999998864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00089 Score=59.35 Aligned_cols=31 Identities=19% Similarity=0.316 Sum_probs=24.0
Q ss_pred CCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 188 ~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.++|+|+++.||+++. +....-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~--~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDE--DARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeC--CCCEEEEECcHhccc
Confidence 4899999999999952 123356999998765
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00039 Score=65.08 Aligned_cols=165 Identities=18% Similarity=0.179 Sum_probs=106.7
Q ss_pred HHHHHHHHHHHHccCCCCeeEeEeEEEcC-CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCE
Q 018786 112 EDVRREVQIMHHLTGHRNIVELKGAYEDR-HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190 (350)
Q Consensus 112 ~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~iv 190 (350)
..+.....+++.+. |++...++++.... ....+|+|++ +.+|++.+..+. +...... +
T Consensus 27 ~~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~ 85 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------A 85 (725)
T ss_pred HHHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------c
Confidence 45777888889988 99999999887543 3477899998 679999887654 2222111 2
Q ss_pred eecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCC
Q 018786 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFW 270 (350)
Q Consensus 191 H~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~ 270 (350)
|+ +.+-||+ +..| -++.. . ... ..+++||||+|.++.++..|...+.
T Consensus 86 ~~-~~~~~~~----------~~td-~~~t~---~---~~~---------------~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 86 HG-VLHLNII----------YITD-HFLTK---Y---PSP---------------IGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred cc-cceehhh----------hccc-ccccc---C---CCC---------------CCcchhhhhHHHHHHHHHHhhHHHH
Confidence 21 1122222 2233 00000 0 111 1249999999999999999988887
Q ss_pred CCCHHHHHHHHHcCCCCCCCCC--------CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 271 GETEQSIFDAILRGHIDFSSDP--------WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.....+....+.+-........ ...++.....+...|+-..|..||...+..++.-|...
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 7666666655554332211110 11356777889999999999999988888877766544
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0041 Score=57.70 Aligned_cols=77 Identities=14% Similarity=0.081 Sum_probs=51.8
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh----hhHHHHHHHHHHHHHccC--CCCeeEeEeEEEcCCceEE
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR----DDVEDVRREVQIMHHLTG--HRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~~e~~~l~~l~~--h~~iv~~~~~~~~~~~~~i 145 (350)
.+.||.|....||+..+. ++.++||.-........ -..++...|.+.|+.+.. ...+++++.++. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 578899999999998874 45689997652211011 134555666777776642 247788888765 44678
Q ss_pred EEecCCC
Q 018786 146 IMDLCAG 152 (350)
Q Consensus 146 v~e~~~~ 152 (350)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0022 Score=59.13 Aligned_cols=79 Identities=13% Similarity=0.145 Sum_probs=53.3
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCC---hhhHHHHHHHHHHHHHccC-CC-CeeEeEeEEEcCCceEEE
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN---RDDVEDVRREVQIMHHLTG-HR-NIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~-h~-~iv~~~~~~~~~~~~~iv 146 (350)
.+.||.|.-.-||++.+...++.++||.-..-.... +-..++..-|.+.|+.... .| .+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 568899999999999985435679999543211111 2245677788888887653 23 46667655 55667789
Q ss_pred EecCCC
Q 018786 147 MDLCAG 152 (350)
Q Consensus 147 ~e~~~~ 152 (350)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0035 Score=56.23 Aligned_cols=106 Identities=9% Similarity=0.007 Sum_probs=73.4
Q ss_pred eeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCC--CCeeEeEeEEEc---CCceE
Q 018786 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH--RNIVELKGAYED---RHSVN 144 (350)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h--~~iv~~~~~~~~---~~~~~ 144 (350)
.-.+.||.|..+.||+....+ + .+++|..+.. .....+.+|...++.+.++ -.++++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 345689999999999986543 3 4677875321 1125788999999998754 367888887654 36689
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM 187 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 187 (350)
+|||+++|.++.+. .........+..+++.+|..||+.
T Consensus 90 LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 90 LLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999877541 123334455667777777777763
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.00018 Score=75.02 Aligned_cols=204 Identities=17% Similarity=0.069 Sum_probs=129.9
Q ss_pred HHHHHHHccCCCCeeEeEeEEE--cCCceEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC--
Q 018786 117 EVQIMHHLTGHRNIVELKGAYE--DRHSVNLIMDLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMG-- 188 (350)
Q Consensus 117 e~~~l~~l~~h~~iv~~~~~~~--~~~~~~iv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~-- 188 (350)
|..-++... |+++.....-.. ....-+..++++.+|.+++.+.+. ....+..+.....+.+.....+|+..
T Consensus 1279 e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1279 ERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 333344445 887776655443 334567889999999999988542 22333333333344366777777542
Q ss_pred ---CEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHH
Q 018786 189 ---VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILL 263 (350)
Q Consensus 189 ---ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll 263 (350)
.+|+++|+-|.++ ..+..+|++++|+.+...+. .......+++.|+.|++.+. .++.++|+|..|+.+|+..
T Consensus 1358 g~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred Cccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 7899999999999 55666999999999843322 22344567888999987764 4667799999999999988
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCCCCC-CC-CCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 264 SGVPPFWGETEQSIFDAILRGHIDFSSDP-WP-NISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 264 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
-|..+|. ...+...++........ .+ -.|.+.......+|-..-..||.-...+....+.-
T Consensus 1435 ~~n~~fi-----~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1435 DGNAYFI-----FFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred cccHHHH-----HHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 8877763 33333333332221111 01 12345555555555566678888888777655543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.017 Score=52.02 Aligned_cols=30 Identities=23% Similarity=0.413 Sum_probs=24.7
Q ss_pred cCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 187 ~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~----~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD----NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC----CcEEEEECccccc
Confidence 47899999999999953 3488999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0073 Score=53.70 Aligned_cols=75 Identities=12% Similarity=0.106 Sum_probs=48.5
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc--CCCCeeEeEeEEEcCCceEEEEe
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
-.+.++.|..+.+|+.. .+++.+.||+-... ....+..|.+-|+.|. ..-.+++++.+....+..++|+|
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 34678989999999887 55678999987522 2256888888888884 24467789998887778899999
Q ss_pred cCCCC
Q 018786 149 LCAGG 153 (350)
Q Consensus 149 ~~~~~ 153 (350)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 98765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0086 Score=55.56 Aligned_cols=78 Identities=21% Similarity=0.195 Sum_probs=48.5
Q ss_pred eeeeeeeccCceEEEEEEEccC-CcE-----EEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 70 IFGRELGRGQFGVTYLVTHKDT-KQQ-----FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~~~-~~~-----~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...+.|..|-.+.+|++..... +.. |.++.... ..+..-.-.+|+.+++.+..+..-+++++.+..
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~---- 124 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD---- 124 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----
Confidence 3455677788899999975432 122 44443311 111111235688899999856666778877653
Q ss_pred EEEEecCCCCCH
Q 018786 144 NLIMDLCAGGEL 155 (350)
Q Consensus 144 ~iv~e~~~~~sL 155 (350)
+++.||++|.+|
T Consensus 125 g~l~efIeGr~l 136 (383)
T PTZ00384 125 FTIQEWVEGNTM 136 (383)
T ss_pred EEEEEEeccccC
Confidence 489999988765
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0046 Score=52.45 Aligned_cols=31 Identities=32% Similarity=0.557 Sum_probs=20.1
Q ss_pred CCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 188 ~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.++|.|+.+.||+++ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEET--SSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEec--cCCCeEEEecHHHHhh
Confidence 488999999999993 3455699999998865
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.013 Score=53.08 Aligned_cols=120 Identities=14% Similarity=0.142 Sum_probs=77.8
Q ss_pred CCCeeEeEeEE-EcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeecCCCCceEeecC
Q 018786 127 HRNIVELKGAY-EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSS 204 (350)
Q Consensus 127 h~~iv~~~~~~-~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~Dlkp~NIl~~~~ 204 (350)
.++..+.+-+- .+..+.|++|++. |+++.. ++ .-..+++..++++.+..++-+..+ .+-|||+...||+|
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI--- 355 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISI-IK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI--- 355 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceeee-ee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---
Confidence 44444443333 4455677888886 666632 22 235778888888888888777754 58899999999999
Q ss_pred CCCCCeEEeecCCcccccCCCccccCCcCccccccccccccCCcchhHHHHHHHH
Q 018786 205 AEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVIL 259 (350)
Q Consensus 205 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl 259 (350)
+ .|.|.|+||-+++.-.+... +.....--|-.+.|.-+.+.+||-+--.+
T Consensus 356 d-~GnvtLIDfklsRl~~~q~~----isy~rldhp~lF~G~dd~QFeIYrlMr~l 405 (488)
T COG5072 356 D-EGNVTLIDFKLSRLSYSQGI----ISYNRLDHPDLFNGVDDYQFEIYRLMRRL 405 (488)
T ss_pred e-cCceEEEEeeeeecccCCce----eeccccCchhhhcCccceeeeHHHHHHHH
Confidence 4 67799999999985332211 11122333445556567778888754443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.087 Score=47.92 Aligned_cols=70 Identities=14% Similarity=0.110 Sum_probs=42.4
Q ss_pred CceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCe--eE---eEe--EEEcCCceEEEEecCC
Q 018786 79 QFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI--VE---LKG--AYEDRHSVNLIMDLCA 151 (350)
Q Consensus 79 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i--v~---~~~--~~~~~~~~~iv~e~~~ 151 (350)
....||+....+ +..+++|+..... .....+..|++.+..|.. .++ +. .-+ +...++..+.++++.+
T Consensus 37 ~eN~vy~v~~~~-~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~-~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 37 YENRVYQFGDED-GRRVVAKFYRPER----WSDAQILEEHAFALELAE-AEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred ccceEEEEecCC-CCEEEEEEcCccc----CCHHHHHHHHHHHHHHHH-CCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 446799887643 5679999875322 123567778888877752 222 21 111 2233567788999987
Q ss_pred CCC
Q 018786 152 GGE 154 (350)
Q Consensus 152 ~~s 154 (350)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 753
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.031 Score=52.96 Aligned_cols=77 Identities=12% Similarity=0.119 Sum_probs=48.0
Q ss_pred eeeeeeccCceEEEEEEEccC--------CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 71 FGRELGRGQFGVTYLVTHKDT--------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
-++.|..|-...+|++..... ++.|++|++-... .... .-.+|..+++.+..+.--.++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 567788888899999875422 4679999874322 1111 23457777777773333345666553
Q ss_pred eEEEEecCCCCCH
Q 018786 143 VNLIMDLCAGGEL 155 (350)
Q Consensus 143 ~~iv~e~~~~~sL 155 (350)
-+.|.+|++|.+|
T Consensus 181 gg~I~efi~g~~l 193 (442)
T PTZ00296 181 GGRIEEWLYGDPL 193 (442)
T ss_pred CCEEEEeeCCccC
Confidence 2357888887643
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.016 Score=48.86 Aligned_cols=116 Identities=16% Similarity=0.135 Sum_probs=75.3
Q ss_pred ccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCCCCHH
Q 018786 77 RGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELF 156 (350)
Q Consensus 77 ~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~ 156 (350)
-++-++.-.+..+. | +..+|.+......- ...-+.++..++.++. +|+++.. ..+..+.++.|+|-.....
T Consensus 72 ~~gNsTl~~~kt~i-G-~L~lKKi~slp~~~--~~~~y~nky~v~Armh---GilrL~N--Dn~~~yGvIlE~Cy~~~i~ 142 (308)
T PF07387_consen 72 FNGNSTLLIGKTKI-G-PLFLKKIRSLPCCI--NDALYFNKYRVFARMH---GILRLKN--DNNYKYGVILERCYKIKIN 142 (308)
T ss_pred cCCceEEEEecccc-c-hhhhhhccCCCccc--chhhhhhhhhHHHHhh---heeEeec--CCCceeEEEEeeccCcccc
Confidence 44555555555544 3 45667665444321 2244678888888875 7888873 2455677999998543221
Q ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--cCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 157 DRIIAKGHYSERAAANLCRQMVTVVHYCHS--MGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 157 ~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
...++..=+.+|...|+ .+.+|+|-.|+|||. +..|-+||.|=+.
T Consensus 143 -------------~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~---D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 143 -------------FSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMC---DKFGYLKLVDPVC 189 (308)
T ss_pred -------------hhHHHHHhHHHHHHhhccCCCeecCCCChhheee---cCCCCEEecChhh
Confidence 11222223567788894 369999999999999 7788899999654
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.034 Score=50.20 Aligned_cols=30 Identities=23% Similarity=0.339 Sum_probs=26.0
Q ss_pred CCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 188 ~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
+++|+|+.+.||++ ++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence 69999999999999 5556689999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.056 Score=56.74 Aligned_cols=34 Identities=26% Similarity=0.344 Sum_probs=25.6
Q ss_pred cCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 187 ~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.++||+|+++.||+++.++.....=|+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999996433222334999998765
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.024 Score=52.07 Aligned_cols=61 Identities=18% Similarity=0.165 Sum_probs=43.9
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHHcCCEeecCCCCceEeec
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY-CHSMGVMHRDLKPENFLFSS 203 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~-lH~~~ivH~Dlkp~NIl~~~ 203 (350)
...++-+|..|.++..+++... .+++....++.-...|+-- |---+++|.|+.|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 3457777888989988887653 3556666666666665433 44568999999999999964
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.079 Score=45.04 Aligned_cols=75 Identities=15% Similarity=0.241 Sum_probs=53.2
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccC--CCCeeEeEeEEEcCCceEEEEecC
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG--HRNIVELKGAYEDRHSVNLIMDLC 150 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--h~~iv~~~~~~~~~~~~~iv~e~~ 150 (350)
+.+..|.-...|...+. ..++-||+- ..+....+..|+.-|..+.. .-.+.+++.+..+.++.|+|+||+
T Consensus 22 ~~v~gG~inea~~v~dg--~~~~FvK~n------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 22 EEVSGGDINEAWRLRDG--TDPFFVKCN------QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cccCCccccceeEeecC--CcceEEEec------chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 45666666667766554 356888875 33345678889888887762 245778888888999999999999
Q ss_pred CCCCH
Q 018786 151 AGGEL 155 (350)
Q Consensus 151 ~~~sL 155 (350)
+-+.+
T Consensus 94 ~~~~~ 98 (286)
T COG3001 94 PTGPL 98 (286)
T ss_pred cCCCC
Confidence 76443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 350 | ||||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-57 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-57 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-56 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-56 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-56 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-56 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-55 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-55 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-55 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-55 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-55 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-55 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-54 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-53 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-53 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-52 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-52 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-52 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-52 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-51 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-51 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-51 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-51 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-51 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-51 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-50 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-50 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-49 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-49 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-48 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-48 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-48 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-48 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-48 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-48 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-48 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-48 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-48 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-48 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-48 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-47 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-47 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-47 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-47 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-47 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-47 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-47 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-47 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-45 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-44 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-44 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-44 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-44 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-44 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-44 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-43 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-43 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-43 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-43 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-43 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-43 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-43 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-43 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-43 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-43 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-43 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-42 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-42 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-42 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-42 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-41 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-40 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-40 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-40 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-37 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-37 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-36 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-36 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-36 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-36 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-36 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-36 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-36 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-36 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-36 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-36 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-36 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-36 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-35 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-35 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-35 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-35 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-35 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-35 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-34 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-34 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-34 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-34 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-34 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-34 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-34 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-34 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-34 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-34 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-34 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-34 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-34 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-34 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-34 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-34 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-34 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-34 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-34 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-34 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-34 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-34 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-34 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-34 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-34 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-34 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-34 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-34 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-34 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-34 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-34 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-34 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-34 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-34 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-33 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-33 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-33 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-33 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-33 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-33 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-33 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-33 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-33 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-33 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-33 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-33 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-33 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-33 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-33 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-33 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-33 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-33 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-33 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-33 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-33 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-33 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-33 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-33 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-33 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-33 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-32 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-32 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-32 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-32 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-32 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-32 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-32 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-32 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-32 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-32 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-32 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-32 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-32 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-32 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-32 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-32 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-32 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-32 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-32 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-32 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-32 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-32 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-32 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-32 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-31 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-31 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-31 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-31 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-31 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-31 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-31 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-31 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-31 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-31 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-31 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-31 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-31 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-31 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-31 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-31 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-31 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-31 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-31 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-31 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-31 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-31 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-31 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-31 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-31 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-31 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-31 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-31 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-31 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-31 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-31 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-31 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-31 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-31 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-31 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-31 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-31 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-30 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-30 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-30 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-30 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-30 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-30 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-30 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-30 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-30 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-30 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-30 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-30 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-30 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-30 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-30 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-30 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-30 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-30 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-30 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-30 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-30 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-30 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-30 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-30 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-30 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-30 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-29 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-29 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-29 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-29 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-29 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-29 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-29 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-29 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-29 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-29 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-29 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-29 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-29 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-29 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-29 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-29 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-29 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-29 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-29 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-29 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-29 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-29 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-29 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-29 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-29 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-29 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-28 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-28 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-28 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-28 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-28 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-28 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-28 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-28 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-28 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-28 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-28 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-27 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-27 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-27 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-27 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-27 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-26 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-26 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-26 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-26 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-26 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-26 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-25 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-25 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-25 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-25 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-25 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-25 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-25 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-25 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-25 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-24 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-24 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-24 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-24 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-24 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-24 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-24 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-23 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-23 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-23 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-23 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-22 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-22 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-22 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-22 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-22 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-22 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-21 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-21 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-21 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-21 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-21 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-21 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-21 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-21 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-21 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-21 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-21 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-21 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-21 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-21 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-21 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-21 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-21 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-21 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-21 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-21 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-20 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-20 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-20 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-20 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-20 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-20 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-20 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-20 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-20 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-19 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-19 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-19 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-19 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-18 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-18 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-17 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-17 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-17 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-17 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-17 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-17 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-17 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-17 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-17 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-17 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-17 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-16 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-16 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-16 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-16 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-16 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-16 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-16 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-16 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-16 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-16 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-15 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-14 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-14 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-14 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-14 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-14 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-14 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-13 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-13 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-13 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-13 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-13 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-13 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-13 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-13 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-13 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-13 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-13 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-13 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-13 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-13 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-13 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-13 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-13 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-13 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-13 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-13 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-13 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-13 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-11 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 7e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-11 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 8e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 9e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 9e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 4e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 8e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-06 |
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 484 bits (1248), Expect = e-173
Identities = 102/285 (35%), Positives = 157/285 (55%), Gaps = 3/285 (1%)
Query: 40 PRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKS 99
P +S + + Y ELG+G F V HK T +FA K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 100 ISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI 159
I+++KL RD + + RE +I L H NIV L + ++ L+ DL GGELF+ I
Sbjct: 62 INTKKLSARD-FQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 119
Query: 160 IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219
+A+ YSE A++ +Q++ + YCHS G++HR+LKPEN L +S A+ + +K DFGL++
Sbjct: 120 VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 220 FFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIF 278
+ + G+ Y++PEVL+++ Y DIW+ GVILYILL G PPFW E + ++
Sbjct: 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 239
Query: 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
I G D+ S W ++ AK ++ ML +PK+R++A + L
Sbjct: 240 AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 480 bits (1238), Expect = e-173
Identities = 104/265 (39%), Positives = 157/265 (59%), Gaps = 4/265 (1%)
Query: 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREV 118
G D+ Y +GRG +G + K T+ + A K I + +DV+ ++E+
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEI 57
Query: 119 QIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMV 178
+IM L H NI+ L +ED + L+M+LC GGELF+R++ K + E AA + + ++
Sbjct: 58 EIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVA 238
+ V YCH + V HRDLKPENFLF + + DSPLK DFGL+ FKPG + + VG+ YYV+
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 239 PEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
P+VL YG E D WSAGV++Y+LL G PPF T+ + I G F W N+S
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236
Query: 299 SAKDIVKKMLHADPKERLSAAEVLS 323
A+ +++++L PK+R+++ + L
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALE 261
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 479 bits (1235), Expect = e-172
Identities = 106/261 (40%), Positives = 148/261 (56%), Gaps = 2/261 (0%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
Y LG+G FG + T+Q++A K I+ N+D + REV+++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLK 76
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
L H NI++L ED S ++ +L GGELFD II + +SE AA + +Q+ + +
Sbjct: 77 KLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
Y H ++HRDLKPEN L S +D +K DFGLS F+ KD +G+AYY+APEVL
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 243 RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302
R Y + D+WSAGVILYILLSG PPF+G+ E I + G F W IS AKD
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 303 IVKKMLHADPKERLSAAEVLS 323
+++KML P R++A + L
Sbjct: 256 LIRKMLTFHPSLRITATQCLE 276
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 486 bits (1254), Expect = e-172
Identities = 115/287 (40%), Positives = 161/287 (56%), Gaps = 7/287 (2%)
Query: 37 PGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFA 96
PG AT G + + Y R LG+G FG L K T Q+ A
Sbjct: 2 PGSMMDHLHATP------GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECA 55
Query: 97 CKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELF 156
K IS R++ + D E + REVQ++ L H NI++L +ED+ L+ ++ GGELF
Sbjct: 56 VKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 114
Query: 157 DRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216
D II++ +SE AA + RQ+++ + Y H ++HRDLKPEN L S ++D+ ++ DFG
Sbjct: 115 DEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 174
Query: 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQS 276
LS F+ KD +G+AYY+APEVL Y + D+WS GVILYILLSG PPF G E
Sbjct: 175 LSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYD 234
Query: 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
I + +G F W +S SAKD+++KML P R+SA + L
Sbjct: 235 ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 479 bits (1236), Expect = e-171
Identities = 95/327 (29%), Positives = 154/327 (47%), Gaps = 15/327 (4%)
Query: 9 SSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNT 68
+ + S DP K++ P + + ++
Sbjct: 36 QRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQK 95
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-----RDDVEDVRREVQIMHH 123
Y +GRG V H+ T +FA K + + E RRE I+
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
+ GH +I+ L +YE + L+ DL GELFD + K SE+ ++ R ++ V +
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR 243
H+ ++HRDLKPEN L ++ ++ +DFG S +PG+ ++L G+ Y+APE+L+
Sbjct: 216 LHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272
Query: 244 -------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296
YG E D+W+ GVIL+ LL+G PPFW + + I+ G FSS W +
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332
Query: 297 SSSAKDIVKKMLHADPKERLSAAEVLS 323
SS+ KD++ ++L DP+ RL+A + L
Sbjct: 333 SSTVKDLISRLLQVDPEARLTAEQALQ 359
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 474 bits (1223), Expect = e-170
Identities = 100/262 (38%), Positives = 153/262 (58%), Gaps = 3/262 (1%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ Y ELG+G F V HK T +FA K I+++KL RD + + RE +I
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICR 60
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
L H NIV L + ++ L+ DL GGELF+ I+A+ YSE A++ +Q++ +
Sbjct: 61 KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
YCHS G++HR+LKPEN L +S A+ + +K DFGL++ + + G+ Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 243 RRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
+++ Y DIW+ GVILYILL G PPFW E + ++ I G D+ S W ++ AK
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 302 DIVKKMLHADPKERLSAAEVLS 323
++ ML +PK+R++A + L
Sbjct: 240 SLIDSMLTVNPKKRITADQALK 261
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 482 bits (1242), Expect = e-170
Identities = 106/261 (40%), Positives = 148/261 (56%), Gaps = 2/261 (0%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
Y LG+G FG + T+Q++A K I+ N+D + REV+++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLK 76
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
L H NI++L ED S ++ +L GGELFD II + +SE AA + +Q+ + +
Sbjct: 77 KL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
Y H ++HRDLKPEN L S +D +K DFGLS F+ KD +G+AYY+APEVL
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 243 RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302
R Y + D+WSAGVILYILLSG PPF+G+ E I + G F W IS AKD
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 303 IVKKMLHADPKERLSAAEVLS 323
+++KML P R++A + L
Sbjct: 256 LIRKMLTFHPSLRITATQCLE 276
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 482 bits (1243), Expect = e-170
Identities = 97/298 (32%), Positives = 154/298 (51%), Gaps = 11/298 (3%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
+ + + G + K + +Y R+LG G +G L K+ +
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64
Query: 96 ACKSISSRKLIN----------RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145
A K I + E++ E+ ++ L H NI++L +ED+ L
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKYFYL 123
Query: 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205
+ + GGELF++II + + E AAN+ +Q+++ + Y H ++HRD+KPEN L +
Sbjct: 124 VTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN 183
Query: 206 EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSG 265
+K DFGLS FF +D +G+AYY+APEVL++ Y + D+WS GVI+YILL G
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCG 243
Query: 266 VPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
PPF G+ +Q I + +G F + W NIS AK+++K ML D +R +A E L+
Sbjct: 244 YPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 478 bits (1233), Expect = e-169
Identities = 104/287 (36%), Positives = 159/287 (55%), Gaps = 2/287 (0%)
Query: 37 PGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFA 96
R + ++ G + + Y ++LG G +G L K T + A
Sbjct: 7 HSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERA 66
Query: 97 CKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELF 156
K I + + + EV ++ L H NI++L +ED+ + L+M+ GGELF
Sbjct: 67 IKIIRKTSVSTSSN-SKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124
Query: 157 DRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216
D II + ++E AA + +Q+++ V Y H ++HRDLKPEN L S +D+ +K DFG
Sbjct: 125 DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQS 276
LS F+ K+ +G+AYY+APEVLR+ Y + D+WS GVIL+ILL+G PPF G+T+Q
Sbjct: 185 LSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244
Query: 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
I + +G F S W N+S AKD++K+ML D + R+SA + L
Sbjct: 245 ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 472 bits (1218), Expect = e-168
Identities = 110/297 (37%), Positives = 168/297 (56%), Gaps = 8/297 (2%)
Query: 29 PNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTH 88
L S++ +A+ + G + + + + ELGRG + Y
Sbjct: 15 TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQ 74
Query: 89 KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148
K T++ +A K + D + VR E+ ++ L+ H NI++LK +E ++L+++
Sbjct: 75 KGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLE 128
Query: 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208
L GGELFDRI+ KG+YSER AA+ +Q++ V Y H G++HRDLKPEN L+++ A D+
Sbjct: 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA 188
Query: 209 PLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVP 267
PLK DFGLS + + K + G+ Y APE+LR YG E D+WS G+I YILL G
Sbjct: 189 PLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE 248
Query: 268 PFWGET-EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
PF+ E +Q +F IL F S W +S +AKD+V+K++ DPK+RL+ + L
Sbjct: 249 PFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 471 bits (1215), Expect = e-168
Identities = 81/280 (28%), Positives = 144/280 (51%), Gaps = 5/280 (1%)
Query: 48 SATSSSVGRVLGKPMEDVRNTY-IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI 106
S + + ME+ N Y + +ELGRG+F V K T Q++A K + R+
Sbjct: 9 SGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR- 67
Query: 107 NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK--GH 164
+D ++ E+ ++ ++ L YE+ + LI++ AGGE+F + +
Sbjct: 68 GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM 127
Query: 165 YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
SE L +Q++ V+Y H ++H DLKP+N L SS +K DFG+S
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 225 DVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR 283
++++G+ Y+APE+L + D+W+ G+I Y+LL+ PF GE Q + I +
Sbjct: 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
Query: 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
++D+S + + ++S A D ++ +L +P++R +A LS
Sbjct: 248 VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 470 bits (1211), Expect = e-167
Identities = 98/288 (34%), Positives = 157/288 (54%), Gaps = 12/288 (4%)
Query: 46 ATSATSSSVGRVLGKPMEDV--RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSR 103
+ S G +L +DV + Y +G+G F V +++T QQFA K +
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 104 KLINRD--DVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA 161
K + ED++RE I H L H +IVEL Y + ++ + G +L I+
Sbjct: 61 KFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK 119
Query: 162 KGH----YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217
+ YSE A++ RQ++ + YCH ++HRD+KP L +S +P+K FG+
Sbjct: 120 RADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179
Query: 218 SV-FFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQ 275
++ + G V VG+ +++APEV++R YG D+W GVIL+ILLSG PF+G T++
Sbjct: 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKE 238
Query: 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+F+ I++G + W +IS SAKD+V++ML DP ER++ E L+
Sbjct: 239 RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 467 bits (1205), Expect = e-167
Identities = 100/266 (37%), Positives = 150/266 (56%), Gaps = 6/266 (2%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQ 119
E+V + Y G ELG GQF V K T Q+A K I R+ + ED+ REV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
I+ + H N++ L YE++ V LI++L AGGELFD + K +E A +Q++
Sbjct: 67 ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 180 VVHYCHSMGVMHRDLKPENFLFSS-SAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVA 238
V+Y HS+ + H DLKPEN + + +K DFGL+ G+ FK++ G+ +VA
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 239 PEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
PE++ G EAD+WS GVI YILLSG PF G+T+Q + + +F + + N S
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLS 323
+ AKD ++++L DPK+R++ + L
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQ 271
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 466 bits (1201), Expect = e-167
Identities = 96/275 (34%), Positives = 159/275 (57%), Gaps = 8/275 (2%)
Query: 53 SVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE 112
S GR + + +IF R+LG G FG +LV + + + K+I+ + + +E
Sbjct: 8 SSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPME 65
Query: 113 DVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK----GHYSER 168
+ E++++ L H NI+++ +ED H++ ++M+ C GGEL +RI++ SE
Sbjct: 66 QIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 169 AAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK 228
A L +QM+ + Y HS V+H+DLKPEN LF ++ SP+K DFGL+ FK +
Sbjct: 125 YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 229 DLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288
+ G+A Y+APEV +R+ + DIWSAGV++Y LL+G PF G + + + ++
Sbjct: 185 NAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY 244
Query: 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ + P ++ A D++K+ML DP+ R SAA+VL
Sbjct: 245 AVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLH 278
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 472 bits (1216), Expect = e-167
Identities = 101/265 (38%), Positives = 151/265 (56%), Gaps = 4/265 (1%)
Query: 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
Y ELG+G F V Q++A I+++KL + D + + RE +I
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARI 63
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
L H NIV L + + LI DL GGELF+ I+A+ +YSE A++ +Q++
Sbjct: 64 CRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAP 239
V +CH MGV+HR+LKPEN L +S + + +K DFGL++ + + G+ Y++P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
Query: 240 EVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
EVLR++ YG D+W+ GVILYILL G PPFW E + ++ I G DF S W ++
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 299 SAKDIVKKMLHADPKERLSAAEVLS 323
AKD++ KML +P +R++AAE L
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALK 267
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 463 bits (1195), Expect = e-166
Identities = 100/265 (37%), Positives = 150/265 (56%), Gaps = 6/265 (2%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD---DVEDVRREVQI 120
V + Y G ELG GQF + K T +++A K I R+L + E++ REV I
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
+ + H NI+ L +E++ V LI++L +GGELFD + K +E A +Q++
Sbjct: 62 LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 181 VHYCHSMGVMHRDLKPENFLFSS-SAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
VHY HS + H DLKPEN + + + +K DFG++ + G+ FK++ G+ +VAP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 240 EVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
E++ G EAD+WS GVI YILLSG PF GET+Q I + DF + + N S
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240
Query: 299 SAKDIVKKMLHADPKERLSAAEVLS 323
AKD ++++L DPK R++ A+ L
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLE 265
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 459 bits (1184), Expect = e-164
Identities = 93/278 (33%), Positives = 140/278 (50%), Gaps = 16/278 (5%)
Query: 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN------RDDVE 112
Y LGRG V HK T +++A K I + ++ E
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 113 DVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAAN 172
+EV I+ ++GH NI++LK YE L+ DL GELFD + K SE+
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232
+ R ++ V+ H + ++HRDLKPEN L +D +K TDFG S PG+ +++ G
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCG 185
Query: 233 SAYYVAPEVLR-------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285
+ Y+APE++ YG E D+WS GVI+Y LL+G PPFW + + I+ G+
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245
Query: 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
F S W + S + KD+V + L P++R +A E L+
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 458 bits (1181), Expect = e-163
Identities = 77/263 (29%), Positives = 138/263 (52%), Gaps = 8/263 (3%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+++ Y+ +LGRG+FG+ + +K+ + K + + D V++E+ I++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVV 181
HRNI+ L ++E + +I + +G ++F+RI +ER + Q+ +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
+ HS + H D++PEN ++ + S +K +FG + KPGD F+ L + Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ + D+WS G ++Y+LLSG+ PF ET Q I + I+ F + + IS A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 301 KDIVKKMLHADPKERLSAAEVLS 323
D V ++L + K R++A+E L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQ 257
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 457 bits (1177), Expect = e-163
Identities = 98/266 (36%), Positives = 145/266 (54%), Gaps = 6/266 (2%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQ 119
+ V + Y G ELG GQF + K T ++A K I R+ E++ REV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
I+ + H N++ L YE+R V LI++L +GGELFD + K SE A + +Q++
Sbjct: 68 ILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSP-LKATDFGLSVFFKPGDVFKDLVGSAYYVA 238
V+Y H+ + H DLKPEN + P +K DFGL+ + G FK++ G+ +VA
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 239 PEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
PE++ G EAD+WS GVI YILLSG PF G+T+Q I DF + + + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLS 323
AKD ++K+L + ++RL+ E L
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALR 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 458 bits (1180), Expect = e-162
Identities = 93/328 (28%), Positives = 150/328 (45%), Gaps = 19/328 (5%)
Query: 7 LPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVR 66
L +SQ Q P P PP P P + K +
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ + + LG G G + +K T+++FA K + D RREV++ +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQ 113
Query: 127 HRNIVELKGAYED----RHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTV 180
+IV + YE+ R + ++M+ GGELF RI +G ++ER A+ + + +
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 240
+ Y HS+ + HRD+KPEN L++S ++ LK TDFG + + + YYVAPE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 241 VL-RRNYGAEADIWSAGVILYILLSGVPPFWGE----TEQSIFDAILRGHIDFSSDPWPN 295
VL Y D+WS GVI+YILL G PPF+ + I G +F + W
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLS 323
+S K +++ +L +P +R++ E ++
Sbjct: 294 VSEEVKMLIRNLLKTEPTQRMTITEFMN 321
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 455 bits (1172), Expect = e-162
Identities = 97/278 (34%), Positives = 144/278 (51%), Gaps = 13/278 (4%)
Query: 51 SSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD 110
S+ + L + + Y ++G G + V HK T +FA K I K
Sbjct: 6 VHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------ 59
Query: 111 VEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAA 170
D E++I+ H NI+ LK Y+D V ++ +L GGEL D+I+ + +SER A
Sbjct: 60 -RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA 118
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED-SPLKATDFGLSVFFKPGD-VFK 228
+ + + V Y H+ GV+HRDLKP N L+ + + ++ DFG + + + +
Sbjct: 119 SAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 229 DLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWG---ETEQSIFDAILRG 284
+A +VAPEVL R Y A DIWS GV+LY +L+G PF +T + I I G
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG 238
Query: 285 HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
S W ++S +AKD+V KMLH DP +RL+AA VL
Sbjct: 239 KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 452 bits (1165), Expect = e-161
Identities = 107/262 (40%), Positives = 151/262 (57%), Gaps = 6/262 (2%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
++R T+IF LG G F +LV + T + FA K I +E E+ ++
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLK 61
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
+ H NIV L+ YE L+M L +GGELFDRI+ +G Y+E+ A+ + +Q+++ V
Sbjct: 62 KIK-HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVK 120
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
Y H G++HRDLKPEN L+ + E+S + TDFGLS + G + G+ YVAPEVL
Sbjct: 121 YLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVL 179
Query: 243 RRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
+ Y D WS GVI YILL G PPF+ ETE +F+ I G+ +F S W +IS SAK
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239
Query: 302 DIVKKMLHADPKERLSAAEVLS 323
D + +L DP ER + + LS
Sbjct: 240 DFICHLLEKDPNERYTCEKALS 261
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 454 bits (1169), Expect = e-161
Identities = 99/266 (37%), Positives = 144/266 (54%), Gaps = 6/266 (2%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD---DVEDVRREVQ 119
+ V + Y G ELG GQF + K T ++A K I R+ E++ REV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
I+ + H NI+ L YE+R V LI++L +GGELFD + K SE A + +Q++
Sbjct: 68 ILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSP-LKATDFGLSVFFKPGDVFKDLVGSAYYVA 238
V+Y H+ + H DLKPEN + P +K DFGL+ + G FK++ G+ +VA
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 239 PEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
PE++ G EAD+WS GVI YILLSG PF G+T+Q I DF + + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLS 323
AKD ++K+L + ++RL+ E L
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALR 272
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 452 bits (1164), Expect = e-161
Identities = 94/272 (34%), Positives = 140/272 (51%), Gaps = 15/272 (5%)
Query: 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ 119
P + + + LG G F + HK + Q FA K IS R + ++E+
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEIT 57
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
+ GH NIV+L + D+ L+M+L GGELF+RI K H+SE A+ + R++V+
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLVGSAYYVA 238
V + H +GV+HRDLKPEN LF+ ++ +K DFG + P K + +Y A
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 239 PEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQS-------IFDAILRGHIDFSS 290
PE+L +N Y D+WS GVILY +LSG PF I I +G F
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
Query: 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
+ W N+S AKD+++ +L DP +RL + +
Sbjct: 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 447 bits (1153), Expect = e-159
Identities = 92/289 (31%), Positives = 139/289 (48%), Gaps = 33/289 (11%)
Query: 64 DVRNTYIFGRE-LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ Y + LG G + T Q++A K I + V REV++++
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLY 65
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
GHRN++EL +E+ L+ + GG + I + H++E A+ + + + + +
Sbjct: 66 QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD 125
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL--------VGSA 234
+ H+ G+ HRDLKPEN L + SP+K DF L K + GSA
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 235 YYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGE---------------T 273
Y+APEV+ Y D+WS GVILYILLSG PPF G
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245
Query: 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
+ +F++I G +F W +IS +AKD++ K+L D K+RLSAA+VL
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 443 bits (1140), Expect = e-156
Identities = 92/299 (30%), Positives = 148/299 (49%), Gaps = 7/299 (2%)
Query: 27 HHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLV 86
K D P V + + V + Y ELG G FGV +
Sbjct: 11 GSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRC 70
Query: 87 THKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146
K T + F K I++ + D V+ E+ IM+ L H ++ L A+ED++ + LI
Sbjct: 71 VEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLI 126
Query: 147 MDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205
++ +GGELFDRI A+ + SE N RQ + + H ++H D+KPEN + +
Sbjct: 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK- 185
Query: 206 EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLS 264
+ S +K DFGL+ P ++ K +A + APE++ R G D+W+ GV+ Y+LLS
Sbjct: 186 KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
Query: 265 GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
G+ PF GE + + R +F D + ++S AKD +K +L +P++RL+ + L
Sbjct: 246 GLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 439 bits (1131), Expect = e-156
Identities = 99/270 (36%), Positives = 139/270 (51%), Gaps = 12/270 (4%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-----NRDDVEDVRRE 117
+ +R+ YI + LG G G L + T ++ A K IS RK D +V E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
++I+ L H I+++K ++ ++++L GGELFD+++ E QM
Sbjct: 66 IEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
+ V Y H G++HRDLKPEN L SS ED +K TDFG S + + L G+ Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 238 APEVL----RRNYGAEADIWSAGVILYILLSGVPPFWGE-TEQSIFDAILRGHIDFSSDP 292
APEVL Y D WS GVIL+I LSG PPF T+ S+ D I G +F +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVL 322
W +S A D+VKK+L DPK R + E L
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEAL 273
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 441 bits (1136), Expect = e-156
Identities = 94/320 (29%), Positives = 159/320 (49%), Gaps = 19/320 (5%)
Query: 8 PSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRN 67
+ + ++ + + L +D P PP P R++ V +
Sbjct: 38 EAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDH----------RIVTAKQGAVNS 87
Query: 68 TYIFGR--ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
Y + LG G+FG + T + A K I +R + D E+V+ E+ +M+ L
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQL- 143
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYC 184
H N+++L A+E ++ + L+M+ GGELFDRII + + +E +Q+ + +
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
H M ++H DLKPEN L + + +K DFGL+ +KP + K G+ ++APEV+
Sbjct: 204 HQMYILHLDLKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY 262
Query: 245 N-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303
+ D+WS GVI Y+LLSG+ PF G+ + + IL D + + +IS AK+
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF 322
Query: 304 VKKMLHADPKERLSAAEVLS 323
+ K+L + R+SA+E L
Sbjct: 323 ISKLLIKEKSWRISASEALK 342
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 443 bits (1142), Expect = e-154
Identities = 95/323 (29%), Positives = 144/323 (44%), Gaps = 12/323 (3%)
Query: 8 PSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVG-----RVLGKPM 62
P T D + + SS + + +
Sbjct: 93 PCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH 152
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ V + Y ELG G FGV + VT + T FA K + + D E VR+E+Q M
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMS 209
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVV 181
L H +V L A+ED + + +I + +GGELF+++ + SE A RQ+ +
Sbjct: 210 VLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 268
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
+ H +H DLKPEN +F++ + LK DFGL+ P K G+A + APEV
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ G D+WS GV+ YILLSG+ PF GE + + + + IS
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387
Query: 301 KDIVKKMLHADPKERLSAAEVLS 323
KD ++K+L ADP R++ + L
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALE 410
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 432 bits (1114), Expect = e-153
Identities = 94/288 (32%), Positives = 141/288 (48%), Gaps = 21/288 (7%)
Query: 48 SATSSSVGRVLGKPMEDVRNTYIFGRE-LGRGQFGVTYLVTHKDTKQQFACKSISSRKLI 106
S+ + + V + Y ++ LG G G H+ T Q+ A K +
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL------ 62
Query: 107 NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH----SVNLIMDLCAGGELFDRIIAK 162
D R+EV +G +IV + YE+ H + +IM+ GGELF RI +
Sbjct: 63 --YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER 120
Query: 163 GH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220
G ++ER AA + R + T + + HS + HRD+KPEN L++S +D+ LK TDFG +
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 221 FKPGDVFKDLVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQ---- 275
+ + YYVAPEVL Y D+WS GVI+YILL G PPF+ T Q
Sbjct: 181 TTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239
Query: 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ I G F + W +S AK +++ +L DP ERL+ + ++
Sbjct: 240 GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 425 bits (1095), Expect = e-149
Identities = 98/270 (36%), Positives = 139/270 (51%), Gaps = 12/270 (4%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-----DDVEDVRRE 117
+ +R+ YI + LG G G L + T ++ A + IS RK D +V E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
++I+ L H I+++K ++ ++++L GGELFD+++ E QM
Sbjct: 191 IEILKKLN-HPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
+ V Y H G++HRDLKPEN L SS ED +K TDFG S + + L G+ Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 238 APEVL----RRNYGAEADIWSAGVILYILLSGVPPFWGE-TEQSIFDAILRGHIDFSSDP 292
APEVL Y D WS GVIL+I LSG PPF T+ S+ D I G +F +
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVL 322
W +S A D+VKK+L DPK R + E L
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEAL 398
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-147
Identities = 93/326 (28%), Positives = 149/326 (45%), Gaps = 52/326 (15%)
Query: 48 SATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL-- 105
++ G + +++ Y +G+G +GV + T+ A K ++ K+
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66
Query: 106 INRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH- 164
IN DVE ++ EV++M L H NI L YED + L+M+LC GG L D++
Sbjct: 67 INPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 165 ---------------------------------------YSERAAANLCRQMVTVVHYCH 185
E+ +N+ RQ+ + +HY H
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-----VFKDLVGSAYYVAPE 240
+ G+ HRD+KPENFLFS++ + +K DFGLS F + G+ Y+VAPE
Sbjct: 186 NQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
Query: 241 VLR---RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
VL +YG + D WSAGV+L++LL G PF G + +L + F + + +S
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLS 304
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLS 323
A+D++ +L+ + ER A L
Sbjct: 305 PLARDLLSNLLNRNVDERFDAMRALQ 330
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 416 bits (1072), Expect = e-147
Identities = 77/274 (28%), Positives = 129/274 (47%), Gaps = 38/274 (13%)
Query: 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ 119
K + + + + LG G G + +K T+++FA K + D RREV+
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 62
Query: 120 IMHHLTGHRNIVELKGAYED----RHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANL 173
+ + +IV + YE+ R + ++M+ GGELF RI +G ++ER A+ +
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
+ + + Y HS+ + HRD+KPEN L++S ++ LK TDFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166
Query: 234 AYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGE----TEQSIFDAILRGHIDFS 289
A E Y D+WS GVI+YILL G PPF+ + I G +F
Sbjct: 167 ----AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222
Query: 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ W +S K +++ +L +P +R++ E ++
Sbjct: 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = e-101
Identities = 76/312 (24%), Positives = 127/312 (40%), Gaps = 29/312 (9%)
Query: 41 RPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSI 100
PS + ++GK ++ LG G G + A K I
Sbjct: 4 SPSLEQDDGDEETSVVIVGK------ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRI 56
Query: 101 SSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRII 160
+ REVQ++ H N++ +DR + ++LC L + +
Sbjct: 57 ------LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVE 109
Query: 161 AKGH-YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA--TDFGL 217
K + L +Q + + + HS+ ++HRDLKP N L S +KA +DFGL
Sbjct: 110 QKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169
Query: 218 SVFFKPGD----VFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLS-GVPP 268
G + G+ ++APE+L N DI+SAG + Y ++S G P
Sbjct: 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229
Query: 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSK--FL 326
F ++ + +D P + A+++++KM+ DP++R SA VL F
Sbjct: 230 FGKSLQRQANILLGACSLDCLH-PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288
Query: 327 IPKKTLQTLADL 338
+K LQ D+
Sbjct: 289 SLEKQLQFFQDV 300
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = e-101
Identities = 72/319 (22%), Positives = 129/319 (40%), Gaps = 46/319 (14%)
Query: 56 RVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR 115
+ + ++N + + LG G G + A K + D +
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRM------LIDFCDIAL 56
Query: 116 REVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERA------ 169
E++++ H N++ + + + ++LC L D + +K E
Sbjct: 57 MEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEY 115
Query: 170 -AANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS----------AEDSPLKATDFGLS 218
+L RQ+ + V + HS+ ++HRDLKP+N L S+S AE+ + +DFGL
Sbjct: 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 219 VFFKPGDV-----FKDLVGSAYYVAPEVLR--------RNYGAEADIWSAGVILYILLS- 264
G + G++ + APE+L R DI+S G + Y +LS
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 265 GVPPFWGETEQSIFDAILRGHIDFS---SDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
G PF + + I+RG ++ + A D++ +M+ DP +R +A +V
Sbjct: 236 GKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
Query: 322 LSK--FLIPKKTLQTLADL 338
L F K L+ L +
Sbjct: 294 LRHPLFWPKSKKLEFLLKV 312
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 3e-93
Identities = 72/296 (24%), Positives = 123/296 (41%), Gaps = 41/296 (13%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+ + LG+G FG + + +A K I + + + + EV ++ L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLN 60
Query: 126 GHRNIVELKGAYEDRHSVN-------------LIMDLCAGGELFDRIIAKGHYSER-AAA 171
H+ +V A+ +R + + M+ C G L+D I ++ +R
Sbjct: 61 -HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK--------- 222
L RQ++ + Y HS G++HRDLKP N E +K DFGL+
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 223 ------PGDVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE 274
D +G+A YVA EVL +Y + D++S G+I + ++ P G
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMER 234
Query: 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330
+I + I+F D N K I++ ++ DP +R A +L+ +P K
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 3e-92
Identities = 68/295 (23%), Positives = 120/295 (40%), Gaps = 43/295 (14%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
++ LG+G + HK T FA K ++ V+ RE +++ L H+
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HK 67
Query: 129 NIVELKGAYEDRHSVN--LIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVTVVHY 183
NIV+L E+ + + LIM+ C G L+ + + E + R +V +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 184 CHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
G++HR++KP N + S K TDFG + + + F L G+ Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 243 RR---------NYGAEADIWSAGVILYILLSGVPPFW----GETEQSIFDAILRG----- 284
R YGA D+WS GV Y +G PF + + I+ G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 285 ----------HIDFSSD--PWPNISSSAKDIVK----KMLHADPKERLSAAEVLS 323
ID+S D ++S + ++ +L AD ++ + +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 3e-90
Identities = 92/302 (30%), Positives = 142/302 (47%), Gaps = 13/302 (4%)
Query: 24 GPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVT 83
GP + K PG P + A + + + VL P R Y+ GR LG+G F
Sbjct: 1 GP-APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRS--RRRYVRGRFLGKGGFAKC 57
Query: 84 YLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143
+ ++ DTK+ FA K + L+ E + E+ I L H+++V G +ED V
Sbjct: 58 FEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFV 116
Query: 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS 203
++++LC L + + +E A RQ+V Y H V+HRDLK N +
Sbjct: 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE 176
Query: 204 SAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLRRN-YGAEADIWSAGVILYI 261
E +K DFGL+ + K L G+ Y+APEVL + + E D+WS G I+Y
Sbjct: 177 DLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 233
Query: 262 LLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
LL G PPF + + I + ++S I+ A +++KML DP R + E+
Sbjct: 234 LLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLIQKMLQTDPTARPTINEL 289
Query: 322 LS 323
L+
Sbjct: 290 LN 291
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 272 bits (696), Expect = 4e-89
Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 43/295 (14%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
++ LG+G + HK T FA K ++ + V+ RE +++ L H+
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLN-HK 67
Query: 129 NIVELKGAYEDRHSVN--LIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVTVVHY 183
NIV+L E+ + + LIM+ C G L+ + + E + R +V +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 184 CHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
G++HR++KP N + S K TDFG + + + F L G+ Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 243 RRN---------YGAEADIWSAGVILYILLSGVPPFW----GETEQSIFDAILRG----- 284
R YGA D+WS GV Y +G PF + + I+ G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 285 ----------HIDFSSD--PWPNISSSAKDIVK----KMLHADPKERLSAAEVLS 323
ID+S D ++S + ++ +L AD ++ + +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 265 bits (681), Expect = 3e-88
Identities = 81/278 (29%), Positives = 140/278 (50%), Gaps = 19/278 (6%)
Query: 49 ATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR 108
+ ++ +G + + G LG+G F Y T + A K I + +
Sbjct: 1 SLATCIGEKIED--------FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKA 52
Query: 109 DDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSE 167
V+ V+ EV+I L H +I+EL +ED + V L++++C GE+ + + +SE
Sbjct: 53 GMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE 111
Query: 168 RAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
A + Q++T + Y HS G++HRDL N L + + +K DFGL+ K
Sbjct: 112 NEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEK 168
Query: 228 KD-LVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285
L G+ Y++PE+ R+ +G E+D+WS G + Y LL G PPF +T ++ + ++
Sbjct: 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD 228
Query: 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ P +S AKD++ ++L +P +RLS + VL
Sbjct: 229 YEM---P-SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 6e-88
Identities = 81/257 (31%), Positives = 125/257 (48%), Gaps = 10/257 (3%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y+ GR LG+G F + ++ DTK+ FA K + L+ E + E+ I L H+
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQ 75
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
++V G +ED V ++++LC L + + +E A RQ+V Y H
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLRRN-Y 246
V+HRDLK N + E +K DFGL+ + K L G+ Y+APEVL + +
Sbjct: 136 VIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306
E D+WS G I+Y LL G PPF + + I + P +I+ A +++K
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPVAASLIQK 248
Query: 307 MLHADPKERLSAAEVLS 323
ML DP R + E+L+
Sbjct: 249 MLQTDPTARPTINELLN 265
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 4e-86
Identities = 82/256 (32%), Positives = 129/256 (50%), Gaps = 10/256 (3%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ GR LG+G+FG YL K K A K + +L +RRE++I HL H
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HP 74
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
NI+ + + DR + L+++ GEL+ + G + E+ +A ++ +HYCH
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL-RRNYG 247
V+HRD+KPEN L E LK DFG SV P + + G+ Y+ PE++ + +
Sbjct: 135 VIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
+ D+W AGV+ Y L G+PPF + I+ + F P P +S +KD++ K+
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF---P-PFLSDGSKDLISKL 246
Query: 308 LHADPKERLSAAEVLS 323
L P +RL V+
Sbjct: 247 LRYHPPQRLPLKGVME 262
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 9e-86
Identities = 86/255 (33%), Positives = 126/255 (49%), Gaps = 10/255 (3%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ GR LG+G+FG YL K +K A K + +L +RREV+I HL H
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
NI+ L G + D V LI++ G ++ + + E+ A ++ + YCHS
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL-RRNYG 247
V+HRD+KPEN L LK DFG SV P DL G+ Y+ PE++ R +
Sbjct: 130 VIHRDIKPENLLLG---SAGELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
+ D+WS GV+ Y L G PPF T Q + I R F P ++ A+D++ ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEGARDLISRL 241
Query: 308 LHADPKERLSAAEVL 322
L +P +R EVL
Sbjct: 242 LKHNPSQRPMLREVL 256
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 5e-85
Identities = 70/306 (22%), Positives = 126/306 (41%), Gaps = 27/306 (8%)
Query: 43 SSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISS 102
+S + + M Y +++G G + V ++ KQ +A K ++
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN- 61
Query: 103 RKLINRDDVEDVRREVQIMHHLTGH-RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA 161
+ + ++ R E+ ++ L H I+ L + ++M+ C +L +
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 120
Query: 162 KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221
K + + M+ VH H G++H DLKP NFL D LK DFG++
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQM 176
Query: 222 KPGD---VFKDLVGSAYYVAPEVL------------RRNYGAEADIWSAGVILYILLSGV 266
+P V VG+ Y+ PE + + ++D+WS G ILY + G
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 267 PPFWGETEQ-SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS-K 324
PF Q S AI+ + + + +D++K L DPK+R+S E+L+
Sbjct: 237 TPFQQIINQISKLHAIIDPNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294
Query: 325 FLIPKK 330
++ +
Sbjct: 295 YVQIQT 300
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 5e-84
Identities = 70/309 (22%), Positives = 122/309 (39%), Gaps = 38/309 (12%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ LG G FG H+DT +Q A K R+ ++ + E E+QIM L H
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKLN-HP 72
Query: 129 NIVELKGAYEDRHSVN------LIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVT 179
N+V + + + L M+ C GG+L + + E L + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
+ Y H ++HRDLKPEN + + K D G + G++ + VG+ Y+AP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 240 EVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR--------------G 284
E+L + Y D WS G + + ++G PF + + +R G
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252
Query: 285 HIDFSSD--PWPNISSSAKDIVKK----MLHADPKERLSAAEVLSKFLIPKKTLQTLADL 338
+ FSS ++S +++ ML ++R + + Q L +
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP-----NVGCFQALDSI 307
Query: 339 LYSQIFARF 347
L ++ +
Sbjct: 308 LSLKLLSVM 316
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 258 bits (659), Expect = 6e-84
Identities = 47/295 (15%), Positives = 81/295 (27%), Gaps = 44/295 (14%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL--- 124
L G V +LV + + FA K + +R ++E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 125 --------------------TGHRNIVELKGAYEDRHSVN--LIMDLCAG------GELF 156
+L +D N L+M + L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 157 DRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216
+ +G A L Q++ + S G++H P+N D L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGDVS 239
Query: 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRRN---YGAEADIWSAGVILYILLSGVPPFWGET 273
K G Y E L + + + W G+ +Y + PF T
Sbjct: 240 ALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 274 EQSIFDAIL-----RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
G + + K ++ + L+ D + RL E +
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 1e-83
Identities = 90/257 (35%), Positives = 129/257 (50%), Gaps = 10/257 (3%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y+ G LG G FG + H+ T + A K ++ +K+ + D V ++RE+Q + H
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HP 71
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+I++L ++M+ +GGELFD I G E A L +Q+++ V YCH
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNY- 246
V+HRDLKPEN L K DFGLS G+ + GS Y APEV+ R Y
Sbjct: 132 VVHRDLKPENVLLD---AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306
G E DIWS GVILY LL G PF E ++F I G F + ++ S ++
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATLLMH 244
Query: 307 MLHADPKERLSAAEVLS 323
ML DP +R + ++
Sbjct: 245 MLQVDPLKRATIKDIRE 261
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 257 bits (657), Expect = 2e-83
Identities = 48/344 (13%), Positives = 98/344 (28%), Gaps = 67/344 (19%)
Query: 33 KIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVR---------NTYIFGRELGRGQFGVT 83
+I S SA S V L + R T + G LG+
Sbjct: 30 RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAY 89
Query: 84 YLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL------------------- 124
T ++T + F + + ++ ++ EV + L
Sbjct: 90 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149
Query: 125 -----TGHRNIVELKGAYEDRHSVN--LIMDLCA------GGELFDRIIAKGHYSERAAA 171
+ ++ ++ D ++ + G L A
Sbjct: 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 209
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
L Q++ ++ H G++H L+P + + + + T F V
Sbjct: 210 QLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFEHLV---RDGARVVSS 263
Query: 232 GSAYYVAPEVLRRN------------YGAEADIWSAGVILYILLSGVPPFWGETEQSIFD 279
S + PE+ R D W+ G+++Y + P + +
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE 323
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
I R NI + +++ L ++RL + +
Sbjct: 324 WIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-83
Identities = 68/274 (24%), Positives = 118/274 (43%), Gaps = 26/274 (9%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
Y +++G G + V ++ KQ +A K ++ + + ++ R E+ ++ L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN-LEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 127 H-RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH 185
H I+ L + ++M+ C +L + K + + M+ VH H
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVL 242
G++H DLKP NFL D LK DFG++ +P V VG+ Y+ PE +
Sbjct: 126 QHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 243 ------------RRNYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFS 289
+ ++D+WS G ILY + G PF Q S AI+ + +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI- 240
Query: 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ +D++K L DPK+R+S E+L+
Sbjct: 241 -EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 5e-83
Identities = 76/261 (29%), Positives = 131/261 (50%), Gaps = 14/261 (5%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ + LG G +G L ++ T++ A K + ++ + D E++++E+ I L H
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HE 65
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
N+V+ G + + L ++ C+GGELFDRI E A Q++ V Y H +G
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL---VGSAYYVAPEVL-RR 244
+ HRD+KPEN L E LK +DFGL+ F+ + + L G+ YVAPE+L RR
Sbjct: 126 ITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 245 NY-GAEADIWSAGVILYILLSGVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSSAKD 302
+ D+WS G++L +L+G P+ ++ + +PW I S+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLA 240
Query: 303 IVKKMLHADPKERLSAAEVLS 323
++ K+L +P R++ ++
Sbjct: 241 LLHKILVENPSARITIPDIKK 261
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 9e-83
Identities = 90/279 (32%), Positives = 146/279 (52%), Gaps = 19/279 (6%)
Query: 47 TSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI 106
+ A+ + +G Y + +G+G F L H T ++ A K I + +
Sbjct: 3 SIASCADEQPHIGN--------YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-L 53
Query: 107 NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYS 166
N ++ + REV+IM L H NIV+L E ++ LIM+ +GGE+FD ++A G
Sbjct: 54 NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK 112
Query: 167 ERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226
E+ A + RQ+V+ V YCH ++HRDLK EN L D +K DFG S F G
Sbjct: 113 EKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD---ADMNIKIADFGFSNEFTVGGK 169
Query: 227 FKDLVGSAYYVAPEVLR-RNY-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG 284
G+ Y APE+ + + Y G E D+WS GVILY L+SG PF G+ + + + +LRG
Sbjct: 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 229
Query: 285 HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ + +S+ ++++K+ L +P +R + +++
Sbjct: 230 --KYRIPFY--MSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 2e-82
Identities = 76/331 (22%), Positives = 134/331 (40%), Gaps = 33/331 (9%)
Query: 10 SQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTY 69
+ L + +D P S++++ V G+ Y
Sbjct: 6 HSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRI-------Y 58
Query: 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-R 128
+++G G + V ++ KQ +A K ++ + + ++ R E+ ++ L H
Sbjct: 59 SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN-LEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
I+ L + ++M+ C +L + K + + M+ VH H G
Sbjct: 117 KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG--DVFKD-LVGSAYYVAPEVL--- 242
++H DLKP NFL D LK DFG++ +P V KD VG+ Y+ PE +
Sbjct: 176 IVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 243 ---------RRNYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDP 292
+ ++D+WS G ILY + G PF Q S AI+ + + +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI--EF 289
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+D++K L DPK+R+S E+L+
Sbjct: 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 6e-82
Identities = 78/262 (29%), Positives = 133/262 (50%), Gaps = 16/262 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ + LG G +G L ++ T++ A K + ++ + D E++++E+ I L H
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HE 65
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
N+V+ G + + L ++ C+GGELFDRI E A Q++ V Y H +G
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL---VGSAYYVAPEVL-RR 244
+ HRD+KPEN L E LK +DFGL+ F+ + + L G+ YVAPE+L RR
Sbjct: 126 ITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 245 NY-GAEADIWSAGVILYILLSGVPPF--WGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
+ D+WS G++L +L+G P+ ++ Q D + +PW I S+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---TYLNPWKKIDSAPL 239
Query: 302 DIVKKMLHADPKERLSAAEVLS 323
++ K+L +P R++ ++
Sbjct: 240 ALLHKILVENPSARITIPDIKK 261
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 1e-81
Identities = 98/282 (34%), Positives = 135/282 (47%), Gaps = 15/282 (5%)
Query: 48 SATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN 107
+ G + M D Y F +++G G FGV L+ K TK+ A K I I+
Sbjct: 2 DRAPVTTGPLDMPIMHDSDR-YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID 60
Query: 108 RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSE 167
E+V+RE+ L H NIV K + +IM+ +GGEL++RI G +SE
Sbjct: 61 ----ENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE 115
Query: 168 RAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
A +Q+++ V YCHSM + HRDLK EN L S LK DFG S
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPR-LKICDFGYSKSSVLHSQP 174
Query: 228 KDLVGSAYYVAPEVL-RRNY-GAEADIWSAGVILYILLSGVPPFWGETEQSIF----DAI 281
K VG+ Y+APEVL R+ Y G AD+WS GV LY++L G PF E + I
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234
Query: 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
L D IS ++ ++ ADP R+S E+ +
Sbjct: 235 LSVKYSIPDDIR--ISPECCHLISRIFVADPATRISIPEIKT 274
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 3e-81
Identities = 75/306 (24%), Positives = 117/306 (38%), Gaps = 17/306 (5%)
Query: 24 GPGHHPNGLKIDPPGPPRPSSSA----TSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQ 79
G L +P + S T S G +P + ++ LG G
Sbjct: 10 GVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGS 69
Query: 80 FGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139
+G + V K+ + +A K S D EV + H V L+ A+E+
Sbjct: 70 YGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128
Query: 140 RHSVNLIMDLCAGGELFDRIIAKGHY-SERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198
+ L +LC G L A G E R + + + HS G++H D+KP N
Sbjct: 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPAN 187
Query: 199 FLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVI 258
K DFGL V + G Y+APE+L+ +YG AD++S G+
Sbjct: 188 IFLGPRGR---CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLT 244
Query: 259 LYILLSGVP-PFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS 317
+ + + P GE Q + L +SS + ++ ML DPK R +
Sbjct: 245 ILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSSELRSVLVMMLEPDPKLRAT 298
Query: 318 AAEVLS 323
A +L+
Sbjct: 299 AEALLA 304
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 5e-81
Identities = 86/256 (33%), Positives = 134/256 (52%), Gaps = 11/256 (4%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
YI LG G FG L TH T+Q+ A K IS + L D V RE+ + L H
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK-LLRHP 69
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+I++L + ++++ AGGELFD I+ K +E +Q++ + YCH
Sbjct: 70 HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNY- 246
++HRDLKPEN L ++ +K DFGLS G+ K GS Y APEV+ + Y
Sbjct: 129 IVHRDLKPENLLLD---DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306
G E D+WS G++LY++L G PF E ++F + + + +S A+ ++++
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDF--LSPGAQSLIRR 241
Query: 307 MLHADPKERLSAAEVL 322
M+ ADP +R++ E+
Sbjct: 242 MIVADPMQRITIQEIR 257
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 2e-80
Identities = 91/256 (35%), Positives = 134/256 (52%), Gaps = 10/256 (3%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
YI G LG G FG + H+ T + A K ++ +K+ + D V +RRE+Q + H
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HP 76
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+I++L + ++M+ +GGELFD I G E+ + L +Q+++ V YCH
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNY- 246
V+HRDLKPEN L K DFGLS G+ + GS Y APEV+ R Y
Sbjct: 137 VVHRDLKPENVLLD---AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306
G E DIWS+GVILY LL G PF + ++F I G F + + ++ S ++K
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLKH 249
Query: 307 MLHADPKERLSAAEVL 322
ML DP +R + ++
Sbjct: 250 MLQVDPMKRATIKDIR 265
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 2e-80
Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 20/295 (6%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
PR S A + GK E + + Y G LG G FG Y
Sbjct: 12 SGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 71
Query: 96 ACKSISSRKLINRDDVED---VRREVQIMHHLT-GHRNIVELKGAYEDRHSVNLIMDLCA 151
A K + ++ + ++ + V EV ++ ++ G ++ L +E S LI++
Sbjct: 72 AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 131
Query: 152 G-GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210
+LFD I +G E A + Q++ V +CH+ GV+HRD+K EN L + + L
Sbjct: 132 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--L 189
Query: 211 KATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNY-GAEADIWSAGVILYILLSGVPP 268
K DFG K V+ D G+ Y PE +R Y G A +WS G++LY ++ G P
Sbjct: 190 KLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
Query: 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
F + E I+RG + F +SS + +++ L P +R + E+ +
Sbjct: 249 FEHDEE------IIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 2e-79
Identities = 74/292 (25%), Positives = 117/292 (40%), Gaps = 22/292 (7%)
Query: 41 RPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSI 100
+P + + GK E Y G LG+G FG + + Q A K I
Sbjct: 5 KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI 64
Query: 101 SSRKLINRDDVED---VRREVQIM---HHLTGHRNIVELKGAYEDRHSVNLIMDL-CAGG 153
+++ + D EV ++ GH ++ L +E + L+++
Sbjct: 65 PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ 124
Query: 154 ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213
+LFD I KG E + Q+V + +CHS GV+HRD+K EN L K
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAKLI 182
Query: 214 DFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNY-GAEADIWSAGVILYILLSGVPPFWG 271
DFG + D G+ Y PE + Y A +WS G++LY ++ G PF
Sbjct: 183 DFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
Query: 272 ETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ E IL + F ++S ++++ L P R S E+L
Sbjct: 242 DQE------ILEAELHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 3e-79
Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 37/286 (12%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-------------------- 106
N Y E+G+G +GV L +++ +A K +S +KLI
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 107 ---NRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHSVNLIMDLCAGGELFDRIIA 161
R +E V +E+ I+ L H N+V+L +D + ++ +L G + + +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPT 130
Query: 162 KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221
SE A + ++ + Y H ++HRD+KP N L ED +K DFG+S F
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEF 187
Query: 222 KPGDVF-KDLVGSAYYVAPEVL---RRNY-GAEADIWSAGVILYILLSGVPPFWGETEQS 276
K D + VG+ ++APE L R+ + G D+W+ GV LY + G PF E
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
+ I P+I+ KD++ +ML +P+ R+ E+
Sbjct: 248 LHSKIKSQ--ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 3e-78
Identities = 75/293 (25%), Positives = 126/293 (43%), Gaps = 30/293 (10%)
Query: 39 PPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACK 98
P + ++ G K Y LG G FG + K+ ++ K
Sbjct: 4 EEPPKAVELEGLAACEGEYSQK--------YSTMSPLGSGAFGFVWTAVDKEKNKEVVVK 55
Query: 99 SISSRKLINRDDVED-----VRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL-CAG 152
I K++ +ED V E+ I+ + H NI+++ +E++ L+M+ +G
Sbjct: 56 FIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSG 114
Query: 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212
+LF I E A+ + RQ+V+ V Y ++HRD+K EN + AED +K
Sbjct: 115 LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKL 171
Query: 213 TDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN-Y-GAEADIWSAGVILYILLSGVPPFW 270
DFG + + + G +F G+ Y APEVL N Y G E ++WS GV LY L+ PF
Sbjct: 172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
Query: 271 GETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ + +S +V +L P+ R + ++++
Sbjct: 232 E------LEETVEA--AIHPPYL--VSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-77
Identities = 59/299 (19%), Positives = 113/299 (37%), Gaps = 49/299 (16%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSIS--------------SRKLINRDDVE 112
N Y R L +G+F L + +A K + K+ + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 113 DVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-------- 164
D + E+QI+ + + + +G + V +I + +
Sbjct: 89 DFKNELQIITDIK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 165 YSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223
+ + + ++ Y H+ + HRD+KP N L + +K +DFG S +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR---VKLSDFGESEYM-V 203
Query: 224 GDVFKDLVGSAYYVAPEVLRRN---YGAEADIWSAGVILYILLSGVPPFWGE-TEQSIFD 279
K G+ ++ PE GA+ DIWS G+ LY++ V PF + + +F+
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 280 AILRGHIDF---------------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
I +I++ S+ +S+ D +K L +P ER+++ + L
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 8e-77
Identities = 70/276 (25%), Positives = 114/276 (41%), Gaps = 23/276 (8%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
M Y +G G +G + K + K + + + + + EV ++
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLL 59
Query: 122 HHLTGHRNIVELKGAYEDRHS--VNLIMDLCAGGELFDRII----AKGHYSERAAANLCR 175
L H NIV DR + + ++M+ C GG+L I + + E +
Sbjct: 60 RELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 176 QMVTVVHYCHSMG-----VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-KD 229
Q+ + CH V+HRDLKP N +K DFGL+ F K
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDG---KQNVKLGDFGLARILNHDTSFAKT 175
Query: 230 LVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288
VG+ YY++PE + +Y ++DIWS G +LY L + +PPF +++ + I G
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-- 233
Query: 289 SSDPWPNI-SSSAKDIVKKMLHADPKERLSAAEVLS 323
P S +I+ +ML+ R S E+L
Sbjct: 234 --RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 6e-76
Identities = 74/306 (24%), Positives = 147/306 (48%), Gaps = 18/306 (5%)
Query: 42 PSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSIS 101
+S + + ME Y+ +++G G FG LV + +Q+ K I+
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN 58
Query: 102 SRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA 161
++ + + E+ RREV ++ ++ H NIV+ + ++E+ S+ ++MD C GG+LF RI A
Sbjct: 59 ISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA 116
Query: 162 --KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219
+ E + Q+ + + H ++HRD+K +N + D ++ DFG++
Sbjct: 117 QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK---DGTVQLGDFGIAR 173
Query: 220 FFKPGDVF-KDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
+ +G+ YY++PE+ Y ++DIW+ G +LY L + F + +++
Sbjct: 174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233
Query: 278 FDAILRGHIDFSSDPWP-NISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLA 336
I+ G P + S + +V ++ +P++R S +L K I K+ + L+
Sbjct: 234 VLKIISGSF----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLS 289
Query: 337 DLLYSQ 342
L ++
Sbjct: 290 PQLIAE 295
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 5e-74
Identities = 71/265 (26%), Positives = 128/265 (48%), Gaps = 20/265 (7%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-VRREVQIMHHLTGH 127
Y+ G LG G +G V +T + A K + +KL + E V++E+Q++ L H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-H 65
Query: 128 RNIVELKG--AYEDRHSVNLIMDLCAGG--ELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
+N+++L E++ + ++M+ C G E+ D + + + A Q++ + Y
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEY 124
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF---FKPGDVFKDLVGSAYYVAPE 240
HS G++H+D+KP N L + LK + G++ F D + GS + PE
Sbjct: 125 LHSQGIVHKDIKPGNLLLT---TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 241 VLR--RNY-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
+ + G + DIWSAGV LY + +G+ PF G+ +F+ I +G ++
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD--CG 237
Query: 298 SSAKDIVKKMLHADPKERLSAAEVL 322
D++K ML +P +R S ++
Sbjct: 238 PPLSDLLKGMLEYEPAKRFSIRQIR 262
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-73
Identities = 69/307 (22%), Positives = 127/307 (41%), Gaps = 18/307 (5%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
G P + + + + + +++GRGQF Y
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 96 ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL 155
A K + L++ D +E+ ++ L H N+++ ++ + + +N++++L G+L
Sbjct: 61 ALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAGDL 119
Query: 156 FDRI----IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211
I K ER Q+ + + + HS VMHRD+KP N ++ +K
Sbjct: 120 SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA---TGVVK 176
Query: 212 ATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPF 269
D GL F LVG+ YY++PE + N Y ++DIWS G +LY + + PF
Sbjct: 177 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236
Query: 270 WGETE--QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327
+G+ S+ I + D+ P + S + +V ++ DP++R V
Sbjct: 237 YGDKMNLYSLCKKIEQC--DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294
Query: 328 PKKTLQT 334
+
Sbjct: 295 MHACTAS 301
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 5e-71
Identities = 65/287 (22%), Positives = 110/287 (38%), Gaps = 38/287 (13%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+ +G G FG + H+ + + K + E REV+ + L
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD 62
Query: 126 GHRNIVELKGAYEDR----------------HSVNLIMDLCAGGELFDRIIAK--GHYSE 167
H NIV G ++ + + M+ C G L I + +
Sbjct: 63 -HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 168 RAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
A L Q+ V Y HS +++RDLKP N + +K DFGL K
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKR 178
Query: 228 KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI 286
G+ Y++PE + ++YG E D+++ G+IL LL F + G I
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFTDLRDGII 236
Query: 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333
K +++K+L P++R + +E+L + KK+ +
Sbjct: 237 S------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 7e-67
Identities = 84/285 (29%), Positives = 129/285 (45%), Gaps = 17/285 (5%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
PRP + + +P ED + FG+ LG G F L T +++
Sbjct: 4 TAAEPRPGAGSLQHAQPPPQPRKKRP-ED----FKFGKILGEGSFSTVVLARELATSREY 58
Query: 96 ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL 155
A K + R +I + V V RE +M L H V+L ++D + + GEL
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGEL 117
Query: 156 FDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215
I G + E ++V+ + Y H G++HRDLKPEN L + D ++ TDF
Sbjct: 118 LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE---DMHIQITDF 174
Query: 216 GLS---VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWG 271
G + VG+A YV+PE+L +D+W+ G I+Y L++G+PPF
Sbjct: 175 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234
Query: 272 ETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL 316
E IF I++ DF A+D+V+K+L D +RL
Sbjct: 235 GNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRL 275
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 4e-65
Identities = 62/310 (20%), Positives = 103/310 (33%), Gaps = 34/310 (10%)
Query: 38 GPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFAC 97
G +S + G + Y+F ++LG G F LV +A
Sbjct: 2 GSSHHHHHHSSGRENL--YFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYAL 59
Query: 98 KSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR----HSVNLIMDLCAGG 153
K I + D E+ +RE + H NI+ L H L++ G
Sbjct: 60 KRI---LCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRG 115
Query: 154 ELFDRI----IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP 209
L++ I +E L + + H+ G HRDLKP N L +
Sbjct: 116 TLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD---EGQ 172
Query: 210 LKATDFGLSVFFKPG----------DVFKDLVGSAYYVAPEVL----RRNYGAEADIWSA 255
D G + + Y APE+ D+WS
Sbjct: 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232
Query: 256 GVILYILLSGVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKE 314
G +LY ++ G P+ ++ ++ + P SS+ ++ M+ DP +
Sbjct: 233 GCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI--PQSPRHSSALWQLLNSMMTVDPHQ 290
Query: 315 RLSAAEVLSK 324
R +LS+
Sbjct: 291 RPHIPLLLSQ 300
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 7e-65
Identities = 76/311 (24%), Positives = 122/311 (39%), Gaps = 51/311 (16%)
Query: 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREV 118
G+ + D + + LGRG FGV + +K +A K I R E V REV
Sbjct: 1 GRYLTD----FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREV 54
Query: 119 QIMHHLTGHRNIVELKGAYEDRHS------------VNLIMDLCAGGELFDRIIAKGHYS 166
+ + L H IV A+ ++++ + + M LC L D + +
Sbjct: 55 KALAKLE-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113
Query: 167 ---ERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223
++ Q+ V + HS G+MHRDLKP N F+ D +K DFGL
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQ 170
Query: 224 GDVFKDL-------------VGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPF 269
+ + + VG+ Y++PE + +Y + DI+S G+IL+ LL PF
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF 227
Query: 270 WGETEQS-IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS----- 323
+ E+ + + +V+ ML P ER A ++
Sbjct: 228 STQMERVRTLTDVRNLKF---PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
Query: 324 KFLIPKKTLQT 334
P KT+
Sbjct: 285 DLDFPGKTVLR 295
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-64
Identities = 75/318 (23%), Positives = 120/318 (37%), Gaps = 47/318 (14%)
Query: 37 PGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFA 96
GP ++ S VG+ + E R L G F Y + +++A
Sbjct: 2 AGPGSLGGASGRDQSDFVGQTV----ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYA 57
Query: 97 CKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN--------LIMD 148
K + S + + +EV M L+GH NIV+ A + L+ +
Sbjct: 58 LKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTE 114
Query: 149 LCAGGELFDRII---AKGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSS 203
LC G+L + + ++G S + Q V + H ++HRDLK EN L S+
Sbjct: 115 LC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN 173
Query: 204 SAEDSPLKATDFGLSVFFKPGDVFKDL-------------VGSAYYVAPEVL----RRNY 246
+K DFG + + + Y PE++
Sbjct: 174 ---QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306
G + DIW+ G ILY+L PF E I+ G P + +++
Sbjct: 231 GEKQDIWALGCILYLLCFRQHPF----EDGAKLRIVNGKYSIP--PHDTQYTVFHSLIRA 284
Query: 307 MLHADPKERLSAAEVLSK 324
ML +P+ERLS AEV+ +
Sbjct: 285 MLQVNPEERLSIAEVVHQ 302
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 5e-64
Identities = 47/341 (13%), Positives = 98/341 (28%), Gaps = 64/341 (18%)
Query: 33 KIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVR---------NTYIFGRELGRGQFGVT 83
+I S SA S V L + R T + G LG+
Sbjct: 35 RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAY 94
Query: 84 YLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL------------------- 124
T ++T + F + + ++ ++ EV + L
Sbjct: 95 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154
Query: 125 -----TGHRNIVELKGAYEDRHSVN--LIMDLCAG------GELFDRIIAKGHYSERAAA 171
+ ++ ++ D ++ + L A
Sbjct: 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 214
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
L Q++ ++ H G++H L+P + + + + T F V + G +
Sbjct: 215 QLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFEHLV--RDGASAVSPI 269
Query: 232 GSAY----YVAPEVLRRN------YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI 281
G + A +L D W+ G+ +Y + P + + I
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI 329
Query: 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
R NI + +++ L ++RL + +
Sbjct: 330 FRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 7e-63
Identities = 46/283 (16%), Positives = 95/283 (33%), Gaps = 36/283 (12%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIM 121
LG G F Y T D KQ+F K + + ++ +
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERL 121
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY-----SERAAANLCRQ 176
++ A+ ++ L+ +L + G L + I + + + +
Sbjct: 122 KPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP--------LKATDFGLSV---FFKPGD 225
M+ ++ H ++H D+KP+NF+ + + L D G S+ F G
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 226 VFKDLVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSI-FDAILR 283
+F ++ + E+L + + + D + +Y +L G + + R
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
Query: 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326
D W + ML+ L + ++L + L
Sbjct: 301 RL--PHLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-61
Identities = 62/286 (21%), Positives = 111/286 (38%), Gaps = 35/286 (12%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ ++G G+FG + + +A K S + L D ++ REV L H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRI----IAKGHYSERAAANLCRQMVTVVHYC 184
++V A+ + + + + C GG L D I ++ E +L Q+ + Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 185 HSMGVMHRDLKPENFLFSSS----------------AEDSPLKATDFGLSVFFKPGDVFK 228
HSM ++H D+KP N S + + K D G V
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE- 190
Query: 229 DLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI 286
G + ++A EVL+ N + +ADI++ + + P + I +G +
Sbjct: 191 --EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHEIRQGRL 245
Query: 287 DFSSDPWP-NISSSAKDIVKKMLHADPKERLSAAEVLS-KFLIPKK 330
P +S +++K M+H DP+ R SA ++ L+
Sbjct: 246 ----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-59
Identities = 68/255 (26%), Positives = 118/255 (46%), Gaps = 15/255 (5%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R +G+G FG +V DTK+ +A K ++ +K + R++V +V +E+QIM L H +V
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVN 79
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L +++D + +++DL GG+L + H+ E ++V + Y + ++HR
Sbjct: 80 LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHR 139
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN----YGA 248
D+KP+N L E + TDF ++ + G+ Y+APE+ Y
Sbjct: 140 DMKPDNILLD---EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSF 196
Query: 249 EADIWSAGVILYILLSGVPPFWG---ETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305
D WS GV Y LL G P+ + + I + + S ++K
Sbjct: 197 AVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQEMVSLLK 252
Query: 306 KMLHADPKERLSAAE 320
K+L +P +R S
Sbjct: 253 KLLEPNPDQRFSQLS 267
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 5e-59
Identities = 77/288 (26%), Positives = 138/288 (47%), Gaps = 24/288 (8%)
Query: 43 SSSATSATSSSVGRVLGKPMEDVRNTYI-------------FGRELGRGQFGVTYLVTHK 89
+++ + SV L K ED + + LG G FG LV HK
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 90 DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149
++ +A K + +K++ +E E +I+ + +V+L+ +++D ++ ++M+
Sbjct: 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEY 122
Query: 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP 209
AGGE+F + G +SE A Q+V Y HS+ +++RDLKPEN L
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ---QGY 179
Query: 210 LKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPP 268
++ TDFG + + L G+ +APE++ Y D W+ GV++Y + +G PP
Sbjct: 180 IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL 316
F+ + I++ I+ G + F + SS KD+++ +L D +R
Sbjct: 238 FFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRF 281
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-57
Identities = 77/249 (30%), Positives = 122/249 (48%), Gaps = 13/249 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG LV HK T++ +A K +S ++I R D E IM +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLF 135
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
A++D + ++M+ GG+L +++ E+ A ++V + HSMG +HRD+
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 194
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD--LVGSAYYVAPEVLRR-----NYG 247
KP+N L S LK DFG + + + VG+ Y++PEVL+ YG
Sbjct: 195 KPDNMLLDKSGH---LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 251
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
E D WS GV LY +L G PF+ ++ + I+ + +IS AK+++
Sbjct: 252 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAF 311
Query: 308 LHADPKERL 316
L D + RL
Sbjct: 312 LT-DREVRL 319
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-56
Identities = 70/249 (28%), Positives = 118/249 (47%), Gaps = 11/249 (4%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ R LG G FG +L+ + + +A K + ++ VE E ++ +T H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HP 66
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
I+ + G ++D + +IMD GGELF + + A ++ + Y HS
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN-YG 247
+++RDLKPEN L + +K TDFG + DV L G+ Y+APEV+ Y
Sbjct: 127 IIYRDLKPENILLDK---NGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 181
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
D WS G+++Y +L+G PF+ ++ IL + F P + KD++ ++
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLSRL 237
Query: 308 LHADPKERL 316
+ D +RL
Sbjct: 238 ITRDLSQRL 246
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 3e-55
Identities = 65/257 (25%), Positives = 113/257 (43%), Gaps = 15/257 (5%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH--HL 124
N + R +GRG FG Y DT + +A K + +++ + E ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC 184
IV + A+ ++ I+DL GG+L + G +SE +++ + +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
H+ V++RDLKP N L E ++ +D GL+ F VG+ Y+APEVL++
Sbjct: 309 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQK 364
Query: 245 N--YGAEADIWSAGVILYILLSGVPPFWGETEQS---IFDAILRGHIDFSSDPWPNISSS 299
Y + AD +S G +L+ LL G PF + I L ++ + S
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPE 420
Query: 300 AKDIVKKMLHADPKERL 316
+ +++ +L D RL
Sbjct: 421 LRSLLEGLLQRDVNRRL 437
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-55
Identities = 76/283 (26%), Positives = 128/283 (45%), Gaps = 15/283 (5%)
Query: 40 PRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKS 99
P+ SS + + LG +++ + F R LG+G FG L K+T +A K
Sbjct: 2 PKESSKEGNGIGVNSSNRLG--IDN----FEFIRVLGKGSFGKVMLARVKETGDLYAVKV 55
Query: 100 ISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI 159
+ ++ DDVE E +I+ H + +L ++ + +M+ GG+L I
Sbjct: 56 LKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI 115
Query: 160 IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS- 218
+ E A ++++ + + H G+++RDLK +N L + K DFG+
Sbjct: 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH---EGHCKLADFGMCK 172
Query: 219 VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
G G+ Y+APE+L+ YG D W+ GV+LY +L G PF E E +
Sbjct: 173 EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232
Query: 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAE 320
F+AIL + + P + A I+K + +P RL +
Sbjct: 233 FEAILNDEVVY---P-TWLHEDATGILKSFMTKNPTMRLGSLT 271
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-54
Identities = 64/254 (25%), Positives = 116/254 (45%), Gaps = 17/254 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG F +V K T Q +A K ++ ++ R +V R E ++ + R I +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLH 127
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
A++D + + L+M+ GG+L + G A ++V + H +G +HRD
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD--LVGSAYYVAPEVLRR------- 244
+KP+N L ++ DFG + + + VG+ Y++PE+L+
Sbjct: 188 IKPDNILLDR---CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244
Query: 245 -NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKD 302
+YG E D W+ GV Y + G PF+ ++ + I+ S + A+D
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARD 304
Query: 303 IVKKMLHADPKERL 316
++++L P+ RL
Sbjct: 305 FIQRLLC-PPETRL 317
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-54
Identities = 68/248 (27%), Positives = 118/248 (47%), Gaps = 9/248 (3%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG +L K T Q FA K++ ++ DDVE E +++ H + +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + ++ +M+ GG+L I + + A +++ + + HS G+++RDL
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144
Query: 195 KPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
K +N L D +K DFG+ G+ Y+APE+L Y D
Sbjct: 145 KLDNILLDK---DGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
WS GV+LY +L G PF G+ E+ +F +I + + P + AKD++ K+ +P
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---P-RWLEKEAKDLLVKLFVREP 257
Query: 313 KERLSAAE 320
++RL
Sbjct: 258 EKRLGVRG 265
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-53
Identities = 69/248 (27%), Positives = 117/248 (47%), Gaps = 9/248 (3%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG L K T + +A K + +I DDVE E +++ + +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + +M+ GG+L I G + E A ++ + + S G+++RDL
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 195 KPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
K +N + S + +K DFG+ G K G+ Y+APE++ YG D
Sbjct: 148 KLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 204
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W+ GV+LY +L+G PF GE E +F +I+ ++ + P ++S A I K ++ P
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICKGLMTKHP 260
Query: 313 KERLSAAE 320
+RL
Sbjct: 261 GKRLGCGP 268
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-53
Identities = 74/292 (25%), Positives = 136/292 (46%), Gaps = 12/292 (4%)
Query: 34 IDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNT---YIFGRELGRGQFGVTYLVTHKD 90
I P P ++ + + ++ P + + F + +G+G FG L HK
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA 61
Query: 91 TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150
+ +A K + + ++ + + + + E ++ H +V L +++ + ++D
Sbjct: 62 EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121
Query: 151 AGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210
GGELF + + + E A ++ + + Y HS+ +++RDLKPEN L S +
Sbjct: 122 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS---QGHI 178
Query: 211 KATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPP 268
TDFGL + G+ Y+APEVL + Y D W G +LY +L G+PP
Sbjct: 179 VLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
Query: 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAE 320
F+ ++D IL + PNI++SA+ +++ +L D +RL A +
Sbjct: 239 FYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKD 286
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-53
Identities = 68/252 (26%), Positives = 122/252 (48%), Gaps = 15/252 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG +V K+ + FA K ++ +++ R + R E ++ + + I L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLH 140
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRII-AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
A++D +++ L+MD GG+L + + E A +MV + H + +HRD
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200
Query: 194 LKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKD-LVGSAYYVAPEVLRRN------ 245
+KP+N L + ++ DFG + G V VG+ Y++PE+L+
Sbjct: 201 IKPDNILMDM---NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW-PNISSSAKDIV 304
YG E D WS GV +Y +L G PF+ E+ + I+ F ++S +AKD++
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLI 317
Query: 305 KKMLHADPKERL 316
++++ + RL
Sbjct: 318 RRLIC-SREHRL 328
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-53
Identities = 79/248 (31%), Positives = 125/248 (50%), Gaps = 10/248 (4%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG LV K T + +A K + +I +D+V E +++ + T H + LK
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
A++ + +M+ GGELF + + ++E A ++V+ + Y HS V++RD+
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 195 KPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
K EN + D +K TDFGL G K G+ Y+APEVL N YG D
Sbjct: 132 KLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W GV++Y ++ G PF+ + + +F+ IL I F +S AK ++ +L DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDP 244
Query: 313 KERLSAAE 320
K+RL
Sbjct: 245 KQRLGGGP 252
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 6e-53
Identities = 70/257 (27%), Positives = 119/257 (46%), Gaps = 15/257 (5%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
NT+ R LG+G FG + T + +ACK + +++ R E QI+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL-EKVN 242
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI--IAKGHYSERAAANLCRQMVTVVHYC 184
R +V L AYE + ++ L++ L GG+L I + + + E A ++ +
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
H +++RDLKPEN L ++ +D GL+V G K VG+ Y+APEV++
Sbjct: 303 HRERIVYRDLKPENILLDD---HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 245 N-YGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAILRGHIDFSSDPWPNISSS 299
Y D W+ G +LY +++G PF ++ + + ++S S
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQ 415
Query: 300 AKDIVKKMLHADPKERL 316
A+ + ++L DP ERL
Sbjct: 416 ARSLCSQLLCKDPAERL 432
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-52
Identities = 77/342 (22%), Positives = 128/342 (37%), Gaps = 30/342 (8%)
Query: 5 NGLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMED 64
+ S Q ++ A + L P + + + V + E+
Sbjct: 3 GSVSSGQAHSLASLAKTWSSGSAKLQRL------GPETEDNEGVLLTEKLKPVDYEYREE 56
Query: 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR-REVQIMHH 123
V +GRG FG + + K T Q A K + +E R E+
Sbjct: 57 VHW-MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV---------RLEVFRVEELVACAG 106
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
L+ IV L GA + VN+ M+L GG L I G E A Q + + Y
Sbjct: 107 LS-SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEY 165
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV------FKDLVGSAYYV 237
H+ ++H D+K +N L SS S DFG ++ +P + + G+ ++
Sbjct: 166 LHTRRILHGDVKADNVLLSSDG--SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 238 APEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDPWPN 295
APEV+ A+ DIWS+ ++ +L+G P+ I P P+
Sbjct: 224 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-KIASEPPPIREIP-PS 281
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLAD 337
+ +++ L +P R SA E+ K + + L
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKS 323
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-52
Identities = 74/308 (24%), Positives = 133/308 (43%), Gaps = 25/308 (8%)
Query: 27 HHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRE-------LGRGQ 79
HH + D P + + E + + G + +GRG
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGS 64
Query: 80 FGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139
+ LV K T + +A + + + + +D++ V+ E + + H +V L ++
Sbjct: 65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 124
Query: 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199
+ +++ GG+L + + E A ++ ++Y H G+++RDLK +N
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184
Query: 200 LFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGV 257
L S + +K TD+G+ +PGD G+ Y+APE+LR YG D W+ GV
Sbjct: 185 LLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 241
Query: 258 ILYILLSGVPPFW---------GETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML 308
+++ +++G PF TE +F IL I ++S A ++K L
Sbjct: 242 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFL 297
Query: 309 HADPKERL 316
+ DPKERL
Sbjct: 298 NKDPKERL 305
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 5e-52
Identities = 69/253 (27%), Positives = 121/253 (47%), Gaps = 18/253 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG + LV K T + +A K + + + +D++ V+ E + + H +V L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + +++ GG+L + + E A ++ ++Y H G+++RDL
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 136
Query: 195 KPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
K +N L S + +K TD+G+ +PGD G+ Y+APE+LR YG D
Sbjct: 137 KLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193
Query: 253 WSAGVILYILLSGVPPFW---------GETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303
W+ GV+++ +++G PF TE +F IL I ++S A +
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASV 249
Query: 304 VKKMLHADPKERL 316
+K L+ DPKERL
Sbjct: 250 LKSFLNKDPKERL 262
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-51
Identities = 85/318 (26%), Positives = 142/318 (44%), Gaps = 17/318 (5%)
Query: 8 PSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKP--MEDV 65
+ + + TTA G PS ++ + M +
Sbjct: 91 ETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE- 149
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+ + + LG+G FG LV K T + +A K + ++ +D+V E +++ + +
Sbjct: 150 ---FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-S 205
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH 185
H + LK +++ + +M+ GGELF + + +SE A ++V+ + Y H
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 186 S-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLR 243
S V++RDLK EN + D +K TDFGL K G K G+ Y+APEVL
Sbjct: 266 SEKNVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 244 RN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302
N YG D W GV++Y ++ G PF+ + + +F+ IL I F + AK
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKS 378
Query: 303 IVKKMLHADPKERLSAAE 320
++ +L DPK+RL
Sbjct: 379 LLSGLLKKDPKQRLGGGS 396
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 2e-51
Identities = 69/260 (26%), Positives = 121/260 (46%), Gaps = 18/260 (6%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ ++ R LGRG FG + K T + +ACK ++ ++L R + E +I+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVH 243
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH----YSERAAANLCRQMVTVVH 182
R IV L A+E + + L+M + GG++ I + E A Q+V+ +
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDLVGSAYYVAPEV 241
+ H +++RDLKPEN L D ++ +D GL+V K G+ ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVLLDD---DGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAILRGHIDFSSDPWPNI 296
L Y D ++ GV LY +++ PF E + + +L + +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKF 416
Query: 297 SSSAKDIVKKMLHADPKERL 316
S ++KD + +L DP++RL
Sbjct: 417 SPASKDFCEALLQKDPEKRL 436
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 2e-51
Identities = 73/316 (23%), Positives = 131/316 (41%), Gaps = 14/316 (4%)
Query: 8 PSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKP-MEDVR 66
+ ++ + KI +A + + + + D
Sbjct: 285 EYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD-- 342
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ F LG+G FG L K T + +A K + +I DDVE E +++
Sbjct: 343 --FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
+ +L ++ + +M+ GG+L I G + E A ++ + + S
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN 245
G+++RDLK +N + S + +K DFG+ G K G+ Y+APE++
Sbjct: 461 KGIIYRDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 246 -YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
YG D W+ GV+LY +L+G PF GE E +F +I+ ++ + ++S A I
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAIC 573
Query: 305 KKMLHADPKERLSAAE 320
K ++ P +RL
Sbjct: 574 KGLMTKHPGKRLGCGP 589
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 4e-51
Identities = 76/248 (30%), Positives = 128/248 (51%), Gaps = 14/248 (5%)
Query: 75 LGRGQFGVTYLVTH---KDTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNI 130
LG+G +G + V +T + FA K + ++ N D + E I+ + H I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFI 83
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
V+L A++ + LI++ +GGELF ++ +G + E A ++ + + H G++
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGII 143
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGA 248
+RDLKPEN + + +K TDFGL G V G+ Y+APE+L R+ +
Sbjct: 144 YRDLKPENIMLNH---QGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200
Query: 249 EADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML 308
D WS G ++Y +L+G PPF GE + D IL+ ++ P P ++ A+D++KK+L
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEARDLLKKLL 256
Query: 309 HADPKERL 316
+ RL
Sbjct: 257 KRNAASRL 264
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-50
Identities = 75/247 (30%), Positives = 122/247 (49%), Gaps = 14/247 (5%)
Query: 75 LGRGQFGVTYLVTH---KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
LG+G FG +LV D +Q +A K + L RD V + E I+ H IV
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVE-VNHPFIV 89
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+L A++ + LI+D GG+LF R+ + ++E ++ + + HS+G+++
Sbjct: 90 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 149
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAE 249
RDLKPEN L + +K TDFGLS G+ Y+APEV+ R +
Sbjct: 150 RDLKPENILLDE---EGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 206
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
AD WS GV+++ +L+G PF G+ + IL+ + P +S A+ +++ +
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEAQSLLRMLFK 262
Query: 310 ADPKERL 316
+P RL
Sbjct: 263 RNPANRL 269
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-50
Identities = 56/259 (21%), Positives = 110/259 (42%), Gaps = 14/259 (5%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
F E+GRG F Y +T + A + RKL + + + + E +++ L H NI
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNI 87
Query: 131 VELKGAYED----RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
V ++E + + L+ +L G L + + + CRQ++ + + H+
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 187 MG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
++HRDLK +N + +K D GL+ K K ++G+ ++APE+
Sbjct: 148 RTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMYEE 204
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDPWPNISSSAKDI 303
Y D+++ G+ + + + P+ I+ + G S K+I
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAIPEVKEI 262
Query: 304 VKKMLHADPKERLSAAEVL 322
++ + + ER S ++L
Sbjct: 263 IEGCIRQNKDERYSIKDLL 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-49
Identities = 69/281 (24%), Positives = 125/281 (44%), Gaps = 25/281 (8%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
LG+G +G+ Y + + A K I + + + E+ + HL H+NIV
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLK-HKNIV 82
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSMG 188
+ G++ + + + M+ GG L + +K +E+ +Q++ + Y H
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-- 245
++HRD+K +N L ++ LK +DFG S + G+ Y+APE++ +
Sbjct: 143 IVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 246 -YGAEADIWSAGVILYILLSGVPPFW--GETEQSIFDAILRGHIDFSSDPWP---NISSS 299
YG ADIWS G + + +G PPF+ GE + ++F + ++S+
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF------KVGMFKVHPEIPESMSAE 254
Query: 300 AKDIVKKMLHADPKERLSAAEVLS-KFLIPKKTLQTLADLL 339
AK + K DP +R A ++L +FL + L
Sbjct: 255 AKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL 295
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 9e-49
Identities = 82/308 (26%), Positives = 143/308 (46%), Gaps = 33/308 (10%)
Query: 35 DPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRE-------------LGRGQFG 81
+ G ++ TSA G L ++R + G LG G +G
Sbjct: 9 EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYG 68
Query: 82 VTYLVTH---KDTKQQFACKSISSRKLINRD-DVEDVRREVQIMHHLTGHRNIVELKGAY 137
+LV DT + +A K + ++ + E R E Q++ H+ +V L A+
Sbjct: 69 KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128
Query: 138 EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPE 197
+ ++LI+D GGELF + + ++E ++V + + H +G+++RD+K E
Sbjct: 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 188
Query: 198 NFLFSSSAEDSPLKATDFGLS--VFFKPGDVFKDLVGSAYYVAPEVLRRN---YGAEADI 252
N L S + + TDFGLS + D G+ Y+AP+++R + D
Sbjct: 189 NILLDS---NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW 245
Query: 253 WSAGVILYILLSGVPPFWGETEQS----IFDAILRGHIDFSSDPWPNISSSAKDIVKKML 308
WS GV++Y LL+G PF + E++ I IL+ + +S+ AKD+++++L
Sbjct: 246 WSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----QEMSALAKDLIQRLL 301
Query: 309 HADPKERL 316
DPK+RL
Sbjct: 302 MKDPKKRL 309
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-47
Identities = 84/323 (26%), Positives = 148/323 (45%), Gaps = 27/323 (8%)
Query: 27 HHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLV 86
HH +G+ + S T + R++ D R ++G G G+ L
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQ-GDPRLLLDSYVKIGEGSTGIVCLA 64
Query: 87 THKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146
K + +Q A K + L + E + EV IM H N+VE+ +Y + ++
Sbjct: 65 REKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVL 120
Query: 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE 206
M+ GG L D I+++ +E A +C ++ + Y H+ GV+HRD+K ++ L +
Sbjct: 121 MEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR 179
Query: 207 DSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLS 264
+K +DFG + LVG+ Y++APEV+ R+ Y E DIWS G+++ ++
Sbjct: 180 ---VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD 236
Query: 265 GVPPFWGETEQSIFDAI-------LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS 317
G PP++ ++ + L+ S +D +++ML DP+ER +
Sbjct: 237 GEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPV--------LRDFLERMLVRDPQERAT 288
Query: 318 AAEVLS-KFLIPKKTLQTLADLL 339
A E+L FL+ + L L+
Sbjct: 289 AQELLDHPFLLQTGLPECLVPLI 311
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-47
Identities = 77/336 (22%), Positives = 134/336 (39%), Gaps = 24/336 (7%)
Query: 13 QLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFG 72
+ D N P A S V + K +D +
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFK--DDPEKLFSDL 59
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
RE+G G FG Y + A K +S + + +D+ +EV+ + L H N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 118
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
+G Y H+ L+M+ C G + K E A + + + Y HS ++HR
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL----RRNYGA 248
D+K N L S +K DFG + P + F VG+ Y++APEV+ Y
Sbjct: 179 DVKAGNILLSEPGL---VKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDG 232
Query: 249 EADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDP---WPNISSSAKDIV 304
+ D+WS G+ L PP + +++ HI + P + S ++ V
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNESPALQSGHWSEYFRNFV 286
Query: 305 KKMLHADPKERLSAAEVLS-KFLIPKKTLQTLADLL 339
L P++R ++ +L +F++ ++ + DL+
Sbjct: 287 DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 322
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-46
Identities = 78/285 (27%), Positives = 135/285 (47%), Gaps = 22/285 (7%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
D + Y ++G+G G Y T Q+ A + + L + E + E+ +M
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMR 72
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
+ NIV +Y + ++M+ AGG L D ++ + E A +CR+ + +
Sbjct: 73 ENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALE 130
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEV 241
+ HS V+HRD+K +N L +K TDFG P + +VG+ Y++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDP----WPN 295
+ R YG + DIWS G++ ++ G PP+ E ++++ I + P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGTPELQNPEK 241
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLS-KFLIPKKTLQTLADLL 339
+S+ +D + + L D ++R SA E+L +FL K L +L L+
Sbjct: 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-45
Identities = 71/281 (25%), Positives = 133/281 (47%), Gaps = 14/281 (4%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
D + ++G+G FG + T++ A K I + D++ED+++E+ ++
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLS 75
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
+ + G+Y + +IM+ GG D ++ G E A + R+++ +
Sbjct: 76 QCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLD 133
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEV 241
Y HS +HRD+K N L S E +K DFG++ + ++ VG+ +++APEV
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 190
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
++++ Y ++ADIWS G+ L G PP + I + + + S
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKPL 247
Query: 301 KDIVKKMLHADPKERLSAAEVLS-KFLIPK-KTLQTLADLL 339
K+ V+ L+ +P R +A E+L KF++ K L +L+
Sbjct: 248 KEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELI 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-44
Identities = 80/290 (27%), Positives = 133/290 (45%), Gaps = 25/290 (8%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
D + ELG G FG Y +K+T A K I + +++ED E++I+
Sbjct: 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILA 71
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHYSERAAANLCRQMVTVV 181
H IV+L GAY + ++++ C GG + + +E +CRQM+ +
Sbjct: 72 TCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 130
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPE 240
++ HS ++HRDLK N L + + ++ DFG+S +D +G+ Y++APE
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 241 VLRRN------YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP-- 292
V+ Y +ADIWS G+ L + PP E + +L I S P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLL--KIAKSDPPTL 242
Query: 293 --WPNISSSAKDIVKKMLHADPKERLSAAEVLS-KFLIPKKTLQTLADLL 339
S +D +K L +P+ R SAA++L F+ + + L +L+
Sbjct: 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELV 292
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-44
Identities = 70/317 (22%), Positives = 136/317 (42%), Gaps = 27/317 (8%)
Query: 44 SSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSR 103
S A+ + + S+ + + D + +G G +G Y H T Q A K +
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-- 58
Query: 104 KLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN------LIMDLCAGGELFD 157
+ D+ E++++E+ ++ + HRNI GA+ ++ L+M+ C G + D
Sbjct: 59 --VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 158 --RIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215
+ E A +CR+++ + + H V+HRD+K +N L + +AE +K DF
Sbjct: 117 LIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE---VKLVDF 173
Query: 216 GLSVFFKPGDVFKD-LVGSAYYVAPEVLRRN------YGAEADIWSAGVILYILLSGVPP 268
G+S ++ +G+ Y++APEV+ + Y ++D+WS G+ + G PP
Sbjct: 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
Query: 269 FWGETEQSIFDAILRGHI-DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS-KFL 326
I R S W S + ++ L + +R + +++ F+
Sbjct: 234 LCDMHPMRALFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290
Query: 327 IPKKTLQTLADLLYSQI 343
+ + + L I
Sbjct: 291 RDQPNERQVRIQLKDHI 307
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-43
Identities = 75/321 (23%), Positives = 131/321 (40%), Gaps = 43/321 (13%)
Query: 33 KIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTK 92
+ PPR S + + + +LG G +G Y HK+T
Sbjct: 4 TVQLRNPPRRQLKKLDEDSLT---------KQPEEVFDVLEKLGEGSYGSVYKAIHKETG 54
Query: 93 QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152
Q A K + D++++ +E+ IM ++V+ G+Y + ++M+ C
Sbjct: 55 QIVAIKQVP-----VESDLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDLWIVMEYCGA 108
Query: 153 GELFDRI-IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211
G + D I + +E A + + + + Y H M +HRD+K N L ++ K
Sbjct: 109 GSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH---AK 165
Query: 212 ATDFG----LSVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGV 266
DFG L+ + +G+ +++APEV++ Y ADIWS G+ + G
Sbjct: 166 LADFGVAGQLTDTMAKRNTV---IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
Query: 267 PPFWGETEQSIFDAI-------LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAA 319
PP+ I R + W S + D VK+ L P++R +A
Sbjct: 223 PPYADIHPMRAIFMIPTNPPPTFRK-----PELW---SDNFTDFVKQCLVKSPEQRATAT 274
Query: 320 EVLS-KFLIPKKTLQTLADLL 339
++L F+ K + L DL+
Sbjct: 275 QLLQHPFVRSAKGVSILRDLI 295
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 78/325 (24%), Positives = 126/325 (38%), Gaps = 49/325 (15%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
P + + V GK E Y + +G G FGV + ++ +
Sbjct: 9 PLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVES-DEV 67
Query: 96 ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK------GAYEDRHSVNLIMDL 149
A K + D RE+QIM + H N+V+LK G +D +NL+++
Sbjct: 68 AIKKV-------LQDKRFKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 150 CAGGELFDRIIAKGHYSERAAANLCR----QMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205
++ + L + Q++ + Y HS+G+ HRD+KP+N L
Sbjct: 120 V-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--P 176
Query: 206 EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILL 263
LK DFG + G+ + S YY APE++ NY DIWS G ++ L+
Sbjct: 177 PSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236
Query: 264 SGVPPFWGETE----QSIFD-----------AILRGHIDFS-----SDPW-----PNISS 298
G P F GE+ I + +++ P+ P
Sbjct: 237 QGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPP 296
Query: 299 SAKDIVKKMLHADPKERLSAAEVLS 323
A D++ ++L P RL+A E L
Sbjct: 297 DAIDLISRLLEYTPSARLTAIEALC 321
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-42
Identities = 65/271 (23%), Positives = 113/271 (41%), Gaps = 42/271 (15%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
E+G G G + + + T A K + R+ N+++ + + ++ ++ IV+
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHR 192
G + V + M+L + +G ER + +V ++Y GV+HR
Sbjct: 90 FGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHR 149
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-----VGSAYYVAPEVLRRN-- 245
D+KP N L + +K DFG+S G + D G A Y+APE +
Sbjct: 150 DVKPSNILLDERGQ---IKLCDFGIS-----GRLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 246 ----YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI----------LRGHIDFSSD 291
Y AD+WS G+ L L +G P+ + ++ F+ + L GH+ FS D
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259
Query: 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
+ VK L D ++R ++L
Sbjct: 260 --------FQSFVKDCLTKDHRKRPKYNKLL 282
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 79/349 (22%), Positives = 128/349 (36%), Gaps = 56/349 (16%)
Query: 12 TQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIF 71
T + + P P +K+ ++ + P +Y
Sbjct: 7 TTSFAESCKPVQQPSAF-GSMKVSRDKDGSKVTTVVATPGQG-------PDRPQEVSYTD 58
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
+ +G G FGV Y D+ + A K + D RE+QIM L H NIV
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIV 110
Query: 132 ELK------GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR----QMVTVV 181
L+ G +D +NL++D ++ + + Q+ +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
Y HS G+ HRD+KP+N L LK DFG + G+ + S YY APE+
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 227
Query: 242 L--RRNYGAEADIWSAGVILYILLSGVPPFWGETE---------------QSIFDAILRG 284
+ +Y + D+WSAG +L LL G P F G++ + +
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287
Query: 285 HIDFS-----SDPW-----PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ +F + PW P A + ++L P RL+ E +
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-42
Identities = 55/253 (21%), Positives = 101/253 (39%), Gaps = 28/253 (11%)
Query: 88 HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147
++ + + + L + ++ +++ M + +N V + + + M
Sbjct: 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQLQPSSPKVYLYIQM 140
Query: 148 DLCAGGELFDRIIAKGHYSER---AAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS 204
LC L D + + +R ++ Q+ V + HS G+MHRDLKP N F+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM- 199
Query: 205 AEDSPLKATDFGLSVFFKPGDVFKDL-------------VGSAYYVAPEVLR-RNYGAEA 250
D +K DFGL + + + VG+ Y++PE + NY +
Sbjct: 200 --DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 251 DIWSAGVILYILLSGVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
DI+S G+IL+ LL F + E+ I + + +V+ ML
Sbjct: 258 DIFSLGLILFELLY---SFSTQMERVRIITDVRNLKF---PLLFTQKYPQEHMMVQDMLS 311
Query: 310 ADPKERLSAAEVL 322
P ER A +++
Sbjct: 312 PSPTERPEATDII 324
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-42
Identities = 65/270 (24%), Positives = 111/270 (41%), Gaps = 35/270 (12%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
E+GRG +G + HK + Q A K I R ++ + + + ++ ++ + IV+
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAK------GHYSERAAANLCRQMVTVVHYCHSM 187
GA + M+L + FD+ E + V +++
Sbjct: 87 YGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 188 G-VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-----VGSAYYVAPEV 241
++HRD+KP N L S +K DFG+S G + + G Y+APE
Sbjct: 145 LKIIHRDIKPSNILLDRSGN---IKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPER 196
Query: 242 L-----RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDA---ILRGHI-DFSSDP 292
+ R+ Y +D+WS G+ LY L +G P+ S+FD +++G S+
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGDPPQLSNSE 254
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVL 322
S S + V L D +R E+L
Sbjct: 255 EREFSPSFINFVNLCLTKDESKRPKYKELL 284
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-42
Identities = 75/302 (24%), Positives = 128/302 (42%), Gaps = 29/302 (9%)
Query: 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREV 118
P R+ Y +G G V K++ A K I+ K + ++++ +E+
Sbjct: 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEI 64
Query: 119 QIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI--------IAKGHYSERAA 170
Q M H NIV ++ + + L+M L +GG + D I G E
Sbjct: 65 QAMSQCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF-FKPGDVFKD 229
A + R+++ + Y H G +HRD+K N L ++ DFG+S F GD+ ++
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS---VQIADFGVSAFLATGGDITRN 180
Query: 230 L-----VGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL 282
VG+ ++APEV+ + Y +ADIWS G+ L +G P+ + L
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240
Query: 283 RG------HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS-KFLIPKKTLQTL 335
+ + S + ++ L DP++R +AAE+L KF K + L
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFL 300
Query: 336 AD 337
+
Sbjct: 301 QE 302
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-41
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 43/290 (14%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHL 124
Y ++G G +GV + ++DT Q A K D V RE++++ L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF---LESEDDPVIKKIALREIRMLKQL 59
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVTVVH 182
H N+V L + + ++L+ + C DR + E ++ Q + V+
Sbjct: 60 K-HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVN 116
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEV 241
+CH +HRD+KPEN L + + +K DFG + + P D + D V + +Y +PE+
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173
Query: 242 L--RRNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAI-------------L 282
L YG D+W+ G + LLSGVP + G+++ I +
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 283 RGHIDFSSDPW----------PNISSSAKDIVKKMLHADPKERLSAAEVL 322
+ PNIS A ++K LH DP ERL+ ++L
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 64/268 (23%), Positives = 114/268 (42%), Gaps = 33/268 (12%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
ELGRG +GV + H + Q A K I R +N + + + ++ I V
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 134 KGAYEDRHSVNLIMDLCAGG--ELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHS-MGV 189
GA V + M+L + + ++I K E + +V + + HS + V
Sbjct: 72 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-----VGSAYYVAPEVLR- 243
+HRD+KP N L ++ + +K DFG+S G + D+ G Y+APE +
Sbjct: 132 IHRDVKPSNVLINALGQ---VKMCDFGIS-----GYLVDDVAKDIDAGCKPYMAPERINP 183
Query: 244 ----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFD---AILRGHI-DFSSDPWPN 295
+ Y ++DIWS G+ + L P+ ++ + F ++ +D +
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPADKF-- 239
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLS 323
S+ D + L + KER + E++
Sbjct: 240 -SAEFVDFTSQCLKKNSKERPTYPELMQ 266
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 90/331 (27%), Positives = 133/331 (40%), Gaps = 51/331 (15%)
Query: 26 GHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYL 85
HH L+ GP S SA + +S ++ Y +LG G +G Y
Sbjct: 6 HHHMGTLEAQTQGPGSMSVSAAPSATS---------IDR----YRRITKLGEGTYGEVYK 52
Query: 86 VTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHLTGHRNIVELKGAYEDRHSV 143
T + A K I +L + ++ REV ++ L HRNI+ELK H +
Sbjct: 53 AIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRL 108
Query: 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS 203
+LI + +L + S R + Q++ V++CHS +HRDLKP+N L S
Sbjct: 109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSV 167
Query: 204 SAEDSP--LKATDFGLSVFF-KPGDVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVI 258
S LK DFGL+ F P F + + +Y PE+L R+Y DIWS I
Sbjct: 168 SDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACI 227
Query: 259 LYILLSGVPPFWGETEQSIFDAILR--GHID------FSSDPW----------------- 293
+L P F G++E I G D ++ P
Sbjct: 228 WAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL 287
Query: 294 -PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ D++ ML DP +R+SA L
Sbjct: 288 GALLDDEGLDLLTAMLEMDPVKRISAKNALE 318
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-40
Identities = 75/292 (25%), Positives = 126/292 (43%), Gaps = 47/292 (16%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMH 122
Y +G G +G+ +KDT + A K K + DD + V+ RE++++
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLK 79
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVTV 180
L H N+V L + + L+ + + + + Q++
Sbjct: 80 QLR-HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIING 136
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAP 239
+ +CHS ++HRD+KPEN L S S +K DFG + PG+V+ D V + +Y AP
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR--GHID------FS 289
E+L YG D+W+ G ++ + G P F G+++ I+ G++ F+
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253
Query: 290 SDPW-------------------PNISSSAKDIVKKMLHADPKERLSAAEVL 322
+P P +S D+ KK LH DP +R AE+L
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-40
Identities = 65/270 (24%), Positives = 118/270 (43%), Gaps = 25/270 (9%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD----VEDVRREVQIMHHLTG 126
+ +++G+G FG+ + K A KS+ + ++ +REV IM +L
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN- 81
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCH 185
H NIV+L G + ++M+ G+L+ R++ K H L + + Y
Sbjct: 82 HPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 186 SMG--VMHRDLKPENFLFSSSAEDSP--LKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
+ ++HRDL+ N S E++P K DFGLS L+G+ ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWMAPET 197
Query: 242 LR---RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
+ +Y +AD +S +ILY +L+G PF + I + P I
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR----PTIPE 253
Query: 299 SA----KDIVKKMLHADPKERLSAAEVLSK 324
+++++ DPK+R + ++ +
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-40
Identities = 64/313 (20%), Positives = 126/313 (40%), Gaps = 35/313 (11%)
Query: 42 PSSSATSATSSSVGRVLGKPMEDVRNTYI------FGRELGRGQFGVTYLVTHKDTKQQF 95
P + + ++ S R + ++ I G +G+G+FG Y +
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH---GEV 58
Query: 96 ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL 155
A + I + N D ++ +REV H N+V GA + +I LC G L
Sbjct: 59 AIRLIDIERD-NEDQLKAFKREVMAYRQTR-HENVVLFMGACMSPPHLAIITSLCKGRTL 116
Query: 156 FDRI-IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214
+ + AK + +++V + Y H+ G++H+DLK +N + ++ + TD
Sbjct: 117 YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITD 172
Query: 215 FGLSVFFKP------GDVFKDLVGSAYYVAPEVLRRN----------YGAEADIWSAGVI 258
FGL D + G ++APE++R+ + +D+++ G I
Sbjct: 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232
Query: 259 LYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSA 318
Y L + PF + ++I + G + + DI+ + +ER +
Sbjct: 233 WYELHAREWPFKTQPAEAIIWQMGTGMK--PNLSQIGMGKEISDILLFCWAFEQEERPTF 290
Query: 319 AEVLSKF-LIPKK 330
+++ +PK+
Sbjct: 291 TKLMDMLEKLPKR 303
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 67/267 (25%), Positives = 117/267 (43%), Gaps = 32/267 (11%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
+GRG FGV + + A K ++ + + + E++ + + H NI
Sbjct: 12 VEEVVGRGAFGVVCKAKWRA--KDVAIK-----QIESESERKAFIVELRQLSRVN-HPNI 63
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSM 187
V+L GA + L+M+ GG L++ + +Y+ A + C Q V Y HSM
Sbjct: 64 VKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 188 ---GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
++HRDLKP N L + + LK DFG + + + GSA ++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEG 177
Query: 245 N-YGAEADIWSAGVILYILLSGVPPFWG--ETEQSIFDAILRGH---IDFSSDPWPNISS 298
+ Y + D++S G+IL+ +++ PF I A+ G + N+
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI------KNLPK 231
Query: 299 SAKDIVKKMLHADPKERLSAAEVLSKF 325
+ ++ + DP +R S E++
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKIM 258
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 74/321 (23%), Positives = 128/321 (39%), Gaps = 28/321 (8%)
Query: 33 KIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTK 92
+++ R A VG + +D + ELG G GV + V+HK +
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGEL---KDDD----FEKISELGAGNGGVVFKVSHKPSG 58
Query: 93 QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152
A K I I + RE+Q++H IV GA+ +++ M+ G
Sbjct: 59 LVMARKLI--HLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG-VMHRDLKPENFLFSSSAEDSPLK 211
G L + G E+ + ++ + Y +MHRD+KP N L +S E +K
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IK 172
Query: 212 ATDFGLSVFFKPGDVFKDL----VGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGV 266
DFG+S G + + VG+ Y++PE L+ Y ++DIWS G+ L + G
Sbjct: 173 LCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
Query: 267 PPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326
P + + +++ P + + + K + + P + E+L
Sbjct: 228 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI--FELLDY-- 283
Query: 327 IPKKTLQTLADLLYSQIFARF 347
I + L ++S F F
Sbjct: 284 IVNEPPPKLPSGVFSLEFQDF 304
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 75/290 (25%), Positives = 121/290 (41%), Gaps = 43/290 (14%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-----VRREVQIM 121
Y LG GQF Y K+T Q A K I KL +R + +D RE++++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLL 66
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVT 179
L+ H NI+ L A+ + +++L+ D + + +
Sbjct: 67 QELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQ 123
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVA 238
+ Y H ++HRDLKP N L + LK DFGL+ F P + V + +Y A
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRA 180
Query: 239 PEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAI----------- 281
PE+L R YG D+W+ G IL LL VP G+++ IF+ +
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 282 --LRGHIDFSSDP-------WPNISSSAKDIVKKMLHADPKERLSAAEVL 322
L ++ F S P + D+++ + +P R++A + L
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 7e-39
Identities = 62/337 (18%), Positives = 119/337 (35%), Gaps = 65/337 (19%)
Query: 63 EDVRNTYIFGRELGRGQ--FGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
Y +G+G L +K T + + I+ + + V ++ E+ +
Sbjct: 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELHV 79
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMV 178
H NIV + + + + ++ A G D +E A A + + ++
Sbjct: 80 SKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF--------KPGDVFKDL 230
+ Y H MG +HR +K + L S + + + ++ D K
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGK---VYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 231 VGSAYYVAPEVLRRN---YGAEADIWSAGVILYILLSGVPPF------------------ 269
V +++PEVL++N Y A++DI+S G+ L +G PF
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255
Query: 270 ------------------WGETEQSIFDAILRGHIDFSSDPWPNI------SSSAKDIVK 305
+ D++ S+ P+ S V+
Sbjct: 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE 315
Query: 306 KMLHADPKERLSAAEVLS-KFL--IPKKTLQTLADLL 339
+ L +P R SA+ +L+ F I ++ + L +LL
Sbjct: 316 QCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELL 352
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 74/302 (24%), Positives = 114/302 (37%), Gaps = 58/302 (19%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-----VRREVQIM 121
+ + +LG G + Y +K T A K + + D E+ RE+ +M
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAIREISLM 57
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIM-----DLCAGGELFDRIIAKGHYSERAAANLCRQ 176
L H NIV L + + L+ DL + Q
Sbjct: 58 KELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAY 235
++ + +CH ++HRDLKP+N L + + LK DFGL+ F P + F V + +
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLW 173
Query: 236 YVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAI-------- 281
Y AP+VL R Y DIWS G IL +++G P F G ++ IFD +
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233
Query: 282 --------------------LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
LR + + D + +L +P RLSA +
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQV--LQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291
Query: 322 LS 323
L
Sbjct: 292 LH 293
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 42/282 (14%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHLTGHRNIVE 132
+G G +G + +++T + A K + +L + D+ RE+ ++ L H+NIV
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELK-HKNIVR 65
Query: 133 LKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
L + L+ + C + FD G + Q++ + +CHS V+
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVL--RRNYG 247
HRDLKP+N L + + E LK +FGL+ F P + V + +Y P+VL + Y
Sbjct: 124 HRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 248 AEADIWSAGVILYILLS-GVPPFWGETE----QSIFDAI-------------LRGHIDFS 289
D+WSAG I L + G P F G + IF + L + +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 290 SDP--------WPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
P P ++++ +D+++ +L +P +R+SA E L
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 74/300 (24%), Positives = 115/300 (38%), Gaps = 63/300 (21%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-----VRREVQIM 121
TYI +LG G + Y K T A K I R + E+ REV ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLL 54
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLC---------AGGELFDRIIAKGHYSERAAAN 172
L H NIV L S+ L+ + G + + K
Sbjct: 55 KDLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVK---------L 104
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLV 231
Q++ + YCH V+HRDLKP+N L + E LK DFGL+ P + + V
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEV 161
Query: 232 GSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IF------- 278
+ +Y P++L +Y + D+W G I Y + +G P F G T + IF
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT 221
Query: 279 DAILRGHIDFS---------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ G + P + S D++ K+L + + R+SA + +
Sbjct: 222 EETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 79/287 (27%), Positives = 123/287 (42%), Gaps = 42/287 (14%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHLTG 126
Y ++G G +GV Y + + FA K I +L D+ RE+ I+ L
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN-YGETFALKKI---RLEKEDEGIPSTTIREISILKELK- 58
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVTVVHYC 184
H NIV+L + + L+ + +L D +G A + Q++ + YC
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYC 116
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVL- 242
H V+HRDLKP+N L + E LK DFGL+ F P + + + +Y AP+VL
Sbjct: 117 HDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 243 -RRNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAI-------------LRG 284
+ Y DIWS G I +++G P F G +E IF + L
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 285 -HIDFSSDP-------WPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+F+ + S D++ KML DP +R++A + L
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 79/321 (24%), Positives = 117/321 (36%), Gaps = 55/321 (17%)
Query: 48 SATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN 107
S S + + + + R G+G FG L K T A K +
Sbjct: 4 SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV------- 56
Query: 108 RDDVEDVRREVQIMHHLT--GHRNIVELK-----GAYEDRHSV--NLIMDLCAGGELFDR 158
D RE+QIM L H NIV+L+ DR + N++M+ L
Sbjct: 57 IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRC 115
Query: 159 IIAKGHYSERAAANLCR----QMVTVVHYCH--SMGVMHRDLKPENFLFSSSAEDSPLKA 212
L + Q++ + H S+ V HRD+KP N L + + D LK
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLKL 173
Query: 213 TDFGLSVFFKPGDVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFW 270
DFG + P + + S YY APE++ ++Y DIWS G I ++ G P F
Sbjct: 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233
Query: 271 GETEQSIFDAILR---------------GHIDFS-----SDPW--------PNISSSAKD 302
G+ I+R H D PW + A D
Sbjct: 234 GDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYD 293
Query: 303 IVKKMLHADPKERLSAAEVLS 323
++ +L P+ER+ E L
Sbjct: 294 LLSALLQYLPEERMKPYEALC 314
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-36
Identities = 65/304 (21%), Positives = 118/304 (38%), Gaps = 61/304 (20%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
++ Y R+LGRG++ + + ++ + K++ + ++RE++I+ +
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVV---V---KILKPVKKKKIKREIKILEN 86
Query: 124 LTGHRNIVELKGAYEDRHSVNLI--------MDLCAGGELFDRIIAKGHYSERAAANLCR 175
L G NI+ L +D S D ++ ++
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF-------KQLYQT--LTDYDIRFYMY 137
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY 235
+++ + YCHSMG+MHRD+KP N + L+ D+GL+ F+ PG + V S Y
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 236 YVAPEVL--RRNYGAEADIWSAGVILYILLSGVPP-FWGETEQSIFDAILR--------- 283
+ PE+L + Y D+WS G +L ++ P F G I +
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255
Query: 284 --GHID----------------------FSSDPWPNISSSAKDIVKKMLHADPKERLSAA 319
+ S+ +S A D + K+L D + RL+A
Sbjct: 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 315
Query: 320 EVLS 323
E +
Sbjct: 316 EAME 319
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 73/290 (25%), Positives = 115/290 (39%), Gaps = 43/290 (14%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHL 124
Y ++G G +GV Y + A K I +L D+ RE+ ++ L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI---RLDAEDEGIPSTAIREISLLKEL 76
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVTVVH 182
H NIV L + L+ + ++ D K + Q++ V
Sbjct: 77 H-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVA 133
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEV 241
+CH ++HRDLKP+N L +S LK DFGL+ F P + V + +Y AP+V
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 242 L--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAI-------------L 282
L + Y DIWS G I +++G P F G T+ IF + L
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250
Query: 283 RGHIDFSSDPW---------PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ + P D++ ML DP +R+SA + ++
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 74/297 (24%), Positives = 113/297 (38%), Gaps = 49/297 (16%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR-----REVQIM 121
+ Y E+G G +G Y + A KS+ ++ N REV ++
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALL 65
Query: 122 HHL--TGHRNIVELK-----GAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAAN 172
L H N+V L + V L+ + D+ G +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKD 124
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232
L RQ + + + H+ ++HRDLKPEN L +S +K DFGL+ + +V
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMALTPVVV 181
Query: 233 SAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAILRGHID 287
+ +Y APEVL + Y D+WS G I + P F G +E IFD L G
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD--LIGLPP 239
Query: 288 ------FSSDPW---------------PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
S P P + S ++ +ML +P +R+SA L
Sbjct: 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 21/266 (7%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD-VEDVRREVQIMHHLTGHRN 129
+G G FG Y + A K+ + +E+VR+E ++ L H N
Sbjct: 11 LEEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPN 67
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG- 188
I+ L+G ++ L+M+ GG L +++ N Q+ ++Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 189 --VMHRDLKPENFLFSSSAEDSP-----LKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
++HRDLK N L E+ LK TDFGL+ G+ ++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHRTTKMSAAGAYAWMAPEV 185
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI--DFSSDPWPNISS 298
+R + + +D+WS GV+L+ LL+G PF G ++ + + S
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPF-- 243
Query: 299 SAKDIVKKMLHADPKERLSAAEVLSK 324
+++ + DP R S +L +
Sbjct: 244 --AKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 68/309 (22%), Positives = 121/309 (39%), Gaps = 31/309 (10%)
Query: 27 HHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLV 86
HH + D P + A + P D+ ++G G FG +
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQGAMDGDDMDI---PWCDL----NIKEKIGAGSFGTVHRA 56
Query: 87 THKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146
A K + + + + V + REV IM L H NIV GA +++++
Sbjct: 57 EWHG--SDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSIV 112
Query: 147 MDLCAGGELFDRII---AKGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLF 201
+ + G L+ + A+ ER ++ + ++Y H+ ++HR+LK N L
Sbjct: 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV 172
Query: 202 SSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVIL 259
+ +K DFGLS + K G+ ++APEVLR ++D++S GVIL
Sbjct: 173 D---KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVIL 229
Query: 260 YILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA----KDIVKKMLHADPKER 315
+ L + P+ + A+ I + I++ +P +R
Sbjct: 230 WELATLQQPWGNLNPAQVVAAVGFKCKR------LEIPRNLNPQVAAIIEGCWTNEPWKR 283
Query: 316 LSAAEVLSK 324
S A ++
Sbjct: 284 PSFATIMDL 292
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 64/278 (23%), Positives = 111/278 (39%), Gaps = 35/278 (12%)
Query: 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
I G LG+G FG VTH++T + K + + + +EV++M L H N
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPN 68
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+++ G +N I + GG L I Y + + + + + Y HSM
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLS---------------VFFKPGDVFKDLVGS 233
++HRDL N L E+ + DFGL+ + +VG+
Sbjct: 129 IIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 234 AYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPF--WGETEQSI---FDAILRGHID 287
Y++APE++ R+Y + D++S G++L ++ V + L +
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC- 244
Query: 288 FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325
P PN S I + DP++R S ++
Sbjct: 245 ----P-PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-35
Identities = 61/271 (22%), Positives = 116/271 (42%), Gaps = 20/271 (7%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
G+ +G G FG Y A K ++ ++ + EV ++ H NI
Sbjct: 28 VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNI 82
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHYSERAAANLCRQMVTVVHYCHSMGV 189
+ G + ++ C G L+ + ++ + + ++ RQ + Y H+ +
Sbjct: 83 LLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLS---VFFKPGDVFKDLVGSAYYVAPEVLRRN- 245
+HRDLK N ED+ +K DFGL+ + F+ L GS ++APEV+R
Sbjct: 142 IHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 246 ---YGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDFSSDPWP-NISSSA 300
Y ++D+++ G++LY L++G P+ I + + RG + N
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 301 KDIVKKMLHADPKERLSAAEVLSKF-LIPKK 330
K ++ + L ER S +L++ + ++
Sbjct: 259 KRLMAECLKKKRDERPSFPRILAEIEELARE 289
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 48/268 (17%), Positives = 96/268 (35%), Gaps = 31/268 (11%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
F +L G + + K + R R D E + + H N+
Sbjct: 14 FLTKLNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRK-SRDFNEECPRLRIFS-HPNV 69
Query: 131 VELKGAYEDRHSVNL--IMDLCAGGELFDRIIAKGHY--SERAAANLCRQMVTVVHYCHS 186
+ + GA + + + I G L++ + ++ + A M + + H+
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 187 MG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
+ + L + + ED + + + F+ + + +VAPE L++
Sbjct: 130 LEPLIPRHALNSRSVMID---EDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQK 182
Query: 245 ----NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI----LRGHIDFSSDPWPNI 296
AD+WS V+L+ L++ PF + I + LR I P P I
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI-----P-PGI 236
Query: 297 SSSAKDIVKKMLHADPKERLSAAEVLSK 324
S ++K ++ DP +R ++
Sbjct: 237 SPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 70/309 (22%), Positives = 123/309 (39%), Gaps = 37/309 (11%)
Query: 24 GPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVT 83
HH + G S S G G Y R +GRG G
Sbjct: 3 SSHHHHH----HSSGLVPRGSHMDGTAESREGTQFGP--------YRLRRLVGRGGMGDV 50
Query: 84 YLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143
Y ++ A K +S + ++RE + L ++V + E +
Sbjct: 51 YEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQL 109
Query: 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS 203
+ M L G +L + +G + A + RQ+ + + H+ G HRD+KPEN L S
Sbjct: 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS- 168
Query: 204 SAEDSPLKATDFGL------SVFFKPGDVFKDLVGSAYYVAPEVLRRNY-GAEADIWSAG 256
D DFG+ + G+ VG+ YY+APE ++ ADI++
Sbjct: 169 --ADDFAYLVDFGIASATTDEKLTQLGNT----VGTLYYMAPERFSESHATYRADIYALT 222
Query: 257 VILYILLSGVPPFWGETEQSIFDAILRGHIDFS----SDPWPNISSSAKDIVKKMLHADP 312
+LY L+G PP+ G+ +++ HI+ + S P I + ++ + + +P
Sbjct: 223 CVLYECLTGSPPYQGDQL-----SVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNP 277
Query: 313 KER-LSAAE 320
++R ++ +
Sbjct: 278 EDRYVTCGD 286
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-33
Identities = 71/333 (21%), Positives = 119/333 (35%), Gaps = 86/333 (25%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSI---SSRKLINRDDVEDVRREVQ 119
E Y G+ LG G FG+ V ++ ++FA K + K RE+
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN----------RELD 52
Query: 120 IMHHLTGHRNIVELK--------------------------------------GAYEDRH 141
IM L H NI++L
Sbjct: 53 IMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111
Query: 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR----QMVTVVHYCHSMGVMHRDLKPE 197
+N+IM+ L + + NL Q+ V + HS+G+ HRD+KP+
Sbjct: 112 YLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQ 170
Query: 198 NFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL--RRNYGAEADIWSA 255
N L +++D+ LK DFG + P + + S +Y APE++ Y D+WS
Sbjct: 171 NLLV--NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228
Query: 256 GVILYILLSGVPPFWGETE---------------QSIFDAILRGHIDFSSDPWPNIS--- 297
G + L+ G P F GET + + + +
Sbjct: 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288
Query: 298 -------SSAKDIVKKMLHADPKERLSAAEVLS 323
S A D+++++L +P R++ E ++
Sbjct: 289 ILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 75/306 (24%), Positives = 125/306 (40%), Gaps = 78/306 (25%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRNI 130
+G+G FG + H+ T Q+ A K K++ ++ E RE++I+ L H N+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQLLK-HENV 78
Query: 131 VELKG--------AYEDRHSVNLIMDLC----AGGELFDRIIAKGHYSERAAANLCRQMV 178
V L + S+ L+ D C AG L + ++ + + ++
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSEIKRVMQMLL 134
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY--- 235
++Y H ++HRD+K N L + LK DFGL+ F + K+ + Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAF---SLAKNSQPNRYTNR 188
Query: 236 -----YVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAILRG 284
Y PE+L R+YG D+W AG I+ + + P G TEQ I L G
Sbjct: 189 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ--LCG 246
Query: 285 HIDFSSDPWPNISS----------------------------SAKDIVKKMLHADPKERL 316
I + + WPN+ + A D++ K+L DP +R+
Sbjct: 247 SI--TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 317 SAAEVL 322
+ + L
Sbjct: 305 DSDDAL 310
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 82/311 (26%), Positives = 130/311 (41%), Gaps = 64/311 (20%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
D+ + Y+ + LG G G+ + D ++ A K I V+ RE++I+
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVKHALREIKIIRR 64
Query: 124 LTGHRNIVELK--------------GAYEDRHSVNLIM-----DLCAGGELFDRIIAKGH 164
L H NIV++ G+ + +SV ++ DL ++ +G
Sbjct: 65 L-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA-------NVLEQGP 116
Query: 165 YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
E A Q++ + Y HS V+HRDLKP N ++ ED LK DFGL+ P
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPH 174
Query: 225 DVFKDL----VGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE---- 274
K + + +Y +P +L NY D+W+AG I +L+G F G E
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234
Query: 275 QSIFDAI------------------LRGHIDFSSDPW----PNISSSAKDIVKKMLHADP 312
Q I ++I +R + P P IS A D ++++L P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 313 KERLSAAEVLS 323
+RL+A E LS
Sbjct: 295 MDRLTAEEALS 305
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 67/293 (22%), Positives = 117/293 (39%), Gaps = 40/293 (13%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
+VR Y + +G G +G T + A K + R + + RE++++ H
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKH 80
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVT 179
+ H N++ L + +++ D +++ E L QM+
Sbjct: 81 MR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLK 139
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
+ Y H+ G++HRDLKP N + D LK DFGL+ V + +Y AP
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNE---DCELKILDFGLARQADSE--MTGYVVTRWYRAP 194
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWG-------------------ETEQSIF 278
EV+ Y DIWS G I+ +++G F G E Q +
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254
Query: 279 DAILRGHID----FSSDPW----PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ ++ + N S A ++++KML D ++R++A E L+
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 70/290 (24%), Positives = 119/290 (41%), Gaps = 53/290 (18%)
Query: 75 LGRGQFGVTYLVTH-KDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHL--TGHRN 129
+G G +G + K+ + A K + ++ ++ + REV ++ HL H N
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 130 IVELK-----GAYEDRHSVNLIM-----DLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
+V L + + L+ DL D++ + ++ Q++
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQDL---TTYLDKV-PEPGVPTETIKDMMFQLLR 131
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
+ + HS V+HRDLKP+N L +SS + +K DFGL+ + +V + +Y AP
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 240 EVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAILRGHID------F 288
EVL + +Y D+WS G I + P F G ++ I D I G
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI--GLPGEEDWPRD 246
Query: 289 SSDPW---------------PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ P +I KD++ K L +P +R+SA LS
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 71/277 (25%), Positives = 120/277 (43%), Gaps = 20/277 (7%)
Query: 54 VGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED 113
+G+++ Y +LG G YL + A K+I + ++
Sbjct: 5 IGKIIN-------ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR 57
Query: 114 VRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL 173
REV L+ H+NIV + E+ L+M+ G L + I + G S A N
Sbjct: 58 FEREVHNSSQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINF 116
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD--LV 231
Q++ + + H M ++HRD+KP+N L + LK DFG++ + + ++
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQTNHVL 173
Query: 232 GSAYYVAPEVLRRNY-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF-- 288
G+ Y +PE + DI+S G++LY +L G PPF GET SI AI
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSVPN 231
Query: 289 -SSDPWPNISSSAKDIVKKMLHADPKER-LSAAEVLS 323
++D +I S +++ + D R + E+
Sbjct: 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKD 268
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-32
Identities = 73/296 (24%), Positives = 123/296 (41%), Gaps = 46/296 (15%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
+V Y +G G +G T + A K +S R + + RE++++ H
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKH 84
Query: 124 LTGHRNIVELK------GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+ H N++ L + E+ + V L+ L G +L + I+ ++ L Q+
Sbjct: 85 MK-HENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQFLIYQI 141
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK-DLVGSAYY 236
+ + Y HS ++HRDLKP N + D LK DFGL+ + V + +Y
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNE---DCELKILDFGLA---RHTADEMTGYVATRWY 195
Query: 237 VAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWG-------------------ETEQ 275
APE++ +Y DIWS G I+ LL+G F G E +
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 276 SIFDAILRGHID----FSSDPW----PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
I R +I + + A D+++KML D +R++AA+ L+
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-32
Identities = 77/293 (26%), Positives = 122/293 (41%), Gaps = 41/293 (13%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
++ TY+ +G G +G K + ++ A K +S R + + RE+ ++ H
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKH 79
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVT 179
+ H N++ L + S+ D +I+ +SE L QM+
Sbjct: 80 MQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM-GLKFSEEKIQYLVYQMLK 137
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
+ Y HS GV+HRDLKP N + D LK DFGL+ V + +Y AP
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNE---DCELKILDFGLARHADAE--MTGYVVTRWYRAP 192
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWG-------------------ETEQSIF 278
EV+ +Y DIWS G I+ +L+G F G E Q +
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252
Query: 279 DAILRGHID----FSSDPW----PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
D + +I + P S A D+++KML D +RL+AA+ L+
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 75/303 (24%), Positives = 120/303 (39%), Gaps = 49/303 (16%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
V Y + +G G G+ ++ A K +S R N+ + RE+ +M
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKC 80
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVT 179
+ H+NI+ L + + S+ D+ EL D ++I ER + L QM+
Sbjct: 81 V-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-YLLYQMLC 138
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
+ + HS G++HRDLKP N + S LK DFGL+ + V + YY AP
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 240 EV-LRRNYGAEADIWSAGVILYILLSGVPPFWGE----------------TEQSI----- 277
EV L Y DIWS G I+ ++ G F G + +
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255
Query: 278 ----------------FDAILRGHIDFSSDPWPNISSS-AKDIVKKMLHADPKERLSAAE 320
F+ + + + + +S A+D++ KML D +R+S E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315
Query: 321 VLS 323
L
Sbjct: 316 ALQ 318
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 76/306 (24%), Positives = 117/306 (38%), Gaps = 62/306 (20%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR---REVQI 120
DV Y +G G +G+ K + A K K+ + + RE++I
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKI 78
Query: 121 MHHLTGHRNIVELK-----GAYEDRHSVNLIM-----DLCAGGELFDRIIAKGHYSERAA 170
+ H NI+ + E V ++ DL +++ H S
Sbjct: 79 LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-------KLLKTQHLSNDHI 130
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230
Q++ + Y HS V+HRDLKP N L ++ LK DFGL+ P
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGF 187
Query: 231 ----VGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWG------------- 271
V + +Y APE++ + Y DIWS G IL +LS P F G
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247
Query: 272 ------ETEQSIFDAILRGHID----FSSDPW----PNISSSAKDIVKKMLHADPKERLS 317
E I + R ++ + PW PN S A D++ KML +P +R+
Sbjct: 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307
Query: 318 AAEVLS 323
+ L+
Sbjct: 308 VEQALA 313
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 72/303 (23%), Positives = 118/303 (38%), Gaps = 49/303 (16%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
V Y + +G G G+ + A K +S R N+ + RE+ +M
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKC 117
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVT 179
+ H+NI+ L + + ++ D+ EL D ++I + + L QM+
Sbjct: 118 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-QMELDHERMSYLLYQMLC 175
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
+ + HS G++HRDLKP N + S D LK DFGL+ + V + YY AP
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 240 EV-LRRNYGAEADIWSAGVILYILLSGVPPFWGE----------------TEQSI----- 277
EV L Y DIWS G I+ ++ F G + +
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 278 ----------------FDAILRGHIDFSSDPWPNISSS-AKDIVKKMLHADPKERLSAAE 320
F + + + + +S A+D++ KML DP +R+S +
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 321 VLS 323
L
Sbjct: 353 ALQ 355
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 70/325 (21%), Positives = 112/325 (34%), Gaps = 71/325 (21%)
Query: 63 EDVRNTY-IFGRELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVED-VRREV 118
E V + + G ++GRG +G Y KD + +A K I + RE+
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI------EGTGISMSACREI 69
Query: 119 QIMHHLTGHRNIVELKGAYEDR--HSVNLIMD--------LCAGGELFDRIIAKGHYSER 168
++ L H N++ L+ + V L+ D +
Sbjct: 70 ALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 169 AAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS-PLKATDFGLS-VFFKPGDV 226
+L Q++ +HY H+ V+HRDLKP N L + +K D G + +F P
Sbjct: 129 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 227 FKDLVGSA---YYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI 281
DL +Y APE+L R+Y DIW+ G I LL+ P F E
Sbjct: 189 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248
Query: 282 LRG----HI-------------DFSSDPW--------------------------PNISS 298
I D P S
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 308
Query: 299 SAKDIVKKMLHADPKERLSAAEVLS 323
A +++K+L DP +R+++ + +
Sbjct: 309 KAFHLLQKLLTMDPIKRITSEQAMQ 333
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 61/309 (19%), Positives = 109/309 (35%), Gaps = 60/309 (19%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-----DDVEDVR--- 115
+++ Y R + G +G A K + + R D +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 116 REVQIMHHLTGHRNIVELK-----GAYEDRHSVNLIMDLCAGGELFD----RIIAKGHY- 165
RE+++++H H NI+ L+ H + L+ EL ++I
Sbjct: 78 REIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVT------ELMRTDLAQVIHDQRIV 130
Query: 166 -SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
S + ++ +H H GV+HRDL P N L + ++ + DF L+
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD---NNDITICDFNLAREDTAD 187
Query: 225 DVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWG----------- 271
V +Y APE++ + + D+WSAG ++ + + F G
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247
Query: 272 --------ETEQSIFDAILRGHIDFS-----SDPW----PNISSSAKDIVKKMLHADPKE 314
E R ++ S + W P A D++ KML +P+
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307
Query: 315 RLSAAEVLS 323
R+S + L
Sbjct: 308 RISTEQALR 316
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 76/313 (24%), Positives = 121/313 (38%), Gaps = 68/313 (21%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR---REVQI 120
++ + + LG G +GV THK T + A K K+ D RE++I
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREIKI 62
Query: 121 MHHLTGHRNIVELK-----GAYEDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAA 171
+ H H NI+ + ++E+ + V +I EL R+I+ S+
Sbjct: 63 LKHFK-HENIITIFNIQRPDSFENFNEVYIIQ------ELMQTDLHRVISTQMLSDDHIQ 115
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDL 230
Q + V H V+HRDLKP N L +S + LK DFGL+ + + +
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIIDESAADNSEP 172
Query: 231 VGSA----------YYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGE------ 272
G +Y APEV+ Y D+WS G IL L P F G
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232
Query: 273 ----------TEQSIFDAI--------LRGHIDFSSDPW----PNISSSAKDIVKKMLHA 310
+ I ++ + + P P ++ D++++ML
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292
Query: 311 DPKERLSAAEVLS 323
DP +R++A E L
Sbjct: 293 DPAKRITAKEALE 305
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 60/293 (20%), Positives = 109/293 (37%), Gaps = 42/293 (14%)
Query: 40 PRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKD-TKQQFACK 98
P S + + G ++ Y + G G YL ++ + K
Sbjct: 60 PYCGSPYSFLPQLNPGDIVA-------GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK 112
Query: 99 SISSRKLINRDDVEDV---RREVQIMHHLTGHRNIVEL--KGAYEDRHSVN---LIMDLC 150
L++ D E E Q + + H +IV++ + DRH ++M+
Sbjct: 113 G-----LVHSGDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVMEYV 166
Query: 151 AGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210
G L A +++ + Y HS+G+++ DLKPEN + + + L
Sbjct: 167 GGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----EEQL 220
Query: 211 KATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFW 270
K D G + F L G+ + APE++R DI++ G L L +P
Sbjct: 221 KLIDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRN 277
Query: 271 GETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER-LSAAEVL 322
G + + DP S ++++ + DP++R +A E+
Sbjct: 278 GRYVDGLPE----------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS 320
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 61/310 (19%), Positives = 111/310 (35%), Gaps = 66/310 (21%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH-HLTGHRN 129
+G+G++G + + + + A K SSR D + RE ++ + + H N
Sbjct: 12 LLECVGKGRYGEVWRGSWQG--ENVAVKIFSSR------DEKSWFRETELYNTVMLRHEN 63
Query: 130 IVELKGAYEDRHSVN------LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
I+ + D S + LI G L+D + + + + + + +
Sbjct: 64 ILGFIAS--DMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASGLAH 120
Query: 184 CHS--------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL----- 230
H + HRDLK +N L ++ D GL+V D+
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVK---KNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 231 VGSAYYVAPEVLR-------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSI-FDAIL 282
VG+ Y+APEVL + DIW+ G++L+ + + + F ++
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237
Query: 283 RGHIDFSSD-----------PWPNISSSA------KDIVKKMLHADPKERLSAAEVLSKF 325
F PN S ++K+ + +P RL+A +
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI---- 293
Query: 326 LIPKKTLQTL 335
KKTL +
Sbjct: 294 ---KKTLTKI 300
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 22/223 (9%)
Query: 115 RREVQIMHHLTGHRNIV------ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSER 168
RRE Q L H IV E + ++M+ G L D + +G + +
Sbjct: 60 RREAQNAAALN-HPAIVAVYDTGEAETPAGPLPY--IVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 169 AAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF- 227
A + +++ H G++HRD+KP N + S + +K DFG++
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSV 173
Query: 228 ---KDLVGSAYYVAPEVLRRNY-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI-- 281
++G+A Y++PE R + A +D++S G +LY +L+G PPF G++ S+ A
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQH 231
Query: 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER-LSAAEVLS 323
+R S +S+ +V K L +P+ R +AAE+ +
Sbjct: 232 VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 4e-28
Identities = 68/355 (19%), Positives = 125/355 (35%), Gaps = 71/355 (20%)
Query: 35 DPPGPPRPSSSATSAT------SSSVGRVLGKPMEDVR---NTYIFGRELGRGQFGVTYL 85
+ P RP S + ++ G G P+ R T + +G+G+FG +
Sbjct: 1 EDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWR 60
Query: 86 VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH-HLTGHRNIVELKGAYEDRHSVN 144
+ ++ A K SSR + RE +I + H NI+ A +
Sbjct: 61 GKWRG--EEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112
Query: 145 ----LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS--------MGVMHR 192
L+ D G LFD + + + L + + + H + HR
Sbjct: 113 TQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-----VGSAYYVAPEVLRRNYG 247
DLK +N L ++ D GL+V D+ VG+ Y+APEVL +
Sbjct: 172 DLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 228
Query: 248 AE-------ADIWSAGVILYILLSGVPPFWGETEQSI-FDAILRGHIDFSS--------- 290
+ ADI++ G++ + + + + + ++
Sbjct: 229 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 288
Query: 291 ------DPWPNISSSA--KDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLAD 337
+ W + + I+++ +A+ RL+A + KKTL L+
Sbjct: 289 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI-------KKTLSQLSQ 336
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 74/338 (21%), Positives = 125/338 (36%), Gaps = 83/338 (24%)
Query: 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREV 118
G+ V Y ++LG+G +G+ + + T + A K I N D + RE+
Sbjct: 1 GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRTFREI 59
Query: 119 QIMHHLTGHRNIVELKGAY--EDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAAN 172
I+ L+GH NIV L ++ V L+ + + +I
Sbjct: 60 MILTELSGHENIVNLLNVLRADNDRDVYLVF------DYMETDLHAVIRANILEPVHKQY 113
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232
+ Q++ V+ Y HS G++HRD+KP N L ++ + +K DFGLS F + +
Sbjct: 114 VVYQLIKVIKYLHSGGLLHRDMKPSNILLNA---ECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 233 SA----------------------YYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPP 268
+ +Y APE+L Y D+WS G IL +L G P
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
Query: 269 FWGE----------------TEQSI--------------------------FDAILRGHI 286
F G + + + D +
Sbjct: 231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN 290
Query: 287 DFSS-DPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+P + + A D++ K+L +P +R+SA + L
Sbjct: 291 LLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK 328
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-26
Identities = 69/347 (19%), Positives = 122/347 (35%), Gaps = 66/347 (19%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYI-FGRELGRGQFGVTYLVTHKDTKQQ 94
PPG S +S S G L ++ I +++G+G++G ++ + ++
Sbjct: 6 PPGESLRDLIEQSQSSGS-GSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRG--EK 62
Query: 95 FACKSISSRKLINRDDVEDVRREVQIMH-HLTGHRNIVELKGAYEDRHSVN----LIMDL 149
A K + + RE +I L H NI+ A LI D
Sbjct: 63 VAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116
Query: 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS--------MGVMHRDLKPENFLF 201
G L+D + ++ L V+ + + H+ + HRDLK +N L
Sbjct: 117 HENGSLYD-YLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 202 SSSAEDSPLKATDFGLSVFFKPGDVFKDL-----VGSAYYVAPEVLRRNYGAE------- 249
++ D GL+V F D+ VG+ Y+ PEVL +
Sbjct: 176 K---KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM 232
Query: 250 ADIWSAGVILYILLSGV----------PPFWGET-EQSIFDAI--------LRGHIDFSS 290
AD++S G+IL+ + P+ ++ + LR +
Sbjct: 233 ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP-NR 291
Query: 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLAD 337
++ + +P RL+A V KKTL +++
Sbjct: 292 WSSDECLRQMGKLMTECWAHNPASRLTALRV-------KKTLAKMSE 331
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 41/295 (13%), Positives = 76/295 (25%), Gaps = 43/295 (14%)
Query: 32 LKIDPPGPPRPSSSATSATSSSV--GRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHK 89
+ D P SSA V R+ Y G +
Sbjct: 1 IAFDALREPDRESSAPPDDVQLVPGARIAN-------GRYRLLIFHGGVPPLQFWQALDT 53
Query: 90 DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149
+Q A + + ++ D +++ + + + + R ++ +
Sbjct: 54 ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGGLVVAEW 112
Query: 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP 209
GG L + +A S A + + H GV P S
Sbjct: 113 IRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID----- 165
Query: 210 LKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPF 269
GDV ++ + + DI G LY LL P
Sbjct: 166 --------------GDV---VLAYPATMPDA------NPQDDIRGIGASLYALLVNRWPL 202
Query: 270 WGETEQSIFDAILRGHIDFSSDPW---PNISSSAKDIVKKMLHADPKERLSAAEV 321
+S R +P +I + + + D R ++ +
Sbjct: 203 PEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 59/279 (21%), Positives = 107/279 (38%), Gaps = 41/279 (14%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+ G ++GRG FG + + A KS R+ + D +E +I+ +
Sbjct: 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQYS 170
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERA-----AANLCRQMVTV 180
H NIV L G + + ++M+L GG+ + +G + M
Sbjct: 171 -HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGME-- 227
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
Y S +HRDL N L + E + LK +DFG+S ++ Y
Sbjct: 228 --YLESKCCIHRDLAARNCLVT---EKNVLKISDFGMS---------REEADGVYAASGG 273
Query: 238 ---------APEVLRRN-YGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHI 286
APE L Y +E+D+WS G++L+ G P+ + Q + + +G
Sbjct: 274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR 333
Query: 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325
+ ++++ +P +R S + + +
Sbjct: 334 ---LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 18/222 (8%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ V Y + +G+G FG Q A K + + K E++I+
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILE 148
Query: 123 HL-----TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY---SERAAANLC 174
HL N++ + + R+ + + +L L++ +I K + S
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFA 206
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA 234
++ + H ++H DLKPEN L S +K DFG S ++ V+ + S
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQ-GRSGIKVIDFG-SSCYEHQRVYTYIQ-SR 263
Query: 235 YYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQ 275
+Y APEV L YG D+WS G IL LL+G P GE E
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 61/312 (19%), Positives = 105/312 (33%), Gaps = 64/312 (20%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
RG+FG + + + A K + EV + + H NI
Sbjct: 28 LLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQD----KQSWQNEYEVYSLPGMK-HENI 80
Query: 131 VELKGAYEDRHSVN------LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC 184
++ GA ++ + LI G L D + S ++ M + Y
Sbjct: 81 LQFIGA--EKRGTSVDVDLWLITAFHEKGSLSD-FLKANVVSWNELCHIAETMARGLAYL 137
Query: 185 HSM----------GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD---LV 231
H + HRD+K +N L + DFGL++ F+ G D V
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLK---NNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 232 GSAYYVAPEVLRRNYGAE------ADIWSAGVILYILLSGVPPFWGETE--QSIFDAILR 283
G+ Y+APEVL + D+++ G++L+ L S G + F+ +
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254
Query: 284 GHIDFSS---------------DPWPNISSSAK--DIVKKMLHADPKERLSAAEVLSKFL 326
H D W + A + +++ D + RLSA V
Sbjct: 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV----- 309
Query: 327 IPKKTLQTLADL 338
+ + + L
Sbjct: 310 --GERITQMQRL 319
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 60/319 (18%), Positives = 109/319 (34%), Gaps = 72/319 (22%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--- 125
YI R+LG G F +L A K + K E E++++ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDAD 76
Query: 126 -------GHRNIVELKGAYEDRHSVN----LIMDLCAGGELFDRIIAKGH--YSERAAAN 172
G +I++L + + ++ ++ G L I H
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 173 LCRQMVTVVHYCHSM-GVMHRDLKPENFLFS---SSAEDSPLKATDFGLSVFFKPGDVFK 228
+ +Q++ + Y H G++H D+KPEN L S +K D G + + + +
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYT 193
Query: 229 DLVGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----------- 276
+ + + Y +PEV L +G ADIWS +++ L++G F + S
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 277 --------------------IFDAILRGHIDFSSDPWPNISSSAK-------------DI 303
F++ WP + D
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 304 VKKMLHADPKERLSAAEVL 322
+ ML DP++R A ++
Sbjct: 314 LSPMLQLDPRKRADAGGLV 332
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 27/222 (12%)
Query: 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
V Y GR +G G FGV + T+ QQ A K R D +R E + L
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLL 62
Query: 125 TGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFD-RIIAKGHYSERAAANLCRQMVTVVH 182
G I + E H+V L++DL G L D + +S + A +QM+ V
Sbjct: 63 AGCTGIPNVYYFGQEGLHNV-LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 183 YCHSMGVMHRDLKPENFLF--SSSAEDSPLKATDFGLSVFFK--------PGDVFKDLVG 232
H +++RD+KP+NFL +S + + DFG+ F++ P K+L G
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 233 SAYYVAPEVLRRNYGAEA----DIWSAGVILYILLSGVPPFW 270
+A Y++ + + G E D+ + G + L G P W
Sbjct: 181 TARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-23
Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 33/238 (13%)
Query: 66 RNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ + LG G FG ++ + K A K + R+ + +++ E +M
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTV 180
+ + ++ L G +V LI L G L D + K + + N C Q+
Sbjct: 72 ASVD-NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
++Y ++HRDL N L + +K TDFGL+ + Y
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLGAEE--------KEYHAEG 178
Query: 238 --------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
A E + R Y ++D+WS GV ++ L++ G P+ G I + +G
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
V N + GR++G G FG YL T+ T ++ A K + + + E +I L
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-----VKTKHPQLLYESKIYRIL 59
Query: 125 TGHRNIVELKGA-YEDRHSVNLIMDLCAG---GELFDRIIAKGHYSERAAANLCRQMVTV 180
G I ++ E ++V L+MDL G +LF+ S + L QM+
Sbjct: 60 QGGTGIPNVRWFGVEGDYNV-LVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINR 115
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK--------PGDVFKDLVG 232
V + HS +HRD+KP+NFL + + DFGL+ ++ P K+L G
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 233 SAYYVAPEVLRRNYGAEA----DIWSAGVILYILLSGVPPFW 270
+A Y + + + G E D+ S G +L L G P W
Sbjct: 176 TARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-23
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
V N Y GR++G G FG YL T ++ A K + + E +I +
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-----VKTKHPQLHIESKIYKMM 61
Query: 125 TGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFD-RIIAKGHYSERAAANLCRQMVTVVH 182
G I ++ E ++V ++M+L G L D +S + L QM++ +
Sbjct: 62 QGGVGIPTIRWCGAEGDYNV-MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK--------PGDVFKDLVGSA 234
Y HS +HRD+KP+NFL + + + DFGL+ ++ P K+L G+A
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 235 YYVAPEVLRRNYGAEA----DIWSAG-VILYILLSGVP 267
Y + + + G E D+ S G V++Y L +P
Sbjct: 180 RYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 3e-23
Identities = 68/353 (19%), Positives = 122/353 (34%), Gaps = 107/353 (30%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIM 121
V + YI +GRG +G YL K+T++ A K ++ + D ++ R RE+ I+
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITIL 79
Query: 122 HHLTGHRNIVELK--------GAYEDRHSVNLIM--DLCAGGELFDRIIAKGHY-SERAA 170
+ L I+ L +++ + V I DL ++ + +E
Sbjct: 80 NRL-KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLK-------KLFKTPIFLTEEHI 131
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKD 229
+ ++ ++ H G++HRDLKP N L + D +K DFGL+ D
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLLNQ---DCSVKVCDFGLARTINSEKDTNIV 188
Query: 230 LVGSA----------------------YYVAPEVL--RRNYGAEADIWSAGVILYILLS- 264
+Y APE++ + NY DIWS G I LL+
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 265 ----------------GVPPFWGETEQSIFDAILRGHID-------------------FS 289
G F +++ + + D +
Sbjct: 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN 308
Query: 290 SD---------------PW----PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
P+IS ++++ ML +P +R++ + L
Sbjct: 309 KPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 5e-23
Identities = 74/391 (18%), Positives = 127/391 (32%), Gaps = 113/391 (28%)
Query: 33 KIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTK 92
+ ++ + + + Y +G G +G K K
Sbjct: 19 TVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEK 78
Query: 93 QQFACKSISSRKLINRDDVEDVR--REVQIMHHLTGHRNIVELK-----GAYEDRHSVNL 145
+ A K I + D ++ R RE+ I++ L H ++V++ E + +
Sbjct: 79 RVVAIKKIL---RVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 146 IMDLCAGGELFD----RIIAKGHY-SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200
++ E+ D ++ Y +E L ++ V Y HS G++HRDLKP N L
Sbjct: 135 VL------EIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL 188
Query: 201 FSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSA------------------------- 234
+ D +K DFGL+ P + L S
Sbjct: 189 VNQ---DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245
Query: 235 --YYVAPEVL--RRNYGAEADIWSAGVILYILL--------------------SGVPPFW 270
+Y APE++ + NY D+WS G I LL S P
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSP 305
Query: 271 GETEQSIFDAILRGHID-----F------SSDPWPNISSS-------------------- 299
+ + F RG+ D F S + +
Sbjct: 306 DQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365
Query: 300 -------AKDIVKKMLHADPKERLSAAEVLS 323
A ++K+ML +P +R++ E L+
Sbjct: 366 FPASSADAIHLLKRMLVFNPNKRITINECLA 396
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 47/220 (21%), Positives = 91/220 (41%), Gaps = 27/220 (12%)
Query: 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
V + G+++G G FG L + T + A K + K + E + L
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMK----SRAPQLHLEYRFYKQL 61
Query: 125 TGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFD-RIIAKGHYSERAAANLCRQMVTVVH 182
I ++ +++ ++++L G L D + +S + + Q+++ +
Sbjct: 62 GSGDGIPQVYYFGPCGKYNA-MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 183 YCHSMGVMHRDLKPENFLF--SSSAEDSPLKATDFGLSVFFK--------PGDVFKDLVG 232
Y HS +++RD+KPENFL + + DF L+ + P K L G
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
Query: 233 SAYYVAPEVLRRNYGAEA----DIWSAG-VILYILLSGVP 267
+A Y++ + + G E D+ + G + +Y L +P
Sbjct: 180 TARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 58/238 (24%), Positives = 101/238 (42%), Gaps = 20/238 (8%)
Query: 59 GKPMEDV----RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDV 114
G P D R +LG GQ+G Y K A K++ + +VE+
Sbjct: 1 GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEF 56
Query: 115 RREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAAN 172
+E +M + H N+V+L G +I + G L D R + S
Sbjct: 57 LKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 115
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232
+ Q+ + + Y +HRDL N L E+ +K DFGLS GD + G
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAG 171
Query: 233 SAYYV---APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
+ + + APE L + ++D+W+ GV+L+ + + G+ P+ G +++ + + +
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 3e-22
Identities = 54/324 (16%), Positives = 106/324 (32%), Gaps = 75/324 (23%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH-HLTGHRN 129
+GRG++G Y + + + A K S + ++ E I L H N
Sbjct: 17 LLELIGRGRYGAVYKGSLDE--RPVAVKVFSFA------NRQNFINEKNIYRVPLMEHDN 68
Query: 130 IVELKGAYEDRHSVN------LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
I ++R + + L+M+ G L ++ ++ L + + Y
Sbjct: 69 IARFIVG-DERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSVTRGLAY 126
Query: 184 CHSM---------GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD----- 229
H+ + HRDL N L D +DFGLS+ + +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVK---NDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 230 ----LVGSAYYVAPEVLR--------RNYGAEADIWSAGVILYILLSGV----------- 266
VG+ Y+APEVL + + D+++ G+I + +
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 267 --PPFWGETEQSIFDAILRGHIDFS------SDPWPNISSSAKDIVKKML---HADPKER 315
F E ++ + + W S + + + + + D + R
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303
Query: 316 LSAAEVLSKFLIPKKTLQTLADLL 339
L+A ++ + L +
Sbjct: 304 LTAQXA-------EERMAELMMIW 320
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 6e-22
Identities = 74/326 (22%), Positives = 117/326 (35%), Gaps = 40/326 (12%)
Query: 21 PDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDV----RNTYIFGRELG 76
+ P N + S + A P R GR +G
Sbjct: 340 LPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIG 399
Query: 77 RGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
GQFG + ++ ++ A K+ + + E +E M H +IV+L
Sbjct: 400 EGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQFD-HPHIVKL 456
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
G + V +IM+LC GEL + K + Q+ T + Y S +HR
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV-----------APEV 241
D+ N L S + +K DFGLS + + S YY APE
Sbjct: 516 DIAARNVLVS---SNDCVKLGDFGLS---------RYMEDSTYYKASKGKLPIKWMAPES 563
Query: 242 LR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
+ R + + +D+W GV ++ +L GV PF G + I G PN +
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPNCPPT 620
Query: 300 AKDIVKKMLHADPKERLSAAEVLSKF 325
++ K DP R E+ ++
Sbjct: 621 LYSLMTKCWAYDPSRRPRFTELKAQL 646
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-22
Identities = 61/237 (25%), Positives = 93/237 (39%), Gaps = 33/237 (13%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
R + R LG G FG Y HK K A K+ +K D+ E E IM
Sbjct: 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMK 68
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVV 181
+L H +IV+L G E +IM+L GEL + K Q+ +
Sbjct: 69 NLD-HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---- 237
Y S+ +HRD+ N L + +K DFGLS + + YY
Sbjct: 127 AYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS---------RYIEDEDYYKASVT 174
Query: 238 -------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
+PE + R + +D+W V ++ +LS G PF+ + + + +G
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD 231
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 53/238 (22%), Positives = 92/238 (38%), Gaps = 33/238 (13%)
Query: 66 RNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ + LG G FG ++ + K A K + R+ + +++ E +M
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTV 180
+ + ++ L G +V LI L G L D + K + + N C Q+
Sbjct: 72 ASVD-NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
++Y ++HRDL N L +K TDFGL+ + Y
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEE--------KEYHAEG 178
Query: 238 --------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
A E + R Y ++D+WS GV ++ L++ G P+ G I + +G
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-21
Identities = 51/250 (20%), Positives = 88/250 (35%), Gaps = 35/250 (14%)
Query: 55 GRVLGKPMEDVRNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDD 110
G + + LG G FG ++ + K K I R
Sbjct: 1 GAMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQS 58
Query: 111 VEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERA 169
+ V + + L H +IV L G S+ L+ G L D + +G +
Sbjct: 59 FQAVTDHMLAIGSLD-HAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQL 116
Query: 170 AANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD 229
N Q+ ++Y G++HR+L N L S ++ DFG++
Sbjct: 117 LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVA---------DL 164
Query: 230 LVGSAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQ 275
L + A E + Y ++D+WS GV ++ L++ G P+ G
Sbjct: 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 224
Query: 276 SIFDAILRGH 285
+ D + +G
Sbjct: 225 EVPDLLEKGE 234
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 60/267 (22%), Positives = 112/267 (41%), Gaps = 19/267 (7%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R +LG GQ+G Y K A K++ + +VE+ +E +M +
Sbjct: 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK 274
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHY 183
H N+V+L G +I + G L D R + S + Q+ + + Y
Sbjct: 275 -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---APE 240
+HR+L N L E+ +K DFGLS GD + G+ + + APE
Sbjct: 334 LEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 389
Query: 241 VLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
L + ++D+W+ GV+L+ + + G+ P+ G +++ + + + +
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGCPE 446
Query: 299 SAKDIVKKMLHADPKERLSAAEVLSKF 325
++++ +P +R S AE+ F
Sbjct: 447 KVYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 18/223 (8%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
E + Y +G+G FG + ++ A K I ++K + EV+++
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ----AQIEVRLLE 105
Query: 123 HL-----TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCR 175
+ IV LK + R+ + L+ ++ L+D + S +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQ 164
Query: 176 QMVTVVHYCHS--MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
QM T + + + + ++H DLKPEN L + + S +K DFG S +++ + S
Sbjct: 165 QMCTALLFLATPELSIIHCDLKPENILLCNP-KRSAIKIVDFG-SSCQLGQRIYQYIQ-S 221
Query: 234 AYYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQ 275
+Y +PEV L Y D+WS G IL + +G P F G E
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 65/326 (19%), Positives = 115/326 (35%), Gaps = 74/326 (22%)
Query: 63 EDVRNTYIFGRELGRGQFG-VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ ++ Y LG G FG V + H K Q A K I + E R E+ ++
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVL 70
Query: 122 HHL-----TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY---SERAAANL 173
+ V + + + + +L G F+ + + ++ ++
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFE-FLKENNFQPYPLPHVRHM 128
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA----------------EDSPLKATDFGL 217
Q+ + + H + H DLKPEN LF +S +++ ++ DFG
Sbjct: 129 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 218 SVFFKPGDVFKDLVGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQS 276
+ F + +V + +Y PEV L + D+WS G IL+ G F +
Sbjct: 189 ATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
Query: 277 IFDAILR--GHID------------FSSD--PWPNISSSAK------------------- 301
+ + G I F W SS +
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306
Query: 302 -----DIVKKMLHADPKERLSAAEVL 322
D++++ML DP +R++ AE L
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEAL 332
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 59/235 (25%), Positives = 89/235 (37%), Gaps = 29/235 (12%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+LG G FGV A K + L + ++D REV MH
Sbjct: 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVV 181
L HRN++ L G + ++ +L G L DR+ +GH+ + Q+ +
Sbjct: 77 SLD-HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---- 237
Y S +HRDL N L ++ +K DFGL D Y +
Sbjct: 135 GYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALPQND-------DHYVMQEHR 184
Query: 238 -------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILR 283
APE L+ R + +D W GV L+ + + G P+ G I I +
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 40/239 (16%), Positives = 74/239 (30%), Gaps = 29/239 (12%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSIS----SRKLINRDDVEDVRREVQIM 121
IF LG+G F + ++ +R+ E +M
Sbjct: 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTV 180
L+ H+++V G L+ + G L + K + + +Q+
Sbjct: 67 SKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPL-----KATDFGLSVFFKPGDVFKDLVGSAY 235
+H+ ++H ++ +N L + K +D G+S ++
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---------ITVLPKDI 176
Query: 236 Y------VAPEVL--RRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
V PE + +N D WS G L+ + S G P Q H
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 62/289 (21%), Positives = 108/289 (37%), Gaps = 47/289 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R R LG G FG Y + + + Q A K++ ++ + D D E I
Sbjct: 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALI 86
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
+ H+NIV G ++M+L AGG+L + + ++ ++ V
Sbjct: 87 ISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 181 V-------HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
Y +HRD+ N L + K DFG++ +D+ +
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIYRA 196
Query: 234 AYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFD 279
+YY PE + ++ D WS GV+L+ + S G P+ ++ Q + +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLSKF 325
+ G DP N I M P++R + A +L +
Sbjct: 257 FVTSGGR---MDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAIILERI 299
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-21
Identities = 62/237 (26%), Positives = 96/237 (40%), Gaps = 33/237 (13%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
R GR +G GQFG + ++ ++ A K+ + + E +E M
Sbjct: 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMR 71
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVV 181
H +IV+L G + V +IM+LC GEL + K + Q+ T +
Sbjct: 72 QFD-HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---- 237
Y S +HRD+ N L S + +K DFGLS + + S YY
Sbjct: 130 AYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS---------RYMEDSTYYKASKG 177
Query: 238 -------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + R + + +D+W GV ++ +L GV PF G + I G
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-21
Identities = 68/329 (20%), Positives = 107/329 (32%), Gaps = 74/329 (22%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ N ++ R++G G FG L H D K+ +A K + + K + E I+
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILK 86
Query: 123 HL----TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQ 176
+ + NIV+ G + + LI + G L++ I + + C +
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE 145
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV----- 231
++ ++Y M + H DLKPEN L + L K
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 232 -GSA--------------YYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQ 275
G A Y APEV L + +D+WS G +L L +G F
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 276 SIFDAILR--GHID---------------FSSDP----WPNISSSAK------------- 301
+ I + D WP +SS
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325
Query: 302 --------DIVKKMLHADPKERLSAAEVL 322
D + +L DP R S AE+L
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELL 354
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 9e-21
Identities = 61/289 (21%), Positives = 107/289 (37%), Gaps = 47/289 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R R LG G FG Y + + + Q A K++ ++ + D D E I
Sbjct: 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALI 127
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
+ H+NIV G ++++L AGG+L + + ++ ++ V
Sbjct: 128 ISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 181 V-------HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
Y +HRD+ N L + K DFG++ +D+ +
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIYRA 237
Query: 234 AYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFD 279
YY PE + ++ D WS GV+L+ + S G P+ ++ Q + +
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLSKF 325
+ G DP N I M P++R + A +L +
Sbjct: 298 FVTSGGR---MDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAIILERI 340
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 40/238 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R +ELG GQFGV L K + A K I ++ +E Q M L+
Sbjct: 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKE----GSMSEDEFFQEAQTMMKLS 61
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERA-----AANLCRQMVTV 180
H +V+ G + + ++ + + G L + + + G E + ++C M
Sbjct: 62 -HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA-- 118
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
+ S +HRDL N L D +K +DFG++ + ++ Y
Sbjct: 119 --FLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMT---------RYVLDDQYVSSVG 164
Query: 238 --------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APEV Y +++D+W+ G++++ + S G P+ T + + +GH
Sbjct: 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 52/232 (22%), Positives = 89/232 (38%), Gaps = 30/232 (12%)
Query: 70 IFGRELGRGQFGVTY--LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH 127
+ +ELG G FG K + A K + + + +++ E +M L +
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-N 77
Query: 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM 187
IV + G E S L+M++ G L + H ++ L Q+ + Y
Sbjct: 78 PYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---------- 237
+HRDL N L K +DFGLS + + YY
Sbjct: 137 NFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADE--------NYYKAQTHGKWPVK 185
Query: 238 --APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + + +++D+WS GV+++ S G P+ G + + +G
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 237
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 58/296 (19%), Positives = 108/296 (36%), Gaps = 61/296 (20%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R RELG+G FG+ Y V + + + A K++ + + + + E +
Sbjct: 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASV 81
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
M ++V L G +IM+L G+L + + + +
Sbjct: 82 MKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 181 VHYCH----------SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230
+ + +HRDL N + + ED +K DFG++ +D+
Sbjct: 141 IQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------RDI 188
Query: 231 VGSAYYV------------APEVLR-RNYGAEADIWSAGVILY-ILLSGVPPFWGETEQS 276
+ YY +PE L+ + +D+WS GV+L+ I P+ G + +
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248
Query: 277 IFDAILRGHI----DFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLSKF 325
+ ++ G + D D + M +PK R S E++S
Sbjct: 249 VLRFVMEGGLLDKPDNCPDMLFEL----------MRMCWQYNPKMRPSFLEIISSI 294
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-20
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 28/230 (12%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDV--EDVRREVQIMHH 123
+ +G+G+FG L ++ K A K I ++D + E +M
Sbjct: 20 MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-------KNDATAQAFLAEASVMTQ 70
Query: 124 LTGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTV 180
L H N+V+L G E++ + ++ + A G L D R + +
Sbjct: 71 LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
+ Y +HRDL N L S ED+ K +DFGL+ + V
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT-----KEASSTQDTGKLPVKWT 181
Query: 238 APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE LR + + ++D+WS G++L+ + S G P+ + + + +G+
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 231
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-20
Identities = 57/236 (24%), Positives = 101/236 (42%), Gaps = 36/236 (15%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+ F +E+G GQFG+ +L + K + A K+I ED E ++M L+
Sbjct: 7 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE----GAMSEEDFIEEAEVMMKLS 61
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL---CRQMVTVVH 182
H +V+L G ++ + L+ + G L D + + AA L C + +
Sbjct: 62 -HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMA 118
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV----- 237
Y V+HRDL N L E+ +K +DFG++ + ++ Y
Sbjct: 119 YLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMT---------RFVLDDQYTSSTGTK 166
Query: 238 ------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
+PEV Y +++D+WS GV+++ + S G P+ + + + I G
Sbjct: 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 222
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 73/326 (22%), Positives = 121/326 (37%), Gaps = 52/326 (15%)
Query: 50 TSSSVGRVLGKPMEDV---RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSR 103
S + L + +EDV + GR LG+G+FG L + + A K + +
Sbjct: 3 DSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA- 61
Query: 104 KLINRDDVEDVRREVQIMHHLTGHRNIVELKGA------YEDRHSVNLIMDLCAGGELFD 157
+I D+E+ RE M H ++ +L G +I+ G+L
Sbjct: 62 DIIASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA 120
Query: 158 RIIAKGHYSERAAANL------CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211
++A L + + Y S +HRDL N + + ED +
Sbjct: 121 FLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVC 177
Query: 212 ATDFGLSVFFKPGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVI 258
DFGLS + + YY A E L Y +D+W+ GV
Sbjct: 178 VADFGLS---------RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228
Query: 259 LYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS 317
++ +++ G P+ G I++ ++ G+ P D++ + ADPK+R S
Sbjct: 229 MWEIMTRGQTPYAGIENAEIYNYLIGGNR---LKQPPECMEEVYDLMYQCWSADPKQRPS 285
Query: 318 AAEV---LSKFLIPKKTLQTLADLLY 340
+ L L L T D LY
Sbjct: 286 FTCLRMELENILGHLSVLSTSQDPLY 311
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-20
Identities = 61/261 (23%), Positives = 100/261 (38%), Gaps = 51/261 (19%)
Query: 61 PMEDVRNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRR 116
P + R+LG G FG Y +T +Q A KS+ + + + D+++
Sbjct: 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKK 72
Query: 117 EVQIMHHLTGHRNIVELKGA--YEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANL 173
E++I+ +L H NIV+ KG + + + LIM+ G L + + K + +
Sbjct: 73 EIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-VG 232
Q+ + Y S +HRDL N L + +K DFGL+ K +
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLT---------KAIETD 179
Query: 233 SAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS--------------- 264
YY APE L + +D+WS GV L+ LL+
Sbjct: 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
Query: 265 GVPPFWGETEQSIFDAILRGH 285
P T + + + G
Sbjct: 240 IGPTHGQMTVTRLVNTLKEGK 260
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-20
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 34/235 (14%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
F +ELG GQFGV + A K I ++ E ++M +L+
Sbjct: 23 PKDLTFLKELGTGQFGVVKYGKWRGQY-DVAIKMIKE----GSMSEDEFIEEAKVMMNLS 77
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHY 183
H +V+L G + + +I + A G L + R + + + +C+ + + Y
Sbjct: 78 -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV------ 237
S +HRDL N L + + +K +DFGLS + ++ Y
Sbjct: 136 LESKQFLHRDLAARNCLVN---DQGVVKVSDFGLS---------RYVLDDEYTSSVGSKF 183
Query: 238 -----APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
PEVL + +++DIW+ GV+++ + S G P+ T + I +G
Sbjct: 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 238
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-20
Identities = 74/325 (22%), Positives = 117/325 (36%), Gaps = 72/325 (22%)
Query: 63 EDVRNTYIFGRELGRGQFG-VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ + Y LG G FG V + HK + A K + + E R E+Q++
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVL 65
Query: 122 HHL-----TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLC 174
HL V++ +E + ++ +L G +D I G + +
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSA----------------EDSPLKATDFGLS 218
Q+ V++ HS + H DLKPEN LF S + +K DFG +
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 219 VFFKPGDVFKDLVGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
+ + LV + +Y APEV L + D+WS G IL G F +
Sbjct: 185 TY--DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242
Query: 278 FDAILR--GHID------------FSSD--PWPNISSSAK-------------------- 301
+ R G + F D W SS+ +
Sbjct: 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302
Query: 302 ----DIVKKMLHADPKERLSAAEVL 322
D+++KML DP +R++ E L
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREAL 327
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-20
Identities = 59/243 (24%), Positives = 89/243 (36%), Gaps = 38/243 (15%)
Query: 66 RNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ +LG+G FG Y +T A K + + D D +RE+QI+
Sbjct: 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQIL 78
Query: 122 HHLTGHRNIVELKG--AYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMV 178
L IV+ +G R S+ L+M+ G L D + + Q+
Sbjct: 79 KAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-VGSAYYV 237
+ Y S +HRDL N L ++ +K DFGL+ K L + YYV
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLA---------KLLPLDKDYYV 185
Query: 238 ------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILR 283
APE L + ++D+WS GV+LY L + E R
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245
Query: 284 GHI 286
Sbjct: 246 DVP 248
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-20
Identities = 62/298 (20%), Positives = 100/298 (33%), Gaps = 60/298 (20%)
Query: 25 PGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGV-- 82
HH + + ++ P + F ++LG+G FG
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMGSAFEDR-------DPTQFEERHLKFLQQLGKGNFGSVE 58
Query: 83 --TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA--YE 138
Y +T + A K + + + + D RE++I+ L H NIV+ KG
Sbjct: 59 MCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA 114
Query: 139 DRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPE 197
R ++ LIM+ G L D + K Q+ + Y + +HRDL
Sbjct: 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 174
Query: 198 NFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-VGSAYYV------------APEVLR- 243
N L ++ +K DFGL+ K L YY APE L
Sbjct: 175 NILVE---NENRVKIGDFGLT---------KVLPQDKEYYKVKEPGESPIFWYAPESLTE 222
Query: 244 RNYGAEADIWSAGVILYILLS----------------GVPPFWGETEQSIFDAILRGH 285
+ +D+WS GV+LY L + G + + +
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 54/234 (23%), Positives = 95/234 (40%), Gaps = 36/234 (15%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDV--EDVRREVQIMHH 123
+ +G+G+FG L ++ K A K I ++D + E +M
Sbjct: 192 MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-------KNDATAQAFLAEASVMTQ 242
Query: 124 LTGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTV 180
L H N+V+L G E++ + ++ + A G L D R + +
Sbjct: 243 LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
+ Y +HRDL N L S ED+ K +DFGL+ K+ +
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---------KEASSTQDTGKLP 349
Query: 238 ----APEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE LR + ++D+WS G++L+ + S G P+ + + + +G+
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 403
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 57/257 (22%), Positives = 92/257 (35%), Gaps = 53/257 (20%)
Query: 66 RNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
F ++LG+G FG Y +T + A K + + + + D RE++I+
Sbjct: 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEIL 65
Query: 122 HHLTGHRNIVELKGA--YEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMV 178
L H NIV+ KG R ++ LIM+ G L D + K Q+
Sbjct: 66 KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-VGSAYYV 237
+ Y + +HRDL N L ++ +K DFGL+ K L ++
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLT---------KVLPQDKEFFK 172
Query: 238 ------------APEVLR-RNYGAEADIWSAGVILYILLS----------------GVPP 268
APE L + +D+WS GV+LY L + G
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 269 FWGETEQSIFDAILRGH 285
+ + +
Sbjct: 233 QGQMIVFHLIELLKNNG 249
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 43/244 (17%), Positives = 86/244 (35%), Gaps = 47/244 (19%)
Query: 59 GKPMED-VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
GK ++D N ++ G+++G G FG+ YL + ++ A + + + + E
Sbjct: 28 GKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK----VEYQENGPLFSE 83
Query: 118 VQIMHHLTGHRNIVELKGAY-------------------EDRHSVNLIMDLCAGGELFDR 158
++ + I + + ++M+ G +L
Sbjct: 84 LKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRF-MVMERL-GIDLQKI 141
Query: 159 IIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218
G + + L +M+ V+ Y H +H D+K N L D + D+GLS
Sbjct: 142 SGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ-VYLADYGLS 200
Query: 219 VFFKPG--------DVFKDLVGSAYYVA------PEVLRRNYGAEADIWSAG-VILYILL 263
+ P + K G+ + + + RR +D+ G +L L
Sbjct: 201 YRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-----SDVEILGYCMLRWLC 255
Query: 264 SGVP 267
+P
Sbjct: 256 GKLP 259
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-19
Identities = 57/241 (23%), Positives = 97/241 (40%), Gaps = 36/241 (14%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
F +GRG FG Y L+ + K A KS+ ++ + +V E IM
Sbjct: 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMK 81
Query: 123 HLTGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTV 180
+ H N++ L G S +++ G+L + I + + + Q+
Sbjct: 82 DFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 140
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
+ Y S +HRDL N + E +K DFGL+ +D+ YY
Sbjct: 141 MKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---------RDMYDKEYYSVHN 188
Query: 238 -----------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284
A E L+ + + ++D+WS GV+L+ L++ G PP+ I +L+G
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
Query: 285 H 285
Sbjct: 249 R 249
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 74/292 (25%), Positives = 113/292 (38%), Gaps = 36/292 (12%)
Query: 15 HSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVR----NTYI 70
D G+ P +I P PRP TS S + + N I
Sbjct: 280 PQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLI 339
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQF--ACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
ELG G FG ++ K+Q A K + ++ + D E++ RE QIMH L +
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLD-NP 396
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSM 187
IV L G + ++ L+M++ GG L ++ + A L Q+ + Y
Sbjct: 397 YIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---------- 237
+HR+L N L K +DFGLS D +YY
Sbjct: 456 NFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADD--------SYYTARSAGKWPLK 504
Query: 238 --APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + R + + +D+WS GV ++ LS G P+ + I +G
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-19
Identities = 49/235 (20%), Positives = 91/235 (38%), Gaps = 34/235 (14%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R T LG GQFG ++ + + A KS+ + E +M L
Sbjct: 12 RETLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQ----GSMSPDAFLAEANLMKQLQ 66
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHY 183
H+ +V L + + +I + G L D + + + ++ Q+ + +
Sbjct: 67 -HQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV------ 237
+HRDL+ N L S + K DFGL+ + + + Y
Sbjct: 125 IEERNYIHRDLRAANILVS---DTLSCKIADFGLA---------RLIEDNEYTAREGAKF 172
Query: 238 -----APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + + ++D+WS G++L +++ G P+ G T + + RG+
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 227
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 62/279 (22%), Positives = 109/279 (39%), Gaps = 45/279 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R + +LG+G FG ++ T T + A K++ E +E Q+M L
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP----GTMSPEAFLQEAQVMKKLR 237
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERA-----AANLCRQMVT 179
H +V+L + + ++ + + G L D + G Y AA + M
Sbjct: 238 -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA- 294
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV-- 237
Y M +HRDL+ N L E+ K DFGL+ + + + Y
Sbjct: 295 ---YVERMNYVHRDLRAANILVG---ENLVCKVADFGLA---------RLIEDNEYTARQ 339
Query: 238 ---------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286
APE + ++D+WS G++L L + G P+ G + + D + RG+
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 399
Query: 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325
P S D++ + +P+ER + + +
Sbjct: 400 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-19
Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 32/230 (13%)
Query: 73 RELGRGQFGVTY--LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
ELG G FG + + + A K + ++ + D E++ RE QIMH L + I
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLD-NPYI 72
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGV 189
V L G + ++ L+M++ GG L ++ + A L Q+ + Y
Sbjct: 73 VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV------------ 237
+HRDL N L K +DFGLS D +YY
Sbjct: 132 VHRDLAARNVLLV---NRHYAKISDFGLSKALGADD--------SYYTARSAGKWPLKWY 180
Query: 238 APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + R + + +D+WS GV ++ LS G P+ + I +G
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 230
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 51/235 (21%), Positives = 94/235 (40%), Gaps = 34/235 (14%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R + ++LG GQFG ++ T+ + A K++ VE E +M L
Sbjct: 187 RESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKP----GSMSVEAFLAEANVMKTLQ 241
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHY 183
H +V+L + + +I + A G L D + + Q+ + +
Sbjct: 242 -HDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV------ 237
+HRDL+ N L S K DFGL+ + + + Y
Sbjct: 300 IEQRNYIHRDLRAANILVS---ASLVCKIADFGLA---------RVIEDNEYTAREGAKF 347
Query: 238 -----APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + ++ ++D+WS G++L +++ G P+ G + + A+ RG+
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 402
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 66/308 (21%), Positives = 118/308 (38%), Gaps = 62/308 (20%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
RN I G+ LG G+FG L T + A K++ ++ ++E+ E M
Sbjct: 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMK 91
Query: 123 HLTGHRNIVELKGAYEDRHSVN-----LIMDLCAGGELFDRIIAKGHYSERAAANL---- 173
+ H N++ L G + S +I+ G+L ++ + L
Sbjct: 92 DFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 174 --CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
+ + Y + +HRDL N + +D + DFGLS K +
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLS---------KKIY 198
Query: 232 GSAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSI 277
YY A E L R Y +++D+W+ GV ++ + + G+ P+ G +
Sbjct: 199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258
Query: 278 FDAILRGHI----DFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLSKFLIPKK 330
+D +L GH + D I M DP +R + + + + +K
Sbjct: 259 YDYLLHGHRLKQPEDCLDELYEI----------MYSCWRTDPLDRPTFSVLRLQL---EK 305
Query: 331 TLQTLADL 338
L++L D+
Sbjct: 306 LLESLPDV 313
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 67/301 (22%), Positives = 115/301 (38%), Gaps = 65/301 (21%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
RN FG+ LG G FG + +D + A K + + + D+ E + E++I
Sbjct: 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKI 102
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD------RIIAKGHYSERAAANL- 173
M HL H NIV L GA V +I + C G+L + R++ A +
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 174 -------CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226
Q+ + + S +HRD+ N L + K DFGL+
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLA-------- 211
Query: 227 FKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILY-ILLSGVPPFWG- 271
+D++ + Y+ APE + Y ++D+WS G++L+ I G+ P+ G
Sbjct: 212 -RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270
Query: 272 ETEQSIFDAILRGHI----DFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLSK 324
+ + G+ F+ +I M +P R + ++ S
Sbjct: 271 LVNSKFYKLVKDGYQMAQPAFAPKNIYSI----------MQACWALEPTHRPTFQQICSF 320
Query: 325 F 325
Sbjct: 321 L 321
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 64/369 (17%), Positives = 114/369 (30%), Gaps = 114/369 (30%)
Query: 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ 119
K + Y R+LG G F +L K+ A K + S E E++
Sbjct: 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIR 85
Query: 120 IMHHLT-------GHRNIVELKGAYE-----DRHSVNLIMDLCAGGELFDRIIAKGH--Y 165
++ + +V+L ++ H ++ ++ G L II +
Sbjct: 86 LLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC-MVFEV-LGHHLLKWIIKSNYQGL 143
Query: 166 SERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSS-------------------- 204
+ +Q++ + Y H+ ++H D+KPEN L S +
Sbjct: 144 PLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 205 --------------------------AEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVA 238
AE +K D G + + F + + + Y +
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRS 261
Query: 239 PEV-LRRNYGAEADIWSAGVILYILLSGVPPF--WGETEQSIFDAILRGHID-------- 287
EV + Y ADIWS + + L +G F E + + + I+
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK 321
Query: 288 -----------FSSD----------PWPNISSSAK-------------DIVKKMLHADPK 313
F+ PW + D + ML P+
Sbjct: 322 LIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPE 381
Query: 314 ERLSAAEVL 322
+R +AAE L
Sbjct: 382 KRATAAECL 390
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 71/369 (19%), Positives = 130/369 (35%), Gaps = 56/369 (15%)
Query: 8 PSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRN 67
S + + T + G ++ V V +
Sbjct: 30 GSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSL 89
Query: 68 TYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
F +GRG FG Y L+ + K A KS+ ++ + +V E IM
Sbjct: 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF 147
Query: 125 TGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVH 182
+ H N++ L G S +++ G+L + I + + + Q+ +
Sbjct: 148 S-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV----- 237
+ S +HRDL N + E +K DFGL+ +D+ +
Sbjct: 207 FLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---------RDMYDKEFDSVHNKT 254
Query: 238 ---------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286
A E L+ + + ++D+WS GV+L+ L++ G PP+ I +L+G
Sbjct: 255 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 314
Query: 287 ----DFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLSKFLIPKKTLQTLADLL 339
++ DP + ML H + R S +E++S+ T
Sbjct: 315 LLQPEYCPDPLYEV----------MLKCWHPKAEMRPSFSELVSRI---SAIFSTFIGEH 361
Query: 340 YSQIFARFL 348
Y + A ++
Sbjct: 362 YVHVNATYV 370
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 65/305 (21%), Positives = 109/305 (35%), Gaps = 69/305 (22%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
RN FG+ LG G FG + D A K + + + + E + E+++
Sbjct: 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKV 79
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL-----------FDRIIAKGHYSERA 169
+ +L H NIV L GA +I + C G+L + +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 170 AANLCRQMVTVVH-------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
A +++ + + S +HRDL N L + K DFGL+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA---- 192
Query: 223 PGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPP 268
+D+ + YV APE + Y E+D+WS G+ L+ L S G P
Sbjct: 193 -----RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 269 FWG-ETEQSIFDAILRGHI----DFSSDPWPNISSSAKDIVKKML---HADPKERLSAAE 320
+ G + + I G + + +I M ADP +R + +
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDI----------MKTCWDADPLKRPTFKQ 297
Query: 321 VLSKF 325
++
Sbjct: 298 IVQLI 302
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 44/245 (17%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
R R +G+G FGV Y + + Q A KS+ ++ VE RE +M
Sbjct: 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMR 77
Query: 123 HLTGHRNIVELKGAYEDRHSVNL-IMDLCAGGELFDRIIAKGHYSERA-----AANLCRQ 176
L H N++ L G + ++ G+L I + + R
Sbjct: 78 GLN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYY 236
M Y +HRDL N + E +K DFGL+ +D++ YY
Sbjct: 137 ME----YLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLA---------RDILDREYY 180
Query: 237 V--------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDA 280
A E L+ + ++D+WS GV+L+ LL+ G PP+ +
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240
Query: 281 ILRGH 285
+ +G
Sbjct: 241 LAQGR 245
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-18
Identities = 59/255 (23%), Positives = 94/255 (36%), Gaps = 51/255 (20%)
Query: 66 RNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ R+LG G FG Y T+ T + A K++ + ++E+ I+
Sbjct: 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDIL 87
Query: 122 HHLTGHRNIVELKGA--YEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
L H +I++ KG S+ L+M+ G L D + + +Q+
Sbjct: 88 RTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICE 145
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-VGSAYYV- 237
+ Y H+ +HRDL N L D +K DFGL+ K + G YY
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGLA---------KAVPEGHEYYRV 193
Query: 238 -----------APEVLR-RNYGAEADIWSAGVILYILLS---------------GVPPFW 270
APE L+ + +D+WS GV LY LL+
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253
Query: 271 GETEQSIFDAILRGH 285
T + + + RG
Sbjct: 254 QMTVLRLTELLERGE 268
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 49/239 (20%), Positives = 87/239 (36%), Gaps = 34/239 (14%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ + +G G G L A K++ + D E IM
Sbjct: 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMG 105
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVV 181
H NI+ L+G ++ + G L + G ++ + R + +
Sbjct: 106 QFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---- 237
Y +G +HRDL N L + K +DFGLS + L
Sbjct: 165 RYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLS---------RVLEDDPDAAYTTT 212
Query: 238 ---------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + R + + +D+WS GV+++ +L+ G P+W T + + ++ G+
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY 271
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-18
Identities = 51/238 (21%), Positives = 92/238 (38%), Gaps = 31/238 (13%)
Query: 66 RNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ + +G G+FG + + A K++ + D E IM
Sbjct: 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIM 100
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTV 180
+ H NI+ L+G + +I + G L + G +S + R +
Sbjct: 101 GQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
+ Y +M +HRDL N L + + K +DFGLS + A Y
Sbjct: 160 MKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDP-------EATYTTSG 209
Query: 238 --------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + R + + +D+WS G++++ +++ G P+W + + AI G
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF 267
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-18
Identities = 60/243 (24%), Positives = 98/243 (40%), Gaps = 31/243 (12%)
Query: 66 RNTYIFGRELGRGQFGVTY--LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
N F +G G FG + + A K + ++ ++DD D E++++
Sbjct: 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCK 81
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD---RIIAKGHYSERAAANLCRQMVTV 180
L H NI+ L GA E R + L ++ G L D + A AN ++
Sbjct: 82 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 181 ---VHYCH----------SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
+H+ +HRDL N L E+ K DFGLS + +V+
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVY 195
Query: 228 KDLVGSAYYV---APEVLR-RNYGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAIL 282
V A E L Y +D+WS GV+L+ I+ G P+ G T +++ +
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255
Query: 283 RGH 285
+G+
Sbjct: 256 QGY 258
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 6e-18
Identities = 62/279 (22%), Positives = 109/279 (39%), Gaps = 45/279 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R + +LG+G FG ++ T T + A K++ E +E Q+M L
Sbjct: 266 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP----GTMSPEAFLQEAQVMKKLR 320
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERA-----AANLCRQMVT 179
H +V+L + + ++ + + G L D + G Y AA + M
Sbjct: 321 -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA- 377
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV-- 237
Y M +HRDL+ N L E+ K DFGL+ + + + Y
Sbjct: 378 ---YVERMNYVHRDLRAANILVG---ENLVCKVADFGLA---------RLIEDNEYTARQ 422
Query: 238 ---------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286
APE + ++D+WS G++L L + G P+ G + + D + RG+
Sbjct: 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 482
Query: 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325
P S D++ + +P+ER + + +
Sbjct: 483 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-18
Identities = 64/341 (18%), Positives = 118/341 (34%), Gaps = 68/341 (19%)
Query: 26 GHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYL 85
G +G + P + S + R + ELG G FG +L
Sbjct: 1 GAMGSGSSLSPT-EGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFL 59
Query: 86 -----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140
+ + K A K++ K + +D +RE +++ L H++IV G +
Sbjct: 60 AECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEG 115
Query: 141 HSVNLIMDLCAGGEL--FDRIIAKGHYSERAAANLCRQMVTVVH-------------YCH 185
+ ++ + G+L F R ++ + + Y
Sbjct: 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV-------- 237
+ +HRDL N L + +K DFG+S +D+ + YY
Sbjct: 176 GLHFVHRDLATRNCLVG---QGLVVKIGDFGMS---------RDIYSTDYYRVGGRTMLP 223
Query: 238 ----APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI----D 287
PE + R + E+D+WS GV+L+ + + G P++ + D I +G
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR 283
Query: 288 FSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLSKF 325
I M +P++R S +V ++
Sbjct: 284 ACPPEVYAI----------MRGCWQREPQQRHSIKDVHARL 314
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-18
Identities = 66/300 (22%), Positives = 116/300 (38%), Gaps = 60/300 (20%)
Query: 66 RNTYIFGRELGRGQFGVTY-------LVTHKDTKQQFACKSISSRKLINRDDVEDVRREV 118
R+ G+ LG G FG A K + + D+ D+ E+
Sbjct: 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEM 91
Query: 119 QIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMV 178
++M + H+NI+ L GA + +I++ + G L + + A+ + ++ R
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 179 TVVH----------------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
+ Y S +HRDL N L + E++ +K DFGL+
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---- 204
Query: 223 PGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILY-ILLSGVPP 268
+D+ YY APE L R Y ++D+WS GV+++ I G P
Sbjct: 205 -----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLSKF 325
+ G + +F + GH D N ++ + M HA P +R + +++
Sbjct: 260 YPGIPVEELFKLLKEGHR---MDKPANCTNELYMM---MRDCWHAVPSQRPTFKQLVEDL 313
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 65/297 (21%), Positives = 117/297 (39%), Gaps = 54/297 (18%)
Query: 66 RNTYIFGRELGRGQFGVTY-------LVTHKDTKQQFACKSISSRKLINRDDVEDVRREV 118
R+ G+ LG G FG A K + + D+ D+ E+
Sbjct: 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEM 137
Query: 119 QIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMV 178
++M + H+NI+ L GA + +I++ + G L + + A+ + ++ R
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 179 TVVH----------------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
+ Y S +HRDL N L + E++ +K DFGL+
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---- 250
Query: 223 PGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILY-ILLSGVPP 268
+D+ YY APE L R Y ++D+WS GV+++ I G P
Sbjct: 251 -----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325
+ G + +F + GH D N ++ +++ HA P +R + +++
Sbjct: 306 YPGIPVEELFKLLKEGHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-17
Identities = 56/255 (21%), Positives = 100/255 (39%), Gaps = 50/255 (19%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
+ F ELG +FG Y + Q A K++ + E+ R E +
Sbjct: 8 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAML 65
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR----- 175
L H N+V L G +++I C+ G+L + ++ + +S+ + + R
Sbjct: 66 RARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 176 -QMVTVVHYCH----------SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
+ VH S V+H+DL N L + +K +D GL
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF------ 175
Query: 225 DVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFW 270
+++ + YY APE + + ++DIWS GV+L+ + S G+ P+
Sbjct: 176 ---REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 232
Query: 271 GETEQSIFDAILRGH 285
G + Q + + I
Sbjct: 233 GYSNQDVVEMIRNRQ 247
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 69/328 (21%), Positives = 118/328 (35%), Gaps = 77/328 (23%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R FG+ LG G FG ++ Q A K + ++ + + E + E+++
Sbjct: 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALMSELKM 101
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL---------------FDRIIAKGHY 165
M L H NIV L GA + LI + C G+L + K
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 166 SERAAANLC-RQMVTVVH-------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217
E L ++ + + +HRDL N L + +K DFGL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGL 218
Query: 218 SVFFKPGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS 264
+ +D++ + YV APE L Y ++D+WS G++L+ + S
Sbjct: 219 A---------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
Query: 265 -GVPPFWG-ETEQSIFDAILRGHI----DFSSDPWPNISSSAKDIVKKML---HADPKER 315
GV P+ G + + + I G ++++ I M D ++R
Sbjct: 270 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYII----------MQSCWAFDSRKR 319
Query: 316 LSAAEVLSKFLIPKKTLQTLADLLYSQI 343
S + S L + +Y +
Sbjct: 320 PSFPNLTSFL---GCQLADAEEAMYQNV 344
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 66/304 (21%), Positives = 116/304 (38%), Gaps = 68/304 (22%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R+ G+ LGRG FG + T + A K + ++ + + E++I
Sbjct: 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKI 83
Query: 121 MHHLTGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFD--------RIIAKGHYSERAAA 171
+ H+ H N+V L GA + + +I++ C G L + K +
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 172 NLC-RQMVTVVH-------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223
L ++ + S +HRDL N L S E + +K DFGL+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA----- 195
Query: 224 GDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILY-ILLSGVPPF 269
+D+ YV APE + R Y ++D+WS GV+L+ I G P+
Sbjct: 196 ----RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
Query: 270 WG-ETEQSIFDAILRGHI----DFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEV 321
G + ++ + G D+++ ML H +P +R + +E+
Sbjct: 252 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT----------MLDCWHGEPSQRPTFSEL 301
Query: 322 LSKF 325
+
Sbjct: 302 VEHL 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 69/300 (23%), Positives = 117/300 (39%), Gaps = 60/300 (20%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQF-------ACKSISSRKLINRDDVEDVRREV 118
R+ + G+ LG G FG L + A K + + D+ D+ E+
Sbjct: 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEM 125
Query: 119 QIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMV 178
++M + H+NI+ L GA + +I++ + G L + + A+ + N
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 179 TVVH----------------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
+ Y S +HRDL N L + ED+ +K DFGL+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA---- 238
Query: 223 PGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILY-ILLSGVPP 268
+D+ YY APE L R Y ++D+WS GV+L+ I G P
Sbjct: 239 -----RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
Query: 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLSKF 325
+ G + +F + GH D N ++ + M HA P +R + +++
Sbjct: 294 YPGVPVEELFKLLKEGHR---MDKPSNCTNELYMM---MRDCWHAVPSQRPTFKQLVEDL 347
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-17
Identities = 51/237 (21%), Positives = 91/237 (38%), Gaps = 30/237 (12%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ +G G+FG L + A K++ + D E IM
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMG 101
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVV 181
H NI+ L+G V ++ + G L + ++ + R + + +
Sbjct: 102 QFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---- 237
Y MG +HRDL N L + + K +DFGL + A Y
Sbjct: 161 KYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDP-------EAAYTTRGG 210
Query: 238 -------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
+PE + R + + +D+WS G++L+ ++S G P+W + Q + A+ G+
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-17
Identities = 62/310 (20%), Positives = 118/310 (38%), Gaps = 75/310 (24%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R + G+ LG G+FG + + A K + ++ + ++ D+ E +
Sbjct: 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLLSEFNV 79
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL-----------FDRIIAKGHYSERA 169
+ + H ++++L GA + LI++ G L + + G + +
Sbjct: 80 LKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 170 AANLCRQMVTV---VHYCH----------SMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216
+ + +T+ + + M ++HRDL N L + E +K +DFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFG 195
Query: 217 LSVFFKPGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILY-IL 262
LS +D+ YV A E L Y ++D+WS GV+L+ I+
Sbjct: 196 LS---------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 263 LSGVPPFWGETEQSIFDAILRGHI----DFSSDPWPNISSSAKDIVKKML---HADPKER 315
G P+ G + +F+ + GH D S+ + ML +P +R
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRL----------MLQCWKQEPDKR 296
Query: 316 LSAAEVLSKF 325
A++
Sbjct: 297 PVFADISKDL 306
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-17
Identities = 66/298 (22%), Positives = 117/298 (39%), Gaps = 60/298 (20%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R + RELG G FG +L ++ K A K++ K +D +RE ++
Sbjct: 14 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAEL 70
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD---------RIIAKGHYSERAAA 171
+ +L H +IV+ G D + ++ + G+L I+ G +
Sbjct: 71 LTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 172 NLCRQMVTVVH-------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
QM+ + Y S +HRDL N L + +K DFG+S
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS------ 180
Query: 225 DVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFW 270
+D+ + YY PE + R + E+D+WS GVIL+ + + G P++
Sbjct: 181 ---RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237
Query: 271 GETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLSKF 325
+ + + I +G + + D+ ML +P++RL+ E+
Sbjct: 238 QLSNTEVIECITQGRV---LERPRVCPKEVYDV---MLGCWQREPQQRLNIKEIYKIL 289
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 44/274 (16%), Positives = 87/274 (31%), Gaps = 44/274 (16%)
Query: 27 HHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLV 86
HH + S TS + G VL + R G+ Y
Sbjct: 5 HHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDK---SGRQWKLKSFQTRDNQGILYEA 61
Query: 87 THKDT--------KQQFACK--SISSRKLINRDDVEDVRREVQI----MHHLTGHRNIVE 132
T KQ+F+ K + R ++ + + +Q+ + T I
Sbjct: 62 APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121
Query: 133 LK--GAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
G ++D++ L++ G L + K SER+ + +++ + + H
Sbjct: 122 CMGFGVHQDKYRF-LVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE 179
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG--------DVFKDLVGSAYYVA-- 238
+H ++ EN + + +G + + P G +++
Sbjct: 180 YVHGNVTAENIFVDPEDQSQ-VTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMD 238
Query: 239 ----PEVLRRNYGAEADIWSAG-VILYILLSGVP 267
RR +D+ S G +L L +P
Sbjct: 239 LHKGCGPSRR-----SDLQSLGYCMLKWLYGFLP 267
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-16
Identities = 42/271 (15%), Positives = 88/271 (32%), Gaps = 50/271 (18%)
Query: 35 DPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQ 94
+ S+ A +VG ++ + G +G+G FG YL ++ +
Sbjct: 6 AAQAGRQSSAKRHLAEQFAVGEIITD---MAAAAWKVGLPIGQGGFGCIYLA-DMNSSES 61
Query: 95 FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK-------------------G 135
+ K + D + E++ I +
Sbjct: 62 VGSDAPCVVK-VEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120
Query: 136 AYEDRHSVNLIMDLCAGG----ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+ +IMD G ++++ +S + L +++ ++ Y H +H
Sbjct: 121 KNGKSYRF-MIMDRF--GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHEYVH 175
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF--------KDLVGSAYYVAPEVLR 243
D+K N L + D + D+GL+ + P V + G+ + + +
Sbjct: 176 GDIKASNLLLNYKNPDQ-VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTS---ID 231
Query: 244 RNYGAEA----DIWSAGVILYILLSGVPPFW 270
+ G D+ G + L+G P W
Sbjct: 232 AHNGVAPSRRGDLEILGYCMIQWLTGHLP-W 261
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 59/310 (19%), Positives = 108/310 (34%), Gaps = 75/310 (24%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
RN + R++G G FG + + + A K + ++ + D D +RE +
Sbjct: 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAAL 103
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL-----------FDRIIAKGHYSERA 169
M + NIV+L G + L+ + A G+L + +
Sbjct: 104 MAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 170 AANLCRQMVTVVH-------------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216
++ ++ Y +HRDL N L E+ +K DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFG 219
Query: 217 LSVFFKPGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILYILL 263
LS +++ + YY PE + Y E+D+W+ GV+L+ +
Sbjct: 220 LS---------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
Query: 264 S-GVPPFWGETEQSIFDAILRGHI----DFSSDPWPNISSSAKDIVKKML---HADPKER 315
S G+ P++G + + + G+I + N+ M P +R
Sbjct: 271 SYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNL----------MRLCWSKLPADR 320
Query: 316 LSAAEVLSKF 325
S +
Sbjct: 321 PSFCSIHRIL 330
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 37/189 (19%), Positives = 70/189 (37%), Gaps = 22/189 (11%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R+ G+ LGRG FG + T + A K + ++ + + E++I
Sbjct: 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKI 78
Query: 121 MHHLTGHRNIVELKGAY-EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
+ H+ H N+V L GA + + +I++ C G L + +K + +
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN----EFVPYKTKGAR 134
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSS--------AEDSPLKATDFGLSVFFKPGDVF--KD 229
+G + DLK +SS E+ L + + D +
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194
Query: 230 LVGSAYYVA 238
L+ ++ VA
Sbjct: 195 LICYSFQVA 203
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 5e-07
Identities = 44/227 (19%), Positives = 81/227 (35%), Gaps = 35/227 (15%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
E + TYL + ++ + K R +D V + +++
Sbjct: 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFR--QGKDYVGAIPVDLKRRLDSITSSQSSAS 164
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
G E++ ++ + + K + Q+ + + S +HRD
Sbjct: 165 SGFVEEKSLSDVEEEEA------PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 218
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV------------APEV 241
L N L S E + +K DFGL+ +D+ YV APE
Sbjct: 219 LAARNILLS---EKNVVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 242 LRRN-YGAEADIWSAGVILY-ILLSGVPPFWG-ETEQSIFDAILRGH 285
+ Y ++D+WS GV+L+ I G P+ G + ++ + G
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 313
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 3e-08
Identities = 39/283 (13%), Positives = 78/283 (27%), Gaps = 65/283 (22%)
Query: 60 KPMEDVRNTYIFG--RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-----DVE 112
P T ++G G FG + T A K I+ + E
Sbjct: 11 VPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFE 68
Query: 113 DVRREVQIMHHLTG--------HRNIVELKGAY--------------------------- 137
++ E+ I L+ + L +
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 138 ---EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH-SMGVMHRD 193
+ ++++ GG +++ K S A ++ Q+ + S+ HRD
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRD 187
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIW 253
L N L ++ L T G S + +V +Y
Sbjct: 188 LHWGNVLLKKTS-LKKLHYTLNGKSSTIPSCGL-------------QVSIIDYTLSRLER 233
Query: 254 SAGVILYILLSGVPPFWGETEQS--IFDAILRGHIDFSSDPWP 294
V+ + F G+ + I+ + + + + + P
Sbjct: 234 DGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHP 276
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 4e-08
Identities = 48/357 (13%), Positives = 112/357 (31%), Gaps = 79/357 (22%)
Query: 50 TSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVT---HKD-----TKQQFACKSIS 101
+ + ++ +F L + + V V + + + + S
Sbjct: 47 SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPS 106
Query: 102 SRKLINRDDVEDVRREVQIM--HHLTGHRNIVELKGA-YEDRHSVNLI---M-------- 147
+ + + + + Q+ ++++ + ++L+ A E R + N++ +
Sbjct: 107 MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWV 166
Query: 148 --DLCAGGEL----FDRI--IAKGHYSERAA-----ANLCRQMVTVVHYC----HSMGVM 190
D+C ++ +I + + + L Q+ ++ HS +
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP--NWTSRSDHSSNIK 224
Query: 191 HR--DLKPE--NFLFSSSAEDSPL-----------KATDFGLSVFFKPGD--VFKDLVGS 233
R ++ E L S E+ L A + + V D + +
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT-DFLSA 283
Query: 234 AYYVAPEVLRRNYGAEADIWSAGVILYIL---LSGVPPFWGETEQ------SIFDAILRG 284
A + + D ++L L +P E SI +R
Sbjct: 284 ATTTHISLDHHSMTLTPD-EVKSLLLKYLDCRPQDLPR---EVLTTNPRRLSIIAESIRD 339
Query: 285 HIDFSSDPWPNISSSA-KDIVKKMLHA-DPKERLSAAEVLSKF----LIPKKTLQTL 335
+ + D W +++ I++ L+ +P E + LS F IP L +
Sbjct: 340 GLA-TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI 395
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 7e-07
Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 11/93 (11%)
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKA--TDFGLSVFFKPGD---VFKDLVGSAYY 236
HY H+ ++HRD+K N L D TDFG+S D + + G+ Y
Sbjct: 153 HYLHTRAIIHRDVKSINILL-----DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 237 VAPEVLRRNYGAE-ADIWSAGVILYILLSGVPP 268
+ PE + E +D++S GV+L+ +L
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 4e-06
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 16/95 (16%)
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKA--TDFGLSVFFKPGDVFKD------LVGSA 234
+ H +HRD+K N L D A +DFGL+ + + F +VG+
Sbjct: 148 FLHENHHIHRDIKSANILL-----DEAFTAKISDFGLA---RASEKFAQTVMTSRIVGTT 199
Query: 235 YYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPF 269
Y+APE LR ++DI+S GV+L +++G+P
Sbjct: 200 AYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 234
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 54/224 (24%), Positives = 82/224 (36%), Gaps = 55/224 (24%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LGRG FG Y D A K + + + + EV+++ HRN++ L+
Sbjct: 38 LGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGEL--QFQTEVEMISMAV-HRNLLRLR 93
Query: 135 G----------AYE-------DRHSVNLIMDLCAGGELFD---RI-IAKGHYSERAAANL 173
G Y + + D R IA G +A L
Sbjct: 94 GFCMTPTERLLVYPYMANGSVASC----LRERPESQPPLDWPKRQRIALG-----SARGL 144
Query: 174 CRQMVTVVHYCH---SMGVMHRDLKPENFLFSSSAEDSPLKA--TDFGLSVFFKPGD--V 226
Y H ++HRD+K N L D +A DFGL+ D V
Sbjct: 145 A--------YLHDHCDPKIIHRDVKAANILL-----DEEFEAVVGDFGLAKLMDYKDTHV 191
Query: 227 FKDLVGSAYYVAPEVLRRNYGAE-ADIWSAGVILYILLSGVPPF 269
+ G+ ++APE L +E D++ GV+L L++G F
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 350 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.53 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.22 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.0 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.95 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.92 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.64 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.47 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.3 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.25 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.15 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.03 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.87 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.82 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.82 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.72 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.72 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.62 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.59 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.58 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.46 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.3 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.03 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.79 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 92.36 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.1 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-66 Score=461.37 Aligned_cols=263 Identities=32% Similarity=0.573 Sum_probs=239.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|++++++++ |||||++++++++.+.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEE
Confidence 67999999999999999999999999999999998665444556788999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC--
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-- 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~-- 224 (350)
|||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCC
Confidence 9999999999999999999999999999999999999999999999999999999 66788999999999876433
Q ss_pred -CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 225 -DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
....+.+||+.|||||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.++. .+++++++
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~d 263 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFPKARD 263 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCHHHHH
Confidence 23456789999999999864 5899999999999999999999999999999999999988877654 57999999
Q ss_pred HHHHhcccCccCCCCHHH------HHhccCCCCCchhhHHH
Q 018786 303 IVKKMLHADPKERLSAAE------VLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~------iL~~~~~~~~~~~~~~~ 337 (350)
||.+||+.||++|||+.| +++|+||.+..|+.+.+
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~ 304 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 304 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcC
Confidence 999999999999999987 68999999999987643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-64 Score=442.47 Aligned_cols=254 Identities=34% Similarity=0.603 Sum_probs=214.8
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+++.+|++++++++ ||||+++++++.+.+.+++|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEE
Confidence 68999999999999999999999999999999998766555566778999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
|||+ +++|.+++..++++++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+...+...
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence 9999 67999999999999999999999999999999999999999999999999 6677899999999988776666
Q ss_pred cccCCcCcccccccccccc--CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~~--~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
..+.+||+.|||||++.+. .+.++|||||||++|+|++|+.||.+....+....+.++...++. .+++++++||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li 243 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLI 243 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence 6778999999999998753 468999999999999999999999999988888888888776654 5799999999
Q ss_pred HHhcccCccCCCCHHHHHhccCCCC
Q 018786 305 KKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
.+||+.||++|||+.|+|+|+||+.
T Consensus 244 ~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHccCChhHCcCHHHHHcCccccc
Confidence 9999999999999999999999964
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-64 Score=454.74 Aligned_cols=258 Identities=29% Similarity=0.491 Sum_probs=229.4
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
...|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|++++ |||||++++++.+.+.+||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~i 148 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWV 148 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence 46799999999999999999999999999999999765432 3356889999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~- 224 (350)
|||||+||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|......
T Consensus 149 vmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSS
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCC
Confidence 9999999999998865 579999999999999999999999999999999999999 66778999999999886543
Q ss_pred CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
......+||+.|||||++.+ .|+.++|||||||++|||++|..||.+....+.+..+...... ....+..+++++.+|
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSLKGF 303 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCSCGGGSCHHHHHH
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccccCCHHHHHH
Confidence 34567899999999998864 5999999999999999999999999999888888887765432 222345789999999
Q ss_pred HHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
|.+||+.||++|||+.|+|+|+||.+...
T Consensus 304 i~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 99999999999999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-63 Score=450.08 Aligned_cols=258 Identities=26% Similarity=0.540 Sum_probs=225.0
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+++.+|++++++++ |||||++++++.+.+.+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEE
Confidence 689999999999999999999999999999999976544 4455678999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 147 MDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||||+||+|.+++..++ .+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCC
Confidence 99999999999997653 47999999999999999999999999999999999999 66778999999999876543
Q ss_pred C-ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 225 D-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 225 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
. .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+.+..+.+..+..+..+.. ...++.++.+
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~ 255 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV---SLHYSYDLRS 255 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---CTTSCHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---CccCCHHHHH
Confidence 2 2345689999999999875 599999999999999999999999999999999888888765432 2468999999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
||.+||+.||++|||+.|+|+|+||.+...
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhcCCC
Confidence 999999999999999999999999976543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-62 Score=434.08 Aligned_cols=257 Identities=21% Similarity=0.416 Sum_probs=219.9
Q ss_pred cce-eeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc----CC
Q 018786 67 NTY-IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED----RH 141 (350)
Q Consensus 67 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----~~ 141 (350)
++| ++.+.||+|+||+||+|.++.+++.||+|++..... .....+++.+|++++++++ |||||++++++.. ..
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCc
Confidence 455 788899999999999999999999999999976543 4455678999999999998 9999999998864 45
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
.++||||||+||+|.+++...+.+++..++.++.||+.||+|||++| ||||||||+|||++ +.++.+||+|||+|+
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCE
Confidence 68999999999999999999899999999999999999999999999 99999999999995 246789999999998
Q ss_pred cccCCCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCCCH
Q 018786 220 FFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.... ....+.+||+.|||||++.+.++.++|||||||++|||++|+.||.+.... .....+..+..+.. ....+++
T Consensus 181 ~~~~-~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~--~~~~~~~ 257 (290)
T 3fpq_A 181 LKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAIP 257 (290)
T ss_dssp GCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--GGGCCCH
T ss_pred eCCC-CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCC--CCccCCH
Confidence 6443 344667899999999999888999999999999999999999999766544 44444444432211 1235688
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
++.+||.+||+.||++|||+.|+|+|+||++.
T Consensus 258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-62 Score=454.09 Aligned_cols=258 Identities=29% Similarity=0.491 Sum_probs=229.7
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.+.|++.+.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|++++ |||||+++++|.+.+.+||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEEEE
Confidence 4679999999999999999999999999999999975543 23456889999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~- 224 (350)
|||||+||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|......
T Consensus 226 VmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSC
T ss_pred EEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCC
Confidence 9999999999998865 569999999999999999999999999999999999999 66778999999999876543
Q ss_pred CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
......+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+....+.+..+....... ...+..+++++.+|
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-~~~~~~~s~~~~dl 380 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-LKNLHKVSPSLKGF 380 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSCTTSSCHHHHHH
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-CcccccCCHHHHHH
Confidence 34567789999999998864 59999999999999999999999999999888888877654332 23345789999999
Q ss_pred HHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
|.+||+.||++|||+.|+|+|+||.+...
T Consensus 381 i~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 99999999999999999999999987654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-63 Score=441.81 Aligned_cols=263 Identities=29% Similarity=0.500 Sum_probs=227.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEc---cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
.++|++++.||+|+||+||+|++. .+++.||||++.+..... ....++.+|++++++++ |||||++++++.+.+.
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGK 100 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCC-CTTEECEEEEEEETTE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCE
Confidence 368999999999999999999984 468899999997654322 22346888999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC--
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceecc
Confidence 99999999999999999999999999999999999999999999999999999999999 667789999999998754
Q ss_pred C-CCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 223 P-GDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 223 ~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
. .....+.+||+.|||||++. ..++.++|||||||++|||++|+.||.+.+..+.+..+.+....++. .+++++
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 253 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEA 253 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----cCCHHH
Confidence 3 33445678999999999886 45899999999999999999999999999999999999888776654 589999
Q ss_pred HHHHHHhcccCccCCCC-----HHHHHhccCCCCCchhhHHH
Q 018786 301 KDIVKKMLHADPKERLS-----AAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~~ 337 (350)
.+||.+||+.||++||| ++|+++|+||.+..|..+.+
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~ 295 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYR 295 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHh
Confidence 99999999999999998 58999999999998877654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-61 Score=432.87 Aligned_cols=254 Identities=25% Similarity=0.325 Sum_probs=219.7
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.+.|.+.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.++++++ |||||++++++.+.+.+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~-HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLS-SPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence 3679999999999999999999999999999999975432 246999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCC-CeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS-PLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~-~vkl~Dfg~a~~~~~~ 224 (350)
|||||+|++|.++++..+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++ .+||+|||+|+.....
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEEC---
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeEccCC
Confidence 99999999999999999999999999999999999999999999999999999999 4444 5999999999876543
Q ss_pred Cc------cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 225 DV------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 225 ~~------~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.. ....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+....+....+.....+.. ..++.++
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s 283 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCA 283 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSC
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCC
Confidence 21 233579999999998864 599999999999999999999999988877777777776654432 2235789
Q ss_pred HHHHHHHHHhcccCccCCCCHHHH-------------HhccCCCCCch
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEV-------------LSKFLIPKKTL 332 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~i-------------L~~~~~~~~~~ 332 (350)
+++.++|.+||+.||++|||+.|+ |+|||+.+..-
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 999999999999999999999998 46888876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-60 Score=437.64 Aligned_cols=262 Identities=27% Similarity=0.406 Sum_probs=224.4
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc-----
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED----- 139 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----- 139 (350)
+.++|.+++.||+|+||+||+|+++.+|+.||||+++.... .....+++.+|+++|++++ |||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcC-CCCcceEeeeeecccccc
Confidence 45789999999999999999999999999999999975432 3445677899999999998 9999999998753
Q ss_pred -CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 140 -RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 140 -~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
.+.+|||||||+ ++|.+++...+.+++..++.+++||+.||.|||++|||||||||+|||+ +.++.+||+|||+|
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla 205 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMA 205 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeeccee
Confidence 467899999995 6899999988899999999999999999999999999999999999999 66778999999999
Q ss_pred ccccCC-----CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 018786 219 VFFKPG-----DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 219 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
+..... ....+.+||+.|||||++.+ .++.++||||+||++|||++|+.||.+.+..+.+..+.......+..
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 875432 23456789999999998754 47999999999999999999999999999888887776433222111
Q ss_pred ---------------------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 292 ---------------------------PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 292 ---------------------------~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.++.+++++.+||.+||+.||++|||+.|+|+|+||.+...
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 12457899999999999999999999999999999987543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-58 Score=410.61 Aligned_cols=257 Identities=22% Similarity=0.397 Sum_probs=210.9
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
++.-.+++.+.+.||+|+||+||+|+++. .||||+++... .+.+..+.+.+|+.++++++ |||||++++++.+ +
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-D 104 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-S
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-C
Confidence 45556889999999999999999998754 59999987543 24556788999999999998 9999999998754 5
Q ss_pred ceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.++||||||+||+|.+++... .++++..+..++.||+.||+|||+++||||||||+|||+ ++++.+||+|||+|+.
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATV 181 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCcee
Confidence 689999999999999999764 579999999999999999999999999999999999999 5667899999999987
Q ss_pred ccCC---CccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CCC
Q 018786 221 FKPG---DVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF--SSD 291 (350)
Q Consensus 221 ~~~~---~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~ 291 (350)
.... ......+||+.|||||++. +.++.++|||||||++|||+||+.||.+.........+....... ...
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 261 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK 261 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence 5432 2234568999999999874 348999999999999999999999998876555444444332222 223
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
..++++.++.+||.+||+.||++|||+.|+++++..
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 345789999999999999999999999999877643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-58 Score=407.58 Aligned_cols=249 Identities=22% Similarity=0.417 Sum_probs=214.5
Q ss_pred cccceeeeeeeeccCceEEEEEEEc-----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
..++|.+.+.||+|+||+||+|++. .++..||||+++.. .....+++.+|++++++++ |||||++++++.+
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~ 86 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVE 86 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEee
Confidence 3478999999999999999999875 35788999999643 3455678999999999998 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCC
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAK-------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE 206 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 206 (350)
.+.+++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++||||||||+|||+ +.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~ 163 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GE 163 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CC
Confidence 99999999999999999999764 358999999999999999999999999999999999999 66
Q ss_pred CCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 018786 207 DSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAI 281 (350)
Q Consensus 207 ~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~ 281 (350)
++.+||+|||+|+....... .....||+.|||||++. +.++.++|||||||++|||+| |+.||.+....+....+
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 77899999999987543322 12346899999999886 569999999999999999998 89999999988888888
Q ss_pred HcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
..+.....+ ..+++++.+|+.+||+.||++|||+.+++.
T Consensus 244 ~~~~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 244 TQGRVLQRP---RTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp HHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 876543222 368999999999999999999999999965
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-57 Score=409.30 Aligned_cols=251 Identities=23% Similarity=0.399 Sum_probs=210.7
Q ss_pred cccceeeeeeeeccCceEEEEEEEc-----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
...++.+.++||+|+||+||+|+++ .+++.||||+++.. .....+.+.+|+++|++++ |||||++++++.+
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTE 114 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence 3478999999999999999999875 35889999999643 3455678999999999998 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecC
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAK---------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS 204 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 204 (350)
.+.++||||||++|+|.++++.. +++++..+..++.||+.||.|||+++||||||||+|||+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl--- 191 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV--- 191 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---
Confidence 99999999999999999998753 358999999999999999999999999999999999999
Q ss_pred CCCCCeEEeecCCcccccCCC---ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 018786 205 AEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFD 279 (350)
Q Consensus 205 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~ 279 (350)
+.++.+||+|||+|+...... ......||+.|||||++. ..++.++|||||||++|||+| |+.||.+....+...
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 567789999999998764332 223467999999999876 469999999999999999998 899999999888888
Q ss_pred HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+..+..... ...+++++.+|+.+||+.||++|||+.|+++++
T Consensus 272 ~i~~g~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L 314 (329)
T 4aoj_A 272 CITQGRELER---PRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314 (329)
T ss_dssp HHHHTCCCCC---CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHH
T ss_pred HHHcCCCCCC---cccccHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 8877643221 236899999999999999999999999998765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-58 Score=409.19 Aligned_cols=257 Identities=27% Similarity=0.434 Sum_probs=200.5
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC----
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH---- 141 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~---- 141 (350)
.++|++++.||+|+||+||+|+++.+|+.||||++.... .....+++.+|++++++++ |||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCcccc
Confidence 357999999999999999999999999999999996543 3445578999999999998 999999999886543
Q ss_pred --------ceEEEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCe
Q 018786 142 --------SVNLIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (350)
Q Consensus 142 --------~~~iv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~v 210 (350)
++|+|||||+|++|.+++..... .++..++.++.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~v 157 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVV 157 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCE
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcE
Confidence 47899999999999999987655 3556789999999999999999999999999999999 667789
Q ss_pred EEeecCCcccccCCCc-------------cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-
Q 018786 211 KATDFGLSVFFKPGDV-------------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ- 275 (350)
Q Consensus 211 kl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~- 275 (350)
||+|||+|+....... ....+||+.|||||++.+ .++.++|||||||++|||++ ||....+.
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~ 234 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV 234 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH
Confidence 9999999987653321 234579999999998874 59999999999999999996 77654332
Q ss_pred HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
.....+.....+ +.++..++.+.+||.+||+.||++|||+.|+|+|+||.+..|+.
T Consensus 235 ~~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 235 RTLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290 (299)
T ss_dssp HHHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred HHHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence 223333333221 11223467788999999999999999999999999999877643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-57 Score=404.95 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=217.1
Q ss_pred cccceeeeeeeeccCceEEEEEEEc-----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
...++++.+.||+|+||+||+|... .+++.||||+++... .....+.+.+|+.++.+++ |||||++++++..
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTK 100 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEE
Confidence 3467899999999999999999863 457899999996443 3345678999999999998 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeec
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS 203 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~ 203 (350)
.+.+++|||||++|+|.+++..+ ..+++..+..++.||+.||.|||+++||||||||+|||+
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl-- 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV-- 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE--
Confidence 99999999999999999999653 358999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeecCCcccccCCC---ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 018786 204 SAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIF 278 (350)
Q Consensus 204 ~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~ 278 (350)
++++.+||+|||+|+...... ......||+.|||||++. +.++.++|||||||++|||+| |..||.+....+..
T Consensus 179 -~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 179 -YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp -CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred -CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 667789999999998754332 234567999999999875 569999999999999999998 89999999998888
Q ss_pred HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..+..+..... .+.++.++.+|+.+||+.||++|||+.||++++
T Consensus 258 ~~i~~~~~~~~---p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 258 EMIRNRQVLPC---PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp HHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 88877654322 236899999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=438.69 Aligned_cols=265 Identities=34% Similarity=0.579 Sum_probs=241.6
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
+.++|.+++.||+|+||+||+|.++.+|+.||+|++.... ....+.+.+|+.+|++++ ||||+++++++.+.+.++
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEE
Confidence 4578999999999999999999999999999999996543 344577899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 145 LIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+|+....
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEECCT
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeEccC
Confidence 99999999999998864 4679999999999999999999999999999999999999642 346899999999999887
Q ss_pred CCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
.......+||+.|||||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......++...++.++.++.+
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 777777899999999998864 5899999999999999999999999999999999999998888887777889999999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
||.+||+.||.+|||+.|+|+|+||....++.
T Consensus 390 li~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred HHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 99999999999999999999999999876643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-57 Score=413.38 Aligned_cols=259 Identities=24% Similarity=0.433 Sum_probs=211.3
Q ss_pred cccccceeeeeeeeccCceEEEEEEEc---cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
..+.++|++.+.||+|+||+||+|+++ .+++.||+|.+.... ...++.+|+++++++.+||||+++++++.+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 356788999999999999999999985 457899999986432 345788999999999779999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
.+.+++||||++|++|.+++ +.+++..++.++.||+.||+|||++||+||||||+|||++. +.+.+||+|||+|+
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~--~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR--RLKKYALVDFGLAQ 166 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCE
T ss_pred CCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC--CCCeEEECcCCCCc
Confidence 99999999999999999987 46999999999999999999999999999999999999963 34679999999997
Q ss_pred cccCCC-----------------------------ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCC
Q 018786 220 FFKPGD-----------------------------VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPP 268 (350)
Q Consensus 220 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~p 268 (350)
...+.. .....+||+.|+|||++.+ .++.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 643321 1234579999999998754 489999999999999999999999
Q ss_pred CCCC-CHHHHHHHHHcC--------------------------------------C------------CCCCCCCCCCCC
Q 018786 269 FWGE-TEQSIFDAILRG--------------------------------------H------------IDFSSDPWPNIS 297 (350)
Q Consensus 269 f~~~-~~~~~~~~~~~~--------------------------------------~------------~~~~~~~~~~~~ 297 (350)
|... ++.+.+..+... . .......+..++
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 9654 343433333210 0 001112355789
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
+++.+||.+||+.||++|+|+.|+|+|+||++..
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-57 Score=434.86 Aligned_cols=265 Identities=26% Similarity=0.399 Sum_probs=227.7
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHH---HHHHHHccCCCCeeEeEeEEEcC
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE---VQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e---~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
...++|.+++.||+|+||+||+|+++.+|+.||||++.+...........+.+| +.+++.+. |||||++++.|.+.
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTP 264 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEEEEEC
Confidence 345889999999999999999999999999999999976543333333444444 44555555 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|..
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACD 341 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeee
Confidence 9999999999999999999999999999999999999999999999999999999999999 6778899999999988
Q ss_pred ccCCCccccCCcCcccccccccc-c-cCCcchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCCC
Q 018786 221 FKPGDVFKDLVGSAYYVAPEVLR-R-NYGAEADIWSAGVILYILLSGVPPFWGE---TEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... ..+.+||+.|||||++. + .|+.++|+|||||++|||++|..||.+. ...++...+......++. .
T Consensus 342 ~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~----~ 416 (689)
T 3v5w_A 342 FSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----S 416 (689)
T ss_dssp CSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT----T
T ss_pred cCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc----c
Confidence 75543 35678999999999885 3 5899999999999999999999999754 333455566666555543 6
Q ss_pred CCHHHHHHHHHhcccCccCCCC-----HHHHHhccCCCCCchhhHHH
Q 018786 296 ISSSAKDIVKKMLHADPKERLS-----AAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~~ 337 (350)
+++++++||.+||+.||.+|++ +.|+++|+||.+..|..+..
T Consensus 417 ~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~ 463 (689)
T 3v5w_A 417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL 463 (689)
T ss_dssp SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHT
T ss_pred CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHc
Confidence 8999999999999999999998 79999999999999987753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-56 Score=402.99 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=213.0
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccC-----CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
++.-.++|++++.||+|+||+||+|.+... ++.||||.+.... .....+.+.+|++++.++..|||||+++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 455568999999999999999999998654 4679999986443 334567899999999999856999999998
Q ss_pred EEc-CCceEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCce
Q 018786 137 YED-RHSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (350)
Q Consensus 137 ~~~-~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NI 199 (350)
+.. ++.+++|||||++|+|.++++.. ..+++..+..++.||+.||.|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 865 56789999999999999999753 3488999999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 018786 200 LFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETE 274 (350)
Q Consensus 200 l~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~ 274 (350)
|+ ++++.+||+|||+|+....... .....||+.|||||++. +.++.++|||||||++|||+| |..||.+...
T Consensus 217 Ll---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 217 LL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp EE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ee---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 99 6667899999999987643322 23457899999999876 569999999999999999998 9999987654
Q ss_pred -HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 275 -QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 275 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
......+..+..... .+.+++++.++|.+||+.||++|||+.|+++|+
T Consensus 294 ~~~~~~~i~~g~~~~~---p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 294 DEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp SHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 344444544432211 135799999999999999999999999999884
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-54 Score=393.58 Aligned_cols=272 Identities=37% Similarity=0.590 Sum_probs=242.5
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh---hhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
..+.++|.+.+.||+|+||+||+|.++.+|+.||+|++........ ...+.+.+|+.+++++. ||||+++++++..
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEEe
Confidence 4567889999999999999999999999999999999976543221 23578999999999998 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCC-CCCeEEeecCCc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE-DSPLKATDFGLS 218 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-~~~vkl~Dfg~a 218 (350)
.+.+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999999988888999999999999999999999999999999999999954321 237999999999
Q ss_pred ccccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+......++...++.++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 98776666667789999999998864 68999999999999999999999999999999999998888777666567889
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhH
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~ 335 (350)
.++.+||.+||+.||.+|||+.|+|+|+||....++..
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~ 284 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQA 284 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHHHH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchhhh
Confidence 99999999999999999999999999999998776543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=385.88 Aligned_cols=259 Identities=35% Similarity=0.609 Sum_probs=234.9
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+++.+|+++++++. ||||+++++++...+.+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEE
Confidence 345789999999999999999999999999999999976543 4455678999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSS
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCC
Confidence 9999999999999999988899999999999999999999999999999999999999 6677899999999988776
Q ss_pred CCccccCCcCcccccccccccc-C-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRRN-Y-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~~-~-~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.......+||+.|+|||++.+. + +.++||||||+++|+|++|..||.+....+....+..+....+. .++.++.
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~ 242 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCE 242 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHH
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHH
Confidence 6666778899999999988643 3 57899999999999999999999999988888888888766554 4799999
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
+||.+||+.||.+|||+.|+|+|+||....
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999999999998643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-54 Score=395.03 Aligned_cols=266 Identities=38% Similarity=0.723 Sum_probs=242.4
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
...+.++|.+.+.||+|+||.||+|.++.+++.||+|++..... .....+.+.+|+.+++++. ||||+++++++.+.+
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEES 101 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCC
Confidence 34566899999999999999999999999999999999976543 3445678999999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
..++||||+.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|||++...
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999999999988888999999999999999999999999999999999999976666678999999999887
Q ss_pred cCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 222 KPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
..........||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+...++...+..++.++
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 76655566789999999998865 58999999999999999999999999999888888888888887777777899999
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
.++|.+||+.||++|||+.++|+|+|+..
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=393.27 Aligned_cols=265 Identities=27% Similarity=0.499 Sum_probs=233.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||+|+||+||+|+++.+++.||||++.+.........+.+.+|..+++.+.+||||+++++++...+.+++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 47899999999999999999999999999999999765443445567789999999998669999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~ 224 (350)
||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ..
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccCC
Confidence 99999999999999988899999999999999999999999999999999999999 667789999999998643 33
Q ss_pred CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
......+||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++. .++.++.++
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l 254 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGI 254 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Confidence 34456789999999998864 5899999999999999999999999999999999999888776654 479999999
Q ss_pred HHHhcccCccCCCCH------HHHHhccCCCCCchhhHHH
Q 018786 304 VKKMLHADPKERLSA------AEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 304 i~~~L~~dp~~Rps~------~~iL~~~~~~~~~~~~~~~ 337 (350)
|.+||+.||.+||++ .++++|+||.+..|..+..
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~ 294 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNH 294 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHT
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhc
Confidence 999999999999999 9999999999998877643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=400.90 Aligned_cols=260 Identities=32% Similarity=0.617 Sum_probs=216.4
Q ss_pred ccccceeee-eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc---
Q 018786 64 DVRNTYIFG-RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--- 139 (350)
Q Consensus 64 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--- 139 (350)
...++|.+. +.||+|+||+||+|.++.+++.||||++... ..+.+|+.++.++.+|+||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 445678776 7899999999999999999999999998532 4577899988777669999999998865
Q ss_pred -CCceEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 140 -RHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 140 -~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
...+++||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 667899999999999999998753 59999999999999999999999999999999999999765557889999999
Q ss_pred CcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCCC
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQ----SIFDAILRGHIDFSSD 291 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~~ 291 (350)
++............+||+.|+|||++. ..++.++||||||+++|+|++|..||...... .....+..+...++..
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 998876555556778999999999886 45899999999999999999999999765432 2445566666666766
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.+..++.++.+||.+||+.||++|||+.|+|+|+||.+..
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 6778999999999999999999999999999999997643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=386.01 Aligned_cols=264 Identities=31% Similarity=0.561 Sum_probs=236.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++++. ||||+++++++...+.+++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEE
Confidence 478999999999999999999999999999999997654333445678899999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-CC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~~ 224 (350)
||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ..
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccCC
Confidence 99999999999999988899999999999999999999999999999999999999 667789999999998643 33
Q ss_pred CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
......+||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......++. .+++++.++
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l 235 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSL 235 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Confidence 34456789999999998864 5899999999999999999999999999888888888877666554 579999999
Q ss_pred HHHhcccCccCCC-----CHHHHHhccCCCCCchhhHHH
Q 018786 304 VKKMLHADPKERL-----SAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 304 i~~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~~ 337 (350)
|.+||+.||++|| ++.|+++|+||.+..|+.+..
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~ 274 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 274 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence 9999999999999 999999999999998877653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=398.24 Aligned_cols=266 Identities=38% Similarity=0.704 Sum_probs=240.2
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
..+.++|.+.+.||+|+||+||+|.++.+|+.+|+|++..... .....+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK-HPNIVRLHDSISEEGH 84 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECSSE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEECCE
Confidence 3566899999999999999999999999999999999976543 3344567999999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
.++||||+.|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+.+++.+||+|||++....
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999999999999999999999999999999999999999999999999999765567889999999998765
Q ss_pred CCC-ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 223 PGD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 223 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+..+...++...++.+++++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 433 3355689999999998865 58999999999999999999999999999999999999998888888888999999
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.+||.+||+.||++|||+.|+|+|+|+...
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999999999999999999999999643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=387.83 Aligned_cols=267 Identities=40% Similarity=0.709 Sum_probs=219.2
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
...+.+.++|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++++. |+||+++++++..
T Consensus 46 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 119 (349)
T 2w4o_A 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFET 119 (349)
T ss_dssp SBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEEC
T ss_pred cccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEec
Confidence 334567789999999999999999999999999999999997432 2356889999999998 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
.+..++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++..+.++.+||+|||++.
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 99999999999999999999888889999999999999999999999999999999999999765557889999999998
Q ss_pred cccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCCC
Q 018786 220 FFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
............||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .....+...........++.++
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 200 IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred ccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 7765555566789999999998764 5899999999999999999999999766544 4666777776666666667899
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.++.+||.+||+.||++|||+.|+|+|+||.+...
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 99999999999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-53 Score=389.83 Aligned_cols=265 Identities=26% Similarity=0.521 Sum_probs=231.1
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+++.||+|+||+||+|+++.+++.||+|++++.........+.+.+|..++.++.+||||+++++++...+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 47899999999999999999999999999999999876554555556788999999988669999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc-ccCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF-FKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~-~~~~ 224 (350)
||||++|++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.. ....
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccCC
Confidence 99999999999999988899999999999999999999999999999999999999 6677899999999986 3344
Q ss_pred CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHcCCCCCCCCCCC
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE---------TEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
......+||+.|+|||++.+ .++.++||||||+++|+|++|..||... ........+......++.
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~---- 283 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---- 283 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT----
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC----
Confidence 45567789999999998764 5899999999999999999999999632 233455666666665554
Q ss_pred CCCHHHHHHHHHhcccCccCCCCH------HHHHhccCCCCCchhhHHH
Q 018786 295 NISSSAKDIVKKMLHADPKERLSA------AEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~------~~iL~~~~~~~~~~~~~~~ 337 (350)
.++.++.+||.+||+.||.+||++ .|+++|+||.+..|..+..
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~ 332 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ 332 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHT
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHc
Confidence 579999999999999999999984 8999999999999887654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-53 Score=381.63 Aligned_cols=271 Identities=38% Similarity=0.636 Sum_probs=239.6
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh---hhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
+.+.++|.+.+.||+|+||.||+|.++.+++.||+|++........ ...+.+.+|+.+++++. ||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence 3566889999999999999999999999999999999976543221 24678999999999998 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC-CCCCeEEeecCCc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGLS 218 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~~~vkl~Dfg~a 218 (350)
.+..++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ ....+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999999998888899999999999999999999999999999999999995433 2337999999999
Q ss_pred ccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+......++...++.++
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 8876555556678999999999886 458999999999999999999999999998888888887776666555456789
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
..+.++|.+||+.||++|||+.|+|+|+||....++.
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 282 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcchh
Confidence 9999999999999999999999999999999887654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=370.19 Aligned_cols=267 Identities=37% Similarity=0.723 Sum_probs=243.7
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.++|++.+.||+|+||.||+|.++.+++.||+|++..... .....+.+.+|+.+++++. |+||+++++++...+..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH 80 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCEE
Confidence 467899999999999999999999999999999999976543 4455678999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||+++++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++.+||+|||.+.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999999999999888899999999999999999999999999999999999997666667799999999988776
Q ss_pred CCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
........||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+.......+...+..+++++.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 666666789999999998764 5899999999999999999999999999998889888888888877777789999999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
+|.+||+.||++|||+.|+|+|+||.+...
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 999999999999999999999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=380.17 Aligned_cols=266 Identities=26% Similarity=0.504 Sum_probs=232.9
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|.+.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|..++.++.+||||+++++++...+.++
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 34789999999999999999999999999999999987666566667789999999999855999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-C
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-P 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~ 223 (350)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... .
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccccCC
Confidence 999999999999999988899999999999999999999999999999999999999 667789999999998632 3
Q ss_pred CCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHcCCCCCCCCCC
Q 018786 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWG---------ETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~---------~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.......+||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .........+......++.
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--- 240 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--- 240 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT---
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC---
Confidence 334456789999999998764 589999999999999999999999965 2334455566666555543
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCH------HHHHhccCCCCCchhhHHH
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSA------AEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~------~~iL~~~~~~~~~~~~~~~ 337 (350)
.++.++.++|.+||+.||.+||++ .|+++|+||.+..|..+..
T Consensus 241 -~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~ 289 (345)
T 3a8x_A 241 -SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ 289 (345)
T ss_dssp -TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHT
T ss_pred -CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHh
Confidence 579999999999999999999995 8999999999998876643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-53 Score=384.23 Aligned_cols=266 Identities=26% Similarity=0.472 Sum_probs=236.1
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|.+.+.||+|+||.||+|+++.+++.||||++++.........+.+.+|..++.++.+||||+++++++.+.+.++
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 34789999999999999999999999999999999976543333456778899999998855999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC-
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP- 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~- 223 (350)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcccC
Confidence 999999999999999988899999999999999999999999999999999999999 6677899999999986432
Q ss_pred CCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
.......+||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+......++. .++.++.+
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 247 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKD 247 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHHHHH
Confidence 233456789999999998764 5899999999999999999999999999988888888877665543 57999999
Q ss_pred HHHHhcccCccCCCCHH-HHHhccCCCCCchhhHHH
Q 018786 303 IVKKMLHADPKERLSAA-EVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~-~iL~~~~~~~~~~~~~~~ 337 (350)
+|.+||+.||++||++. ++++|+||.+..|+.+..
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~ 283 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQHPLFREINWEELER 283 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHT
T ss_pred HHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhh
Confidence 99999999999999998 999999999998877654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-53 Score=381.92 Aligned_cols=262 Identities=30% Similarity=0.583 Sum_probs=236.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.++|.+.+.||+|+||+||+|.+..+++.+|+|++... ......+.+|+.+++++. ||||+++++++.+.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEE
Confidence 3568999999999999999999999999999999998643 234567899999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .++.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECC
Confidence 9999999999999999765 469999999999999999999999999999999999999542 26789999999999877
Q ss_pred CCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 223 PGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.........||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++...++.++.++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 6666666789999999998865 478999999999999999999999999999999999988887777666678899999
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
++|.+||+.||.+|||+.|+|+|+||.+..
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 999999999999999999999999998764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=404.91 Aligned_cols=269 Identities=42% Similarity=0.701 Sum_probs=247.5
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
...+.++|++.+.||+|+||.||+|.++.+++.||||++...........+.+.+|+.+++++. ||||+++++++...+
T Consensus 21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence 3456789999999999999999999999999999999997665544556788999999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.+++||||+.+++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++...
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999999998889999999999999999999999999999999999999976666788999999999887
Q ss_pred cCCCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 222 KPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
..........||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+..+...+..+.+..+++++.
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 180 EASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred ccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 76666666789999999999988899999999999999999999999999999999999999888877777778999999
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
+||.+||+.||.+|||+.|+|+|+||....
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 999999999999999999999999997543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=401.77 Aligned_cols=268 Identities=38% Similarity=0.671 Sum_probs=240.6
Q ss_pred cccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
....+.++|++++.||+|+||+||+|.++.++..||+|++..... .......+.+|+.+++++. ||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 108 (494)
T 3lij_A 31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDK 108 (494)
T ss_dssp CBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred CCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence 344566889999999999999999999999999999999976543 2233567899999999998 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
+.+++||||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++..
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999999999998888999999999999999999999999999999999999997666677899999999988
Q ss_pred ccCCCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 221 FKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
...........||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+..+...+....|+.++.++
T Consensus 189 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 268 (494)
T 3lij_A 189 FENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268 (494)
T ss_dssp CBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred CCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence 77666667778999999999998889999999999999999999999999999999999999988888877788899999
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.+||.+||+.||.+|||+.++|+|+||.+.
T Consensus 269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999999999999999999999764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=377.85 Aligned_cols=262 Identities=26% Similarity=0.521 Sum_probs=235.5
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|..+++.+. ||||+++++++.+.+.+++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEEEE
Confidence 478999999999999999999999999999999997654333345677889999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC-
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCCc-
Confidence 99999999999999988899999999999999999999999999999999999999 66778999999999875433
Q ss_pred ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
....+||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......++. .++.++.++|
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li 234 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLL 234 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHH
Confidence 34568999999999876 45899999999999999999999999999888888888887666553 5799999999
Q ss_pred HHhcccCccCCC-----CHHHHHhccCCCCCchhhHHH
Q 018786 305 KKMLHADPKERL-----SAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 305 ~~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~~ 337 (350)
.+||+.||++|| ++.++++|+||.+..|+.+..
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~ 272 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLS 272 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHT
T ss_pred HHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHh
Confidence 999999999999 999999999999988876643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=383.82 Aligned_cols=266 Identities=26% Similarity=0.481 Sum_probs=237.1
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|.+.+.||+|+||.||+|+++.+++.||||++.+.........+.+.+|..++..+..||+|+++++++...+.++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 45789999999999999999999999999999999976543334456778899999988866999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-C
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-P 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~ 223 (350)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... .
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccccC
Confidence 999999999999999988899999999999999999999999999999999999999 667789999999998643 3
Q ss_pred CCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
.......+||+.|+|||++. ..++.++||||||+++|||++|..||.+....+....+......++. .++.++.+
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 250 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVA 250 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHH
Confidence 33445678999999999876 45899999999999999999999999999998999888887766654 57999999
Q ss_pred HHHHhcccCccCCCC-----HHHHHhccCCCCCchhhHHH
Q 018786 303 IVKKMLHADPKERLS-----AAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 303 li~~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~~ 337 (350)
+|.+||+.||.+||+ +.++++|+||....|..+..
T Consensus 251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~ 290 (353)
T 2i0e_A 251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER 290 (353)
T ss_dssp HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHT
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHh
Confidence 999999999999994 69999999999998877653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=385.58 Aligned_cols=265 Identities=27% Similarity=0.534 Sum_probs=225.7
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHH-HHccCCCCeeEeEeEEEcCCce
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM-HHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l-~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
..++|.+.+.||+|+||.||+|+++.+++.||||++.+...........+.+|..++ +.+. ||||+++++++...+.+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCCEE
Confidence 457899999999999999999999999999999999876654445556677777764 4555 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK- 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~- 222 (350)
++||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGBC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCcccccccc
Confidence 9999999999999999988899999999999999999999999999999999999999 667789999999998643
Q ss_pred CCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 223 PGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
........+||+.|+|||++.+ .++.++|+||||+++|||++|..||......+.+..+......++. .++.++.
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~ 267 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSAR 267 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS----SSCHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC----CCCHHHH
Confidence 3334456789999999998764 5899999999999999999999999999988888888887665543 5799999
Q ss_pred HHHHHhcccCccCCCCH----HHHHhccCCCCCchhhHHH
Q 018786 302 DIVKKMLHADPKERLSA----AEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~----~~iL~~~~~~~~~~~~~~~ 337 (350)
++|.+||+.||.+||++ .++++|+||.+..|..+..
T Consensus 268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~ 307 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLIN 307 (373)
T ss_dssp HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred HHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHh
Confidence 99999999999999986 6999999999999877643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=384.40 Aligned_cols=267 Identities=26% Similarity=0.490 Sum_probs=236.3
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
....++|.+.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCE
Confidence 344588999999999999999999999999999999997655444455678999999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+++||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeecc
Confidence 99999999999999999988899999999999999999999999999999999999999 667789999999999877
Q ss_pred CCCccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCCC
Q 018786 223 PGDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGE---TEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
........+||+.|+|||++. ..++.++||||||+++|+|++|..||... ........+......++. .
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~----~ 242 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----A 242 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT----T
T ss_pred CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC----c
Confidence 666667788999999999875 24889999999999999999999999743 344555555555555443 5
Q ss_pred CCHHHHHHHHHhcccCccCCCC-HHHHHhccCCCCCchhhHHH
Q 018786 296 ISSSAKDIVKKMLHADPKERLS-AAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps-~~~iL~~~~~~~~~~~~~~~ 337 (350)
++.++.+||.+||+.||.+||+ +.++++|+||.+..|..+..
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~ 285 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQ 285 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHT
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHh
Confidence 7999999999999999999998 99999999999999977654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=372.50 Aligned_cols=263 Identities=40% Similarity=0.790 Sum_probs=240.3
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.++|++.+.||+|+||.||+|.+..++..+|+|.+..... ...+.+.+|+++++++. |+||+++++++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNTDI 81 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCeE
Confidence 456889999999999999999999999999999999975432 33578999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++..++.++.+||+|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999999999999999888899999999999999999999999999999999999997666678899999999988776
Q ss_pred CCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
........||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+..+....+...+..+++++.++
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (277)
T 3f3z_A 162 GKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241 (277)
T ss_dssp TSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHH
T ss_pred ccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHH
Confidence 66666778999999999998889999999999999999999999999999888888888887777665556789999999
Q ss_pred HHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
|.+||+.||++|||+.++|+|+||.+.
T Consensus 242 i~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 242 IRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999999999754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=380.90 Aligned_cols=262 Identities=28% Similarity=0.547 Sum_probs=236.8
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++++. ||||+++++++.+.+.++
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEE
Confidence 4588999999999999999999999999999999997654434445678899999999997 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccCC
Confidence 999999999999999988899999999999999999999999999999999999999 66778999999999876543
Q ss_pred CccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
....+||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+..+...++. .++.++.++
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l 268 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDL 268 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHH
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Confidence 34567999999999875 45899999999999999999999999999988888888887766553 579999999
Q ss_pred HHHhcccCccCCCC-----HHHHHhccCCCCCchhhHH
Q 018786 304 VKKMLHADPKERLS-----AAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 304 i~~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~ 336 (350)
|.+||+.||.+||+ +.|+++|+||.+..|..+.
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~ 306 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHH
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHh
Confidence 99999999999998 9999999999999887664
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=399.52 Aligned_cols=266 Identities=40% Similarity=0.702 Sum_probs=241.2
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.++|.+.+.||+|+||+||+|.++.+++.||||++...... ......+.+|+.+++++. ||||+++++++...+.+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcCCEE
Confidence 4568999999999999999999999999999999999654322 234578999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||+.+++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999999998888999999999999999999999999999999999999998766778899999999988766
Q ss_pred CCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
........||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+..+...+..+.+..++.++.+|
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 66666778999999999998889999999999999999999999999999999999999888877777777899999999
Q ss_pred HHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
|.+||+.||.+|||+.++|+|+||.+..
T Consensus 257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 9999999999999999999999997653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=398.93 Aligned_cols=269 Identities=36% Similarity=0.661 Sum_probs=240.0
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCC----------hhhHHHHHHHHHHHHHccCCCCee
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN----------RDDVEDVRREVQIMHHLTGHRNIV 131 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~~h~~iv 131 (350)
...+.++|.+++.||+|+||+||+|.++.+++.||+|++....... ....+.+.+|+.+++++. ||||+
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv 109 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNII 109 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTBC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCCC
Confidence 3456789999999999999999999999999999999997654321 134578999999999998 99999
Q ss_pred EeEeEEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeE
Q 018786 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211 (350)
Q Consensus 132 ~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vk 211 (350)
++++++.+...+++||||++|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....+|
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999999999999888999999999999999999999999999999999999997655455799
Q ss_pred EeecCCcccccCCCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 018786 212 ATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 212 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
|+|||++.............||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+..+...++..
T Consensus 190 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp ECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred EEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 99999999877666667778999999999998889999999999999999999999999999999999999888777766
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.|+.++.++.+||.+||+.||.+|||+.|+|+|+||.+..
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 6678999999999999999999999999999999997654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=378.01 Aligned_cols=285 Identities=29% Similarity=0.516 Sum_probs=243.1
Q ss_pred CCCccccccCCcccccccceeee-eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCC
Q 018786 50 TSSSVGRVLGKPMEDVRNTYIFG-RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128 (350)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~ 128 (350)
..+....+.....+.+.++|.+. +.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++++..|+
T Consensus 11 ~~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~ 89 (327)
T 3lm5_A 11 VDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCP 89 (327)
T ss_dssp -----CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCT
T ss_pred ccccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCC
Confidence 33444455566678889999998 899999999999999999999999999976543 3344678999999999998789
Q ss_pred CeeEeEeEEEcCCceEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCC
Q 018786 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE 206 (350)
Q Consensus 129 ~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 206 (350)
||+++++++...+..++||||+.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++....
T Consensus 90 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~ 169 (327)
T 3lm5_A 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYP 169 (327)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTT
T ss_pred CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCC
Confidence 999999999999999999999999999998854 367999999999999999999999999999999999999965444
Q ss_pred CCCeEEeecCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Q 018786 207 DSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285 (350)
Q Consensus 207 ~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~ 285 (350)
++.+||+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+....
T Consensus 170 ~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 249 (327)
T 3lm5_A 170 LGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249 (327)
T ss_dssp BCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc
Confidence 7789999999998876665556678999999999876 458999999999999999999999999999888888888887
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhH
Q 018786 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~ 335 (350)
...+...+..++..+.++|.+||+.||++|||+.++|+|+||.+..++..
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 250 VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 77777777789999999999999999999999999999999999877654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=366.61 Aligned_cols=262 Identities=35% Similarity=0.656 Sum_probs=225.0
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.++|.+.+.||+|+||.||+|.++.+++.+|+|++.... .....+.+.+|+++++++. ||||+++++++...+..
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCC-CchHHhHHHheecCCeE
Confidence 45689999999999999999999999999999999997543 2334678999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 144 NLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
++||||+++++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999998854 3679999999999999999999999999999999999999766667889999999998
Q ss_pred cccCCCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHH
Q 018786 220 FFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (350)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
............||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+............... ...++++
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 254 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQ 254 (285)
T ss_dssp C----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHH
T ss_pred ecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcCCHH
Confidence 776665556678999999999998889999999999999999999999999988777776666554444332 2347899
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
+.++|.+||+.||++|||+.|+|+|+||++
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999999976
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=383.24 Aligned_cols=266 Identities=34% Similarity=0.653 Sum_probs=229.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccC--ChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
.+.++|.+.+.||+|+||+||+|.++.+++.||||++...... .....+.+.+|+.+++++. ||||+++++++...+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDG 99 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence 4568999999999999999999999999999999999653321 1224578999999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 142 SVNLIMDLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
.+++||||++|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999998877543 3589999999999999999999999999999999999997666667799999999
Q ss_pred cccccCCCc-cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 218 SVFFKPGDV-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 218 a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
+........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+. .......+..+........++.
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTT
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccccc
Confidence 987654432 345689999999998864 5899999999999999999999999875 4456666666666555444567
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
++.++.++|.+||+.||++|||+.++|+|+||....
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 899999999999999999999999999999998643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=373.61 Aligned_cols=249 Identities=21% Similarity=0.285 Sum_probs=191.0
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC----
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH---- 141 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~---- 141 (350)
..+|.+.+.||+|+||+||+|++ +|+.||||++.... ........|+..+.+++ |||||++++++...+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCce
Confidence 36799999999999999999987 47899999986432 11122345666666787 999999999987553
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCEeecCCCCceEeecCCCCCCeEEe
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM--------GVMHRDLKPENFLFSSSAEDSPLKAT 213 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~ivH~Dlkp~NIl~~~~~~~~~vkl~ 213 (350)
.++|||||+++|+|.++++.. ++++..+..++.|++.||.|||++ +||||||||+|||+ +.++.+||+
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~ 150 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEE
Confidence 579999999999999998764 689999999999999999999987 99999999999999 677889999
Q ss_pred ecCCcccccCCCc-----cccCCcCccccccccccc-------cCCcchhHHHHHHHHHHHHhCCCCCCCC---------
Q 018786 214 DFGLSVFFKPGDV-----FKDLVGSAYYVAPEVLRR-------NYGAEADIWSAGVILYILLSGVPPFWGE--------- 272 (350)
Q Consensus 214 Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~Dv~slG~vl~~ll~g~~pf~~~--------- 272 (350)
|||+|+....... ....+||+.|||||++.+ .++.++|||||||++|||++|..||...
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 9999987654332 234579999999998754 3677999999999999999997765321
Q ss_pred ------CHHHHHHHHHcCCCCCCCC-CC--CCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 273 ------TEQSIFDAILRGHIDFSSD-PW--PNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 273 ------~~~~~~~~~~~~~~~~~~~-~~--~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
........+.........+ .+ ...+..+.+|+.+||+.||++|||+.|+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 292 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 1223333333332221111 11 11235788999999999999999999998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=380.71 Aligned_cols=264 Identities=33% Similarity=0.576 Sum_probs=235.6
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.++|.+.+.||+|+||.||+|.++.+++.||+|++.... ......+.+|+.+++++. |+||+++++++.+...+
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEM 123 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCCEE
Confidence 34578999999999999999999999999999999986432 234467899999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.++.+||+|||++....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccceecC
Confidence 9999999999999988765 36999999999999999999999999999999999999953 234679999999999876
Q ss_pred CCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 223 PGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+......+....+..++.++.
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 6655566689999999998864 589999999999999999999999999988888888888877777777778999999
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
++|.+||+.||++|||+.|+|+|+||.+...
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 9999999999999999999999999987643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=392.00 Aligned_cols=266 Identities=30% Similarity=0.551 Sum_probs=226.2
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|.+.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++++. ||||+++++++...+.+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEE
Confidence 34578999999999999999999999999999999997654444455567889999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||||+++++|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||+ +.++.+||+|||++....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTC
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceecc
Confidence 9999999999999999988899999999999999999999998 999999999999999 566789999999998643
Q ss_pred -CCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 223 -PGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 223 -~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
........+||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......++. .+++++
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~ 376 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEA 376 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHH
Confidence 333445678999999999875 46899999999999999999999999999988888888877766554 579999
Q ss_pred HHHHHHhcccCccCCC-----CHHHHHhccCCCCCchhhHHH
Q 018786 301 KDIVKKMLHADPKERL-----SAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~~ 337 (350)
.+||.+||+.||.+|| ++.|+|+|+||.+..|+.+..
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~ 418 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYE 418 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhh
Confidence 9999999999999999 999999999999998877643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=371.37 Aligned_cols=272 Identities=36% Similarity=0.597 Sum_probs=238.8
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh---hhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
..+.++|.+.+.||+|+||.||+|.++.+|+.||+|++........ ...+.+.+|+.+++++. ||||+++++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence 4567889999999999999999999999999999999976543221 23678999999999998 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCC-CCCeEEeecCCc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE-DSPLKATDFGLS 218 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-~~~vkl~Dfg~a 218 (350)
.+..++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999999998888999999999999999999999999999999999999953321 127999999999
Q ss_pred ccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+.......+...+..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 8876665556678999999999876 458999999999999999999999999998888888888776665544445789
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhH
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~ 335 (350)
..+.++|.+||+.||++|||+.|+|+|+||....++..
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~~~ 284 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcccc
Confidence 99999999999999999999999999999998776543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=387.44 Aligned_cols=267 Identities=28% Similarity=0.468 Sum_probs=230.9
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|.+.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence 34578999999999999999999999999999999997543222233345889999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeecc
Confidence 999999999999998865 469999999999999999999999999999999999999 6677899999999987654
Q ss_pred CCc--cccCCcCccccccccccc-c----CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 224 GDV--FKDLVGSAYYVAPEVLRR-N----YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 224 ~~~--~~~~~gt~~y~aPE~~~~-~----~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
... ....+||+.|+|||++.+ . ++.++||||||+++|+|++|..||.+.........+.........+....+
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 300 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 300 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCC
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccc
Confidence 432 346789999999998753 2 788999999999999999999999999988888888765433333334578
Q ss_pred CHHHHHHHHHhcccCccC--CCCHHHHHhccCCCCCchhhH
Q 018786 297 SSSAKDIVKKMLHADPKE--RLSAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~--Rps~~~iL~~~~~~~~~~~~~ 335 (350)
+.++.+||.+||+.+|.+ |+++.|+++|+||.+..|..+
T Consensus 301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~ 341 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE 341 (410)
T ss_dssp CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred cHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence 999999999999999988 999999999999999877543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=370.41 Aligned_cols=265 Identities=29% Similarity=0.514 Sum_probs=222.6
Q ss_pred ccccceeeeeeeeccCceEEEEEEEc---cCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
...++|.+.+.||+|+||.||+|++. .+++.||+|+++..... .......+.+|+.+++++. ||||+++++++..
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQT 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEc
Confidence 44588999999999999999999985 67899999999765322 2234466889999999998 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
.+.+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCccc
Confidence 99999999999999999999988889999999999999999999999999999999999999 667789999999987
Q ss_pred cccC-CCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 220 FFKP-GDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 220 ~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.... ........||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......++. .++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~ 245 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLT 245 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT----TSC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----CCC
Confidence 6432 23344567999999999875 45899999999999999999999999999888888888877665543 579
Q ss_pred HHHHHHHHHhcccCccCCC-----CHHHHHhccCCCCCchhhHH
Q 018786 298 SSAKDIVKKMLHADPKERL-----SAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~ 336 (350)
.++.++|.+||+.||++|| ++.++++|+||.+..|..+.
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~ 289 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELL 289 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHH
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHh
Confidence 9999999999999999999 89999999999998876654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=378.88 Aligned_cols=260 Identities=37% Similarity=0.638 Sum_probs=228.6
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
..+.++|.+.+.||+|+||+||+|.++.+++.||||++..... ...+|++++.++.+||||+++++++.+.+.
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 3567899999999999999999999999999999999975432 234688888888669999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecC-CCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS-AEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~~~vkl~Dfg~a~~~ 221 (350)
.++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||++...
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999999999988889999999999999999999999999999999999998543 22356999999999876
Q ss_pred cCC-CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 222 KPG-DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWG---ETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 222 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
... ......+||+.|+|||++.+ .++.++||||||+++|+|++|..||.. ....+....+..+........++.+
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 250 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence 443 23455689999999998865 488999999999999999999999975 4566777888888888777777889
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
+.++.+||.+||+.||++|||+.++|+|+||.+
T Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 999999999999999999999999999999965
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=381.36 Aligned_cols=257 Identities=33% Similarity=0.581 Sum_probs=222.5
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|.+.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++++. ||||+++++++...+..+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEE
Confidence 4578999999999999999999999999999999997543322333467899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+||||+ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTTTS
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceeccCC
Confidence 999999 77999999988899999999999999999999999999999999999999 66778999999999887776
Q ss_pred CccccCCcCcccccccccccc--CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~~--~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
......+||+.|+|||++.+. .+.++||||||+++|+|++|..||...........+.......+ ..+++++.+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 237 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPGAQS 237 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSCHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCCHHHHH
Confidence 666777899999999998653 37899999999999999999999977654433333322222222 357899999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
+|.+||+.||.+|||+.|+++|+||...
T Consensus 238 li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 9999999999999999999999999764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=364.76 Aligned_cols=259 Identities=27% Similarity=0.464 Sum_probs=223.5
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|++.+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+++++. ||||+++++++...+..
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCC-CCCCCeEeEEEEECCEE
Confidence 345789999999999999999999999999999999865433 23467899999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCC
Confidence 9999999999999988765 69999999999999999999999999999999999999 6667899999999887654
Q ss_pred CC-ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 224 GD-VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 224 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.. ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......... ....++..+.
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 247 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-NPEKLSAIFR 247 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS-CGGGSCHHHH
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-CccccCHHHH
Confidence 33 334567999999999875 45899999999999999999999999988876666555443222111 1236789999
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
++|.+||+.||++|||+.|+|+|+||....
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 999999999999999999999999998654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=378.41 Aligned_cols=264 Identities=33% Similarity=0.582 Sum_probs=228.6
Q ss_pred cccceee--eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 65 VRNTYIF--GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 65 ~~~~y~~--~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
....|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++++. |+||+++++++...+.
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD-HANLIQLYDAFESKND 160 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence 3345555 678999999999999999999999999997543 244578999999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||++...
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceec
Confidence 99999999999999988754 46999999999999999999999999999999999999954 23567999999999987
Q ss_pred cCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 222 KPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
..........||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+.+..+.......+...++.++.++
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 7666556678999999999876 458899999999999999999999999999988888888887777766667899999
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
.+||.+||+.||.+|||+.|+|+|+||.+..+.
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~~ 352 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDHKLH 352 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCCchh
Confidence 999999999999999999999999999987653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=387.33 Aligned_cols=268 Identities=24% Similarity=0.472 Sum_probs=231.6
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|.+.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|..++.++. |+||+++++++.+.+.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCEE
Confidence 34589999999999999999999999999999999997543222223345889999999997 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcc
Confidence 999999999999999987 5779999999999999999999999999999999999999 667789999999997765
Q ss_pred CCCc--cccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCC
Q 018786 223 PGDV--FKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH--IDFSSDP 292 (350)
Q Consensus 223 ~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~ 292 (350)
.... ....+||+.|+|||++. +.++.++||||||+++|||++|..||.+....+.+..+.... ..++. .
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~ 305 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT-Q 305 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS-S
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc-c
Confidence 4332 23468999999999874 358999999999999999999999999999888888876543 23332 2
Q ss_pred CCCCCHHHHHHHHHhcccCccC--CCCHHHHHhccCCCCCchhhHH
Q 018786 293 WPNISSSAKDIVKKMLHADPKE--RLSAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~--Rps~~~iL~~~~~~~~~~~~~~ 336 (350)
+..+++++.+||++||..+|++ |+++.|+++|+||.+..|..+.
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~ 351 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR 351 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence 2468999999999999998888 9999999999999999988763
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=373.92 Aligned_cols=267 Identities=29% Similarity=0.451 Sum_probs=216.3
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|++.+.||+|+||+||+|.+..+++.||||++..... .....+.+.+|+.+++++. |+||+++++++...+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRL 108 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETTEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCEE
Confidence 445789999999999999999999999999999999975432 2333466789999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC--CCCCeEEeecCCcccc
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--EDSPLKATDFGLSVFF 221 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~~~vkl~Dfg~a~~~ 221 (350)
++||||+++ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++.+||+|||++...
T Consensus 109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999999975 9999999988999999999999999999999999999999999999996532 3456999999999875
Q ss_pred cCC-CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC----
Q 018786 222 KPG-DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP---- 294 (350)
Q Consensus 222 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 294 (350)
... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+...........++
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 432 23345578999999998754 48999999999999999999999999988877776665432211111111
Q ss_pred ----------------------CCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 295 ----------------------NISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 295 ----------------------~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
.++.++.+||.+||+.||++|||+.|+|+|+||.+..|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 167899999999999999999999999999999988764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=363.05 Aligned_cols=270 Identities=34% Similarity=0.639 Sum_probs=236.8
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCC------hhhHHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN------RDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
.+.++|.+.+.||+|+||.||+|.++.+++.||||++....... ....+.+.+|+.+++++.+||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45689999999999999999999999999999999997543111 123467889999999997799999999999
Q ss_pred EcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 138 EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 138 ~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
...+..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||.
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEecccc
Confidence 9999999999999999999999988889999999999999999999999999999999999999 6677799999999
Q ss_pred cccccCCCccccCCcCcccccccccc-------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLR-------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS 290 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 290 (350)
+.............|++.|+|||++. ..++.++||||||+++|+|++|..||...........+.......+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 98876665566678999999999873 34788999999999999999999999998888888888887777766
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHH
Q 018786 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 291 ~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~ 336 (350)
..+..++.++.++|.+||+.||++|||+.++|+|+||.+..++.+.
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-----
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhhc
Confidence 6666789999999999999999999999999999999988776654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=369.17 Aligned_cols=267 Identities=34% Similarity=0.584 Sum_probs=220.8
Q ss_pred ccccceeee-eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 64 DVRNTYIFG-RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 64 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
.+.++|.+. +.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++.++.+|+||+++++++...+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 356789985 78999999999999999999999999996543 23457899999999997569999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999999999988889999999999999999999999999999999999999755555569999999987653
Q ss_pred CCC--------ccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCC---------------
Q 018786 223 PGD--------VFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGET--------------- 273 (350)
Q Consensus 223 ~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~--------------- 273 (350)
... ......||+.|+|||++. ..++.++||||||+++|+|++|..||....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 211 123356999999999875 347899999999999999999999997654
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
.......+......++...+..++.++.+||.+||+.||++|||+.|+|+|+||.+...+
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence 234556666666665544445689999999999999999999999999999999986554
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=361.70 Aligned_cols=259 Identities=25% Similarity=0.461 Sum_probs=216.2
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++.+.||+|+||+||+|.++.+++.||+|++..... .......+.+|+.+++++. |+||+++++++...+..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEE
Confidence 579999999999999999999999999999999976543 3444577889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-
Q 018786 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~- 224 (350)
|||+++ ++.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCC
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCcc
Confidence 999976 66666654 6789999999999999999999999999999999999999 66778999999999876433
Q ss_pred CccccCCcCccccccccccc-c-CCcchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCC-----------
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-N-YGAEADIWSAGVILYILLSGVPPF-WGETEQSIFDAILRGHIDFSS----------- 290 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~-~~~~~Dv~slG~vl~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~----------- 290 (350)
.......||+.|+|||++.+ . ++.++||||||+++|+|++|..|| .+....+....+.........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 33355678999999998753 3 799999999999999999888774 555555555555432111111
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 291 --------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 291 --------------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
...+.++.++.+||.+||+.||++|||+.|+|+|+||.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 11235789999999999999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=374.57 Aligned_cols=260 Identities=36% Similarity=0.646 Sum_probs=208.9
Q ss_pred ccceeee---eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 66 RNTYIFG---RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 66 ~~~y~~~---~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
.++|.+. +.||+|+||+||+|.++.+++.||||++... ....+.+|+.+++++.+||||+++++++.+...
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~ 80 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH 80 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence 3567765 7899999999999999999999999998543 346788999999999889999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
.++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+..+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 99999999999999999998899999999999999999999999999999999999999765555589999999998654
Q ss_pred CC-CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCCCCC
Q 018786 223 PG-DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET-------EQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 223 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~ 293 (350)
.. .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.... ..+....+..+...+....+
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (325)
T 3kn6_A 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW 240 (325)
T ss_dssp C----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHH
T ss_pred CCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccc
Confidence 33 23345678999999998864 58999999999999999999999997643 34566777777776666556
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
..+++++.+||.+||+.||++|||+.|+++|+||.+..
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 67899999999999999999999999999999998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=365.04 Aligned_cols=267 Identities=40% Similarity=0.702 Sum_probs=239.4
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+++++++. |+||+++++++...+.
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCCCe
Confidence 4566899999999999999999999999999999999975443 2345678999999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
.++|||++++++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+..+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999999999888889999999999999999999999999999999999999766666789999999998766
Q ss_pred CCCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 223 PGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
.........|++.|+|||++.+.++.++||||||+++|+|++|..||......+....+..+........+..++.++.+
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence 55544556789999999999888999999999999999999999999999888888888887766665556678999999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
+|.+||+.||++|||+.++|+|+||.+..
T Consensus 256 li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999999997543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=366.40 Aligned_cols=265 Identities=26% Similarity=0.414 Sum_probs=218.0
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
.+.+.++|++.+.||+|+||+||+|.+.. ++.||+|++..... .......+.+|+.+++++. ||||+++++++...+
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAE-DEGIPSTAIREISLLKELH-HPNIVSLIDVIHSER 92 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCSS
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccc-cchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccCC
Confidence 45677999999999999999999999965 89999999975432 3334567889999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..++||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARA 168 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCcee
Confidence 99999999975 888888764 459999999999999999999999999999999999999 5667899999999987
Q ss_pred ccCC-CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC------
Q 018786 221 FKPG-DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD------ 291 (350)
Q Consensus 221 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------ 291 (350)
.... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+..........
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 6433 23345678999999998753 58999999999999999999999998877666555543311111110
Q ss_pred --------------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 292 --------------------PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 292 --------------------~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
..+.++.++.+||.+||+.||++|||+.|+|+|+||.+...+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence 023467899999999999999999999999999999987654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=382.21 Aligned_cols=267 Identities=24% Similarity=0.446 Sum_probs=229.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|.+.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|..++.++. |+||+++++++.+.+.+
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYL 136 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEE
Confidence 44689999999999999999999999999999999997543323333456889999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheecc
Confidence 9999999999999999875 479999999999999999999999999999999999999 667789999999998765
Q ss_pred CCCc--cccCCcCcccccccccc--------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCC
Q 018786 223 PGDV--FKDLVGSAYYVAPEVLR--------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH--IDFSS 290 (350)
Q Consensus 223 ~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~ 290 (350)
.... ....+||+.|+|||++. ..++.++||||||+++|||++|+.||......+.+..+.... ..++.
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence 4432 23468999999999875 358999999999999999999999999998888887776532 22221
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCC---CCHHHHHhccCCCCCchhhHH
Q 018786 291 DPWPNISSSAKDIVKKMLHADPKER---LSAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 291 ~~~~~~~~~l~~li~~~L~~dp~~R---ps~~~iL~~~~~~~~~~~~~~ 336 (350)
....++.++++||.+||. +|.+| +++.|+++|+||.+..|..+.
T Consensus 294 -~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 294 -VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR 340 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred -cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 123689999999999999 99998 599999999999999887764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=388.82 Aligned_cols=260 Identities=34% Similarity=0.577 Sum_probs=233.2
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
....++|.+++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+. ||||+++++++...+.
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSD 90 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 345588999999999999999999999999999999997554333345678999999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhcc
Confidence 99999999999999999888889999999999999999999999999999999999999 667789999999999877
Q ss_pred CCCccccCCcCcccccccccccc--CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 223 PGDVFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
........+||+.|+|||++.+. .+.++||||||+++|+|++|..||...........+..+....+. .+++++
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 243 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----YLNPSV 243 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT----TCCHHH
T ss_pred ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc----cCCHHH
Confidence 66666677899999999988653 478999999999999999999999988888888888877655443 578999
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.+||.+||+.||++|||+.|+++|+||.+.
T Consensus 244 ~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999999999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=364.42 Aligned_cols=265 Identities=25% Similarity=0.382 Sum_probs=216.1
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccC--ChhhHHHHHHHHHHHHHcc--CCCCeeEeEeEEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--NRDDVEDVRREVQIMHHLT--GHRNIVELKGAYE 138 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~ 138 (350)
..+.++|++.+.||+|+||+||+|++..+++.||||++...... .......+.+|+.+++++. .||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 45678999999999999999999999999999999999743321 1112345667777777664 3999999999987
Q ss_pred cCC-----ceEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeE
Q 018786 139 DRH-----SVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211 (350)
Q Consensus 139 ~~~-----~~~iv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vk 211 (350)
... .+++|||++. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+||++ +.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~k 160 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVK 160 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEE
Confidence 655 5899999996 599999987654 9999999999999999999999999999999999999 6677899
Q ss_pred EeecCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 018786 212 ATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS 290 (350)
Q Consensus 212 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 290 (350)
|+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+.......+.
T Consensus 161 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp ECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred EeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99999998876666666778999999999874 56899999999999999999999999999888777776543222111
Q ss_pred CC-----------------------CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 291 DP-----------------------WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 291 ~~-----------------------~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.. .+.++.++.+||.+||+.||++|||+.|+|+|+||.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 11 135789999999999999999999999999999998753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=369.10 Aligned_cols=262 Identities=31% Similarity=0.525 Sum_probs=233.6
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|.+.+.||+|+||.||++.+..+++.||+|++...........+.+.+|+.+++++. |+||+++++++.+.+..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeE
Confidence 45689999999999999999999999999999999998765555566788999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceeccc
Confidence 9999999999999999888889999999999999999999999999999999999999 5667899999999987643
Q ss_pred C-CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 224 G-DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 224 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
. .......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......+. .++.++.
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 269 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAA 269 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHH
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHHH
Confidence 2 33345679999999998764 5889999999999999999999999988887777777776655443 5789999
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
++|.+||+.||++|||+.|+|+|+||.....+
T Consensus 270 ~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 270 SLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 99999999999999999999999999877643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=372.99 Aligned_cols=263 Identities=34% Similarity=0.671 Sum_probs=232.9
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccC-C----hhhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-N----RDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~----~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
.+.++|.+.+.||+|+||.||+|.++.+|+.||||++...... . ....+.+.+|+.+++++.+||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 3457899999999999999999999989999999998754321 1 1224568899999999955999999999999
Q ss_pred cCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
..+..++||||++|++|.+++.....+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFS 247 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCcc
Confidence 999999999999999999999988889999999999999999999999999999999999999 66778999999999
Q ss_pred ccccCCCccccCCcCccccccccccc-------cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLRR-------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
.............||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+...+..+
T Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 88776666667789999999998742 47889999999999999999999999988888888888777666555
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
.+..++..+.++|.+||+.||++|||+.++|+|+||.+
T Consensus 328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 55678999999999999999999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=384.94 Aligned_cols=272 Identities=36% Similarity=0.631 Sum_probs=223.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCC-----hhhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-----RDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
.+.++|.+.+.||+|+||+||+|.+..+++.||||++....... ......+.+|+.+++++. ||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 45689999999999999999999999999999999997654321 122235889999999998 999999999986
Q ss_pred cCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
. +..++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++..+||+|||++
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 5 457899999999999999888888999999999999999999999999999999999999977666778999999999
Q ss_pred ccccCCCccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCC
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 293 (350)
.............||+.|+|||++. ..++.++||||||+++|+|++|..||...... .....+..+........+
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 9876665556778999999999874 35788999999999999999999999765433 344555566555554445
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHH
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~ 337 (350)
..++..+.++|.+||+.||++|||+.|+|+|+||.+..++....
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~ 413 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 413 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHHHHH
Confidence 67899999999999999999999999999999999877655443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=401.36 Aligned_cols=266 Identities=26% Similarity=0.481 Sum_probs=239.2
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|.+++.||+|+||.||+|+++.+++.||||++++.........+.+.+|..++..+..|++|+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 45789999999999999999999999999999999976543334455778899999998877999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc-C
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-P 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~-~ 223 (350)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... .
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccccC
Confidence 999999999999999988899999999999999999999999999999999999999 667789999999998643 3
Q ss_pred CCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
.......+||+.|+|||++. ..++.++||||||+++|||++|..||.+....+.+..+......++. .++.++.+
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 571 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVA 571 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHHHHH
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHH
Confidence 34455678999999999876 46899999999999999999999999999999999999988777664 57999999
Q ss_pred HHHHhcccCccCCCCH-----HHHHhccCCCCCchhhHHH
Q 018786 303 IVKKMLHADPKERLSA-----AEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 303 li~~~L~~dp~~Rps~-----~~iL~~~~~~~~~~~~~~~ 337 (350)
||.+||+.||++|+++ .|+++|+||.+..|+.+..
T Consensus 572 li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~ 611 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER 611 (674)
T ss_dssp HHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTT
T ss_pred HHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHh
Confidence 9999999999999997 9999999999999887654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=388.19 Aligned_cols=266 Identities=29% Similarity=0.501 Sum_probs=232.3
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|.+.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++++. |+||+++++++.+.+.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEE
Confidence 44588999999999999999999999999999999997654333344567899999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 144 NLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
++||||++|++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceec
Confidence 999999999999999987543 9999999999999999999999999999999999999 66778999999999887
Q ss_pred cCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCCCCCCCC
Q 018786 222 KPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET----EQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.........+||+.|+|||++.+ .++.++||||||+++|+|++|..||.... .......+......++ ..+
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~ 412 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERF 412 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTS
T ss_pred ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccC
Confidence 66655566789999999998764 58999999999999999999999998753 3445555555444443 368
Q ss_pred CHHHHHHHHHhcccCccCCC-----CHHHHHhccCCCCCchhhHHH
Q 018786 297 SSSAKDIVKKMLHADPKERL-----SAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~~ 337 (350)
+.++.+||.+||+.||.+|| ++.|+++|+||.+..|+.+..
T Consensus 413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~ 458 (576)
T 2acx_A 413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGA 458 (576)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHT
T ss_pred CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhc
Confidence 99999999999999999999 899999999999988876653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=370.45 Aligned_cols=259 Identities=36% Similarity=0.554 Sum_probs=208.7
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|.+.+.||+|+||+||+++++.+++.||||++..... ..+.+.+|+.+++++. ||||+++++++...+.+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLR-HPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEE
Confidence 345789999999999999999999999999999999975432 2256889999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+ ..+.+||+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~-~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS-SSCCEEECCCCCC-----
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCceEEEeecCccccccc
Confidence 9999999999999999888899999999999999999999999999999999999999532 234599999999986554
Q ss_pred CCccccCCcCccccccccccc-cCCc-chhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCCCCC
Q 018786 224 GDVFKDLVGSAYYVAPEVLRR-NYGA-EADIWSAGVILYILLSGVPPFWGETE----QSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~-~~Dv~slG~vl~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
........||+.|+|||++.+ .+.. ++||||||+++|+|++|+.||..... ......+.......+.. ..++
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s 248 (361)
T 3uc3_A 171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD--IRIS 248 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT--SCCC
T ss_pred cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc--CCCC
Confidence 444556789999999998754 4544 48999999999999999999976543 34444455544444332 3579
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.++.+||.+||+.||++|||+.|+++|+||.+.
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 999999999999999999999999999999554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=385.45 Aligned_cols=266 Identities=24% Similarity=0.406 Sum_probs=203.4
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE-----
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE----- 138 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~----- 138 (350)
.+.++|.+++.||+|+||+||+|.++.+++.||||++... .......+++.+|+.+++++. |+||+++++++.
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVE 127 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCcc
Confidence 4568999999999999999999999999999999998643 234455678999999999998 999999999984
Q ss_pred cCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
....+++|||++ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla 203 (458)
T 3rp9_A 128 KFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLA 203 (458)
T ss_dssp TCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred cCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccc
Confidence 335799999998 56999999888889999999999999999999999999999999999999 66778999999999
Q ss_pred ccccCCC----------------------------ccccCCcCccccccccc-c-ccCCcchhHHHHHHHHHHHHh----
Q 018786 219 VFFKPGD----------------------------VFKDLVGSAYYVAPEVL-R-RNYGAEADIWSAGVILYILLS---- 264 (350)
Q Consensus 219 ~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~slG~vl~~ll~---- 264 (350)
....... .....+||+.|+|||++ . ..++.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 8754221 23445789999999975 3 459999999999999999998
Q ss_pred -------CCCCCCCCCH--------------------HHHHHHHHc-----------------------CCCC----CCC
Q 018786 265 -------GVPPFWGETE--------------------QSIFDAILR-----------------------GHID----FSS 290 (350)
Q Consensus 265 -------g~~pf~~~~~--------------------~~~~~~~~~-----------------------~~~~----~~~ 290 (350)
|.++|.+... .+.+..+.. .... ...
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 6666655431 122221111 0000 001
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhH
Q 018786 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 291 ~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~ 335 (350)
..++.++.++.+||.+||+.||++|||+.|+|+|+||.+..+...
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~ 408 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV 408 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence 124567999999999999999999999999999999998866544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=360.62 Aligned_cols=269 Identities=38% Similarity=0.654 Sum_probs=231.1
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh---hhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
+.++|.+.+.||+|+||.||+|.+..+++.||+|++........ ...+.+.+|+.+++++. |+||+++++++...+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKT 81 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCC
Confidence 45789999999999999999999999999999999976543221 23678999999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC-CCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~~~vkl~Dfg~a~~ 220 (350)
..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+..+||+|||.+..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999999998888899999999999999999999999999999999999996433 234799999999988
Q ss_pred ccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHH
Q 018786 221 FKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (350)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
...........|++.|+|||++. ..++.++||||||+++|+|++|..||......+....+...........++.++..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 76555556667999999999876 45899999999999999999999999998888888887776665554444578999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
+.++|.+||+.||++|||+.++|+|+||.....+.
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 99999999999999999999999999998765544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=361.07 Aligned_cols=263 Identities=41% Similarity=0.717 Sum_probs=232.9
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++++. ||||+++++++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIK-HENIVTLEDIYESTTHY 81 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCC-CCCeeehhhhcccCCEE
Confidence 456899999999999999999999999999999999975432 23356889999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++..++.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999999999998888999999999999999999999999999999999999996656678899999999876443
Q ss_pred CCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
. ......|++.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+...++...+..++.++.+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 162 G-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp B-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred C-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 2 2344568999999998864 5899999999999999999999999999888888888888777766666788999999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
+|.+||+.||++|||+.++|+|+||.+..
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999999999997654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=364.54 Aligned_cols=265 Identities=25% Similarity=0.397 Sum_probs=207.4
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+.+|+.+++++. ||||+++++++...+..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEE
Confidence 368999999999999999999999999999999997543 2233467889999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 146 IMDLCAGGELFDRIIAK------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCE
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccce
Confidence 9999974 999988754 358999999999999999999999999999999999999 667789999999998
Q ss_pred cccCC-CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-----
Q 018786 220 FFKPG-DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD----- 291 (350)
Q Consensus 220 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 291 (350)
..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+..........
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 76432 23345678999999998754 58999999999999999999999999988877776654321111000
Q ss_pred -------------------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHH
Q 018786 292 -------------------------PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 292 -------------------------~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~ 337 (350)
....++.++.+||.+||+.||++|||+.|+|+|+||.+......+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~ 307 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMG 307 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-----
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhcc
Confidence 0124688999999999999999999999999999999887765544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=361.35 Aligned_cols=258 Identities=30% Similarity=0.567 Sum_probs=216.5
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCC-----------------------hhhHHHHHHHHHHH
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-----------------------RDDVEDVRREVQIM 121 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----------------------~~~~~~~~~e~~~l 121 (350)
..++|.+.+.||+|+||.||+|.+..+++.||||++....... ....+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3478999999999999999999999999999999997543211 11235689999999
Q ss_pred HHccCCCCeeEeEeEEEc--CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCce
Q 018786 122 HHLTGHRNIVELKGAYED--RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (350)
Q Consensus 122 ~~l~~h~~iv~~~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NI 199 (350)
+++. ||||+++++++.. .+.+++||||+++++|.+++ ..+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 91 ~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 91 KKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 9998 9999999999876 67899999999999997754 345799999999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecCCcccccCCC-ccccCCcCcccccccccccc----CCcchhHHHHHHHHHHHHhCCCCCCCCCH
Q 018786 200 LFSSSAEDSPLKATDFGLSVFFKPGD-VFKDLVGSAYYVAPEVLRRN----YGAEADIWSAGVILYILLSGVPPFWGETE 274 (350)
Q Consensus 200 l~~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~Dv~slG~vl~~ll~g~~pf~~~~~ 274 (350)
|+ +.++.+||+|||++....... ......||+.|+|||++.+. .+.++||||||+++|+|++|..||.....
T Consensus 169 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 169 LV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99 666789999999998765433 23456799999999988643 37789999999999999999999998887
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
......+.......+. .+.++.++.++|.+||+.||++|||+.|+|+|+||.+
T Consensus 246 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 7777777666554443 2468999999999999999999999999999999853
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=357.17 Aligned_cols=258 Identities=33% Similarity=0.577 Sum_probs=226.0
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++. ||||+++++++.+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEE
Confidence 4588999999999999999999999999999999997544333344577899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC---
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCCcc
Confidence 999999999999999988889999999999999999999999999999999999999 66778999999998664433
Q ss_pred CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
......|++.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......+. .++.++.++
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l 237 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDL 237 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHH
T ss_pred -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHHHHHH
Confidence 2345678999999998764 5788999999999999999999999999888888888776665553 578999999
Q ss_pred HHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
|.+||+.||++|||+.|+|+|+||....
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCc
Confidence 9999999999999999999999997654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=360.77 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=212.9
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
.+.+.++|++.+.||+|+||+||+|.+..+++.||||++..... ......+...|+..+.++..|+||+++++++.+.+
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 34566899999999999999999999999999999999865432 33344556677777777755999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEE
T ss_pred EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeee
Confidence 999999999 66998888764 469999999999999999999999999999999999999 5567799999999988
Q ss_pred ccCCCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 221 FKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
...........||+.|+|||++.+.++.++||||||+++|+|++|..|+..... ...+...... ......++.++
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~l 281 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLP--PEFTAGLSSEL 281 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCC--HHHHTTSCHHH
T ss_pred cccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCC--cccccCCCHHH
Confidence 765555566679999999999988899999999999999999999777654322 3333332221 11123679999
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
.++|.+||+.||++|||+.|+|+|+||++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=367.36 Aligned_cols=259 Identities=29% Similarity=0.559 Sum_probs=217.4
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
+.++|++.+.||+|+||+||+|.+..+++.||||++..... ....+.+.+|+.+++++. |+||+++++++...+..+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence 45889999999999999999999999999999999964432 223356889999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccceeccC
Confidence 999999999999999888889999999999999999999999999999999999999 66678999999999865422
Q ss_pred C---ccccCCcCccccccccccc-c-CCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCCCH
Q 018786 225 D---VFKDLVGSAYYVAPEVLRR-N-YGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 225 ~---~~~~~~gt~~y~aPE~~~~-~-~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
. ......||+.|+|||++.+ . .+.++||||||+++|+|++|..||...... ............. ..+..++.
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKKIDS 236 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS--TTGGGSCH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC--CccccCCH
Confidence 2 2345689999999998754 3 477899999999999999999999876553 2233333322222 22456899
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
++.+||.+||+.||++|||+.|+++|+||.+..
T Consensus 237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 999999999999999999999999999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=356.62 Aligned_cols=263 Identities=31% Similarity=0.524 Sum_probs=234.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|.+.+.||+|+||.||+|.+..+++.+|+|++...........+.+.+|+.+++++. |+||+++++++...+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCEE
Confidence 45689999999999999999999999999999999998765555566788999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+.....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceeccc
Confidence 9999999999999999888899999999999999999999999999999999999999 5677899999999987643
Q ss_pred C-CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 224 G-DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 224 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
. .......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......+. .++..+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 243 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAA 243 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHH
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc----ccCHHHH
Confidence 2 33345678999999998764 5889999999999999999999999998888777777776655443 5789999
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
++|.+||+.||++|||+.|+++|+||.....+.
T Consensus 244 ~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 244 SLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 999999999999999999999999998776544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=355.32 Aligned_cols=260 Identities=33% Similarity=0.566 Sum_probs=221.1
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
....++|.+.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++++. |+||+++++++...+.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTD 85 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCe
Confidence 345689999999999999999999999999999999997544333345678999999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
.++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCCC
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccccC
Confidence 99999999999999999988889999999999999999999999999999999999999 566779999999998876
Q ss_pred CCCccccCCcCcccccccccccc--CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 223 PGDVFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
.........|++.|+|||.+.+. .+.++||||||+++|+|++|..||...........+.......+. .++.++
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l 238 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSV 238 (276)
T ss_dssp C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCch----hcCHHH
Confidence 55555566799999999998754 368999999999999999999999988888877777776554443 578999
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.++|.+||+.||++|||+.++++|+||.+.
T Consensus 239 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 999999999999999999999999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=358.26 Aligned_cols=257 Identities=29% Similarity=0.468 Sum_probs=212.5
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||+||+|.+ .+++.||+|++..... .....+.+.+|+.+++++. ||||+++++++...+..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEE
Confidence 5799999999999999999999 5689999999965432 2233467889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-
Q 018786 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~- 224 (350)
|||+.+ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC--
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCccc
Confidence 999975 999988764 679999999999999999999999999999999999999 66778999999999775432
Q ss_pred CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC------------
Q 018786 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS------------ 290 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------ 290 (350)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+.........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 22344578999999998753 4899999999999999999999999988877666655431110000
Q ss_pred -------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 291 -------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 291 -------------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.....++.++.++|.+||+.||++|||+.|+|+|+||.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0123578999999999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=367.44 Aligned_cols=271 Identities=37% Similarity=0.642 Sum_probs=225.1
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccC-----ChhhHHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-----NRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
..+.++|.+.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++++. |+||+++++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 84 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF 84 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEE
Confidence 34568999999999999999999999999999999999754321 1222345889999999998 99999999998
Q ss_pred EcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 138 EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 138 ~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
.... .++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+..+||+|||+
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 7665 899999999999999998888899999999999999999999999999999999999997665666799999999
Q ss_pred cccccCCCccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCC
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDP 292 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 292 (350)
+.............||+.|+|||++. ..++.++||||||+++|+|++|..||...... .....+..+........
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 98876554445567899999999863 45889999999999999999999999765433 33444555544443333
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhH
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~ 335 (350)
+..++.++.++|.+||+.||++|||+.++|+|+||....++..
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~~~ 286 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 286 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHHHH
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHHHH
Confidence 4568999999999999999999999999999999998776543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=371.83 Aligned_cols=264 Identities=21% Similarity=0.309 Sum_probs=217.4
Q ss_pred cccceeeeeeeecc--CceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 65 VRNTYIFGRELGRG--QFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 65 ~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
..++|++++.||+| +||.||+|+++.+++.||||++..... .....+.+.+|+.+++++. ||||+++++++...+.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECCE
Confidence 45889999999999 999999999999999999999976543 4455678899999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 143 VNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||.+..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEccccccee
Confidence 99999999999999999875 679999999999999999999999999999999999999 6677899999998865
Q ss_pred ccCCC--------ccccCCcCccccccccccc---cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-
Q 018786 221 FKPGD--------VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF- 288 (350)
Q Consensus 221 ~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~- 288 (350)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.........+..+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 42221 1223478999999998764 58999999999999999999999998765544443332221110
Q ss_pred -----------------------------------------CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 289 -----------------------------------------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 289 -----------------------------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
.......+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 001123578899999999999999999999999999999
Q ss_pred CCCchh
Q 018786 328 PKKTLQ 333 (350)
Q Consensus 328 ~~~~~~ 333 (350)
.+..+.
T Consensus 338 ~~~~~~ 343 (389)
T 3gni_B 338 KQIKRR 343 (389)
T ss_dssp GGC---
T ss_pred HHHhhc
Confidence 876643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=373.87 Aligned_cols=262 Identities=30% Similarity=0.497 Sum_probs=210.2
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC-
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH- 141 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~- 141 (350)
..+.++|.+.+.||+|+||.||+|.++.+++.||||++... ........++.+|+.+++++.+|+||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 45568999999999999999999999999999999998643 2344556788899999999988999999999987543
Q ss_pred -ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 -SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 -~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.+++||||++ ++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRS 158 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCccccc
Confidence 7899999996 589888876 579999999999999999999999999999999999999 6677899999999976
Q ss_pred ccC----------------------CCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 018786 221 FKP----------------------GDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQS 276 (350)
Q Consensus 221 ~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~ 276 (350)
... .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 532 112344689999999998753 58999999999999999999999999988877
Q ss_pred HHHHHHcCCCCCC------------------------------C-------------CCCCCCCHHHHHHHHHhcccCcc
Q 018786 277 IFDAILRGHIDFS------------------------------S-------------DPWPNISSSAKDIVKKMLHADPK 313 (350)
Q Consensus 277 ~~~~~~~~~~~~~------------------------------~-------------~~~~~~~~~l~~li~~~L~~dp~ 313 (350)
.+..+........ . .....+++++.+||.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 7766543211100 0 01125789999999999999999
Q ss_pred CCCCHHHHHhccCCCCC
Q 018786 314 ERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 314 ~Rps~~~iL~~~~~~~~ 330 (350)
+|||+.|+|+|+||...
T Consensus 319 ~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 319 KRISANDALKHPFVSIF 335 (388)
T ss_dssp GSCCHHHHTTSTTTTTT
T ss_pred cCCCHHHHhCCHHHHHh
Confidence 99999999999998654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=360.01 Aligned_cols=264 Identities=27% Similarity=0.477 Sum_probs=217.3
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++++. |+||+++++++...+..++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEE
Confidence 3689999999999999999999999999999999865432 3344577889999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~- 224 (350)
||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence 99999999999888888889999999999999999999999999999999999999 66778999999999876533
Q ss_pred CccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Q 018786 225 DVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI---------------- 286 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~---------------- 286 (350)
.......||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+.....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2334567899999999875 3579999999999999999999999998887766554432111
Q ss_pred ---CCCCC--------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 287 ---DFSSD--------PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 287 ---~~~~~--------~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
..+.. .++.++.++.++|.+||+.||++|||+.|+|+|+||.+.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 00100 1246789999999999999999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=371.13 Aligned_cols=270 Identities=34% Similarity=0.622 Sum_probs=228.7
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEeccccc--CChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL--INRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
...+.++|.+.+.||+|+||+||+|.+..+++.||+|++..... ......+.+.+|+.+++++. ||||+++++++.+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 99 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYED 99 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhcc
Confidence 44667999999999999999999999999999999999975432 13345678999999999998 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHH----------------------------------------cCCCCHHHHHHHHHHHHH
Q 018786 140 RHSVNLIMDLCAGGELFDRIIA----------------------------------------KGHYSERAAANLCRQMVT 179 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~----------------------------------------~~~~~~~~~~~i~~~i~~ 179 (350)
.+..++||||++|++|.+++.. ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999998742 112367888999999999
Q ss_pred HHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-----ccccCCcCcccccccccc---ccCCcchh
Q 018786 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-----VFKDLVGSAYYVAPEVLR---RNYGAEAD 251 (350)
Q Consensus 180 ~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~D 251 (350)
||.|||++||+||||||+||+++.+ ....+||+|||++....... ......||+.|+|||++. ..++.++|
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCS-SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecC-CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999999999999999999999532 23379999999998653321 234567999999999875 45889999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 252 IWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 252 v~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
|||||+++|+|++|..||.+....+....+......+....+..++.++.++|.+||+.||.+|||+.++|+|+||.+..
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999999999999888888888877776666667899999999999999999999999999999998765
Q ss_pred hh
Q 018786 332 LQ 333 (350)
Q Consensus 332 ~~ 333 (350)
.+
T Consensus 339 ~~ 340 (345)
T 3hko_A 339 DK 340 (345)
T ss_dssp SC
T ss_pred Hh
Confidence 43
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=366.60 Aligned_cols=262 Identities=24% Similarity=0.394 Sum_probs=221.1
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++++. ||||+++++++.....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETP 86 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEET
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCC
Confidence 456789999999999999999999999999999999998765555566778999999999998 9999999998876543
Q ss_pred ----eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 143 ----VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 143 ----~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
.++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIA 163 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECCCSCC
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEeeccCc
Confidence 49999999999999999988899999999999999999999999999999999999999 45667999999999
Q ss_pred ccccCCC----ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 219 VFFKPGD----VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 219 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.................+....
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 8754332 2233568999999998764 5899999999999999999999999998887777776666554443334
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCC
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
..++.++.++|.+||+.||++||++.++|.+.|+.
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 56899999999999999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=381.32 Aligned_cols=266 Identities=27% Similarity=0.472 Sum_probs=231.2
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++++. ||||+++++++...+.+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEE
Confidence 34588999999999999999999999999999999997654433445678899999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 144 NLIMDLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
++||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAV 337 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceee
Confidence 9999999999999998763 369999999999999999999999999999999999999 667789999999998
Q ss_pred cccCCCc-cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCCCCC
Q 018786 220 FFKPGDV-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET----EQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 220 ~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~ 293 (350)
....... ....+||+.|+|||++.+ .++.++||||||+++|||++|..||.... ..+....+......++.
T Consensus 338 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~--- 414 (543)
T 3c4z_A 338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--- 414 (543)
T ss_dssp ECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT---
T ss_pred eccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc---
Confidence 7654433 344589999999998764 58999999999999999999999997753 35566666666555543
Q ss_pred CCCCHHHHHHHHHhcccCccCCCC-----HHHHHhccCCCCCchhhHHH
Q 018786 294 PNISSSAKDIVKKMLHADPKERLS-----AAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~~ 337 (350)
.++.++.++|.+||+.||.+||+ +.++++|+||.+..|..+..
T Consensus 415 -~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~ 462 (543)
T 3c4z_A 415 -KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEA 462 (543)
T ss_dssp -TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHT
T ss_pred -ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHc
Confidence 67999999999999999999996 58999999999988876653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=366.08 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=215.6
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC-
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR- 140 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~- 140 (350)
...+.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+++.+|+.+++++. |+||+++++++...
T Consensus 20 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 20 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE 97 (367)
T ss_dssp EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred eeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCC
Confidence 3456789999999999999999999999999999999986432 24445678999999999998 99999999998765
Q ss_pred -----CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeec
Q 018786 141 -----HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (350)
Q Consensus 141 -----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Df 215 (350)
..+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+||
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Df 172 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDF 172 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCC
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEee
Confidence 3469999999 8899988876 579999999999999999999999999999999999999 56778999999
Q ss_pred CCcccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------
Q 018786 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID------ 287 (350)
Q Consensus 216 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~------ 287 (350)
|++...... .....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+......
T Consensus 173 g~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 173 GLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp TTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 999875432 355688999999998754 5899999999999999999999999988877666655432111
Q ss_pred -----------------CCC----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 288 -----------------FSS----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 288 -----------------~~~----~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
... ..++.+++++.+||.+||+.||++|||+.|+|+|+||.....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 111 123467899999999999999999999999999999987654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=364.22 Aligned_cols=262 Identities=25% Similarity=0.441 Sum_probs=225.3
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
...+|.+.+.||+|+||+||+|.+..+++.||||++...........+.+.+|+.+++++. ||||+++++++...+..+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCeEE
Confidence 4467999999999999999999999999999999997654444455678999999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 145 LIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS
T ss_pred EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecCC
Confidence 9999996 588887754 5679999999999999999999999999999999999999 5567799999999987543
Q ss_pred CCccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
. ....||+.|+|||++. +.++.++||||||+++|+|++|..||...........+......... ...++..
T Consensus 207 ~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 281 (348)
T 1u5q_A 207 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEY 281 (348)
T ss_dssp B---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC--CTTSCHH
T ss_pred C---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHH
Confidence 2 4567999999999873 45899999999999999999999999988877666666554433222 2367899
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHH
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~ 336 (350)
+.++|.+||+.||++|||+.++|+|+|+.....+...
T Consensus 282 l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~~~ 318 (348)
T 1u5q_A 282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 318 (348)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHH
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChhhhccCCcchh
Confidence 9999999999999999999999999999887654443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=367.11 Aligned_cols=268 Identities=25% Similarity=0.446 Sum_probs=224.1
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc------
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED------ 139 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~------ 139 (350)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++++. |+||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhcc-CCCcccHhheeeccccccc
Confidence 4789999999999999999999999999999999875543 2233456889999999998 9999999998876
Q ss_pred --CCceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 140 --RHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 140 --~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
.+.+++||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg 169 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFG 169 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCT
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccch
Confidence 4568999999975 777777653 679999999999999999999999999999999999999 667789999999
Q ss_pred CcccccCC-----CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 018786 217 LSVFFKPG-----DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289 (350)
Q Consensus 217 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 289 (350)
++...... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+.......+
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99875422 22345678999999998753 479999999999999999999999999988877777665444444
Q ss_pred CCCCCCC----------------------------CHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHHHh
Q 018786 290 SDPWPNI----------------------------SSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLADLL 339 (350)
Q Consensus 290 ~~~~~~~----------------------------~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~~~ 339 (350)
...++.. ++++.+||.+||+.||++|||+.|+|+|+||.....+......
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~ 327 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGM 327 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCSHHH
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccccccc
Confidence 3333322 6779999999999999999999999999999988776554433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=355.23 Aligned_cols=261 Identities=30% Similarity=0.556 Sum_probs=199.3
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++++. ||||+++++++...+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeEEE
Confidence 478999999999999999999999999999999997544333344578999999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccCC
Confidence 99999999999999875 669999999999999999999999999999999999999 56678999999999876432
Q ss_pred -CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 225 -DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+.......+ ..++.++.+
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 241 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP----SFLSIEAKD 241 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC----TTSCHHHHH
T ss_pred CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc----cccCHHHHH
Confidence 22334578999999998764 588899999999999999999999987665554444333332222 357899999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
+|.+||+.||++|||+.++|+|+||.+.....
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 273 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNSSTK 273 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC------
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCCCCcc
Confidence 99999999999999999999999998876443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=355.88 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=217.2
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++...........+++.+|+.+++++. ||||+++++++...+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDD 84 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSS
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCC
Confidence 3466789999999999999999999999999999999997665556666788999999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
..++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCcccc
Confidence 999999999999999999988899999999999999999999999999999999999999 66678999999999876
Q ss_pred cCCC--ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCCCC
Q 018786 222 KPGD--VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS-SDPWPNIS 297 (350)
Q Consensus 222 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 297 (350)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.................. ....+.++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP 241 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSC
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCC
Confidence 5332 2234579999999998764 588999999999999999999999998887666655554433221 22335689
Q ss_pred HHHHHHHHHhcccCccCCC-CHHHHHh
Q 018786 298 SSAKDIVKKMLHADPKERL-SAAEVLS 323 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rp-s~~~iL~ 323 (350)
..+.++|.+||+.||++|| ++.++.+
T Consensus 242 ~~l~~li~~~l~~dp~~R~~~~~~l~~ 268 (294)
T 4eqm_A 242 QSLSNVILRATEKDKANRYKTIQEMKD 268 (294)
T ss_dssp HHHHHHHHHHSCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHHHhcCCHhHccccHHHHHH
Confidence 9999999999999999999 5555544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=353.04 Aligned_cols=259 Identities=30% Similarity=0.586 Sum_probs=228.9
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++++. |+||+++++++...+..+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEEE
Confidence 3478999999999999999999999999999999997543323334577999999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECSSS
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCccc
Confidence 999999999999999988889999999999999999999999999999999999999 56677999999998765433
Q ss_pred CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
......|++.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++. .++.++.++
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l 242 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDL 242 (284)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHHH
T ss_pred -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC----cCCHHHHHH
Confidence 2345679999999998764 5889999999999999999999999998888888777776655443 579999999
Q ss_pred HHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
|.+||+.||.+|||+.++++|+||.....
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 99999999999999999999999976543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=365.21 Aligned_cols=268 Identities=24% Similarity=0.412 Sum_probs=223.9
Q ss_pred cccccCCcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc----CCCC
Q 018786 54 VGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT----GHRN 129 (350)
Q Consensus 54 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~ 129 (350)
...........+.++|.+.+.||+|+||+||+|++..+++.||||++... ....+.+..|+.+++++. +|+|
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 34444566677889999999999999999999999999999999998632 234567788999999986 4999
Q ss_pred eeEeEeEEEcCCceEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecC---
Q 018786 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS--- 204 (350)
Q Consensus 130 iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~--- 204 (350)
|+++++++...+..++|||++ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence 999999999999999999999 889999998754 59999999999999999999999999999999999999531
Q ss_pred -------------------CCCCCeEEeecCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh
Q 018786 205 -------------------AEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS 264 (350)
Q Consensus 205 -------------------~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~ 264 (350)
..++.+||+|||++...... .....||+.|+|||++. ..++.++||||||+++|+|++
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 12678999999999875432 34567999999999875 468999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------CCC---------------------CCCHHHHH
Q 018786 265 GVPPFWGETEQSIFDAILRGHIDFSSD---------------------PWP---------------------NISSSAKD 302 (350)
Q Consensus 265 g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------~~~---------------------~~~~~l~~ 302 (350)
|..||......+....+.......+.. .++ ..++.+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 999999888777666655433222210 000 12367889
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCC
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
||.+||+.||++|||+.|+|+|+||+
T Consensus 335 li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHhcCChhhCCCHHHHhcCcccC
Confidence 99999999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=379.38 Aligned_cols=259 Identities=27% Similarity=0.405 Sum_probs=210.4
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC---
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 140 (350)
.+.++|++++.||+|+||+||+|.+..+++.||||++.... ......+++.+|+.+++++. |+||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCcc
Confidence 45689999999999999999999999999999999997542 24455678999999999998 99999999998654
Q ss_pred ---CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 141 ---HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 141 ---~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
..+++||||+++ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 210 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEe
Confidence 457999999965 5666664 358999999999999999999999999999999999999 6677899999999
Q ss_pred cccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF-------- 288 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------- 288 (350)
+............+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 98876665566788999999999875 468999999999999999999999999988777766654421111
Q ss_pred --------------CCCCC----CC------------CCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 289 --------------SSDPW----PN------------ISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 289 --------------~~~~~----~~------------~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
....+ +. .+.++.+||.+||+.||++|||+.|+|+|+||...
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 10000 00 04578999999999999999999999999999853
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=350.21 Aligned_cols=259 Identities=21% Similarity=0.392 Sum_probs=219.5
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc----C
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED----R 140 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----~ 140 (350)
....|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++++. ||||+++++++.. .
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSC
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCC
Confidence 34679999999999999999999999999999999975443 4455678999999999998 9999999998864 4
Q ss_pred CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
..+++||||+++++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++ +.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCc
Confidence 568999999999999999998888999999999999999999999999 99999999999995 25677999999999
Q ss_pred ccccCCCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCCCC
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSI-FDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 297 (350)
...... ......||+.|+|||++.+.++.++||||||+++|+|++|..||........ ...+........ .....+
T Consensus 180 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 256 (290)
T 1t4h_A 180 TLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAI 256 (290)
T ss_dssp GGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--GGGCCC
T ss_pred cccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc--cCCCCC
Confidence 764433 3345679999999999988899999999999999999999999987554443 333433322211 122467
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
+++.++|.+||+.||++|||+.|+|+|+||.+.
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 899999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=354.94 Aligned_cols=259 Identities=28% Similarity=0.481 Sum_probs=223.7
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
..|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++++. |+||+++++++...+..++|
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEE
Confidence 35888899999999999999999899999999996543 234577899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
|||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC
T ss_pred EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc
Confidence 999999999987754 579999999999999999999999999999999999999 566789999999998765432
Q ss_pred ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......... ....++.++.++|
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li 275 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK-NSHKVSPVLRDFL 275 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCT-TGGGSCHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcC-ccccCCHHHHHHH
Confidence 334568999999999876 45899999999999999999999999988877777766655433221 1235789999999
Q ss_pred HHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 305 KKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
.+||+.||++|||+.++|+|+||.+...+.
T Consensus 276 ~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 305 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDHPFLLQTGLPE 305 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred HHHccCChhhCcCHHHHhcChhhccCCCcc
Confidence 999999999999999999999998776543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=364.07 Aligned_cols=254 Identities=28% Similarity=0.504 Sum_probs=218.8
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh-----hhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-----DDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
.+.++|.+.+.||+|+||.||+|.++.+++.||||++........ ...+.+.+|+.+++++. |+||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~ 99 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFE 99 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 456899999999999999999999999999999999976543221 13346778999999998 999999999999
Q ss_pred cCCceEEEEecCCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 139 DRHSVNLIMDLCAGG-ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~-sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
..+..++|||++.++ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGS 176 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeeccc
Confidence 999999999998666 999999988899999999999999999999999999999999999999 6677899999999
Q ss_pred cccccCCCccccCCcCccccccccccc-cC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR-NY-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
+.............||+.|+|||++.+ .+ +.++||||||+++|+|++|..||..... ....... ....
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~----~~~~ 246 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIH----PPYL 246 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCC----CSSC
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccC----CCcc
Confidence 988776666666789999999998764 34 7899999999999999999999975322 1111111 1225
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
++.++.++|.+||+.||++|||+.++|+|+||.+..
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 799999999999999999999999999999998753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=355.77 Aligned_cols=258 Identities=25% Similarity=0.476 Sum_probs=213.8
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc--CCc
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHS 142 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~ 142 (350)
..++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++++.+|+||+++++++.. ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 358899999999999999999999999999999998632 246789999999999889999999999987 678
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
.++||||+.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++. ++..+||+|||++....
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC--CCCEEEEEeCCCceEcC
Confidence 899999999999988764 4899999999999999999999999999999999999953 23369999999998876
Q ss_pred CCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH-------------HcCCC
Q 018786 223 PGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAI-------------LRGHI 286 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~-~~~~~~~~-------------~~~~~ 286 (350)
.........|++.|+|||++.+ .++.++||||||+++|+|++|..||.... ..+.+..+ .....
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 6666667789999999998753 58999999999999999999999995433 22222211 11111
Q ss_pred CCC--------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 287 DFS--------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 287 ~~~--------------------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
... ......++.++.+||.+||+.||++|||+.|+|+|+||....++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence 110 00112378999999999999999999999999999999987653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=370.09 Aligned_cols=269 Identities=25% Similarity=0.447 Sum_probs=214.6
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC--
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR-- 140 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-- 140 (350)
..+.++|.+.+.||+|+||+||+|.++.+++.||||++.... ......+++.+|+.+++++. |+||+++++++...
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDL 99 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCC
Confidence 345789999999999999999999999999999999996432 24455678999999999998 99999999998765
Q ss_pred ---CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 141 ---HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 141 ---~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
..+++|||++. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGl 175 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGL 175 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCC
Confidence 57999999995 5999999888889999999999999999999999999999999999999 6677899999999
Q ss_pred cccccCCC-----------------------ccccCCcCccccccccc-c-ccCCcchhHHHHHHHHHHHHhCC------
Q 018786 218 SVFFKPGD-----------------------VFKDLVGSAYYVAPEVL-R-RNYGAEADIWSAGVILYILLSGV------ 266 (350)
Q Consensus 218 a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~Dv~slG~vl~~ll~g~------ 266 (350)
+....... .....+||+.|+|||++ . ..++.++|||||||++|||++|.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 98764332 13567899999999975 3 45899999999999999999843
Q ss_pred -----CCCCCCC-----------------HHHHHHHHHc-----------------------CCCCCCC----CCCCCCC
Q 018786 267 -----PPFWGET-----------------EQSIFDAILR-----------------------GHIDFSS----DPWPNIS 297 (350)
Q Consensus 267 -----~pf~~~~-----------------~~~~~~~~~~-----------------------~~~~~~~----~~~~~~~ 297 (350)
++|.+.. ..+.+..+.. ....... ..++.++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 3333322 1112211111 1000000 0124689
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHH
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~ 337 (350)
+++.+||.+||+.||++|||+.|+|+|+||.+..++..+.
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC-
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCc
Confidence 9999999999999999999999999999999987765543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=362.22 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=211.8
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++++. |+||+++++++...+..++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEE
Confidence 579999999999999999999999999999999964432 111123557999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-
Q 018786 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~- 224 (350)
|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC----
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCc
Confidence 99996 4898888775 458999999999999999999999999999999999999 56678999999998765432
Q ss_pred CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC----------
Q 018786 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP---------- 292 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------- 292 (350)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+...........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 23345578999999998753 589999999999999999999999999888777766654322222211
Q ss_pred ----------------CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 293 ----------------WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 293 ----------------~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
.+.++.++.+||.+||+.||++|||+.|+|+|+||.+...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 12468899999999999999999999999999999876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=352.15 Aligned_cols=275 Identities=23% Similarity=0.413 Sum_probs=224.2
Q ss_pred cccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc-
Q 018786 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED- 139 (350)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~- 139 (350)
......++|.+.+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++++.+|+||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34456789999999999999999999999999999999986433 2346788999999999559999999999876
Q ss_pred -----CCceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEE
Q 018786 140 -----RHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212 (350)
Q Consensus 140 -----~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl 212 (350)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEE
Confidence 56899999999999999999864 569999999999999999999999999999999999999 56778999
Q ss_pred eecCCcccccCCC-ccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Q 018786 213 TDFGLSVFFKPGD-VFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285 (350)
Q Consensus 213 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~ 285 (350)
+|||++....... ......|++.|+|||++. ..++.++||||||+++|+|++|..||...........+....
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 9999988754332 234457899999999874 358899999999999999999999998887766666655543
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHHHhhHHHH
Q 018786 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLADLLYSQIF 344 (350)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~~~~~~~~ 344 (350)
.... ....++..+.++|.+||+.||.+|||+.++++|+||.+..........+.+.+
T Consensus 251 ~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~~~~~~~~~~ 307 (326)
T 2x7f_A 251 APRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHI 307 (326)
T ss_dssp CCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHHHHHHHHHHHH
T ss_pred cccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccccceeehhhhhh
Confidence 3222 22467999999999999999999999999999999998877655544444433
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=365.67 Aligned_cols=267 Identities=29% Similarity=0.527 Sum_probs=224.0
Q ss_pred cccceeeeeeeeccCceEEEEEEEc---cCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
..++|.+.+.||+|+||.||+|++. .+++.||||+++..... .....+.+.+|+++++++.+|+||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 3479999999999999999999984 57899999999754321 1223356778999999996699999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
+..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 208 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence 9999999999999999999988899999999999999999999999999999999999999 6677899999999986
Q ss_pred ccCCC--ccccCCcCccccccccccc---cCCcchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCCC
Q 018786 221 FKPGD--VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGET----EQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 221 ~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~ 291 (350)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.... .......+.......+
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP-- 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--
Confidence 54322 2234579999999998863 37889999999999999999999996432 3344445555444433
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCC-----CHHHHHhccCCCCCchhhHHHH
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERL-----SAAEVLSKFLIPKKTLQTLADL 338 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~~~ 338 (350)
..++..+.++|.+||+.||.+|| ++.++++|+||.+..|..+...
T Consensus 287 --~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~ 336 (355)
T 1vzo_A 287 --QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAK 336 (355)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred --cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhc
Confidence 36789999999999999999999 9999999999999988776543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=346.46 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=213.9
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.++|.+.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+..+.++..||||+++++++...+..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 456889999999999999999999999999999999975433 2334567889999999995599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC--------------
Q 018786 144 NLIMDLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA-------------- 205 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-------------- 205 (350)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999999764 6799999999999999999999999999999999999996443
Q ss_pred --CCCCeEEeecCCcccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 018786 206 --EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI 281 (350)
Q Consensus 206 --~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~ 281 (350)
....+||+|||.+...... ....||+.|+|||++.+ .++.++||||||+++|+|++|..++.... ....+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~ 240 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI 240 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHH
T ss_pred cCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHH
Confidence 4567999999999876543 23468999999998864 35679999999999999999988775443 23444
Q ss_pred HcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
..+..... ...++.++.++|.+||+.||++|||+.|+|+|+||.+..
T Consensus 241 ~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 241 RQGRLPRI---PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HTTCCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HcCCCCCC---CcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 44433222 236799999999999999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=350.84 Aligned_cols=260 Identities=24% Similarity=0.365 Sum_probs=209.8
Q ss_pred cccCCcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEe
Q 018786 56 RVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKG 135 (350)
Q Consensus 56 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~ 135 (350)
...+...+...++|++.+.||+|+||+||+|.+ +++.||||++..... .....+.+.+|+.++++++ |+||+++++
T Consensus 26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~ 101 (309)
T 3p86_A 26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMG 101 (309)
T ss_dssp ------CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEE
T ss_pred CCCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence 344555666779999999999999999999987 478899999875443 4455678999999999998 999999999
Q ss_pred EEEcCCceEEEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcC--CEeecCCCCceEeecCCCCCCe
Q 018786 136 AYEDRHSVNLIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPL 210 (350)
Q Consensus 136 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~v 210 (350)
++...+..++||||+++++|.+++...+. +++..++.++.||+.||.|||++| |+||||||+||++ +.++.+
T Consensus 102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~ 178 (309)
T 3p86_A 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTV 178 (309)
T ss_dssp EECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCE
T ss_pred EEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcE
Confidence 99999999999999999999999987543 999999999999999999999999 9999999999999 667789
Q ss_pred EEeecCCcccccCCC-ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Q 018786 211 KATDFGLSVFFKPGD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288 (350)
Q Consensus 211 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 288 (350)
||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......
T Consensus 179 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (309)
T 3p86_A 179 KVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258 (309)
T ss_dssp EECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC
T ss_pred EECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 999999997644332 2345679999999998764 58999999999999999999999999888877776664333222
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 289 ~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
.. ...+++++.++|.+||+.||.+|||+.++++.
T Consensus 259 ~~--~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 292 (309)
T 3p86_A 259 EI--PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292 (309)
T ss_dssp CC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC--CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22 23689999999999999999999999999974
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=359.12 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=216.7
Q ss_pred cccccceeeeeeeeccCceEEEEEEEc-------cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEe
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHK-------DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKG 135 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~ 135 (350)
+...++|.+.+.||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+++++.+||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 344689999999999999999999974 345679999996542 34456789999999999944999999999
Q ss_pred EEEcCCceEEEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCce
Q 018786 136 AYEDRHSVNLIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (350)
Q Consensus 136 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NI 199 (350)
++...+.+++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999998653 478999999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecCCcccccCCC---ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 018786 200 LFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETE 274 (350)
Q Consensus 200 l~~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~ 274 (350)
|+ +.++.+||+|||++....... ......+|+.|+|||++. ..++.++||||||+++|||++ |..||.+...
T Consensus 235 ll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 235 LV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp EE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99 667789999999998754332 223345778999999875 458999999999999999999 9999998887
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+....+..+..... ...++.++.++|.+||+.||++|||+.|+++++
T Consensus 312 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 312 EELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp GGHHHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 777777666543222 236789999999999999999999999999764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=362.62 Aligned_cols=259 Identities=26% Similarity=0.443 Sum_probs=216.7
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccC-CCCeeEeEeEEEcCCc
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG-HRNIVELKGAYEDRHS 142 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-h~~iv~~~~~~~~~~~ 142 (350)
....+|.+.+.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.+++++.. |+||+++++++...+.
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 345679999999999999999999876 89999999976543 44556789999999999974 6999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+++||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC-
T ss_pred EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCcccccc
Confidence 999999 55889999999988999999999999999999999999999999999999993 3679999999998765
Q ss_pred CCC---ccccCCcCccccccccccc------------cCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCC
Q 018786 223 PGD---VFKDLVGSAYYVAPEVLRR------------NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHI 286 (350)
Q Consensus 223 ~~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~ 286 (350)
... .....+||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ...+..+.....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence 332 2345679999999998753 588899999999999999999999987543 344555555443
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
....+ ...+.++.++|.+||+.||.+|||+.|+|+|+||....
T Consensus 286 ~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 286 EIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 33322 23478999999999999999999999999999997654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=357.71 Aligned_cols=263 Identities=25% Similarity=0.434 Sum_probs=218.1
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++++. |+||+++++++...+..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEEE
Confidence 4588999999999999999999999999999999986543 23444567889999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCC
Confidence 999999998888877777889999999999999999999999999999999999999 66678999999999775432
Q ss_pred -CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------------
Q 018786 225 -DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID-------------- 287 (350)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------- 287 (350)
.......|++.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 23345679999999998764 5889999999999999999999999988876655544321100
Q ss_pred -----CCC--------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 288 -----FSS--------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 288 -----~~~--------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.+. ...+.++.++.+||.+||+.||++|||+.|+|+|+||....+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 315 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF 315 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGH
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCCh
Confidence 000 012357899999999999999999999999999999987643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=360.03 Aligned_cols=264 Identities=25% Similarity=0.389 Sum_probs=214.0
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCC--hhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN--RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
...++|.+.+.||+|+||.||+|.+..+|+.||||++....... ....+.+.+|+.+++++. |+||+++++++...+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKS 85 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTT
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeCC
Confidence 44688999999999999999999999999999999997533211 112246889999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..++||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKS 161 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGST
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEeccccee
Confidence 99999999976 888888764 468999999999999999999999999999999999999 6677899999999987
Q ss_pred ccCC-CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC-----
Q 018786 221 FKPG-DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP----- 292 (350)
Q Consensus 221 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 292 (350)
.... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+.+..+...........
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 6433 23455679999999998753 478999999999999999999999999888777766654321111111
Q ss_pred -------------------CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 293 -------------------WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 293 -------------------~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
+..++.++.+||.+||+.||++|||+.|+|+|+||.+..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 1356789999999999999999999999999999987543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=358.48 Aligned_cols=259 Identities=36% Similarity=0.636 Sum_probs=191.5
Q ss_pred ccccceeeee-eeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc---
Q 018786 64 DVRNTYIFGR-ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--- 139 (350)
Q Consensus 64 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--- 139 (350)
.+.++|.+.+ .||+|+||+||+|.++.+++.||||++... ....+|+..+.+..+|+||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 4668999965 699999999999999999999999998542 2233444444444459999999999875
Q ss_pred -CCceEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 140 -RHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 140 -~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
....++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++.++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 556899999999999999998754 69999999999999999999999999999999999999776667889999999
Q ss_pred CcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCCC
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSI----FDAILRGHIDFSSD 291 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~----~~~~~~~~~~~~~~ 291 (350)
++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||........ ...+.......+..
T Consensus 177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 177 FAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred cceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 99875433 234567899999999885 4588899999999999999999999977655433 22333344445555
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.+..++.++.++|.+||+.||++|||+.|+|+|+||.+..
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 5667899999999999999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=355.07 Aligned_cols=260 Identities=24% Similarity=0.401 Sum_probs=214.8
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC--
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-- 141 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-- 141 (350)
...++|.+.+.||+|+||+||+|.+..+++.||||++..... ....+.+.+|+++++++. |+||+++++++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR 82 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCc
Confidence 456899999999999999999999999999999999975432 233577889999999998 999999999987655
Q ss_pred ceEEEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeec-CCCCCCeEEeecCC
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS-SAEDSPLKATDFGL 217 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~-~~~~~~vkl~Dfg~ 217 (350)
..++||||+++++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+.. ++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 78999999999999999986433 999999999999999999999999999999999999843 24456799999999
Q ss_pred cccccCCCccccCCcCcccccccccc---------ccCCcchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcC
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLR---------RNYGAEADIWSAGVILYILLSGVPPFWGET----EQSIFDAILRG 284 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~----~~~~~~~~~~~ 284 (350)
+.............||+.|+|||++. ..++.++||||||+++|+|++|..||.... ..+....+..+
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 99877666666778999999999874 458899999999999999999999996432 23444444443
Q ss_pred CCCC-------------------C--CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 285 HIDF-------------------S--SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 285 ~~~~-------------------~--~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
.+.. + ......++..+.++|.+||+.||++|||+.|+|+|+-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 3211 0 0111234567899999999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=345.50 Aligned_cols=262 Identities=29% Similarity=0.551 Sum_probs=221.0
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
+.++|++.+.||+|+||.||+|.++.+++.||+|++..... ....+.+.+|+.+++++. |+||+++++++...+..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEE
Confidence 34789999999999999999999999999999999965432 334578999999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+||||+++++|.+++.....+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||.+......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCC
Confidence 999999999999988877789999999999999999999999999999999999999 56677999999999765432
Q ss_pred C---ccccCCcCccccccccccc-c-CCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCCCH
Q 018786 225 D---VFKDLVGSAYYVAPEVLRR-N-YGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 225 ~---~~~~~~gt~~y~aPE~~~~-~-~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
. ......|++.|+|||++.+ . .+.++||||||+++|+|++|..||...... ............. ..+..++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKKIDS 236 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS--TTGGGSCH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc--CchhhcCH
Confidence 2 2345678999999998864 3 477899999999999999999999776543 2333333322221 22346899
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
.+.++|.+||+.||++|||+.|+++|+||.+...+.
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 272 (276)
T 2yex_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 272 (276)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred HHHHHHHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence 999999999999999999999999999998875443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=348.26 Aligned_cols=261 Identities=23% Similarity=0.263 Sum_probs=199.7
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
+...++|++.+.||+|+||+||+|.+..+++.||+|++..... .....+.+.++...++.+. ||||+++++++...+.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVD-CPFTVTFYGALFREGD 80 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSS
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCC-CCeEEEEeeeeeccCC
Confidence 3456899999999999999999999999999999999965432 1222233344444455565 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 143 VNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
.++||||+++ +|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGI 156 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC--
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCC
Confidence 9999999975 88777654 46799999999999999999999998 99999999999999 5667899999999
Q ss_pred cccccCCCccccCCcCcccccccccc-----ccCCcchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCCCC
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLR-----RNYGAEADIWSAGVILYILLSGVPPFWGE-TEQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~ 291 (350)
+.............||+.|+|||++. ..++.++||||||+++|+|++|..||... .................
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 234 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL-- 234 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC--
T ss_pred cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc--
Confidence 98876655555568999999999852 35888999999999999999999999763 33344444333322221
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
....++.++.++|.+||+.||++|||+.|+++|+||....
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 1236799999999999999999999999999999997654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=360.86 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=207.2
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC--
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-- 141 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-- 141 (350)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++++. ||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCST
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeecccccc
Confidence 45689999999999999999999999999999999997533 24455678899999999998 999999999987654
Q ss_pred ----ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 142 ----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 142 ----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
..++||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 100 EEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 173 (371)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC
T ss_pred ccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeec
Confidence 78999999965 7888775 458999999999999999999999999999999999999 6677899999999
Q ss_pred cccccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-----
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD----- 291 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 291 (350)
+.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+.+..+..........
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 987665544556789999999998764 58999999999999999999999999988877776665532211100
Q ss_pred ------------C--------------CC-------CCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 292 ------------P--------------WP-------NISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 292 ------------~--------------~~-------~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
. ++ ..+.++.+||.+||+.||++|||+.|+|+|+||....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 0 00 0146789999999999999999999999999997543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=350.93 Aligned_cols=254 Identities=21% Similarity=0.345 Sum_probs=215.9
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCc---EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQ---QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
+...++|.+.+.||+|+||.||+|.+..+++ .||||+++... .....+.+.+|+.+++++. |+||+++++++..
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 121 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVVTR 121 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence 3456899999999999999999999986554 59999996432 3445678999999999998 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
.+..++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLS 198 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcc
Confidence 99999999999999999999764 579999999999999999999999999999999999999 66778999999999
Q ss_pred ccccCCCc----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 018786 219 VFFKPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292 (350)
Q Consensus 219 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+........
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 275 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA--- 275 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC---
Confidence 87643321 12234677899999886 458999999999999999999 9999999988888887776533222
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
...++.++.++|.+||+.||++|||+.++++.+
T Consensus 276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 236899999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=353.66 Aligned_cols=260 Identities=26% Similarity=0.433 Sum_probs=212.9
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCC-CCeeEeEeEEEcCC
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVELKGAYEDRH 141 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~iv~~~~~~~~~~ 141 (350)
....++|.+.+.||+|+||.||++.+. +++.||||++..... .....+.+.+|+.+++++..| +||+++++++...+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 345688999999999999999999985 488999999975442 445567899999999999832 99999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.+++|||+ .+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC
T ss_pred EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeeccccccc
Confidence 99999995 5789999999988999999999999999999999999999999999999995 356999999999876
Q ss_pred cCCC---ccccCCcCcccccccccc------------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCC
Q 018786 222 KPGD---VFKDLVGSAYYVAPEVLR------------RNYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGH 285 (350)
Q Consensus 222 ~~~~---~~~~~~gt~~y~aPE~~~------------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~ 285 (350)
.... ......||+.|+|||++. ..++.++||||||+++|+|++|..||..... ......+....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 237 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC
Confidence 4332 223567999999999874 3578899999999999999999999977543 33444444433
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.....+ ...+.++.++|.+||+.||.+|||+.|+|+|+||....
T Consensus 238 ~~~~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 238 HEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp SCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cccCCc--ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 322221 24578999999999999999999999999999997543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=355.11 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=206.4
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC---
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH--- 141 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~--- 141 (350)
+.++|++.+.||+|+||.||+|+++.+++.||||++.... .....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccch
Confidence 4578999999999999999999999999999999997543 3345678999999999998 999999999875443
Q ss_pred ------------------------------------------------------ceEEEEecCCCCCHHHHHHHcCC---
Q 018786 142 ------------------------------------------------------SVNLIMDLCAGGELFDRIIAKGH--- 164 (350)
Q Consensus 142 ------------------------------------------------------~~~iv~e~~~~~sL~~~l~~~~~--- 164 (350)
..++||||+++++|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999987543
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-------------ccccCC
Q 018786 165 YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-------------VFKDLV 231 (350)
Q Consensus 165 ~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~ 231 (350)
.++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....... ......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 5666789999999999999999999999999999999 566789999999998765432 223457
Q ss_pred cCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
||+.|+|||++.+ .++.++||||||+++|+|++|..|+.. .............+. .+...++++.++|.+||+.
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~ 312 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPL---LFTQKYPQEHMMVQDMLSP 312 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCH---HHHHHCHHHHHHHHHHHCS
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCc---ccccCChhHHHHHHHHccC
Confidence 9999999998764 589999999999999999998766421 112222233322111 1124567889999999999
Q ss_pred CccCCCCHHHHHhccCCCC
Q 018786 311 DPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 311 dp~~Rps~~~iL~~~~~~~ 329 (350)
||++|||+.|+|+|+||.+
T Consensus 313 ~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 313 SPTERPEATDIIENAIFEN 331 (332)
T ss_dssp SGGGSCCHHHHHHSTTCCC
T ss_pred CCCcCCCHHHHhhchhhhc
Confidence 9999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=358.50 Aligned_cols=262 Identities=21% Similarity=0.316 Sum_probs=222.3
Q ss_pred cccccceeeeeeeeccCceEEEEEE-----EccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVT-----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
+...++|.+.+.||+|+||+||+|. +..+++.||||++... ........+.+|+.+++++. |+||+++++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~ 143 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVS 143 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence 4456899999999999999999999 4456789999998633 23445567899999999998 99999999999
Q ss_pred EcCCceEEEEecCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCe
Q 018786 138 EDRHSVNLIMDLCAGGELFDRIIAKG-------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (350)
Q Consensus 138 ~~~~~~~iv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~v 210 (350)
......++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999998653 48999999999999999999999999999999999999765566779
Q ss_pred EEeecCCcccccCC---CccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 018786 211 KATDFGLSVFFKPG---DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285 (350)
Q Consensus 211 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~ 285 (350)
||+|||++...... .......||+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999754221 2223456789999999875 568999999999999999998 999999999888888877765
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
..... ..++..+.++|.+||+.||++|||+.+++++++....
T Consensus 304 ~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 304 RMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCC---ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 33322 3679999999999999999999999999999876543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=345.01 Aligned_cols=259 Identities=25% Similarity=0.441 Sum_probs=224.7
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..+.|.+.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++++. |+||+++++++...+..+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEE
Confidence 45779999999999999999999999999999999975432 345678999999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+......
T Consensus 97 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTT
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCcc
Confidence 99999999999998754 579999999999999999999999999999999999999 56678999999999876543
Q ss_pred C-ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 225 D-VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 225 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
. ......|++.|+|||++. ..++.++||||||+++|+|++|..||...........+........ ...++..+.+
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~ 249 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL---EGNYSKPLKE 249 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---CSSCCHHHHH
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC---ccccCHHHHH
Confidence 3 234567899999999876 4588999999999999999999999998887777666655443322 2367999999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
+|.+||+.||++|||+.++++|+||.....+
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 280 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKHKFILRNAKK 280 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred HHHHHcCCChhhCcCHHHHhhChhhhcCCCc
Confidence 9999999999999999999999999765543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=345.93 Aligned_cols=276 Identities=27% Similarity=0.437 Sum_probs=228.3
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++++. ||||+++++++...+..
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-CE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCCeE
Confidence 4568899999999999999999999999999999998644 2344678999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCcccc
Confidence 999999999999998876 5679999999999999999999999999999999999999 566779999999875432
Q ss_pred CC-CccccCCcCccccccccc------cccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 223 PG-DVFKDLVGSAYYVAPEVL------RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 223 ~~-~~~~~~~gt~~y~aPE~~------~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. .......|++.|+|||++ ...++.++||||||+++|+|++|..||...........+......... ....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 247 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL-TPSK 247 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-SGGG
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccC-Cccc
Confidence 11 112345789999999987 245788999999999999999999999988877776666655433221 1235
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHHHhhHHHHhhh
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLADLLYSQIFARF 347 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (350)
++.++.++|.+||+.||++|||+.++++|+||....+....+....+...++
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~ 299 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEV 299 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccchhHHHHHHHHhhhh
Confidence 7899999999999999999999999999999999988766666656555544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=360.86 Aligned_cols=262 Identities=27% Similarity=0.416 Sum_probs=203.0
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC-
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR- 140 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~- 140 (350)
...+.++|.+.+.||+|+||.||+|.+..+|+.||||++.... .......++.+|+.+++++. |+||+++++++...
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 101 (367)
T ss_dssp EEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred ccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCC
Confidence 3455689999999999999999999999999999999986432 23445678899999999998 99999999998653
Q ss_pred -----CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeec
Q 018786 141 -----HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (350)
Q Consensus 141 -----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Df 215 (350)
..+++|+|++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+||
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DF 176 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDF 176 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC-
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeec
Confidence 5689999999 7799888765 579999999999999999999999999999999999999 56778999999
Q ss_pred CCcccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------
Q 018786 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID------ 287 (350)
Q Consensus 216 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~------ 287 (350)
|++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.+....
T Consensus 177 G~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 177 GLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999875432 345679999999998754 5899999999999999999999999988877666655432111
Q ss_pred -----------------CCCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 288 -----------------FSSD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 288 -----------------~~~~----~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.+.. .++.+++++.+||.+||+.||++|||+.|+|+|+||.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 1111 12356889999999999999999999999999999987543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=363.52 Aligned_cols=263 Identities=24% Similarity=0.382 Sum_probs=216.2
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc-----CCCCeeEeE
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT-----GHRNIVELK 134 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~iv~~~ 134 (350)
.+.+.+..+|.+.+.||+|+||+||+|.+..+++.||||++... ....+.+.+|+.+++.+. +|+||++++
T Consensus 90 ~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 90 VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp CTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred cCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 44566778999999999999999999999999999999999643 234467888999988884 377999999
Q ss_pred eEEEcCCceEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCC--e
Q 018786 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP--L 210 (350)
Q Consensus 135 ~~~~~~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~--v 210 (350)
+.+...+.+++|||++. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++. +
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~v 241 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGI 241 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCE
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcce
Confidence 99999999999999995 59999888754 499999999999999999999999999999999999994 4444 9
Q ss_pred EEeecCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 018786 211 KATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289 (350)
Q Consensus 211 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 289 (350)
||+|||++...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+.......+
T Consensus 242 kL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 242 KVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp EECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EEeecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999999764432 34568999999999875 4589999999999999999999999999887776655543110000
Q ss_pred C--------------------------------------------------C-----CCCCCCHHHHHHHHHhcccCccC
Q 018786 290 S--------------------------------------------------D-----PWPNISSSAKDIVKKMLHADPKE 314 (350)
Q Consensus 290 ~--------------------------------------------------~-----~~~~~~~~l~~li~~~L~~dp~~ 314 (350)
. . .....++++.+||.+||+.||++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 0 0 00123688999999999999999
Q ss_pred CCCHHHHHhccCCCCCch
Q 018786 315 RLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 315 Rps~~~iL~~~~~~~~~~ 332 (350)
|||+.|+|+|+||.+...
T Consensus 400 Rpta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 400 RMTPGQALRHPWLRRRLP 417 (429)
T ss_dssp SCCHHHHHTSTTTC----
T ss_pred CCCHHHHhCChhhccCCC
Confidence 999999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=358.85 Aligned_cols=264 Identities=25% Similarity=0.374 Sum_probs=222.1
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
+...++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++++. |+||+++++++...+.
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETTE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECCE
Confidence 455689999999999999999999999999999999997542 4455678999999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.++||||+++++|.+++...+.+++..+..++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||++...
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCccc
Confidence 999999999999999999888999999999999999999999996 99999999999999 56677999999998765
Q ss_pred cCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------------
Q 018786 222 KPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDA-------------------- 280 (350)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~-------------------- 280 (350)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........
T Consensus 183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 183 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp HHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 322 2244578999999998764 589999999999999999999999987665443222
Q ss_pred ----------------------HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhH
Q 018786 281 ----------------------ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 281 ----------------------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~ 335 (350)
+...... ......++.++.+||.+||+.||++|||+.|+|+|+||.+..++.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPP--KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCC--CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred CcccccccCCCCcccchhhhhHHhccCCC--CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhh
Confidence 1111111 1112347889999999999999999999999999999988765443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=364.88 Aligned_cols=257 Identities=28% Similarity=0.436 Sum_probs=210.8
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc----
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED---- 139 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~---- 139 (350)
....+|.+.+.||+|+||+||+|++..+|+.||||++..... ...+|+++++++. |+||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEETT
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccCCC
Confidence 345689999999999999999999999999999999864321 2346999999998 9999999998743
Q ss_pred --CCceEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEe
Q 018786 140 --RHSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (350)
Q Consensus 140 --~~~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~ 213 (350)
..++++||||+++ ++.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +++.+||+
T Consensus 123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~~kl~ 199 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLC 199 (420)
T ss_dssp TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET--TTTEEEEC
T ss_pred CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC--CCCeEEec
Confidence 2246799999965 66665542 467999999999999999999999999999999999999953 34568999
Q ss_pred ecCCcccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------
Q 018786 214 DFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH------ 285 (350)
Q Consensus 214 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~------ 285 (350)
|||++.............||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+.+..+.+..
T Consensus 200 DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 200 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp CCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999988765555566789999999998753 58999999999999999999999999888766665544310
Q ss_pred -----------CCCCC---C-----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 286 -----------IDFSS---D-----PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 286 -----------~~~~~---~-----~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
..++. . ..+.++.++.+||.+||+.||.+|||+.|+|+|+||....
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 11110 0 0124689999999999999999999999999999997654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=359.82 Aligned_cols=257 Identities=27% Similarity=0.447 Sum_probs=211.8
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE----
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE---- 138 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~---- 138 (350)
+...++|.+.+.||+|+||+||+|.+..+|+.||||++..... ...+|+.+++++. |+||+++++++.
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLD-HVNIIKLVDYFYTTGD 74 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCC-CTTBCCEEEEEEEC--
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcC-CCCccchhheeeecCc
Confidence 3456889999999999999999999999999999999865432 2237999999998 999999999883
Q ss_pred ----------------------------------cCCceEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHH
Q 018786 139 ----------------------------------DRHSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTV 180 (350)
Q Consensus 139 ----------------------------------~~~~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~ 180 (350)
...+.++||||+++ +|.+.+.. ...+++..++.++.||+.|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp -----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence 33458899999975 87776653 5679999999999999999
Q ss_pred HHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHH
Q 018786 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVI 258 (350)
Q Consensus 181 l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~v 258 (350)
|.|||++||+||||||+||+++ ..++.+||+|||++.............||+.|+|||++.+ .++.++||||||++
T Consensus 154 L~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 154 VGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999999999999999999995 2466799999999998766666667789999999998753 48999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------CCCC---C-----CCCCCCHHHHHHHHHhcccCcc
Q 018786 259 LYILLSGVPPFWGETEQSIFDAILRGHI-----------------DFSS---D-----PWPNISSSAKDIVKKMLHADPK 313 (350)
Q Consensus 259 l~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------------~~~~---~-----~~~~~~~~l~~li~~~L~~dp~ 313 (350)
+|+|++|+.||.+....+.+..+..... .++. . ....++.++.+||.+||+.||+
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999999888777666543111 0110 0 0124788999999999999999
Q ss_pred CCCCHHHHHhccCCCCC
Q 018786 314 ERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 314 ~Rps~~~iL~~~~~~~~ 330 (350)
+|||+.|+|+|+||...
T Consensus 312 ~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHL 328 (383)
T ss_dssp GSCCHHHHHTSGGGHHH
T ss_pred hCCCHHHHhcCHHHHHH
Confidence 99999999999999754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=353.53 Aligned_cols=256 Identities=26% Similarity=0.431 Sum_probs=219.7
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccC-------CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDT-------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~ 134 (350)
++...++|.+.+.||+|+||.||+|.+..+ +..||||++.... .....+.+.+|+++++++.+|+||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 455668999999999999999999997533 3579999996542 4455678999999999995599999999
Q ss_pred eEEEcCCceEEEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCc
Q 018786 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (350)
Q Consensus 135 ~~~~~~~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~N 198 (350)
+++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999998754 48999999999999999999999999999999999
Q ss_pred eEeecCCCCCCeEEeecCCcccccCCC---ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 018786 199 FLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGET 273 (350)
Q Consensus 199 Il~~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~ 273 (350)
||+ +.++.+||+|||++....... ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||....
T Consensus 222 Ill---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999 666789999999998764332 223446788999999875 458999999999999999999 999999988
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..+....+......... ..++.++.++|.+||+.||++|||+.|+++++
T Consensus 299 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 299 VEELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp HHHHHHHHHTTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 88887777765433222 36799999999999999999999999999865
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=356.04 Aligned_cols=271 Identities=22% Similarity=0.424 Sum_probs=231.3
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhh--------------HHHHHHHHHHHHHccCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD--------------VEDVRREVQIMHHLTGH 127 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--------------~~~~~~e~~~l~~l~~h 127 (350)
.....++|.+.+.||+|+||.||+|.+ +++.||||++.......... .+.+.+|+.+++++. |
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h 102 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-N 102 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-C
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-C
Confidence 344568999999999999999999999 78999999997543322211 278999999999998 9
Q ss_pred CCeeEeEeEEEcCCceEEEEecCCCCCHHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCc
Q 018786 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDR------IIA--KGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPEN 198 (350)
Q Consensus 128 ~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~------l~~--~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~N 198 (350)
+||+++++++...+..++||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999999999999999999999999999988 655 5679999999999999999999999 999999999999
Q ss_pred eEeecCCCCCCeEEeecCCcccccCCCccccCCcCcccccccccccc--CCc-chhHHHHHHHHHHHHhCCCCCCCCCH-
Q 018786 199 FLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN--YGA-EADIWSAGVILYILLSGVPPFWGETE- 274 (350)
Q Consensus 199 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~Dv~slG~vl~~ll~g~~pf~~~~~- 274 (350)
|++ +.++.+||+|||.+...... ......|++.|+|||++.+. ++. ++||||||+++|+|++|..||.....
T Consensus 183 il~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999 66778999999999876544 34556799999999988643 555 89999999999999999999988776
Q ss_pred HHHHHHHHcCCCCCCCCC---------------CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHHHh
Q 018786 275 QSIFDAILRGHIDFSSDP---------------WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLADLL 339 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~---------------~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~~~ 339 (350)
.+....+......++... ...++.++.++|.+||+.||.+|||+.|+|+|+||.+..++.+..+.
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~~~~~~ 338 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFS 338 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHHHHHHH
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHHHHHHH
Confidence 677777776655554211 14679999999999999999999999999999999999988877654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=370.04 Aligned_cols=252 Identities=16% Similarity=0.181 Sum_probs=204.3
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc--CCCCeeEeE-------e
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELK-------G 135 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~-------~ 135 (350)
..++|.+.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+. .||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3588999999999999999999999999999999998655555566788999996555543 399999988 6
Q ss_pred EEEcCC-----------------ceEEEEecCCCCCHHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHHHcCCEe
Q 018786 136 AYEDRH-----------------SVNLIMDLCAGGELFDRIIAKGHYSE-------RAAANLCRQMVTVVHYCHSMGVMH 191 (350)
Q Consensus 136 ~~~~~~-----------------~~~iv~e~~~~~sL~~~l~~~~~~~~-------~~~~~i~~~i~~~l~~lH~~~ivH 191 (350)
++...+ ..++||||+ +++|.+++...+.+++ ..++.++.||+.||+|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 666554 388999999 6799999987655555 788889999999999999999999
Q ss_pred ecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccCCcCccccccccccc------------cCCcchhHHHHHHHH
Q 018786 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR------------NYGAEADIWSAGVIL 259 (350)
Q Consensus 192 ~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~~Dv~slG~vl 259 (350)
|||||+|||+ +.++.+||+|||++..... ......| +.|+|||++.+ .++.++||||||+++
T Consensus 230 rDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 230 TYLRPVDIVL---DQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp SCCCGGGEEE---CTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred CCCCHHHEEE---cCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999 5667899999999986432 3455677 99999998753 589999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 260 YILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 260 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
|+|++|+.||...........+.. .++.++.++.++|.+||+.||++|||+.|+|+|+||.+..
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHSSCCC------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHHCCCCCcccccccchhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 999999999976554332222221 2246899999999999999999999999999999997643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=355.42 Aligned_cols=260 Identities=29% Similarity=0.454 Sum_probs=217.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC---
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 140 (350)
.+.++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+++++++. |+||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE 100 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCcc
Confidence 44589999999999999999999999999999999996432 3445578999999999998 99999999998654
Q ss_pred --CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 141 --HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 141 --~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
...++|||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA 175 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred ccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcce
Confidence 46899999996 499888865 469999999999999999999999999999999999999 66777999999999
Q ss_pred ccccCCCc----cccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---
Q 018786 219 VFFKPGDV----FKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS--- 289 (350)
Q Consensus 219 ~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--- 289 (350)
........ .....||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+........
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 87543321 24458999999999764 3489999999999999999999999988876666555442111100
Q ss_pred --------------------CC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 290 --------------------SD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 290 --------------------~~----~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.. ..+.++.++.+||.+||+.||++|||+.|+|+|+||.+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 00 1246789999999999999999999999999999998753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=342.54 Aligned_cols=259 Identities=26% Similarity=0.467 Sum_probs=220.9
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE--cCCc
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE--DRHS 142 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~--~~~~ 142 (350)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++++. |+||+++++++. ....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCce
Confidence 34789999999999999999999999999999999976543 3445678999999999998 999999999774 4678
Q ss_pred eEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CEeecCCCCceEeecCCCCCCeEEe
Q 018786 143 VNLIMDLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMG-----VMHRDLKPENFLFSSSAEDSPLKAT 213 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~-----ivH~Dlkp~NIl~~~~~~~~~vkl~ 213 (350)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||++ +.++.+||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~ 158 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLG 158 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEEC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEe
Confidence 99999999999999998753 34999999999999999999999999 9999999999999 667789999
Q ss_pred ecCCcccccCCCc-cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 018786 214 DFGLSVFFKPGDV-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 214 Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
|||.+........ .....|++.|+|||++.+ .++.++||||||+++|+|++|..||......+....+..+......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~- 237 (279)
T 2w5a_A 159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP- 237 (279)
T ss_dssp CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC-
T ss_pred cCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC-
Confidence 9999887654322 234568999999998764 5889999999999999999999999998887777777766543222
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
..++.++.++|.+||+.||++|||+.|+|+++|+.+..
T Consensus 238 --~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 238 --YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred --cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 25799999999999999999999999999999998653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=364.21 Aligned_cols=269 Identities=16% Similarity=0.167 Sum_probs=204.0
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc-CCCCeeEeE-------eEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT-GHRNIVELK-------GAY 137 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~iv~~~-------~~~ 137 (350)
..+|.+.+.||+|+||+||+|.+..+++.||||++...........+.+.+|+.+++.+. .||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999999999999999998765444455677888866555554 399988754 444
Q ss_pred EcC-----------------CceEEEEecCCCCCHHHHHHHc-CCCCHHHH------HHHHHHHHHHHHHHHHcCCEeec
Q 018786 138 EDR-----------------HSVNLIMDLCAGGELFDRIIAK-GHYSERAA------ANLCRQMVTVVHYCHSMGVMHRD 193 (350)
Q Consensus 138 ~~~-----------------~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~------~~i~~~i~~~l~~lH~~~ivH~D 193 (350)
... ..+++||||++ ++|.+++... ..++...+ ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 332 33799999997 7999999864 33455555 67779999999999999999999
Q ss_pred CCCCceEeecCCCCCCeEEeecCCcccccCCCccccCCcCccccccccccc---cCCcchhHHHHHHHHHHHHhCCCCCC
Q 018786 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFW 270 (350)
Q Consensus 194 lkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~g~~pf~ 270 (350)
|||+|||+ +.++.+||+|||++...... .....+|+.|+|||++.+ .++.++||||||+++|+|++|+.||.
T Consensus 220 ikp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFI---MPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEE---CTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEE---CCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999 66778999999999875432 224567799999998763 58999999999999999999999997
Q ss_pred CCCHHHH--HHH---HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHHHhh
Q 018786 271 GETEQSI--FDA---ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLADLLY 340 (350)
Q Consensus 271 ~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~~~~ 340 (350)
....... +.. ............++.++.++.+||.+||+.||++|||+.++|+|+||.+..++..+.++-
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~s~ 369 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLST 369 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHHHHHHC-
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHHhhhhhc
Confidence 7643210 000 011111222233457899999999999999999999999999999999888777766553
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=348.32 Aligned_cols=267 Identities=28% Similarity=0.465 Sum_probs=199.1
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
.....++|.+.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++++. ||||+++++++...+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKD 86 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSS
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecC
Confidence 44556899999999999999999999998899999999864432 234567889999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEe
Q 018786 142 SVNLIMDLCAGGELFDRIIA--------KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~ 213 (350)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEE
Confidence 99999999999999999874 3558999999999999999999999999999999999999 567789999
Q ss_pred ecCCcccccCCC------ccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Q 018786 214 DFGLSVFFKPGD------VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285 (350)
Q Consensus 214 Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~ 285 (350)
|||.+....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||................
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 999987654321 123457899999999875 358999999999999999999999998877666555554443
Q ss_pred CCCCC------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 286 IDFSS------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 286 ~~~~~------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
..... .....++.++.++|.+||+.||.+|||+.++++|+||.+...+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 298 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence 32211 12346789999999999999999999999999999999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=357.56 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=212.1
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
...+....+|.+.+.||+|+||+||+|++..+++ +|+|.+..... ...+|+++++++. |+||+++++++..
T Consensus 33 ~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~-h~niv~l~~~~~~ 103 (394)
T 4e7w_A 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVK-HPNVVDLKAFFYS 103 (394)
T ss_dssp SSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEE
T ss_pred CCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCC-CCCcceEEEEEEe
Confidence 3445567899999999999999999999988665 88887754332 1236999999998 9999999998854
Q ss_pred CC------ceEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCC
Q 018786 140 RH------SVNLIMDLCAGGELFDRII----AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP 209 (350)
Q Consensus 140 ~~------~~~iv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~ 209 (350)
.+ .+++||||+++ ++.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++ ..++.
T Consensus 104 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~ 180 (394)
T 4e7w_A 104 NGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGV 180 (394)
T ss_dssp ESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTE
T ss_pred cCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCc
Confidence 33 38899999976 4444333 256799999999999999999999999999999999999995 25677
Q ss_pred eEEeecCCcccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-
Q 018786 210 LKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI- 286 (350)
Q Consensus 210 vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~- 286 (350)
+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.+...
T Consensus 181 ~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 260 (394)
T 4e7w_A 181 LKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260 (394)
T ss_dssp EEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999999988766666667789999999998753 489999999999999999999999999887766665543110
Q ss_pred ----------------CCCC---C-----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 287 ----------------DFSS---D-----PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 287 ----------------~~~~---~-----~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.++. . ..+.+++++.+||.+||+.||.+|||+.|+|+|+||.+..+
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 0000 0 11247899999999999999999999999999999987644
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=346.63 Aligned_cols=264 Identities=24% Similarity=0.354 Sum_probs=218.2
Q ss_pred ccccceeeeeeeeccCceEEEEEEEc-cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc--CCCCeeEeEeEEE--
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHK-DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYE-- 138 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~-- 138 (350)
...++|++.+.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.+++++. .||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 34588999999999999999999995 67899999999754321 122234667887777763 3999999999886
Q ss_pred ---cCCceEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEe
Q 018786 139 ---DRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (350)
Q Consensus 139 ---~~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~ 213 (350)
.....++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEe
Confidence 5677899999997 59999998753 49999999999999999999999999999999999999 667789999
Q ss_pred ecCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----
Q 018786 214 DFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF---- 288 (350)
Q Consensus 214 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---- 288 (350)
|||.+.............|++.|+|||++. ..++.++||||||+++|+|++|..||.+.........+.......
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 999998766554555678999999999875 458999999999999999999999999988877766655321100
Q ss_pred -------------------CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 289 -------------------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 289 -------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.....+.++..+.++|.+||+.||++|||+.|+|+|+||.+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 00112467899999999999999999999999999999987653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=345.65 Aligned_cols=259 Identities=27% Similarity=0.513 Sum_probs=219.3
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHHccCCCCeeEeEeEE--EcCC
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNIVELKGAY--EDRH 141 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~--~~~~ 141 (350)
+.++|.+.+.||+|+||.||+|.+..+++.+|+|++...... .....+.+.+|+.+++++. |+||+++++++ ....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCC
Confidence 457899999999999999999999999999999999754321 1234578999999999998 99999999988 4556
Q ss_pred ceEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 142 SVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
..++||||+.++ |.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+.
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeecccccc
Confidence 899999999765 7777765 4569999999999999999999999999999999999999 566789999999998
Q ss_pred cccCC---CccccCCcCccccccccccc---cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 220 FFKPG---DVFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 220 ~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
..... .......|++.|+|||++.+ ..+.++||||||+++|+|++|..||......+....+.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--- 234 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG--- 234 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS---
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC---
Confidence 75422 22345578999999998764 2477999999999999999999999998888888888777655443
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.++..+.++|.+||+.||++|||+.|+++|+||.+...
T Consensus 235 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 235 -DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp -SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred -ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 57999999999999999999999999999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=353.87 Aligned_cols=256 Identities=24% Similarity=0.380 Sum_probs=211.6
Q ss_pred ccccccceeeeeeeeccCceEEEEEE-----EccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVT-----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
++...++|.+.+.||+|+||.||+|. +..+++.||||++.... .....+.+.+|++++.++.+||||++++++
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 45567899999999999999999999 45567899999996432 344557899999999999669999999999
Q ss_pred EEcCC-ceEEEEecCCCCCHHHHHHHcCC---------------------------------------------------
Q 018786 137 YEDRH-SVNLIMDLCAGGELFDRIIAKGH--------------------------------------------------- 164 (350)
Q Consensus 137 ~~~~~-~~~iv~e~~~~~sL~~~l~~~~~--------------------------------------------------- 164 (350)
+...+ .+++||||+++++|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 87654 48999999999999999976543
Q ss_pred ---------------CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC---c
Q 018786 165 ---------------YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---V 226 (350)
Q Consensus 165 ---------------~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~---~ 226 (350)
+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... .
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccchh
Confidence 8999999999999999999999999999999999999 556779999999998654332 2
Q ss_pred cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIF-DAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
.....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+.. ..+..... ... ...+++++.++
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~l~~l 328 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRA--PDYTTPEMYQT 328 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CCC--CTTCCHHHHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC-CCC--CCCCCHHHHHH
Confidence 23456888999999875 558999999999999999998 99999877644433 33333322 211 13578999999
Q ss_pred HHHhcccCccCCCCHHHHHhcc
Q 018786 304 VKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~ 325 (350)
|.+||+.||++|||+.|+++|+
T Consensus 329 i~~~l~~dP~~Rps~~ell~~L 350 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEHL 350 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHHH
Confidence 9999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=343.78 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=209.4
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++++. ||||+++++++...+..+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCeEE
Confidence 3478999999999999999999999999999999997665545555678999999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCcccccc
Confidence 999999999999999988889999999999999999999999999999999999999 56678999999998775443
Q ss_pred C--ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 225 D--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 225 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
. ......|++.|+|||++. ..++.++||||||+++|+|++|..||...........+ ......+....+.++.++.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTTCCTHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCCCCHHHH
Confidence 2 223457899999999876 45889999999999999999999999877665443333 3333333333457899999
Q ss_pred HHHHHhcccCccCCC-CHHHHHhcc
Q 018786 302 DIVKKMLHADPKERL-SAAEVLSKF 325 (350)
Q Consensus 302 ~li~~~L~~dp~~Rp-s~~~iL~~~ 325 (350)
++|.+||+.||++|| ++.++++.+
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~~l 291 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSAAA 291 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHHHH
Confidence 999999999999999 888888754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=354.08 Aligned_cols=262 Identities=29% Similarity=0.448 Sum_probs=215.5
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
.....+.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++++. |+||+++++++..
T Consensus 35 ~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 112 (371)
T 4exu_A 35 KTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTP 112 (371)
T ss_dssp TEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECS
T ss_pred cceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheec
Confidence 334456789999999999999999999999999999999997543 23445678899999999998 9999999999987
Q ss_pred CCce------EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEe
Q 018786 140 RHSV------NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (350)
Q Consensus 140 ~~~~------~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~ 213 (350)
.+.. ++||||+. ++|.+.+ ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+
T Consensus 113 ~~~~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~ 186 (371)
T 4exu_A 113 ASSLRNFYDFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKIL 186 (371)
T ss_dssp CSSSTTCCCCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEEC
T ss_pred cCCcccceeEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEE
Confidence 7654 99999996 5887766 3459999999999999999999999999999999999999 667789999
Q ss_pred ecCCcccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----
Q 018786 214 DFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID---- 287 (350)
Q Consensus 214 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~---- 287 (350)
|||++...... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+......
T Consensus 187 Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 187 DFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp STTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 99999875433 345678999999998754 5899999999999999999999999988877666555431111
Q ss_pred -------------------CCCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 288 -------------------FSSD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 288 -------------------~~~~----~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.... .++.+++++.+||.+||+.||++|||+.|+|+|+||....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 0100 1235789999999999999999999999999999998654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=362.16 Aligned_cols=265 Identities=27% Similarity=0.469 Sum_probs=199.3
Q ss_pred cccccceee-eeeeeccCceEEEEEEEc--cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE-
Q 018786 63 EDVRNTYIF-GRELGRGQFGVTYLVTHK--DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE- 138 (350)
Q Consensus 63 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~- 138 (350)
..+.+.|.+ +++||+|+||+||+|+++ .+++.||||++..... ...+.+|+.+++++. ||||+++++++.
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 89 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLS 89 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCC-CTTBCCCCEEEEE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcC-CCCeeeEeeEEec
Confidence 345677887 458999999999999976 4688999999964322 246889999999998 999999999984
Q ss_pred -cCCceEEEEecCCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecC-CCC
Q 018786 139 -DRHSVNLIMDLCAGGELFDRIIAK---------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS-AED 207 (350)
Q Consensus 139 -~~~~~~iv~e~~~~~sL~~~l~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~ 207 (350)
....+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 47789999999964 888877532 248999999999999999999999999999999999999653 456
Q ss_pred CCeEEeecCCcccccCC----CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH------
Q 018786 208 SPLKATDFGLSVFFKPG----DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQ------ 275 (350)
Q Consensus 208 ~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~------ 275 (350)
+.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 78999999999876432 22345679999999998764 4899999999999999999999999765542
Q ss_pred ---HHHHHHHcCCCCCCCCCCC----------------------------------CCCHHHHHHHHHhcccCccCCCCH
Q 018786 276 ---SIFDAILRGHIDFSSDPWP----------------------------------NISSSAKDIVKKMLHADPKERLSA 318 (350)
Q Consensus 276 ---~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~l~~li~~~L~~dp~~Rps~ 318 (350)
+.+..+...........|. ..+..+.+||.+||+.||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 3333333221111111111 126788999999999999999999
Q ss_pred HHHHhccCCCCCchhh
Q 018786 319 AEVLSKFLIPKKTLQT 334 (350)
Q Consensus 319 ~~iL~~~~~~~~~~~~ 334 (350)
.|+|+|+||.+..++.
T Consensus 329 ~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 329 EQAMQDPYFLEDPLPT 344 (405)
T ss_dssp HHHHTSGGGTSSSCCC
T ss_pred HHHhcChhhccCCCCc
Confidence 9999999999876543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=354.53 Aligned_cols=265 Identities=26% Similarity=0.380 Sum_probs=216.6
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCC-----CeeEeE
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-----NIVELK 134 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-----~iv~~~ 134 (350)
...+.+.++|.+.+.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.+..|+ +|++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 44566789999999999999999999999999999999999643 234567888999998886455 499999
Q ss_pred eEEEcCCceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HcCCEeecCCCCceEeecCCCCCCe
Q 018786 135 GAYEDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCH--SMGVMHRDLKPENFLFSSSAEDSPL 210 (350)
Q Consensus 135 ~~~~~~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH--~~~ivH~Dlkp~NIl~~~~~~~~~v 210 (350)
+++...+..++|||++.+ +|.+++... +.+++..++.++.||+.||.||| +.||+||||||+|||++. +.++.+
T Consensus 123 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~ 200 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAI 200 (382)
T ss_dssp EEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCE
T ss_pred eeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcE
Confidence 999999999999999965 999999875 46999999999999999999999 579999999999999953 235679
Q ss_pred EEeecCCcccccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 018786 211 KATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289 (350)
Q Consensus 211 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 289 (350)
||+|||++...... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+....+.+..+.......+
T Consensus 201 kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 201 KIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp EECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred EEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999999876433 345689999999998764 589999999999999999999999999888777666544211110
Q ss_pred ------------------CCC-----------------CCC-------------------------CCHHHHHHHHHhcc
Q 018786 290 ------------------SDP-----------------WPN-------------------------ISSSAKDIVKKMLH 309 (350)
Q Consensus 290 ------------------~~~-----------------~~~-------------------------~~~~l~~li~~~L~ 309 (350)
... ... ...++.+||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 000 000 01378999999999
Q ss_pred cCccCCCCHHHHHhccCCCCCch
Q 018786 310 ADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 310 ~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.||++|||+.|+|+|+||.+...
T Consensus 359 ~dP~~Rpta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFFKKTAD 381 (382)
T ss_dssp SCTTTSCCHHHHTTSGGGCC---
T ss_pred CChhhCCCHHHHhcCcccccCCC
Confidence 99999999999999999987653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=342.77 Aligned_cols=263 Identities=24% Similarity=0.408 Sum_probs=218.3
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+.+|+.+++++. |+||+++++++...+..
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEE
Confidence 34678999999999999999999999999999999996532 2467899999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||.+....
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhh
Confidence 999999999999999874 5679999999999999999999999999999999999999 566779999999997765
Q ss_pred CCC-ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 223 PGD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 223 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||...........+........ .....++..+
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 255 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF-RKPELWSDNF 255 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGGSCHHH
T ss_pred hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc-CCcccCCHHH
Confidence 432 2345578999999998764 589999999999999999999999988777665555544332211 1123468999
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHH
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~ 336 (350)
.++|.+||+.||.+|||+.++|+|+||.........
T Consensus 256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~ 291 (314)
T 3com_A 256 TDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSIL 291 (314)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGG
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchHH
Confidence 999999999999999999999999999988754433
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=337.15 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=214.9
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
++...++|++.+.||+|+||+||++.+. ++..||+|++..... ..+.+.+|+.+++++. |+||+++++++...+
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQR 92 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCC-CCCEeeEEEEEecCC
Confidence 3455689999999999999999999887 467899999975432 2367899999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRY 169 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGG
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccc
Confidence 99999999999999999976 5679999999999999999999999999999999999999 6677899999999987
Q ss_pred ccCCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 221 FKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 221 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
...... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+......... ..+
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 246 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLA 246 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTC
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcC
Confidence 543321 22345678899999876 568999999999999999998 99999998888888777766443333 256
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
+..+.++|.+||+.||++|||+.++++++.
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 276 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSNIL 276 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 899999999999999999999999998763
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=348.33 Aligned_cols=268 Identities=28% Similarity=0.440 Sum_probs=214.3
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE---
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE--- 138 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~--- 138 (350)
...+.++|.+.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++++. |+||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSG 81 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTS
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccc
Confidence 446779999999999999999999999999999999998643 3455678999999999998 999999999873
Q ss_pred -----------cCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCC
Q 018786 139 -----------DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (350)
Q Consensus 139 -----------~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 207 (350)
.....++||||+. ++|.+++. .+.+++..++.++.||+.||+|||++||+||||||+||+++. ++
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~ 157 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--ED 157 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--TT
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CC
Confidence 4467899999997 59988775 467999999999999999999999999999999999999962 45
Q ss_pred CCeEEeecCCcccccCC----CccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 018786 208 SPLKATDFGLSVFFKPG----DVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI 281 (350)
Q Consensus 208 ~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~ 281 (350)
+.+||+|||++...... .......++..|+|||.+. ..++.++||||||+++|+|++|..||.+....+....+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 67999999999875432 1223446789999999764 45899999999999999999999999988877666655
Q ss_pred HcCCCCCC----------------------C----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhH
Q 018786 282 LRGHIDFS----------------------S----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 282 ~~~~~~~~----------------------~----~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~ 335 (350)
........ . ...+.++.++.++|.+||+.||++|||+.|+|+|+||....++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~ 317 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD 317 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccC
Confidence 44321110 0 012357999999999999999999999999999999998888766
Q ss_pred HH
Q 018786 336 AD 337 (350)
Q Consensus 336 ~~ 337 (350)
++
T Consensus 318 ~~ 319 (320)
T 2i6l_A 318 EP 319 (320)
T ss_dssp --
T ss_pred CC
Confidence 54
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=346.45 Aligned_cols=267 Identities=23% Similarity=0.387 Sum_probs=199.3
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCc---EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQ---QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
.....++|.+.+.||+|+||+||+|.+..++. .||||++..... .....+.+.+|+.+++++. |+||+++++++.
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 95 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFD-HPHVAKLVGVSL 95 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEE
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCC-CCceehhhceee
Confidence 34456889999999999999999999887665 899999975433 3345678999999999997 999999999987
Q ss_pred cCCce------EEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCC
Q 018786 139 DRHSV------NLIMDLCAGGELFDRIIAKG------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE 206 (350)
Q Consensus 139 ~~~~~------~iv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 206 (350)
..... ++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++ +.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cC
Confidence 76655 99999999999999986532 58999999999999999999999999999999999999 66
Q ss_pred CCCeEEeecCCcccccCCCc---cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 018786 207 DSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAI 281 (350)
Q Consensus 207 ~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~ 281 (350)
++.+||+|||++........ .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+....+....+
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 67899999999987644332 123456788999998764 58999999999999999999 99999998888877777
Q ss_pred HcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCC-------HHHHHhccCCCCCchhhHH
Q 018786 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS-------AAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps-------~~~iL~~~~~~~~~~~~~~ 336 (350)
......... +.++.++.++|.+||+.||++||| +.+++.|+|+.......+.
T Consensus 253 ~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~ 311 (323)
T 3qup_A 253 IGGNRLKQP---PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY 311 (323)
T ss_dssp HTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------
T ss_pred hcCCCCCCC---CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence 765433222 367899999999999999999999 8888899999887765544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=332.59 Aligned_cols=254 Identities=23% Similarity=0.384 Sum_probs=218.2
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
+...++|++.+.||+|+||.||+|.++. +..||+|++..... ..+.+.+|+.+++++. ||||+++++++...+.
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYP 77 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSS
T ss_pred EechhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC----cHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCc
Confidence 3456899999999999999999998874 67899999965432 3467899999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEEC
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceec
Confidence 999999999999999998754 59999999999999999999999999999999999999 66778999999999876
Q ss_pred cCCCcc--ccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 222 KPGDVF--KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 222 ~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
...... ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||...........+......... ..++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 231 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLAS 231 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSC
T ss_pred chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcCh
Confidence 544322 23346678999998864 58899999999999999999 99999998888877777766544333 2468
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCC
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
+.+.++|.+||+.||++|||+.++++++.-.
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 232 DTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 9999999999999999999999999987543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=341.24 Aligned_cols=262 Identities=27% Similarity=0.464 Sum_probs=214.7
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc-----
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED----- 139 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----- 139 (350)
+.++|.+.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++++. ||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence 457899999999999999999999999999999998542 344578899999999998 9999999998754
Q ss_pred --------CCceEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCe
Q 018786 140 --------RHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (350)
Q Consensus 140 --------~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~v 210 (350)
.+..++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~ 155 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV 155 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCE
Confidence 457899999999999999998644 57899999999999999999999999999999999999 667789
Q ss_pred EEeecCCcccccCC---------------CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCC-
Q 018786 211 KATDFGLSVFFKPG---------------DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGE- 272 (350)
Q Consensus 211 kl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~- 272 (350)
||+|||.+...... .......|++.|+|||++.+ .++.++||||||+++|+|++ ||...
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 99999999765422 12234568999999998763 58999999999999999998 55433
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHH
Q 018786 273 TEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~ 337 (350)
........+......++.......+..+.++|.+||+.||++|||+.++|+|+||....++...+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~ 297 (303)
T 1zy4_A 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIK 297 (303)
T ss_dssp HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHHHHH
T ss_pred hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHHHHH
Confidence 33445555555555555554556788999999999999999999999999999999887765443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=346.71 Aligned_cols=264 Identities=27% Similarity=0.415 Sum_probs=217.3
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC-
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR- 140 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~- 140 (350)
...+.++|.+.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++++. |+||+++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFK-HENIITIFNIQRPDS 82 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccc
Confidence 345678999999999999999999999999999999999533 23445567889999999998 99999999987654
Q ss_pred ----CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 141 ----HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 141 ----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
...++||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||
T Consensus 83 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg 157 (353)
T 2b9h_A 83 FENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFG 157 (353)
T ss_dssp STTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCT
T ss_pred cCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEecc
Confidence 67899999996 589888776 579999999999999999999999999999999999999 567789999999
Q ss_pred CcccccCCCc-----------cccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Q 018786 217 LSVFFKPGDV-----------FKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR 283 (350)
Q Consensus 217 ~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~ 283 (350)
++........ .....||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 9987543211 22357899999999764 4589999999999999999999999998876655544332
Q ss_pred CC------------------------CCCCCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 284 GH------------------------IDFSSD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 284 ~~------------------------~~~~~~----~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
.. ...+.. .++.++.++.++|.+||+.||++|||+.|+|+|+||......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 10 000100 124678999999999999999999999999999999876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=347.52 Aligned_cols=256 Identities=24% Similarity=0.377 Sum_probs=219.1
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEc-----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
.+...++|.+.+.||+|+||.||+|.+. .+++.||||+++... .....+.+.+|+.+++++. ||||++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~ 118 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGV 118 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEE
Confidence 3455689999999999999999999997 345899999997442 3445678999999999998 9999999999
Q ss_pred EEcCCceEEEEecCCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEee
Q 018786 137 YEDRHSVNLIMDLCAGGELFDRIIAK------------------------GHYSERAAANLCRQMVTVVHYCHSMGVMHR 192 (350)
Q Consensus 137 ~~~~~~~~iv~e~~~~~sL~~~l~~~------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~ 192 (350)
+...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 99999999999999999999999764 568999999999999999999999999999
Q ss_pred cCCCCceEeecCCCCCCeEEeecCCcccccCCC---ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCC
Q 018786 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVP 267 (350)
Q Consensus 193 Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~ 267 (350)
||||+||++ +.++.+||+|||++....... ......+|+.|+|||++. ..++.++||||||+++|+|++ |..
T Consensus 199 Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 999999999 556779999999997653322 223456788999999875 468999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 268 PFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
||......+....+..+...... ..++.++.++|.+||+.||++|||+.++++++-
T Consensus 276 p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCCCCChHHHHHHHhCCCcCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 99998888888777766543322 367899999999999999999999999997654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=345.84 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=217.5
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEE-ccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCC------CeeE
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTH-KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR------NIVE 132 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~------~iv~ 132 (350)
...+.+.++|++.+.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|+.+++.+. |+ ++++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~ 81 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLN-TTDPNSTFRCVQ 81 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHH-HHCTTCTTCBCC
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhh-hcCCCCceeeEe
Confidence 44567789999999999999999999998 567899999998643 234567889999999987 44 5999
Q ss_pred eEeEEEcCCceEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCC----
Q 018786 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE---- 206 (350)
Q Consensus 133 ~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~---- 206 (350)
+++++...+..++||||+ +++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 999999999999999999 889999998765 6899999999999999999999999999999999999964321
Q ss_pred ------------CCCeEEeecCCcccccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 018786 207 ------------DSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET 273 (350)
Q Consensus 207 ------------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~ 273 (350)
++.+||+|||++...... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||....
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred CCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 567999999999875432 345679999999998764 58999999999999999999999999888
Q ss_pred HHHHHHHHHcCCCCCCCC----------------------------------------CCCCCCHHHHHHHHHhcccCcc
Q 018786 274 EQSIFDAILRGHIDFSSD----------------------------------------PWPNISSSAKDIVKKMLHADPK 313 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~l~~li~~~L~~dp~ 313 (350)
..+....+.......+.. .....++++.+||.+||+.||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 766555443321111100 0012246789999999999999
Q ss_pred CCCCHHHHHhccCCCCC
Q 018786 314 ERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 314 ~Rps~~~iL~~~~~~~~ 330 (350)
+|||+.|+|+|+||...
T Consensus 319 ~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 319 KRITLREALKHPFFDLL 335 (339)
T ss_dssp TSCCHHHHTTSGGGGGG
T ss_pred cccCHHHHhcCHHHHHH
Confidence 99999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=333.21 Aligned_cols=254 Identities=25% Similarity=0.417 Sum_probs=204.3
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCC-hhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
..++|++.+.||+|+||.||+|.+. ++.+|||++....... ....+.+.+|+++++++. ||||+++++++...+..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--C
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCce
Confidence 3578999999999999999999985 7889999987543322 334578999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---CEeecCCCCceEeecCC-----CCCCeEEeec
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG---VMHRDLKPENFLFSSSA-----EDSPLKATDF 215 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~-----~~~~vkl~Df 215 (350)
++||||+++++|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+||+++... .++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999988774 557999999999999999999999999 89999999999996422 2677999999
Q ss_pred CCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 216 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
|.+....... .....||+.|+|||++. ..++.++||||||+++|+|++|..||...................+.. .
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 237 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP--S 237 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC--T
T ss_pred Cccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC--c
Confidence 9998755433 23457899999999876 458999999999999999999999999888877777666655443322 3
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.++..+.++|.+||+.||++|||+.|+++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 6799999999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=340.13 Aligned_cols=247 Identities=25% Similarity=0.416 Sum_probs=207.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+++++++. ||||+++++++.+.+..++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEE
Confidence 47899999999999999999999999999999988532 4456678999999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceecccc
Confidence 9999999999999987 5679999999999999999999999999999999999999 66778999999999876433
Q ss_pred Ccc---------------ccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHc
Q 018786 225 DVF---------------KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQS-----IFDAILR 283 (350)
Q Consensus 225 ~~~---------------~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~-----~~~~~~~ 283 (350)
... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||....... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 221 14579999999998764 58999999999999999999999986432110 0111111
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.. ..+.+++.+.++|.+||+.||++|||+.++++.+
T Consensus 242 ~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 242 RY------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp HT------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cc------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 11 1135788999999999999999999999998744
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=341.24 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=217.2
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEc-----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
.+...++|.+.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+++++++. ||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~ 94 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHVIKLYGA 94 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCceeeEEEE
Confidence 3445689999999999999999999983 445889999996432 4455678999999999998 9999999999
Q ss_pred EEcCCceEEEEecCCCCCHHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCCEee
Q 018786 137 YEDRHSVNLIMDLCAGGELFDRIIAKGH------------------------YSERAAANLCRQMVTVVHYCHSMGVMHR 192 (350)
Q Consensus 137 ~~~~~~~~iv~e~~~~~sL~~~l~~~~~------------------------~~~~~~~~i~~~i~~~l~~lH~~~ivH~ 192 (350)
+...+..++||||+++++|.+++..... +++..++.++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999987543 8999999999999999999999999999
Q ss_pred cCCCCceEeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCC
Q 018786 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVP 267 (350)
Q Consensus 193 Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~ 267 (350)
||||+||++ +.++.+||+|||++........ .....+++.|+|||++. ..++.++||||||+++|+|++ |..
T Consensus 175 dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 175 DLAARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCSGGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccchheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999 4566799999999987644322 22345778899999875 458999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 268 PFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 268 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
||.+.........+........ ...++.++.++|.+||+.||++|||+.++++++
T Consensus 252 p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l 306 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGHRMER---PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306 (314)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCHHHHHHHhhcCCcCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9998887777776666543222 236899999999999999999999999998864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=332.60 Aligned_cols=250 Identities=24% Similarity=0.444 Sum_probs=215.8
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
...++|++.+.||+|+||.||+|.+.. ++.||+|++..... ..+.+.+|+.+++++. ||||+++++++.+.+..
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSE
T ss_pred eChhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc----CHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCce
Confidence 345889999999999999999999875 67899999975432 2367899999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEecccccccccc
Confidence 9999999999999999764 458999999999999999999999999999999999999 556679999999998654
Q ss_pred CCC--ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 223 PGD--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 223 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
... ......+++.|+|||++. ..++.++||||||+++|+|++ |..||......+....+......... ..++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 234 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLAST 234 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCH
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC---CcCCH
Confidence 332 123345677899999886 568999999999999999999 99999999888888887766433332 25789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++.++|.+||+.||++|||+.++++++
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~ll~~l 261 (269)
T 4hcu_A 235 HVYQIMNHCWRERPEDRPAFSRLLRQL 261 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 999999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=352.45 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=216.8
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
+....++|.+.+.||+|+||.||+|.++.+++.||||+++.. ......+.+.+|+++++++. ||||+++++++...+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCC
Confidence 344568999999999999999999999988999999998643 23344567889999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSRE 262 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEE
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCcee
Confidence 999999999999999999765 459999999999999999999999999999999999999 6677899999999986
Q ss_pred ccCCCcc---ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 221 FKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 221 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
....... ....++..|+|||++. +.++.++||||||+++|||++ |..||......+....+..+..... ...
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 339 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC---PEL 339 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC---CTT
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCC
Confidence 5433211 1123567799999876 568999999999999999998 9999998888777776665533221 135
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++.++.++|.+||+.||++|||+.++++.+
T Consensus 340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 369 (377)
T 3cbl_A 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 789999999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=345.23 Aligned_cols=262 Identities=22% Similarity=0.319 Sum_probs=218.2
Q ss_pred cccccceeeeeeeeccCceEEEEEE-----EccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVT-----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
+...++|.+.+.||+|+||.||+|. +..+++.||||++... .......++.+|+.+++++. ||||+++++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 102 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVS 102 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCC-CCCCCeEEEEE
Confidence 4556899999999999999999999 5567889999999633 23445567899999999997 99999999999
Q ss_pred EcCCceEEEEecCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCe
Q 018786 138 EDRHSVNLIMDLCAGGELFDRIIAKG-------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (350)
Q Consensus 138 ~~~~~~~iv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~v 210 (350)
...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+..+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999998753 48999999999999999999999999999999999999765567789
Q ss_pred EEeecCCcccccCCC---ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 018786 211 KATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285 (350)
Q Consensus 211 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~ 285 (350)
||+|||++....... ......+++.|+|||++. ..++.++||||||+++|+|++ |..||......+....+....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999999987643222 123346788999999875 568999999999999999998 999999888887777776654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
..... ..++..+.++|.+||+.||.+|||+.+++++++....
T Consensus 263 ~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 263 RMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 33222 3679999999999999999999999999999886543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=343.01 Aligned_cols=265 Identities=24% Similarity=0.354 Sum_probs=199.9
Q ss_pred CCcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHH-HHHHHHHHHHccCCCCeeEeEeEE
Q 018786 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-VRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 59 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~-~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
+.......++|.+.+.||+|+||.||+|.++.+|+.||||++.... ......+ +.++..+++.+. |+||+++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~ 93 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHD-CPYIVQCFGTF 93 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS--CHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEE
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc--cchHHHHHHHHHHHHHHhcC-CCceeeEEEEE
Confidence 3444455689999999999999999999999999999999997543 2222233 444444566666 99999999999
Q ss_pred EcCCceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeecCCCCceEeecCCCCCCeEEeec
Q 018786 138 EDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDF 215 (350)
Q Consensus 138 ~~~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~vkl~Df 215 (350)
...+..++||||+ +..+..+... ...+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+||
T Consensus 94 ~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~df 169 (318)
T 2dyl_A 94 ITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDF 169 (318)
T ss_dssp ECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCC
T ss_pred ecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEEC
Confidence 9999999999999 5566655544 56799999999999999999999995 99999999999999 66778999999
Q ss_pred CCcccccCCCccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCC
Q 018786 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGE-TEQSIFDAILRGHIDF 288 (350)
Q Consensus 216 g~a~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~ 288 (350)
|++.............|++.|+|||++. ..++.++||||||+++|+|++|..||... ...+....+.......
T Consensus 170 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 170 GISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL 249 (318)
T ss_dssp TTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC
T ss_pred CCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC
Confidence 9998766555555667999999999873 34788999999999999999999999874 4455555555554332
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 289 ~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.. ....++.++.++|.+||+.||.+|||+.++++|+||.+..
T Consensus 250 ~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 250 LP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp CC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred CC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 22 1235799999999999999999999999999999997643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=338.18 Aligned_cols=255 Identities=26% Similarity=0.464 Sum_probs=204.0
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++++. |+||+++++++...+..+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcEE
Confidence 4578999999999999999999999999999999997655555666788999999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 145 LIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC-----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccceee
Confidence 99999999999998864 4568999999999999999999999999999999999999 5667899999999877
Q ss_pred ccCCC-ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCCC
Q 018786 221 FKPGD-VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGET--EQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 221 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
..... ......|++.|+|||++. ..++.++||||||+++|+|++|..||.+.. .......+....... .....+
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 263 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP--LPSDHY 263 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC--CCTTTS
T ss_pred ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC--Cccccc
Confidence 54332 233457899999999876 458899999999999999999999997643 233444444443322 222468
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+.++.++|.+||+.||++|||+.++++.+
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~l 292 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDVA 292 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 99999999999999999999999999765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=340.50 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=216.3
Q ss_pred cccccceeeeeeeeccCceEEEEEEEc-------cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEe
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHK-------DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKG 135 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~ 135 (350)
+...++|.+.+.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+++++.+||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 445689999999999999999999985 357789999996432 34456789999999999955999999999
Q ss_pred EEEcCCceEEEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCce
Q 018786 136 AYEDRHSVNLIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (350)
Q Consensus 136 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NI 199 (350)
++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999998653 389999999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 018786 200 LFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETE 274 (350)
Q Consensus 200 l~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~ 274 (350)
++ +.++.+||+|||++........ .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.+...
T Consensus 189 ll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 189 LV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp EE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 99 6677899999999987654332 23345678899999875 458999999999999999999 9999998888
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+....+........ ...++.++.++|.+||+.||.+|||+.++++++
T Consensus 266 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 266 EELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp HHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHhcCCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 877777766543222 236799999999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=346.22 Aligned_cols=268 Identities=22% Similarity=0.367 Sum_probs=218.9
Q ss_pred CCcccccccceeeeeeeeccCceEEEEEEEccCC-cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCC------ee
Q 018786 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTK-QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN------IV 131 (350)
Q Consensus 59 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~------iv 131 (350)
....+.+.++|++.+.||+|+||+||+|.+..++ +.||+|++... ....+.+.+|+.+++++. |++ ++
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~ 85 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIK-EKDKENKFLCV 85 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHH-HHCTTSCSCBC
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHh-hcCCCCceeEE
Confidence 3445667899999999999999999999998776 78999999642 234567889999999987 544 89
Q ss_pred EeEeEEEcCCceEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecC-----
Q 018786 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS----- 204 (350)
Q Consensus 132 ~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~----- 204 (350)
.+++++...+..++||||+ ++++.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||+..+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999999 667777777653 69999999999999999999999999999999999999543
Q ss_pred -----------CCCCCeEEeecCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 018786 205 -----------AEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGE 272 (350)
Q Consensus 205 -----------~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~ 272 (350)
+.++.+||+|||++...... .....||+.|+|||++. ..++.++||||||+++|+|++|..||...
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 34678999999999874433 34567999999999875 46899999999999999999999999988
Q ss_pred CHHHHHHHHHcCCCCCCCC----------------CC------------------------CCCCHHHHHHHHHhcccCc
Q 018786 273 TEQSIFDAILRGHIDFSSD----------------PW------------------------PNISSSAKDIVKKMLHADP 312 (350)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~----------------~~------------------------~~~~~~l~~li~~~L~~dp 312 (350)
...+....+.......+.. .| ...+.++.+||.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 8766555443322111100 00 1123578899999999999
Q ss_pred cCCCCHHHHHhccCCCCCchhh
Q 018786 313 KERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 313 ~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
++|||+.|+|+|+||.+...+.
T Consensus 323 ~~Rpt~~e~l~hp~f~~~~~~~ 344 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAGLTPEE 344 (355)
T ss_dssp TTSCCHHHHTTSGGGGGCCHHH
T ss_pred hhCcCHHHHhcChhhcCCChhh
Confidence 9999999999999999876653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=334.35 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=209.0
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhh----HHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD----VEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~----~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.......... .+.+.+|+.+++++. |+||+++++++.+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecC
Confidence 34588999999999999999999999999999999997544322222 267899999999998 9999999999866
Q ss_pred CCceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CEeecCCCCceEeecCCC--CCCeEEee
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAE--DSPLKATD 214 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~--~~~vkl~D 214 (350)
.. ++||||+++++|.+.+... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++. ...+||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 54 6999999999999888654 46999999999999999999999999 999999999999954322 22499999
Q ss_pred cCCcccccCCCccccCCcCcccccccccc---ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHcCCCCCC
Q 018786 215 FGLSVFFKPGDVFKDLVGSAYYVAPEVLR---RNYGAEADIWSAGVILYILLSGVPPFWGETEQSI--FDAILRGHIDFS 289 (350)
Q Consensus 215 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~ 289 (350)
||++..... ......||+.|+|||++. ..++.++||||||+++|+|++|..||........ ...+........
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 999986443 345567999999999883 3478899999999999999999999976554332 333333332222
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 290 ~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
....+++++.++|.+||+.||++|||+.++++.+
T Consensus 251 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 251 --IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 2246899999999999999999999999999754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=344.80 Aligned_cols=264 Identities=28% Similarity=0.490 Sum_probs=220.2
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh---hhHHHHHHHHHHHHHcc-CCCCeeEeEe
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQIMHHLT-GHRNIVELKG 135 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~l~-~h~~iv~~~~ 135 (350)
...+.+.++|++.+.||+|+||.||+|.+..+++.||||++........ ...+.+.+|+.+++++. +|+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 3455678999999999999999999999999999999999976543221 12245778999999997 3799999999
Q ss_pred EEEcCCceEEEEecCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEee
Q 018786 136 AYEDRHSVNLIMDLCAG-GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 136 ~~~~~~~~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
++...+..++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .+++.+||+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~D 193 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLID 193 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEee
Confidence 99999999999999976 89999999888999999999999999999999999999999999999995 2456799999
Q ss_pred cCCcccccCCCccccCCcCccccccccccc-c-CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 018786 215 FGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-N-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292 (350)
Q Consensus 215 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
||++...... ......||+.|+|||++.+ . .+.++||||||+++|+|++|..||.... .+........
T Consensus 194 fg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~--- 263 (320)
T 3a99_A 194 FGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--- 263 (320)
T ss_dssp CTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS---
T ss_pred Cccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc---
Confidence 9999876543 3345679999999998753 3 4678999999999999999999996532 1223332222
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHH
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~ 336 (350)
..++.++.++|.+||+.||++|||+.++++|+||.+...+...
T Consensus 264 -~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~~ 306 (320)
T 3a99_A 264 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 306 (320)
T ss_dssp -SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHHHH
T ss_pred -ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCcccc
Confidence 3579999999999999999999999999999999998765544
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=339.08 Aligned_cols=265 Identities=25% Similarity=0.419 Sum_probs=214.6
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccC-CCCeeEeEeEEE
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG-HRNIVELKGAYE 138 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-h~~iv~~~~~~~ 138 (350)
.......++|.+.+.||+|+||.||++.+.. ++.||||++..... .....+.+.+|+.+++++.. |+||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 3455567889999999999999999999865 88999999975433 44556789999999999984 699999999999
Q ss_pred cCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
..+..++|||+ .+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++
T Consensus 99 ~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~ 173 (313)
T 3cek_A 99 TDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIA 173 (313)
T ss_dssp CSSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSS
T ss_pred cCCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeecccc
Confidence 99999999994 5789999999988999999999999999999999999999999999999994 267999999999
Q ss_pred ccccCCCc---cccCCcCccccccccccc------------cCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Q 018786 219 VFFKPGDV---FKDLVGSAYYVAPEVLRR------------NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAIL 282 (350)
Q Consensus 219 ~~~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~ 282 (350)
........ .....|++.|+|||++.+ .++.++||||||+++|+|++|..||..... ......+.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence 87643321 234578999999998753 578899999999999999999999976543 33344444
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
......... ...+.++.++|.+||+.||.+|||+.|+|+|+||.....+
T Consensus 254 ~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 254 DPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp CTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred hcccccCCc--ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 433322221 2458899999999999999999999999999999876543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=334.98 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=204.3
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccC---CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
.+...++|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCccceEEEEEc
Confidence 355678999999999999999999998653 5579999986432 3455678999999999998 999999999974
Q ss_pred cCCceEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
.+..++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGL 162 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC---
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECcccc
Confidence 567889999999999999998654 699999999999999999999999999999999999995 456799999999
Q ss_pred cccccCCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 218 SVFFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 218 a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
+........ .....+++.|+|||++. ..++.++||||||+++|+|++ |..||......+....+........ .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~---~ 239 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---P 239 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---C
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC---C
Confidence 987654332 22345678899999876 458999999999999999996 9999998887777777766543222 2
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+.++.++.++|.+||+.||++|||+.++++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 271 (281)
T 1mp8_A 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 36899999999999999999999999998764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=344.54 Aligned_cols=259 Identities=27% Similarity=0.500 Sum_probs=205.0
Q ss_pred cccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh---hhHHHHHHHHHHHHHcc---CCCCeeEeE
Q 018786 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQIMHHLT---GHRNIVELK 134 (350)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~l~---~h~~iv~~~ 134 (350)
..+.+.++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.++.++. +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 345677899999999999999999999999999999999975443221 12334667999999983 399999999
Q ss_pred eEEEcCCceEEEEec-CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEe
Q 018786 135 GAYEDRHSVNLIMDL-CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (350)
Q Consensus 135 ~~~~~~~~~~iv~e~-~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~ 213 (350)
+++...+..++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ ..++.+||+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~ 182 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLI 182 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEEC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEE
Confidence 999999999999999 78899999999888899999999999999999999999999999999999995 256679999
Q ss_pred ecCCcccccCCCccccCCcCccccccccccc-cC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 018786 214 DFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NY-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 214 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
|||++....... .....|++.|+|||++.+ .+ +.++||||||+++|+|++|+.||.... .+......++
T Consensus 183 dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~-- 253 (312)
T 2iwi_A 183 DFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP-- 253 (312)
T ss_dssp CCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC--
T ss_pred EcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc--
Confidence 999998765433 355679999999998753 33 458999999999999999999996532 1223333332
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
..++.++.++|.+||+.||++|||+.|+|+|+||.....
T Consensus 254 --~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 254 --AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred --ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 357999999999999999999999999999999987653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=338.91 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=214.2
Q ss_pred ccccccceeeeeeeeccCceEEEEEEE-----ccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTH-----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
.+...++|.+.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++.+||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 345568999999999999999999985 4567899999997543 334567899999999999449999999999
Q ss_pred EEcCCceEEEEecCCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCc
Q 018786 137 YEDRHSVNLIMDLCAGGELFDRIIAKG------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (350)
Q Consensus 137 ~~~~~~~~iv~e~~~~~sL~~~l~~~~------------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~N 198 (350)
+...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 999999999999999999999998654 48999999999999999999999999999999999
Q ss_pred eEeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 018786 199 FLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGET 273 (350)
Q Consensus 199 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~ 273 (350)
|++ +.++.+||+|||++........ .....+++.|+|||++. ..++.++||||||+++|+|++ |..||....
T Consensus 176 il~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999 5567799999999987654432 22345778899999875 568999999999999999998 999998776
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
................. ...++.++.++|.+||+.||.+|||+.++++++
T Consensus 253 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 302 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (313)
T ss_dssp SSHHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred chhHHHHHhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 54444443333222221 236799999999999999999999999999765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=338.83 Aligned_cols=259 Identities=22% Similarity=0.360 Sum_probs=220.5
Q ss_pred CCcccccccceeeeeeeeccCceEEEEEEEc-----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEe
Q 018786 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133 (350)
Q Consensus 59 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~ 133 (350)
...++...++|.+.+.||+|+||.||+|.++ .+++.||+|++.... .......+.+|+.+++++. |+||+++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~ 93 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRL 93 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEeee
Confidence 3445667799999999999999999999887 357889999986432 3344567899999999998 9999999
Q ss_pred EeEEEcCCceEEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeec
Q 018786 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAK----------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS 203 (350)
Q Consensus 134 ~~~~~~~~~~~iv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~ 203 (350)
++++...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli-- 171 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV-- 171 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE--
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE--
Confidence 99999999999999999999999998753 457999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 018786 204 SAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIF 278 (350)
Q Consensus 204 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~ 278 (350)
+.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.........
T Consensus 172 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 250 (322)
T 1p4o_A 172 -AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250 (322)
T ss_dssp -CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred -cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence 5677899999999986543321 22345688999999876 458999999999999999999 89999998888877
Q ss_pred HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
..+......... ..++..+.++|.+||+.||++|||+.|+++++.
T Consensus 251 ~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~ 295 (322)
T 1p4o_A 251 RFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295 (322)
T ss_dssp HHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred HHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 777765443222 367999999999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=342.94 Aligned_cols=252 Identities=26% Similarity=0.362 Sum_probs=211.2
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEE--EEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQF--ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.++|.+.+.||+|+||.||+|.+..++..+ |+|.+.... .....+.+.+|+.+++++.+||||+++++++...+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 488999999999999999999999888765 999886422 3344567899999999995599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCC
Q 018786 144 NLIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 207 (350)
++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||++ +.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCC
Confidence 99999999999999997654 69999999999999999999999999999999999999 556
Q ss_pred CCeEEeecCCcccccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 018786 208 SPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285 (350)
Q Consensus 208 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~ 285 (350)
+.+||+|||++.............+++.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+..+.
T Consensus 179 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 258 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258 (327)
T ss_dssp GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence 6799999999875443333344567889999998764 57899999999999999998 999999988877777666553
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
... ....++.++.++|.+||+.||.+|||+.++++++
T Consensus 259 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 259 RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp CCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 221 1236789999999999999999999999999865
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=344.92 Aligned_cols=255 Identities=19% Similarity=0.251 Sum_probs=208.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+.+++++.+|+||+++++++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 456889999999999999999999999999999999865432 235889999999995599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCC--CCCeEEeecCCccc
Q 018786 144 NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE--DSPLKATDFGLSVF 220 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~~~vkl~Dfg~a~~ 220 (350)
++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999 8999999987 467999999999999999999999999999999999999954322 22399999999987
Q ss_pred ccCCCc--------cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCC
Q 018786 221 FKPGDV--------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET---EQSIFDAILRGHIDF 288 (350)
Q Consensus 221 ~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~ 288 (350)
...... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.. ..+.+..+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 643322 245679999999998764 58999999999999999999999998743 333344443322222
Q ss_pred CCCC-CCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 289 SSDP-WPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 289 ~~~~-~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+... ...++ ++.++|..||+.||.+||++.++++.+
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l 276 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLF 276 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHH
Confidence 2111 12345 999999999999999999999998733
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=344.85 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=212.8
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEc-----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
++...++|.+.+.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+++++.+||||++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4455689999999999999999999973 456789999997432 233457899999999999449999999999
Q ss_pred EEcCCceEEEEecCCCCCHHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeec
Q 018786 137 YEDRHSVNLIMDLCAGGELFDRIIAKG-----------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRD 193 (350)
Q Consensus 137 ~~~~~~~~iv~e~~~~~sL~~~l~~~~-----------------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~D 193 (350)
+...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 999999999999999999999997643 278999999999999999999999999999
Q ss_pred CCCCceEeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCC
Q 018786 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPP 268 (350)
Q Consensus 194 lkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~p 268 (350)
|||+||++ +.++.+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++ |..|
T Consensus 198 ikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 198 LAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp CSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CChhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 99999999 5566799999999987643322 23345788899999875 568999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
|..................... ...++.++.++|.+||+.||.+|||+.++++++.-
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 331 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccCCcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 9887655545444443332222 23579999999999999999999999999988753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=334.48 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=219.5
Q ss_pred cccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
.++...++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.+++++. |+||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE 81 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence 4556779999999999999999999999999999999998643 234578999999999998 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLS 158 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccc
Confidence 9999999999999999999874 448999999999999999999999999999999999999 55667999999999
Q ss_pred ccccCCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 219 VFFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 219 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
........ .....+++.|+|||++. ..++.++||||||+++|+|++ |..||...........+........ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 235 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---PE 235 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC---CT
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCC---CC
Confidence 87654332 23345678899999876 568999999999999999999 9999988887777766665533222 23
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.++..+.++|.+||+.||.+|||+.++++.+
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l 266 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence 6799999999999999999999999998755
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=350.61 Aligned_cols=264 Identities=22% Similarity=0.356 Sum_probs=209.1
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccC--------ChhhHHHHHHHHHHHHHccCCCCeeEe
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--------NRDDVEDVRREVQIMHHLTGHRNIVEL 133 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~~~e~~~l~~l~~h~~iv~~ 133 (350)
...+.++|.+.+.||+|+||.||+|.+.. ++.||||++...... .....+.+.+|+.+++++. ||||+++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~ 94 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGL 94 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCC
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccce
Confidence 45667999999999999999999999876 899999998653321 2223478999999999998 9999999
Q ss_pred EeEEE-----cCCceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCC
Q 018786 134 KGAYE-----DRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (350)
Q Consensus 134 ~~~~~-----~~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 207 (350)
++++. ....+++||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||++ +.+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~ 170 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADN 170 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTT
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCC
Confidence 99884 3346899999997 5888888754 469999999999999999999999999999999999999 666
Q ss_pred CCeEEeecCCcccccCCCccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Q 018786 208 SPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285 (350)
Q Consensus 208 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~ 285 (350)
+.+||+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+....
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 171 NDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp CCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 779999999998765555556678999999999875 458999999999999999999999999888766665553311
Q ss_pred C------------------------CCCCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 286 I------------------------DFSSD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 286 ~------------------------~~~~~----~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
. ..+.. ..+.+++.+.+||.+||+.||++|||+.|+|+|+||....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 1 01110 1235688999999999999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=348.11 Aligned_cols=261 Identities=26% Similarity=0.338 Sum_probs=203.8
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc-
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS- 142 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~- 142 (350)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..++++.+..+. |+||+++++++...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSS
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcC-CCCcccHHHhhhccccc
Confidence 345789999999999999999999999999999999865432 2235667888888888 9999999999865333
Q ss_pred ------eEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH--HcCCEeecCCCCceEeecCCCCCCe
Q 018786 143 ------VNLIMDLCAGGELFDRII----AKGHYSERAAANLCRQMVTVVHYCH--SMGVMHRDLKPENFLFSSSAEDSPL 210 (350)
Q Consensus 143 ------~~iv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH--~~~ivH~Dlkp~NIl~~~~~~~~~v 210 (350)
+++||||+.+ +|.+.+. ....+++..++.++.||+.||.||| ++||+||||||+|||++. .++.+
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET--TTTEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC--CCCcE
Confidence 8899999976 5554443 3567899999999999999999999 999999999999999952 36679
Q ss_pred EEeecCCcccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Q 018786 211 KATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288 (350)
Q Consensus 211 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 288 (350)
||+|||++.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+......+..+.+.....
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 9999999998776666667789999999998743 38999999999999999999999999988877766655321110
Q ss_pred C----------------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 289 S----------------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 289 ~----------------------------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
+ .......+.++.+||.+||+.||.+|||+.|+|+|+||.+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 0 0001125688999999999999999999999999999987653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=344.35 Aligned_cols=259 Identities=29% Similarity=0.449 Sum_probs=213.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc-
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS- 142 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~- 142 (350)
.+.++|.+.+.||+|+||.||+|.++.+|+.||||++.... ......+++.+|+.+++++. |+||+++++++...+.
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSL 98 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccccc
Confidence 45689999999999999999999999999999999996533 23445678899999999998 9999999999876654
Q ss_pred -----eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 143 -----VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 143 -----~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
+++||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 99 RNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGL 172 (353)
T ss_dssp GGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTC
T ss_pred ccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeeccc
Confidence 499999996 58877663 359999999999999999999999999999999999999 6677899999999
Q ss_pred cccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH---------- 285 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~---------- 285 (350)
+...... .....+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+.+..+....
T Consensus 173 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 173 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred ccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 9875432 345678999999998754 58899999999999999999999999887766555543210
Q ss_pred -------------CCC----CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 286 -------------IDF----SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 286 -------------~~~----~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
... ....++.++.++.++|.+||+.||++|||+.++|+|+||.....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 000 11123467899999999999999999999999999999987543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=353.36 Aligned_cols=261 Identities=22% Similarity=0.351 Sum_probs=208.3
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc-------CCCCeeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT-------GHRNIVELK 134 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-------~h~~iv~~~ 134 (350)
.+.+.++|.+.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++++. +|+||++++
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 455678999999999999999999999999999999999643 334577899999999986 277899999
Q ss_pred eEEE----cCCceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCEeecCCCCceEeecCC--
Q 018786 135 GAYE----DRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSA-- 205 (350)
Q Consensus 135 ~~~~----~~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~-- 205 (350)
+++. ....+++||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence 9887 566899999999 56777777654 4699999999999999999999998 999999999999995432
Q ss_pred --------------------------------------------CCCCeEEeecCCcccccCCCccccCCcCcccccccc
Q 018786 206 --------------------------------------------EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241 (350)
Q Consensus 206 --------------------------------------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~ 241 (350)
....+||+|||.+...... .....||+.|+|||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChh
Confidence 1137999999999876433 345679999999998
Q ss_pred ccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCCCCC------------------------C
Q 018786 242 LRR-NYGAEADIWSAGVILYILLSGVPPFWGET------EQSIFDAILRGHIDFS------------------------S 290 (350)
Q Consensus 242 ~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~------------------------~ 290 (350)
+.+ .++.++||||||+++|+|++|..||.... .......+.......+ .
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 764 58999999999999999999999997654 2222222221100000 0
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 291 --------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 291 --------------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
......+..+.+||.+||+.||++|||+.|+|+|+||..
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000122457889999999999999999999999999963
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=336.83 Aligned_cols=258 Identities=22% Similarity=0.290 Sum_probs=212.2
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
...+.++|.+.+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+..++++.+|++++++++++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 34567899999999999999999999999999999999864332 2457889999999966999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC--CCCCeEEeecCCc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--EDSPLKATDFGLS 218 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~~~vkl~Dfg~a 218 (350)
..++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++ ....+||+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 899999998754 599999999999999999999999999999999999996432 2345999999999
Q ss_pred ccccCCCc--------cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCC
Q 018786 219 VFFKPGDV--------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET---EQSIFDAILRGHI 286 (350)
Q Consensus 219 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~---~~~~~~~~~~~~~ 286 (350)
........ .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.... .......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 87654322 345579999999998764 58999999999999999999999997743 3333333332221
Q ss_pred CCC-CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 287 DFS-SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 287 ~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..+ ....+.++.++.++|.+||+.||++|||+.++++.+
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l 278 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 278 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 111 111236799999999999999999999999998653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=337.06 Aligned_cols=254 Identities=22% Similarity=0.370 Sum_probs=203.8
Q ss_pred ccccccceeeeeeeeccCceEEEEEE----EccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVT----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
.+...++|++.+.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+++++. |+||+++++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 80 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVC 80 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence 34556899999999999999999998 5667999999998643 3455678999999999998 99999999988
Q ss_pred Ec--CCceEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEee
Q 018786 138 ED--RHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 138 ~~--~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
.. ...+++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~D 157 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGD 157 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEcc
Confidence 54 456899999999999999998754 499999999999999999999999999999999999994 456799999
Q ss_pred cCCcccccCCC----ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--------------
Q 018786 215 FGLSVFFKPGD----VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQ-------------- 275 (350)
Q Consensus 215 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~-------------- 275 (350)
||++....... ......++..|+|||++. ..++.++||||||+++|+|++|..||......
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 99998764332 123345777899999876 45899999999999999999999998654321
Q ss_pred --HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 276 --SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 276 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.....+.... ..+ ....++.++.++|.+||+.||++|||+.|+++.+
T Consensus 238 ~~~~~~~~~~~~-~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 238 VFHLIELLKNNG-RLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp HHHHHHHHHTTC-CCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhccC-cCC--CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 1122222221 111 1236899999999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=343.13 Aligned_cols=267 Identities=22% Similarity=0.299 Sum_probs=195.4
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
.....++|++.+.||+|+||.||+|.++.+++.||||++.... .......+..|+..+.+..+|+||+++++++...+
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 4455689999999999999999999999999999999997542 23344566667764444334999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeecCCCCceEeecCCCCCCeEEeec
Q 018786 142 SVNLIMDLCAGGELFDRIIA-----KGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDF 215 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~vkl~Df 215 (350)
..++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+||++ +.++.+||+||
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Df 170 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDF 170 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCC
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccC
Confidence 99999999975 88887764 56799999999999999999999999 99999999999999 55667999999
Q ss_pred CCcccccCCCccccCCcCcccccccccc-----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCC-CCC
Q 018786 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLR-----RNYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGH-IDF 288 (350)
Q Consensus 216 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~-~~~ 288 (350)
|++.............||+.|+|||++. ..++.++||||||+++|+|++|..||...... +....+..+. ..+
T Consensus 171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 9998776554445557999999999873 34889999999999999999999999765421 2222222221 122
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhh
Q 018786 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334 (350)
Q Consensus 289 ~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~ 334 (350)
.......++.++.++|.+||+.||++|||+.++++|+||.....+.
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 296 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSC
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhH
Confidence 2222346899999999999999999999999999999998765543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=335.82 Aligned_cols=251 Identities=18% Similarity=0.293 Sum_probs=207.3
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCC-------cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTK-------QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
...++|.+.+.||+|+||+||+|.+..++ ..||+|++.... ....+.+.+|+.+++++. |+||++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 80 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLS-HKHLVLNYGV 80 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSC-CTTBCCEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCC-CCCEeEEEEE
Confidence 34589999999999999999999998876 469999986432 345578999999999998 9999999999
Q ss_pred EEcCCceEEEEecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCC-----CCe
Q 018786 137 YEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED-----SPL 210 (350)
Q Consensus 137 ~~~~~~~~iv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~-----~~v 210 (350)
+...+..++||||+++++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.. +.+
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999987654 9999999999999999999999999999999999999653321 229
Q ss_pred EEeecCCcccccCCCccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCC-CCCCCCHHHHHHHHHcCCCC
Q 018786 211 KATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVP-PFWGETEQSIFDAILRGHID 287 (350)
Q Consensus 211 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~-pf~~~~~~~~~~~~~~~~~~ 287 (350)
||+|||.+...... ....|++.|+|||++. ..++.++||||||+++|+|++|.. ||......... ........
T Consensus 161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~~~ 236 (289)
T 4fvq_A 161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRHQ 236 (289)
T ss_dssp EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTCC
T ss_pred eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhccCC
Confidence 99999998765432 3345788999999876 458999999999999999999554 55544444433 33333333
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 288 FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
.+. ..+.++.++|.+||+.||++|||+.++++++-
T Consensus 237 ~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 271 (289)
T 4fvq_A 237 LPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271 (289)
T ss_dssp CCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 332 45788999999999999999999999998763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=346.46 Aligned_cols=254 Identities=21% Similarity=0.359 Sum_probs=205.2
Q ss_pred cccccceeeeeeeeccCceEEEEEEEc---cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
+...++|.+.+.||+|+||.||+|+++ .++..||||+++... .....+.+.+|+.+++++. |+||+++++++..
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 117 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTK 117 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEee
Confidence 344579999999999999999999987 457789999996432 3445678999999999998 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
.+..++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLG 194 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC---
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCccc
Confidence 999999999999999999998754 69999999999999999999999999999999999999 66778999999999
Q ss_pred ccccCCCc----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 018786 219 VFFKPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292 (350)
Q Consensus 219 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
........ .....++..|+|||++. ..++.++||||||+++|||++ |..||......+....+..+.....
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~--- 271 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP--- 271 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC---
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 87643321 11223567899999876 568999999999999999998 9999999888887777765532222
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
...++..+.++|.+||+.||++||++.++++.+
T Consensus 272 ~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L 304 (373)
T 2qol_A 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304 (373)
T ss_dssp CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CccccHHHHHHHHHHhCcChhhCcCHHHHHHHH
Confidence 235789999999999999999999999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=334.40 Aligned_cols=255 Identities=26% Similarity=0.460 Sum_probs=206.6
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEe
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
|.....||+|+||.||+|.+..+++.||||.+.... ....+.+.+|+.+++++. |+||+++++++...+..++|||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEEE
Confidence 444458999999999999999999999999986542 334577999999999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 149 LCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 149 ~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|+++++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++. .++.+||+|||.+.......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTCCEEECCTTTCEESCC--
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC--CCCCEEEeecccccccCCCC
Confidence 999999999998652 4679999999999999999999999999999999999953 25679999999998764332
Q ss_pred -ccccCCcCccccccccccc---cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HH-HHH-HcCCCCCCCCCCCCCCH
Q 018786 226 -VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQS-IF-DAI-LRGHIDFSSDPWPNISS 298 (350)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~-~~-~~~-~~~~~~~~~~~~~~~~~ 298 (350)
......|++.|+|||++.+ .++.++||||||+++|+|++|..||....... .. ... ....... ...++.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 253 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI----PESMSA 253 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCC----CTTSCH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccc----cccCCH
Confidence 2345578999999998753 37899999999999999999999997544322 11 111 1212222 236799
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
++.++|.+||+.||++|||+.++|+|+||.....+
T Consensus 254 ~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 288 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence 99999999999999999999999999999877543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=339.97 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=204.4
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEE----EEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQF----ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
..++|++.+.||+|+||+||+|.+..+++.+ |+|.+.... .....+.+.+|+.+++++. |+||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecC
Confidence 3578999999999999999999998777654 777764322 3345578999999999998 99999999999876
Q ss_pred CceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 141 HSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
. .+++++++.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTHHH
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCccee
Confidence 5 7789999999999999987 45699999999999999999999999999999999999994 45679999999998
Q ss_pred cccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 220 FFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 220 ~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+........ .+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 242 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PP 242 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CT
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC---Cc
Confidence 7643322 22345678999999875 458999999999999999999 9999998887777766665543222 23
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.++.++.+++.+||+.||++|||+.++++++
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 273 (327)
T 3poz_A 243 ICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 5789999999999999999999999999865
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=352.73 Aligned_cols=260 Identities=24% Similarity=0.407 Sum_probs=213.3
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC-
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH- 141 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~- 141 (350)
....++|.+.+.||+|+||+||+|.+..+++.||||++..... ....+.+.+|+++++++. |+||+++++++...+
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTT 81 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTT
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCC
Confidence 3567899999999999999999999999999999999975432 234577889999999998 999999999987655
Q ss_pred -ceEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeec-CCCCCCeEEeecC
Q 018786 142 -SVNLIMDLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS-SAEDSPLKATDFG 216 (350)
Q Consensus 142 -~~~iv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~-~~~~~~vkl~Dfg 216 (350)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+.. ++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 7899999999999999987543 3999999999999999999999999999999999999843 2345679999999
Q ss_pred CcccccCCCccccCCcCcccccccccc---------ccCCcchhHHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHHc
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR---------RNYGAEADIWSAGVILYILLSGVPPFWG----ETEQSIFDAILR 283 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~Dv~slG~vl~~ll~g~~pf~~----~~~~~~~~~~~~ 283 (350)
++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.. ....+....+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 998876665556678999999999874 3478899999999999999999999964 233455555554
Q ss_pred CCCCCC---------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 284 GHIDFS---------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 284 ~~~~~~---------------------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+.+... ......++..+.++|.+||+.||++||++.++++++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l 304 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHH
Confidence 432210 000112456788999999999999999999997654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=331.80 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=211.7
Q ss_pred cccccceeeee-eeeccCceEEEEEEE--ccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 63 EDVRNTYIFGR-ELGRGQFGVTYLVTH--KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 63 ~~~~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
....++|.+.+ .||+|+||+||+|.+ ..+++.||||++..... .....+.+.+|+.+++++. ||||+++++++ .
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGIC-E 88 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-E
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-C
Confidence 34457899998 999999999999954 56678999999975432 3344678999999999998 99999999998 5
Q ss_pred CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
.+..++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++.
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCcce
Confidence 667899999999999999999888899999999999999999999999999999999999995 45679999999998
Q ss_pred cccCCCcc----ccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 220 FFKPGDVF----KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 220 ~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
........ ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+........ .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 242 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---P 242 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---C
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence 76543321 22346788999998764 58889999999999999999 9999999888877777766543222 2
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
..++.++.++|.+||+.||++|||+.++++.
T Consensus 243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 273 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTYDVENRPGFAAVELR 273 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3679999999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=334.63 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=212.9
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc---
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--- 139 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--- 139 (350)
..+..+|++.+.||+|+||.||+|.+..+++.||+|++.... +.+.+|+++++++. |+||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEE
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEecccc
Confidence 456789999999999999999999999899999999996532 35678999999998 9999999998754
Q ss_pred -------------CCceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecC
Q 018786 140 -------------RHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS 204 (350)
Q Consensus 140 -------------~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 204 (350)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-- 156 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV-- 156 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc--
Confidence 45589999999999999999764 5799999999999999999999999999999999999995
Q ss_pred CCCCCeEEeecCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Q 018786 205 AEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR 283 (350)
Q Consensus 205 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~ 283 (350)
.++.+||+|||++.............|++.|+|||++. ..++.++||||||+++|+|++|..|+... ......+..
T Consensus 157 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~ 233 (284)
T 2a19_B 157 -DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD 233 (284)
T ss_dssp -ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT
T ss_pred -CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc
Confidence 45679999999998876655556677999999999876 45899999999999999999999887432 223333333
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHH
Q 018786 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~ 337 (350)
.... ..++..+.++|.+||+.||++|||+.|++++++..+...+..++
T Consensus 234 ~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~ 281 (284)
T 2a19_B 234 GIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281 (284)
T ss_dssp TCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-------
T ss_pred cccc------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcccc
Confidence 3221 25789999999999999999999999999999988776665443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=339.31 Aligned_cols=259 Identities=26% Similarity=0.430 Sum_probs=194.6
Q ss_pred ccCCcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE
Q 018786 57 VLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 57 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
..+...+....+|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++++.+|+||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 94 (337)
T 3ll6_A 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94 (337)
T ss_dssp STTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred hhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccc
Confidence 33445556678999999999999999999999999999999998543 344567789999999999779999999999
Q ss_pred EE--------cCCceEEEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeecCCCCceEeec
Q 018786 137 YE--------DRHSVNLIMDLCAGGELFDRIIA---KGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSS 203 (350)
Q Consensus 137 ~~--------~~~~~~iv~e~~~~~sL~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~Dlkp~NIl~~~ 203 (350)
+. ....++++|||+. ++|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~-- 171 (337)
T 3ll6_A 95 ASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL-- 171 (337)
T ss_dssp EEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE--
T ss_pred ccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE--
Confidence 83 3445899999995 699888865 466999999999999999999999999 9999999999999
Q ss_pred CCCCCCeEEeecCCcccccCCCcc-------------ccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCC
Q 018786 204 SAEDSPLKATDFGLSVFFKPGDVF-------------KDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGV 266 (350)
Q Consensus 204 ~~~~~~vkl~Dfg~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~ 266 (350)
+.++.+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++|.
T Consensus 172 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~ 250 (337)
T 3ll6_A 172 -SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250 (337)
T ss_dssp -CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred -CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCC
Confidence 56678999999999876543221 1446899999999872 34788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCC
Q 018786 267 PPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
.||.......... .....+. ....+..+.++|.+||+.||++|||+.|+++++.-.
T Consensus 251 ~p~~~~~~~~~~~----~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 251 HPFEDGAKLRIVN----GKYSIPP--HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp CCC----------------CCCCT--TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhHHHhhc----CcccCCc--ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9997655433222 2222221 235678899999999999999999999999987543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=329.16 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=210.1
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEcc---CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKD---TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
.....++|.+.+.||+|+||+||+|.+.. ++..||+|++.... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 83 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIE 83 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEEC
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEc
Confidence 34456899999999999999999999754 34569999987542 3445678999999999998 999999999986
Q ss_pred cCCceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
+. ..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGL 159 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCG
T ss_pred CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCC
Confidence 54 568999999999999999765 4599999999999999999999999999999999999995 456799999999
Q ss_pred cccccCCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 218 SVFFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 218 a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
+........ .....+++.|+|||++. ..++.++||||||+++|+|++ |..||...........+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 236 (281)
T 3cc6_A 160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP--- 236 (281)
T ss_dssp GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC---
T ss_pred CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC---
Confidence 987654321 23345788899999886 458999999999999999998 99999887777666666654332222
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..+++.+.++|.+||+.||++|||+.++++++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 268 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 35789999999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=335.62 Aligned_cols=254 Identities=22% Similarity=0.372 Sum_probs=209.8
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCC----cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTK----QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
+....+|.+.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+++++. |+||+++++++.
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 116 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS 116 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEe
Confidence 455689999999999999999999987543 459999986432 3445567899999999998 999999999999
Q ss_pred cCCceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGL 193 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCc
Confidence 999999999999999999999764 579999999999999999999999999999999999999 5677899999999
Q ss_pred cccccCCCc----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 018786 218 SVFFKPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 218 a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
+........ .....+++.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+.....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~-- 271 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-- 271 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC--
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC--
Confidence 987643321 12234678899999876 458999999999999999998 9999998888877777766532221
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
...++..+.++|.+||+.||++||++.++++++
T Consensus 272 -~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 304 (333)
T 1mqb_A 272 -PMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304 (333)
T ss_dssp -CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred -cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 236789999999999999999999999999865
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=336.70 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=210.6
Q ss_pred cccccceeeeeeeeccCceEEEEEEE-----ccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTH-----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
+...++|++.+.||+|+||+||+|.+ ..+++.||||++.... .....+.+.+|+.+++++.+||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 44568999999999999999999985 3567899999996542 3445567999999999996699999999998
Q ss_pred EcC-CceEEEEecCCCCCHHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceE
Q 018786 138 EDR-HSVNLIMDLCAGGELFDRIIAKGH----------------YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200 (350)
Q Consensus 138 ~~~-~~~~iv~e~~~~~sL~~~l~~~~~----------------~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl 200 (350)
... ..+++||||+++++|.+++..... +++..++.++.||+.||.|||++||+||||||+||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 765 458999999999999999987544 899999999999999999999999999999999999
Q ss_pred eecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 018786 201 FSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQ 275 (350)
Q Consensus 201 ~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~ 275 (350)
+ +.++.+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++ |..||......
T Consensus 181 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 181 L---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp E---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred E---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 9 5567799999999987543322 23345788999999875 458999999999999999998 99999876543
Q ss_pred H-HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 276 S-IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 276 ~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
. ....+..+..... ...+++++.++|.+||+.||.+|||+.++++++
T Consensus 258 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 258 EEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp HHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhccCccCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 3 3333443322111 135789999999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=324.44 Aligned_cols=249 Identities=24% Similarity=0.446 Sum_probs=214.5
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++++. ||||+++++++...+..+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeE
Confidence 3578999999999999999999987 467899999975432 2367899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 145 LIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
+||||+++++|.+++... ..+++..++.++.||+.||.+||++||+||||||+||++ +.++.+||+|||.+.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCC
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEccccccccccc
Confidence 999999999999999875 568999999999999999999999999999999999999 5567799999999987543
Q ss_pred CC--ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHH
Q 018786 224 GD--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (350)
Q Consensus 224 ~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.. ......++..|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+...... ..++..
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~ 233 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTH 233 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCHH
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCC---ccCcHH
Confidence 21 123345678899999876 558899999999999999999 89999998888888777766433222 257899
Q ss_pred HHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 300 AKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 300 l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+.++|.+||+.||++|||+.++++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L 259 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQL 259 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99999999999999999999999764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=341.26 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=208.6
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcE----EEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQ----FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
..++|++.+.||+|+||+||+|.+..+++. +|+|.+.... .......+.+|+.+++++. |+||+++++++. .
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-G 86 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-B
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-C
Confidence 357899999999999999999999888776 6777664322 2223356778999999998 999999999886 5
Q ss_pred CceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
+..++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVAD 163 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGG
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCccc
Confidence 5688999999999999999764 579999999999999999999999999999999999999 566779999999998
Q ss_pred cccCCC---ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 220 FFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 220 ~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
...... ......++..|+|||++. +.++.++||||||+++|+|++ |..||.+....+....+......... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 240 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---Q 240 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---T
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---C
Confidence 764332 223456788999999876 568999999999999999999 99999988877777777665433222 2
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.++.++.++|.+||+.||.+|||+.++++++
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~el~~~l 271 (325)
T 3kex_A 241 ICTIDVYMVMVKCWMIDENIRPTFKELANEF 271 (325)
T ss_dssp TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHH
T ss_pred cCcHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 4688999999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=326.71 Aligned_cols=249 Identities=18% Similarity=0.262 Sum_probs=211.6
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC--C
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--H 141 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~ 141 (350)
...++|.+.+.||+|+||.||+|++. ++.+|||++..... .....+.+.+|+.+++++. ||||+++++++... +
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSS
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCC
Confidence 34578999999999999999999985 78899999976432 4445678999999999998 99999999999876 7
Q ss_pred ceEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 142 SVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||++ +.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADV 159 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGS
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccc
Confidence 8899999999999999998765 4899999999999999999999999 9999999999999 6677799999888
Q ss_pred cccccCCCccccCCcCcccccccccccc----CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLRRN----YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
+..... ....||+.|+|||++.+. ++.++||||||+++|+|++|..||...........+......... .
T Consensus 160 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~ 233 (271)
T 3kmu_A 160 KFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI--P 233 (271)
T ss_dssp CCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC--C
T ss_pred eeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC--C
Confidence 765332 345789999999987642 334799999999999999999999988887776666654433322 2
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..++.++.++|.+||+.||++|||+.++++.+
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L 265 (271)
T 3kmu_A 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 36899999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=328.61 Aligned_cols=254 Identities=25% Similarity=0.361 Sum_probs=213.7
Q ss_pred cccccceeeee-eeeccCceEEEEEEEc--cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 63 EDVRNTYIFGR-ELGRGQFGVTYLVTHK--DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 63 ~~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
....++|.+.+ .||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+++++++. ||||+++++++ .
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~ 80 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVC-Q 80 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-E
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-c
Confidence 34457888887 9999999999999864 467889999997542 4455678999999999998 99999999998 4
Q ss_pred CCceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
.+..++|||++++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLS 157 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccce
Confidence 56689999999999999988654 5699999999999999999999999999999999999995 4567999999999
Q ss_pred ccccCCCc----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 018786 219 VFFKPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292 (350)
Q Consensus 219 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~--- 234 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC--- 234 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC---
Confidence 87643322 12335688999999886 458999999999999999998 9999998888777777766543222
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
.+.++.++.++|.+||+.||++||++.+++++++
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 2368999999999999999999999999998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=331.87 Aligned_cols=257 Identities=25% Similarity=0.473 Sum_probs=201.7
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
.+.+...++|++.+.||+|+||+||+|.+.. .+|+|+++.... .....+.+.+|+.+++++. |+||++++++. .
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~ 90 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-T 90 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-C
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-c
Confidence 3456677899999999999999999998754 499999975432 4455678999999999998 99999999965 5
Q ss_pred CCceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
....++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLA 167 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC--
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceec
Confidence 5678999999999999998864 4569999999999999999999999999999999999999 45667999999999
Q ss_pred ccccC---CCccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCC-
Q 018786 219 VFFKP---GDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQS-IFDAILRGHIDFS- 289 (350)
Q Consensus 219 ~~~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~- 289 (350)
..... ........||+.|+|||++. ..++.++||||||+++|+|++|..||......+ ....+........
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence 76542 22234457899999999874 347889999999999999999999998765544 4444444433322
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 290 ~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
......++.++.++|.+||+.||++|||+.++++.+
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 283 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 222346889999999999999999999999999754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=352.46 Aligned_cols=254 Identities=22% Similarity=0.378 Sum_probs=218.1
Q ss_pred cccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
.++....+|.+.+.||+|+||.||+|.++.++..||||+++... ...+.+.+|+.+++++. |+||+++++++...
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 288 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE 288 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcC-CCCEeeEEEEEecC
Confidence 34556688999999999999999999999989999999997543 23578999999999998 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a 365 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLS 365 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCE
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccc
Confidence 9999999999999999999864 458999999999999999999999999999999999999 55677999999999
Q ss_pred ccccCCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 219 VFFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 219 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
........ .....++..|+|||++. +.++.++||||||+++|||++ |..||.+....+....+....... ...
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 442 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME---RPE 442 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC---CCT
T ss_pred eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCC
Confidence 87654322 12334677899999876 458999999999999999999 999999888777776666543221 123
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.++.++.++|.+||+.||++|||+.++++.+
T Consensus 443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~~L 473 (495)
T 1opk_A 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473 (495)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 6899999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=336.74 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=212.9
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCc-----EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQ-----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
.+...++|.+.+.||+|+||.||+|.+..+++ .||+|.+.... .....+.+.+|+.+++++.+||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34556899999999999999999999976654 79999986433 344567899999999999449999999999
Q ss_pred EEcCCceEEEEecCCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEee
Q 018786 137 YEDRHSVNLIMDLCAGGELFDRIIAK--------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFS 202 (350)
Q Consensus 137 ~~~~~~~~iv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~ 202 (350)
+...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 99999999999999999999998753 3579999999999999999999999999999999999994
Q ss_pred cCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 018786 203 SSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSI 277 (350)
Q Consensus 203 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~ 277 (350)
.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+......
T Consensus 199 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 199 ---NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp ---GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred ---CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 456799999999986543322 22345678899999875 468999999999999999998 9999987765544
Q ss_pred HHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
............. ...++..+.++|.+||+.||.+|||+.++++++
T Consensus 276 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 321 (333)
T 2i1m_A 276 FYKLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321 (333)
T ss_dssp HHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 4444433332222 135689999999999999999999999999754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=348.25 Aligned_cols=248 Identities=22% Similarity=0.362 Sum_probs=209.9
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
++...++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+++++. |+||+++++++....
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEK 259 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTT
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCC
Confidence 3455689999999999999999999885 6789999997432 3467999999999998 999999999876654
Q ss_pred -ceEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 142 -SVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 142 -~~~iv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
.+++||||+++++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT 336 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCc
Confidence 79999999999999999987644 7999999999999999999999999999999999999 66778999999999
Q ss_pred ccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
...... .....++..|+|||++. ..++.++||||||+++|||++ |..||......+....+..+.... ....+
T Consensus 337 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---~p~~~ 411 (450)
T 1k9a_A 337 KEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGC 411 (450)
T ss_dssp EECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC---CCTTC
T ss_pred cccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCcC
Confidence 864432 22336788999999875 468999999999999999998 999998887777777776653222 12368
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++++.++|.+||+.||++|||+.++++.+
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99999999999999999999999998643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=330.45 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=206.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCC-eeEeEeEEEcCCc
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN-IVELKGAYEDRHS 142 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-iv~~~~~~~~~~~ 142 (350)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+.+++++. |++ +..+..+....+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHT-TSTTCCCEEEEEEETTE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhh-cCCCCCccccccCCCCc
Confidence 456899999999999999999999999999999999865432 245889999999999 555 5555555577888
Q ss_pred eEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++.+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99999999 8899999974 567999999999999999999999999999999999999965456778999999999876
Q ss_pred cCCCc--------cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCC
Q 018786 222 KPGDV--------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE---QSIFDAILRGHIDFS 289 (350)
Q Consensus 222 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~ 289 (350)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... ......+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 54322 245679999999998764 589999999999999999999999976432 222323222221111
Q ss_pred -CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 290 -SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 290 -~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
......+++++.++|.+||+.||++|||+.++++.+
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 275 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence 011135789999999999999999999999998653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=346.92 Aligned_cols=258 Identities=16% Similarity=0.187 Sum_probs=195.0
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccC-----CcEEEEEEecccccCChh--------hHHHHHHHHHHHHHccCCCCe
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRD--------DVEDVRREVQIMHHLTGHRNI 130 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~--------~~~~~~~e~~~l~~l~~h~~i 130 (350)
...++|.+.+.||+|+||+||+|.+..+ ++.||||++......... ....+..|+..+..+. |+||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~i 110 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGV 110 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCS
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCC
Confidence 4557999999999999999999999764 588999998643210000 0011223334444555 9999
Q ss_pred eEeEeEEEcC----CceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC
Q 018786 131 VELKGAYEDR----HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205 (350)
Q Consensus 131 v~~~~~~~~~----~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 205 (350)
+++++++... ...++||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. +
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~ 188 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K 188 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence 9999988654 5589999999 99999999875 67999999999999999999999999999999999999963 1
Q ss_pred CCCCeEEeecCCcccccCCCc--------cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 018786 206 EDSPLKATDFGLSVFFKPGDV--------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQS 276 (350)
Q Consensus 206 ~~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~ 276 (350)
.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 567899999999977543221 133459999999998865 48999999999999999999999998543222
Q ss_pred HHHH-HHc----CCCCCC--CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 277 IFDA-ILR----GHIDFS--SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 277 ~~~~-~~~----~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
.... ... ...... ......++.++.++|..||+.||++||++.++++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 1111 110 000000 00013579999999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=329.69 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=204.7
Q ss_pred ccccceeeeeeeeccCceEEEEEE----EccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVT----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
....+|++.+.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|+.+++++. |+||+++++++..
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTE 94 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEec
Confidence 345779999999999999999999 56779999999997543 3345678999999999998 9999999999876
Q ss_pred C--CceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 140 R--HSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 140 ~--~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
. ..+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg 171 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFG 171 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECccc
Confidence 6 678999999999999999954 46799999999999999999999999999999999999994 45679999999
Q ss_pred CcccccCCCc----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCC--------------CHH-H
Q 018786 217 LSVFFKPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGE--------------TEQ-S 276 (350)
Q Consensus 217 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~--------------~~~-~ 276 (350)
++........ .....||..|+|||++. ..++.++||||||+++|+|++|..|+... ... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 9987654432 23456888899999875 45889999999999999999999876322 111 1
Q ss_pred HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
....+.... ..+ ..+.+++++.++|.+||+.||.+|||+.++++.+
T Consensus 252 ~~~~~~~~~-~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 252 LVNTLKEGK-RLP--CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp HHHHHHTTC-CCC--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhccC-CCC--CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 222222222 221 2236899999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=348.14 Aligned_cols=252 Identities=22% Similarity=0.375 Sum_probs=214.6
Q ss_pred cccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
.++...++|.+.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+++++. ||||+++++++. .
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-K 254 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS----BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC-S
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC----ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe-C
Confidence 355667899999999999999999999865 6789999997533 24578999999999998 999999999986 6
Q ss_pred CceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
+..++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLA 331 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCc
Confidence 6789999999999999999753 368999999999999999999999999999999999999 66778999999999
Q ss_pred ccccCCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 219 VFFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 219 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
........ .....++..|+|||++. +.++.++||||||+++|||++ |..||.+....+....+..+..... ..
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~ 408 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---PE 408 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC---CT
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence 87643221 12334677899999886 568999999999999999999 9999999888888877776533222 23
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.++.++.++|.+||+.||++|||+.++++.+
T Consensus 409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L 439 (454)
T 1qcf_A 409 NCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439 (454)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 6899999999999999999999999998644
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=337.54 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=200.5
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
.....++|++.+.||+|+||+||+|++. ++.||||++.... .......+|+.+++++. ||||+++++++....
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMK-HENILQFIGAEKRGT 91 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEEC
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCC-CCCchhhcceeccCC
Confidence 3344589999999999999999999876 6899999996432 23345667888899998 999999999987654
Q ss_pred ----ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc----------CCEeecCCCCceEeecCCCC
Q 018786 142 ----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM----------GVMHRDLKPENFLFSSSAED 207 (350)
Q Consensus 142 ----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~----------~ivH~Dlkp~NIl~~~~~~~ 207 (350)
.+++||||+++++|.+++... .+++..++.++.||+.||.|||++ ||+||||||+|||+ +.+
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~ 167 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNN 167 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTT
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCC
Confidence 369999999999999998764 599999999999999999999999 99999999999999 667
Q ss_pred CCeEEeecCCcccccCCCc---cccCCcCccccccccccc------cCCcchhHHHHHHHHHHHHhCCCCCCCCCH----
Q 018786 208 SPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLRR------NYGAEADIWSAGVILYILLSGVPPFWGETE---- 274 (350)
Q Consensus 208 ~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~---- 274 (350)
+.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+...
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 7899999999977654332 234579999999998764 466788999999999999999999965421
Q ss_pred ------------HHHHHHHHcCCCCCCCC-CCC--CCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 275 ------------QSIFDAILRGHIDFSSD-PWP--NISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 275 ------------~~~~~~~~~~~~~~~~~-~~~--~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
................. .+. ..+.++.++|.+||+.||++|||+.++++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 313 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 12222222222111110 000 1234599999999999999999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=330.46 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=204.7
Q ss_pred cccceeeeeeeeccCceEEEEEEEcc-CC--cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKD-TK--QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
..++|++.+.||+|+||+||+|.+.. ++ ..||||++...........+.+.+|+++++++. |+||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC
Confidence 45789999999999999999998643 33 368999997655445556788999999999998 999999999987665
Q ss_pred ceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++..
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRA 170 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEE
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEcccccccc
Confidence 88999999999999998764 5699999999999999999999999999999999999995 456799999999987
Q ss_pred ccCCCc----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 221 FKPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 221 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
...... .....++..|+|||++. ..++.++||||||+++|+|++ |..||......+....+.......+. ..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 248 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PE 248 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CT
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--Cc
Confidence 654332 12345778899999876 457899999999999999999 99999998888888777765544333 23
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.++.++.++|.+||+.||++|||+.++++++
T Consensus 249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 279 (291)
T 1u46_A 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279 (291)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 6899999999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=324.14 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=213.7
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
..++...++|++.+.||+|+||.||+|.+.. ++.||+|++.... ...+.+.+|+++++++. |+||+++++++.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~- 78 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVT- 78 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC-
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc----ccHHHHHHHHHHHHhCC-CcCcceEEEEEc-
Confidence 4566677999999999999999999999864 6789999986533 23467899999999998 999999999876
Q ss_pred CCceEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
.+..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.
T Consensus 79 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGL 155 (279)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcc
Confidence 456889999999999999886543 69999999999999999999999999999999999999 5677899999999
Q ss_pred cccccCCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 218 SVFFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 218 a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
+........ .....++..|+|||++. +.++.++||||||+++|+|++ |..||......+....+........ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 232 (279)
T 1qpc_A 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---P 232 (279)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---C
T ss_pred cccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC---c
Confidence 987654432 22345678899999886 458899999999999999999 9999998888877777766533222 2
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
..++.++.++|.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 263 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSV 263 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 3679999999999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=341.74 Aligned_cols=258 Identities=22% Similarity=0.356 Sum_probs=208.2
Q ss_pred cccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
..+...++|.+.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+++++. ||||+++++++...
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE---SSQGIEEFETEIETLSFCR-HPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCC
Confidence 34556789999999999999999999975 5889999988643 2345678999999999998 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKG----HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
+..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeecc
Confidence 99999999999999999886543 58999999999999999999999999999999999999 667789999999
Q ss_pred CcccccCC---CccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCC
Q 018786 217 LSVFFKPG---DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIF-------DAILRGH 285 (350)
Q Consensus 217 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~-------~~~~~~~ 285 (350)
++...... .......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+.. .......
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99764322 1223456899999999875 56899999999999999999999999754322111 1111111
Q ss_pred CC------CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 286 ID------FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 286 ~~------~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
.. ......+.++..+.+++.+||+.||++|||+.|+++++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11 011111234567899999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=332.05 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=204.9
Q ss_pred cccccceeeeeeeeccCceEEEEEEEcc---CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKD---TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
....++|.+.+.||+|+||.||+|.+.. +++.||+|++..... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 107 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFS-HPNVIRLLGVCIE 107 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCC-CCCeeeeeEEEee
Confidence 3446899999999999999999998865 456899999875432 3445678999999999998 9999999999876
Q ss_pred CC-----ceEEEEecCCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCC
Q 018786 140 RH-----SVNLIMDLCAGGELFDRIIA------KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 140 ~~-----~~~iv~e~~~~~sL~~~l~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~ 208 (350)
.+ ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCC
Confidence 54 45999999999999999853 3569999999999999999999999999999999999999 5667
Q ss_pred CeEEeecCCcccccCCC---ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHc
Q 018786 209 PLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILR 283 (350)
Q Consensus 209 ~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~ 283 (350)
.+||+|||++....... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 89999999998764332 122345788899999875 458999999999999999999 9999998888777777766
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
...... ...++.++.++|.+||+.||.+|||+.++++++
T Consensus 265 ~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 303 (313)
T 3brb_A 265 GHRLKQ---PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303 (313)
T ss_dssp TCCCCC---BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCC---CccccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 543222 236789999999999999999999999999765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=334.83 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=204.7
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEE----EEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQF----ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
..++|++.+.||+|+||.||+|.+..+++.+ |+|.+... ......+.+.+|+.+++++. ||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecC
Confidence 3588999999999999999999998887765 55555422 23345678999999999998 99999999998876
Q ss_pred CceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 141 HSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
. .+++++++.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC--
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCccee
Confidence 5 7889999999999999987 45699999999999999999999999999999999999994 45669999999998
Q ss_pred cccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 220 FFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 220 ~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+......... +
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 242 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---P 242 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---T
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC---c
Confidence 7643322 22345678899999876 458999999999999999999 99999988887777776665432222 3
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.++.++.++|.+||+.||.+|||+.|+++.+
T Consensus 243 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 273 (327)
T 3lzb_A 243 ICTIDVYMIMRKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 5789999999999999999999999999754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=359.05 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=208.1
Q ss_pred cceeee-eeeeccCceEEEEEEE--ccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 67 NTYIFG-RELGRGQFGVTYLVTH--KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 67 ~~y~~~-~~lg~G~~g~V~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
..+.+. +.||+|+||.||+|.+ +.+++.||||+++... ......+.+.+|+++++++. |+||+++++++.. +..
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~ 444 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESW 444 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCE
Confidence 344443 4799999999999965 4567899999997543 24455678999999999998 9999999999865 458
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCcccccc
Confidence 89999999999999999888899999999999999999999999999999999999994 456799999999987643
Q ss_pred CCc----cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 224 GDV----FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 224 ~~~----~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... .....+|+.|+|||++.+ .++.++||||||+++|||++ |..||.+....+....+..+...... ..++
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~ 598 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---AGCP 598 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTCC
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCC
Confidence 321 223346788999998864 68999999999999999998 99999999988888887776533222 3689
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.++.++|.+||+.||++|||+.++++.+
T Consensus 599 ~~l~~li~~cl~~dP~~RPs~~~l~~~L 626 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRPGFAAVELRL 626 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999999999999999999997643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=356.13 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=207.1
Q ss_pred ccccceeeee-eeeccCceEEEEEEEc--cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 64 DVRNTYIFGR-ELGRGQFGVTYLVTHK--DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 64 ~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
....++.+.+ .||+|+||.||+|.++ .++..||||+++... .....+.+.+|+++++++. |+||+++++++..
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~- 407 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA- 407 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-
Confidence 3445666666 8999999999999876 346679999997542 3345678999999999998 9999999999876
Q ss_pred CceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
+.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSK 484 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCSTTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccCcc
Confidence 5689999999999999998754 4599999999999999999999999999999999999994 55679999999998
Q ss_pred cccCCCc----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 220 FFKPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 220 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
....... .....+++.|+|||++. +.++.++||||||+++|||++ |..||......+....+..+..... .
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p 561 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---P 561 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC---C
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence 7643321 12234567899999886 568999999999999999998 9999999888888877776643222 2
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
..++.++.++|.+||+.||++||++.++++.
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~ 592 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQR 592 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3689999999999999999999999999754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=325.78 Aligned_cols=248 Identities=22% Similarity=0.363 Sum_probs=202.2
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc-C
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-R 140 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~-~ 140 (350)
+....++|++.+.||+|+||.||++.+. ++.||||++... ...+.+.+|+.+++++. |+||+++++++.. .
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEK 87 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC-
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-----hHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCC
Confidence 3445689999999999999999999875 789999998643 23567899999999998 9999999998654 4
Q ss_pred CceEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
+..++||||+++++|.+++...+. +++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT 164 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeecccc
Confidence 578999999999999999976543 8999999999999999999999999999999999999 56678999999998
Q ss_pred ccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
....... ....+++.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+.... ....+
T Consensus 165 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 239 (278)
T 1byg_A 165 KEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGC 239 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC---CCTTC
T ss_pred ccccccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CcccC
Confidence 8654332 3346788999999876 458999999999999999998 999998887777776665543221 22468
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++.+.++|.+||+.||++|||+.++++.+
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L 268 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQL 268 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHHHH
Confidence 99999999999999999999999998743
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=328.66 Aligned_cols=240 Identities=32% Similarity=0.620 Sum_probs=195.7
Q ss_pred ccccceeee-eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc---
Q 018786 64 DVRNTYIFG-RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--- 139 (350)
Q Consensus 64 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--- 139 (350)
.+.++|.+. +.||+|+||.||+|.+..+++.||+|++... ..+.+|+.++.++.+|+||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 455778887 7899999999999999999999999998532 4577899988666569999999999876
Q ss_pred -CCceEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 140 -RHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 140 -~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
...+++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 778999999999999999998764 69999999999999999999999999999999999999765557889999999
Q ss_pred CcccccCCCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc----CCCCCCCCC
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR----GHIDFSSDP 292 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~ 292 (350)
++..... ..++.++||||||+++|+|++|..||.............. .....+...
T Consensus 166 ~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 166 FAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp TCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred ccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 9876432 2357799999999999999999999977654332211111 111111111
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
+..++.++.++|.+||+.||++|||+.|+|+|+||.+..
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 246799999999999999999999999999999997765
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=333.66 Aligned_cols=250 Identities=23% Similarity=0.392 Sum_probs=206.7
Q ss_pred ccceeeeeeeeccCceEEEEEE----EccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE--c
Q 018786 66 RNTYIFGRELGRGQFGVTYLVT----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE--D 139 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~--~ 139 (350)
.++|++.+.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+++++++. |+||+++++++. +
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Confidence 4799999999999999999999 5677899999999643 3445577999999999997 999999999876 5
Q ss_pred CCceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
....++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcccccc
Confidence 5678999999999999999976 45699999999999999999999999999999999999994 4567999999999
Q ss_pred ccccCCCc----cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHH
Q 018786 219 VFFKPGDV----FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ---------------SIF 278 (350)
Q Consensus 219 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~---------------~~~ 278 (350)
........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 87654332 233467888999998764 5789999999999999999999998654322 122
Q ss_pred HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..+.... ..+ ..+.++.++.++|.+||+.||++|||+.++++++
T Consensus 255 ~~~~~~~-~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 298 (327)
T 3lxl_A 255 ELLEEGQ-RLP--APPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298 (327)
T ss_dssp HHHHTTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhhccc-CCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2222222 111 1246899999999999999999999999997655
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=334.63 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=207.2
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE----c
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE----D 139 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~----~ 139 (350)
...++|++.+.||+|+||.||++.+..+++.||||++... .....+.+.+|+.+++++. |+||+++++++. .
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGA 101 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETT
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCC
Confidence 3458999999999999999999999999999999998542 3455678999999999998 999999999886 3
Q ss_pred CCceEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeec
Q 018786 140 RHSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Df 215 (350)
....++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+||
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~df 178 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDL 178 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEec
Confidence 4578999999999999998876 4669999999999999999999999999999999999999 56677999999
Q ss_pred CCcccccCCCc----------cccCCcCccccccccccc----cCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH
Q 018786 216 GLSVFFKPGDV----------FKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWGETE--QSIFD 279 (350)
Q Consensus 216 g~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~--~~~~~ 279 (350)
|.+........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... .....
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 258 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence 99876432110 123457999999998753 268899999999999999999999953111 11122
Q ss_pred HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.+.. ....+ ..+.++.++.++|.+||+.||.+|||+.++++++.-....
T Consensus 259 ~~~~-~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 259 AVQN-QLSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHHC-C--CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred Hhhc-cCCCC--ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 2222 22222 2246799999999999999999999999999987554443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=342.99 Aligned_cols=260 Identities=22% Similarity=0.403 Sum_probs=207.3
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc----------CCCCeeEeE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT----------GHRNIVELK 134 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~----------~h~~iv~~~ 134 (350)
..++|.+.+.||+|+||+||+|.+..+++.||||++... ....+.+.+|+.+++++. +|+||++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 357899999999999999999999999999999998643 234467889999998876 278999999
Q ss_pred eEEEcCC----ceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCEeecCCCCceEeecCC--
Q 018786 135 GAYEDRH----SVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSA-- 205 (350)
Q Consensus 135 ~~~~~~~----~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~-- 205 (350)
+++...+ .+++|||++ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9987554 789999999 88999999873 4599999999999999999999998 999999999999996432
Q ss_pred -CCCCeEEeecCCcccccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC------HHHH
Q 018786 206 -EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET------EQSI 277 (350)
Q Consensus 206 -~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~------~~~~ 277 (350)
..+.+||+|||++...... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.... ....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 3447999999999876533 345579999999998764 58999999999999999999999997654 2222
Q ss_pred HHHHHcCCCCCCC--------------------------------------CCCCCCCHHHHHHHHHhcccCccCCCCHH
Q 018786 278 FDAILRGHIDFSS--------------------------------------DPWPNISSSAKDIVKKMLHADPKERLSAA 319 (350)
Q Consensus 278 ~~~~~~~~~~~~~--------------------------------------~~~~~~~~~l~~li~~~L~~dp~~Rps~~ 319 (350)
...+.......+. .....++.++.+||.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 2222211100000 00012356889999999999999999999
Q ss_pred HHHhccCCCCCc
Q 018786 320 EVLSKFLIPKKT 331 (350)
Q Consensus 320 ~iL~~~~~~~~~ 331 (350)
|+|+|+||.+..
T Consensus 330 ell~hp~f~~~~ 341 (373)
T 1q8y_A 330 GLVNHPWLKDTL 341 (373)
T ss_dssp HHHTCGGGTTCT
T ss_pred HHhhChhhhccc
Confidence 999999999763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=328.23 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=200.5
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... .+.+.+|+.+++++.+++++..+..++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 456899999999999999999999999999999998754432 134788999999999444455555566788889
Q ss_pred EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999999 8899999875 5679999999999999999999999999999999999999655567789999999998765
Q ss_pred CCCc--------cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCC-
Q 018786 223 PGDV--------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ---SIFDAILRGHIDFS- 289 (350)
Q Consensus 223 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~- 289 (350)
.... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .....+.......+
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 4322 235679999999998764 5899999999999999999999999764321 22222222211111
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 290 ~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
......++.++.++|.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 274 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHH
Confidence 11113578999999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=349.04 Aligned_cols=259 Identities=25% Similarity=0.338 Sum_probs=200.4
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
-..+|.+.+.||+|+||+|+. ....+++.||||++..... ..+.+|+.+++++.+||||+++++++.+.+..+
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 346799999999999998764 3345689999999864322 235689999999955999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC--CCCCeEEeecCCcccc
Q 018786 145 LIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--EDSPLKATDFGLSVFF 221 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~~~vkl~Dfg~a~~~ 221 (350)
+|||++. ++|.+++.... .+.+..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++...
T Consensus 95 lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp EEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred EEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 9999995 59999987653 456667789999999999999999999999999999996433 3346889999999876
Q ss_pred cCCC----ccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 018786 222 KPGD----VFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292 (350)
Q Consensus 222 ~~~~----~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
.... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.................... ..
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~-~~ 252 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL-HP 252 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS-CT
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc-Cc
Confidence 5332 234467999999999885 346789999999999999999 9999966554433322222111111 11
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
....+..+.+||.+||+.||++|||+.++|+|+||....+
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence 1223566899999999999999999999999999987655
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=323.33 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=206.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCc---EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQ---QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
...|.+.+.||+|+||+||+|.+..+++ .+|+|++... ......+.+.+|+.+++++. |+||+++++++...+.
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEG 96 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCC
Confidence 4567888999999999999999765544 7999998642 24455678999999999998 9999999999976655
Q ss_pred e-EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 143 V-NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 143 ~-~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
. +++|||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARD 173 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCccc
Confidence 4 999999999999999976 4568999999999999999999999999999999999999 6677899999999976
Q ss_pred ccCCC-----ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 221 FKPGD-----VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSG-VPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 221 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
..... ......+++.|+|||.+.+ .++.++||||||+++|+|++| .+||...........+.........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~--- 250 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP--- 250 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCC---
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCC---
Confidence 54322 2234567889999998764 589999999999999999995 4555555655565555554432222
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..++.++.++|.+||+.||.+|||+.++++.+
T Consensus 251 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l 282 (298)
T 3pls_A 251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccchHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 35789999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=342.83 Aligned_cols=251 Identities=23% Similarity=0.373 Sum_probs=208.8
Q ss_pred cccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
.++...++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+++++. ||||+++++++..
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE- 250 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-
Confidence 345567899999999999999999999976 4679999997543 23467999999999998 9999999999876
Q ss_pred CceEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 141 HSVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLA 327 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTT
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccc
Confidence 678999999999999999964 3569999999999999999999999999999999999999 55677999999999
Q ss_pred ccccCCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 219 VFFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 219 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
........ .....++..|+|||++. +.++.++||||||+++|||++ |..||.+....+....+..+..... .+
T Consensus 328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~ 404 (452)
T 1fmk_A 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PP 404 (452)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CT
T ss_pred eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence 87643321 22345678899999875 568999999999999999999 9999999888888877766533221 23
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
.++..+.++|.+||+.||++|||+.++++.
T Consensus 405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~ 434 (452)
T 1fmk_A 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAF 434 (452)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 679999999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=333.98 Aligned_cols=267 Identities=19% Similarity=0.261 Sum_probs=209.5
Q ss_pred ccCCcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE
Q 018786 57 VLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 57 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
+.........++|.+.+.||+|+||.||+|.+. +++.||||++...... .....+.+|+.+++++. |+||++++++
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~ 95 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAV-HRNLLRLRGF 95 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEE
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhcc-CCCccceEEE
Confidence 334455667799999999999999999999865 5889999999754321 12236889999999998 9999999999
Q ss_pred EEcCCceEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCEeecCCCCceEeecCCCCCC
Q 018786 137 YEDRHSVNLIMDLCAGGELFDRIIAKG----HYSERAAANLCRQMVTVVHYCHSM---GVMHRDLKPENFLFSSSAEDSP 209 (350)
Q Consensus 137 ~~~~~~~~iv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~ 209 (350)
+...+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~ 172 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFE 172 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCC
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCC
Confidence 999999999999999999999997643 389999999999999999999999 99999999999999 66778
Q ss_pred eEEeecCCcccccCCC--ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHH
Q 018786 210 LKATDFGLSVFFKPGD--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGE----TEQSIFDAIL 282 (350)
Q Consensus 210 vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~----~~~~~~~~~~ 282 (350)
+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||... ..........
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 9999999998764332 234456999999999875 55899999999999999999999999521 1111111111
Q ss_pred cCCCCCC-----------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 283 RGHIDFS-----------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 283 ~~~~~~~-----------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
....... .......+..+.+++.+||+.||.+|||+.++++++.-.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 1111000 00011223679999999999999999999999999865443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=325.58 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=208.3
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccC---CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE-Ec
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY-ED 139 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~-~~ 139 (350)
....+|++.+.||+|+||+||+|.+..+ +..+|+|.+... ......+.+.+|+.+++++. |+||+++++++ ..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRS 98 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCS
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcC
Confidence 3457899999999999999999997543 346899988642 24455678999999999998 99999999985 55
Q ss_pred CCceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLA 175 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGG
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECccccc
Confidence 6788999999999999999976 4558999999999999999999999999999999999999 66778999999999
Q ss_pred ccccCCC-----ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 018786 219 VFFKPGD-----VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSD 291 (350)
Q Consensus 219 ~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
....... ......+|+.|+|||.+. ..++.++||||||+++|+|++ |.+||......+....+.........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 254 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP- 254 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC-
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC-
Confidence 8654332 123346778899999876 458999999999999999999 66777777666666666665544333
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..++..+.++|.+||+.||++|||+.++++.+
T Consensus 255 --~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 286 (298)
T 3f66_A 255 --EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286 (298)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 25789999999999999999999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=327.11 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=197.0
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHH--ccCCCCeeEeEeEEEc-
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH--LTGHRNIVELKGAYED- 139 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~--l~~h~~iv~~~~~~~~- 139 (350)
..+.++|++.+.||+|+||+||+|.+ +++.||||++... ....+.+|.+++.. +. ||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLR-HENILGFIASDMTS 74 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCC-CTTBCCEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhcc-CcCeeeEEEeeccc
Confidence 35678999999999999999999987 5789999998543 33566677777777 56 9999999998643
Q ss_pred ---CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCEeecCCCCceEeecCCCCC
Q 018786 140 ---RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH--------SMGVMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 140 ---~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~ivH~Dlkp~NIl~~~~~~~~ 208 (350)
....++||||+++++|.++++ ...+++..++.++.||+.||.||| ++||+||||||+|||+ +.++
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~ 150 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNG 150 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTS
T ss_pred cCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCC
Confidence 356899999999999999885 457999999999999999999999 9999999999999999 5677
Q ss_pred CeEEeecCCcccccCCCc-----cccCCcCccccccccccc-------cCCcchhHHHHHHHHHHHHhC----------C
Q 018786 209 PLKATDFGLSVFFKPGDV-----FKDLVGSAYYVAPEVLRR-------NYGAEADIWSAGVILYILLSG----------V 266 (350)
Q Consensus 209 ~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~Dv~slG~vl~~ll~g----------~ 266 (350)
.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++| .
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 899999999976544332 233479999999998764 344789999999999999999 8
Q ss_pred CCCCCCC----HHHHHHHHHcCCCCCCCCC----CCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 267 PPFWGET----EQSIFDAILRGHIDFSSDP----WPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 267 ~pf~~~~----~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.||.... ...............+... ...++.++.++|.+||+.||++|||+.++++.+
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 8885432 2222333222211111110 012457799999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=329.78 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=204.4
Q ss_pred ccccce-eeeeeeeccCceEEEEEEE----ccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 64 DVRNTY-IFGRELGRGQFGVTYLVTH----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 64 ~~~~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
.+.++| ++++.||+|+||+||++.. ..+++.||||++.... .....+.+.+|+++++++. |+||+++++++.
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 103 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY-HEHIIKYKGCCE 103 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CcchhhEEEEEe
Confidence 455666 9999999999999988754 4578999999997542 4455678999999999998 999999999987
Q ss_pred c--CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 139 D--RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 139 ~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
+ ...+++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg 179 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFG 179 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGG
T ss_pred cCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCcc
Confidence 6 46789999999999999988654 59999999999999999999999999999999999999 667789999999
Q ss_pred CcccccCCCc----cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---------------H
Q 018786 217 LSVFFKPGDV----FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ---------------S 276 (350)
Q Consensus 217 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~---------------~ 276 (350)
++........ .....++..|+|||++.+ .++.++||||||+++|+|++|..||...... .
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 9988654432 234567888999998764 5889999999999999999999998654321 1
Q ss_pred HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
....+.... ..+ ....++.++.++|.+||+.||++|||+.++++.+
T Consensus 260 ~~~~~~~~~-~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 305 (318)
T 3lxp_A 260 LTELLERGE-RLP--RPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305 (318)
T ss_dssp HHHHHHTTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhccc-CCC--CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 112222222 111 1236899999999999999999999999998654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=341.90 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=200.3
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+++++.+||||+++++++...+.
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 83 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF 83 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence 3456778888999999999998754 456899999998543 235678999999987559999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCC-------CHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecC----------C
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHY-------SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS----------A 205 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~-------~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~----------~ 205 (350)
.++||||+. ++|.+++...... ++..++.++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 999999995 5999999865432 233457899999999999999999999999999999753 2
Q ss_pred CCCCeEEeecCCcccccCCCc-----cccCCcCcccccccccc--------ccCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 018786 206 EDSPLKATDFGLSVFFKPGDV-----FKDLVGSAYYVAPEVLR--------RNYGAEADIWSAGVILYILLS-GVPPFWG 271 (350)
Q Consensus 206 ~~~~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~--------~~~~~~~Dv~slG~vl~~ll~-g~~pf~~ 271 (350)
.+..+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++ |..||..
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 456799999999987654321 23457999999999874 347899999999999999999 9999976
Q ss_pred CCHHHHHHHHHcCCCCCCCCC---CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 272 ETEQSIFDAILRGHIDFSSDP---WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
..... ..+..+........ ...++.++.++|.+||+.||.+|||+.++++|+||...
T Consensus 243 ~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 243 KYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp TTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred chhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 65443 23344433332211 11245789999999999999999999999999999764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=341.12 Aligned_cols=263 Identities=16% Similarity=0.187 Sum_probs=201.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEcc---CCcEEEEEEecccccCChh--------hHHHHHHHHHHHHHccCCCCeeE
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKD---TKQQFACKSISSRKLINRD--------DVEDVRREVQIMHHLTGHRNIVE 132 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~--------~~~~~~~e~~~l~~l~~h~~iv~ 132 (350)
...++|.+.+.||+|+||.||+|.+.. ++..+|+|++......... ....+.+|+..++.+. |+||++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~ 112 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPL 112 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcce
Confidence 345889999999999999999999987 7889999998754311000 1123567788888887 999999
Q ss_pred eEeEEEc----CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCC
Q 018786 133 LKGAYED----RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 133 ~~~~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~ 208 (350)
+++++.. ....++||||+ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~ 190 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PD 190 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-TT
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-CC
Confidence 9999877 78899999999 999999998877899999999999999999999999999999999999996432 23
Q ss_pred CeEEeecCCcccccCCC--------ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCC--CHHHH
Q 018786 209 PLKATDFGLSVFFKPGD--------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE--TEQSI 277 (350)
Q Consensus 209 ~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~--~~~~~ 277 (350)
.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||... .....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 79999999997754221 1244579999999998765 4899999999999999999999999652 22222
Q ss_pred HHHHHcCCCCCCCC-----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 278 FDAILRGHIDFSSD-----PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 278 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
...........+.. ....++.++.++|.+||+.||++|||+.++++.+.-..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 21111111111110 01157899999999999999999999999998775443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=346.21 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=209.0
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.+..++++..+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 456899999999999999999999999999999998865432 134788999999999667788888888889999
Q ss_pred EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|||++....
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 8899999975 5679999999999999999999999999999999999999654567789999999998765
Q ss_pred CCCc--------cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCC-
Q 018786 223 PGDV--------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE---QSIFDAILRGHIDFS- 289 (350)
Q Consensus 223 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~- 289 (350)
.... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+... ...+..+........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 4332 225679999999998764 589999999999999999999999976443 233333222211111
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 290 ~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
......++.++.++|..||+.||++||++.++++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1111357899999999999999999999998875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=337.11 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=199.9
Q ss_pred ccceeeeeeeeccCceEEEEEEEccC---CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE-cCC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE-DRH 141 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~-~~~ 141 (350)
...|.+.+.||+|+||+||+|.+..+ +..||+|.+... ......+.+.+|+.+++++. ||||+++++++. ..+
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG 164 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSS
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCC
Confidence 35688999999999999999998643 346899988642 24455678999999999998 999999999864 556
Q ss_pred ceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARD 241 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-----
T ss_pred CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeecccccc
Confidence 889999999999999999764 458999999999999999999999999999999999999 6677899999999986
Q ss_pred ccCCCc-----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 221 FKPGDV-----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 221 ~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
...... .....+++.|+|||++. ..++.++||||||+++|+|++ |.+||......+....+..+......
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p--- 318 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--- 318 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC---
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC---
Confidence 543321 12345778899999876 458999999999999999999 78888777666666666655433322
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..++..+.++|.+||+.||++|||+.++++++
T Consensus 319 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 350 (373)
T 3c1x_A 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 350 (373)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 35789999999999999999999999999764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=332.32 Aligned_cols=261 Identities=22% Similarity=0.352 Sum_probs=213.6
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
...+...++|++.+.||+|+||.||+|.+.. .+|+|++..... .....+.+.+|+.+++++. |+||+++++++..
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTR-HENVVLFMGACMS 100 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEEC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEec
Confidence 4455567899999999999999999999864 499999875432 2233456788999999998 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
.+..++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLF 176 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCC
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCc
Confidence 999999999999999999987654 699999999999999999999999999999999999994 457999999997
Q ss_pred ccccC------CCccccCCcCccccccccccc----------cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 018786 219 VFFKP------GDVFKDLVGSAYYVAPEVLRR----------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL 282 (350)
Q Consensus 219 ~~~~~------~~~~~~~~gt~~y~aPE~~~~----------~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~ 282 (350)
..... ........|++.|+|||++.. .++.++||||||+++|+|++|..||...........+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 65421 122234568999999998753 36889999999999999999999999988887777776
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.+...... ...++.++.++|.+||+.||++|||+.++++.+--....
T Consensus 257 ~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 257 TGMKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp TTCCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred cCCCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 65443322 235789999999999999999999999999876655444
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=327.22 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=204.3
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEeccccc-CChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL-INRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
.|..++.||+|+||.||+|.+ +++.||||++..... ......+.+.+|+.+++++. ||||+++++++...+..++|
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEE
Confidence 355568999999999999987 478899999875432 23345678999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 147 MDLCAGGELFDRIIA---KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~ 185 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEK 185 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeeccccccccc
Confidence 999999999999874 3469999999999999999999999999999999999999 6677899999999887543
Q ss_pred CC---ccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCC-------CC
Q 018786 224 GD---VFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAILRGHID-------FS 289 (350)
Q Consensus 224 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~----~~~~~~~~~~~-------~~ 289 (350)
.. ......||+.|+|||++.+.++.++||||||+++|+|++|..||....... ....+...... ..
T Consensus 186 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 186 FAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp CSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred ccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 22 123457899999999988888999999999999999999999997654322 22222221110 00
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 290 ~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.......+..+.+++.+||+.||.+|||+.++++++
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 111113456789999999999999999999999765
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=346.61 Aligned_cols=252 Identities=23% Similarity=0.381 Sum_probs=213.8
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
..++...++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+++++++. |+||+++++++.+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEee
Confidence 3355667899999999999999999999976 46799999975432 3467999999999998 9999999999866
Q ss_pred CCceEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 140 RHSVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
+..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGL 409 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTS
T ss_pred -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEccccc
Confidence 678999999999999999964 3569999999999999999999999999999999999999 5567799999999
Q ss_pred cccccCCC--ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 218 SVFFKPGD--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 218 a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
+....... ......++..|+|||++. +.++.++||||||+++|||++ |..||.+....+....+..+..... .
T Consensus 410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~ 486 (535)
T 2h8h_A 410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---P 486 (535)
T ss_dssp TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC---C
T ss_pred ceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence 98764321 112334678899999875 568999999999999999999 9999999888888877766533221 2
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
..++.++.+||.+||+.||++|||+.++++.
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3679999999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=322.50 Aligned_cols=242 Identities=29% Similarity=0.461 Sum_probs=194.6
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+.+.||+|+||+||+|.+. ++.||||.+.. ....+.+.+|+.+++++. ||||+++++++. +..++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----ESERKAFIVELRQLSRVN-HPNIVKLYGACL--NPVCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-----TTHHHHHHHHHHHHHHCC-CTTBCCEEEBCT--TTTEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-----hhHHHHHHHHHHHHhcCC-CCCcCeEEEEEc--CCcEE
Confidence 478999999999999999999885 67899999853 234577999999999998 999999999876 44889
Q ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---cCCEeecCCCCceEeecCCCCCC-eEEeecCCc
Q 018786 146 IMDLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHS---MGVMHRDLKPENFLFSSSAEDSP-LKATDFGLS 218 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~-vkl~Dfg~a 218 (350)
||||+++++|.+++.... .++...++.++.||+.||.|||+ +||+||||||+||+++ .++. +||+|||++
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTA 153 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC-
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEcccccc
Confidence 999999999999998654 37899999999999999999999 8999999999999995 3443 799999999
Q ss_pred ccccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCC
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE--QSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 295 (350)
...... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... ............. .....
T Consensus 154 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 228 (307)
T 2eva_A 154 CDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP---PLIKN 228 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC---CCBTT
T ss_pred cccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC---Ccccc
Confidence 765432 234568999999998764 589999999999999999999999975432 2333333333222 12246
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++..+.++|.+||+.||++|||+.++++++
T Consensus 229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L 258 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 899999999999999999999999999754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=336.59 Aligned_cols=247 Identities=15% Similarity=0.207 Sum_probs=200.7
Q ss_pred ccceeeeeeeeccCceEEEEEEEcc--------CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeE-----
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKD--------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE----- 132 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~----- 132 (350)
.++|.+.+.||+|+||.||+|.+.. .++.||+|++... +.+.+|+.+++++. |+||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence 5899999999999999999999987 4889999998643 35789999999998 988887
Q ss_pred ----------eEeEEEc-CCceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCce
Q 018786 133 ----------LKGAYED-RHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (350)
Q Consensus 133 ----------~~~~~~~-~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NI 199 (350)
+++++.. .+..++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 5666665 78899999999 99999999876 7799999999999999999999999999999999999
Q ss_pred EeecCCCCC--CeEEeecCCcccccCCC--------ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCC
Q 018786 200 LFSSSAEDS--PLKATDFGLSVFFKPGD--------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPP 268 (350)
Q Consensus 200 l~~~~~~~~--~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~p 268 (350)
+++ .++ .+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..|
T Consensus 191 l~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 191 FVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 995 344 79999999997754322 1133479999999998865 689999999999999999999999
Q ss_pred CCCCC--HHHHHHHH---HcCCCCCC--CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 269 FWGET--EQSIFDAI---LRGHIDFS--SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 269 f~~~~--~~~~~~~~---~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
|.... ........ ......+. ...+..++.++.++|.+||+.||++|||+.++++.+
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 97653 22222222 22222111 111235789999999999999999999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=335.47 Aligned_cols=248 Identities=18% Similarity=0.252 Sum_probs=197.2
Q ss_pred ccccccceeeeeeeeccCceEEEEEE-----EccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccC--CCCeeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVT-----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG--HRNIVELK 134 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--h~~iv~~~ 134 (350)
.+...++|.+.+.||+|+||+||+|. +..+++.||||++... ....+.+|+++++++.. |+||+.++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 34456889999999999999999994 6677999999998643 23567788888887753 89999999
Q ss_pred eEEEcCCceEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeec------
Q 018786 135 GAYEDRHSVNLIMDLCAGGELFDRIIA-----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS------ 203 (350)
Q Consensus 135 ~~~~~~~~~~iv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~------ 203 (350)
+++...+..++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999999974 456999999999999999999999999999999999999954
Q ss_pred --CCCCCCeEEeecCCccccc---CCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 018786 204 --SAEDSPLKATDFGLSVFFK---PGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSI 277 (350)
Q Consensus 204 --~~~~~~vkl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~ 277 (350)
++.++.+||+|||++.... ........+||+.|+|||++.+ .++.++||||||+++|+|++|+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 2226889999999996543 3334456789999999998764 58999999999999999999999996443210
Q ss_pred HHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
......+.. . ..++.+.+++..||+.+|.+|++..+.|.
T Consensus 293 ----~~~~~~~~~--~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 293 ----CKPEGLFRR--L-PHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp ----EEECSCCTT--C-SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred ----eeechhccc--c-CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 000001111 1 23678999999999999999975544443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=324.02 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=204.2
Q ss_pred ccccceeeeeeeeccCceEEEEEE----EccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVT----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
...++|++.+.||+|+||.||+|. +..+++.||||++... .....+.+.+|+.+++++. |+||+++++++..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYS 113 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEe
Confidence 446889999999999999999998 4567999999998653 3445678999999999998 9999999998865
Q ss_pred C--CceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 140 R--HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 140 ~--~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
. ...++||||+++++|.+++... ..+++..++.++.||+.||.+||++||+||||||+||+++ .++.+||+|||
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~Dfg 190 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFG 190 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCT
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEecCc
Confidence 4 3789999999999999999875 4599999999999999999999999999999999999994 45679999999
Q ss_pred CcccccCCCc----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----------------
Q 018786 217 LSVFFKPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQ---------------- 275 (350)
Q Consensus 217 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~---------------- 275 (350)
++........ .....++..|+|||++. ..++.++||||||+++|+|++|..||......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 9987654432 12345677899999876 45889999999999999999999988643111
Q ss_pred HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
.....+.... ..+ ....++.++.++|.+||+.||++|||+.++++.
T Consensus 271 ~~~~~~~~~~-~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~ 316 (326)
T 2w1i_A 271 HLIELLKNNG-RLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316 (326)
T ss_dssp HHHHHHHTTC-CCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcCC-CCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1112222221 111 123689999999999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=358.34 Aligned_cols=261 Identities=24% Similarity=0.402 Sum_probs=212.1
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc------
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED------ 139 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~------ 139 (350)
.++|.+.+.||+|+||.||+|.+..+|+.||||++... ......+.+.+|+.+++++. ||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccC
Confidence 37899999999999999999999999999999998643 24455678999999999998 9999999998755
Q ss_pred CCceEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
.+..++||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 677899999999999999998644 58999999999999999999999999999999999999766555669999999
Q ss_pred CcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------------
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI-------------- 281 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~-------------- 281 (350)
.+.............||+.|+|||++. ..++.++||||||+++|+|++|..||........+...
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 999877666666778999999999876 56899999999999999999999999765433221000
Q ss_pred HcCCCCC------CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 282 LRGHIDF------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 282 ~~~~~~~------~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
..+...+ +....+.++..+.++|.+||+.||++|||+.++|+|+||..
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0011111 11112235688999999999999999999999999999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=323.56 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=195.0
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc-CCCCeeEeEeEEEcC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT-GHRNIVELKGAYEDR 140 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~iv~~~~~~~~~ 140 (350)
...+.++|++.+.||+|+||.||+|++. ++.||||++.... .....+|.+++..+. .|+||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3456789999999999999999999886 7899999985332 244555666665541 499999999998877
Q ss_pred ----CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCEeecCCCCceEeecCCCCC
Q 018786 141 ----HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM--------GVMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 141 ----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~ivH~Dlkp~NIl~~~~~~~~ 208 (350)
...++||||+++++|.++++.. .+++..++.++.|++.||.|||++ ||+||||||+|||+ +.++
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~ 179 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNG 179 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTS
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCC
Confidence 7899999999999999998654 699999999999999999999999 99999999999999 5677
Q ss_pred CeEEeecCCcccccCCCc-----cccCCcCcccccccccccc-CCc------chhHHHHHHHHHHHHhC----------C
Q 018786 209 PLKATDFGLSVFFKPGDV-----FKDLVGSAYYVAPEVLRRN-YGA------EADIWSAGVILYILLSG----------V 266 (350)
Q Consensus 209 ~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~------~~Dv~slG~vl~~ll~g----------~ 266 (350)
.+||+|||++........ .....||+.|+|||++.+. ... ++||||||+++|+|++| .
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 899999999976543322 1245799999999988643 333 38999999999999999 7
Q ss_pred CCCCCCC----HHHHHHHHH-cCCCCCCCCC---CCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 267 PPFWGET----EQSIFDAIL-RGHIDFSSDP---WPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 267 ~pf~~~~----~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.||.... ......... .......... ...++.++.++|.+||+.||++|||+.++++++
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 7775432 112222222 2111111110 113457799999999999999999999999876
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=321.56 Aligned_cols=231 Identities=14% Similarity=0.099 Sum_probs=191.0
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+..+.++. |+||+++++++...+..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEECCcE
Confidence 56688999999999999999999999999999999998765555566788999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||++|++|.+++... .....+..++.||+.||.|||++||+||||||+|||+ +.++.+||++++.
T Consensus 107 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~~------ 175 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPAT------ 175 (286)
T ss_dssp EEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCCC------
T ss_pred EEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEeccc------
Confidence 9999999999999988542 4666789999999999999999999999999999999 5566799985543
Q ss_pred CCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHcCCCCCCCCCCCCCCHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFD---AILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l 300 (350)
++ .++.++||||||+++|+|++|+.||.+........ .........+....+.++.++
T Consensus 176 -------------~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 176 -------------MP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp -------------CT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred -------------cC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 23 25789999999999999999999998765422110 011111111111234689999
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccC
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
.++|.+||+.||++| |+.|+++.+.
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~L~ 261 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNLMQ 261 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHHHHH
Confidence 999999999999999 9999998653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=323.56 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=202.0
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHH--ccCCCCeeEeEeEEEcC
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH--LTGHRNIVELKGAYEDR 140 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~--l~~h~~iv~~~~~~~~~ 140 (350)
..+.++|.+.+.||+|+||.||+|.+ +++.||||++... ....+.+|++++.. +. |+||+++++++...
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLR-HENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCC-CTTBCCEEEEEECC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcC-CCcEEEEEeeeccc
Confidence 45668999999999999999999998 4789999998532 34667889999888 55 99999999998877
Q ss_pred C----ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCEeecCCCCceEeecCCCCC
Q 018786 141 H----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH--------SMGVMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 141 ~----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~ivH~Dlkp~NIl~~~~~~~~ 208 (350)
. ..++||||+++++|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+||++ +.++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~ 184 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNG 184 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTS
T ss_pred CCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCC
Confidence 5 79999999999999999875 46899999999999999999999 8999999999999999 5667
Q ss_pred CeEEeecCCcccccCCC-----ccccCCcCcccccccccccc-------CCcchhHHHHHHHHHHHHhC----------C
Q 018786 209 PLKATDFGLSVFFKPGD-----VFKDLVGSAYYVAPEVLRRN-------YGAEADIWSAGVILYILLSG----------V 266 (350)
Q Consensus 209 ~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~Dv~slG~vl~~ll~g----------~ 266 (350)
.+||+|||++....... ......||+.|+|||++.+. ++.++||||||+++|+|++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 89999999998765443 22445799999999987643 33689999999999999999 7
Q ss_pred CCCCCCC-----HHHHHHHHHcCCCCCCCC-CC--CCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 267 PPFWGET-----EQSIFDAILRGHIDFSSD-PW--PNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 267 ~pf~~~~-----~~~~~~~~~~~~~~~~~~-~~--~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.||.... .......+.......... .+ ..++..+.++|.+||+.||++|||+.++++++
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 8886542 233333333322221111 00 12346789999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=344.09 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=211.1
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccC---CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
.+...++|.+.+.||+|+||.||+|.+..+ +..+|+|.+... ......+.+.+|+.+++++. ||||+++++++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence 344568899999999999999999998643 567999988643 23445678999999999998 999999999985
Q ss_pred cCCceEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
.+..++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG~ 537 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGL 537 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecCC
Confidence 456899999999999999998654 689999999999999999999999999999999999995 456799999999
Q ss_pred cccccCCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 218 SVFFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 218 a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
+........ .....+++.|+|||++. ..++.++||||||+++|||++ |..||.+....+....+..+..... .
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---~ 614 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---P 614 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC---C
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence 987654332 22345678899999876 458999999999999999997 9999999888888777776543222 2
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+.++..+.++|.+||+.||++|||+.++++.+
T Consensus 615 ~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L 646 (656)
T 2j0j_A 615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646 (656)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 36799999999999999999999999998653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=323.92 Aligned_cols=246 Identities=22% Similarity=0.316 Sum_probs=185.9
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHH--HHccCCCCeeEeEeEEE----
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM--HHLTGHRNIVELKGAYE---- 138 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l--~~l~~h~~iv~~~~~~~---- 138 (350)
..++|++.+.||+|+||.||+|++ +++.||||++.... ...+..|.+++ ..+. |+||+++++.+.
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLME-HDNIARFIVGDERVTA 81 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECT
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhcc-Ccchhhheeccccccc
Confidence 348899999999999999999976 57899999986432 23444444443 3466 999999997553
Q ss_pred -cCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCEeecCCCCceEeecCCCCC
Q 018786 139 -DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM---------GVMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 139 -~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~---------~ivH~Dlkp~NIl~~~~~~~~ 208 (350)
....+++||||+++++|.+++... ..++..++.++.||+.||.|||++ ||+||||||+|||+ +.++
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~ 157 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDG 157 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTS
T ss_pred CCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCC
Confidence 233578999999999999998765 458999999999999999999999 99999999999999 5667
Q ss_pred CeEEeecCCcccccCCC---------ccccCCcCccccccccccc--------cCCcchhHHHHHHHHHHHHhCCCCCCC
Q 018786 209 PLKATDFGLSVFFKPGD---------VFKDLVGSAYYVAPEVLRR--------NYGAEADIWSAGVILYILLSGVPPFWG 271 (350)
Q Consensus 209 ~vkl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~Dv~slG~vl~~ll~g~~pf~~ 271 (350)
.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 89999999998764321 1234579999999998764 356789999999999999999777643
Q ss_pred CCH-----------------HHHHHHHH-cCC--CCCCCC--CCCCCCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 272 ETE-----------------QSIFDAIL-RGH--IDFSSD--PWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 272 ~~~-----------------~~~~~~~~-~~~--~~~~~~--~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
... ........ ... ..++.. ....++.++.++|.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 211 11111111 111 111111 01113457999999999999999999999964
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=334.22 Aligned_cols=250 Identities=16% Similarity=0.179 Sum_probs=194.0
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCC-CCe---------e---
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNI---------V--- 131 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~i---------v--- 131 (350)
....|++.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+. | .+. +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCCC
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccch
Confidence 3456899999999999999999999999999999997554444445678999999999887 4 221 1
Q ss_pred ---------EeEeEEEc-----CCceEEEEecCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHcCCE
Q 018786 132 ---------ELKGAYED-----RHSVNLIMDLCAGGELFDRIIA-------KGHYSERAAANLCRQMVTVVHYCHSMGVM 190 (350)
Q Consensus 132 ---------~~~~~~~~-----~~~~~iv~e~~~~~sL~~~l~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~iv 190 (350)
.+...+.. ...++++|+++ +++|.+++.. .+.+++..+..++.||+.||.|||++||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 11111111 23467788876 6799988852 23377888999999999999999999999
Q ss_pred eecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccCCcCccccccccc----------cc-cCCcchhHHHHHHHH
Q 018786 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL----------RR-NYGAEADIWSAGVIL 259 (350)
Q Consensus 191 H~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~~Dv~slG~vl 259 (350)
||||||+|||+ +.++.+||+|||++...... ....+| +.|+|||++ .. .++.++||||||+++
T Consensus 234 HrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999 66677999999998875433 455677 999999987 32 377899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 260 YILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 260 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
|+|++|+.||...........+.. .+..++.++.+||.+||+.||++||++.++|+|+||...
T Consensus 308 ~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 999999999987654333222211 223678999999999999999999999999999998654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=348.40 Aligned_cols=245 Identities=23% Similarity=0.354 Sum_probs=201.6
Q ss_pred cccccccceeeeeeeeccCceEEEEEEEcc-CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKD-TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
..+.+.++|++.+.||+|+||+||+|.+.. +++.||||++.... .....+.+.+|+.++.++. ||||+++++++..
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEH 150 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEee
Confidence 345667999999999999999999999976 68999999986432 3445677899999999998 9999999999987
Q ss_pred CCc-----eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEee
Q 018786 140 RHS-----VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 140 ~~~-----~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
.+. .++||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~----~~~kl~D 224 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE----EQLKLID 224 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS----SCEEECC
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC----CcEEEEe
Confidence 665 7999999999999887654 7999999999999999999999999999999999999953 2699999
Q ss_pred cCCcccccCCCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 215 FGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 215 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
||++...... ....||+.|+|||++.+..+.++||||||+++|+|++|..||.+.... . .. ......
T Consensus 225 FG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~-~~-~~~~~~ 291 (681)
T 2pzi_A 225 LGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD--------G-LP-EDDPVL 291 (681)
T ss_dssp CTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS--------S-CC-TTCHHH
T ss_pred cccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc--------c-cc-cccccc
Confidence 9999876543 456799999999998877789999999999999999999888643210 0 00 000011
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
..+..+.++|.+||+.||++||+..+.+.+.|.
T Consensus 292 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 292 KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp HHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 236789999999999999999998888877664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=323.87 Aligned_cols=251 Identities=16% Similarity=0.211 Sum_probs=196.9
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEeccccc-----CChhhHHHHHHHHHHHHHcc--------CCCCeeE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL-----INRDDVEDVRREVQIMHHLT--------GHRNIVE 132 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~--------~h~~iv~ 132 (350)
.++|.+.+.||+|+||+||+|++ +|+.||||++..... ......+.+.+|+.+++.+. .|+||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 47899999999999999999998 579999999976532 13344578999999999886 5888888
Q ss_pred eEeEEE------------------------------cCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 018786 133 LKGAYE------------------------------DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182 (350)
Q Consensus 133 ~~~~~~------------------------------~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~ 182 (350)
+.+.+. ..+.+++||||++++++.+.+.. +.+++..++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 877642 26789999999999877666643 56899999999999999999
Q ss_pred HHH-HcCCEeecCCCCceEeecCCC-----------------CCCeEEeecCCcccccCCCccccCCcCccccccccccc
Q 018786 183 YCH-SMGVMHRDLKPENFLFSSSAE-----------------DSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244 (350)
Q Consensus 183 ~lH-~~~ivH~Dlkp~NIl~~~~~~-----------------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 244 (350)
||| ++||+||||||+|||++.++. ...+||+|||+|+..... ..+||+.|+|||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 999999999999999975431 127999999999876543 3479999999999987
Q ss_pred cCCcchhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHcC-CCC--CCCCCCCCCCHHHHHHHHHhcccCccCCCCHH
Q 018786 245 NYGAEADIWSAGVI-LYILLSGVPPFWGETE-QSIFDAILRG-HID--FSSDPWPNISSSAKDIVKKMLHADPKERLSAA 319 (350)
Q Consensus 245 ~~~~~~Dv~slG~v-l~~ll~g~~pf~~~~~-~~~~~~~~~~-~~~--~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~ 319 (350)
..+.++|||||+++ .+++++|..||..... ......+... ... .....++.+++++.+||.+||+.| |+.
T Consensus 252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 67899999998777 7778889999843221 1122233321 111 111112346789999999999876 999
Q ss_pred HHH-hccCCC
Q 018786 320 EVL-SKFLIP 328 (350)
Q Consensus 320 ~iL-~~~~~~ 328 (350)
|+| +|+||+
T Consensus 327 e~l~~Hp~f~ 336 (336)
T 2vuw_A 327 DLLCQHSLFK 336 (336)
T ss_dssp HHHHHCGGGC
T ss_pred HHHhcCCCcC
Confidence 999 999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=283.34 Aligned_cols=189 Identities=16% Similarity=0.119 Sum_probs=138.4
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCC-------hhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-------RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
....+.|+.|.+..++....|+.+++|++.+..... ....+++.+|+++|+++..|+||+++++++++++..|
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 345678888888888888889999999997653221 2335679999999999987999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
|||||++|++|.+++...+++++. +|+.||+.||+|+|++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC--
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCC
Confidence 999999999999999998888875 578999999999999999999999999999 66778999999999876433
Q ss_pred -CccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCC
Q 018786 225 -DVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGV 266 (350)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~ 266 (350)
....+.+||+.|+|||++.+....++|+||+|++++++.++.
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC-----------------CCCCTTH
T ss_pred CccccCceechhhccHHHhCCCCCCcccccccccchhhhcccc
Confidence 334557899999999999988888999999999988766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-29 Score=239.29 Aligned_cols=184 Identities=18% Similarity=0.172 Sum_probs=142.3
Q ss_pred eeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChh-----hHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-----DVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-----~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
...+.||+|+||.||+|. ..++.+++|........... ..+++.+|+++++++. |+||+++..++...+..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccE
Confidence 445789999999999994 34678999987553332221 2456899999999998 999996555555777789
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
+||||++|++|.+++.. +..++.||+.||.|||++||+||||||+|||++ . .+||+|||+++.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCCc
Confidence 99999999999998765 668999999999999999999999999999995 3 7999999999987543
Q ss_pred Cc--------cccCCcCccccccccccc---cCCcchhHHHHHHHHHHHHhCCCCC
Q 018786 225 DV--------FKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPF 269 (350)
Q Consensus 225 ~~--------~~~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~g~~pf 269 (350)
.. .....||+.|+|||++.. .|+...|+|+..+-..+-+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 22 135679999999999864 4788889999988888877766665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-26 Score=202.03 Aligned_cols=148 Identities=18% Similarity=0.208 Sum_probs=115.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh---------------hhHHHHHHHHHHHHHccCCCCee
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---------------DDVEDVRREVQIMHHLTGHRNIV 131 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~~h~~iv 131 (350)
..|.+++.||+|+||.||+|.+ .+|+.||||+++....... .....+.+|+.+++++. |.
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~--- 164 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GL--- 164 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TS---
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CC---
Confidence 3455669999999999999999 7799999999964321111 13467899999999998 54
Q ss_pred EeEeEEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeE
Q 018786 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211 (350)
Q Consensus 132 ~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vk 211 (350)
++.+++.. +..++||||++|++|.+ + .......++.||+.||.+||++||+||||||+|||++ ++.+|
T Consensus 165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~vk 232 (282)
T 1zar_A 165 AVPKVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIW 232 (282)
T ss_dssp SSCCEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEE
T ss_pred CcCeEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcEE
Confidence 44444433 55699999999999987 3 1234557999999999999999999999999999995 66799
Q ss_pred EeecCCcccccCCCccccCCcCcccccccccc
Q 018786 212 ATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR 243 (350)
Q Consensus 212 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 243 (350)
|+|||+|.. +..++|||.+.
T Consensus 233 l~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 233 IIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp ECCCTTCEE------------TTSTTHHHHHH
T ss_pred EEECCCCeE------------CCCCCHHHHHH
Confidence 999999875 34578888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=175.77 Aligned_cols=143 Identities=13% Similarity=0.108 Sum_probs=109.3
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcE--EEEEEecccccCCh---------------------hhHHHHHHHHHHHHH
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQ--FACKSISSRKLINR---------------------DDVEDVRREVQIMHH 123 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~~~---------------------~~~~~~~~e~~~l~~ 123 (350)
..|.+.+.||+|+||.||+|.+..+|+. ||||+++....... .....+.+|+.++.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3478999999999999999999777889 99999754321100 112368899999999
Q ss_pred ccCCCCe--eEeEeEEEcCCceEEEEecCCC-C----CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HcCCEeecCC
Q 018786 124 LTGHRNI--VELKGAYEDRHSVNLIMDLCAG-G----ELFDRIIAKGHYSERAAANLCRQMVTVVHYCH-SMGVMHRDLK 195 (350)
Q Consensus 124 l~~h~~i--v~~~~~~~~~~~~~iv~e~~~~-~----sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~ivH~Dlk 195 (350)
+. |+++ +.++++ +..++||||+.+ + +|.+.... .++..+..++.||+.+|.+|| ++||+|||||
T Consensus 127 l~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 127 AK-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HH-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HH-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 98 7754 344432 357899999932 3 66665332 235567899999999999999 9999999999
Q ss_pred CCceEeecCCCCCCeEEeecCCccccc
Q 018786 196 PENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 196 p~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
|+|||++ . .++|+|||+|....
T Consensus 199 p~NILl~---~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 199 EYNIMYI---D--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TTSEEES---S--SEEECCCTTCEETT
T ss_pred HHHEEEc---C--cEEEEECcccccCC
Confidence 9999994 3 79999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.2e-19 Score=163.40 Aligned_cols=145 Identities=16% Similarity=0.179 Sum_probs=104.4
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCC-----------hhh--------HHHHHHHHHHHHHccCC
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-----------RDD--------VEDVRREVQIMHHLTGH 127 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----------~~~--------~~~~~~e~~~l~~l~~h 127 (350)
.-|.+++.||.|++|.||+|.+. +|+.||||+++...... ... .-...+|...|.++. +
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~ 172 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-E 172 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-H
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-h
Confidence 34899999999999999999986 48999999986432110 000 011346778888886 5
Q ss_pred CCee--EeEeEEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC
Q 018786 128 RNIV--ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205 (350)
Q Consensus 128 ~~iv--~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 205 (350)
.++. ..+++ . ..++||||++|.+|.++. .......++.||+.+|.+||++|||||||||.|||++.++
T Consensus 173 ~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 173 EGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp TTCSCCCEEEE--E--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred cCCCCCeeeec--c--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence 5543 23322 2 247999999998886532 2234567889999999999999999999999999997543
Q ss_pred CC-------CCeEEeecCCcccccC
Q 018786 206 ED-------SPLKATDFGLSVFFKP 223 (350)
Q Consensus 206 ~~-------~~vkl~Dfg~a~~~~~ 223 (350)
+. ..+.|+||+.+....+
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETTS
T ss_pred CcccccccccceEEEEeCCcccCCC
Confidence 21 1389999998876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=5.8e-14 Score=122.46 Aligned_cols=141 Identities=18% Similarity=0.174 Sum_probs=111.8
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
..|.+...++.|+.+.||++... ++.+++|+...... .....+.+|+.+++.+..+..++++++++...+..++|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 56889999999999999999754 57899999864321 11235889999999997677788999999888999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS---------------------------------------- 186 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~---------------------------------------- 186 (350)
||+++|.+|.+.+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999876521 223345788999999999998
Q ss_pred -------------------cCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 187 -------------------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 187 -------------------~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..++|+|++|.||+++ ++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence 4589999999999994 334467999997754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.4e-12 Score=113.23 Aligned_cols=136 Identities=13% Similarity=0.127 Sum_probs=97.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCC-eeEeEeEEEcCCceEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN-IVELKGAYEDRHSVNL 145 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-iv~~~~~~~~~~~~~i 145 (350)
..|.+....+.|..+.||++.. .+|..+++|+.... ....+.+|+.+++.+..+.- +++++.+....+..++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 4566555445666799999965 44677999997543 12457889999999974422 5668888888888999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC-------------------------------------
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG------------------------------------- 188 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~------------------------------------- 188 (350)
|||+++|.+|. . ...+ ...++.+++..|..||+..
T Consensus 93 v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 93 LLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99999998883 1 1112 2356677777777777643
Q ss_pred ---------------------CEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 189 ---------------------VMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 189 ---------------------ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
++|+|++|.||+++ ++..+.|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence 99999999999994 334467999998765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=2.9e-11 Score=110.24 Aligned_cols=143 Identities=21% Similarity=0.352 Sum_probs=104.2
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEEEEec--ccccCChhhHHHHHHHHHHHHHccC-CCCeeEeEeEEEcC---CceE
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSIS--SRKLINRDDVEDVRREVQIMHHLTG-HRNIVELKGAYEDR---HSVN 144 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~--~~~~~~~~~~~~~~~e~~~l~~l~~-h~~iv~~~~~~~~~---~~~~ 144 (350)
..+.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+++.+.. +..+++++.++.+. +..+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4678899999999998765 3578899875 3221 1123468889999999973 23477888887766 4589
Q ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 018786 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-------------------------------------- 186 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~-------------------------------------- 186 (350)
+|||+++|..+.+. ....++......++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999877431 12346788888999999999999997
Q ss_pred --------------------cCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 187 --------------------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 187 --------------------~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..++|+|+++.||+++.++. ..+.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECcccccc
Confidence 35899999999999953221 2368999998865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.22 E-value=1.8e-11 Score=109.08 Aligned_cols=185 Identities=17% Similarity=0.229 Sum_probs=122.4
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCC--eeEeEeEEEcCC---ceEEE
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN--IVELKGAYEDRH---SVNLI 146 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~--iv~~~~~~~~~~---~~~iv 146 (350)
.+.++.|..+.||++. ..+++|+.... .....+.+|..+++.+..+.. +++++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3568999999999863 45899986422 345679999999999853443 344554433333 35789
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS---------------------------------------- 186 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~---------------------------------------- 186 (350)
|++++|.++.+... ..++......++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988865433 346778888888899888888886
Q ss_pred ------------------cCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccCCcCcccccccccc---cc
Q 018786 187 ------------------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR---RN 245 (350)
Q Consensus 187 ------------------~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~ 245 (350)
..++|+|+++.||+++.+ .+..+.|+||+.+.................-..|+... ..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 136999999999999632 14457899999987633221111100000002222211 11
Q ss_pred C------------CcchhHHHHHHHHHHHHhCCCCC
Q 018786 246 Y------------GAEADIWSAGVILYILLSGVPPF 269 (350)
Q Consensus 246 ~------------~~~~Dv~slG~vl~~ll~g~~pf 269 (350)
| ....++|+++.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 12268999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=2.3e-08 Score=88.99 Aligned_cols=138 Identities=20% Similarity=0.281 Sum_probs=95.5
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCC--CeeEeEeEEE-cCCceEEEEe
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR--NIVELKGAYE-DRHSVNLIMD 148 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~--~iv~~~~~~~-~~~~~~iv~e 148 (350)
.+.++.|....||+. +..+++|+.. .......+.+|..+++.+..+- .+++++.+.. ..+..++||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 356888998999988 4568999853 2234567999999999997432 3566666664 4566789999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------
Q 018786 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM----------------------------------------- 187 (350)
Q Consensus 149 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~----------------------------------------- 187 (350)
+++|.++.+... ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988865321 2244555555555555555555532
Q ss_pred -------------------CCEeecCCCCceEeecCCCCCCe-EEeecCCcccc
Q 018786 188 -------------------GVMHRDLKPENFLFSSSAEDSPL-KATDFGLSVFF 221 (350)
Q Consensus 188 -------------------~ivH~Dlkp~NIl~~~~~~~~~v-kl~Dfg~a~~~ 221 (350)
.++|+|+++.||+++.++.++.+ .|+||+.+..-
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 35999999999999642224444 89999988663
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=1.6e-08 Score=88.21 Aligned_cols=134 Identities=19% Similarity=0.216 Sum_probs=98.5
Q ss_pred eeeccCc-eEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecCCC
Q 018786 74 ELGRGQF-GVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 74 ~lg~G~~-g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 152 (350)
.+..|.. +.||+......+..+++|+... .....+.+|...|+.+..+-.+++++.++.+.+..++|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 4444544 4799988887788899998643 23467889999999987655578899998889999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 018786 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS---------------------------------------------- 186 (350)
Q Consensus 153 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~---------------------------------------------- 186 (350)
.++.+..... ......++.++...|..||+
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8887755432 12233455666666666663
Q ss_pred ------------cCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 187 ------------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 187 ------------~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..++|+|+++.|||++ +++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECccccc
Confidence 0278999999999994 344567999998765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=2.5e-07 Score=85.30 Aligned_cols=80 Identities=11% Similarity=0.147 Sum_probs=51.3
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEeccccc-CC---hhhHHHHHHHHHHHHHccCC-C-CeeEeEeEEEcCCceEE
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL-IN---RDDVEDVRREVQIMHHLTGH-R-NIVELKGAYEDRHSVNL 145 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~---~~~~~~~~~e~~~l~~l~~h-~-~iv~~~~~~~~~~~~~i 145 (350)
.+.||.|..+.||++....+++.++||....... .. ....+++..|.++++.+... + .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5689999999999998766678899998653211 00 11235677899999888633 3 34456544 3445689
Q ss_pred EEecCCCC
Q 018786 146 IMDLCAGG 153 (350)
Q Consensus 146 v~e~~~~~ 153 (350)
|||+++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1.4e-07 Score=85.71 Aligned_cols=86 Identities=8% Similarity=0.088 Sum_probs=56.4
Q ss_pred eeeeee-eccCceEEEEEEEc--c----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCC--CCeeEeEeEEEcC
Q 018786 70 IFGREL-GRGQFGVTYLVTHK--D----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH--RNIVELKGAYEDR 140 (350)
Q Consensus 70 ~~~~~l-g~G~~g~V~~~~~~--~----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h--~~iv~~~~~~~~~ 140 (350)
...+.| +.|..+.+|+.... . +++.+++|+..............+.+|+.+++.+..+ -.+++++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 88888999988754 1 1567999987543200000013467888888888644 3467788776655
Q ss_pred ---CceEEEEecCCCCCH
Q 018786 141 ---HSVNLIMDLCAGGEL 155 (350)
Q Consensus 141 ---~~~~iv~e~~~~~sL 155 (350)
+..++|||+++|.++
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 357899999988654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.30 E-value=7.5e-06 Score=75.94 Aligned_cols=77 Identities=13% Similarity=0.097 Sum_probs=46.1
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEeccccc-CCh-----hhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL-INR-----DDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~-----~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.+.||.|..+.||++.. +++.++||....... ... .....+..|+..+..-.....+++++.+. .+..++
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 46789999999999964 467899994332111 011 12233444444333222134566777664 566789
Q ss_pred EEecC-CC
Q 018786 146 IMDLC-AG 152 (350)
Q Consensus 146 v~e~~-~~ 152 (350)
|||++ +|
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 77
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.25 E-value=1.7e-05 Score=71.05 Aligned_cols=75 Identities=11% Similarity=0.068 Sum_probs=42.8
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCC-CCeeEeEe------EEEcCCceE
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVELKG------AYEDRHSVN 144 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~iv~~~~------~~~~~~~~~ 144 (350)
.+.|+.|..+.||++.... ..+++|+.... ...+..|+.+++.|..+ -.+++++. +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~--~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDS--GAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEETT--EEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEeCC--CCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 3456667789999987643 35899998641 13344556666555411 12344432 123466789
Q ss_pred EEEecCCCCCH
Q 018786 145 LIMDLCAGGEL 155 (350)
Q Consensus 145 iv~e~~~~~sL 155 (350)
++|+|++|.++
T Consensus 108 ~l~~~i~G~~~ 118 (346)
T 2q83_A 108 VVYDWIEGRPF 118 (346)
T ss_dssp EEEECCCCBCC
T ss_pred EEEEeecCccC
Confidence 99999998643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.15 E-value=1.6e-05 Score=70.49 Aligned_cols=77 Identities=14% Similarity=0.111 Sum_probs=60.3
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCC--CCeeEeEeEEEcCCceEEEEe
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH--RNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h--~~iv~~~~~~~~~~~~~iv~e 148 (350)
-.+.|+.|..+.+|+... ++..+++|+.... ....+..|...|+.|... ..+++++.+....+..++|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 346789999999999875 3567899987532 246788999999888633 567888888888888999999
Q ss_pred cCCCCCH
Q 018786 149 LCAGGEL 155 (350)
Q Consensus 149 ~~~~~sL 155 (350)
+++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9988653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.03 E-value=7.7e-05 Score=61.59 Aligned_cols=135 Identities=16% Similarity=0.091 Sum_probs=88.6
Q ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCccccC
Q 018786 153 GELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230 (350)
Q Consensus 153 ~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 230 (350)
.+|.++|.. ..+++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++ ..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------
Confidence 489999986 4679999999999999999877622 222233445688888 4555575543 1110
Q ss_pred CcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 018786 231 VGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (350)
Q Consensus 231 ~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 310 (350)
.....+.+||......+.+.=|||||+++|.-+-=..| ...-..+++.|..||..|...
T Consensus 98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence 11234668887655567788999999999997742121 111136899999999999765
Q ss_pred -------------------------CccCCCCHHHHHh
Q 018786 311 -------------------------DPKERLSAAEVLS 323 (350)
Q Consensus 311 -------------------------dp~~Rps~~~iL~ 323 (350)
.+..|.+..+||+
T Consensus 157 ~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 157 VEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp CC--------------------CCSCCCCCCSHHHHHH
T ss_pred ccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 2468899999996
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.87 E-value=9.9e-05 Score=65.03 Aligned_cols=72 Identities=7% Similarity=-0.045 Sum_probs=46.1
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecC-
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC- 150 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~- 150 (350)
.+.|+.|..+.+|++ ..+++|+....... .....+|+.+++.+..+.-.++++.. +.+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 688999999999998 34899988542110 01134688888777633322566654 333456899999
Q ss_pred CCCCH
Q 018786 151 AGGEL 155 (350)
Q Consensus 151 ~~~sL 155 (350)
+|.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 76554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=4e-05 Score=69.85 Aligned_cols=141 Identities=13% Similarity=0.138 Sum_probs=84.3
Q ss_pred eeeeeccCceEEEEEEEcc-------CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 72 GRELGRGQFGVTYLVTHKD-------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
.+.|..|-...+|++.... +++.+++|+.-.. ........+|..+++.+..+.-.+++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 4678888889999988742 3578999986321 12245566899999888754444677766543 2
Q ss_pred EEEecCCCCCHH--------------HHH---HHc-----CCCC--HHHHHHHHHHHHH-------------------HH
Q 018786 145 LIMDLCAGGELF--------------DRI---IAK-----GHYS--ERAAANLCRQMVT-------------------VV 181 (350)
Q Consensus 145 iv~e~~~~~sL~--------------~~l---~~~-----~~~~--~~~~~~i~~~i~~-------------------~l 181 (350)
+||||++|.+|. +.+ +.. +... +..+..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 899999875542 111 111 1112 3455556554422 23
Q ss_pred HHHHH--------cCCEeecCCCCceEeecC-CCCCCeEEeecCCccc
Q 018786 182 HYCHS--------MGVMHRDLKPENFLFSSS-AEDSPLKATDFGLSVF 220 (350)
Q Consensus 182 ~~lH~--------~~ivH~Dlkp~NIl~~~~-~~~~~vkl~Dfg~a~~ 220 (350)
..|.+ ..++|+|+.+.||+++.+ +..+.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33332 249999999999999753 1235799999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.82 E-value=4.6e-05 Score=70.78 Aligned_cols=75 Identities=9% Similarity=0.088 Sum_probs=51.3
Q ss_pred eeeeeeccCceEEEEEEEcc-------CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 71 FGRELGRGQFGVTYLVTHKD-------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
-.+.|+.|....||++.... .++.+++|+.... ...+.+.+|..+++.+..+.-.+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678889899999998653 2578999998421 1114456799999888744334667766543
Q ss_pred EEEEecCCCCC
Q 018786 144 NLIMDLCAGGE 154 (350)
Q Consensus 144 ~iv~e~~~~~s 154 (350)
.+|+||++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38999997643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.73 E-value=8e-05 Score=66.60 Aligned_cols=140 Identities=14% Similarity=0.096 Sum_probs=71.7
Q ss_pred eeeeccCceE-EEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCC-CeeEeEeEEEcCCceEEEEecC
Q 018786 73 RELGRGQFGV-TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-NIVELKGAYEDRHSVNLIMDLC 150 (350)
Q Consensus 73 ~~lg~G~~g~-V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~~~~~~~~~iv~e~~ 150 (350)
+.|+.|+... +|+.... +++.+++|....... +.+..|+.+++.+..+. .+++++.+....+ +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEECT-TCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 4565555544 6676542 256678876533210 23456777777775332 2456666533333 6899999
Q ss_pred CCCCHHHHHHHc--------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHH
Q 018786 151 AGGELFDRIIAK--------------------------GHYSERAAA-------N-L------------CRQMVTVVHYC 184 (350)
Q Consensus 151 ~~~sL~~~l~~~--------------------------~~~~~~~~~-------~-i------------~~~i~~~l~~l 184 (350)
.+.++.+.+... ..++..... . + ...+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 776665443211 012221111 0 0 01111222333
Q ss_pred H------HcCCEeecCCCCceEeecCCC-CCCeEEeecCCcccc
Q 018786 185 H------SMGVMHRDLKPENFLFSSSAE-DSPLKATDFGLSVFF 221 (350)
Q Consensus 185 H------~~~ivH~Dlkp~NIl~~~~~~-~~~vkl~Dfg~a~~~ 221 (350)
. ...++|+|+.+.|||++.+.. .+.+.|+||+.+..-
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1 246999999999999953211 256899999988763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00034 Score=61.10 Aligned_cols=81 Identities=15% Similarity=0.044 Sum_probs=56.1
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCC--CeeEeEeEEEcCCce
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR--NIVELKGAYEDRHSV 143 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~--~iv~~~~~~~~~~~~ 143 (350)
+....-++.+|.|..+.||+.... +|+.|++|+..... ......+..|+..|+.|.... .+++++.+ + ..
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DR 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TT
T ss_pred CCCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--Cc
Confidence 345566788999999999999875 47889999865332 122245788999999886332 34455554 2 24
Q ss_pred EEEEecCCCCC
Q 018786 144 NLIMDLCAGGE 154 (350)
Q Consensus 144 ~iv~e~~~~~s 154 (350)
++|||++++..
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 68999987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=6.5e-05 Score=66.80 Aligned_cols=140 Identities=16% Similarity=0.154 Sum_probs=77.6
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCC-CeeEeEeE------EEcCCce
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-NIVELKGA------YEDRHSV 143 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~------~~~~~~~ 143 (350)
-.+.|+.|....+|++.... | .+++|+..... . .+.+..|+.+++.+..+. .+++++.. ....+..
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEECC---EEEEEEEESS-C-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred EeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 34567788889999987643 3 68899986421 1 134567788777775321 12333321 1234567
Q ss_pred EEEEecCCCCCHH-----------H---HHHHc-CCC--------CHHHHHH---------------HHHHHHHHHHHHH
Q 018786 144 NLIMDLCAGGELF-----------D---RIIAK-GHY--------SERAAAN---------------LCRQMVTVVHYCH 185 (350)
Q Consensus 144 ~iv~e~~~~~sL~-----------~---~l~~~-~~~--------~~~~~~~---------------i~~~i~~~l~~lH 185 (350)
++++++++|..+. . .++.. ..+ ....... +...+...++.+.
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999999886431 0 11211 111 1110000 0112344555555
Q ss_pred H-------cCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 186 S-------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 186 ~-------~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
+ .+++|+|+++.||+++ ++..+.|+||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEe---CCceEEEecchhccC
Confidence 3 3699999999999995 333457999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00022 Score=63.51 Aligned_cols=76 Identities=11% Similarity=0.149 Sum_probs=48.0
Q ss_pred eeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCC-CeeEeEeE-----EEcCCceEEE
Q 018786 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-NIVELKGA-----YEDRHSVNLI 146 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~-----~~~~~~~~iv 146 (350)
..++ |....||++... +|+.+++|+...... ..+.+..|..+++.+..+. .+++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 788899987653 356799999853211 2356777888888876321 13444432 2234566889
Q ss_pred EecCCCCC
Q 018786 147 MDLCAGGE 154 (350)
Q Consensus 147 ~e~~~~~s 154 (350)
|++++|.+
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00039 Score=64.93 Aligned_cols=77 Identities=12% Similarity=0.097 Sum_probs=49.7
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecC
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~ 150 (350)
-.+.|+.|-...+|++.....+..+++|+...... ... .-.+|..+++.|..+.-.+++++.+. + ..|+||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EII-NREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCS-CHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEee
Confidence 34678889999999998765457899998743211 111 12579999999984444467777663 2 2599999
Q ss_pred CCCCH
Q 018786 151 AGGEL 155 (350)
Q Consensus 151 ~~~sL 155 (350)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00018 Score=65.34 Aligned_cols=75 Identities=9% Similarity=0.115 Sum_probs=45.3
Q ss_pred eeeeeccCceEEEEEEEcc--------CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 72 GRELGRGQFGVTYLVTHKD--------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.|+.|....+|++.... .++.+++|+...... .......|..+++.+..+.-++++++.. . -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 4677888889999998754 136789998753211 1112357888888886333345666543 2 3
Q ss_pred EEEEecCCCCC
Q 018786 144 NLIMDLCAGGE 154 (350)
Q Consensus 144 ~iv~e~~~~~s 154 (350)
++||+|++|.+
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0019 Score=57.90 Aligned_cols=68 Identities=10% Similarity=0.032 Sum_probs=42.2
Q ss_pred ccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccC--CCCeeEeEeE------EEcCCceEEEEe
Q 018786 77 RGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG--HRNIVELKGA------YEDRHSVNLIMD 148 (350)
Q Consensus 77 ~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--h~~iv~~~~~------~~~~~~~~iv~e 148 (350)
.|....||++.... | .+++|+...... ..|+.+++.|.. -+.+++.+.. ....+..+++|+
T Consensus 33 ~g~~N~vy~v~~~~-g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~ 101 (339)
T 3i1a_A 33 ADTNAFAYQADSES-K-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYP 101 (339)
T ss_dssp SCSSCEEEEEECSS-C-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEE
T ss_pred CccccceEEEEeCC-C-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEe
Confidence 33368999987543 4 799998754321 345566655542 2334444432 234577899999
Q ss_pred cCCCCCH
Q 018786 149 LCAGGEL 155 (350)
Q Consensus 149 ~~~~~sL 155 (350)
|++|..+
T Consensus 102 ~i~G~~~ 108 (339)
T 3i1a_A 102 FIHAPNG 108 (339)
T ss_dssp CCCCCBT
T ss_pred ccCCCcC
Confidence 9988755
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0012 Score=60.61 Aligned_cols=32 Identities=28% Similarity=0.428 Sum_probs=26.4
Q ss_pred CEeecCCCCceEeecC---CCCCCeEEeecCCccc
Q 018786 189 VMHRDLKPENFLFSSS---AEDSPLKATDFGLSVF 220 (350)
Q Consensus 189 ivH~Dlkp~NIl~~~~---~~~~~vkl~Dfg~a~~ 220 (350)
++|+|+.+.||++..+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999642 4567799999998865
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0019 Score=59.63 Aligned_cols=76 Identities=9% Similarity=0.130 Sum_probs=49.7
Q ss_pred eeeeeeccCceEEEEEEEccC-------CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 71 FGRELGRGQFGVTYLVTHKDT-------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
-++.+..|-...+|+...... ++.+++|+..... ...-...+|..+++.+..+.-.+++++.+. -
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 346778888899999987521 5779999874321 111123578888888864444456665432 2
Q ss_pred EEEEecCCCCC
Q 018786 144 NLIMDLCAGGE 154 (350)
Q Consensus 144 ~iv~e~~~~~s 154 (350)
+.|++|++|.+
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 68999998865
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=92.36 E-value=0.95 Score=39.73 Aligned_cols=140 Identities=11% Similarity=0.082 Sum_probs=77.8
Q ss_pred ceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE-----------
Q 018786 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA----------- 136 (350)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~----------- 136 (350)
+...++....|..|.++... ++..++||-.. .-..+.+-.++...-.+. .|...-+...
T Consensus 70 ~v~~I~~s~~Gstgvff~~t---d~~~~VVK~s~------~l~~E~l~s~LA~~LGlp-iP~~Riv~~~~~E~~e~~~~L 139 (342)
T 1cja_A 70 QFKGIERSEKGTEGLFFVET---ESGVFIVKRST------NIESETFCSLLCMRLGLH-APKVRVVSSNSEEGTNMLECL 139 (342)
T ss_dssp GEEEEEECCSTTSCEEEEEE---SSCEEEEECCT------THHHHHHHHHHHHHHTCC-CCCEEEEESSSHHHHHHHHHH
T ss_pred CeeEEEeccCCCCCeEEEEe---CCCEEEEeCcH------HHHHHHHHHHHHHHhCCC-CCCeeEEeeCcHHHHHHHHHH
Confidence 46677777888877665555 36678999441 123344555555555555 5554333211
Q ss_pred --E---------EcCCceEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcC-----CEeecCCCCc
Q 018786 137 --Y---------EDRHSVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMG-----VMHRDLKPEN 198 (350)
Q Consensus 137 --~---------~~~~~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~-----ivH~Dlkp~N 198 (350)
. .......++|+|.+|..|.+.-.. ...+..+....+. -+-+++.+..++ +.+.--+++|
T Consensus 140 ~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG--~Ii~FDi~InN~DR~Pl~W~n~GN~~N 217 (342)
T 1cja_A 140 AAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG--SLMALDVIVNNSDRLPIAWTNEGNLDN 217 (342)
T ss_dssp HHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH--HHHHHHHHHTCCSSSCSSSCSCCCGGG
T ss_pred HHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhc--hhheehhhhcCCccCcccccCCCChhh
Confidence 0 012246699999987766432110 0112333322221 134566666553 2223368999
Q ss_pred eEeecCCCCCCeEEeecCCcccc
Q 018786 199 FLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 199 Il~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
||+..+ ++.+.++|-+.+..-
T Consensus 218 IL~~~~--n~~~~~IDhn~af~~ 238 (342)
T 1cja_A 218 IMLSER--GATVVPIDSKIIPLD 238 (342)
T ss_dssp EEEESB--TTCEEECSCCCCCCC
T ss_pred eEEeCC--CCeEEEEcCCccccC
Confidence 999753 346999999988763
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.10 E-value=0.09 Score=49.01 Aligned_cols=62 Identities=5% Similarity=0.033 Sum_probs=16.4
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEE------EEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFAC------KSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~av------K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
+.+.|| ||.||+|.......+||+ |..+... ...+....+.+|..+++.+. |+|+++.+.+.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~-~~~e~~~~~~rea~l~~~~~-H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG-VSEKRLTSLVRRATLKENEQ-IPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCcccccccc-cccccccccccccccccccc-ccccCCCcceE
Confidence 345565 999999998765567888 6554322 12333456778888888887 99999988765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 350 | ||||
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-88 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-84 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-84 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-83 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-82 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-81 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-81 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-80 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-80 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-79 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-77 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-77 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-77 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-75 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-73 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-73 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-70 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-70 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-69 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-69 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-69 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-68 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-66 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-63 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-63 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-62 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-61 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-61 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-61 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-61 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-60 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-60 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-60 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-60 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-58 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-57 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-57 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-52 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-45 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-23 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 1e-05 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 265 bits (678), Expect = 4e-88
Identities = 111/265 (41%), Positives = 152/265 (57%), Gaps = 4/265 (1%)
Query: 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ 119
K ED+R+ Y F LG G F L K T++ A K I+ + L + E+
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIA 59
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
++H + H NIV L YE + LIM L +GGELFDRI+ KG Y+ER A+ L Q++
Sbjct: 60 VLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
V Y H +G++HRDLKPEN L+ S EDS + +DFGLS PG V G+ YVAP
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 178
Query: 240 EVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
EVL + Y D WS GVI YILL G PPF+ E + +F+ IL+ +F S W +IS
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 299 SAKDIVKKMLHADPKERLSAAEVLS 323
SAKD ++ ++ DP++R + + L
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 255 bits (652), Expect = 2e-84
Identities = 93/268 (34%), Positives = 140/268 (52%), Gaps = 16/268 (5%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN------RDDVEDVRREVQIMH 122
Y LGRG V HK T +++A K I + ++ E +EV I+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
++GH NI++LK YE L+ DL GELFD + K SE+ + R ++ V+
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
H + ++HRDLKPEN L +D +K TDFG S PG+ +++ G+ Y+APE++
Sbjct: 125 ALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181
Query: 243 -------RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295
YG E D+WS GVI+Y LL+G PPFW + + I+ G+ F S W +
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLS 323
S + KD+V + L P++R +A E L+
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 256 bits (654), Expect = 7e-84
Identities = 90/263 (34%), Positives = 135/263 (51%), Gaps = 7/263 (2%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ V + Y ELG G FGV + VT + T FA K + + + D E VR+E+Q M
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMS 78
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVV 181
L H +V L A+ED + + +I + +GGELF+++ + SE A RQ+ +
Sbjct: 79 VLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
+ H +H DLKPEN +F++ + LK DFGL+ P K G+A + APEV
Sbjct: 138 CHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ G D+WS GV+ YILLSG+ PF GE + + + + IS
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256
Query: 301 KDIVKKMLHADPKERLSAAEVLS 323
KD ++K+L ADP R++ + L
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 254 bits (649), Expect = 4e-83
Identities = 87/262 (33%), Positives = 143/262 (54%), Gaps = 7/262 (2%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
V + Y ELG G FGV + K T + F K I++ +++ V+ E+ IM+
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQ 82
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVH 182
L H ++ L A+ED++ + LI++ +GGELFDRI A+ + SE N RQ +
Sbjct: 83 LH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
+ H ++H D+KPEN + + + S +K DFGL+ P ++ K +A + APE++
Sbjct: 142 HMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200
Query: 243 RRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
R G D+W+ GV+ Y+LLSG+ PF GE + + R +F D + ++S AK
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260
Query: 302 DIVKKMLHADPKERLSAAEVLS 323
D +K +L +P++RL+ + L
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALE 282
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (638), Expect = 1e-82
Identities = 87/263 (33%), Positives = 128/263 (48%), Gaps = 14/263 (5%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ED + GR LG+G+FG YL K +K A K + +L +RREV+I
Sbjct: 5 LED----FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
HL H NI+ L G + D V LI++ G ++ + + E+ A ++ +
Sbjct: 61 SHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 119
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
YCHS V+HRD+KPEN L S LK DFG SV P L G+ Y+ PE+
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEM 175
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ R + + D+WS GV+ Y L G PPF T Q + I R F ++ A
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGA 231
Query: 301 KDIVKKMLHADPKERLSAAEVLS 323
+D++ ++L +P +R EVL
Sbjct: 232 RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (634), Expect = 1e-81
Identities = 106/279 (37%), Positives = 157/279 (56%), Gaps = 7/279 (2%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD---VEDVRREVQ 119
E+V + Y G ELG GQF V K T Q+A K I R+ + ED+ REV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
I+ + H N++ L YE++ V LI++L AGGELFD + K +E A +Q++
Sbjct: 66 ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSP-LKATDFGLSVFFKPGDVFKDLVGSAYYVA 238
V+Y HS+ + H DLKPEN + P +K DFGL+ G+ FK++ G+ +VA
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184
Query: 239 PEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
PE++ G EAD+WS GVI YILLSG PF G+T+Q + + +F + + N S
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLS-KFLIPKKTLQTL 335
+ AKD ++++L DPK+R++ + L ++ PK T Q L
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 283
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 1e-81
Identities = 81/282 (28%), Positives = 146/282 (51%), Gaps = 15/282 (5%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+++ Y+ +LGRG+FG+ + +K+ + K + + D V++E+ I++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILN 56
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVV 181
HRNI+ L ++E + +I + +G ++F+RI +ER + Q+ +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
+ HS + H D++PEN ++ + S +K +FG + KPGD F+ L + Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ + D+WS G ++Y+LLSG+ PF ET Q I + I+ F + + IS A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 301 KDIVKKMLHADPKERLSAAEVLS-KFL------IPKKTLQTL 335
D V ++L + K R++A+E L +L + K ++TL
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (625), Expect = 2e-80
Identities = 81/263 (30%), Positives = 127/263 (48%), Gaps = 12/263 (4%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ FG+ LG G F L T +++A K + R +I + V V RE +M L H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 68
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
V+L ++D + + GEL I G + E ++V+ + Y H G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-R 244
++HRDLKPEN L + ED ++ TDFG + P VG+A YV+PE+L +
Sbjct: 129 IIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
+ +D+W+ G I+Y L++G+PPF E IF I++ DF A+D+V
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPKARDLV 241
Query: 305 KKMLHADPKERLSAAEVLSKFLI 327
+K+L D +RL E+ +
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 244 bits (625), Expect = 4e-80
Identities = 70/282 (24%), Positives = 124/282 (43%), Gaps = 14/282 (4%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+D + RE+G G FG Y + A K +S + + +D+ +EV+ +
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
L H N ++ +G Y H+ L+M+ C G + K E A + + +
Sbjct: 71 KLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
Y HS ++HRD+K N L S E +K DFG + P + F VG+ Y++APEV+
Sbjct: 130 YLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVI 183
Query: 243 R----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
Y + D+WS G+ L PP + S I + + + + S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSE 241
Query: 299 SAKDIVKKMLHADPKERLSAAEVLS-KFLIPKKTLQTLADLL 339
++ V L P++R ++ +L +F++ ++ + DL+
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (617), Expect = 5e-79
Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 12/280 (4%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
D + Y ++G+G G Y T Q+ A + + L + E + E+ +M
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMR 72
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
+ NIV +Y + ++M+ AGG L D ++ + E A +CR+ + +
Sbjct: 73 EN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALE 130
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAPEV 241
+ HS V+HRD+K +N L D +K TDFG +VG+ Y++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ R YG + DIWS G++ ++ G PP+ E I +P +S+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIF 246
Query: 301 KDIVKKMLHADPKERLSAAEVLS-KFLIPKKTLQTLADLL 339
+D + + L D ++R SA E+L +FL K L +L L+
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 2e-77
Identities = 73/260 (28%), Positives = 132/260 (50%), Gaps = 12/260 (4%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ + LG G +G L ++ T++ A K + ++ + D E++++E+ I L H
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HE 63
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
N+V+ G + + L ++ C+GGELFDRI E A Q++ V Y H +G
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLRRN 245
+ HRD+KPEN L LK +DFGL+ F+ + + + G+ YVAPE+L+R
Sbjct: 124 ITHRDIKPENLLLDE---RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 246 --YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303
+ D+WS G++L +L+G P+ ++ + + + +PW I S+ +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKIDSAPLAL 239
Query: 304 VKKMLHADPKERLSAAEVLS 323
+ K+L +P R++ ++
Sbjct: 240 LHKILVENPSARITIPDIKK 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 3e-77
Identities = 72/268 (26%), Positives = 129/268 (48%), Gaps = 16/268 (5%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
+ + + ELG G FG Y +K+T A K I ++ + +++ED E+ I+
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 65
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRII-AKGHYSERAAANLCRQMVTVVH 182
H NIV+L A+ +++ ++++ CAGG + ++ + +E +C+Q + ++
Sbjct: 66 CD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPEV 241
Y H ++HRDLK N LF+ D +K DFG+S + +G+ Y++APEV
Sbjct: 125 YLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181
Query: 242 L------RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295
+ R Y +AD+WS G+ L + PP + I + + P
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SR 240
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLS 323
SS+ KD +KK L + R + +++L
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 8e-77
Identities = 82/266 (30%), Positives = 136/266 (51%), Gaps = 19/266 (7%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ + LG G G + +K T+++FA K + D RREV++ +
Sbjct: 14 KVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCP 65
Query: 129 NIVELKGAYEDRHSVN----LIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVH 182
+IV + YE+ ++ ++M+ GGELF RI +G ++ER A+ + + + +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
Y HS+ + HRD+KPEN L++S ++ LK TDFG + + + YYVAPEVL
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185
Query: 243 R-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDA----ILRGHIDFSSDPWPNIS 297
Y D+WS GVI+YILL G PPF+ +I I G +F + W +S
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLS 323
K +++ +L +P +R++ E ++
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 4e-75
Identities = 72/263 (27%), Positives = 128/263 (48%), Gaps = 13/263 (4%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ED +I + LG+G FG +L K T Q FA K++ ++ DDVE E +++
Sbjct: 1 IED----FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 56
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
H + + ++ + ++ +M+ GG+L I + + A +++ +
Sbjct: 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 116
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-VFKDLVGSAYYVAPE 240
+ HS G+++RDLK +N L +D +K DFG+ GD G+ Y+APE
Sbjct: 117 QFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 241 VLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
+L + Y D WS GV+LY +L G PF G+ E+ +F +I + + +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKE 229
Query: 300 AKDIVKKMLHADPKERLSAAEVL 322
AKD++ K+ +P++RL +
Sbjct: 230 AKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 1e-73
Identities = 55/262 (20%), Positives = 111/262 (42%), Gaps = 14/262 (5%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
F E+GRG F Y +T + A + RKL + + + + E +++ L H
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HP 68
Query: 129 NIVELKGAYED----RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC 184
NIV ++E + + L+ +L G L + + + CRQ++ + +
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 185 HSMG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
H+ ++HRDLK +N + +K D GL+ K K ++G+ ++APE+
Sbjct: 129 HTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMY 185
Query: 243 RRNYGAEADIWSAGVILYILLSGVPPFWGE-TEQSIFDAILRGHIDFSSDPWPNISSSAK 301
Y D+++ G+ + + + P+ I+ + G + K
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEVK 243
Query: 302 DIVKKMLHADPKERLSAAEVLS 323
+I++ + + ER S ++L+
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLN 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 226 bits (576), Expect = 4e-73
Identities = 61/267 (22%), Positives = 111/267 (41%), Gaps = 7/267 (2%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ Y G LG G +L + A K + + + RRE Q L
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-N 65
Query: 127 HRNIVELKGAYEDRHSVN----LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
H IV + E ++M+ G L D + +G + + A + ++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG-LSVFFKPGDVFKDLVGSAYYVAPEV 241
+ H G++HRD+KP N + S++ + ++ ++G+A Y++PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
R + A +D++S G +LY +L+G PPF G++ S+ +R S +S+
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 301 KDIVKKMLHADPKERLSAAEVLSKFLI 327
+V K L +P+ R A + L+
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 1e-70
Identities = 70/304 (23%), Positives = 114/304 (37%), Gaps = 49/304 (16%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
ME + + ELG G GV + V+HK + A K I I + RE+Q++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVL 58
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
H IV GA+ +++ M+ GG L + G E+ + ++ +
Sbjct: 59 HECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 182 HYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 240
Y +MHRD+KP N L +S +K DFG+S + VG+ Y++PE
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPE 173
Query: 241 VLR-RNYGAEADIWSAGVILYILLSGVPPFWGETE---QSIFDAILRGHIDFSSD----- 291
L+ +Y ++DIWS G+ L + G P + +F + G +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 292 --------------------------------PWPNISSSAKDIVKKMLHADPKERLSAA 319
P S +D V K L +P ER
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 320 EVLS 323
+++
Sbjct: 294 QLMV 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 4e-70
Identities = 69/267 (25%), Positives = 112/267 (41%), Gaps = 21/267 (7%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y +G G +G + K + K + + + + + EV ++ L H
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD-YGSMTEAEKQMLVSEVNLLRELK-HP 63
Query: 129 NIVELKGAYEDRHS--VNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVH 182
NIV DR + + ++M+ C GG+L I + + E + Q+ +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 183 YCHSMG-----VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-KDLVGSAYY 236
CH V+HRDLKP N +K DFGL+ F K VG+ YY
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180
Query: 237 VAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295
++PE + R Y ++DIWS G +LY L + +PPF +++ + I G
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYR 237
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVL 322
S +I+ +ML+ R S E+L
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 217 bits (554), Expect = 3e-69
Identities = 72/268 (26%), Positives = 127/268 (47%), Gaps = 20/268 (7%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
++D + R LG G FG +L+ + + +A K + ++ VE E ++
Sbjct: 3 LQD----FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 58
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
+T H I+ + G ++D + +IMD GGELF + + A ++ +
Sbjct: 59 SIVT-HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
Y HS +++RDLKPEN L ++ +K TDFG + + DV L G+ Y+APEV
Sbjct: 118 EYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEV 172
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ + Y D WS G+++Y +L+G PF+ ++ IL + F P +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDV 228
Query: 301 KDIVKKMLHADPKERL-----SAAEVLS 323
KD++ +++ D +RL +V +
Sbjct: 229 KDLLSRLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 218 bits (555), Expect = 8e-69
Identities = 68/266 (25%), Positives = 119/266 (44%), Gaps = 14/266 (5%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT- 125
N + R +GRG FG Y DT + +A K + +++ + E ++ ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 126 -GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC 184
IV + A+ ++ I+DL GG+L + G +SE +++ + +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
H+ V++RDLKP N L E ++ +D GL+ F VG+ Y+APEVL++
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQK 179
Query: 245 N--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302
Y + AD +S G +L+ LL G PF + I R + + + + S +
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRS 238
Query: 303 IVKKMLHADPKERLS-----AAEVLS 323
+++ +L D RL A EV
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKE 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 8e-69
Identities = 60/268 (22%), Positives = 109/268 (40%), Gaps = 19/268 (7%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
G+ +G G FG Y A K ++ ++ + EV ++
Sbjct: 7 DGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR 62
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHYSERAAANLCRQMVTVVHYC 184
H NI+ G Y + ++ C G L+ + I + + ++ RQ + Y
Sbjct: 63 -HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEV 241
H+ ++HRDLK N ED +K DFGL+ F+ L GS ++APEV
Sbjct: 121 HAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 242 LRRN----YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS--SDPWPN 295
+R Y ++D+++ G++LY L++G P+ + ++ S N
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ K ++ + L ER ++L+
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 4e-68
Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 25/277 (9%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED---VRREVQIMHHL- 124
Y G LG G FG Y A K + ++ + ++ + V EV ++ +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAGG-ELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
+G ++ L +E S LI++ +LFD I +G E A + Q++ V +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR 243
CH+ GV+HRD+K EN L LK DFG K V+ D G+ Y PE +R
Sbjct: 126 CHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 182
Query: 244 --RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
R +G A +WS G++LY ++ G PF + E I+RG + F +SS +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFF----RQRVSSECQ 232
Query: 302 DIVKKMLHADPKERLSAAEVLS-----KFLIPKKTLQ 333
+++ L P +R + E+ + L+P++T +
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-66
Identities = 82/264 (31%), Positives = 133/264 (50%), Gaps = 15/264 (5%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
N + + + LG+G FG LV K T + +A K + +I +D+V E +++ +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR- 63
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
H + LK A++ + +M+ GGELF + + ++E A ++V+ + Y HS
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPEVLRRN 245
V++RD+K EN + +D +K TDFGL G K G+ Y+APEVL N
Sbjct: 124 RDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 246 -YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
YG D W GV++Y ++ G PF+ + + +F+ IL I F +S AK ++
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLL 236
Query: 305 KKMLHADPKERLS-----AAEVLS 323
+L DPK+RL A EV+
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVME 260
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-63
Identities = 69/277 (24%), Positives = 108/277 (38%), Gaps = 33/277 (11%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD--VEDVRREVQIMHHLTGHRNIVE 132
LG GQF Y K+T Q A K I D RE++++ L+ H NI+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIG 64
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L A+ + +++L+ D + + + Y H ++HR
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPEVLR--RNYGAE 249
DLKP N L E+ LK DFGL+ F P + V + +Y APE+L R YG
Sbjct: 125 DLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP--------------- 294
D+W+ G IL LL VP G+++ I + + WP
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241
Query: 295 ---------NISSSAKDIVKKMLHADPKERLSAAEVL 322
D+++ + +P R++A + L
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-63
Identities = 73/261 (27%), Positives = 129/261 (49%), Gaps = 12/261 (4%)
Query: 69 YIFGRELGRGQFGVTYLVTH---KDTKQQFACKSISSRKLINR-DDVEDVRREVQIMHHL 124
+ + LG G +G +LV DT + +A K + ++ + E R E Q++ H+
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC 184
+V L A++ ++LI+D GGELF + + ++E ++V + +
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 145
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP--GDVFKDLVGSAYYVAPEVL 242
H +G+++RD+K EN L + + TDFGLS F + D G+ Y+AP+++
Sbjct: 146 HKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 243 R---RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
R + D WS GV++Y LL+G PF + E++ I R + +S+
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262
Query: 300 AKDIVKKMLHADPKERLSAAE 320
AKD+++++L DPK+RL
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGP 283
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 5e-63
Identities = 65/300 (21%), Positives = 117/300 (39%), Gaps = 27/300 (9%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
N F +G G FG K + ++ ++DD D E++++ L
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI----------------IAKGHYSERA 169
H NI+ L GA E R + L ++ G L D + S +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 170 AANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD 229
+ + + Y +HRDL N L E+ K DFGLS +
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTM 185
Query: 230 LVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHID 287
++A E L + Y +D+WS GV+L+ ++S G P+ G T +++ + +G
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG--- 242
Query: 288 FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLADLLYSQIFARF 347
+ + N D++++ P ER S A++L + L+ + + ++ +F
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL---NRMLEERKTYVNTTLYEKF 299
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 2e-62
Identities = 72/263 (27%), Positives = 134/263 (50%), Gaps = 16/263 (6%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ + + LG G FG LV HK++ +A K + +K++ +E E +I+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
+V+L+ +++D ++ ++M+ AGGE+F + G +SE A Q+V Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RN 245
+ +++RDLKPEN L + ++ TDFG + K L G+ +APE++ +
Sbjct: 160 LDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKG 214
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305
Y D W+ GV++Y + +G PPF+ + I++ I+ G + F + SS KD+++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLR 270
Query: 306 KMLHADPKERL-----SAAEVLS 323
+L D +R ++ +
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 198 bits (504), Expect = 1e-61
Identities = 66/296 (22%), Positives = 126/296 (42%), Gaps = 49/296 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
++ Y R+LGRG++ + + ++ K++ + ++RE++I+ +L
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVV------KILKPVKKKKIKREIKILENLR 87
Query: 126 GHRNIVELKGAYEDR--HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
G NI+ L +D + L+ + + ++ +++ + Y
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 144
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR 243
CHSMG+MHRD+KP N + E L+ D+GL+ F+ PG + V S Y+ PE+L
Sbjct: 145 CHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 202
Query: 244 --RNYGAEADIWSAGVILYILLSGVPPFWGETE--------------QSIFDAILRGHID 287
+ Y D+WS G +L ++ PF+ + + ++D I + +I+
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 288 --------------------FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
S+ +S A D + K+L D + RL+A E +
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-61
Identities = 68/299 (22%), Positives = 118/299 (39%), Gaps = 40/299 (13%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
+ K +VR Y + +G G +G T + A K + R + + RE
Sbjct: 9 VTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRE 67
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL----FDRIIAKGHYSERAAANL 173
++++ H+ H N++ L + +++ D +++ E L
Sbjct: 68 LRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL 126
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
QM+ + Y H+ G++HRDLKP N + ED LK DFGL+ V +
Sbjct: 127 VYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ--ADSEMTGYVVT 181
Query: 234 AYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291
+Y APEV+ Y DIWS G I+ +++G F G I++ ++
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 292 PW---------------------------PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
N S A ++++KML D ++R++A E L+
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 4e-61
Identities = 60/270 (22%), Positives = 110/270 (40%), Gaps = 25/270 (9%)
Query: 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
M++ + +G+G+FG L ++ K A K I N + E +
Sbjct: 5 NMKE----LKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIK-----NDATAQAFLAEASV 53
Query: 121 MHHLTGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQM 177
M L H N+V+L G E++ + ++ + A G L D + ++G +
Sbjct: 54 MTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
+ Y +HRDL N L S ED+ K +DFGL+ +
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQ--DTGKLPVKWT 167
Query: 238 APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295
APE LR + + ++D+WS G++L+ + S G P+ + + + +G + D
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDG 224
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKF 325
+ +++K H D R S ++ +
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 5e-61
Identities = 77/315 (24%), Positives = 121/315 (38%), Gaps = 49/315 (15%)
Query: 45 SATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRK 104
S + ++ G+ +P E +Y + +G G FGV Y D+ + A K +
Sbjct: 1 SKVTTVVATPGQGPDRPQEV---SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---- 53
Query: 105 LINRDDVEDVRREVQIMHHLTGHRNIVELKGAY------EDRHSVNLIMDLCAGG---EL 155
D RE+QIM L H NIV L+ + +D +NL++D
Sbjct: 54 ---LQDKRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 156 FDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215
AK Q+ + Y HS G+ HRD+KP+N L + + LK DF
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDF 167
Query: 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGET 273
G + G+ + S YY APE++ Y + D+WSAG +L LL G P F G++
Sbjct: 168 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227
Query: 274 EQSIFDAILRG-------------------------HIDFSSDPWPNISSSAKDIVKKML 308
I++ ++ P A + ++L
Sbjct: 228 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 287
Query: 309 HADPKERLSAAEVLS 323
P RL+ E +
Sbjct: 288 EYTPTARLTPLEACA 302
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 5e-61
Identities = 62/289 (21%), Positives = 108/289 (37%), Gaps = 36/289 (12%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL---INRDDVEDVRREVQIMH 122
R FG+ LG G FG T + ++ + L + + E + E+++M
Sbjct: 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 95
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH------------------ 164
L H NIV L GA + LI + C G+L + + +K
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 165 -----YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219
+ Q+ + + +HRDL N L + +K DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLAR 212
Query: 220 FFKPGD---VFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETE 274
V + ++APE L Y ++D+WS G++L+ + S GV P+ G
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ F +++ D + I++ D ++R S + S
Sbjct: 273 DANFYKLIQNGFKM--DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 8e-61
Identities = 72/297 (24%), Positives = 114/297 (38%), Gaps = 44/297 (14%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
DV Y +G G +G+ K + A K I ++ + RE++I+
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLR 62
Query: 124 LTGHRNIVELKGAYEDRHSVNL----IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
H NI+ + + ++ G +L+ ++ H S Q++
Sbjct: 63 FR-HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILR 120
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG----DVFKDLVGSAY 235
+ Y HS V+HRDLKP N L + LK DFGL+ P + V + +
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 236 YVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293
Y APE++ + Y DIWS G IL +LS P F G+ + IL S +
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 294 ---------------------------PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
PN S A D++ KML +P +R+ + L+
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (495), Expect = 1e-60
Identities = 56/277 (20%), Positives = 98/277 (35%), Gaps = 20/277 (7%)
Query: 64 DVR--NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
++R N Y GR++G G FG YL T ++ A K + + E +I
Sbjct: 2 ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIY 56
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
+ G I ++ + ++M+L +S + L QM++ +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF--------KDLVGS 233
Y HS +HRD+KP+NFL + + + DFGL+ ++ K+L G+
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 234 AYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292
A Y + D+ S G +L G P+ G + R S P
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 293 ----WPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325
S + ++ + + F
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-60
Identities = 61/268 (22%), Positives = 101/268 (37%), Gaps = 17/268 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQ---FACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+LG G FGV + A K + L + ++D REV MH L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYC 184
HRN++ L G + ++ +L G L DR+ GH+ + Q+ + Y
Sbjct: 70 -HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD----VFKDLVGSAYYVAPE 240
S +HRDL N L + +K DFGL D + + + APE
Sbjct: 128 ESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 241 VLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
L+ R + +D W GV L+ + + G P+ G I I + +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--PRPEDCPQ 242
Query: 299 SAKDIVKKMLHADPKERLSAAEVLSKFL 326
+++ + P++R + + L
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 193 bits (492), Expect = 2e-60
Identities = 79/290 (27%), Positives = 121/290 (41%), Gaps = 38/290 (13%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
ME Y ++G G +GV Y + + FA K I K + RE+ I+
Sbjct: 1 MEK----YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISIL 54
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
L H NIV+L + + L+ + + +G A + Q++ +
Sbjct: 55 KELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPE 240
YCH V+HRDLKP+N L + + LK DFGL+ F P + + + +Y AP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINR---EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
Query: 241 VLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI-- 296
VL + Y DIWS G I +++G P F G +E I R +S WPN+
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 297 -----------------------SSSAKDIVKKMLHADPKERLSAAEVLS 323
S D++ KML DP +R++A + L
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-60
Identities = 66/279 (23%), Positives = 110/279 (39%), Gaps = 20/279 (7%)
Query: 66 RNTYIFG-RELGRGQFGVTYLVTHKDTKQQ--FACKSISSRKLINRDDVEDVRREVQIMH 122
R+ + ELG G FG ++ K+Q A K + ++ + D E++ RE QIMH
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMH 64
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVV 181
L + IV L G + ++ L+M++ GG L ++ K A L Q+ +
Sbjct: 65 QLD-NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL----VGSAYYV 237
Y +HRDL N L K +DFGLS D + +
Sbjct: 123 KYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 238 APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295
APE + R + + +D+WS GV ++ LS G P+ + I +G + P
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPE 236
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQT 334
++ ++R V + +L +
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-60
Identities = 68/298 (22%), Positives = 118/298 (39%), Gaps = 48/298 (16%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y ++G+G FG + H+ T Q+ A K + RE++I+ L H
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLL-KHE 69
Query: 129 NIVELKGAYED--------RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
N+V L + S+ L+ D C ++ + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-----DVFKDLVGSAY 235
++Y H ++HRD+K N L + D LK DFGL+ F + + + V + +
Sbjct: 130 LYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 236 YVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293
Y PE+L R+YG D+W AG I+ + + P G TEQ I + + + W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 294 PNI----------------------------SSSAKDIVKKMLHADPKERLSAAEVLS 323
PN+ A D++ K+L DP +R+ + + L+
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 6e-60
Identities = 67/291 (23%), Positives = 117/291 (40%), Gaps = 38/291 (13%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
M+ Y ++G G +G + +++T + A K + + RE+ ++
Sbjct: 1 MQK----YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLL 55
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
L H+NIV L + L+ + C G + Q++ +
Sbjct: 56 KELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPE 240
+CHS V+HRDLKP+N L + + LK +FGL+ F P + V + +Y P+
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINR---NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171
Query: 241 VL--RRNYGAEADIWSAGVILYILLSG-VPPFWGETEQSIFDAILRGHIDFSSDPW---- 293
VL + Y D+WSAG I L + P F G I R + + W
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 294 ---------------------PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
P ++++ +D+++ +L +P +R+SA E L
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 8e-60
Identities = 55/260 (21%), Positives = 100/260 (38%), Gaps = 17/260 (6%)
Query: 73 RELGRGQFGVTYLVTHKDTK--QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
+ELG G FG ++ K + A K + + + +++ E +M L + I
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLD-NPYI 70
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
V + G E S L+M++ G L + H ++ L Q+ + Y +
Sbjct: 71 VRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD----LVGSAYYVAPEVLRRN- 245
HRDL N L + K +DFGLS + + + + APE +
Sbjct: 130 HRDLAARNVLLVT---QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
+ +++D+WS GV+++ S G P+ G + + +G D++
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLM 243
Query: 305 KKMLHADPKERLSAAEVLSK 324
D + R A V +
Sbjct: 244 NLCWTYDVENRPGFAAVELR 263
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (487), Expect = 2e-59
Identities = 67/288 (23%), Positives = 112/288 (38%), Gaps = 37/288 (12%)
Query: 69 YIFGRELGRGQFGVTYLVTH-KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG- 126
Y E+G G +G + K+ + A K + + REV ++ HL
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLETF 67
Query: 127 -HRNIVELKGAYEDRHS-----VNLIMDLCAGGEL-FDRIIAKGHYSERAAANLCRQMVT 179
H N+V L + + L+ + + + + ++ Q++
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
+ + HS V+HRDLKP+N L +S +K DFGL+ + +V + +Y AP
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 240 EVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP---- 294
EVL ++ Y D+WS G I + P F G ++ IL + WP
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 295 -------------------NISSSAKDIVKKMLHADPKERLSAAEVLS 323
+I KD++ K L +P +R+SA LS
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (484), Expect = 4e-59
Identities = 57/271 (21%), Positives = 108/271 (39%), Gaps = 17/271 (6%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISS-RKLINRDDVEDVRREVQIM 121
E + + +G G+FG K ++ +I + + D E IM
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTV 180
H N++ L+G V +I + G L + G ++ + R +
Sbjct: 82 GQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL------VGSA 234
+ Y M +HRDL N L + + K +DFGLS F +
Sbjct: 141 MKYLADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 235 YYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292
+ APE ++ R + + +D+WS G++++ ++S G P+W T Q + +AI + D+ P
Sbjct: 198 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPP 254
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ S+ ++ D R ++++
Sbjct: 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-58
Identities = 67/264 (25%), Positives = 109/264 (41%), Gaps = 14/264 (5%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSI-SSRKLINRDDVEDVRREVQIMHHL 124
R GR +G GQFG + + + +I + + + E +E M
Sbjct: 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 65
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHY 183
H +IV+L G + V +IM+LC GEL + + + Q+ T + Y
Sbjct: 66 -DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK--DLVGSAYYVAPEV 241
S +HRD+ N L SS+ +K DFGLS + + +K ++APE
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 242 LR-RNYGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
+ R + + +D+W GV ++ IL+ GV PF G + I G PN +
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPT 237
Query: 300 AKDIVKKMLHADPKERLSAAEVLS 323
++ K DP R E+ +
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-58
Identities = 61/263 (23%), Positives = 110/263 (41%), Gaps = 17/263 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
F +ELG GQFGV + A K I + ++ E ++M +L+ H
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSE----DEFIEEAKVMMNLS-HE 59
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHYSERAAANLCRQMVTVVHYCHSM 187
+V+L G + + +I + A G L + + + + + +C+ + + Y S
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD--VFKDLVGSAYYVAPEVLRRN 245
+HRDL N L + + +K +DFGLS + + + PEVL +
Sbjct: 120 QFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 246 -YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303
+ +++DIW+ GV+++ + S G P+ T + I +G + S I
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASEKVYTI 233
Query: 304 VKKMLHADPKERLSAAEVLSKFL 326
+ H ER + +LS L
Sbjct: 234 MYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (476), Expect = 5e-58
Identities = 59/266 (22%), Positives = 107/266 (40%), Gaps = 17/266 (6%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R +LG GQ+G Y K A K++ + +VE+ +E +M +
Sbjct: 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK 71
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY--SERAAANLCRQMVTVVHY 183
H N+V+L G +I + G L D + S + Q+ + + Y
Sbjct: 72 -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD--VFKDLVGSAYYVAPEV 241
+HRDL N L E+ +K DFGLS + APE
Sbjct: 131 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 242 LRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
L N + ++D+W+ GV+L+ + + G+ P+ G +++ + + D+ +
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEK 244
Query: 300 AKDIVKKMLHADPKERLSAAEVLSKF 325
++++ +P +R S AE+ F
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 6e-58
Identities = 72/291 (24%), Positives = 116/291 (39%), Gaps = 38/291 (13%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
ME+ + ++G G +GV Y +K T + A K I RE+ ++
Sbjct: 1 MEN----FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLL 55
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCA-GGELFDRIIAKGHYSERAAANLCRQMVTV 180
L H NIV+L + + L+ + + F A + Q++
Sbjct: 56 KEL-NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAP 239
+ +CHS V+HRDLKP+N L + + +K DFGL+ F P + V + +Y AP
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 240 EVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW---- 293
E+L Y DIWS G I +++ F G++E I R W
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 294 ---------------------PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
P + + ++ +MLH DP +R+SA L+
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-57
Identities = 57/264 (21%), Positives = 111/264 (42%), Gaps = 19/264 (7%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R + +LG+G FG ++ T T + A K++ + E +E Q+M L
Sbjct: 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKL- 69
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHY 183
H +V+L + + ++ + + G L D + + + ++ Q+ + + Y
Sbjct: 70 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD--LVGSAYYVAPEV 241
M +HRDL+ N L E+ K DFGL+ + + + APE
Sbjct: 129 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185
Query: 242 LRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
+ ++D+WS G++L L + G P+ G + + D + RG + P S
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 242
Query: 300 AKDIVKKMLHADPKERLSAAEVLS 323
D++ + +P+ER + + +
Sbjct: 243 LHDLMCQCWRKEPEERPTFEYLQA 266
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 186 bits (473), Expect = 2e-57
Identities = 61/291 (20%), Positives = 100/291 (34%), Gaps = 20/291 (6%)
Query: 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
V Y GR +G G FGV + T+ QQ A K R D +R E + L
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLL 57
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC 184
G I + ++ L++DL + +S + A +QM+ V
Sbjct: 58 AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 185 HSMGVMHRDLKPENFLFSS--SAEDSPLKATDFGLSVFFKPGDV--------FKDLVGSA 234
H +++RD+KP+NFL S + + DFG+ F++ K+L G+A
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 235 YYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP- 292
Y++ R D+ + G + L G P+ G + R S P
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 293 ---WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLADLLY 340
+ + + F + L T D +
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-57
Identities = 59/262 (22%), Positives = 113/262 (43%), Gaps = 17/262 (6%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+ F +E+G GQFG+ +L + + A K+I + ED E ++M L+
Sbjct: 4 PSELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAM----SEEDFIEEAEVMMKLS 58
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYC 184
H +V+L G ++ + L+ + G L D + + ++ +C + + Y
Sbjct: 59 -HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD--VFKDLVGSAYYVAPEVL 242
V+HRDL N L E+ +K +DFG++ F + +PEV
Sbjct: 118 EEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 243 RRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ Y +++D+WS GV+++ + S G P+ + + + I G F S+
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHV 231
Query: 301 KDIVKKMLHADPKERLSAAEVL 322
I+ P++R + + +L
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLL 253
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 7e-57
Identities = 72/299 (24%), Positives = 121/299 (40%), Gaps = 40/299 (13%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L K + +V Y +G G +G T + A K +S R + + RE
Sbjct: 9 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRE 67
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSV----NLIMDLCAGGELFDRIIAKGHYSERAAANL 173
++++ H+ H N++ L + S+ ++ + G + I+ ++ L
Sbjct: 68 LRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
Q++ + Y HS ++HRDLKP N + ED LK DFGL+ D V +
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHT--DDEMTGYVAT 181
Query: 234 AYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS-- 289
+Y APE++ Y DIWS G I+ LL+G F G ILR
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 290 -------------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
++ + + A D+++KML D +R++AA+ L+
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-56
Identities = 52/264 (19%), Positives = 100/264 (37%), Gaps = 19/264 (7%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R T LG GQFG ++ + + A KS+ + + E +M L
Sbjct: 12 RETLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 66
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHY 183
H+ +V L + +I + G L D + + ++ Q+ + +
Sbjct: 67 -HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD--LVGSAYYVAPEV 241
+HRDL+ N L S + K DFGL+ + + + APE
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 242 LRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
+ + ++D+WS G++L +++ G P+ G T + + RG + N
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEE 238
Query: 300 AKDIVKKMLHADPKERLSAAEVLS 323
+++ P++R + + S
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-56
Identities = 66/285 (23%), Positives = 108/285 (37%), Gaps = 35/285 (12%)
Query: 66 RNTYIFGRELGRGQFGVTYLVT-----HKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
RN FG+ LG G FG T D A K + + + E + E+++
Sbjct: 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKV 79
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH---------------- 164
+ +L H NIV L GA +I + C G+L + + K
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 165 --YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
+ Q+ + + S +HRDL N L + K DFGL+ K
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIK 196
Query: 223 PGD---VFKDLVGSAYYVAPEVLRRNY-GAEADIWSAGVILYILLS-GVPPFWGETEQSI 277
V + ++APE + E+D+WS G+ L+ L S G P+ G S
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
F +++ + + DI+K ADP +R + +++
Sbjct: 257 FYKMIKEGFRM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-56
Identities = 57/282 (20%), Positives = 110/282 (39%), Gaps = 30/282 (10%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQ-------QFACKSISSRKLINRDDVEDVRREV 118
R+ + G+ LG G FG L + + A K + + D+ D+ E+
Sbjct: 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEM 69
Query: 119 QIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI----------------IAK 162
++M + H+NI+ L GA + +I++ + G L + + +
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 163 GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
S + + Q+ + Y S +HRDL N L +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 223 PGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDA 280
+ ++APE L R Y ++D+WS GV+L+ + + G P+ G + +F
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
+ GH D N ++ +++ HA P +R + +++
Sbjct: 250 LKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 1e-55
Identities = 63/296 (21%), Positives = 113/296 (38%), Gaps = 43/296 (14%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRR 116
+E RN + R++G G FG + + A K + + D D +R
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQR 65
Query: 117 EVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY----------- 165
E +M + NIV+L G + L+ + A G+L + + + +
Sbjct: 66 EAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 166 -------------SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212
S + RQ+ + Y +HRDL N L E+ +K
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKI 181
Query: 213 TDFGLSVFFKPGDVFK---DLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLS-GVP 267
DFGLS D +K + ++ PE + N Y E+D+W+ GV+L+ + S G+
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 268 PFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
P++G + + + G+I N ++++ P +R S +
Sbjct: 242 PYYGMAHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-53
Identities = 57/265 (21%), Positives = 101/265 (38%), Gaps = 16/265 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSI--SSRKLINRDDVEDVRREVQIMHHLTG 126
+ + LG G FG Y ++ R+ + +++ E +M +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCH 185
+ ++ L G V LI L G L D + K + + N C Q+ ++Y
Sbjct: 70 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVL 242
++HRDL N L +K TDFGL+ + + ++A E +
Sbjct: 129 DRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 243 R-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
R Y ++D+WS GV ++ L++ G P+ G I + +G P +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPICTIDV 242
Query: 301 KDIVKKMLHADPKERLSAAEVLSKF 325
I+ K D R E++ +F
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-52
Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 23/286 (8%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQ----FACKSISSRKLINRDDVEDVRREVQIM 121
+ + +G G+FG Y K + + A K++ + D E IM
Sbjct: 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIM 63
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTV 180
H NI+ L+G + +I + G L + K G +S + R +
Sbjct: 64 GQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD----VFKDLVGSAYY 236
+ Y +M +HRDL N L +S+ K +DFGLS + +
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 237 VAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294
APE + R + + +D+WS G++++ +++ G P+W + + AI G F
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPM 236
Query: 295 NISSSAKDIVKKMLHADPKERLSAAEV---LSKFLIPKKTLQTLAD 337
+ S+ ++ + + R A++ L K + +L+TLAD
Sbjct: 237 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-52
Identities = 72/311 (23%), Positives = 119/311 (38%), Gaps = 53/311 (17%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
+G V Y + +G G G+ + A K +S R N+ + RE
Sbjct: 8 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRE 66
Query: 118 VQIMHHLTGHRNIVELKGAY------EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA 171
+ +M + H+NI+ L + E+ V L+M+L + +
Sbjct: 67 LVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMS 122
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
L QM+ + + HS G++HRDLKP N + S D LK DFGL+ + V
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 179
Query: 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG------ 284
+ YY APEV+ Y DIWS G I+ ++ F G ++ ++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
Query: 285 ----------------HIDFSSDPWPNI----------------SSSAKDIVKKMLHADP 312
++ +P + +S A+D++ KML DP
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 313 KERLSAAEVLS 323
+R+S + L
Sbjct: 300 AKRISVDDALQ 310
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 4e-50
Identities = 66/307 (21%), Positives = 122/307 (39%), Gaps = 32/307 (10%)
Query: 62 MEDVRNTYI--------FGRELGRGQFGVTYLVTHKD---TKQQFACKSISSRKLINRDD 110
++ V++ I F +GRG FG Y T D K A KS+ ++ + +
Sbjct: 14 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGE 71
Query: 111 VEDVRREVQIMHHLTGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFDRIIAKGH-YSER 168
V E IM + H N++ L G S +++ G+L + I + H + +
Sbjct: 72 VSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130
Query: 169 AAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK 228
Q+ + + S +HRDL N + E +K DFGL+ +
Sbjct: 131 DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDS 187
Query: 229 DL-----VGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAI 281
++A E L+ + + ++D+WS GV+L+ L++ G PP+ I +
Sbjct: 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247
Query: 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLADLLYS 341
L+G + +++ K H + R S +E++S+ T Y
Sbjct: 248 LQGRRLLQPE---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRI---SAIFSTFIGEHYV 301
Query: 342 QIFARFL 348
+ A ++
Sbjct: 302 HVNATYV 308
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-49
Identities = 56/280 (20%), Positives = 115/280 (41%), Gaps = 29/280 (10%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R RELG+G FG+ Y K + + + A K++ + + + + E +
Sbjct: 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASV 76
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH----------YSERAA 170
M ++V L G +IM+L G+L + + S
Sbjct: 77 MKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK-- 228
+ ++ + Y ++ +HRDL N + + ED +K DFG++ D ++
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 229 -DLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGV-PPFWGETEQSIFDAILRGH 285
+ +++PE L+ + +D+WS GV+L+ + + P+ G + + + ++ G
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252
Query: 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325
+ D N ++++ +PK R S E++S
Sbjct: 253 LL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-46
Identities = 60/285 (21%), Positives = 108/285 (37%), Gaps = 34/285 (11%)
Query: 66 RNTYIFGRELGRGQFGVTYLVT-----HKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R+ G+ LGRG FG T + A K + ++ + + E++I
Sbjct: 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKI 69
Query: 121 MHHLTGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFDRI----------------IAKG 163
+ H+ H N+V L GA + + +I++ C G L + + K
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 164 HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223
+ Q+ + + S +HRDL N L S E + +K DFGL+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYK 186
Query: 224 GDVF---KDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGV-PPFWGETEQSIF 278
+ D ++APE + Y ++D+WS GV+L+ + S P+ G F
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246
Query: 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323
L+ + + H +P +R + +E++
Sbjct: 247 CRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 2e-45
Identities = 55/302 (18%), Positives = 100/302 (33%), Gaps = 51/302 (16%)
Query: 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
+ T + +G+G+FG + K ++ A K SSR+ + E+ L
Sbjct: 1 IARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSRE----ERSWFREAEIYQTVML 54
Query: 125 TGHRNIVELKGAYEDRHSVN----LIMDLCAGGELFDRIIAKGHYSERA-------AANL 173
H NI+ A + L+ D G LFD + E A+ L
Sbjct: 55 R-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 113
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-----VFK 228
+ +V + HRDLK +N L ++ D GL+V
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAPN 170
Query: 229 DLVGSAYYVAPEVLRRN-------YGAEADIWSAGVILYILLSGVPPFWGETE------- 274
VG+ Y+APEVL + ADI++ G++ + + +
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230
Query: 275 --------QSIFDAILRGHIDFSSDPW---PNISSSAKDIVKKMLHADPKERLSAAEVLS 323
+ + + + + I+++ +A+ RL+A +
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
Query: 324 KF 325
Sbjct: 291 TL 292
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 138 bits (347), Expect = 2e-38
Identities = 56/329 (17%), Positives = 105/329 (31%), Gaps = 72/329 (21%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
G+P +D R YI R+LG G F +L A K + K+ E E
Sbjct: 6 KGEPYKDAR--YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDE 59
Query: 118 VQIMHHL----------TGHRNIVELKGAYEDRHSVNLIMDL-----CAGGELFDRIIAK 162
++++ + G +I++L + + + + + +
Sbjct: 60 IKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH 119
Query: 163 GHYSERAAANLCRQMVTVVHYC-HSMGVMHRDLKPENFLFSSS---AEDSPLKATDFGLS 218
+ +Q++ + Y G++H D+KPEN L +K D G +
Sbjct: 120 RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 179
Query: 219 VFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
++ + Y +PEVL +G ADIWS +++ L++G F + S
Sbjct: 180 CWYDEHYTNSI--QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237
Query: 278 FDAI--------------------------------------------LRGHIDFSSDPW 293
L +
Sbjct: 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297
Query: 294 PNISSSAKDIVKKMLHADPKERLSAAEVL 322
+ + D + ML DP++R A ++
Sbjct: 298 KDEAKEISDFLSPMLQLDPRKRADAGGLV 326
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.2 bits (228), Expect = 7e-23
Identities = 37/201 (18%), Positives = 69/201 (34%), Gaps = 25/201 (12%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACK-----SISSRKLINRDDVEDVR-REVQIMHHLT 125
G+ +G G+ + + + K S +K+ + D D+ + I
Sbjct: 5 GKLMGEGKESAVFNCYSEKF-GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 126 GHRNIVELKGAYEDRH----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
R + +L+G + ++M+L EL+ + ++ V
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELY-------RVRVENPDEVLDMILEEV 116
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
+ G++H DL N L S + + DF SV +++++
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSVEVGEEG-WREILERDVRNIITY 171
Query: 242 LRRNYGAEADIWSAGVILYIL 262
R Y E DI S I IL
Sbjct: 172 FSRTYRTEKDINS--AIDRIL 190
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 44.0 bits (103), Expect = 1e-05
Identities = 15/147 (10%), Positives = 47/147 (31%), Gaps = 4/147 (2%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD----DVEDVRREVQIMHHLTGHR 128
+E+G G + + ++ + K + + ++ R E + H
Sbjct: 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV 91
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+ + Y D +M+ + ++ + + +G + ++ + + Y
Sbjct: 92 PHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYA 151
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDF 215
+ + K F++ + F
Sbjct: 152 LEPKVKKQLVKQFTNPELCDITERLVF 178
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 350 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.8 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.56 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.87 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.44 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.89 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 85.95 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-62 Score=438.11 Aligned_cols=265 Identities=42% Similarity=0.751 Sum_probs=223.6
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
+.+.++|++.+.||+|+||+||+|+++.+++.||||++.+.... .....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIK-HPNIVALDDIYESGGH 81 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 45678899999999999999999999999999999999765432 22356889999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++...++++.+||+|||+|....
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999999999998899999999999999999999999999999999999999776678899999999998877
Q ss_pred CCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 223 PGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+.......+.+.++.+++++.
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 6666677889999999998864 589999999999999999999999999999999999999888887777778999999
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
+||.+||+.||++|||+.|+|+|+||.+.
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999854
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-62 Score=428.15 Aligned_cols=254 Identities=33% Similarity=0.582 Sum_probs=231.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|++++++++ ||||+++++++.+.+.+++|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEE
Confidence 67999999999999999999999999999999997655444455678999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
|||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|.......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCC-
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCCc-
Confidence 9999999999999998899999999999999999999999999999999999999 666789999999998765443
Q ss_pred cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 305 (350)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.+....++. .+++++.+||.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~ 236 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLIS 236 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHHHH
Confidence 355689999999999875 5899999999999999999999999999998899888887766554 57999999999
Q ss_pred HhcccCccCCCCHHHHHhccCCCC
Q 018786 306 KMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 306 ~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
+||+.||++|||+.|+|+|+||..
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCC
Confidence 999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-62 Score=430.91 Aligned_cols=264 Identities=31% Similarity=0.571 Sum_probs=235.2
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|++++++++ ||||+++++++.+.+.+++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEE
Confidence 468999999999999999999999999999999997655444455678999999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ ++++.+||+|||+|.......
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccCC
Confidence 99999999999999999999999999999999999999999999999999999999 667789999999998765332
Q ss_pred ---ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 226 ---VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 226 ---~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.+....++. .+++++.
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~ 238 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKAR 238 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----TCCHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----cCCHHHH
Confidence 2345689999999999864 5899999999999999999999999999998999888888766553 5799999
Q ss_pred HHHHHhcccCccCCCCHHH------HHhccCCCCCchhhHHH
Q 018786 302 DIVKKMLHADPKERLSAAE------VLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~------iL~~~~~~~~~~~~~~~ 337 (350)
+||.+||+.||++|||++| +++|+||.+..|+.+.+
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~ 280 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 280 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred HHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc
Confidence 9999999999999999987 68899999998887654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-61 Score=428.44 Aligned_cols=271 Identities=38% Similarity=0.625 Sum_probs=239.6
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCC---hhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN---RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENK 85 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 35678999999999999999999999999999999997654322 234678999999999998 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCC-CCCeEEeecCCcc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE-DSPLKATDFGLSV 219 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-~~~vkl~Dfg~a~ 219 (350)
+.+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++. ...+||+|||+|.
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999999998889999999999999999999999999999999999999965432 3469999999999
Q ss_pred cccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 220 FFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......++...++.++.
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 8877666677889999999999875 589999999999999999999999999999999999888877766555567899
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhH
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTL 335 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~ 335 (350)
++.+||.+||+.||++|||+.|+|+|+||++..++..
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC------
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHh
Confidence 9999999999999999999999999999998776554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-61 Score=425.12 Aligned_cols=258 Identities=29% Similarity=0.546 Sum_probs=218.1
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|++++.||+|+||+||+|+++.+|+.||||++..... .+..+.+.+|++++++++ ||||+++++++.+.+.+++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeEE
Confidence 4689999999999999999999999999999999975432 223467899999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
||||++|++|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|.......
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCC
Confidence 99999999999999888889999999999999999999999999999999999999 566789999999998764332
Q ss_pred ---ccccCCcCccccccccccc-c-CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 018786 226 ---VFKDLVGSAYYVAPEVLRR-N-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (350)
Q Consensus 226 ---~~~~~~gt~~y~aPE~~~~-~-~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (350)
.....+||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.................. ....++.+++++
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~ 236 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKKIDSAP 236 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-TSTTGGGSCHHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCccccCCHHH
Confidence 2355689999999998864 3 467899999999999999999999776544333222222222 222345789999
Q ss_pred HHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 301 KDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 301 ~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.+||.+||+.||++|||+.|+|+|+||++.
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 999999999999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-60 Score=432.79 Aligned_cols=263 Identities=34% Similarity=0.585 Sum_probs=238.1
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
+.++|.+++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.++++++ ||||+++++++.+.+.++
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 3478999999999999999999999999999999996543 344577899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 145 LIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||++. +.++.+||+|||++.....
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheeccc
Confidence 99999999999998854 567999999999999999999999999999999999999964 2357899999999998877
Q ss_pred CCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+.......+...++.+++++.+
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 777777899999999998864 5899999999999999999999999999999999999888877776666789999999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
||.+||+.||++|||+.|+|+|+||....+
T Consensus 259 li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 999999999999999999999999987654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-60 Score=427.51 Aligned_cols=264 Identities=31% Similarity=0.563 Sum_probs=239.5
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|.+++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++++. ||||+++++++.+.+.+++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeecccccccc
Confidence 368999999999999999999999999999999998655444455688999999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC-C
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-G 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~-~ 224 (350)
||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.... .
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTT
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCC
Confidence 99999999999999999999999999999999999999999999999999999999 6678899999999987543 3
Q ss_pred CccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
......+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.+..+....+..+...++. .+++++.+|
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dl 235 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSL 235 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHH
Confidence 4456678999999999986 45999999999999999999999999999999999999888776654 589999999
Q ss_pred HHHhcccCccCCCC-----HHHHHhccCCCCCchhhHHH
Q 018786 304 VKKMLHADPKERLS-----AAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 304 i~~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~~ 337 (350)
|.+||+.||.+|++ +.|+++|+||.+..|+.+..
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~ 274 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 274 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred HHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHh
Confidence 99999999999994 99999999999988776543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.7e-60 Score=414.73 Aligned_cols=261 Identities=36% Similarity=0.649 Sum_probs=237.4
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh------hhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR------DDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
.++|.+.+.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+++++..||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4789999999999999999999999999999999976543221 2245688999999999889999999999999
Q ss_pred CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
++..++||||+++++|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchhee
Confidence 99999999999999999999999999999999999999999999999999999999999999 667789999999999
Q ss_pred cccCCCccccCCcCccccccccccc-------cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 018786 220 FFKPGDVFKDLVGSAYYVAPEVLRR-------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292 (350)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
............||+.|+|||.+.+ .++.++||||+||++|+|++|+.||.+.........+..+...++...
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 8876666677889999999998742 367899999999999999999999999999998888888887777767
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
++.+++++++||.+||+.||.+|||+.|+|+|+||++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 7789999999999999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-60 Score=418.05 Aligned_cols=263 Identities=27% Similarity=0.466 Sum_probs=226.3
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|++.+.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.++++++ ||||+++++++.+.+.+++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEEE
Confidence 4689999999999999999999999999999999975543 23467999999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~- 224 (350)
||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|......
T Consensus 95 vmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTT
T ss_pred EEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeecccc
Confidence 9999999999987655 579999999999999999999999999999999999999 56678999999999886543
Q ss_pred CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+........ ...+.+++++++|
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~l 249 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAIFRDF 249 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SSGGGSCHHHHHH
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CCcccCCHHHHHH
Confidence 34456689999999998864 589999999999999999999999998887776666554432211 1224689999999
Q ss_pred HHHhcccCccCCCCHHHHHhccCCCCC-chhhHHH
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLIPKK-TLQTLAD 337 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~~~~-~~~~~~~ 337 (350)
|.+||+.||++|||+.|+|+|+||+.. ....+..
T Consensus 250 i~~~L~~dP~~R~s~~eil~Hp~~~~~~~~~~l~p 284 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTTCGGGGGCCCGGGGHH
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCCCCCCCcCCC
Confidence 999999999999999999999999743 3333433
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-60 Score=414.06 Aligned_cols=255 Identities=22% Similarity=0.416 Sum_probs=219.0
Q ss_pred cce-eeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc----CC
Q 018786 67 NTY-IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED----RH 141 (350)
Q Consensus 67 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----~~ 141 (350)
++| ++.+.||+|+||+||+|.++.+++.||+|.+..... .....+.+.+|++++++++ ||||+++++++.. ..
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCC
Confidence 445 678899999999999999999999999999876543 4455678999999999998 9999999998864 45
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
.+++||||+++++|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++ ++++.+||+|||+|.
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcce
Confidence 68999999999999999998889999999999999999999999999 99999999999995 346779999999998
Q ss_pred cccCCCccccCCcCccccccccccccCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 220 FFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
..... .....+||+.|+|||++.+.++.++|||||||++|+|++|+.||..... ......+..+..+.. ....+++
T Consensus 164 ~~~~~-~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~--~~~~~~~ 240 (270)
T d1t4ha_ 164 LKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAIP 240 (270)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--GGGCCCH
T ss_pred eccCC-ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcc--cCccCCH
Confidence 64433 3456789999999999988899999999999999999999999976654 444455544432221 1235789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhccCCC
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKFLIP 328 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~~~~ 328 (350)
++.++|.+||+.||++|||+.|+|+|+||+
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-60 Score=422.67 Aligned_cols=258 Identities=25% Similarity=0.435 Sum_probs=228.7
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
..|++++.||+|+||+||+|+++.+++.||||++...........+.+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEEEE
Confidence 56999999999999999999999999999999998765545556678999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
||||.+++|..++..++++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|......
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB--
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCCC--
Confidence 9999999998777778889999999999999999999999999999999999999 55677999999999875433
Q ss_pred cccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (350)
....||+.|+|||++. +.++.++|||||||++|||++|..||.+....+.+..+.....+.... ..+++++.+
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~~~~ 245 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS--GHWSEYFRN 245 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC--TTSCHHHHH
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC--CCCCHHHHH
Confidence 4568999999999874 348899999999999999999999999888887777776665443322 367999999
Q ss_pred HHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 303 IVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 303 li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
||.+||+.||++|||+.|+|+|+||.+...+
T Consensus 246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~ 276 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HHHHHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence 9999999999999999999999999876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.6e-60 Score=428.90 Aligned_cols=261 Identities=33% Similarity=0.580 Sum_probs=237.2
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEE
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~i 145 (350)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+|+.+++++. ||||+++++++.+++.+++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence 467999999999999999999999999999999986543 234567889999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
|||||+|++|.+.+... .++++..++.++.||+.||.|||++||+||||||+|||++. ..++.+||+|||+|......
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTT
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCCC
Confidence 99999999999887654 46999999999999999999999999999999999999953 24578999999999998777
Q ss_pred CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......++...++.+++++.+|
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 76777889999999998864 58999999999999999999999999999999999999988888877778899999999
Q ss_pred HHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 304 VKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
|.+||+.||.+|||+.|+|+|+||++..
T Consensus 263 i~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 9999999999999999999999998643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-60 Score=419.03 Aligned_cols=263 Identities=27% Similarity=0.466 Sum_probs=228.1
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
+.|++++.||+|+||+||+|+++.+++.||||++.... ....+.+.+|++++++++ ||||+++++++.+.+.+++|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEEEE
Confidence 56999999999999999999999999999999996542 334567899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-
Q 018786 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~- 224 (350)
|||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|......
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCCc
Confidence 999999999998765 4569999999999999999999999999999999999999 56678999999999765432
Q ss_pred CccccCCcCcccccccccc------ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCH
Q 018786 225 DVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~------~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+.....+... ....+++
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~s~ 243 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRWSS 243 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS-SGGGSCH
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-ccccCCH
Confidence 2234568999999999873 34789999999999999999999999998888888887776543322 1246899
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHhccCCCCCchhhHHH
Q 018786 299 SAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 299 ~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~~~~~ 337 (350)
++.+||.+||+.||++|||+.|+|+|+||.....+.+.+
T Consensus 244 ~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~~p~~~ 282 (288)
T d2jfla1 244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRE 282 (288)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCCHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCcHH
Confidence 999999999999999999999999999998765554443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.6e-60 Score=422.48 Aligned_cols=260 Identities=27% Similarity=0.524 Sum_probs=236.8
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++++++ ||||+++++++.+.+.+++|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeE
Confidence 67999999999999999999999999999999997654434455678999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
|||++|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|......
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEeccc--
Confidence 9999999999999999999999999999999999999999999999999999999 66778999999999886543
Q ss_pred cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 305 (350)
....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+..+...++. .+++++.++|.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~ 233 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLS 233 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----CCCHHHHHHHH
Confidence 346789999999999875 5899999999999999999999999999999999888887766553 57999999999
Q ss_pred HhcccCccCCC-----CHHHHHhccCCCCCchhhHH
Q 018786 306 KMLHADPKERL-----SAAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 306 ~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~ 336 (350)
+||+.||.+|+ |++++|+|+||++..|+.+.
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~ 269 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLL 269 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHH
T ss_pred HHhhhCHHhccccchhhHHHHHcCcccccCCHHHHH
Confidence 99999999996 99999999999999887654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-59 Score=412.64 Aligned_cols=254 Identities=27% Similarity=0.492 Sum_probs=212.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc--CCce
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHSV 143 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~~ 143 (350)
.++|++.+.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|++++++++ ||||+++++++.+ .+.+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEE
Confidence 3689999999999999999999999999999999976544 4455678999999999998 9999999998854 4668
Q ss_pred EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----CEeecCCCCceEeecCCCCCCeEEee
Q 018786 144 NLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMG-----VMHRDLKPENFLFSSSAEDSPLKATD 214 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~-----ivH~Dlkp~NIl~~~~~~~~~vkl~D 214 (350)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~D 157 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGD 157 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEee
Confidence 999999999999998854 467999999999999999999999976 9999999999999 6677899999
Q ss_pred cCCcccccCCC-ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 018786 215 FGLSVFFKPGD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292 (350)
Q Consensus 215 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
||+|....... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+....+..+......
T Consensus 158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~-- 235 (269)
T d2java1 158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP-- 235 (269)
T ss_dssp HHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC--
T ss_pred ccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence 99998865443 3355789999999998864 5899999999999999999999999999888888888776654322
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCC
Q 018786 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLI 327 (350)
Q Consensus 293 ~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~ 327 (350)
..+++++.+||.+||+.||++|||+.|+|+|||+
T Consensus 236 -~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 -YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 3689999999999999999999999999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-59 Score=423.85 Aligned_cols=261 Identities=28% Similarity=0.551 Sum_probs=237.1
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++++. ||||+++++++.....+++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccccccccc
Confidence 78999999999999999999999999999999997654444455678999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~ 226 (350)
|||+.|++|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc--
Confidence 9999999999999998999999999999999999999999999999999999999 66778999999999887543
Q ss_pred cccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 305 (350)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+.......+. .+++++.+||.
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHHH
Confidence 345689999999998864 5899999999999999999999999999988888888887766543 68999999999
Q ss_pred HhcccCccCCC-----CHHHHHhccCCCCCchhhHHH
Q 018786 306 KMLHADPKERL-----SAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 306 ~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~~ 337 (350)
+||+.||.+|+ |+.|+++|+||.+..|..+..
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~ 307 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQ 307 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHT
T ss_pred HHhhhCHHhccccccccHHHHHcCccccCCCHHHHHh
Confidence 99999999995 999999999999998877653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-59 Score=420.50 Aligned_cols=261 Identities=30% Similarity=0.592 Sum_probs=236.1
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+.++|.+++.||+|+||+||+|.++.+++.||||+++... .....+.+|+++|++++ ||||+++++++.+.+.+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence 35688999999999999999999999999999999997543 23356889999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 144 NLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
|+|||||+|++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++...+||+|||++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccc
Confidence 99999999999999998765 7999999999999999999999999999999999999954 234679999999999877
Q ss_pred CCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 223 PGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.........+|+.|+|||.+. ..++.++|||||||++|+|++|..||.+....+.+..+.+....++...++.++.++.
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 666666778999999999876 4589999999999999999999999999999999999999888877766678999999
Q ss_pred HHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
+||.+||+.||++|||+.|+|+|+||.+.
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=423.13 Aligned_cols=261 Identities=26% Similarity=0.367 Sum_probs=219.0
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
+...++|++++.||+|+||+||+|+++.+|+.||+|+++... .....+++.+|+.++++++ ||||+++++++.+.+.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 78 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 78 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 345689999999999999999999999999999999997543 3344578999999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
+++||||++|++|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||+|...
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCcccc
Confidence 99999999999999999988899999999999999999999997 599999999999999 66778999999999876
Q ss_pred cCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------------
Q 018786 222 KPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFD--------------------- 279 (350)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~--------------------- 279 (350)
.+.. ..+.+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+........
T Consensus 156 ~~~~-~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 156 IDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HHHT-C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred CCCc-cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 4332 345689999999998864 69999999999999999999999997654322110
Q ss_pred ---------------------HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 280 ---------------------AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 280 ---------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.+..... +......++.++.+||.+||+.||.+|||+.|+|+|+||++..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCC--CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCC--ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 0011100 01111236789999999999999999999999999999986544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-58 Score=415.52 Aligned_cols=262 Identities=27% Similarity=0.499 Sum_probs=232.7
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHH-ccCCCCeeEeEeEEEcCCceEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH-LTGHRNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~-l~~h~~iv~~~~~~~~~~~~~i 145 (350)
++|.+++.||+|+||+||+|+++.+++.||||++++.........+.+..|..++.+ ++ ||||+++++++.+.+.+|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~-hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-HPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT-CTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCC-CCcEEEEEEEEccCCceeE
Confidence 579999999999999999999999999999999976543334455677788887764 56 9999999999999999999
Q ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC-
Q 018786 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~- 224 (350)
||||+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence 99999999999999999999999999999999999999999999999999999999 66778999999999875433
Q ss_pred CccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 018786 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (350)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (350)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+..+.+.++. .+++++.+|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dl 233 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDL 233 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHH
Confidence 33455789999999998764 6999999999999999999999999999999999888887766553 579999999
Q ss_pred HHHhcccCccCCCCHH-HHHhccCCCCCchhhHH
Q 018786 304 VKKMLHADPKERLSAA-EVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 304 i~~~L~~dp~~Rps~~-~iL~~~~~~~~~~~~~~ 336 (350)
|.+||+.||++|||+. ++++|+||.+..|..+.
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~ 267 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREINWEELE 267 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHH
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhccCCHHHHH
Confidence 9999999999999995 89999999998776554
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.8e-58 Score=417.70 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=220.6
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHH---HHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE---VQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e---~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
++|.+.+.||+|+||.||+|+++.+|+.||||++.+...........+.+| +.+++.+. ||||+++++++...+.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEEECCEE
Confidence 679999999999999999999999999999999975443233333344444 55555555 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
++||||++|++|.+++.....+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|.....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence 9999999999999999998999999999999999999999999999999999999999 6677899999999987654
Q ss_pred CCccccCCcCcccccccccc-c-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 224 GDVFKDLVGSAYYVAPEVLR-R-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
.. .....||+.|+|||++. + .++.++|||||||++|+|++|+.||............. ............+++++.
T Consensus 160 ~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTMAVELPDSFSPELR 237 (364)
T ss_dssp SC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-HSSSCCCCCCSSSCHHHH
T ss_pred Cc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcccCCCCCCCCCCHHHH
Confidence 43 34568999999999875 3 48999999999999999999999998765433322222 122222222346899999
Q ss_pred HHHHHhcccCccCCCC-----HHHHHhccCCCCCchhhHH
Q 018786 302 DIVKKMLHADPKERLS-----AAEVLSKFLIPKKTLQTLA 336 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps-----~~~iL~~~~~~~~~~~~~~ 336 (350)
+||.+||+.||++||| ++|+++|+||.+..|+.+.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~ 277 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVF 277 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHH
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHh
Confidence 9999999999999999 7999999999998876654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-58 Score=418.84 Aligned_cols=259 Identities=32% Similarity=0.605 Sum_probs=220.2
Q ss_pred ccccceeeee-eeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc---
Q 018786 64 DVRNTYIFGR-ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--- 139 (350)
Q Consensus 64 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--- 139 (350)
.+.++|.+.+ .||+|+||+||+|+++.+++.||||+++.. ..+.+|+.++.++.+||||++++++|.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 3457899875 599999999999999999999999998532 4578899998777569999999998865
Q ss_pred -CCceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 140 -RHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 140 -~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
...+|+|||||+||+|.+++..+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+++.+.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 46789999999999999999874 369999999999999999999999999999999999999876677889999999
Q ss_pred CcccccCCCccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HcCCCCCCCC
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI----LRGHIDFSSD 291 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~----~~~~~~~~~~ 291 (350)
+|.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+ ......++..
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 9998777666677889999999999875 5999999999999999999999999776554443333 3334444444
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.+..+++++.+||.+||+.||++|||+.|+|+|+||.+.
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 445689999999999999999999999999999999654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-56 Score=395.78 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=218.5
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC--
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-- 141 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-- 141 (350)
.+.++|++.+.||+|+||+||+|+++.+|+.||||+++.....+....+++.+|++++++++ ||||+++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA 82 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence 45688999999999999999999999999999999998766656666788999999999998 999999999887543
Q ss_pred --ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 142 --SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 142 --~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
.+|+||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||.+.
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIAR 159 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTCE
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhhh
Confidence 488999999999999999999999999999999999999999999999999999999999 556679999999987
Q ss_pred cccCCC----ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 220 FFKPGD----VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 220 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
...... .....+||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+....+....+.......+....+
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence 653322 3345679999999998865 58999999999999999999999999998888888887776666655567
Q ss_pred CCCHHHHHHHHHhcccCccCCC-CHHHHHh
Q 018786 295 NISSSAKDIVKKMLHADPKERL-SAAEVLS 323 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rp-s~~~iL~ 323 (350)
.+|+++.++|.+||+.||++|| |+.++++
T Consensus 240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~ 269 (277)
T d1o6ya_ 240 GLSADLDAVVLKALAKNPENRYQTAAEMRA 269 (277)
T ss_dssp SCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCHHHHHHHHHHccCCHhHCHhHHHHHHH
Confidence 8999999999999999999999 5666654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=394.57 Aligned_cols=256 Identities=29% Similarity=0.502 Sum_probs=218.0
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChh---hHHHHHHHHHHHHHcc-CCCCeeEeEeEEEcC
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD---DVEDVRREVQIMHHLT-GHRNIVELKGAYEDR 140 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~~e~~~l~~l~-~h~~iv~~~~~~~~~ 140 (350)
+.++|++.+.||+|+||+||+|+++.+|+.||||++.+....... ...++.+|+.+++++. .||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 457899999999999999999999999999999999765432221 2234678999999986 489999999999999
Q ss_pred CceEEEEecCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 141 HSVNLIMDLCAG-GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 141 ~~~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
+..++|||++.+ +++.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++. +++.+||+|||+|.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCE
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--CCCeEEECccccce
Confidence 999999999976 578888888889999999999999999999999999999999999999963 34679999999998
Q ss_pred cccCCCccccCCcCccccccccccc-c-CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 220 FFKPGDVFKDLVGSAYYVAPEVLRR-N-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
..... ......||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.... .+.+....++ +.++
T Consensus 160 ~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~----~~~s 228 (273)
T d1xwsa_ 160 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRVS 228 (273)
T ss_dssp ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----SCCC
T ss_pred ecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCC----CCCC
Confidence 75443 3456789999999998764 3 4678999999999999999999997532 2444444433 3689
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
+++.+||.+||+.||++|||+.|+|+|+||++...+
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~p 264 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCCC
Confidence 999999999999999999999999999999987653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-57 Score=402.18 Aligned_cols=258 Identities=25% Similarity=0.377 Sum_probs=214.4
Q ss_pred eeeeeeccCceEEEEEEEccCCcEEEEEEecccccCCh--hhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEe
Q 018786 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR--DDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (350)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e 148 (350)
.++.||+|+||+||+|+++.+|+.||||++........ ...+.+.+|+.++++++ ||||+++++++..++.+++|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhh
Confidence 35899999999999999999999999999975433221 12356889999999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-cc
Q 018786 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-VF 227 (350)
Q Consensus 149 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-~~ 227 (350)
|+.++++..+......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||.|....... ..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcccc
Confidence 99887776666666779999999999999999999999999999999999999 667789999999998765433 34
Q ss_pred ccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC--------------
Q 018786 228 KDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD-------------- 291 (350)
Q Consensus 228 ~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------- 291 (350)
...+||+.|+|||++. ..++.++|||||||++|||++|..||.+..+.+.+..+.+........
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 5568999999999875 347999999999999999999999999998888777765421111110
Q ss_pred ----------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 292 ----------PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 292 ----------~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.++.+++++.+||.+||+.||++|||+.|+|+|+||.....
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 02356889999999999999999999999999999987654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-56 Score=390.53 Aligned_cols=256 Identities=24% Similarity=0.424 Sum_probs=209.2
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
++...++|.+.+.||+|+||+||+|+.+. .||||+++.... .....+.+.+|+.++++++ ||||+++++++. .+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-AP 76 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSC-CTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe-cc
Confidence 44556889999999999999999997643 599999975543 4456788999999999998 999999999865 45
Q ss_pred ceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.+++||||+++++|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|..
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATV 153 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceee
Confidence 689999999999999999764 569999999999999999999999999999999999999 5667899999999977
Q ss_pred ccCCC---ccccCCcCcccccccccc----ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHcCCCCC-CCC
Q 018786 221 FKPGD---VFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDA-ILRGHIDF-SSD 291 (350)
Q Consensus 221 ~~~~~---~~~~~~gt~~y~aPE~~~----~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~-~~~ 291 (350)
..... ......||+.|+|||++. +.++.++||||||+++|||++|+.||.+......... +.++.... ...
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchh
Confidence 54322 234567999999999874 2478999999999999999999999988765544444 33333222 122
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 292 ~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
...++++++.+||.+||+.||++|||+.|+++++.
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 34578999999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-55 Score=389.80 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=213.9
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
++...++|++.+.||+|+||+||+|.++.+++.||||+++.+. ...+++.+|++++++++ ||||+++++++.+.+
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREP 86 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCC-CCCEecCCccEeeCC
Confidence 4555689999999999999999999999999999999986543 23567999999999998 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 142 SVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
.+++||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSR 163 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTT
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEcccccee
Confidence 999999999999999998764 568999999999999999999999999999999999999 566789999999998
Q ss_pred cccCCCc--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 220 FFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPF-WGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 220 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
....... .....|++.|+|||++. +.++.++||||||+++|||++|..|| ...........+..+.. .. ....
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~-~~--~~~~ 240 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-ME--RPEG 240 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-CC--CCTT
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC-CC--CCcc
Confidence 7654432 23345789999999875 56999999999999999999976665 45555555555544422 22 2246
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
+++++.+||.+||+.||++|||+.|+++.
T Consensus 241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~ 269 (287)
T d1opja_ 241 CPEKVYELMRACWQWNPSDRPSFAEIHQA 269 (287)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=392.70 Aligned_cols=260 Identities=27% Similarity=0.411 Sum_probs=215.5
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++++.||+|+||+||+|.++.+|+.||||+++.... .....+.+.+|+++++++. ||||+++++++.+.+.+++|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEE
Confidence 589999999999999999999999999999999975432 3334578899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 147 MDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
|||+.+ .+.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||.|......
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCC
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCC
Confidence 999965 55555543 4569999999999999999999999999999999999999 56678999999999876433
Q ss_pred -CccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC---------
Q 018786 225 -DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP--------- 292 (350)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------- 292 (350)
.......||+.|+|||++.. .++.++||||||+++|+|++|+.||.+.+..+.+..+...........
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 33455689999999997643 468899999999999999999999998887777666543211111111
Q ss_pred ----------------CCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 293 ----------------WPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 293 ----------------~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
.+.++.++.+||.+||+.||++|||+.|+|+|+||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 2356789999999999999999999999999999987543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-55 Score=389.31 Aligned_cols=251 Identities=22% Similarity=0.372 Sum_probs=205.6
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCc---EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQ---QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
.++|++.+.||+|+||+||+|.++.+++ .||||.+.... .....+.+.+|+++|++++ |||||++++++...+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCE
Confidence 4789999999999999999999986654 58888875432 4455678999999999998 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
+++||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++++||+|||+++..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence 99999999999999988764 569999999999999999999999999999999999999 67788999999999876
Q ss_pred cCCCcc------ccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 222 KPGDVF------KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 222 ~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
...... ....||+.|+|||.+. +.++.++|||||||++|||++ |..||.+....+....+..+..... .
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---~ 255 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP---P 255 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---C
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence 543221 1245789999999876 568999999999999999998 8999999998888888776543222 2
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..++.++.+||.+||+.||++|||+.|+++.+
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L 287 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 36899999999999999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=395.30 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=212.7
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCc-----EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQ-----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
+.-.++|.+++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.++.++.+|||||++++++
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 3445789999999999999999999876543 69999986443 2334467899999999995599999999999
Q ss_pred EcCCceEEEEecCCCCCHHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecC
Q 018786 138 EDRHSVNLIMDLCAGGELFDRIIAKG-----------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194 (350)
Q Consensus 138 ~~~~~~~iv~e~~~~~sL~~~l~~~~-----------------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dl 194 (350)
.+.+.+++||||+++|+|.+++..+. .+++..++.++.||+.||.|||++|||||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 99999999999999999999997542 4789999999999999999999999999999
Q ss_pred CCCceEeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCC
Q 018786 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPF 269 (350)
Q Consensus 195 kp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf 269 (350)
||+||++ +.++.+||+|||+|+....... .....||+.|+|||++. +.++.++|||||||++|||++ |..||
T Consensus 191 Kp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 191 AARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp SGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred chhcccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 9999999 5567799999999987654332 23456899999999875 568999999999999999997 89999
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 270 WGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+......+..+.......+. ...+++++.+||.+||+.||++|||+.|+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 887666555555554433332 236899999999999999999999999999886
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=379.47 Aligned_cols=247 Identities=24% Similarity=0.452 Sum_probs=203.9
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+.+.||+|+||+||+|.+.. ++.||||++.... ...+++.+|++++++++ ||||+++++++...+..++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA----MSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc----CcHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEE
Confidence 679999999999999999999874 6789999986533 23467999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC---------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCC
Confidence 9999999999988764 568999999999999999999999999999999999999 566779999999998765433
Q ss_pred c--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 226 V--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 226 ~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
. .....||+.|+|||++. +.++.++||||||+++|||++ |.+||......+....+..+.....+ ..+++++.
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~ 232 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVY 232 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC---TTSCHHHH
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc---cccCHHHH
Confidence 2 23457899999999886 469999999999999999999 56777777777777777765433322 35789999
Q ss_pred HHHHHhcccCccCCCCHHHHHhcc
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++|.+||+.||++|||+.|+++++
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHHH
Confidence 999999999999999999999873
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=388.48 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=214.8
Q ss_pred ccceeeeeeeeccCceEEEEEEEccC-CcEEEEEEecccccCChhhHHHHHHHHHHHHHcc--CCCCeeEeEeEEE----
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDT-KQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYE---- 138 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~---- 138 (350)
.++|++++.||+|+||+||+|++..+ ++.||||+++..... ......+.+|+.+++.+. .||||+++++++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 47899999999999999999999755 678999999754332 222234667888777763 4999999999874
Q ss_pred -cCCceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecC
Q 018786 139 -DRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (350)
Q Consensus 139 -~~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg 216 (350)
....++++||++.++.+...... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence 34578999999988766544333 4568999999999999999999999999999999999999 667789999999
Q ss_pred CcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------
Q 018786 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS------ 289 (350)
Q Consensus 217 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------ 289 (350)
.+.............||+.|+|||++. ..++.++|||||||++|||++|..||.+....+.+..+........
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 998876666667789999999999875 5699999999999999999999999999888877776643211100
Q ss_pred -----------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 290 -----------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 290 -----------------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
......+++++.+||.+||+.||++|||+.|+|+|+||++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 011245789999999999999999999999999999998753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.9e-55 Score=385.40 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=214.0
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|.+++.||+|+||+||+|+++ +|+.||||++..... .....+++.+|+.+++++. ||||+++++++...+..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEE
Confidence 68999999999999999999986 679999999976543 3334578999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
||++.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||.+.......
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc
Confidence 9999876666665667789999999999999999999999999999999999999 667789999999998765332
Q ss_pred ccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-------------
Q 018786 226 VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS------------- 290 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 290 (350)
......+++.|+|||.+. ..++.++||||||+++|||++|+.||.+....+....+.........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 234457899999999875 34789999999999999999999999988877776665432111110
Q ss_pred ------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCC
Q 018786 291 ------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPK 329 (350)
Q Consensus 291 ------------~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~ 329 (350)
...+.+++++.+||.+||+.||++|||+.|+|+|+||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112356889999999999999999999999999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=374.88 Aligned_cols=247 Identities=24% Similarity=0.421 Sum_probs=216.7
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++++.||+|+||+||+|+++ +++.||||+++.... ..+.+.+|+.+++++. ||||+++++++.+.+.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Confidence 67999999999999999999985 578899999976433 3467999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC
Q 018786 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 225 (350)
|||+++++|.+++.. ...+++..+..++.||++||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSS
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCC
Confidence 999999999988765 4668999999999999999999999999999999999999 667889999999998754433
Q ss_pred c--cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 018786 226 V--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (350)
Q Consensus 226 ~--~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (350)
. .....||+.|+|||.+. +.++.++||||||+++|||++ |+.||......+....+..+.....+ ..+++++.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~ 231 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKVY 231 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc---ccccHHHH
Confidence 2 23467899999999876 568999999999999999998 89999999988888888775433322 36789999
Q ss_pred HHHHHhcccCccCCCCHHHHHhcc
Q 018786 302 DIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 302 ~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+||.+||+.||++|||+.++|+|+
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHHh
Confidence 999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=381.79 Aligned_cols=242 Identities=22% Similarity=0.339 Sum_probs=203.9
Q ss_pred eeeeccCceEEEEEEEc--cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEEEecC
Q 018786 73 RELGRGQFGVTYLVTHK--DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (350)
Q Consensus 73 ~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv~e~~ 150 (350)
++||+|+||+||+|.++ .+++.||||+++.... +....+++.+|++++++++ ||||+++++++..+ ..++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCC-CCCCceEEEEeccC-CEEEEEEcC
Confidence 46999999999999865 3467899999975432 4445678999999999998 99999999998654 578999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCCc----
Q 018786 151 AGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---- 226 (350)
Q Consensus 151 ~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~---- 226 (350)
++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccccc
Confidence 999999999998899999999999999999999999999999999999999 4566799999999987654322
Q ss_pred cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 018786 227 FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (350)
Q Consensus 227 ~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 304 (350)
.....||+.|+|||++. +.++.++||||||+++|||++ |+.||.+....+....+.++.....+ ..+++++.+||
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~~~~~li 243 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---AGCPREMYDLM 243 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTCCHHHHHHH
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC---cccCHHHHHHH
Confidence 22346899999999875 558999999999999999998 89999998888888877765432222 36899999999
Q ss_pred HHhcccCccCCCCHHHHHh
Q 018786 305 KKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 305 ~~~L~~dp~~Rps~~~iL~ 323 (350)
.+||+.||++|||+.++++
T Consensus 244 ~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 244 NLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp HHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999854
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-54 Score=377.95 Aligned_cols=251 Identities=20% Similarity=0.339 Sum_probs=211.8
Q ss_pred CcccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
..++...++|++.+.||+|+||+||+|.++ +++.||||++.... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ 79 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCC-CCCEeEEEeeecc
Confidence 345556689999999999999999999986 46789999996433 23467999999999998 9999999998754
Q ss_pred CCceEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 140 RHSVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
+..++||||+++++|.+++.. ..++++..+..++.||+.||.|||++||+||||||+|||+ ++++.+||+|||+
T Consensus 80 -~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGL 155 (272)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccc
Confidence 567899999999999987754 3369999999999999999999999999999999999999 6678899999999
Q ss_pred cccccCCC--ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 218 SVFFKPGD--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSG-VPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 218 a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
|+...... ......||+.|+|||++. +.++.++||||||+++|||+|| .+||......+....+..+......
T Consensus 156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p--- 232 (272)
T d1qpca_ 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP--- 232 (272)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---
T ss_pred eEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCc---
Confidence 98875443 223457899999999876 5689999999999999999995 5566677777777777665433222
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
..+++++.+||.+||+.||++|||+.++++
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 368999999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=379.70 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=211.1
Q ss_pred ccceeeeee-eeccCceEEEEEEEcc--CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 66 RNTYIFGRE-LGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 66 ~~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
.++|.+.+. ||+|+||+||+|.++. ++..||||+++... .....+++.+|++++++++ |||||++++++.. +.
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EA 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SS
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-Ce
Confidence 467888885 9999999999998764 45579999996432 4455678999999999998 9999999999865 45
Q ss_pred eEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
+++||||+++++|.+++.. +..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhcc
Confidence 8899999999999998765 45799999999999999999999999999999999999994 5667999999999876
Q ss_pred cCCCc----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 222 KPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 222 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... .....||+.|+|||++. +.++.++||||||+++|||++ |..||.+....+....+.++..... .+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~ 236 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPE 236 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTT
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCc
Confidence 54332 23346889999999876 568999999999999999998 9999998888888877776643322 246
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHhc
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLSK 324 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~~ 324 (350)
+++++.+||.+||+.||++|||+.++++.
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~ 265 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQR 265 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999999653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-54 Score=384.99 Aligned_cols=263 Identities=26% Similarity=0.429 Sum_probs=214.9
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc------
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED------ 139 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~------ 139 (350)
-++|++++.||+|+||+||+|+++.+|+.||||++..... ......++.+|++++++++ |+||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccccc
Confidence 3899999999999999999999999999999999876543 3344577889999999998 9999999998754
Q ss_pred --CCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 140 --RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 140 --~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
.+.+++|||++.++.+.........+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecce
Confidence 45689999999776665544556779999999999999999999999999999999999999 6677899999999
Q ss_pred cccccCCC-----ccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 018786 218 SVFFKPGD-----VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS 290 (350)
Q Consensus 218 a~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 290 (350)
+....... .....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.........+.........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 97654222 233457999999999875 35899999999999999999999999988887777666554333322
Q ss_pred CCCCC----------------------------CCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCchh
Q 018786 291 DPWPN----------------------------ISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTLQ 333 (350)
Q Consensus 291 ~~~~~----------------------------~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~~ 333 (350)
..+.. .++++.+||.+||+.||++|||+.|+|+|+||.....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p 314 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 314 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCC
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCC
Confidence 22111 25678899999999999999999999999999976554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=387.01 Aligned_cols=269 Identities=29% Similarity=0.510 Sum_probs=222.4
Q ss_pred ccceeeeeeeeccCceEEEEEEE---ccCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTH---KDTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
.++|++++.||+|+||+||+|++ +.+|+.||||++++.... +....+.+.+|+++++++++||||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 37899999999999999999997 446899999999754321 22234668899999999985589999999999999
Q ss_pred ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.++++|||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhh
Confidence 999999999999999999999999999999999999999999999999999999999999 56678999999999875
Q ss_pred cCCC--ccccCCcCccccccccccc---cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 222 KPGD--VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 222 ~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... ......|++.|++||.+.+ .++.++|||||||++|+|++|..||.+.........+.+..........+.+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 4332 2345679999999998753 4788999999999999999999999776544333333322211222222368
Q ss_pred CHHHHHHHHHhcccCccCCC-----CHHHHHhccCCCCCchhhHHH
Q 018786 297 SSSAKDIVKKMLHADPKERL-----SAAEVLSKFLIPKKTLQTLAD 337 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rp-----s~~~iL~~~~~~~~~~~~~~~ 337 (350)
++++.+||.+||+.||++|| |++|+|+|+||++..|..+..
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~ 305 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA 305 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHh
Confidence 99999999999999999999 589999999999988766554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-53 Score=384.88 Aligned_cols=257 Identities=25% Similarity=0.479 Sum_probs=213.4
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc--CCc
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHS 142 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~ 142 (350)
..++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+++.+|+++|+++.+||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 347899999999999999999999999999999998643 246789999999999779999999999874 456
Q ss_pred eEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCccccc
Q 018786 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 222 (350)
+++||||+.+++|... .+.+++..++.++.||+.||.|||++||+||||||+|||++. +++.+||+|||+|....
T Consensus 107 ~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~--~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 107 PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCGGGCEECC
T ss_pred eeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC--CCCeeeecccccceecc
Confidence 9999999999998664 356999999999999999999999999999999999999963 34469999999999877
Q ss_pred CCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHc-------------CCC
Q 018786 223 PGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILR-------------GHI 286 (350)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~-------------~~~ 286 (350)
.........+|+.|+|||.+.+ .++.++||||+|+++|+|++|..||..... .+....+.. ...
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 7666777889999999998653 479999999999999999999999976543 222222111 000
Q ss_pred C--------------------CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 287 D--------------------FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 287 ~--------------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
. ........+++++.+||++||+.||++|||++|+|+|+||+...|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0 011112246889999999999999999999999999999988655
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=388.79 Aligned_cols=254 Identities=29% Similarity=0.424 Sum_probs=210.1
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc------C
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED------R 140 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~------~ 140 (350)
.+|+.+++||+|+||+||+|+++.+|+.||||++..... ...+|++++++++ |+||+++++++.. .
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCc
Confidence 479999999999999999999999999999999975432 2347999999998 9999999998843 3
Q ss_pred CceEEEEecCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 141 HSVNLIMDLCAGGELFDRI---IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
.++++||||++++.+..+. .....+++..++.++.||+.||+|||++||+||||||+|||++. ++..+||+|||+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~--~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGS 169 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TTCCEEECCCTT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec--CCCceeEecccc
Confidence 4578999999765333322 23567999999999999999999999999999999999999952 234799999999
Q ss_pred cccccCCCccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH---------- 285 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~---------- 285 (350)
+.............||+.|+|||.+. ..++.++|||||||++|||++|..||......+.+..+.+..
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 99887776677788999999999764 358999999999999999999999999888777666554311
Q ss_pred -------CCCC--------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 286 -------IDFS--------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 286 -------~~~~--------~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
..++ ....+.+++++.+||.+||+.||++|||+.|+|+|+||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0000 01123578999999999999999999999999999999754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-53 Score=372.24 Aligned_cols=252 Identities=22% Similarity=0.364 Sum_probs=204.7
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCC----cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTK----QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 140 (350)
..+.|.+.+.||+|+||+||+|.++.++ ..||||++.... .......+.+|++++++++ |||||++++++...
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKY 81 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecC
Confidence 3467999999999999999999987654 479999986432 3444567899999999998 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 141 HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 141 ~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
+..++||||+.++++.+.+... +.+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhh
Confidence 9999999999999999887654 579999999999999999999999999999999999999 667889999999998
Q ss_pred cccCCC----ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 018786 220 FFKPGD----VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSG-VPPFWGETEQSIFDAILRGHIDFSSDPW 293 (350)
Q Consensus 220 ~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
...... ......||+.|+|||++. +.++.++||||||+++|||++| .+|+......+....+..+..... .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---~ 235 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT---P 235 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---C
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC---c
Confidence 764332 122346899999999876 4689999999999999999995 455666666777776665533222 2
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 294 PNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 294 ~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..++.++.+||.+||+.||++|||+.|+++.+
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence 36889999999999999999999999998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-53 Score=373.98 Aligned_cols=259 Identities=24% Similarity=0.434 Sum_probs=219.1
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceEEE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~iv 146 (350)
++|++++.||+|+||+||+|+++.+++.||||+++.... ......++.+|+.++++++ |+||+++++++......+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEE
Confidence 589999999999999999999999999999999976543 4455688999999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCCC-
Q 018786 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (350)
Q Consensus 147 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~- 225 (350)
++++.++++..++...+.+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||.+.......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc
Confidence 9999999998888888899999999999999999999999999999999999999 556679999999998865433
Q ss_pred ccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCCCC--------------
Q 018786 226 VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFW-GETEQSIFDAILRGHIDF-------------- 288 (350)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~-------------- 288 (350)
......+++.|+|||.+.+ .++.++|||||||++|||++|+.||. +....+....+.......
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 3344567888999998753 37899999999999999999999864 445555555443211111
Q ss_pred -----------CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCC
Q 018786 289 -----------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKK 330 (350)
Q Consensus 289 -----------~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~ 330 (350)
.....+.+++++.+||.+||+.||.+|||+.|+|+|+||.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 011123568899999999999999999999999999999753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=385.06 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=212.7
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC--
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-- 141 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-- 141 (350)
.+.++|++++.||+|+||+||+|.++.+|+.||||+++... ......+.+.+|+++|+++. ||||+++++++...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETL 92 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSST
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCccc
Confidence 36789999999999999999999999999999999997543 34455678999999999998 999999999987554
Q ss_pred ----ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCC
Q 018786 142 ----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (350)
Q Consensus 142 ----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~ 217 (350)
.+++||||+ +.+|..+++ ++.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||.
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGL 167 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred cccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccc
Confidence 579999999 667766554 5679999999999999999999999999999999999999 6677899999999
Q ss_pred cccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------
Q 018786 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID-------- 287 (350)
Q Consensus 218 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------- 287 (350)
|...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 168 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 168 ARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 9886543 356789999999998753 4789999999999999999999999888776655444321111
Q ss_pred ---------------CCC----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 288 ---------------FSS----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 288 ---------------~~~----~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
... ...+.+++++.+||.+||+.||++|||+.|+|+|+||....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 111 12346789999999999999999999999999999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=372.53 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=205.1
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccC---CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 139 (350)
+...++|.+++.||+|+||+||+|.+..+ +..||||.++.. ......+.+.+|+.++++++ ||||+++++++.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT- 78 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-
Confidence 34457999999999999999999998654 456888887533 24455678999999999998 999999999985
Q ss_pred CCceEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 140 RHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 140 ~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
.+.+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+|
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS 155 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC----
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchhh
Confidence 4678999999999999998765 45699999999999999999999999999999999999994 4566999999999
Q ss_pred ccccCCC--ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 018786 219 VFFKPGD--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (350)
Q Consensus 219 ~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
....... ......||+.|+|||++. +.++.++||||||+++|||++ |.+||......+....+..+.... ..+
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~---~~~ 232 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPP 232 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCT
T ss_pred eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCC
Confidence 8765332 223456889999999886 568999999999999999998 899999988888888877764332 234
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 295 NISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 295 ~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
++++++.+||.+||+.||++|||+.|+++++
T Consensus 233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L 263 (273)
T d1mp8a_ 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 263 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 7899999999999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=368.09 Aligned_cols=256 Identities=22% Similarity=0.357 Sum_probs=208.8
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 141 (350)
++.-.++|++.+.||+|+||+||+|.++.+ +.||||+++... ...+.+.+|+.++++++ |+|||++++++.+ +
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E 84 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc----CCHHHHHHHHHHHHhcc-cCCEeEEEEEEec-C
Confidence 444568899999999999999999999765 579999996543 23467999999999998 9999999999854 5
Q ss_pred ceEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 142 SVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
.+++||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~ 161 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 161 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhh
Confidence 67899999999999888754 4569999999999999999999999999999999999999 556789999999998
Q ss_pred cccCCC--ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 220 FFKPGD--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSG-VPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 220 ~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
...... ......||+.|+|||++. +.++.++||||||+++|||++| .+|+......+.+..+..+.... ..+.
T Consensus 162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~---~~~~ 238 (285)
T d1fmka3 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPE 238 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTT
T ss_pred hccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---CCcc
Confidence 764333 223457899999999875 5689999999999999999995 55566667777777776653322 2246
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHh--ccCCCCC
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLS--KFLIPKK 330 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~--~~~~~~~ 330 (350)
+++++.++|.+||+.||++|||+.++++ +.|+...
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 8999999999999999999999999987 6677554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=381.73 Aligned_cols=261 Identities=28% Similarity=0.443 Sum_probs=210.9
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCC--
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-- 141 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-- 141 (350)
.+..+|++++.||+|+||+||+|.++.+|+.||||++.+.. .....+++.+|+.+|+++. ||||+++++++....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecccc
Confidence 35578999999999999999999999999999999996433 3445678899999999998 999999999986543
Q ss_pred --ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 142 --SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 142 --~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
..+++++++.+++|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLAR 157 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred ccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCcee
Confidence 23444556668999998865 479999999999999999999999999999999999999 667789999999998
Q ss_pred cccCCC----ccccCCcCcccccccccc--ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------
Q 018786 220 FFKPGD----VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID------ 287 (350)
Q Consensus 220 ~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~------ 287 (350)
...... .....+||+.|+|||++. ..++.++||||+|+++|+|++|+.||.+....+...........
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 754332 234567999999999874 34789999999999999999999999887765554443221100
Q ss_pred -----------------CCC----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 288 -----------------FSS----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 288 -----------------~~~----~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
... ..++.++.++.+||.+||+.||.+|||+.|+|+|+||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 000 11346788999999999999999999999999999998544
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-53 Score=377.15 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=209.8
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcE--EEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQ--FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
++|++.+.||+|+||+||+|.++.++.. ||||.+... ......+.+.+|+++++++.+||||+++++++..++..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 7899999999999999999999988775 566666432 233445679999999999955999999999999999999
Q ss_pred EEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCC
Q 018786 145 LIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~ 208 (350)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCC
Confidence 999999999999998653 568999999999999999999999999999999999999 5567
Q ss_pred CeEEeecCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHcCCC
Q 018786 209 PLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGV-PPFWGETEQSIFDAILRGHI 286 (350)
Q Consensus 209 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~-~pf~~~~~~~~~~~~~~~~~ 286 (350)
.+||+|||++.............||..|+|||.+. +.++.++||||||+++|||++|. +||.+....+....+.++..
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence 79999999998765554445567899999999875 56899999999999999999965 57888888888877766532
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.. ....+++++.+||.+||+.||++|||+.|+++++
T Consensus 245 ~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 245 LE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp CC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CC---CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 21 2236899999999999999999999999999873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=368.03 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=202.9
Q ss_pred ccceeeeeeeeccCceEEEEEEEccC---CcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
.++|++.+.||+|+||.||+|+.... ...||||++.+.........+++.+|+.++++++ ||||+++++++.+ ..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PP 84 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-cc
Confidence 36799999999999999999986532 2468999998766555666788999999999998 9999999999965 46
Q ss_pred eEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.++||||++++++.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~---~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRAL 161 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc---cccceeeccchhhhhc
Confidence 7899999999999987765 45699999999999999999999999999999999999995 4567999999999886
Q ss_pred cCCCc----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 018786 222 KPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (350)
Q Consensus 222 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... .....|+..|+|||.+. ..++.++||||||+++|||++ |..||.+....+....+.+.....+. .+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~ 239 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED 239 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--ccc
Confidence 44322 22345788999999876 458999999999999999998 89999999999888888776544432 347
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 296 ISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 296 ~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
++.++.+||.+||+.||++|||+.++++
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999999999999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=371.82 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=200.3
Q ss_pred ccccceeeeeeeeccCceEEEEEEEcc-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 138 (350)
...++|++.+.||+|+||.||+|.+.. +++.||||+++... .....+.+.+|...+.++..|+||+.+++++.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 445789999999999999999999754 35689999986433 34445678889999999877999999999875
Q ss_pred c-CCceEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEe
Q 018786 139 D-RHSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLF 201 (350)
Q Consensus 139 ~-~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~ 201 (350)
. +..+++||||+++++|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||+
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 4 45689999999999999999753 248899999999999999999999999999999999999
Q ss_pred ecCCCCCCeEEeecCCcccccCCC---ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhC-CCCCCCCCHHH
Q 018786 202 SSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSG-VPPFWGETEQS 276 (350)
Q Consensus 202 ~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g-~~pf~~~~~~~ 276 (350)
+.++.+||+|||+|+...... ......||+.|+|||++. +.++.++|||||||++|||++| ..||.+....+
T Consensus 168 ---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 168 ---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp ---CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ---CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 566789999999998654332 233457999999999876 4589999999999999999986 56787665444
Q ss_pred HH-HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 277 IF-DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 277 ~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.+ ..+..+... . ....+++++.++|.+||+.||++|||+.|+++|+
T Consensus 245 ~~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L 291 (299)
T d1ywna1 245 EFCRRLKEGTRM-R--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291 (299)
T ss_dssp HHHHHHHHTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhcCCCC-C--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 33 444443322 1 1235799999999999999999999999999884
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=374.09 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=205.5
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCc----EEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQ----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
.+|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.++++++ ||||+++++++.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-C
Confidence 569999999999999999999987776 57888775332 3345678999999999998 99999999998765 4
Q ss_pred eEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccc
Q 018786 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (350)
Q Consensus 143 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 221 (350)
.+++++++.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|...
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceec
Confidence 67788888899999888764 569999999999999999999999999999999999999 45667999999999876
Q ss_pred cCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 018786 222 KPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (350)
Q Consensus 222 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
..... .....||+.|+|||++. +.++.++||||||+++|||+| |..||.+....+....+.++...... +.+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p---~~~ 238 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---PIC 238 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC---TTB
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC---ccc
Confidence 43322 23346899999999875 568999999999999999998 89999988877777777665432221 368
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHhccC
Q 018786 297 SSSAKDIVKKMLHADPKERLSAAEVLSKFL 326 (350)
Q Consensus 297 ~~~l~~li~~~L~~dp~~Rps~~~iL~~~~ 326 (350)
+.++.+||.+||+.||++|||+.|+++++.
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence 999999999999999999999999998854
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-52 Score=370.28 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=216.0
Q ss_pred cccccceeeeeeeeccCceEEEEEEEc-----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 137 (350)
+.-.++|.+.+.||+|+||+||+|+.+ .+++.||||+++... .....+++.+|++++++++ |+||+++++++
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~ 85 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVC 85 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceeee
Confidence 344678999999999999999999975 356789999986433 4445678999999999998 99999999999
Q ss_pred EcCCceEEEEecCCCCCHHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeec
Q 018786 138 EDRHSVNLIMDLCAGGELFDRIIAKG------------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRD 193 (350)
Q Consensus 138 ~~~~~~~iv~e~~~~~sL~~~l~~~~------------------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~D 193 (350)
...+..+++|||+++++|.+++.... .+++..+..++.||+.||+|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999986532 378999999999999999999999999999
Q ss_pred CCCCceEeecCCCCCCeEEeecCCcccccCCC---ccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCC-CC
Q 018786 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGV-PP 268 (350)
Q Consensus 194 lkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~-~p 268 (350)
|||+|||+ +.++.+||+|||+|....... ......|++.|+|||.+. ..++.++||||||+++|||++|. .|
T Consensus 166 lKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 166 LATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EcccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999 566779999999997654332 223467889999999876 46999999999999999999985 68
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
|.+....+....+.++..... ...+++++.+||.+||+.||++|||+.|+++.+
T Consensus 243 ~~~~~~~e~~~~v~~~~~~~~---p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp TTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999998888888887654322 236899999999999999999999999997643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=366.90 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=212.8
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEccCC-------cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTK-------QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~ 134 (350)
++...++|.+++.||+|+||.||+|++..++ ..||||+++... .......+.+|...+.++.+||||++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 3445689999999999999999999976543 479999986543 3445678999999999996699999999
Q ss_pred eEEEcCCceEEEEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCc
Q 018786 135 GAYEDRHSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (350)
Q Consensus 135 ~~~~~~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~N 198 (350)
+++.+.+..++||||+++|+|.+++..+ ..+++..++.++.||+.||+|||+++||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 9999999999999999999999999754 348999999999999999999999999999999999
Q ss_pred eEeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 018786 199 FLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGET 273 (350)
Q Consensus 199 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~ 273 (350)
||+ +.++.+||+|||++........ .....+++.|+|||.+. +.++.++||||||+++|||++ |..||.+..
T Consensus 166 iLl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 166 VLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EEE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999 6677899999999987654432 23457899999999875 569999999999999999998 789998888
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
.......+..+..... ...+++++.+||.+||+.||++|||+.|+++.+
T Consensus 243 ~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 243 VEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp HHHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCC---CccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 8877777766533222 236899999999999999999999999998754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=380.55 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=203.4
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE------
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE------ 138 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~------ 138 (350)
+.++|++++.||+|+||+||+|+++.+|+.||||++..... +.....++.+|+.++++++ ||||+++++++.
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccccc
Confidence 34789999999999999999999999999999999976543 4556678999999999998 999999999985
Q ss_pred cCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 139 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
....+|+||||+.+ ++.+.+ ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|++|||++
T Consensus 93 ~~~~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 93 EFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 166 (355)
T ss_dssp TCCEEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-
T ss_pred cCceeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhh
Confidence 34688999999966 454444 3568999999999999999999999999999999999999 56677999999999
Q ss_pred ccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI----------- 286 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~----------- 286 (350)
.............+|+.|+|||++. ..++.++||||+||++|+|++|+.||.+.........+.....
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 8877666667778999999999876 4589999999999999999999999988877665554432111
Q ss_pred -----------CCCCCCC----------------CCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCch
Q 018786 287 -----------DFSSDPW----------------PNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKTL 332 (350)
Q Consensus 287 -----------~~~~~~~----------------~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~~ 332 (350)
......+ ...++++.+||++||+.||++|||++|+|+|+||.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 1110000 012567899999999999999999999999999987543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=362.17 Aligned_cols=247 Identities=22% Similarity=0.358 Sum_probs=203.0
Q ss_pred cccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEE-cCC
Q 018786 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE-DRH 141 (350)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~-~~~ 141 (350)
+...++|++.+.||+|+||.||+|.++ |..||||+++.+. ..+.+.+|++++++++ ||||+++++++. ..+
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 74 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCC
Confidence 344578999999999999999999985 6789999996432 3467999999999998 999999999884 456
Q ss_pred ceEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcc
Q 018786 142 SVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (350)
Q Consensus 142 ~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~ 219 (350)
.+++||||+++++|.+++..++ .+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++.
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccce
Confidence 7899999999999999986543 48999999999999999999999999999999999999 667789999999998
Q ss_pred cccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 220 FFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
..... .....++..|+|||.+. +.++.++||||||+++|||+| |..||......+....+.++..... .+.++
T Consensus 152 ~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~ 226 (262)
T d1byga_ 152 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---PDGCP 226 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC---CTTCC
T ss_pred ecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CccCC
Confidence 75433 34456889999999875 569999999999999999998 7899988888887777765433222 23578
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+++.+||.+||+.||.+|||+.++++++
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 9999999999999999999999998864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=379.19 Aligned_cols=260 Identities=26% Similarity=0.397 Sum_probs=213.3
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcC---
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 140 (350)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+... +....+++.+|++++++++ |+||+++++++...
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSST
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeecccc
Confidence 346789999999999999999999999999999999975432 4445678899999999998 99999999998532
Q ss_pred --CceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCc
Q 018786 141 --HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 141 --~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a 218 (350)
...+++++++.|++|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|++|||.+
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA 168 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC---
T ss_pred ccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchh
Confidence 334566677779999987754 579999999999999999999999999999999999999 66778999999999
Q ss_pred ccccCCCccccCCcCccccccccccc--cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------
Q 018786 219 VFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS------- 289 (350)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------- 289 (350)
..... ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+.......+........
T Consensus 169 ~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 169 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp -CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 77532 3356679999999997543 478999999999999999999999998887766666544322111
Q ss_pred ----------------CC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHhccCCCCCc
Q 018786 290 ----------------SD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLSKFLIPKKT 331 (350)
Q Consensus 290 ----------------~~----~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~~~~~~~ 331 (350)
.. .+..+++++.+||.+||+.||.+|||+.|+|+|+||.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00 1235789999999999999999999999999999998653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=362.23 Aligned_cols=255 Identities=27% Similarity=0.383 Sum_probs=212.4
Q ss_pred ccccccceeeeeeeeccCceEEEEEEEc-----cCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeE
Q 018786 62 MEDVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (350)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 136 (350)
++.-.++|.+++.||+|+||.||+|++. .+++.||||+++... .......+.+|+.+++++.+||||++++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4455689999999999999999999863 457789999997543 344556799999999999669999999999
Q ss_pred EEcCCceEEEEecCCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCc
Q 018786 137 YEDRHSVNLIMDLCAGGELFDRIIAKG------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (350)
Q Consensus 137 ~~~~~~~~iv~e~~~~~sL~~~l~~~~------------------~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~N 198 (350)
+.+.+..++||||+++++|.+++.... .+++..+..++.||+.||.|||++|||||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 999999999999999999999987543 58899999999999999999999999999999999
Q ss_pred eEeecCCCCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 018786 199 FLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGET 273 (350)
Q Consensus 199 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~-g~~pf~~~~ 273 (350)
|++ +.++.+||+|||.+........ .....||+.|+|||.+. +.++.++||||||+++|||++ |.+||....
T Consensus 176 Il~---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 176 ILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccc---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 999 5566799999999987654322 23457899999999876 568999999999999999998 666676666
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
..+.+..+.........+ ..++.++.+||.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 555554444332222221 357899999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=360.30 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=218.7
Q ss_pred cccccccceeeeeeeeccCceEEEEEEEcc-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEe
Q 018786 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKG 135 (350)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~ 135 (350)
.++...++|.+.+.||+|+||+||+|.++. ++..||||+++... .......+.+|+++++++. ||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~ 90 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLG 90 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCCEeeeee
Confidence 355667999999999999999999998853 35789999996432 4445567899999999998 999999999
Q ss_pred EEEcCCceEEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC
Q 018786 136 AYEDRHSVNLIMDLCAGGELFDRIIAK----------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205 (350)
Q Consensus 136 ~~~~~~~~~iv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 205 (350)
++...+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+ +
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d 167 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---A 167 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---C
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---c
Confidence 999999999999999999999988642 246889999999999999999999999999999999999 6
Q ss_pred CCCCeEEeecCCcccccCCCc---cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHH
Q 018786 206 EDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSG-VPPFWGETEQSIFDA 280 (350)
Q Consensus 206 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g-~~pf~~~~~~~~~~~ 280 (350)
.++.+||+|||++........ .....||+.|+|||.+. +.++.++||||||+++|||++| ..||.+....+.+..
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~ 247 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 778899999999986543322 23446899999999876 5588999999999999999998 588888888888888
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+.++...... +.++..+.++|.+||+.||++|||+.++++++
T Consensus 248 i~~~~~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L 289 (308)
T d1p4oa_ 248 VMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289 (308)
T ss_dssp HHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhCCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 8776543222 36789999999999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-50 Score=361.34 Aligned_cols=257 Identities=21% Similarity=0.290 Sum_probs=204.3
Q ss_pred cccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCceE
Q 018786 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (350)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 144 (350)
++++|++++.||+|+||+||+|++..+|+.||||++..... .+++.+|+++++++.+|++|+.+..++...+..+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 45789999999999999999999999999999999865432 1347889999999985566777777888899999
Q ss_pred EEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccC
Q 018786 145 LIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (350)
Q Consensus 145 iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 223 (350)
+||||+ ++++.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++..+.+..+||+|||+|.....
T Consensus 80 ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999999 5566666554 56799999999999999999999999999999999999997666677899999999988654
Q ss_pred CC--------ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HcCCCCC-CC
Q 018786 224 GD--------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI---LRGHIDF-SS 290 (350)
Q Consensus 224 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~-~~ 290 (350)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..||...........+ ....... ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 32 2234579999999998765 5899999999999999999999999776543332221 1111111 11
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCCCCHHHH---HhccCC
Q 018786 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEV---LSKFLI 327 (350)
Q Consensus 291 ~~~~~~~~~l~~li~~~L~~dp~~Rps~~~i---L~~~~~ 327 (350)
...+++|+++.++|..||+.||++||++.++ |+++|.
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 1234689999999999999999999998755 556554
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=355.28 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=200.9
Q ss_pred eeeeeeeccCceEEEEEEEccCC---cEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEc-CCceEE
Q 018786 70 IFGRELGRGQFGVTYLVTHKDTK---QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-RHSVNL 145 (350)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~-~~~~~i 145 (350)
.+.++||+|+||+||+|.+..++ ..||||.++. ..+....+++.+|++++.+++ ||||+++++++.. ++..++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC--CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc--ccCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEE
Confidence 34688999999999999986543 3689999863 235556788999999999998 9999999998754 568999
Q ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEeecCCcccccCC
Q 018786 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (350)
Q Consensus 146 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 224 (350)
||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+ ++++.+||+|||++......
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTT
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccc
Confidence 99999999999988754 457888999999999999999999999999999999999 66778999999999876433
Q ss_pred Cc-----cccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCCCC
Q 018786 225 DV-----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDFSSDPWPNIS 297 (350)
Q Consensus 225 ~~-----~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.. .....||+.|+|||.+. +.++.++||||||+++|||++|..||.... ..+....+..+.....+ +.++
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p---~~~~ 260 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EYCP 260 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC---TTCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc---ccCc
Confidence 22 22356899999999875 568999999999999999999777775543 33445555555433222 3678
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 298 SSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 298 ~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
+++.+||.+||+.||++|||+.|+++++
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~L 288 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSRI 288 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999999999999999999999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.5e-49 Score=348.63 Aligned_cols=254 Identities=22% Similarity=0.272 Sum_probs=206.8
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.++++|++++.||+|+||+||+|++..+|+.||||++..... .+.+.+|++.++.+.+|+|++.+++++......
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 356899999999999999999999999999999999864332 234778999999998679999999999999999
Q ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCC--CCCCeEEeecCCccc
Q 018786 144 NLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--EDSPLKATDFGLSVF 220 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~~~vkl~Dfg~a~~ 220 (350)
++|||++ +++|.+++... ..++...+..++.|++.||+|||++||+||||||+|||++... .++.+||+|||+|+.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999 77999988765 4699999999999999999999999999999999999996432 356799999999987
Q ss_pred ccCCC--------ccccCCcCccccccccccc-cCCcchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCC-C
Q 018786 221 FKPGD--------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET---EQSIFDAILRGHI-D 287 (350)
Q Consensus 221 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Dv~slG~vl~~ll~g~~pf~~~~---~~~~~~~~~~~~~-~ 287 (350)
..... ......||+.|+|||++.+ .++.++||||||+++|||++|..||.+.. .......+..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 64331 2334679999999998764 59999999999999999999999997543 2222322222111 1
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHh
Q 018786 288 FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLS 323 (350)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rps~~~iL~ 323 (350)
......+++|+++.+++..|++.+|++||++..+.+
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 111122468999999999999999999998776543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=347.16 Aligned_cols=247 Identities=21% Similarity=0.294 Sum_probs=190.0
Q ss_pred ccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHH--HHHHHHHHccCCCCeeEeEeEEEcCC--
Q 018786 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHLTGHRNIVELKGAYEDRH-- 141 (350)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~--~e~~~l~~l~~h~~iv~~~~~~~~~~-- 141 (350)
..+|.+.+.||+|+||.||+|+. +|+.||||+++.+. ..... .|+..+.+++ ||||+++++++...+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~ 72 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGT 72 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCc
Confidence 46799999999999999999986 47899999986432 23333 4555555677 999999999986543
Q ss_pred --ceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--------cCCEeecCCCCceEeecCCCCCCeE
Q 018786 142 --SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS--------MGVMHRDLKPENFLFSSSAEDSPLK 211 (350)
Q Consensus 142 --~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~--------~~ivH~Dlkp~NIl~~~~~~~~~vk 211 (350)
.+++||||+++++|.+++++. ++++..+..++.|++.||.|||+ +||+||||||+|||+ +.++.+|
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~K 148 (303)
T d1vjya_ 73 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCC 148 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEE
T ss_pred ceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeE
Confidence 589999999999999999764 68999999999999999999996 599999999999999 6678899
Q ss_pred EeecCCcccccCCC-----ccccCCcCcccccccccccc-------CCcchhHHHHHHHHHHHHhCCCCCCCC-------
Q 018786 212 ATDFGLSVFFKPGD-----VFKDLVGSAYYVAPEVLRRN-------YGAEADIWSAGVILYILLSGVPPFWGE------- 272 (350)
Q Consensus 212 l~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~Dv~slG~vl~~ll~g~~pf~~~------- 272 (350)
|+|||++....... ......||+.|+|||++.+. ++.++||||||+++|||++|..||...
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 99999998764432 22456799999999987642 567899999999999999998876321
Q ss_pred --------CHHHHHHHHHcCCCCCCCC-CC--CCCCHHHHHHHHHhcccCccCCCCHHHHHhcc
Q 018786 273 --------TEQSIFDAILRGHIDFSSD-PW--PNISSSAKDIVKKMLHADPKERLSAAEVLSKF 325 (350)
Q Consensus 273 --------~~~~~~~~~~~~~~~~~~~-~~--~~~~~~l~~li~~~L~~dp~~Rps~~~iL~~~ 325 (350)
..................+ .+ ......+.+|+.+||+.||++|||+.|+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L 292 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 1122233333222211110 00 11234689999999999999999999998764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-44 Score=326.35 Aligned_cols=263 Identities=23% Similarity=0.412 Sum_probs=195.4
Q ss_pred cccc-cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHcc----------CCCCee
Q 018786 63 EDVR-NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT----------GHRNIV 131 (350)
Q Consensus 63 ~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~----------~h~~iv 131 (350)
+.+. ++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+++.+. +|+||+
T Consensus 8 ~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 3443 56999999999999999999999999999999997543 23466788999888875 267899
Q ss_pred EeEeEEEc--CCceEEEEecCCCCC-HHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeecCCCCceEeecCC
Q 018786 132 ELKGAYED--RHSVNLIMDLCAGGE-LFDRII--AKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSA 205 (350)
Q Consensus 132 ~~~~~~~~--~~~~~iv~e~~~~~s-L~~~l~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~ 205 (350)
++++++.. ....+++++++.... ...... ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163 (362)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence 99988753 345566666654443 333332 24568999999999999999999998 8999999999999997543
Q ss_pred CC---CCeEEeecCCcccccCCCccccCCcCcccccccccc-ccCCcchhHHHHHHHHHHHHhCCCCCCCCCHH------
Q 018786 206 ED---SPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQ------ 275 (350)
Q Consensus 206 ~~---~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Dv~slG~vl~~ll~g~~pf~~~~~~------ 275 (350)
.. ..++++|||.+...... ....+||+.|+|||++. ..++.++|+||+|+++++|++|+.||......
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cccccceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 22 24899999999875433 35668999999999865 56899999999999999999999999654321
Q ss_pred HHHHHHHcC--C------------------C----CCCC--------------CCCCCCCHHHHHHHHHhcccCccCCCC
Q 018786 276 SIFDAILRG--H------------------I----DFSS--------------DPWPNISSSAKDIVKKMLHADPKERLS 317 (350)
Q Consensus 276 ~~~~~~~~~--~------------------~----~~~~--------------~~~~~~~~~l~~li~~~L~~dp~~Rps 317 (350)
+........ . . .... ......++++.+||.+||+.||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 111111100 0 0 0000 001123577899999999999999999
Q ss_pred HHHHHhccCCCCCc
Q 018786 318 AAEVLSKFLIPKKT 331 (350)
Q Consensus 318 ~~~iL~~~~~~~~~ 331 (350)
++|+|+|+||+...
T Consensus 322 a~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 322 AGGLVNHPWLKDTL 335 (362)
T ss_dssp HHHHHTCGGGTTCT
T ss_pred HHHHhcCcccCCCC
Confidence 99999999998553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=3e-27 Score=195.39 Aligned_cols=167 Identities=18% Similarity=0.172 Sum_probs=122.9
Q ss_pred eeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccC-----C----------hhhHHHHHHHHHHHHHccCCCCeeEe
Q 018786 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-----N----------RDDVEDVRREVQIMHHLTGHRNIVEL 133 (350)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~----------~~~~~~~~~e~~~l~~l~~h~~iv~~ 133 (350)
+.+++.||+|+||+||+|.+. +|+.||||+++..... . ........+|...+.++. |.+++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence 568899999999999999986 5889999987532110 0 011234567888999998 8999888
Q ss_pred EeEEEcCCceEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeecCCCCceEeecCCCCCCeEEe
Q 018786 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (350)
Q Consensus 134 ~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~vkl~ 213 (350)
+++. ..+++||++++..+. .++...+..++.||+.+|.+||++||+||||||+|||++. ..++|+
T Consensus 80 ~~~~----~~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~----~~~~li 144 (191)
T d1zara2 80 YAWE----GNAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE----EGIWII 144 (191)
T ss_dssp EEEE----TTEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET----TEEEEC
T ss_pred EEec----CCEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC----CCEEEE
Confidence 7653 236999999886553 2566667889999999999999999999999999999963 238999
Q ss_pred ecCCcccccCCCccccCCcCccccc------cccccccCCcchhHHHHHHHH
Q 018786 214 DFGLSVFFKPGDVFKDLVGSAYYVA------PEVLRRNYGAEADIWSAGVIL 259 (350)
Q Consensus 214 Dfg~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~Dv~slG~vl 259 (350)
|||.|....+.... .|.. .+.+.+.++.++|+||+.--+
T Consensus 145 DFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99999875433221 1111 123345688999999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.80 E-value=1.4e-08 Score=85.93 Aligned_cols=144 Identities=17% Similarity=0.150 Sum_probs=96.3
Q ss_pred ccccceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCce
Q 018786 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (350)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 143 (350)
.+...|+..+..+.++.+.||+... +++.++||+........ ...+.+|...+..+..+--+++++.+....+..
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 3446677777766666789998753 35668889876443222 234678888888887555577888888888899
Q ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 018786 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS------------------------------------- 186 (350)
Q Consensus 144 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~------------------------------------- 186 (350)
++||++++|.++.+..... .....++.++...+..||+
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 9999999998775433211 1112233334444444442
Q ss_pred ----------------------cCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 187 ----------------------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 187 ----------------------~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
..++|+|+.|.||+++ +++.+-|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec---CCceEEEeechhccc
Confidence 1278999999999995 344456999998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.56 E-value=1.5e-07 Score=84.47 Aligned_cols=82 Identities=11% Similarity=0.149 Sum_probs=52.3
Q ss_pred eeeeeccCceEEEEEEEccCCcEEEEEEecccccC----ChhhHHHHHHHHHHHHHccCC--CCeeEeEeEEEcCCceEE
Q 018786 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI----NRDDVEDVRREVQIMHHLTGH--RNIVELKGAYEDRHSVNL 145 (350)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~e~~~l~~l~~h--~~iv~~~~~~~~~~~~~i 145 (350)
.+.||.|....||++.+..+++.++||.-...... -....++...|.+.|+.+..+ ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999998887889999975421110 111234567788888877543 345566654 4455678
Q ss_pred EEecCCCCCH
Q 018786 146 IMDLCAGGEL 155 (350)
Q Consensus 146 v~e~~~~~sL 155 (350)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.43 E-value=2.5e-07 Score=77.57 Aligned_cols=75 Identities=11% Similarity=0.122 Sum_probs=52.4
Q ss_pred eeeccC-ceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCC-CCeeEeEeEEEcCCceEEEEecCC
Q 018786 74 ELGRGQ-FGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVELKGAYEDRHSVNLIMDLCA 151 (350)
Q Consensus 74 ~lg~G~-~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~iv~~~~~~~~~~~~~iv~e~~~ 151 (350)
.+..|. .+.||+..... +..+++|...... ...+.+|...++.+..+ -.+++++.+..+.+..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-SCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeCC-CCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 444444 46799887643 6678999875432 23467788888877632 225677888888889999999998
Q ss_pred CCCH
Q 018786 152 GGEL 155 (350)
Q Consensus 152 ~~sL 155 (350)
|.++
T Consensus 90 G~~~ 93 (255)
T d1nd4a_ 90 GQDL 93 (255)
T ss_dssp SEET
T ss_pred cccc
Confidence 8665
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.87 E-value=2.2e-05 Score=70.00 Aligned_cols=77 Identities=10% Similarity=0.116 Sum_probs=53.3
Q ss_pred eeeeeeeccCceEEEEEEEcc-------CCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEEEcCCc
Q 018786 70 IFGRELGRGQFGVTYLVTHKD-------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (350)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 142 (350)
.-++.|+.|-...+|++.... ..+.|+++++-.. .......+|..+++.+..+.-.+++++++.+
T Consensus 45 l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--- 116 (395)
T d1nw1a_ 45 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG--- 116 (395)
T ss_dssp EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred eEEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence 345789999999999998753 2456788876421 1223456899999988755555678877643
Q ss_pred eEEEEecCCCCCH
Q 018786 143 VNLIMDLCAGGEL 155 (350)
Q Consensus 143 ~~iv~e~~~~~sL 155 (350)
.+|+||++|.++
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 588999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.44 E-value=0.00027 Score=60.88 Aligned_cols=68 Identities=12% Similarity=0.142 Sum_probs=44.9
Q ss_pred ceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCee--EeE-----eEEEcCCceEEEEecCCC
Q 018786 80 FGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV--ELK-----GAYEDRHSVNLIMDLCAG 152 (350)
Q Consensus 80 ~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv--~~~-----~~~~~~~~~~iv~e~~~~ 152 (350)
...||++...+ |..|++|+..... ...+.+..|...+..|. ..++. ... ..+..++..+.++++..|
T Consensus 35 EN~vy~v~~~d-g~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~-~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQDED-RRRFVVKFYRPER----WTADQILEEHQFALQLV-NDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECCTT-CCCEEEEEECTTT----SCHHHHHHHHHHHHHHH-HTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEcCC-CCEEEEEEeCCCC----CCHHHHHHHHHHHHHHH-hcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 46899998754 7889999985432 13466888998888876 22222 111 123456778899999876
Q ss_pred C
Q 018786 153 G 153 (350)
Q Consensus 153 ~ 153 (350)
.
T Consensus 109 ~ 109 (325)
T d1zyla1 109 R 109 (325)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.89 E-value=0.001 Score=56.68 Aligned_cols=31 Identities=32% Similarity=0.435 Sum_probs=25.5
Q ss_pred cCCEeecCCCCceEeecCCCCCCeEEeecCCccc
Q 018786 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (350)
Q Consensus 187 ~~ivH~Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 220 (350)
.|+||+|+.++||+++ ++...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFL---GDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcc---cccceeEeccccccc
Confidence 4799999999999995 444468999998765
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=85.95 E-value=2.5 Score=34.64 Aligned_cols=138 Identities=11% Similarity=0.101 Sum_probs=75.0
Q ss_pred cceeeeeeeeccCceEEEEEEEccCCcEEEEEEecccccCChhhHHHHHHHHHHHHHccCCCCeeEeEeEE---------
Q 018786 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY--------- 137 (350)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~--------- 137 (350)
..++.++.=..|+.|+.|.- .+ +..++||.-. ....+.+-.++...-.+. .|...-+.-.-
T Consensus 69 ~~~K~i~~s~~Gs~Gv~FV~--~e-~gaiVlK~s~------tta~E~y~~eLAr~LGvp-vPqmRvI~~~~~E~~~~~~~ 138 (342)
T d1cjaa_ 69 QQFKGIERSEKGTEGLFFVE--TE-SGVFIVKRST------NIESETFCSLLCMRLGLH-APKVRVVSSNSEEGTNMLEC 138 (342)
T ss_dssp GGEEEEEECCSTTSCEEEEE--ES-SCEEEEECCT------THHHHHHHHHHHHHHTCC-CCCEEEEESSSHHHHHHHHH
T ss_pred HhhhceEEeecCCceEEEEE--cC-CceEEEecCC------chHHHHHHHHHHHHhCCC-CCceEEecCCCHHHHHHHHH
Confidence 45555565567777776652 22 3357788632 234466777777666666 67665543100
Q ss_pred -------------EcCCceEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc----CCEeecC-CCC
Q 018786 138 -------------EDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSM----GVMHRDL-KPE 197 (350)
Q Consensus 138 -------------~~~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~----~ivH~Dl-kp~ 197 (350)
.......++|||.+|.+|.+.-... ..+....+..+.+ +-+++.+-.+ .+.+|+- ++.
T Consensus 139 ~l~~~e~d~~I~sel~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~LGk--IiaFDifInN~DR~PL~Wrn~GN~~ 216 (342)
T d1cjaa_ 139 LAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLGS--LMALDVIVNNSDRLPIAWTNEGNLD 216 (342)
T ss_dssp HHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHHH--HHHHHHHHTCCSSSCSSSCSCCCGG
T ss_pred HhcCCChhHHHHHHHhcccceeeeccCCccccccccccchhhhcHHHHHHhhh--HHHHHHHHcCCccccccccCCCCcc
Confidence 1234578999999988775422100 1123333222211 2233333322 3555532 899
Q ss_pred ceEeecCCCCCCeEEeecCCc
Q 018786 198 NFLFSSSAEDSPLKATDFGLS 218 (350)
Q Consensus 198 NIl~~~~~~~~~vkl~Dfg~a 218 (350)
||++..+ +..+..+|=+..
T Consensus 217 Niml~~n--~~~~~~IDs~i~ 235 (342)
T d1cjaa_ 217 NIMLSER--GATVVPIDSKII 235 (342)
T ss_dssp GEEEESB--TTCEEECSCCCC
T ss_pred ceEEecC--CcEEEEecCCcc
Confidence 9999743 335888885554
|